{"dz":["nasopharyngeal-carcinoma","oesophageal-squamous-cell-carcinoma","hepatocellular-carcinoma","stomach-cancer","lung-cancer","pancreatic-cancer","breast-cancer","glioma","hepatoblastoma","retinoblastoma","chordoma","osteosarcoma","gastrointestinal-stromal-tumor","neuroblastoma","ewing-sarcoma","multiple-myeloma","b-cell-acute-lymphoblastic-leukaemia-b-all","aplastic-anaemia","haemophagocytic-lymphohistiocytosis-hlh","lymphoma","beta-thalassemia","hemophilia-a","atypical-hemolytic-uremic-syndrome","thrombotic-thrombocytopenic-purpura","fanconi-anemia","neuromyelitis-optica-spectrum-disorder","igg4-related-disease","myasthenia-gravis","moyamoya-disease","wilson-disease","biliary-atresia","coronary-heart-disease","congenital-heart-disease","scoliosis","anti-nmda-receptor-encephalitis","takayasu-arteritis","hepatic-echinococcosis","idiopathic-pulmonary-fibrosis","lymphangioleiomyomatosis","amyotrophic-lateral-sclerosis","spinal-muscular-atrophy","fabry-disease","pompe-disease","duchenne-muscular-dystrophy","behcet-syndrome","alport-syndrome","iga-nephropathy","gaucher-disease","niemann-pick-disease-type-c","osteogenesis-imperfecta","primary-biliary-cholangitis","primary-sclerosing-cholangitis","congenital-diaphragmatic-hernia","hirschsprung-disease","epidermolysis-bullosa","hereditary-angioedema","familial-adenomatous-polyposis","leber-hereditary-optic-neuropathy","majeed-syndrome","ngly1-deficiency","isg15-deficiency"],"h":[["zhujiang-hospital","Zhujiang Hospital"],["guangzhou-women-and-children-s-medical-center","Guangzhou Women and Children's Medical Center"],["chongqing-university-cancer-hospital","Chongqing University Cancer Hospital"],["beijing-gobroad-hospital","Beijing GoBroad Hospital"],["affiliated-huizhou-hospital-of-guangzhou-medical-university","Affiliated Huizhou Hospital of Guangzhou Medical University"],["first-affiliated-hospital-of-soochow-university","First Affiliated Hospital of Soochow University"],["zhongshan-hospital-fudan-university","Zhongshan Hospital, Fudan University"],["hainan-general-hospital-hainan-medical-university-hospitals","Hainan General Hospital / Hainan Medical University hospitals"],["first-affiliated-hospital-of-xiamen-university","First Affiliated Hospital of Xiamen University"],["fudan-university-shanghai-cancer-center","Fudan University Shanghai Cancer Center"],["second-xiangya-hospital","Second Xiangya Hospital"],["xiangya-hospital","Xiangya Hospital"],["union-hospital-wuhan","Union Hospital"],["hunan-cancer-hospital","Hunan Cancer Hospital"],["first-affiliated-hospital-of-nanchang-university","First Affiliated Hospital of Nanchang University"],["first-affiliated-hospital-of-guangxi-medical-university","First Affiliated Hospital of Guangxi Medical University"],["renmin-hospital-of-wuhan-university","Renmin Hospital of Wuhan University"],["daping-hospital-army-medical-university","Daping Hospital, Army Medical University"],["liaoning-cancer-hospital-institute-cancer-hospital-of-china-medical-university","Liaoning Cancer Hospital & Institute"],["hubei-cancer-hospital","Hubei Cancer Hospital"],["third-xiangya-hospital","Third Xiangya Hospital"],["first-affiliated-hospital-of-xinxiang-medical-university","First Affiliated Hospital of Xinxiang Medical University"],["shanxi-bethune-hospital-taiyuan","Shanxi Bethune Hospital"],["national-cancer-center-cancer-hospital-cams","National Cancer Center / Cancer Hospital, CAMS"],["fourth-hospital-of-hebei-medical-university-hebei-cancer-hospital","Fourth Hospital of Hebei Medical University"],["first-affiliated-hospital-of-zhengzhou-university","First Affiliated Hospital of Zhengzhou University"],["chinese-pla-general-hospital","Chinese PLA General Hospital"],["first-hospital-of-jilin-university","First Hospital of Jilin University"],["yantai-yuhuangding-hospital","Yantai Yuhuangding Hospital"],["peking-university-first-hospital","Peking University First Hospital"],["fujian-cancer-hospital","Fujian Cancer Hospital"],["second-affiliated-hospital-of-anhui-medical-university","Second Affiliated Hospital of Anhui Medical University"],["the-university-of-hong-kong-shenzhen-hospital","The University of Hong Kong–Shenzhen Hospital"],["affiliated-hospital-of-liaoning-university-of-traditional-chinese-medicine","Affiliated Hospital of Liaoning University of Traditional Chinese Medicine"],["first-affiliated-hospital-of-henan-university-of-chinese-medicine","First Affiliated Hospital of Henan University of Chinese Medicine"],["xiyuan-hospital-beijing","Xiyuan Hospital"],["tongji-hospital-wuhan","Tongji Hospital"],["henan-cancer-hospital","Henan Cancer Hospital"],["peking-union-medical-college-hospital-pumch","Peking Union Medical College Hospital"],["beijing-friendship-hospital","Beijing Friendship Hospital"],["west-china-hospital","West China Hospital"],["renji-hospital","Renji Hospital"],["shanghai-chest-hospital","Shanghai Chest Hospital"],["guangdong-provincial-people-s-hospital","Guangdong Provincial People's Hospital"],["zhejiang-cancer-hospital","Zhejiang Cancer Hospital"],["harbin-medical-university-cancer-hospital","Harbin Medical University Cancer Hospital"],["first-affiliated-hospital-zhejiang-university","First Affiliated Hospital, Zhejiang University"],["sichuan-cancer-hospital","Sichuan Cancer Hospital"],["peking-university-people-s-hospital","Peking University People's Hospital"],["first-affiliated-hospital-of-sun-yat-sen-university","First Affiliated Hospital of Sun Yat-sen University"],["guangxi-medical-university-cancer-hospital","Guangxi Medical University Cancer Hospital"],["linyi-cancer-hospital-2","LinYi Cancer Hospital"],["first-affiliated-hospital-of-jinan-university","First Affiliated Hospital of Jinan University"],["sun-yat-sen-university-cancer-center-sysucc","Sun Yat-sen University Cancer Center"],["second-affiliated-hospital-zhejiang-university","Second Affiliated Hospital, Zhejiang University"],["affiliated-hospital-of-qingdao-university","Affiliated Hospital of Qingdao University"],["shanghai-pulmonary-hospital","Shanghai Pulmonary Hospital"],["shandong-cancer-hospital-and-institute","Shandong Cancer Hospital and Institute"],["tianjin-medical-university-cancer-institute-hospital","Tianjin Medical University Cancer Institute & Hospital"],["tianjin-medical-university-general-hospital","Tianjin Medical University General Hospital"],["nanjing-drum-tower-hospital","Nanjing Drum Tower Hospital"],["beijing-chest-hospital","Beijing Chest Hospital"],["china-japan-friendship-hospital","China-Japan Friendship Hospital"],["northern-jiangsu-people-s-hospital","Northern Jiangsu People's Hospital"],["affiliated-hospital-of-xuzhou-medical-university","Affiliated Hospital of Xuzhou Medical University"],["shanghai-east-hospital-tongji-university","Shanghai East Hospital, Tongji University"],["taizhou-hospital-wenzhou-medical-university","Taizhou Hospital, Wenzhou Medical University"],["linyi-cancer-hospital","Linyi Cancer Hospital"],["first-affiliated-hospital-of-ustc-anhui-provincial-hospital","First Affiliated Hospital of USTC"],["institute-of-hematology-blood-diseases-hospital-cams-pumc","Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC"],["nanfang-hospital","Nanfang Hospital"],["xuanwu-hospital","Xuanwu Hospital"],["affiliated-cancer-hospital-of-xinjiang-medical-university","Affiliated Cancer Hospital of Xinjiang Medical University"],["gansu-provincial-cancer-hospital-lanzhou","Gansu Provincial Cancer Hospital"],["peking-university-cancer-hospital","Peking University Cancer Hospital"],["sixth-affiliated-hospital-of-sun-yat-sen-university","Sixth Affiliated Hospital of Sun Yat-sen University"],["children-s-hospital-of-fudan-university","Children's Hospital of Fudan University"],["third-affiliated-hospital-of-zhengzhou-university","Third Affiliated Hospital of Zhengzhou University"],["jiangsu-province-hospital-first-affiliated-hospital-of-nanjing-medical-universit","Jiangsu Province Hospital"],["first-affiliated-hospital-of-chongqing-medical-university","First Affiliated Hospital of Chongqing Medical University"],["second-affiliated-hospital-of-nanchang-university","Second Affiliated Hospital of Nanchang University"],["first-affiliated-hospital-of-wenzhou-medical-university","First Affiliated Hospital of Wenzhou Medical University"],["sir-run-run-shaw-hospital","Sir Run Run Shaw Hospital"],["central-hospital-affiliated-to-shandong-first-medical-university-jinan-central-h","Central Hospital Affiliated to Shandong First Medical University"],["shanxi-cancer-hospital-taiyuan","Shanxi Cancer Hospital"],["jiangmen-central-hospital","Jiangmen Central Hospital"],["xiangyang-central-hospital","Xiangyang Central Hospital"],["first-affiliated-hospital-of-henan-university-of-science-and-technology","First Affiliated Hospital of Henan University of Science and Technology"],["anhui-provincial-cancer-hospital-hefei","Anhui Provincial Cancer Hospital"],["beijing-chao-yang-hospital","Beijing Chao-Yang Hospital"],["xinhua-hospital","Xinhua Hospital"],["shanghai-children-s-medical-center","Shanghai Children's Medical Center"],["henan-provincial-people-s-hospital","Henan Provincial People's Hospital"],["jinling-hospital","Jinling Hospital"],["beijing-hospital","Beijing Hospital"],["affiliated-cancer-hospital-of-guangzhou-medical-university","Affiliated Cancer Hospital of Guangzhou Medical University"],["people-s-hospital-of-guangxi-zhuang-autonomous-region","People's Hospital of Guangxi Zhuang Autonomous Region"],["second-affiliated-hospital-of-xi-an-jiaotong-university","Second Affiliated Hospital of Xi'an Jiaotong University"],["sichuan-provincial-people-s-hospital","Sichuan Provincial People's Hospital"],["sun-yat-sen-memorial-hospital","Sun Yat-sen Memorial Hospital"],["beijing-tsinghua-changgung-hospital","Beijing Tsinghua Changgung Hospital"],["xuzhou-central-hospital","Xuzhou Central Hospital"],["beijing-tiantan-hospital","Beijing Tiantan Hospital"],["huashan-hospital","Huashan Hospital"],["shenzhen-second-people-s-hospital","Shenzhen Second People's Hospital"],["nanjing-tianyinshan-hospital","Nanjing Tianyinshan Hospital"],["cancer-hospital-cams-shenzhen","Cancer Hospital CAMS – Shenzhen"],["guangdong-provincial-hospital-of-chinese-medicine","Guangdong Provincial Hospital of Chinese Medicine"],["first-affiliated-hospital-of-guangzhou-university-of-chinese-medicine","First Affiliated Hospital of Guangzhou University of Chinese Medicine"],["beijing-anzhen-hospital","Beijing Anzhen Hospital"],["affiliated-hospital-of-nantong-university","Affiliated Hospital of Nantong University"],["first-affiliated-hospital-of-xi-an-jiaotong-university","First Affiliated Hospital of Xi'an Jiaotong University"],["first-affiliated-hospital-of-anhui-medical-university","First Affiliated Hospital of Anhui Medical University"],["shandong-provincial-hospital","Shandong Provincial Hospital"],["weifang-people-s-hospital","Weifang People's Hospital"],["peking-university-third-hospital","Peking University Third Hospital"],["jiangxi-cancer-hospital","Jiangxi Cancer Hospital"],["guizhou-provincial-people-s-hospital-guiyang","Guizhou Provincial People's Hospital"],["first-hospital-of-china-medical-university","First Hospital of China Medical University"],["nanjing-first-hospital","Nanjing First Hospital"],["zhongda-hospital-southeast-university","Zhongda Hospital, Southeast University"],["shanghai-general-hospital","Shanghai General Hospital"],["tangdu-hospital","Tangdu Hospital"],["ruijin-hospital","Ruijin Hospital"],["qilu-hospital-of-shandong-university","Qilu Hospital of Shandong University"],["shantou-university-medical-college-hospitals","Shantou University Medical College hospitals"],["peking-university-shenzhen-hospital","Peking University Shenzhen Hospital"],["jiangsu-cancer-hospital","Jiangsu Cancer Hospital"],["shenyang-northern-hospital","Shenyang Northern Hospital"],["affiliated-hospital-of-guangdong-medical-university","Affiliated Hospital of Guangdong Medical University"],["dongguan-people-s-hospital","Dongguan People's Hospital"],["xijing-hospital","Xijing Hospital"],["first-affiliated-hospital-of-guangzhou-medical-university","First Affiliated Hospital of Guangzhou Medical University"],["zhongnan-hospital-of-wuhan-university","Zhongnan Hospital of Wuhan University"],["zhongshan-city-people-s-hospital","Zhongshan City People's Hospital"],["yunnan-cancer-hospital","Yunnan Cancer Hospital"],["first-affiliated-hospital-of-fujian-medical-university","First Affiliated Hospital of Fujian Medical University"],["affiliated-hospital-of-guizhou-medical-university","Affiliated Hospital of Guizhou Medical University"],["jilin-cancer-hospital-changchun","Jilin Cancer Hospital"],["huadong-hospital-fudan-university","Huadong Hospital, Fudan University"],["fujian-medical-university-union-hospital","Fujian Medical University Union Hospital"],["gansu-provincial-hospital","Gansu Provincial Hospital"],["first-hospital-of-lanzhou-university","First Hospital of Lanzhou University"],["shengjing-hospital-of-china-medical-university","Shengjing Hospital of China Medical University"],["shaanxi-provincial-people-s-hospital","Shaanxi Provincial People's Hospital"],["third-affiliated-hospital-of-soochow-university","Third Affiliated Hospital of Soochow University"],["affiliated-hospital-of-north-sichuan-medical-college","Affiliated Hospital of North Sichuan Medical College"],["china-japan-union-hospital-jilin-university","China-Japan Union Hospital, Jilin University"],["fujian-provincial-hospital","Fujian Provincial Hospital"],["affiliated-hospital-of-chengde-medical-university","Affiliated Hospital of Chengde Medical University"],["anyang-tumor-hospital-fourth-affiliated-hospital-of-henan-university-of-science-","Anyang Tumor Hospital"],["qingdao-municipal-hospital","Qingdao Municipal Hospital"],["linyi-people-s-hospital","Linyi People's Hospital"],["beijing-ditan-hospital-capital-medical-university","Beijing Ditan Hospital, Capital Medical University"],["guangzhou-eighth-people-s-hospital","Guangzhou Eighth People's Hospital"],["second-hospital-of-dalian-medical-university","Second Hospital of Dalian Medical University"],["second-hospital-of-jilin-university","Second Hospital of Jilin University"],["zhanjiang-central-hospital","Zhanjiang Central Hospital"],["second-affiliated-hospital-of-wannan-medical-college","Second Affiliated Hospital of Wannan Medical College"],["huangshan-city-people-s-hospital","Huangshan City People's Hospital"],["shantou-central-hospital","Shantou Central Hospital"],["beijing-tongren-hospital","Beijing Tongren Hospital"],["tongji-hospital-shanghai","Tongji Hospital"],["quanzhou-first-hospital-fujian-medical-university","Quanzhou First Hospital, Fujian Medical University"],["first-affiliated-hospital-of-bengbu-medical-university","First Affiliated Hospital of Bengbu Medical University"],["hainan-cancer-hospital","Hainan Cancer Hospital"],["second-affiliated-hospital-of-chongqing-medical-university","Second Affiliated Hospital of Chongqing Medical University"],["xinqiao-hospital-army-medical-university","Xinqiao Hospital, Army Medical University"],["shenzhen-people-s-hospital","Shenzhen People's Hospital"],["tianjin-chest-hospital","Tianjin Chest Hospital"],["affiliated-hospital-of-guilin-medical-university","Affiliated Hospital of Guilin Medical University"],["fifth-affiliated-hospital-of-sun-yat-sen-university","Fifth Affiliated Hospital of Sun Yat-sen University"],["general-hospital-of-ningxia-medical-university","General Hospital of Ningxia Medical University"],["cangzhou-central-hospital","Cangzhou Central Hospital"],["binzhou-medical-university-hospital","Binzhou Medical University Hospital"],["affiliated-hospital-of-hebei-university","Affiliated Hospital of Hebei University"],["first-hospital-of-shanxi-medical-university","First Hospital of Shanxi Medical University"],["changhai-hospital","Changhai Hospital"],["chongqing-university-three-gorges-hospital","Chongqing University Three Gorges Hospital"],["children-s-hospital-zhejiang-university-school-of-medicine","Children's Hospital, Zhejiang University School of Medicine"],["affiliated-hospital-of-jiangnan-university","Affiliated Hospital of Jiangnan University"],["beijing-youan-hospital-capital-medical-university","Beijing Youan Hospital, Capital Medical University"],["first-affiliated-hospital-of-ningbo-university","First Affiliated Hospital of Ningbo University"],["zhejiang-provincial-people-s-hospital","Zhejiang Provincial People's Hospital"],["second-hospital-of-shanxi-medical-university","Second Hospital of Shanxi Medical University"],["hangzhou-first-people-s-hospital","Hangzhou First People's Hospital"],["second-hospital-of-hebei-medical-university","Second Hospital of Hebei Medical University"],["second-affiliated-hospital-of-soochow-university","Second Affiliated Hospital of Soochow University"],["second-affiliated-hospital-and-yuying-children-s-hospital-of-wenzhou-medical-uni","Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University"],["guangzhou-first-people-s-hospital","Guangzhou First People's Hospital"],["mengchao-hepatobiliary-hospital-of-fujian-medical-university","Mengchao Hepatobiliary Hospital of Fujian Medical University"],["first-teaching-hospital-tianjin-university-of-traditional-chinese-medicine","First Teaching Hospital, Tianjin University of Traditional Chinese Medicine"],["affiliated-hospital-of-qinghai-university","Affiliated Hospital of Qinghai University"],["southwest-hospital-army-medical-university","Southwest Hospital, Army Medical University"],["second-hospital-of-tianjin-medical-university","Second Hospital of Tianjin Medical University"],["lanzhou-university-second-hospital","Lanzhou University Second Hospital"],["first-affiliated-hospital-of-harbin-medical-university","First Affiliated Hospital of Harbin Medical University"],["beijing-luhe-hospital","Beijing Luhe Hospital"],["first-people-s-hospital-of-foshan","First People's Hospital of Foshan"],["cancer-hospital-shandong-first-medical-university","Cancer Hospital, Shandong First Medical University"],["zhengzhou-second-hospital","Zhengzhou Second Hospital"],["first-affiliated-hospital-of-kunming-medical-university","First Affiliated Hospital of Kunming Medical University"],["shanghai-sixth-people-s-hospital","Shanghai Sixth People's Hospital"],["children-s-hospital-of-soochow-university","Children's Hospital of Soochow University"],["second-affiliated-hospital-of-zunyi-medical-university","Second Affiliated Hospital of Zunyi Medical University"],["affiliated-hospital-of-inner-mongolia-medical-university","Affiliated Hospital of Inner Mongolia Medical University"],["second-affiliated-hospital-of-harbin-medical-university","Second Affiliated Hospital of Harbin Medical University"],["first-affiliated-hospital-of-xinjiang-medical-university","First Affiliated Hospital of Xinjiang Medical University"],["liaocheng-people-s-hospital","Liaocheng People's Hospital"],["third-affiliated-hospital-of-sun-yat-sen-university","Third Affiliated Hospital of Sun Yat-sen University"],["first-affiliated-hospital-of-dalian-medical-university","First Affiliated Hospital of Dalian Medical University"],["affiliated-wuxi-people-s-hospital-of-nanjing-medical-university","Affiliated Wuxi People's Hospital of Nanjing Medical University"],["changzheng-hospital","Changzheng Hospital"],["fuwai-hospital","Fuwai Hospital"],["yichang-central-people-s-hospital","Yichang Central People's Hospital"],["ningbo-medical-center-lihuili-hospital","Ningbo Medical Center Lihuili Hospital"],["jiangxi-provincial-people-s-hospital","Jiangxi Provincial People's Hospital"],["affiliated-hospital-of-kunming-university-of-science-and-technology","Affiliated Hospital of Kunming University of Science and Technology"],["second-affiliated-hospital-of-xiamen-medical-college","Second Affiliated Hospital of Xiamen Medical College"],["nanyang-first-people-s-hospital","Nanyang First People's Hospital"],["first-affiliated-hospital-of-shandong-first-medical-university","First Affiliated Hospital of Shandong First Medical University"],["third-hospital-of-hebei-medical-university","Third Hospital of Hebei Medical University"],["anhui-chest-hospital-hefei","Anhui Chest Hospital"],["fujian-provencial-hospital-fuzhou","Fujian Provencial Hospital"],["first-affiliated-hospital-of-xi-an-medical-college","First Affiliated Hospital of Xi'an Medical College"],["yuncheng-central-hospital","Yuncheng Central Hospital"],["meizhou-people-s-hospital","Meizhou People's Hospital"],["renmin-hospital","Renmin Hospital"],["second-affiliated-hospital-of-fujian-medical-university","Second Affiliated Hospital of Fujian Medical University"],["weihai-municipal-hospital","Weihai Municipal Hospital"],["changzhou-no-2-people-s-hospital","Changzhou No.2 People's Hospital"],["anhui-provincial-cancer-hospital","Anhui Provincial Cancer Hospital"],["child-health-hospital-chengdu","Child Health Hospital"],["tianjin-first-central-hospital","Tianjin First Central Hospital"],["affiliated-huai-an-hospital-of-xuzhou-medical-university","Affiliated Huai'an Hospital of Xuzhou Medical University"],["affiliated-yongchuan-hospital-of-chongqing-medical-university","Affiliated Yongchuan Hospital of Chongqing Medical University"],["eye-ent-hospital-of-fudan-university","Eye & ENT Hospital of Fudan University"],["army-hospital","Army Hospital"],["affiliated-hospital-of-southwest-medical-university","Affiliated Hospital of Southwest Medical University"],["nanchang-people-s-hospital","Nanchang People's Hospital"],["pu-er-people-s-hospital","Pu'er People's Hospital"],["sanbo-brain-hospital","Sanbo Brain Hospital"],["second-affiliated-hospital-of-nanjing-medical-university","Second Affiliated Hospital of Nanjing Medical University"],["zhongshan-hospital-xiamen-university","Zhongshan Hospital, Xiamen University"],["affiliated-hospital-of-jining-medical-university","Affiliated Hospital of Jining Medical University"],["affiliated-cancer-hospital-of-guizhou-medical-university","Affiliated Cancer Hospital of Guizhou Medical University"],["guangzhou-panyu-central-hospital","Guangzhou Panyu Central Hospital"],["xi-an-international-medical-center-hospital","Xi'an International Medical Center Hospital"],["third-affiliated-hospital-of-southern-medical-university","Third Affiliated Hospital of Southern Medical University"],["shenzhen-children-s-hospital","Shenzhen Children's Hospital"],["west-china-second-university-hospital","West China Second University Hospital"],["wuhan-children-s-hospital","Wuhan Children's Hospital"],["children-s-hospital-of-chongqing-medical-university","Children's Hospital of Chongqing Medical University"],["children-s-hospital-of-nanjing-medical-university","Children's Hospital of Nanjing Medical University"],["anhui-provincial-children-s-hospital","Anhui Provincial Children's Hospital"],["shanghai-children-s-hospital","Shanghai Children's Hospital"],["hunan-children-s-hospital","Hunan Children's Hospital"],["jiangxi-provincial-children-s-hospital-nanchang","Jiangxi Provincial Children's Hospital"],["northwest-women-s-hospital-xi-an","Northwest Women's Hospital"],["beidahuang-industry-group-general-hospital","Beidahuang Industry Group General Hospital"],["nantong-tumor-hospital","Nantong Tumor Hospital"],["first-affiliated-hospital-of-jinzhou-medical-university","First Affiliated Hospital of Jinzhou Medical University"],["third-affiliated-hospital-of-zhejiang-chinese-medical-university-2","Third Affiliated hospital of Zhejiang Chinese Medical University"],["third-affiliated-hospital-of-zhejiang-chinese-medical-university","Third Affiliated Hospital of Zhejiang Chinese Medical University"],["fuwai-central-china-cardiovascular-hospital-zhengzhou","Fuwai Central China Cardiovascular Hospital"],["first-affiliated-hospital-of-naval-medical-university","First Affiliated Hospital of Naval Medical University"],["gansu-wuwei-tumor-hospital","Gansu Wuwei Tumor Hospital"],["second-affiliated-hospital-of-kunming-medical-university","Second Affiliated Hospital of Kunming Medical University"],["technology-affiliated-hospital","Technology Affiliated Hospital"],["first-affiliated-hospital-of-guangdong-pharmaceutical-university","First Affiliated Hospital of Guangdong Pharmaceutical University"],["first-affiliated-hospital-of-gannan-medical-university","First Affiliated Hospital of Gannan Medical University"],["first-affiliated-hospital-of-wannan-medical-college","First Affiliated Hospital of Wannan Medical College"],["cancer-hospital-fudan-university","Cancer Hospital, Fudan University"],["affiliated-hospital-of-zunyi-medical-university","Affiliated Hospital of Zunyi Medical University"],["zhejiang-hospital-hangzhou","Zhejiang Hospital"],["first-affiliated-hospital-of-zhejiang-chinese-medical-university","First Affiliated Hospital of Zhejiang Chinese Medical University"],["nanjing-chest-hospital","Nanjing Chest Hospital"],["eastern-hepatobiliary-surgery-hospital-third-affiliated-hospital-of-naval-medica","Eastern Hepatobiliary Surgery Hospital"],["second-affiliated-hospital-of-guangzhou-medical-university","Second Affiliated Hospital of Guangzhou Medical University"],["qinghai-red-cross-hospital","Qinghai Red Cross Hospital"],["guang-anmen-hospital-beijing","Guang'anmen Hospital"],["tianjin-huanhu-hospital","Tianjin Huanhu Hospital"],["wuhan-asia-heart-hospital","Wuhan Asia Heart Hospital"],["first-affiliated-hospital-of-baotou-medical-college","First Affiliated Hospital of Baotou Medical College"],["beijing-children-s-hospital","Beijing Children's Hospital"],["affiliated-hospital-of-jiangsu-university","Affiliated Hospital of Jiangsu University"],["shanghai-fourth-people-s-hospital","Shanghai Fourth People's Hospital"],["fourth-hospital-of-sichuan-university","Fourth Hospital of Sichuan University"],["jiangsu-provincial-people-s-hospital-nanjing","Jiangsu Provincial People's Hospital"],["first-hospital-of-hebei-medical-university","First Hospital of Hebei Medical University"],["henan-provincial-chest-hospital-zhengzhou","Henan Provincial Chest Hospital"],["first-affiliated-hospital-university-of-south-china","First Affiliated Hospital, University of South China"],["tangshan-people-s-hospital","Tangshan People's Hospital"],["changzhi-people-s-hospital-changzhi-medical-college","Changzhi People's Hospital, Changzhi Medical College"],["sanbo-brain-hospital-capital-medical-university","Sanbo Brain Hospital, Capital Medical University"],["beijing-boren-hospital","Beijing Boren Hospital"],["shanghai-tenth-people-s-hospital","Shanghai Tenth People's Hospital"],["hebei-general-hospital","Hebei General Hospital"],["affiliated-hospital-of-shandong-university-of-traditional-chinese-medicine","Affiliated Hospital of Shandong University of Traditional Chinese Medicine"],["affiliated-hospital-of-changchun-university-of-chinese-medicine","Affiliated Hospital of Changchun University of Chinese Medicine"],["dongfang-hospital","Dongfang Hospital"],["first-affiliated-hospital-of-hebei-north-university","First Affiliated Hospital of Hebei North University"],["eighth-affiliated-hospital-of-sun-yat-sen-university","Eighth Affiliated Hospital of Sun Yat-sen University"],["huzhou-central-hospital","Huzhou Central Hospital"],["daqing-oilfield-general-hospital","Daqing Oilfield General Hospital"],["zhuhai-people-s-hospital","Zhuhai People's Hospital"],["beijing-shijitan-hospital","Beijing Shijitan Hospital"],["beijing-haidian-hospital","Beijing Haidian Hospital"],["yuebei-people-s-hospital","Yuebei People's Hospital"],["hangzhou-xixi-hospital","Hangzhou Xixi Hospital"],["taihe-hospital","Taihe Hospital"],["tianjin-third-central-hospital","Tianjin Third Central Hospital"],["shenzhen-third-people-s-hospital","Shenzhen Third People's Hospital"],["fourth-affiliated-hospital-of-harbin-medical-university","Fourth Affiliated Hospital of Harbin Medical University"],["xiamen-hospital","Xiamen Hospital"],["baoji-people-s-hospital","Baoji People's Hospital"],["shanghai-proton-and-heavy-ion-center","Shanghai Proton and Heavy Ion Center"],["wuzhou-red-cross-hospital","Wuzhou Red Cross Hospital"],["fu-wai-hospital-beijing","Fu Wai Hospital"],["qingdao-central-hospital","Qingdao Central Hospital"],["fifth-affiliated-hospital-of-guangzhou-medical-university","Fifth Affiliated Hospital of Guangzhou Medical University"],["central-china-fuwai-hospital-zhengzhou","Central China Fuwai Hospital"],["qingdao-women-and-children-s-hospital","Qingdao Women and Children's Hospital"],["affiliated-people-s-hospital-of-ningbo-university","Affiliated People's Hospital of Ningbo University"],["teda-international-cardiovascular-hospital-tianjin","TEDA International Cardiovascular Hospital"],["kaifeng-central-hospital","Kaifeng Central Hospital"],["shenzhen-university-general-hospital","Shenzhen University General Hospital"],["yishui-central-hospital-linyi","Yishui Central Hospital"],["affiliated-hospital-of-central-south-university","Affiliated Hospital of Central South University"],["liuzhou-people-s-hospital","Liuzhou People's Hospital"],["jilin-heart-hospital-changchun","Jilin Heart Hospital"],["affiliated-hospital-of-northwest-university","Affiliated Hospital of Northwest University"],["shanghai-ninth-people-s-hospital","Shanghai Ninth People's Hospital"],["harbin-medical-university-hospital","Harbin Medical University Hospital"],["shanghai-xuhui-central-hospital","Shanghai Xuhui Central Hospital"],["ganzhou-cancer-hospital","Ganzhou Cancer Hospital"],["second-affiliated-hospital-of-shandong-first-medical-university","Second Affiliated Hospital of Shandong First Medical University"],["third-people-s-hospital-guangzhou-medical-university","Third People's Hospital, Guangzhou Medical University"],["peking-university-shougang-hospital-beijing","Peking University Shougang Hospital"],["chongqing-general-hospital","Chongqing General Hospital"],["huai-an-first-people-s-hospital","Huai'an First People's Hospital"],["900th-hospital-of-the-pla-joint-logistics-support-force","900th Hospital of the PLA Joint Logistics Support Force"],["fourth-affiliated-hospital-of-guangxi-medical-university","Fourth Affiliated Hospital of Guangxi Medical University"],["fourth-affiliated-hospital-of-zhejiang-university","Fourth Affiliated Hospital of Zhejiang University"],["shijiazhuang-people-s-hospital","Shijiazhuang People's Hospital"],["nanchong-central-hospital","Nanchong Central Hospital"],["tongde-hospital-hangzhou","Tongde Hospital"],["shaoxing-people-s-hospital","Shaoxing People's Hospital"],["kunming-children-s-hospital","Kunming Children's Hospital"],["beijing-jishuitan-hospital","Beijing Jishuitan Hospital"],["second-affiliated-hospital-of-jiaxing-university","Second Affiliated Hospital of Jiaxing University"],["hangzhou-cancer-hospital","Hangzhou Cancer Hospital"],["zibo-central-hospital","Zibo Central Hospital"],["east-hospital-shanghai","East Hospital"],["dongguan-taixin-hospital","Dongguan Taixin Hospital"],["zibo-municipal-hospital","Zibo Municipal Hospital"],["second-hospital-of-shandong-university","Second Hospital of Shandong University"],["affiliated-hospital-of-putian-university","Affiliated Hospital of Putian University"],["xian-central-hospital","Xian Central Hospital"],["zhengzhou-people-s-hospital","Zhengzhou People's Hospital"],["cancer-hospital-chinese-academy-of-medical-sciences-and-peking-union-medical-col","Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College"],["gynecology-hospital-fudan-university","Gynecology Hospital, Fudan University"],["yan-an-university-affiliated-hospital","Yan'an University Affiliated Hospital"],["hunan-provincial-people-s-hospital-first-affiliated-hospital-of-hunan-normal-uni","Hunan Provincial People's Hospital"],["fourth-affiliated-hospital-of-soochow-university","Fourth Affiliated Hospital of Soochow University"],["first-affiliated-hospital-of-fujan-medical-university","First Affiliated Hospital of Fujan Medical University"],["taizhou-hospital","Taizhou Hospital"],["dapping-hospital-chongqing","Dapping Hospital"],["guangdong-second-provincial-general-hospital","Guangdong Second Provincial General Hospital"],["zhongshan-ophthalmic-center","Zhongshan Ophthalmic Center"],["anhui-chest-hospital","Anhui Chest Hospital"],["mianyang-central-hospital","Mianyang Central Hospital"],["affiliated-jinhua-hospital-of-zhejiang-university","Affiliated Jinhua Hospital of Zhejiang University"],["affiliated-taizhou-people-s-hospital-of-nanjing-medical-university","Affiliated Taizhou People's Hospital of Nanjing Medical University"],["hebei-yanda-lu-daopei-hospital","Hebei Yanda Lu Daopei Hospital"],["nanxishan-hospital-guilin","Nanxishan Hospital"],["affiliated-hospital-of-youjiang-medical-university","Affiliated Hospital of Youjiang Medical University"],["longhua-hospital","Longhua Hospital"],["dongzhimen-hospital","Dongzhimen Hospital"],["fujian-union-medical-college-hospital-fuzhou","Fujian Union Medical College Hospital"],["university-hospital","University Hospital"],["hunan-provincal-tumor-hospital-changsha","Hunan Provincal Tumor Hospital"],["chifeng-tumor-hospital","Chifeng Tumor Hospital"],["third-affiliated-hospital-of-harbin-medical-university","Third Affiliated Hospital of Harbin Medical University"],["xiang-an-hospital-xiamen-university","Xiang'an Hospital, Xiamen University"],["beijing-an-hospital","Beijing An Hospital"],["zhuzhou-hospital-xiangya-medical-college","Zhuzhou Hospital, Xiangya Medical College"],["shanxi-cardiovascular-hospital-taiyuan","Shanxi Cardiovascular Hospital"],["affiliated-zhongshan-hospital-of-dalian-university","Affiliated Zhongshan Hospital of Dalian University"],["qinghai-provincial-women-and-children-s-hospital","Qinghai Provincial Women and Children's Hospital"],["affiliated-hospital-of-jiaxing-university","Affiliated Hospital of Jiaxing University"],["zhejiang-hospital","Zhejiang Hospital"],["affiliated-hospital-of-hangzhou-normal-university","Affiliated Hospital of Hangzhou Normal University"],["guiping-people-s-hospital","Guiping People's Hospital"],["inner-mongolia-baogang-hospital","Inner Mongolia Baogang Hospital"],["nanchang-university-affiliated-rehabilitation-hospital","Nanchang University Affiliated Rehabilitation Hospital"],["shanxi-provincial-people-s-hospital-taiyuan","Shanxi Provincial People's Hospital"],["hushan-hospital","Hushan Hospital"],["second-affiliated-hospital-of-zhengzhou-university","Second Affiliated Hospital of Zhengzhou University"],["fuwai-yunnan-cardiovascular-hospital-kunming","Fuwai Yunnan Cardiovascular Hospital"],["wenzhou-central-hospital","Wenzhou Central Hospital"]],"c":[["guangzhou","Guangzhou"],["chongqing","Chongqing"],["beijing","Beijing"],["huizhou","Huizhou"],["suzhou","Suzhou"],["shanghai","Shanghai"],["haikou","Haikou"],["xiamen","Xiamen"],["changsha","Changsha"],["nanchang","Nanchang"],["nanning","Nanning"],["shenyang","Shenyang"],["taiyuan","Taiyuan"],["wuhan","Wuhan"],["xinxiang","Xinxiang"],["changchun","Changchun"],["fuzhou","Fuzhou"],["hefei","Hefei"],["shijiazhuang","Shijiazhuang"],["yantai","Yantai"],["zhengzhou","Zhengzhou"],["shenzhen","Shenzhen"],["chengdu","Chengdu"],["hangzhou","Hangzhou"],["harbin","Harbin"],["linyi","Linyi"],["qingdao","Qingdao"],["jinan","Jinan"],["nanjing","Nanjing"],["taizhou","Taizhou"],["tianjin","Tianjin"],["xuzhou","Xuzhou"],["yangzhou","Yangzhou"],["lanzhou","Lanzhou"],["urumqi","Urumqi"],["jiangmen","Jiangmen"],["luoyang","Luoyang"],["wenzhou","Wenzhou"],["xiangyang","Xiangyang"],["xi-an","Xi'an"],["nantong","Nantong"],["guiyang","Guiyang"],["weifang","Weifang"],["shantou","Shantou"],["dongguan","Dongguan"],["zhanjiang","Zhanjiang"],["zhongshan","Zhongshan"],["kunming","Kunming"],["anyang","Anyang"],["changzhou","Changzhou"],["chengde","Chengde"],["nanchong","Nanchong"],["dalian","Dalian"],["huangshan-city","Huangshan City"],["wuhu","Wuhu"],["bengbu","Bengbu"],["quanzhou","Quanzhou"],["guilin","Guilin"],["yinchuan","Yinchuan"],["zhuhai","Zhuhai"],["wuxi","Wuxi"],["ningbo","Ningbo"],["xining","Xining"],["foshan","Foshan"],["zunyi","Zunyi"],["hohhot","Hohhot"],["liaocheng","Liaocheng"],["nanyang","Nanyang"],["yichang","Yichang"],["yuncheng","Yuncheng"],["meizhou","Meizhou"],["shiyan","Shiyan"],["weihai","Weihai"],["luzhou","Luzhou"],["pu-er","Pu'er"],["jining","Jining"],["wuwei","Wuwei"],["tangshan","Tangshan"],["ganzhou","Ganzhou"],["baotou","Baotou"],["hengyang","Hengyang"],["changzhi","Changzhi"],["daqing","Daqing"],["huzhou","Huzhou"],["zhangjiakou","Zhangjiakou"],["shaoguan","Shaoguan"],["baoji","Baoji"],["wuzhou","Wuzhou"],["liuzhou","Liuzhou"],["huai-an","Huai'an"],["jiaxing","Jiaxing"],["zibo","Zibo"],["putian","Putian"],["yan-an","Yan'an"],["mianyang","Mianyang"],["jinhua","Jinhua"],["taizhou-js","Taizhou (Jiangsu)"],["langfang","Langfang"],["chifeng","Chifeng"],["zhuzhou","Zhuzhou"],["guigang","Guigang"]],"t":[{"n":"NCT06902012","t":"Safety and Efficacy of Early Second Infusion of Axi-cel Based on ctDNA for R/R Large B - Cell Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[0],"l":[[0,"lymph"]],"po":"2025-03-30","u":"2025-03-30","st":"2027-02","ag":"18 and over"},{"n":"NCT05199688","t":"A Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)","s":"rec","p":"phase3","d":[25],"c":[0],"a":"child","h":[1],"po":"2022-01-20","u":"2026-10-01","st":"2026-05","ag":"2–11"},{"n":"NCT06059261","t":"Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.","s":"rec","p":"phase2","d":[0],"c":[1],"lc":[1],"a":"adult older","h":[2],"l":[[2,"npc"]],"po":"2023-09-28","u":"2026-02-18","st":"2026-02","ag":"18–65"},{"n":"NCT06326008","t":"Safety, Tolerability, and Pharmacokinetics of Donor-derived CD19 CAR Therapy Bridged Allo-HSCT and Sequential Donor-derived CD22 CAR Therapy for r/r B-ALL: a Clinical Trial","s":"rec","p":"phase1","d":[16],"c":[2],"lc":[2],"a":"child adult","h":[3],"l":[[3,"ball"]],"po":"2024-03-22","u":"2026-03-09","st":"2026-03","ag":"1–18"},{"n":"NCT06462092","t":"Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Cancer","s":"rec","p":"phase1phase2","d":[6],"c":[3],"lc":[3],"a":"adult older","h":[4],"l":[[4,"breast"]],"po":"2024-06-17","u":"2025-09-29","st":"2026-01","ag":"18–75"},{"n":"NCT06726577","t":"TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis","s":"rec","p":"phase1phase2","d":[39],"c":[4],"a":"adult older","h":[5],"po":"2024-12-10","u":"2026-10-02","st":"2026-06","ag":"18 and over"},{"n":"NCT06794073","t":"Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study","s":"rec","p":"na","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"hcc"]],"po":"2025-01-27","u":"2026-05-11","st":"2026-01","ag":"18–80"},{"n":"NCT06796270","t":"Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma","s":"rec","p":"na","d":[0],"c":[6],"lc":[6],"a":"adult older","h":[7],"l":[[7,"npc"]],"po":"2025-01-28","u":"2025-01-28","st":"2026-02","ag":"18–75"},{"n":"NCT06875063","t":"GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL","s":"rec","p":"phase1","d":[19],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"lymph"]],"po":"2025-03-13","u":"2026-03-13","st":"2026-04","ag":"18–70"},{"n":"NCT06889610","t":"A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2025-03-21","u":"2026-07-13","st":"2026-03","ag":"18–80"},{"n":"NCT06951646","t":"ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)","s":"rec","p":"phase2","d":[4],"c":[8,1,9,10,11,12,13,14],"lc":[8],"a":"adult older","h":[10,11,12,13,14,15,16,17,18,19,20,21,22],"l":[[10,"lung"]],"po":"2025-04-30","u":"2026-03-09","st":"2026-03","ag":"18–75"},{"n":"NCT06993506","t":"Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer","s":"rec","p":"na","d":[6],"c":[2,15,16,17,5,18,13,7,19,20],"lc":[2],"a":"adult older","h":[23,24,25,12,26,27,8,19,28,6,29,30,31],"l":[[23,"breast"]],"po":"2025-05-29","u":"2026-08-18","st":"2026-05","ag":"18 and over"},{"n":"NCT07013461","t":"International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer","s":"rec","p":"na","d":[0],"c":[21],"lc":[21],"a":"adult older","h":[32],"l":[[32,"npc"]],"po":"2025-06-10","u":"2026-05-04","st":"2026-01","ag":"18 and over"},{"n":"NCT07019714","t":"Daoyin Technique for Improving Exercise Endurance in IPF","s":"rec","p":"na","d":[37],"c":[2,11,20],"lc":[11],"a":"adult older","h":[33,34,35],"l":[[33,"ipf"]],"po":"2025-06-13","u":"2026-09-29","st":"2026-04","ag":"40–85"},{"n":"NCT07039474","t":"The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy","s":"rec","p":"na","d":[3,4,6,19],"c":[2],"lc":[2],"a":"adult older","h":[29],"l":[[29,"gc"]],"po":"2025-06-26","u":"2026-09-28","st":"2026-09","ag":"18–75"},{"n":"NCT07055581","t":"Durvalumab as Consolidation for Patients LS-SCLC","s":"rec","p":"phase2","d":[4],"c":[13,20],"a":"adult older","h":[36,37],"po":"2025-07-09","u":"2026-03-27","st":"2026-02","ag":"18 and over"},{"n":"NCT07061938","t":"Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease","s":"rec","p":"phase1phase2","d":[26],"c":[2,22,5,13],"a":"adult older","h":[38,39,40,36,41],"po":"2025-07-14","u":"2026-11-17","st":"2026-01","ag":"18 and over"},{"n":"NCT07063745","t":"A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion","s":"rec","p":"phase2phase3","d":[4],"c":[2,8,22,16,0,23,24,25,9,10,5,11,13,7],"a":"adult older","h":[40,42,43,44,6,12,45,46,13,47,14,48,30,49,18,19,50,8,51],"po":"2025-07-14","u":"2026-11-13","st":"2026-01","ag":"18 and over"},{"n":"NCT07070076","t":"A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (Selective Internal Radiation Therapy) Therapy and Hepatic Arterial Infusion Chemotherapy (Hepatic Artery Infusion Chemotherapy) for Potentially Resectable Intermediate and Advanced Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[52],"l":[[52,"hcc"]],"po":"2025-07-17","u":"2025-08-27","st":"2026-08","ag":"18–75"},{"n":"NCT07076836","t":"Zusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"lung"]],"po":"2025-07-22","u":"2026-09-02","st":"2026-08","ag":"18–80"},{"n":"NCT07084519","t":"Hypofractionated vs Conventional RT After Prosthetic Breast Reconstruction","s":"rec","p":"phase3","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2025-07-24","u":"2026-06-22","st":"2026-03","ag":"18–75"},{"n":"NCT07103395","t":"A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2025-08-05","u":"2026-01-14","st":"2026-01","ag":"18–75"},{"n":"NCT07105176","t":"HS-IT101 Injection for Advanced NSCLC(FASTIL-Lung01)","s":"rec","p":"phase1","d":[4],"c":[0],"a":"adult older","h":[43],"po":"2025-08-05","u":"2026-10-14","st":"2026-08","ag":"18–75"},{"n":"NCT07164560","t":"Exploratory Study of Umbilical Cord Blood-Derived CAR-NK Cell Therapy Targeting TRBC1/2 for Relapsed/Refractory T-Cell Lymphoma","s":"rec","p":"phase1","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lymph"]],"po":"2025-09-10","u":"2026-03-17","st":"2026-04","ag":"18–75"},{"n":"NCT07177937","t":"A Study of DXC014 in Patients With Advanced Solid Tumors.","s":"rec","p":"phase1","d":[4],"c":[2,8,23,9,26],"a":"adult older","h":[44,55,13,14,29],"po":"2025-09-17","u":"2026-09-23","st":"2026-03","ag":"18 and over"},{"n":"NCT07195695","t":"Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations","s":"rec","p":"phase3","d":[4],"c":[2,15,8,22,0,23,24,27,25,9,28,5,18,4,29,30,13,31,32,20],"a":"adult older","h":[40,56,57,58,44,5,11,12,45,24,46,59,13,47,27,14,37,60,61,49,62,63,64,65,66,67],"po":"2025-09-29","u":"2026-11-18","st":"2026-01","ag":"18 and over"},{"n":"NCT07203729","t":"The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral Crisis","s":"rec","p":"phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2025-10-02","u":"2026-10-15","st":"2026-03","ag":"18–75"},{"n":"NCT07208149","t":"A Study of MR001 in Patients With Locally Recurrent or Metastatic Advanced Triple-Negative Breast Cancer (TNBC)","s":"rec","p":"phase1phase2","d":[6],"c":[2,8,13],"a":"adult older","h":[23,12,13],"po":"2025-10-06","u":"2026-11-06","st":"2026-01","ag":"18–75"},{"n":"NCT07211048","t":"Anti CD19 Gene Therapy for B-cell Lymphoma","s":"rec","p":"na","d":[19],"c":[17],"lc":[17],"a":"adult older","h":[68],"l":[[68,"lymph"]],"po":"2025-10-07","u":"2026-01-21","st":"2026-03","ag":"18 and over"},{"n":"NCT07218341","t":"A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma","s":"rec","p":"phase4","d":[19],"c":[2,8,0,33,9,5,30,34,31,20],"a":"adult older","h":[53,58,64,69,9,37,70,14,13,71,72,73],"po":"2025-10-20","u":"2026-11-04","st":"2026-03","ag":"18 and over"},{"n":"NCT07221149","t":"A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)","s":"rec","p":"phase2phase3","d":[3],"c":[2,16,0,10,5],"a":"adult older","h":[74,75,30,65,50],"po":"2025-10-27","u":"2026-11-05","st":"2026-03","ag":"18 and over"},{"n":"NCT07221669","t":"A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)","s":"rec","p":"phase3","d":[40],"c":[5,20],"a":"child","h":[76,77],"po":"2025-10-28","u":"2026-10-23","st":"2026-04","ag":"0 days–42 days"},{"n":"NCT07222566","t":"Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[2,15,8,22,1,16,0,23,17,35,27,25,36,9,28,10,5,12,29,37,13,38,14,32,20],"a":"adult older","h":[42,9,78,38,11,12,74,10,46,47,79,27,80,14,81,37,70,82,60,61,30,2,83,63,65,19,50,66,31,84,21,85,86,87,88,51],"po":"2025-10-30","u":"2026-10-08","st":"2026-01","ag":"18 and over"},{"n":"NCT07227025","t":"A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer","s":"rec","p":"phase1phase2","d":[4],"c":[0,24,5],"a":"adult older","h":[45,49,65],"po":"2025-11-12","u":"2026-11-03","st":"2026-03","ag":"18 and over"},{"n":"NCT07227298","t":"Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers","s":"rec","p":"phase1phase2","d":[4],"c":[2,16,28,5,29,13],"a":"adult older","h":[42,9,78,38,74,36,30,66],"po":"2025-11-12","u":"2026-10-08","st":"2026-01","ag":"18 and over"},{"n":"NCT07227597","t":"A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)","s":"rec","p":"phase1phase2","d":[4],"c":[2,22,16,0,23,24,35,9,5,29],"a":"adult older","h":[74,45,46,47,14,70,30,65,66,85],"po":"2025-11-12","u":"2026-11-09","st":"2026-01","ag":"18 and over"},{"n":"NCT07229495","t":"Tegileridine for Postoperative Pain After Adolescent Scoliosis Surgery","s":"rec","p":"phase4","d":[33],"c":[2,9,5,20],"lc":[2],"a":"child","h":[38,89,90,14,91,92],"l":[[38,"scol"]],"po":"2025-11-17","u":"2026-10-13","st":"2026-04","ag":"10–17"},{"n":"NCT07230405","t":"A Phase II Study of SKB571 in Patients With Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[0,20],"a":"adult older","h":[53,37],"po":"2025-11-17","u":"2026-05-12","st":"2026-01","ag":"18–75"},{"n":"NCT07231445","t":"Study of ZG006 in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors as First-Line Standard Therapy in Participants With Extensive Stage Small-Cell Lung Cancer","s":"rec","p":"phase1","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2025-11-17","u":"2026-04-28","st":"2026-04","ag":"18–75"},{"n":"NCT07235176","t":"Phase Ib/II Clinical Study of QLS1304 Combined With Endocrine Therapy in the Treatment of ER+/HER2- Breast Cancer Patients","s":"rec","p":"phase1phase2","d":[6],"c":[5],"a":"adult older","h":[9],"po":"2025-11-19","u":"2026-05-22","st":"2026-01","ag":"18 and over"},{"n":"NCT07235319","t":"PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC","s":"rec","p":"phase3","d":[0],"c":[8,16,0,23,10],"lc":[0],"a":"adult older","h":[53,30,13,50,44],"l":[[53,"npc"]],"po":"2025-11-19","u":"2026-08-28","st":"2026-04","ag":"18–70"},{"n":"NCT07237126","t":"Single-port Robotic Radical Gastrectomy for Gastric Cancer","s":"rec","p":"na","d":[3],"c":[1],"lc":[1],"a":"adult older","h":[17],"l":[[17,"gc"]],"po":"2025-11-19","u":"2026-08-04","st":"2026-07","ag":"18–75"},{"n":"NCT07238894","t":"A Cohort Study of Combined Cryoablation and Thermal Ablation for Non-surgical Treatment of Breast Cancer Patients","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[48],"l":[[48,"breast"]],"po":"2025-11-20","u":"2026-07-13","st":"2026-03","ag":"18–80"},{"n":"NCT07240766","t":"HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation","s":"rec","p":"phase2","d":[5],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"panc"]],"po":"2025-11-21","u":"2026-02-13","st":"2026-02","ag":"18–75"},{"n":"NCT07243340","t":"A Phase I/IIa Study of C5252 in Patients With Intracranial Tumor","s":"rec","p":"phase1phase2","d":[7],"c":[30],"a":"adult older","h":[58],"po":"2025-11-21","u":"2026-08-17","st":"2026-04","ag":"18 and over"},{"n":"NCT07244978","t":"Neoadjuvant Ivonescimab（AK112） Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"escc"]],"po":"2025-11-24","u":"2026-10-02","st":"2026-06","ag":"18–75"},{"n":"NCT07246304","t":"TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC","s":"rec","p":"earlyphase1","d":[4],"c":[28],"a":"adult older","h":[93],"po":"2025-11-24","u":"2026-10-26","st":"2026-06","ag":"18–75"},{"n":"NCT07246330","t":"Stratified Treatment in Unresectable Locally Advanced ESCC Without Progression After Chemoimmunotherapy Induction Plus CCRT: Toripalimab Consolidation vs observation--a Prospective, Randomized, Controlled Phase III Multicenter Study","s":"rec","p":"phase3","d":[1],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"escc"]],"po":"2025-11-24","u":"2026-10-23","st":"2026-03","ag":"18–75"},{"n":"NCT07246707","t":"KSV01 Injection as the Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia","s":"rec","p":"phase1","d":[16],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"ball"]],"po":"2025-11-24","u":"2026-07-17","st":"2026-01","ag":"18–80"},{"n":"NCT07249632","t":"A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)","s":"rec","p":"phase3","d":[27],"c":[2],"a":"child adult older","h":[94],"po":"2025-11-25","u":"2026-04-09","st":"2026-01","ag":"12–80"},{"n":"NCT07249879","t":"This Study is an Open-lable, Early Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory Small Cell Lung Cancer.","s":"rec","p":"phase1","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2025-11-25","u":"2026-05-01","st":"2026-03","ag":"18–75"},{"n":"NCT07251582","t":"Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2025-11-26","u":"2026-08-13","st":"2026-08","ag":"18–75"},{"n":"NCT07253142","t":"A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects With Advanced Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[16,0,24,17,10,5,13,14,31],"a":"adult older","h":[42,45,30,64,19,95,31,96,21],"po":"2025-11-28","u":"2026-07-21","st":"2026-02","ag":"18–75"},{"n":"NCT07255898","t":"A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies","s":"rec","p":"phase1","d":[15],"c":[22],"a":"adult older","h":[40],"po":"2025-12-01","u":"2026-06-04","st":"2026-03","ag":"18 and over"},{"n":"NCT07258511","t":"A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma","s":"rec","p":"phase3","d":[15],"c":[2,22,23,28,10,37,13,39],"a":"adult older","h":[46,36,48,60,97,29,98,15,81],"po":"2025-12-02","u":"2026-11-03","st":"2026-02","ag":"18 and over"},{"n":"NCT07264816","t":"A Study of BL-M07D1 in Combination With Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic HER2-Overexpressing Non-Squamous NSCLC","s":"rec","p":"phase2","d":[4],"c":[13],"a":"adult older","h":[36],"po":"2025-12-04","u":"2026-03-05","st":"2026-02","ag":"18–75"},{"n":"NCT07269782","t":"A Phase II Study to Evaluate the Efficacy and Safety of HLX43 + Serplulimab as Neoadjuvant Therapy in Subjects With NSCLC","s":"rec","p":"phase2","d":[4],"c":[5],"a":"adult older","h":[56],"po":"2025-12-08","u":"2026-06-04","st":"2026-01","ag":"18–75"},{"n":"NCT07281976","t":"A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer","s":"rec","p":"phase1phase2","d":[6],"c":[15,0,24,28,11,20],"a":"adult older","h":[78,53,45,99,27,37,18],"po":"2025-12-15","u":"2026-02-12","st":"2026-01","ag":"18 and over"},{"n":"NCT07283692","t":"Neoadjuvant Serplulimab Plus Weekly Paclitaxel and Carboplatin in TNBC (Neo-SERPENT)","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[41],"l":[[41,"breast"]],"po":"2025-12-16","u":"2026-05-13","st":"2026-03","ag":"18–70"},{"n":"NCT07288177","t":"Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[2,28,5,30,20],"a":"adult older","h":[58,78,74,37,65],"po":"2025-12-17","u":"2026-11-03","st":"2026-01","ag":"18 and over"},{"n":"NCT07294508","t":"A Study to Evaluate HLX22 in Combination With HLX87 in Patients With HER2-Positive Recurrent or Metastatic Breast Cancer","s":"rec","p":"phase2phase3","d":[6],"c":[2],"a":"adult older","h":[23],"po":"2025-12-19","u":"2026-03-20","st":"2026-02","ag":"18 and over"},{"n":"NCT07295262","t":"NIR-II Fluorescence-Guided Hepatectomy Using ICG-Cisplatin Nanoprobes for HCC","s":"rec","p":"earlyphase1","d":[2],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"hcc"]],"po":"2025-12-19","u":"2025-12-19","st":"2026-01","ag":"18–75"},{"n":"NCT07295275","t":"Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection","s":"rec","p":"na","d":[2],"c":[2,22,31],"lc":[22],"a":"adult older","h":[40,100,101],"l":[[40,"hcc"]],"po":"2025-12-19","u":"2026-03-03","st":"2026-03","ag":"18–80"},{"n":"NCT07295340","t":"Diagnostic Accuracy of Folate-Targeted NIR-II Carbon Dots for Ex Vivo HCC Detection","s":"rec","p":"na","d":[2],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"hcc"]],"po":"2025-12-19","u":"2025-12-19","st":"2026-01","ag":"18–80"},{"n":"NCT07296341","t":"HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors","s":"rec","p":"phase1phase2","d":[5],"c":[2],"a":"adult older","h":[38],"po":"2025-12-22","u":"2026-01-14","st":"2026-01","ag":"18–75"},{"n":"NCT07296809","t":"SKB500 Combinations in Patients With Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[0],"a":"adult older","h":[43],"po":"2025-12-22","u":"2026-05-08","st":"2026-01","ag":"18–75"},{"n":"NCT07297212","t":"A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma","s":"rec","p":"phase2","d":[7],"c":[2,5,21,13],"a":"adult older","h":[102,103,12,104],"po":"2025-12-22","u":"2026-10-28","st":"2026-01","ag":"18–75"},{"n":"NCT07300514","t":"Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma","s":"rec","p":"phase3","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lymph"]],"po":"2025-12-23","u":"2026-03-31","st":"2026-03","ag":"18 and over"},{"n":"NCT07308106","t":"A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities","s":"rec","p":"phase2","d":[4],"c":[5],"a":"adult older","h":[56],"po":"2025-12-29","u":"2026-07-30","st":"2026-04","ag":"18–75"},{"n":"NCT07309276","t":"A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[5],"a":"adult older","h":[65],"po":"2025-12-30","u":"2026-05-18","st":"2026-01","ag":"18–75"},{"n":"NCT07310056","t":"The Construction and Clinical Application of an Integrated Perioperative Management System for Lung Cancer Based on Wearable Devices and Intelligent Platforms","s":"rec","p":"na","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"lung"]],"po":"2025-12-30","u":"2026-09-09","st":"2026-01","ag":"18–85"},{"n":"NCT07310173","t":"Phase IIb Study of AST-3424 in Patients With AKR1C3-high Expressing Advanced Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[28],"a":"adult older","h":[105],"po":"2025-12-30","u":"2025-12-30","st":"2026-01","ag":"18–75"},{"n":"NCT07311408","t":"SHR-1701 + Rivoceranib (± SHR-2554) in Advanced GC After First-Line Immunotherapy Failure","s":"rec","p":"phase2","d":[3],"c":[11],"lc":[11],"a":"adult older","h":[18],"l":[[18,"gc"]],"po":"2025-12-31","u":"2025-12-31","st":"2026-01","ag":"18 and over"},{"n":"NCT07314216","t":"Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary Adenocarcinoma","s":"rec","p":"phase2","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2026-01-02","u":"2026-07-08","st":"2026-06","ag":"18 and over"},{"n":"NCT07315672","t":"Acupressure for Cough in Lung Cancer Survivors","s":"rec","p":"na","d":[4],"c":[21],"a":"adult older","h":[32],"po":"2026-01-02","u":"2026-08-11","st":"2026-03","ag":"18 and over"},{"n":"NCT07315750","t":"A Study of Disitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus Chemotherapy Combined With Trastuzumab With or Without Pembrolizumab in HER2-high Expression Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.","s":"rec","p":"phase3","d":[3],"c":[2],"a":"adult older","h":[74],"po":"2026-01-02","u":"2026-09-22","st":"2026-01","ag":"18–75"},{"n":"NCT07318831","t":"Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children","s":"rec","p":"phase2","d":[13],"c":[30],"lc":[30],"a":"child adult","h":[58],"l":[[58,"nb"]],"po":"2026-01-06","u":"2026-10-01","st":"2026-01","ag":"0–18"},{"n":"NCT07320105","t":"Postoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy Era (Phase II)","s":"rec","p":"phase4","d":[4],"c":[16],"lc":[16],"a":"adult older","h":[30],"l":[[30,"lung"]],"po":"2026-01-06","u":"2026-01-06","st":"2026-01","ag":"18–75"},{"n":"NCT07321015","t":"A Single-Arm Phase Ⅱ Study of Fluzoparib Maintenance in Platinum-sensitive Advanced Triple-Negative Breast Cance","s":"rec","p":"phase2","d":[6],"c":[30],"lc":[30],"a":"adult older","x":"female","h":[58],"l":[[58,"breast"]],"po":"2026-01-06","u":"2026-08-21","st":"2026-01","ag":"18–75"},{"n":"NCT07322159","t":"IASO206 in Patients With Relapsed/Refractory Multiple Myeloma","s":"rec","p":"earlyphase1","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2026-01-07","u":"2026-11-09","st":"2026-01","ag":"18–75"},{"n":"NCT07323056","t":"Neoadjuvant Sacituzumab Tirumotecan and Limertinib for Potentially Resectable Stage Ⅲ EGFR-mutant Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2026-01-07","u":"2026-01-07","st":"2026-01","ag":"18 and over"},{"n":"NCT07324824","t":"Sintilimab Plus Bevacizumab Biosimilar as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"hcc"]],"po":"2026-01-08","u":"2026-01-16","st":"2026-01","ag":"18 and over"},{"n":"NCT07325136","t":"A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer","s":"rec","p":"phase1phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[65],"l":[[65,"lung"]],"po":"2026-01-08","u":"2026-09-14","st":"2026-02","ag":"18 and over"},{"n":"NCT07325539","t":"LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC","s":"rec","p":"phase2","d":[0],"c":[0,21],"lc":[0],"a":"adult older","h":[53,106],"l":[[53,"npc"]],"po":"2026-01-08","u":"2026-05-22","st":"2026-01","ag":"18–65"},{"n":"NCT07328009","t":"A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"hcc"]],"po":"2026-01-08","u":"2026-04-21","st":"2026-01","ag":"18 and over"},{"n":"NCT07329322","t":"Phase II Study of Sacituzumab Tirumotecan in Combination With Osimertinib for Neoadjuvant Treatment in Patients With Resectable Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[2],"a":"adult older","h":[23],"po":"2026-01-09","u":"2026-08-20","st":"2026-03","ag":"18–75"},{"n":"NCT07331428","t":"MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC","s":"rec","p":"phase2","d":[0],"c":[16],"lc":[16],"a":"adult older","h":[30],"l":[[30,"npc"]],"po":"2026-01-09","u":"2026-10-19","st":"2026-06","ag":"18–70"},{"n":"NCT07332247","t":"PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC","s":"rec","p":"phase2","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2026-01-12","u":"2026-02-04","st":"2026-02","ag":"18–70"},{"n":"NCT07332858","t":"First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion","s":"rec","p":"phase1phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[62],"l":[[62,"lung"]],"po":"2026-01-12","u":"2026-05-15","st":"2026-04","ag":"18–75"},{"n":"NCT07336732","t":"Andamertinib With or Without Platinum-doublet Chemotherapy Versus Platinum-doublet Chemotherapy in Patients With NSCLC Harboring Atypical EGFR Mutations","s":"rec","p":"phase2","d":[4],"c":[0],"a":"adult older","h":[53],"po":"2026-01-13","u":"2026-03-20","st":"2026-03","ag":"18 and over"},{"n":"NCT07337096","t":"Electro-Acupuncture in Lung cancER : EALER Study","s":"rec","p":"na","d":[4],"c":[0],"a":"adult older","h":[107,108],"po":"2026-01-13","u":"2026-06-24","st":"2026-01","ag":"18 and over"},{"n":"NCT07341932","t":"Helium-free Magnetocardiography Guided Therapy for Stable Coronary Artery Disease - A Randomized Controlled Trial","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[109],"l":[[109,"cad"]],"po":"2026-01-15","u":"2026-04-02","st":"2026-03","ag":"18–80"},{"n":"NCT07342283","t":"QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[40],"lc":[40],"a":"adult older","h":[110],"l":[[110,"breast"]],"po":"2026-01-15","u":"2026-03-02","st":"2026-02","ag":"18 and over"},{"n":"NCT07344818","t":"An Open and Dose-escalation Early Clinical Study of CD19 and CD20 CAR-T Cell Therapy for Relapsed or Refractory Aggressive B-cell Lymphoma","s":"rec","p":"earlyphase1","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"lymph"]],"po":"2026-01-15","u":"2026-01-15","st":"2026-01","ag":"18 and over"},{"n":"NCT07347600","t":"A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer","s":"rec","p":"na","d":[6],"c":[2,15,22,1,0,41,6,24,17,27,9,28,5,11,18,12,29,42,13,39,7,32,20],"a":"adult older","h":[9,78,45,99,111,24,79,27,37,18,2,112,8,7,19,6,29,113,98,114,115,116,0,63,117,66,84],"po":"2026-01-16","u":"2026-11-05","st":"2026-01","ag":"18 and over"},{"n":"NCT07348211","t":"First in Human Study of SIM0610 in Solid Tumors","s":"rec","p":"phase1","d":[2,4],"c":[1,24,5,11],"a":"adult older","h":[6,118,45,65,2,56],"po":"2026-01-16","u":"2026-01-23","st":"2026-01","ag":"18 and over"},{"n":"NCT07348965","t":"Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal Metastasis","s":"rec","p":"na","d":[4],"c":[0],"a":"adult older","h":[107],"po":"2026-01-16","u":"2026-04-02","st":"2026-03","ag":"18–75"},{"n":"NCT07349069","t":"A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[28,5],"a":"adult older","x":"female","h":[9,78],"po":"2026-01-16","u":"2026-05-22","st":"2026-03","ag":"18–75"},{"n":"NCT07349875","t":"Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial","s":"rec","p":"phase4","d":[31],"c":[28],"lc":[28],"a":"adult older","h":[78,119],"l":[[78,"cad"]],"po":"2026-01-20","u":"2026-01-20","st":"2026-01","ag":"18 and over"},{"n":"NCT07350863","t":"U69-CART-Cells For R/R T-ALL","s":"rec","p":"phase1","d":[19],"c":[4],"lc":[4],"a":"child adult older","h":[5],"l":[[5,"lymph"]],"po":"2026-01-20","u":"2026-09-02","st":"2026-10","ag":"15–75"},{"n":"NCT07351474","t":"Remimazolam for Reducing Postoperative Delirium in Elderly Patients Undergoing Laparoscopic Gastrectomy","s":"rec","p":"na","d":[3],"c":[28],"lc":[28],"a":"older","h":[78],"l":[[78,"gc"]],"po":"2026-01-20","u":"2026-11-04","st":"2026-01","ag":"65–100"},{"n":"NCT07351669","t":"A Multicenter Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[28],"lc":[28],"a":"adult older","h":[120],"l":[[120,"hcc"]],"po":"2026-01-20","u":"2026-06-10","st":"2026-01","ag":"18–75"},{"n":"NCT07352930","t":"A Novel Intraoperative Fluorescence-guided System for Evaluating Margins During Breast-conserving Surgery for Breast Cancer","s":"rec","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[43],"l":[[43,"breast"]],"po":"2026-01-20","u":"2026-06-29","st":"2026-04","ag":"18 and over"},{"n":"NCT07353645","t":"KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer","s":"rec","p":"phase1phase2","d":[5],"c":[28],"lc":[28],"a":"adult older","h":[60],"l":[[60,"panc"]],"po":"2026-01-20","u":"2026-04-15","st":"2026-03","ag":"18–75"},{"n":"NCT07353840","t":"T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-CR","s":"rec","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[121],"l":[[121,"lymph"]],"po":"2026-01-20","u":"2026-01-20","st":"2026-01","ag":"18–70"},{"n":"NCT07354022","t":"A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Metastatic Breast Cancer Resistant to Adjuvant Endocrine Therapy.","s":"rec","p":"phase3","d":[6],"c":[2],"a":"adult older","x":"female","h":[26],"po":"2026-01-21","u":"2026-06-02","st":"2026-05","ag":"18–75"},{"n":"NCT07354061","t":"Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC)","s":"rec","p":"phase1phase2","d":[4],"c":[39],"lc":[39],"a":"adult older","h":[122],"l":[[122,"lung"]],"po":"2026-01-21","u":"2026-04-01","st":"2026-03","ag":"18–75"},{"n":"NCT07354711","t":"A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors","s":"rec","p":"phase1phase2","d":[3,4],"c":[2],"a":"adult older","h":[74],"po":"2026-01-21","u":"2026-01-21","st":"2026-01","ag":"18 and over"},{"n":"NCT07354932","t":"A Study of SHR-2173 in Participants With Primary IgA Nephropathy","s":"rec","p":"phase2","d":[46],"c":[0,5],"a":"adult older","h":[49,123],"po":"2026-01-21","u":"2026-05-13","st":"2026-03","ag":"18 and over"},{"n":"NCT07358676","t":"A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2026-01-22","u":"2026-07-06","st":"2026-02","ag":"18–75"},{"n":"NCT07361497","t":"A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)","s":"rec","p":"phase3","d":[4],"c":[2,22,1,16,0,23,27,9,43,21,4,12,29,39,20],"a":"adult older","h":[40,53,57,44,5,111,74,124,54,47,80,37,30,2,97,125,66,126,84],"po":"2026-01-23","u":"2026-11-05","st":"2026-03","ag":"18 and over"},{"n":"NCT07361510","t":"A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)","s":"rec","p":"phase3","d":[4],"c":[22,16,0,23,27,9,28,10,5,43],"a":"adult older","h":[42,57,127,54,47,80,70,82,60,30,125,65,50],"po":"2026-01-23","u":"2026-10-23","st":"2026-03","ag":"18 and over"},{"n":"NCT07361705","t":"Zorifertinib With Osimertinib for NSCLC With Meningeal Progression","s":"rec","p":"phase1","d":[4],"c":[2,11,12,20],"a":"adult older","h":[23,118,37,84],"po":"2026-01-23","u":"2026-06-22","st":"2026-01","ag":"18 and over"},{"n":"NCT07362186","t":"LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction Adenocarcinoma","s":"rec","p":"phase3","d":[3],"c":[2],"a":"adult older","h":[74],"po":"2026-01-23","u":"2026-05-11","st":"2026-04","ag":"18 and over"},{"n":"NCT07362966","t":"Precision Colchicine Intervention to Suppress Atherosclerosis in TET2 Clonal Hematopoiesis","s":"rec","p":"phase4","d":[31],"c":[11],"lc":[11],"a":"adult older","h":[128],"l":[[128,"cad"]],"po":"2026-01-23","u":"2026-10-01","st":"2026-06","ag":"40–85"},{"n":"NCT07362979","t":"Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma","s":"rec","p":"phase2","d":[0],"c":[44,0,21,45],"lc":[0],"a":"adult older","h":[53,129,106,130],"l":[[53,"npc"]],"po":"2026-01-23","u":"2026-03-17","st":"2026-03","ag":"18–70"},{"n":"NCT07365267","t":"Study on the Cosmetic Outcome and Safety Evaluation of 3D Printed Biodegradable Biological Mesh for One-Stage Breast Reconstruction After Radical Mastectomy","s":"rec","p":"na","d":[6],"c":[39],"lc":[39],"a":"adult older","x":"female","h":[131],"l":[[131,"breast"]],"po":"2026-01-26","u":"2026-01-26","st":"2026-01","ag":"18–70"},{"n":"NCT07366112","t":"CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment","s":"rec","p":"phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[48],"l":[[48,"breast"]],"po":"2026-01-26","u":"2026-07-13","st":"2026-04","ag":"18–75"},{"n":"NCT07367529","t":"A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection","s":"rec","p":"phase1phase2","d":[4],"c":[2,8,22,0,23,24,9,28,10,5,12,29,30,13,39,32,46],"a":"adult older","h":[23,56,58,132,111,45,47,133,14,82,60,122,63,50,20,66,134,84],"po":"2026-01-26","u":"2026-09-08","st":"2026-02","ag":"18–75"},{"n":"NCT07372079","t":"Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and Tuvonralimab Injection in Combination With Chemotherapy","s":"rec","p":"phase2","d":[6],"c":[30],"lc":[30],"a":"adult older","x":"female","h":[58],"l":[[58,"breast"]],"po":"2026-01-28","u":"2026-09-28","st":"2026-04","ag":"18–75"},{"n":"NCT07372352","t":"Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL","s":"rec","p":"phase2","d":[19],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"lymph"]],"po":"2026-01-28","u":"2026-01-28","st":"2026-01","ag":"18 and over"},{"n":"NCT07374614","t":"Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib","s":"rec","p":"na","d":[4],"c":[21],"lc":[21],"a":"adult older","h":[126],"l":[[126,"lung"]],"po":"2026-01-29","u":"2026-01-29","st":"2026-01","ag":"18 and over"},{"n":"NCT07375602","t":"A Multimodal AI Prediction Model for Complications After Transcatheter Closure of Perimembranous VSD in Children","s":"rec","p":"na","d":[32],"c":[5],"lc":[5],"a":"child adult","h":[90],"l":[[90,"chd"]],"po":"2026-01-29","u":"2026-08-05","st":"2026-02","ag":"Up to 18"},{"n":"NCT07375758","t":"A Study of MIL116 in Healthy Participants and Patients With IgA Nephropathy.","s":"rec","p":"phase1phase2","d":[46],"c":[2],"a":"adult older","h":[29],"po":"2026-01-29","u":"2026-04-13","st":"2026-02","ag":"18 and over"},{"n":"NCT07376174","t":"The Prognostic Impact of HER2 Expression in Non-Metastatic HER2-Positive Breast Cancer Treated With Dual HER2-Targeted Therapy","s":"rec","p":"na","d":[6],"c":[27],"lc":[27],"a":"adult older","x":"female","h":[57],"l":[[57,"breast"]],"po":"2026-01-29","u":"2026-01-29","st":"2026-01","ag":"18 and over"},{"n":"NCT07376538","t":"Response-Based Local Therapy for Regionally Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2026-01-29","u":"2026-02-11","st":"2026-02","ag":"18–75"},{"n":"NCT07376603","t":"IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features","s":"rec","p":"na","d":[0],"c":[16],"lc":[16],"a":"adult older","h":[30],"l":[[30,"npc"]],"po":"2026-01-29","u":"2026-01-29","st":"2026-01","ag":"18–70"},{"n":"NCT07377578","t":"A Study of Rocbrutinib Versus Investigator's Choice of BTK Inhibitors in Patients With Relapsed or Refractory Mantle Cell Lymphoma","s":"rec","p":"phase3","d":[19],"c":[2,10],"a":"adult older","h":[74,15],"po":"2026-01-30","u":"2026-02-06","st":"2026-02","ag":"18 and over"},{"n":"NCT07378306","t":"FMD and Neoadjuvant Chemo-immunotherapy in TNBC","s":"rec","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[53],"l":[[53,"breast"]],"po":"2026-01-30","u":"2026-04-21","st":"2026-03","ag":"18–70"},{"n":"NCT07379047","t":"Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)","s":"rec","p":"phase2phase3","d":[12],"c":[2,15,8,22,1,16,0,41,23,24,17,27,47,9,28,10,26,5,18,12,13,20],"a":"adult older","h":[40,12,78,79,74,41,49,46,25,14,55,24,113,11,135,47,53,136,82,19,137,37,45,31,50,9,127,57,112,84,138],"po":"2026-01-30","u":"2026-11-12","st":"2026-05","ag":"18 and over"},{"n":"NCT07380646","t":"the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"breast"]],"po":"2026-02-02","u":"2026-09-28","st":"2026-01","ag":"18 and over"},{"n":"NCT07380984","t":"PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL","s":"rec","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2026-02-02","u":"2026-03-20","st":"2026-03","ag":"18 and over"},{"n":"NCT07381634","t":"The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities","s":"rec","p":"phase2","d":[2],"c":[37],"lc":[37],"a":"adult older","h":[81],"l":[[81,"hcc"]],"po":"2026-02-02","u":"2026-08-04","st":"2026-04","ag":"18–80"},{"n":"NCT07381660","t":"SBRT Versus Surgical Resection for Small HCC","s":"rec","p":"phase3","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"hcc"]],"po":"2026-02-02","u":"2026-09-01","st":"2026-03","ag":"18–75"},{"n":"NCT07381738","t":"Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders","s":"rec","p":"phase2","d":[19],"c":[5],"a":"child adult older","h":[103,139],"po":"2026-02-02","u":"2026-02-02","st":"2026-01","ag":"14–80"},{"n":"NCT07383818","t":"Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)","s":"rec","p":"phase2","d":[6],"c":[23,24,17,5,39],"lc":[23],"a":"adult older","x":"female","h":[46,45,97,112,6],"l":[[46,"breast"]],"po":"2026-02-03","u":"2026-02-03","st":"2026-02","ag":"18–70"},{"n":"NCT07385001","t":"A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC","s":"rec","p":"phase1phase2","d":[1],"c":[39],"lc":[39],"a":"adult older","h":[122],"l":[[122,"escc"]],"po":"2026-02-03","u":"2026-02-03","st":"2026-01","ag":"18–75"},{"n":"NCT07385703","t":"Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.","s":"rec","p":"phase3","d":[3],"c":[48,2,15,8,49,50,22,1,16,0,6,23,17,27,47,33,25,36,9,51,28,26,5,43,11,18,4,12,30,34,13,39,7,31,32,20],"a":"adult older","h":[74,78,40,140,6,60,118,25,24,14,5,9,12,58,37,141,111,46,131,54,63,36,142,39,75,82,27,18,30,79,57,8,83,7,121,143,144,127,125,13,145,146,98,68,147,43,31,148,64,149,87,122,47,150,19,135,84,151,116,72,67,152,88,138],"po":"2026-02-04","u":"2026-06-25","st":"2026-04","ag":"18 and over"},{"n":"NCT07387549","t":"A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis","s":"rec","p":"phase3","d":[51],"c":[2,15,0,27,9,5,30,20],"a":"adult older","h":[41,39,38,80,124,27,59,92,48,153,154],"po":"2026-02-04","u":"2026-10-23","st":"2026-05","ag":"18–75"},{"n":"NCT07389616","t":"A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma","s":"rec","p":"phase2phase3","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[121],"l":[[121,"lymph"]],"po":"2026-02-05","u":"2026-02-05","st":"2026-02","ag":"18–70"},{"n":"NCT07389733","t":"A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer","s":"rec","p":"phase1phase2","d":[6],"c":[22,52],"a":"adult older","x":"female","h":[40,155],"po":"2026-02-05","u":"2026-04-03","st":"2026-03","ag":"18–75"},{"n":"NCT07390123","t":"Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN","s":"rec","p":"phase3","d":[46],"c":[2,15,8,53,25,5,54,39,45],"a":"adult older","h":[29,131,156,41,11,157,152,158,159],"po":"2026-02-05","u":"2026-05-28","st":"2026-04","ag":"18 and over"},{"n":"NCT07390565","t":"YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2026-02-05","u":"2026-11-13","st":"2026-12","ag":"18 and over"},{"n":"NCT07392320","t":"A Phase II Trial Comparing Immunotherapy Versus Capecitabine Maintenance After Chemo-chemoradiotherapy for High-risk Nasopharyngeal Carcinoma","s":"rec","p":"phase2","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2026-02-06","u":"2026-04-24","st":"2026-02","ag":"18–70"},{"n":"NCT07392892","t":"Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer","s":"rec","p":"phase2phase3","d":[3],"c":[22,0,5,13],"a":"adult older","h":[6,75,47,19],"po":"2026-02-06","u":"2026-10-13","st":"2026-05","ag":"18 and over"},{"n":"NCT07393425","t":"Neoadjuvant Trastuzumab Deruxtecan (SHR-A1811) + Pertuzumab in HER2+ Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[123],"l":[[123,"breast"]],"po":"2026-02-06","u":"2026-02-06","st":"2026-02","ag":"18–70"},{"n":"NCT07396324","t":"Neoadjuvant QL1706 in Patients With Hormone Receptor Positive, HER2-negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"breast"]],"po":"2026-02-09","u":"2026-05-13","st":"2026-05","ag":"18 and over"},{"n":"NCT07396454","t":"Study on the Treatment of HER2-negative Breast Cancer Brain Metastases With Radiotherapy Combined With Anlotinib","s":"rec","p":"phase2","d":[6],"c":[28],"lc":[28],"a":"adult older","x":"female","h":[78],"l":[[78,"breast"]],"po":"2026-02-09","u":"2026-02-09","st":"2026-02","ag":"18–70"},{"n":"NCT07397832","t":"CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL","s":"rec","p":"phase2","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lymph"]],"po":"2026-02-09","u":"2026-07-29","st":"2026-02","ag":"60 and over"},{"n":"NCT07398599","t":"Double-Dose Third-Generation EGFR-TKI Plus Bevacizumab and Intrathecal Chemotherapy for Refractory Leptomeningeal Metastatic NSCLC: A Phase II Study","s":"rec","p":"na","d":[4],"c":[9],"lc":[9],"a":"adult older","h":[80],"l":[[80,"lung"]],"po":"2026-02-10","u":"2026-04-23","st":"2026-02","ag":"18–99"},{"n":"NCT07398937","t":"Comparison of Serplulimab Versus Nivolumab in Neoadjuvant Therapy for Resectable Stage II-IIIA Squamous NSCLC","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2026-02-10","u":"2026-02-10","st":"2026-02","ag":"18–75"},{"n":"NCT07398963","t":"Clinical Study of Oncolytic Vaccinia VIrus Delivering Targeted CD19 in Vivo CAR-T/M Therapy for Refractory/Relapsed B-cell Lymphoma","s":"rec","p":"phase1","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lymph"]],"po":"2026-02-10","u":"2026-02-10","st":"2026-02","ag":"18–75"},{"n":"NCT07400341","t":"Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA","s":"rec","p":"phase2","d":[17],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"aa"]],"po":"2026-02-10","u":"2026-04-15","st":"2026-01","ag":"18–65"},{"n":"NCT07400523","t":"Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy","s":"rec","p":"phase3","d":[6],"c":[0,43,45],"lc":[0],"a":"adult older","x":"female","h":[99,129,160],"l":[[99,"breast"]],"po":"2026-02-10","u":"2026-04-28","st":"2026-02","ag":"18 and over"},{"n":"NCT07401173","t":"DeepComp for Prediction of Gastric Cancer Postoperative Complications (DeepComp-Prospective)","s":"rec","p":"na","d":[3],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"gc"]],"po":"2026-02-10","u":"2026-04-09","st":"2026-03","ag":"18–85"},{"n":"NCT07401199","t":"Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)","s":"rec","p":"na","d":[3],"c":[18,13],"a":"adult older","h":[24,16],"po":"2026-02-10","u":"2026-05-15","st":"2026-02","ag":"18 and over"},{"n":"NCT07401303","t":"Full-time RDI for ESD: Impact on Major Adverse Events and Procedure Time","s":"rec","p":"na","d":[3],"c":[39],"lc":[39],"a":"adult older","h":[131],"l":[[131,"gc"]],"po":"2026-02-10","u":"2026-08-17","st":"2026-03","ag":"18–75"},{"n":"NCT07403136","t":"Becotatug Vedotin ± Anti-PD-1 in Pretreated Advanced ESCC","s":"rec","p":"phase2","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"escc"]],"po":"2026-02-11","u":"2026-07-07","st":"2026-04","ag":"18 and over"},{"n":"NCT07405125","t":"Safety of Robotic Surgery for GISTs at Special Anatomic Sites","s":"rec","p":"na","d":[12],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"gist"]],"po":"2026-02-12","u":"2026-02-12","st":"2026-02","ag":"18–75"},{"n":"NCT07405151","t":"A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)","s":"rec","p":"phase1phase2","d":[1],"c":[2,23,17,27,7,31,20],"a":"adult older","h":[74,44,37,68,8,101,83],"po":"2026-02-12","u":"2026-11-10","st":"2026-03","ag":"18 and over"},{"n":"NCT07408505","t":"Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer","s":"rec","p":"na","d":[5],"c":[27],"lc":[27],"a":"adult older","h":[57],"l":[[57,"panc"]],"po":"2026-02-13","u":"2026-10-13","st":"2026-06","ag":"18–75"},{"n":"NCT07408635","t":"IBI363 (PD-1/IL-2α-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in Initially Unresectable Stage III Non-Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2026-02-13","u":"2026-02-13","st":"2026-01","ag":"18 and over"},{"n":"NCT07409246","t":"A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)","s":"rec","p":"phase1","d":[15],"c":[23,30],"a":"adult older","h":[46,69],"po":"2026-02-13","u":"2026-10-20","st":"2026-02","ag":"18 and over"},{"n":"NCT07409272","t":"A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer","s":"rec","p":"phase3","d":[5],"c":[0,5],"a":"adult older","h":[9,99],"po":"2026-02-13","u":"2026-11-03","st":"2026-02","ag":"18 and over"},{"n":"NCT07409428","t":"A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL","s":"rec","p":"phase3","d":[19],"c":[2,55,15,8,22,1,16,0,41,23,24,17,27,9,28,10,26,56,5,11,12,30,13,39,7,31,20],"a":"adult older","h":[40,53,123,25,46,58,12,140,161,64,69,9,8,124,37,45,55,27,43,2,79,60,162,31,15,10,44,111,143,0,98,57,13,116,137,97,163,127,19,164,84,3],"po":"2026-02-13","u":"2026-11-10","st":"2026-03","ag":"18 and over"},{"n":"NCT07409454","t":"MRD-Guided BCMA/CD3 Bispecific Antibody Treatment After Stem Cell Transplant for Newly Diagnosed Multiple Myeloma","s":"rec","p":"phase2","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2026-02-13","u":"2026-08-07","st":"2026-07","ag":"18 and over"},{"n":"NCT07410039","t":"Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study","s":"rec","p":"phase4","d":[25],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"nmosd"]],"po":"2026-02-13","u":"2026-03-12","st":"2026-02","ag":"18–65"},{"n":"NCT07410169","t":"Efficacy and Safety of Hyperbaric Oxygen Therapy in Improving Nab-paclitaxel-Induced Peripheral Neuropathy","s":"rec","p":"phase2phase3","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[43],"l":[[43,"breast"]],"po":"2026-02-13","u":"2026-09-30","st":"2026-09","ag":"18–75"},{"n":"NCT07410520","t":"PD-1 Inhibitor Combined With Rituximab, Methotrexate, and Orelabrutinib (PD-1i+RMO) for Newly Diagnosed PCNSL and SCNSL.","s":"rec","p":"phase2","d":[19],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"lymph"]],"po":"2026-02-13","u":"2026-02-13","st":"2026-02","ag":"18 and over"},{"n":"NCT07410715","t":"Surgery vs. Watch-and-Wait Strategy in Partial & Complete Responders for Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"hcc"]],"po":"2026-02-13","u":"2026-10-02","st":"2026-03","ag":"18–80"},{"n":"NCT07410975","t":"Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III Non-Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2026-02-13","u":"2026-02-13","st":"2026-01","ag":"18 and over"},{"n":"NCT07412262","t":"A Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) With Acquired Resistance to Immunotherapy and High Yes-associated Protein (YAP) Expression","s":"rec","p":"phase2","d":[4],"c":[0,13],"a":"adult older","h":[43,36],"po":"2026-02-17","u":"2026-08-25","st":"2026-08","ag":"18 and over"},{"n":"NCT07413042","t":"A Phase I Study to Evaluate the Safety and Preliminary Efficacy of [225Ac]Ac-DOTATATE Injection Combined With Tislelizumab in the Maintenance Treatment Period for Patients of Extensive-stage Small Cell Lung Cancer (ES-SCLC) With Somatostatin Receptors (SSTR)+ as First-line Treatment","s":"rec","p":"phase1","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"lung"]],"po":"2026-02-17","u":"2026-02-17","st":"2026-01","ag":"18–80"},{"n":"NCT07413354","t":"Tislelizumab Combined With Huaier Granule as First-line Treatment for Unresectable Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2026-02-17","u":"2026-05-12","st":"2026-04","ag":"18 and over"},{"n":"NCT07413835","t":"Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG)","s":"rec","p":"na","d":[27],"c":[31],"lc":[31],"a":"adult older","h":[64],"l":[[64,"mg"]],"po":"2026-02-17","u":"2026-03-18","st":"2026-03","ag":"18–80"},{"n":"NCT07413939","t":"RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive","s":"rec","p":"phase2phase3","d":[6],"c":[2,55,8,22,16,0,23,17,27,47,28,10,5,43,30,34,13],"a":"adult older","h":[9,23,40,58,53,99,36,74,123,54,125,164,57,140,50,135,13,68,19,60,48,72],"po":"2026-02-17","u":"2026-11-05","st":"2026-05","ag":"18 and over"},{"n":"NCT07414758","t":"Golidocitinib Versus Placebo as Maintenance Therapy in PTCL Patients With Response (CR/PR) After First-Line Chemotherapy","s":"rec","p":"phase3","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[121],"l":[[121,"lymph"]],"po":"2026-02-17","u":"2026-02-24","st":"2026-02","ag":"18 and over"},{"n":"NCT07416058","t":"PHOENIX: QL1706 Plus Chemotherapy and Bevacizumab in AGA-Resistant, PD-L1 ≥50% Non-Squamous NSCLC","s":"rec","p":"phase2","d":[4],"c":[0],"a":"adult older","h":[43],"po":"2026-02-17","u":"2026-10-23","st":"2026-04","ag":"18–75"},{"n":"NCT07416240","t":"Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer.","s":"rec","p":"earlyphase1","d":[5],"c":[6],"lc":[6],"a":"adult older","h":[165],"l":[[165,"panc"]],"po":"2026-02-18","u":"2026-02-18","st":"2026-02","ag":"18–80"},{"n":"NCT07416474","t":"RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)","s":"rec","p":"phase3","d":[4],"c":[48,2,15,8,22,1,16,0,57,23,24,17,35,27,47,33,25,36,9,28,10,26,5,11,21,18,4,12,29,30,34,37,13,7,38,14,31,19,58,20,59],"a":"adult older","h":[40,42,56,53,58,9,38,44,25,5,132,11,12,74,45,118,24,127,55,59,13,47,133,14,81,37,15,82,140,112,30,135,49,0,166,92,167,18,83,64,120,19,168,101,138,169,170,171,66,172,72,142,173,174,95,8,175,116,84,176,21,85,86,87,150,67],"po":"2026-02-18","u":"2026-07-14","st":"2026-04","ag":"18–75"},{"n":"NCT07416526","t":"A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A","s":"rec","p":"phase3","d":[21],"c":[2],"a":"child adult older","h":[48],"po":"2026-02-18","u":"2026-10-26","st":"2026-05","ag":"12 and over"},{"n":"NCT07416604","t":"A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A","s":"rec","p":"phase3","d":[21],"c":[2,16,0,30],"a":"child adult older","h":[69,38,70,140],"po":"2026-02-18","u":"2026-11-03","st":"2026-04","ag":"12 and over"},{"n":"NCT07416695","t":"A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC","s":"rec","p":"phase1","d":[4],"c":[2,5],"a":"adult older","h":[42,38],"po":"2026-02-18","u":"2026-07-08","st":"2026-04","ag":"18–75"},{"n":"NCT07416890","t":"Thiotepa in Combination With Pirtobrutinib (a BTK Inhibitor) and Sintilimab (a PD-1 Inhibitor) for Frail or Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma","s":"rec","p":"phase2","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"lymph"]],"po":"2026-02-18","u":"2026-02-18","st":"2026-02","ag":"18–80"},{"n":"NCT07417397","t":"Adjuvant TACE in HCC With High-risk Recurrence Factors","s":"rec","p":"phase3","d":[2],"c":[10],"lc":[10],"a":"adult older","h":[50],"l":[[50,"hcc"]],"po":"2026-02-18","u":"2026-02-18","st":"2026-02","ag":"18–70"},{"n":"NCT07418190","t":"Efficacy and Safety of Zanubrutinib, Rituximab, and Lenalidomide (ZR²) in Combination With Tislelizumab for Relapsed/Refractory Follicular Lymphoma","s":"rec","p":"phase2","d":[19],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"lymph"]],"po":"2026-02-18","u":"2026-02-18","st":"2026-02","ag":"18–75"},{"n":"NCT07420296","t":"Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder","s":"rec","p":"phase3","d":[25],"c":[30],"lc":[30],"a":"adult older","h":[59],"l":[[59,"nmosd"]],"po":"2026-02-19","u":"2026-05-14","st":"2026-01","ag":"18–80"},{"n":"NCT07422753","t":"A Prospective, Randomized Study of TACE Combined With Sintilimab, Bevacizumab, and Ipilimumab N01 Treating Advanced HCC","s":"rec","p":"phase2","d":[2],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"hcc"]],"po":"2026-02-20","u":"2026-04-24","st":"2026-03","ag":"18–75"},{"n":"NCT07424833","t":"A Study of APG-3288 in Relapsed/Refractory Blood Cancers","s":"rec","p":"phase1","d":[19],"c":[20],"a":"adult older","h":[37],"po":"2026-02-20","u":"2026-10-15","st":"2026-03","ag":"18 and over"},{"n":"NCT07425483","t":"CAR-NK Cells (CL-NK-003) in Pancreatic Cancer","s":"rec","p":"phase1","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[177],"l":[[177,"panc"]],"po":"2026-02-23","u":"2026-02-23","st":"2026-02","ag":"18–75"},{"n":"NCT07429461","t":"Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia","s":"rec","p":"earlyphase1","d":[16],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"ball"]],"po":"2026-02-24","u":"2026-02-24","st":"2026-02","ag":"18–75"},{"n":"NCT07429721","t":"A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019A in Patients With Relapsed/Refractory Multiple Myeloma.","s":"rec","p":"earlyphase1","d":[15],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"mm"]],"po":"2026-02-24","u":"2026-07-22","st":"2026-03","ag":"18 and over"},{"n":"NCT07431827","t":"MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)","s":"rec","p":"phase3","d":[4],"c":[2,8,22,1,16,0,23,9,10,5,18,34,13],"a":"adult older","h":[40,56,53,9,38,44,6,11,12,74,36,24,46,13,47,14,48,82,30,136,50,72,178],"po":"2026-02-25","u":"2026-11-16","st":"2026-03","ag":"18 and over"},{"n":"NCT07432178","t":"CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer（Cinnamon）","s":"rec","p":"phase3","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2026-02-25","u":"2026-09-28","st":"2026-04","ag":"18–70"},{"n":"NCT07434518","t":"A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[121],"l":[[121,"lung"]],"po":"2026-02-25","u":"2026-02-25","st":"2026-01","ag":"18–100"},{"n":"NCT07435038","t":"Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS","s":"rec","p":"phase1phase2","d":[4,5],"c":[23],"a":"adult older","h":[44],"po":"2026-02-27","u":"2026-09-18","st":"2026-01","ag":"18 and over"},{"n":"NCT07436741","t":"Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer","s":"rec","p":"phase3","d":[5],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"panc"]],"po":"2026-02-27","u":"2026-07-10","st":"2026-03","ag":"18–75"},{"n":"NCT07438106","t":"A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"panc"]],"po":"2026-02-27","u":"2026-08-12","st":"2026-01","ag":"18–75"},{"n":"NCT07439757","t":"AI-Powered Precision Decision-Making for Pancreatic Diseases","s":"rec","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[177],"l":[[177,"panc"]],"po":"2026-02-27","u":"2026-02-27","st":"2026-03","ag":"18–80"},{"n":"NCT07441460","t":"A Phase III Study of KN026 in Combination With HB1801 as Adjuvant Therapy for Resectable HER2-Positive Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[5],"a":"adult older","h":[9],"po":"2026-03-02","u":"2026-04-08","st":"2026-03","ag":"18 and over"},{"n":"NCT07441850","t":"Digital Rehabilitation for Gastric Cancer Surgery After Neoadjuvant Therapy","s":"rec","p":"na","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[39],"l":[[39,"gc"]],"po":"2026-03-02","u":"2026-07-09","st":"2026-03","ag":"18–70"},{"n":"NCT07441993","t":"Exploratory Study of Orelabrutinib in the Treatment of Early-stage Untreated MZL","s":"rec","p":"phase2","d":[19],"c":[2,15,8,0,27,9,40,30,13,20],"lc":[30],"a":"adult older","h":[69,36,113,161,124,37,110,27,70,10,57,14],"l":[[69,"lymph"]],"po":"2026-03-02","u":"2026-03-02","st":"2026-01","ag":"18 and over"},{"n":"NCT07444437","t":"A Phase II Trial of LM103 for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[0,20],"a":"adult older","h":[43,0,92],"po":"2026-03-03","u":"2026-05-13","st":"2026-02","ag":"18–75"},{"n":"NCT07444476","t":"A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With Risdiplam","s":"rec","p":"phase3","d":[40],"c":[2],"lc":[2],"a":"child adult","h":[38],"l":[[38,"sma"]],"po":"2026-03-03","u":"2026-11-18","st":"2026-09","ag":"15–60"},{"n":"NCT07449793","t":"Biochemical Response and Clinical Outcomes in Patients With PBC","s":"rec","p":"na","d":[50],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"pbc"]],"po":"2026-03-04","u":"2026-03-04","st":"2026-02","ag":"18–85"},{"n":"NCT07450872","t":"Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors","s":"rec","p":"na","d":[7],"c":[23],"lc":[23],"a":"child adult","h":[179],"l":[[179,"glioma"]],"po":"2026-03-05","u":"2026-06-05","st":"2026-01","ag":"8–18"},{"n":"NCT07452003","t":"An Exploratory Study of QL1706 Plus Chemotherapy in Perioperative NSCLC","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"lung"]],"po":"2026-03-05","u":"2026-03-05","st":"2026-01","ag":"18 and over"},{"n":"NCT07452198","t":"A Study of GR1803 Injection Versus Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Participants With Relapsed or Refractory Multiple Myeloma","s":"rec","p":"phase3","d":[15],"c":[30],"a":"adult older","h":[69],"po":"2026-03-05","u":"2026-03-25","st":"2026-03","ag":"18 and over"},{"n":"NCT07452601","t":"Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC","s":"rec","p":"phase2","d":[1],"c":[39],"lc":[39],"a":"adult older","h":[122],"l":[[122,"escc"]],"po":"2026-03-05","u":"2026-05-28","st":"2026-05","ag":"18–75"},{"n":"NCT07454187","t":"To Evaluate the Safety of SG2918 in Patients With Relapsed/Refractory Multiple Myeloma","s":"rec","p":"phase1phase2","d":[15],"c":[23,4,39,20],"a":"adult older","h":[5,37,97,54],"po":"2026-03-06","u":"2026-07-10","st":"2026-04","ag":"18–80"},{"n":"NCT07456371","t":"PIC1 Injection Therapy for Relapsed/Refractory B-NHL","s":"rec","p":"phase1","d":[19],"c":[13],"a":"adult older","h":[36],"po":"2026-03-06","u":"2026-03-06","st":"2026-03","ag":"18–75"},{"n":"NCT07457359","t":"Neoadjuvant Toripalimab Plus SBRT for Chemo-Resistant Triple-Negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2026-03-09","u":"2026-03-09","st":"2026-01","ag":"18–75"},{"n":"NCT07457528","t":"Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC","s":"rec","p":"phase2","d":[1],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"escc"]],"po":"2026-03-09","u":"2026-03-11","st":"2026-03","ag":"18–75"},{"n":"NCT07459283","t":"The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors","s":"rec","p":"earlyphase1","d":[4,6],"c":[60],"a":"adult older","h":[180],"po":"2026-03-09","u":"2026-09-04","st":"2026-04","ag":"18–75"},{"n":"NCT07459296","t":"Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC","s":"rec","p":"phase3","d":[0],"c":[10],"lc":[10],"a":"adult older","h":[15],"l":[[15,"npc"]],"po":"2026-03-09","u":"2026-11-09","st":"2026-03","ag":"18–70"},{"n":"NCT07459751","t":"A Global Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX43 Monotherapy or HLX43 in Combination With HLX07 Versus Docetaxel in Advanced or Metastatic Squamous Non-Small Cell Lung Cancer","s":"rec","p":"phase2phase3","d":[4],"c":[2],"a":"adult older","h":[23],"po":"2026-03-10","u":"2026-06-01","st":"2026-05","ag":"18 and over"},{"n":"NCT07461116","t":"Adverse Effects of ATG/ALG Therapy in Aplastic Anemia","s":"rec","p":"na","d":[17],"c":[30],"lc":[30],"a":"child adult older","h":[69],"l":[[69,"aa"]],"po":"2026-03-10","u":"2026-03-10","st":"2026-02","ag":"Not stated"},{"n":"NCT07461454","t":"YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[5],"a":"adult older","x":"female","h":[9],"po":"2026-03-10","u":"2026-05-26","st":"2026-03","ag":"18–75"},{"n":"NCT07463248","t":"PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy","s":"rec","p":"phase2","d":[2],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"hcc"]],"po":"2026-03-11","u":"2026-09-02","st":"2026-04","ag":"18–75"},{"n":"NCT07463573","t":"QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase3","d":[1],"c":[2],"a":"adult older","h":[74],"po":"2026-03-11","u":"2026-04-24","st":"2026-04","ag":"18 and over"},{"n":"NCT07464756","t":"SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"gc"]],"po":"2026-03-11","u":"2026-07-16","st":"2026-04","ag":"18 and over"},{"n":"NCT07465718","t":"Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.","s":"rec","p":"phase3","d":[29],"c":[2,23],"a":"child adult older","h":[54,181,39],"po":"2026-03-12","u":"2026-10-15","st":"2026-09","ag":"8 and over"},{"n":"NCT07467863","t":"Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC","s":"rec","p":"phase1phase2","d":[4],"c":[21],"a":"adult older","h":[126],"po":"2026-03-12","u":"2026-03-12","st":"2026-02","ag":"18–75"},{"n":"NCT07470073","t":"A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Kinetics of Universal Car-t Cell Injection in CD19 and / or CD20 Positive Relapsed / Refractory B-cell Acute Lymphoblastic Leukemia in Adolescents, Children and Adults","s":"rec","p":"earlyphase1","d":[16],"c":[13],"lc":[13],"a":"child adult older","h":[12],"l":[[12,"ball"]],"po":"2026-03-13","u":"2026-03-13","st":"2026-04","ag":"12–75"},{"n":"NCT07470151","t":"Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases","s":"rec","p":"na","d":[27],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"mg"]],"po":"2026-03-13","u":"2026-03-13","st":"2026-03","ag":"18–70"},{"n":"NCT07471776","t":"Study on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2026-03-13","u":"2026-03-13","st":"2026-03","ag":"18 and over"},{"n":"NCT07472478","t":"Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12C-Mutant NSCLC (GIVEN Study)","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"lung"]],"po":"2026-03-16","u":"2026-10-23","st":"2026-03","ag":"18–80"},{"n":"NCT07472517","t":"DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy","s":"rec","p":"phase3","d":[4],"c":[2,55,8,22,16,0,23,24,27,25,9,28,10,61,5,12,30,37,13,38,31,32,20],"a":"adult older","h":[40,42,56,53,57,58,25,12,74,45,46,13,47,80,14,164,81,37,82,60,61,30,49,182,63,64,121,50,84,86,67],"po":"2026-03-16","u":"2026-11-10","st":"2026-04","ag":"18 and over"},{"n":"NCT07474324","t":"Disitamab Vedotin Combined With SOX Regimen Versus SOX Alone as Adjuvant Therapy for HER2-Moderate/High Expressing Stage Ⅲ Gastric Cancer: A Prospective, Multicenter, Randomized, Phase Ⅱ Clinical Trial","s":"rec","p":"phase2","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"gc"]],"po":"2026-03-16","u":"2026-03-16","st":"2026-03","ag":"18–75"},{"n":"NCT07475026","t":"A Study of Neoadjuvant Tislelizumab Plus Lenvatinib in Resectable HCC at High Risk of Recurrence","s":"rec","p":"phase3","d":[2],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"hcc"]],"po":"2026-03-16","u":"2026-08-05","st":"2026-06","ag":"18–75"},{"n":"NCT07476287","t":"Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[2,16,23,9,5,13,20],"a":"adult older","h":[42,38,12,46,14,37,30],"po":"2026-03-17","u":"2026-10-09","st":"2026-07","ag":"18 and over"},{"n":"NCT07477587","t":"A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma","s":"rec","p":"phase1","d":[15],"c":[2,55,8,22,1,16,0,41,23,24,17,27,9,28,61,26,5,11,21,18,4,12,30,42,37,13,60,7,31,20],"a":"adult older","h":[46,89,64,12,6,36,37,29,136,25,10,98,133,80,58,183,137,55,8,143,31,115,45,113,184,164,185,92,79,118,82,120,175,43,14,182,186,0,187,188,180,126,189,114,84,88],"po":"2026-03-17","u":"2026-09-24","st":"2026-05","ag":"18 and over"},{"n":"NCT07478302","t":"A Study of SHR-2524 Plus Bevacizumab in the First-line Treatment of Advanced Hepatocellular Carcinoma","s":"rec","p":"phase1","d":[2],"c":[16,10],"a":"adult older","h":[15,190],"po":"2026-03-17","u":"2026-05-01","st":"2026-04","ag":"18 and over"},{"n":"NCT07478809","t":"A Retrospective Real-World Study Based on RATIONALE-307","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"child adult older","h":[23],"l":[[23,"lung"]],"po":"2026-03-18","u":"2026-03-27","st":"2026-02","ag":"Not stated"},{"n":"NCT07479485","t":"MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)","s":"rec","p":"phase1phase2","d":[2],"c":[2,16,28,30,20],"a":"adult older","h":[78,23,58,190,181,38,37],"po":"2026-03-18","u":"2026-07-28","st":"2026-04","ag":"18 and over"},{"n":"NCT07479732","t":"Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma","s":"rec","p":"phase1phase2","d":[11],"c":[2],"lc":[2],"a":"child adult older","h":[48],"l":[[48,"os"]],"po":"2026-03-18","u":"2026-03-18","st":"2026-03","ag":"12–65"},{"n":"NCT07480213","t":"Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)","s":"rec","p":"phase1phase2","d":[4],"c":[21],"a":"adult older","h":[126],"po":"2026-03-18","u":"2026-11-12","st":"2026-02","ag":"18–75"},{"n":"NCT07480941","t":"Dual-Targeting CAR-NK Cell Therapy for Recurrent/Progressive Glioblastoma and High-Grade Glioma","s":"rec","p":"phase1","d":[7],"c":[21],"a":"adult older","h":[126],"po":"2026-03-18","u":"2026-11-12","st":"2026-02","ag":"18–75"},{"n":"NCT07481669","t":"ASCT With TEAM Conditioning for Lymphoma With High Risk of CNS Relapse","s":"rec","p":"phase2","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lymph"]],"po":"2026-03-19","u":"2026-03-19","st":"2026-03","ag":"18–70"},{"n":"NCT07481786","t":"Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases","s":"rec","p":"phase3","d":[4],"c":[1,0],"lc":[0],"a":"adult older","h":[53,79,108],"l":[[53,"lung"]],"po":"2026-03-19","u":"2026-04-06","st":"2026-03","ag":"18 and over"},{"n":"NCT07482059","t":"A Multicenter Clinical Study of Combined Therapy for Unresectable Hepatocellular Carcinoma","s":"rec","p":"phase1phase2","d":[2],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"hcc"]],"po":"2026-03-19","u":"2026-03-19","st":"2026-02","ag":"18–80"},{"n":"NCT07483359","t":"Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus","s":"rec","p":"phase2","d":[2],"c":[11],"lc":[11],"a":"adult older","h":[118],"l":[[118,"hcc"]],"po":"2026-03-19","u":"2026-05-28","st":"2026-05","ag":"18–80"},{"n":"NCT07483554","t":"IBI343 in Combination Therapy for Advanced Malignant Solid Tumors","s":"rec","p":"phase2","d":[3,5],"c":[23],"a":"adult older","h":[46],"po":"2026-03-19","u":"2026-06-03","st":"2026-04","ag":"18 and over"},{"n":"NCT07484087","t":"Ablation Compare With Surgery for Early Breast Cancer","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[48],"l":[[48,"breast"]],"po":"2026-03-19","u":"2026-03-19","st":"2026-01","ag":"50 and over"},{"n":"NCT07486089","t":"Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)","s":"rec","p":"phase1phase2","d":[6],"c":[21],"a":"adult older","h":[126],"po":"2026-03-20","u":"2026-03-20","st":"2026-02","ag":"18–75"},{"n":"NCT07486817","t":"Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"lung"]],"po":"2026-03-23","u":"2026-11-09","st":"2026-06","ag":"18 and over"},{"n":"NCT07487662","t":"TACE or Ablation Combined With Sintilimab and Ipilimumab N01 as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With Intermediate-High Recurrence Risk","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[49],"l":[[49,"hcc"]],"po":"2026-03-23","u":"2026-10-27","st":"2026-03","ag":"18–75"},{"n":"NCT07487883","t":"Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"lung"]],"po":"2026-03-23","u":"2026-04-02","st":"2026-03","ag":"18 and over"},{"n":"NCT07489066","t":"Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC","s":"rec","p":"phase2","d":[4],"c":[2,0,5],"a":"adult older","h":[9,43,74],"po":"2026-03-23","u":"2026-10-08","st":"2026-06","ag":"18 and over"},{"n":"NCT07490262","t":"A Study to Evaluate the Efficacy and Safety of IBI310 and Sintilimab Combination Therapy in Patients With Hepatocellular Carcinoma as First-line Treatment.","s":"rec","p":"phase2phase3","d":[2],"c":[5],"a":"adult older","h":[6],"po":"2026-03-24","u":"2026-04-16","st":"2026-03","ag":"18–75"},{"n":"NCT07490613","t":"A Phase I Study of SHR-3836 in Patients With Multiple Myeloma","s":"rec","p":"phase1","d":[15],"c":[4],"a":"adult older","h":[5],"po":"2026-03-24","u":"2026-06-04","st":"2026-06","ag":"18 and over"},{"n":"NCT07490938","t":"Electroacupuncture vs. Auricular Acupressure vs. Waitlist Control for Breast Cancer Endocrine Therapy-Related Joint Pain","s":"rec","p":"na","d":[6],"c":[30,13,62],"lc":[30],"a":"adult older","x":"female","h":[191,58,19,192],"l":[[191,"breast"]],"po":"2026-03-24","u":"2026-09-02","st":"2026-04","ag":"18–75"},{"n":"NCT07492342","t":"Fulzerasib Sequential Sintilimab Plus Platinum-Doublet Neoadjuvant Therapy for Resectable KRAS G12C-Mutant NSCLC","s":"rec","p":"phase2","d":[4],"c":[2,0,23],"a":"adult older","h":[38,132,46],"po":"2026-03-25","u":"2026-03-25","st":"2026-01","ag":"18 and over"},{"n":"NCT07492615","t":"A Clinical Study of Sintilimab Combined With Chemothrapy Versus Chemotherapy as Adjuvant Therapy for Gastric/Gastroesophageal Junction Adenocarcinoma","s":"rec","p":"phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"gc"]],"po":"2026-03-25","u":"2026-03-25","st":"2026-01","ag":"18 and over"},{"n":"NCT07492641","t":"BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease","s":"rec","p":"phase3","d":[6],"c":[2,55,8,22,1,16,0,6,23,24,17,47,9,28,10,40,5,43,18,30,42,37,13,39,20],"a":"adult older","h":[9,78,58,45,99,24,74,79,25,12,125,11,164,110,81,97,140,50,135,68,82,7,19,30,98,114,116,175],"po":"2026-03-25","u":"2026-10-26","st":"2026-05","ag":"18 and over"},{"n":"NCT07493044","t":"An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma","s":"rec","p":"phase1","d":[2],"c":[0],"a":"adult older","h":[53],"po":"2026-03-25","u":"2026-05-14","st":"2026-03","ag":"18–75"},{"n":"NCT07493109","t":"Chidamide for Maintenance Treatment of HBV-infected Diffuse DLBCL in Patients Initially Treated With R-CHOP","s":"rec","p":"phase3","d":[19],"c":[15],"a":"adult older","h":[27],"po":"2026-03-25","u":"2026-03-25","st":"2026-05","ag":"18–80"},{"n":"NCT07493135","t":"A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma","s":"rec","p":"earlyphase1","d":[15],"c":[5],"a":"adult older","h":[41],"po":"2026-03-25","u":"2026-09-03","st":"2026-04","ag":"18–80"},{"n":"NCT07493148","t":"Chidamide Combination With R-mini CHOP Followed by Chidamide+CD20 Maintenance in Elderly Newly Diagnosed MYC/BCL2+ DLBCL","s":"rec","p":"phase2","d":[19],"c":[15],"a":"older","h":[27],"po":"2026-03-25","u":"2026-03-25","st":"2026-04","ag":"70 and over"},{"n":"NCT07493421","t":"To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.","s":"rec","p":"na","d":[5],"c":[5],"a":"adult older","h":[6],"po":"2026-03-25","u":"2026-03-25","st":"2026-03","ag":"18 and over"},{"n":"NCT07494565","t":"Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL","s":"rec","p":"phase2","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2026-03-27","u":"2026-07-22","st":"2026-03","ag":"18–80"},{"n":"NCT07495735","t":"Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[37],"lc":[37],"a":"adult older","h":[81],"l":[[81,"hcc"]],"po":"2026-03-27","u":"2026-08-04","st":"2026-03","ag":"18 and over"},{"n":"NCT07496190","t":"Becotatug Vedotin for LA-NPC With a Suboptimal Response to Induction Chemotherapy Combined With Immunotherapy","s":"rec","p":"phase2","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2026-03-27","u":"2026-04-13","st":"2026-02","ag":"18–70"},{"n":"NCT07496229","t":"Assessing Treatment of T-Cell Lymphoma With GW5282 in Combination With Golidocitinib (BEI-DOU3)","s":"rec","p":"phase1phase2","d":[19],"c":[22,1,16,28,10,5,12,37,13,20],"a":"adult older","h":[40,12,9,37,2,60,92,30,81,50,84],"po":"2026-03-27","u":"2026-10-22","st":"2026-04","ag":"18 and over"},{"n":"NCT07497386","t":"A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[2],"a":"adult older","x":"female","h":[23],"po":"2026-03-27","u":"2026-05-11","st":"2026-04","ag":"18–75"},{"n":"NCT07498478","t":"Efficacy and Safety of Tinengotinib Tablets Combined With Fulvestrant Injection in Patients With HR Positive and HER-2 Negative Recurrent or Metastatic Breast Cancer Who Have Failed Prior Treatment","s":"rec","p":"phase2","d":[6],"c":[2,8,1,0,23,27,25,28,5,30,13],"a":"adult older","x":"female","h":[9,23,78,58,74,44,43,26,133,57,13,193,67],"po":"2026-03-27","u":"2026-03-27","st":"2026-03","ag":"18 and over"},{"n":"NCT07498673","t":"A Study of YKST02 in Participants With Primary IgA Nephropathy","s":"rec","p":"earlyphase1","d":[46],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"iga"]],"po":"2026-03-27","u":"2026-05-12","st":"2026-05","ag":"18–75"},{"n":"NCT07499271","t":"Genetic Subtype-matched Targeted Therapy for the Treatment of Newly Diagnosed DLBCL With TP53 Mutation","s":"rec","p":"phase2","d":[19],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"lymph"]],"po":"2026-03-30","u":"2026-03-30","st":"2026-01","ag":"18–70"},{"n":"NCT07500220","t":"Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC","s":"rec","p":"phase1phase2","d":[2],"c":[21],"a":"adult older","h":[126],"po":"2026-03-30","u":"2026-03-30","st":"2026-03","ag":"18–75"},{"n":"NCT07500428","t":"Construction of a Benchmark for Breast Ultrasound AI Interpretation and Performance Evaluation of Multimodal AI Models","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[38],"l":[[38,"breast"]],"po":"2026-03-30","u":"2026-03-30","st":"2026-03","ag":"18–75"},{"n":"NCT07501351","t":"Efficacy and Safety Comparison Between Intensified Therapy and Conversion Therapy For Advanced HCC After Failure of First-line","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"hcc"]],"po":"2026-03-30","u":"2026-03-30","st":"2026-01","ag":"18–75"},{"n":"NCT07501559","t":"A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)","s":"rec","p":"phase1phase2","d":[7],"c":[5],"a":"adult older","h":[103],"po":"2026-03-30","u":"2026-08-10","st":"2026-06","ag":"18 and over"},{"n":"NCT07502287","t":"Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma","s":"rec","p":"phase1phase2","d":[13],"c":[21],"a":"child adult","h":[126],"po":"2026-03-30","u":"2026-11-12","st":"2026-03","ag":"12 months–21"},{"n":"NCT07502300","t":"A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing Chemotherapy Combined With Tislelizumab as First-line Treatment in Patients With Extensive-stage Small Cell Lung Cancer(PANKU-Lung07)","s":"rec","p":"phase3","d":[4],"c":[5,20],"a":"adult older","h":[37,65],"po":"2026-03-30","u":"2026-10-28","st":"2026-06","ag":"18 and over"},{"n":"NCT07502768","t":"Tislelizumab Plus Zeprumetostat for Relapsed or Refractory NK/T-Cell Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lymph"]],"po":"2026-03-31","u":"2026-06-18","st":"2026-04","ag":"18 and over"},{"n":"NCT07504367","t":"Large Language Models Assist in Tumor MDT","s":"rec","p":"na","d":[3,4,6],"c":[0],"lc":[0],"a":"adult","h":[99],"l":[[99,"gc"]],"po":"2026-03-31","u":"2026-03-31","st":"2026-01","ag":"25–33"},{"n":"NCT07504471","t":"Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases","s":"rec","p":"phase2","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"panc"]],"po":"2026-03-31","u":"2026-03-31","st":"2026-03","ag":"18 and over"},{"n":"NCT07505173","t":"Hippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metastases in EGFR-Mutated Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2026-04-01","u":"2026-04-01","st":"2026-01","ag":"18–75"},{"n":"NCT07505186","t":"Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"escc"]],"po":"2026-04-01","u":"2026-10-02","st":"2026-08","ag":"18–75"},{"n":"NCT07507201","t":"Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease","s":"rec","p":"earlyphase1","d":[46],"c":[23],"lc":[23],"a":"child adult older","h":[179],"l":[[179,"iga"]],"po":"2026-04-02","u":"2026-04-02","st":"2026-04","ag":"3 and over"},{"n":"NCT07507318","t":"Chidamide Maintenance for MRD-Positive Double-Expressor DLBCL in First Complete Remission","s":"rec","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lymph"]],"po":"2026-04-02","u":"2026-06-18","st":"2026-06","ag":"18–80"},{"n":"NCT07509333","t":"MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients","s":"rec","p":"na","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"lung"]],"po":"2026-04-03","u":"2026-09-03","st":"2026-04","ag":"60–90"},{"n":"NCT07510802","t":"Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC","s":"rec","p":"phase1phase2","d":[6],"c":[21],"a":"adult older","h":[126],"po":"2026-04-06","u":"2026-04-06","st":"2026-02","ag":"18–75"},{"n":"NCT07511725","t":"Prophylactic Regimen With Intrathecal Thiotepa in SVZ-positive or Meningeal-risk Glioblastoma","s":"rec","p":"phase2","d":[7],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"glioma"]],"po":"2026-04-06","u":"2026-04-06","st":"2026-01","ag":"18–75"},{"n":"NCT07514052","t":"Predicting Response to Selinexor-Based Therapy in Relapsed/Refractory Multiple Myeloma: A Multicenter Prospective Study","s":"rec","p":"na","d":[15],"c":[12],"lc":[12],"a":"adult older","h":[22],"l":[[22,"mm"]],"po":"2026-04-07","u":"2026-04-07","st":"2026-01","ag":"18 and over"},{"n":"NCT07514169","t":"The Efficacy and Safety of Pola-ZR-Glo in Older Treatment-naive Patients With LBCL","s":"rec","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"older","h":[123],"l":[[123,"lymph"]],"po":"2026-04-07","u":"2026-05-08","st":"2026-03","ag":"70 and over"},{"n":"NCT07514611","t":"Weight Loss Via Intelligent Guidance in Patients With Coronary Heart Disease and Obesity: a Randomized Clinical Trial","s":"rec","p":"na","d":[31],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"cad"]],"po":"2026-04-07","u":"2026-05-12","st":"2026-04","ag":"18–65"},{"n":"NCT07515027","t":"Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung Cancer Surgery","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2026-04-07","u":"2026-04-13","st":"2026-04","ag":"18 and over"},{"n":"NCT07517107","t":"Dynamic Circulating Tumor DNA Monitoring to Guide Systemic Therapy in Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"gc"]],"po":"2026-04-08","u":"2026-04-08","st":"2026-01","ag":"18 and over"},{"n":"NCT07518147","t":"A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment","s":"rec","p":"phase3","d":[3],"c":[2],"a":"adult older","h":[74],"po":"2026-04-08","u":"2026-11-02","st":"2026-05","ag":"18–75"},{"n":"NCT07518160","t":"JS212 Plus JS111 in EGFR-Mutant Advanced NSCLC: A Phase II Study","s":"rec","p":"phase2","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2026-04-08","u":"2026-07-07","st":"2026-04","ag":"18–75"},{"n":"NCT07518173","t":"A Study of BL-M07D1 Combined With Pertuzumab Versus Docetaxel Plus Trastuzumab and Pertuzumab in Patients With First-line HER2-positive Recurrent or Metastatic Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[22,0],"a":"adult older","x":"female","h":[40,99],"po":"2026-04-08","u":"2026-06-04","st":"2026-04","ag":"18–75"},{"n":"NCT07518186","t":"A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma","s":"rec","p":"phase3","d":[15],"c":[2,15,22,23,9,28,21,30,37,13,39],"a":"adult older","h":[46,89,69,38,36,27,60,97,29,98,58,81,14,126],"po":"2026-04-08","u":"2026-09-25","st":"2026-05","ag":"18 and over"},{"n":"NCT07519486","t":"Intensive Nutritional Support in Conversion Therapy for Locally Advanced Unresectable ESCC","s":"rec","p":"phase2","d":[1],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"escc"]],"po":"2026-04-09","u":"2026-04-15","st":"2026-04","ag":"18–80"},{"n":"NCT07519772","t":"A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)","s":"rec","p":"phase1phase2","d":[19],"c":[2,16,0,5,20],"a":"adult older","h":[53,74,9,37,30],"po":"2026-04-09","u":"2026-11-13","st":"2026-05","ag":"18 and over"},{"n":"NCT07520760","t":"A Multicenter, Single-Arm, Phase II Exploratory Study of Eribulin in Combination With Anlotinib for HER2-Negative Recurrent/Metastatic Breast Cancer Previously Treated With Antibody-Drug Conjugates","s":"rec","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[53],"l":[[53,"breast"]],"po":"2026-04-09","u":"2026-04-09","st":"2026-04","ag":"18 and over"},{"n":"NCT07521007","t":"A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis","s":"rec","p":"phase2","d":[31],"c":[2,15,8,22,16,0,23,24,17,33,5,4,30,13,39],"a":"adult older","h":[40,43,10,140,194,112,27,68,5,144,98,195,133,183,41,196,197],"po":"2026-04-09","u":"2026-11-05","st":"2026-07","ag":"18–80"},{"n":"NCT07521852","t":"A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and PK of CVM-1118 in Combination With Sintilimab and TACE in Participants With Incurable/Non-metastatic HCC","s":"rec","p":"phase2","d":[2],"c":[16,5],"a":"adult older","h":[6,190],"po":"2026-04-13","u":"2026-07-23","st":"2026-03","ag":"18 and over"},{"n":"NCT07522151","t":"Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer","s":"rec","p":"phase3","d":[3],"c":[2],"a":"adult older","h":[74],"po":"2026-04-13","u":"2026-05-13","st":"2026-05","ag":"18–75"},{"n":"NCT07523529","t":"Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors","s":"rec","p":"phase1phase2","d":[2,3],"c":[21],"a":"adult older","h":[126],"po":"2026-04-13","u":"2026-04-13","st":"2026-03","ag":"18–75"},{"n":"NCT07523555","t":"Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies","s":"rec","p":"phase1phase2","d":[15,19],"c":[21],"a":"adult older","h":[126],"po":"2026-04-13","u":"2026-04-13","st":"2026-03","ag":"18–75"},{"n":"NCT07523737","t":"Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[161],"l":[[161,"lymph"]],"po":"2026-04-13","u":"2026-04-15","st":"2026-04","ag":"18–75"},{"n":"NCT07525466","t":"Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH)","s":"rec","p":"phase1phase2","d":[18,19],"c":[2],"lc":[2],"a":"adult older","h":[161],"l":[[161,"hlh"]],"po":"2026-04-13","u":"2026-04-13","st":"2026-04","ag":"18 and over"},{"n":"NCT07525765","t":"AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer","s":"rec","p":"na","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"gc"]],"po":"2026-04-13","u":"2026-04-13","st":"2026-04","ag":"18–90"},{"n":"NCT07526493","t":"Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.","s":"rec","p":"phase1","d":[25,27],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"nmosd"]],"po":"2026-04-13","u":"2026-05-12","st":"2026-04","ag":"18–75"},{"n":"NCT07527689","t":"Ultra-Hypofractionated vs Moderate Hypofractionated Radiotherapy for Regional Lymph Nodes in High Risk Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[123],"l":[[123,"breast"]],"po":"2026-04-14","u":"2026-06-30","st":"2026-04","ag":"18 and over"},{"n":"NCT07528066","t":"Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC","s":"rec","p":"na","d":[4],"c":[16,0,28,26,5,21,30],"lc":[5],"a":"child adult older","h":[42,58,43,127,55,140,168],"l":[[42,"lung"]],"po":"2026-04-14","u":"2026-04-14","st":"2026-03","ag":"Not stated"},{"n":"NCT07528183","t":"Maintenance Immunotherapy With Deferred Salvage Radiotherapy After Response to Chemoimmunotherapy in Recurrent Nasopharyngeal Carcinoma","s":"rec","p":"phase2","d":[0],"c":[16,0,10,13],"lc":[0],"a":"adult older","h":[53,30,50,12],"l":[[53,"npc"]],"po":"2026-04-14","u":"2026-07-23","st":"2026-07","ag":"18–70"},{"n":"NCT07528274","t":"Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure","s":"rec","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2026-04-14","u":"2026-04-14","st":"2026-05","ag":"18 and over"},{"n":"NCT07528716","t":"Artificial Intelligence Model-Guided Neoadjuvant Anti-HER2 Targeted Therapy","s":"rec","p":"phase3","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2026-04-14","u":"2026-07-08","st":"2026-05","ag":"18–75"},{"n":"NCT07529626","t":"Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer","s":"rec","p":"na","d":[5],"c":[8,5,39],"lc":[5],"a":"adult older","h":[6,111,20],"l":[[6,"panc"]],"po":"2026-04-14","u":"2026-06-29","st":"2026-05","ag":"18 and over"},{"n":"NCT07529782","t":"Study to Assess Safety and Efficacy of HDP-101 in Chinese Patients With Relapsed or Refractory Multiple Myeloma","s":"rec","p":"phase1","d":[15],"c":[2,23,27,4,30],"a":"child adult","h":[46,89,69,5,124],"po":"2026-04-14","u":"2026-04-14","st":"2026-03","ag":"Up to 18"},{"n":"NCT07533123","t":"A Phase III Study of JSKN016 Versus Treatment of Physician's Choice in Patients With Triple-Negative Breast Cancer Who Have Failed Standard of Care","s":"rec","p":"phase3","d":[6],"c":[0],"a":"adult older","h":[99],"po":"2026-04-16","u":"2026-04-16","st":"2026-03","ag":"18–75"},{"n":"NCT07536789","t":"Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"hcc"]],"po":"2026-04-17","u":"2026-04-21","st":"2026-04","ag":"18 and over"},{"n":"NCT07537348","t":"Safety and Efficacy of Leucine-Restricted Diet Combined With Chemotherapy and Immunotherapy in Advanced Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[27],"lc":[27],"a":"adult older","h":[124],"l":[[124,"gc"]],"po":"2026-04-17","u":"2026-04-17","st":"2026-01","ag":"18–70"},{"n":"NCT07537361","t":"Safety and Efficacy of Leucine-Restricted Diet Combined With Neoadjuvant Chemotherapy and Immunotherapy in Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[27],"lc":[27],"a":"adult older","h":[124],"l":[[124,"gc"]],"po":"2026-04-17","u":"2026-04-17","st":"2026-01","ag":"18–70"},{"n":"NCT07538635","t":"CAR-T Combined With ASCT in the Treatment of Relapsed/Refractory Large B-cell Lymphoma With High-risk Factors.","s":"rec","p":"phase2","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"lymph"]],"po":"2026-04-20","u":"2026-05-13","st":"2026-04","ag":"18 and over"},{"n":"NCT07538882","t":"AI-Assisted Staging and Treatment Decision-Making for Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[2],"a":"adult older","h":[100],"po":"2026-04-20","u":"2026-04-20","st":"2026-04","ag":"18 and over"},{"n":"NCT07540533","t":"A Multicohort Study of Toripalimab in Combination With Investigator-Selected Chemotherapy for Advanced HER2-Negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"breast"]],"po":"2026-04-20","u":"2026-04-20","st":"2026-01","ag":"18 and over"},{"n":"NCT07541170","t":"A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)","s":"rec","p":"phase3","d":[4],"c":[2,15,22,63,0,23,17,27,9,21,4,29,30],"a":"adult older","h":[58,43,5,74,113,54,47,27,80,14,82,68,168,66,198,199],"po":"2026-04-21","u":"2026-11-09","st":"2026-10","ag":"18 and over"},{"n":"NCT07541521","t":"RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC","s":"rec","p":"na","d":[4],"c":[16,0,28,26,5,21,30],"lc":[5],"a":"child adult older","h":[42,58,43,127,55,140,168],"l":[[42,"lung"]],"po":"2026-04-21","u":"2026-04-21","st":"2026-04","ag":"Not stated"},{"n":"NCT07541664","t":"Digital Mind-Body Therapy for Neoadjuvant Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2026-04-21","u":"2026-04-21","st":"2026-03","ag":"18 and over"},{"n":"NCT07543536","t":"Megestrol Acetate for Fatigue Management in T-DXd Treated Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[53],"l":[[53,"breast"]],"po":"2026-04-22","u":"2026-08-14","st":"2026-06","ag":"18–75"},{"n":"NCT07544056","t":"A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer","s":"rec","p":"phase2phase3","d":[6],"c":[8,0],"a":"adult older","x":"female","h":[99,13],"po":"2026-04-22","u":"2026-08-18","st":"2026-06","ag":"18–75"},{"n":"NCT07545395","t":"Safety of KN057 Prophylaxis in Patients With Haemophilia A or B","s":"rec","p":"phase3","d":[21],"c":[30],"a":"child adult older","x":"male","h":[69],"po":"2026-04-22","u":"2026-04-22","st":"2026-03","ag":"12–65"},{"n":"NCT07547553","t":"A Phase Ib/II Trial to Evaluate the Efficacy and Safety of HH-009 for the Treatment of FGF19-positive Advanced or Unresectable HCC","s":"rec","p":"phase1phase2","d":[2],"c":[2,55,15,16,0,24,17,9,28,10,5,11,30,20],"a":"adult older","h":[6,26,50,70,112,68,58,190,27,153,45,164,37,18,96,116,105],"po":"2026-04-23","u":"2026-06-16","st":"2026-05","ag":"18–75"},{"n":"NCT07548060","t":"A Phase II Study of Sacituzumab Tirumotecan in Combination With Furmonertinib in Patients With Non-squamous Non-Small Cell Lung Cancer Who Have Progressed After EGFR-TKI and Platinum-Based Chemotherapy","s":"rec","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2026-04-23","u":"2026-04-23","st":"2026-02","ag":"18–75"},{"n":"NCT07548697","t":"A Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin Lymphoma","s":"rec","p":"earlyphase1","d":[19],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lymph"]],"po":"2026-04-23","u":"2026-04-23","st":"2026-04","ag":"18–75"},{"n":"NCT07549061","t":"Vebreltinib Plus Chemotherapy as First-line Treatment for MET-overexpressing NSCLC","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2026-04-23","u":"2026-11-10","st":"2026-09","ag":"18 and over"},{"n":"NCT07551050","t":"Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2026-04-24","u":"2026-04-24","st":"2026-05","ag":"18–75"},{"n":"NCT07551336","t":"Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma","s":"rec","p":"phase1","d":[7],"c":[21],"a":"adult older","h":[126],"po":"2026-04-24","u":"2026-11-12","st":"2026-03","ag":"18–75"},{"n":"NCT07551362","t":"Dual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ Cancer","s":"rec","p":"phase1phase2","d":[3],"c":[21],"a":"adult older","h":[126],"po":"2026-04-24","u":"2026-11-12","st":"2026-03","ag":"18–75"},{"n":"NCT07551466","t":"AI Model for Early Gastric Cancer Diagnosis Using Endoscopic Imaging","s":"rec","p":"na","d":[3],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"gc"]],"po":"2026-04-24","u":"2026-04-24","st":"2026-05","ag":"18–80"},{"n":"NCT07552233","t":"NK Cell Therapy for Malignant Solid Brain Tumors","s":"rec","p":"na","d":[7],"c":[2,20],"lc":[2],"a":"adult older","h":[115,200],"l":[[115,"glioma"]],"po":"2026-04-27","u":"2026-04-27","st":"2026-04","ag":"18–70"},{"n":"NCT07552402","t":"Oral Paclitaxel Plus Fruquintinib Verus Investigator's Choice in Second-Line Advanced Gastric Cancer","s":"rec","p":"na","d":[3],"c":[2,22,52,16,23,10,5,18,4,13,58],"a":"adult older","h":[40,140,44,24,12,41,15,187,115,172,155],"po":"2026-04-27","u":"2026-10-28","st":"2026-06","ag":"18–75"},{"n":"NCT07552467","t":"Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors","s":"rec","p":"na","d":[4,5,6,7],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lung"]],"po":"2026-04-27","u":"2026-04-27","st":"2026-04","ag":"18 and over"},{"n":"NCT07554339","t":"A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)","s":"rec","p":"phase3","d":[4],"c":[2,8,22,1,16,0,57,23,17,27,28,10,5,18,12,29,34,37,13,7],"a":"adult older","h":[40,42,57,9,38,44,132,6,12,74,10,24,13,47,81,60,30,2,19,50,170,66,72,8,84,88],"po":"2026-04-28","u":"2026-11-12","st":"2026-06","ag":"18 and over"},{"n":"NCT07554456","t":"A Study of BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizumab as First-line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus02)","s":"rec","p":"phase2phase3","d":[1],"c":[2],"a":"adult older","h":[74],"po":"2026-04-28","u":"2026-07-16","st":"2026-06","ag":"18–75"},{"n":"NCT07554846","t":"Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLC","s":"rec","p":"phase3","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2026-04-28","u":"2026-09-10","st":"2026-05","ag":"18–75"},{"n":"NCT07554898","t":"Ultra-low-dose Radiation Therapy Followed by Orelabrutinib as First-line Treatment for Stage Ⅰ-Ⅱ MALT Lymphoma","s":"rec","p":"phase2","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[44,46],"l":[[44,"lymph"]],"po":"2026-04-28","u":"2026-05-11","st":"2026-04","ag":"18 and over"},{"n":"NCT07554924","t":"A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I","s":"rec","p":"phase1phase2","d":[40],"c":[2,23,5],"a":"child","h":[76,179,29],"po":"2026-04-28","u":"2026-10-14","st":"2026-07","ag":"Up to 180 days"},{"n":"NCT07555470","t":"Mosunetuzumab and Zeprumetostat in Treating Patients With Follicular Lymphoma","s":"rec","p":"phase2","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"lymph"]],"po":"2026-04-29","u":"2026-06-09","st":"2026-04","ag":"18 and over"},{"n":"NCT07555938","t":"Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma","s":"rec","p":"phase3","d":[15],"c":[0,23,27,47,28,26,5,4,30,37,13],"a":"adult older","h":[46,69,5,41,6,36,60,53,55,81,70,124,201],"po":"2026-04-29","u":"2026-11-18","st":"2026-06","ag":"18 and over"},{"n":"NCT07556640","t":"LM-302 and S-1 Plus Intraperitoneal Paclitaxel With or Without Cadonilimab for Claudin 18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis: a Prospective, Exploratory Study","s":"rec","p":"phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"gc"]],"po":"2026-04-29","u":"2026-04-29","st":"2026-04","ag":"18 and over"},{"n":"NCT07557225","t":"18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors","s":"rec","p":"na","d":[2,4,5,6],"c":[2],"lc":[2],"a":"adult older","h":[29],"l":[[29,"hcc"]],"po":"2026-04-29","u":"2026-05-14","st":"2026-04","ag":"18 and over"},{"n":"NCT07557446","t":"A Dose REgimen-Finding Study of AGA2115 in Chinese Patients With Osteogenesis ImpeRfecta (EIR)","s":"rec","p":"phase2","d":[49],"c":[2,8,5,21,4],"a":"child adult older","h":[38,202,32,203,10],"po":"2026-04-29","u":"2026-09-22","st":"2026-07","ag":"12–75"},{"n":"NCT07557654","t":"Opportunistic Breast Cancer Screening Using Non-Contrast Chest CT","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2026-04-29","u":"2026-10-29","st":"2026-05","ag":"18 and over"},{"n":"NCT07559045","t":"Induction Chemo-Immunotherapy + Radiotherapy vs Concurrent Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[64],"lc":[64],"a":"adult older","h":[204],"l":[[204,"escc"]],"po":"2026-04-30","u":"2026-04-30","st":"2026-01","ag":"18–75"},{"n":"NCT07559786","t":"A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy","s":"rec","p":"phase2","d":[4],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"lung"]],"po":"2026-04-30","u":"2026-07-21","st":"2026-07","ag":"18–75"},{"n":"NCT07559877","t":"Topical Chlorhexidine Spray for the Prevention of Acute Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma:","s":"rec","p":"phase3","d":[0],"c":[9],"lc":[9],"a":"adult older","h":[116],"l":[[116,"npc"]],"po":"2026-04-30","u":"2026-11-18","st":"2026-04","ag":"18–75"},{"n":"NCT07559929","t":"A Study of DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung Cancer.","s":"rec","p":"phase1phase2","d":[4],"c":[0],"a":"adult older","h":[53],"po":"2026-04-30","u":"2026-09-24","st":"2026-08","ag":"18–75"},{"n":"NCT07560111","t":"A Phase II Study of GC101 in NSCLC","s":"rec","p":"phase2","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2026-04-30","u":"2026-08-05","st":"2026-06","ag":"18–70"},{"n":"NCT07560488","t":"Ipilimumab N01 Combined With Sintilimab, Bevacizumab Biosimilar, and Hepatic Arterial Infusion Chemotherapy as Conversion Therapy for Unresectable Intermediate-Advanced Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"hcc"]],"po":"2026-05-01","u":"2026-05-01","st":"2026-03","ag":"18–75"},{"n":"NCT07561567","t":"Feasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation Device","s":"rec","p":"na","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2026-05-01","u":"2026-05-01","st":"2026-05","ag":"18 and over"},{"n":"NCT07561723","t":"IMP3-saRNA Vaccine in Advanced NSCLC","s":"rec","p":"phase1","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"lung"]],"po":"2026-05-01","u":"2026-05-12","st":"2026-04","ag":"18 and over"},{"n":"NCT07562022","t":"A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma","s":"rec","p":"phase3","d":[19],"c":[2],"a":"adult older","h":[74],"po":"2026-05-01","u":"2026-08-13","st":"2026-06","ag":"18–80"},{"n":"NCT07562581","t":"A Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC","s":"rec","p":"phase2","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2026-05-01","u":"2026-09-02","st":"2026-06","ag":"18–75"},{"n":"NCT07564557","t":"Septum-guided Segmentectomy for Deep Early-stage Lung Cancer (SGS2512)","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2026-05-04","u":"2026-05-04","st":"2026-04","ag":"18–80"},{"n":"NCT07565532","t":"Establishment of a Prospective Clinical Cohort of Small Cell Lung Cancer Patients Receiving Radiotherapy-Involved Comprehensive Treatment","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2026-05-04","u":"2026-05-04","st":"2026-04","ag":"18 and over"},{"n":"NCT07566052","t":"A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation","s":"rec","p":"phase3","d":[4],"c":[22,1,0,23,65,9,10,4,12],"a":"adult older","h":[53,5,54,47,14,2,50,205,176],"po":"2026-05-04","u":"2026-11-09","st":"2026-08","ag":"18 and over"},{"n":"NCT07567742","t":"Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma","s":"rec","p":"phase2","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2026-05-05","u":"2026-10-30","st":"2026-05","ag":"18–70"},{"n":"NCT07570017","t":"A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma","s":"rec","p":"phase1","d":[19],"c":[0,5],"a":"adult older","h":[53,9],"po":"2026-05-06","u":"2026-09-10","st":"2026-06","ag":"18 and over"},{"n":"NCT07570823","t":"A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma","s":"rec","p":"phase3","d":[19],"c":[2],"a":"adult older","h":[74],"po":"2026-05-06","u":"2026-08-13","st":"2026-06","ag":"18–80"},{"n":"NCT07575919","t":"Targeted CD22/CD19 CAR-T Therapy for Consolidation in Standard-Risk B-ALL","s":"rec","p":"phase1phase2","d":[16],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"ball"]],"po":"2026-05-08","u":"2026-06-15","st":"2026-01","ag":"18–85"},{"n":"NCT07575971","t":"Exploratory Study of CD22/CD19 Dual-Target CAR-T Cell Therapy as Consolidation Treatment After First Remission in High-Risk B-Cell Acute Lymphoblastic Leukemia","s":"rec","p":"phase1phase2","d":[16],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"ball"]],"po":"2026-05-08","u":"2026-06-25","st":"2026-01","ag":"18–85"},{"n":"NCT07579234","t":"A Multicenter, Randomized, Open-label, Parallel-group, Controlled, Superiority Phase III Clinical Study Comparing the Efficacy and Safety of F182112 Versus Standard of Care in Patients With Relapsed or Refractory Multiple Myeloma","s":"rec","p":"phase3","d":[15],"c":[30],"a":"adult older","h":[69],"po":"2026-05-12","u":"2026-05-12","st":"2026-01","ag":"18 and over"},{"n":"NCT07581795","t":"Study of Paclitaxel Polymeric Micelles Combined With HP and Adebelimab Versus Taxane Combined With HP as First-Line Treatment for Advanced HER2-Positive Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2026-05-12","u":"2026-11-02","st":"2026-07","ag":"18 and over"},{"n":"NCT07581834","t":"Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study","s":"rec","p":"phase2","d":[6],"c":[22,16],"lc":[16],"a":"adult older","x":"female","h":[30,40],"l":[[30,"breast"]],"po":"2026-05-12","u":"2026-05-12","st":"2026-01","ag":"18 and over"},{"n":"NCT07581977","t":"A Novel Two-Tooth Clip for ESD and EFTR of GIST","s":"rec","p":"na","d":[12],"c":[2],"a":"adult older","h":[26],"po":"2026-05-12","u":"2026-05-22","st":"2026-04","ag":"18–85"},{"n":"NCT07582133","t":"A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With Primary IgA Nephropathy","s":"rec","p":"phase2","d":[46],"c":[2],"a":"adult older","h":[29],"po":"2026-05-12","u":"2026-07-22","st":"2026-07","ag":"18 and over"},{"n":"NCT07583550","t":"Low-dose Thoracic Radiotherapy Followed by Adebrelimab Plus Chemotherapy, and Then Sequential Maintenance Therapy With Adebrelimab for Extensive-stage Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[35],"lc":[35],"a":"adult older","h":[85],"l":[[85,"lung"]],"po":"2026-05-13","u":"2026-09-22","st":"2026-07","ag":"18–75"},{"n":"NCT07584499","t":"Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors","s":"rec","p":"phase1","d":[0,7,13],"c":[0],"lc":[0],"a":"child adult","h":[53],"l":[[53,"npc"]],"po":"2026-05-13","u":"2026-05-13","st":"2026-05","ag":"2–18"},{"n":"NCT07585760","t":"CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Renal Impairment","s":"rec","p":"phase2","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2026-05-14","u":"2026-09-17","st":"2026-09","ag":"18–80"},{"n":"NCT07586202","t":"A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC","s":"rec","p":"phase2","d":[4],"c":[2,22,0,27,5,30],"a":"adult older","h":[40,56,57,43,74,47,169],"po":"2026-05-14","u":"2026-11-03","st":"2026-07","ag":"18 and over"},{"n":"NCT07586267","t":"CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease","s":"rec","p":"earlyphase1","d":[46],"c":[23],"lc":[23],"a":"child adult older","h":[179],"l":[[179,"iga"]],"po":"2026-05-14","u":"2026-05-14","st":"2026-05","ag":"3 and over"},{"n":"NCT07586735","t":"A Novel Conditioning Regimen for Haplo-HSCT in Older Patients With SAA","s":"rec","p":"na","d":[17],"c":[2],"lc":[2],"a":"adult","h":[48],"l":[[48,"aa"]],"po":"2026-05-14","u":"2026-07-06","st":"2026-06","ag":"40–60"},{"n":"NCT07587099","t":"Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I)","s":"rec","p":"na","d":[31],"c":[2,6,24,27,66,9,26,34],"a":"adult older","h":[206,207,113,80,7,208,151,197],"po":"2026-05-14","u":"2026-08-17","st":"2026-05","ag":"18 and over"},{"n":"NCT07587840","t":"CD19/CD22 CAR-T as First-line Consolidation in Follicular Lymphoma","s":"rec","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2026-05-14","u":"2026-05-14","st":"2026-01","ag":"18–85"},{"n":"NCT07589205","t":"Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors","s":"rec","p":"phase1","d":[4,5],"c":[30],"a":"adult older","h":[58],"po":"2026-05-15","u":"2026-07-23","st":"2026-03","ag":"18 and over"},{"n":"NCT07589244","t":"A Study of VRT106, Combined With Camrelizumab, and Apatinib for Advanced HCC","s":"rec","p":"phase2phase3","d":[2],"c":[0],"a":"adult older","h":[209],"po":"2026-05-15","u":"2026-10-30","st":"2026-05","ag":"18–75"},{"n":"NCT07589257","t":"A Study of VRT106 in Combination With Radiotherapy in Adult Patients With Diffuse Midline Glioma / Diffuse Intrinsic Pontine Glioma","s":"rec","p":"phase2","d":[7],"c":[0],"a":"adult older","h":[53],"po":"2026-05-15","u":"2026-10-30","st":"2026-05","ag":"18–75"},{"n":"NCT07589569","t":"An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[28,30],"a":"adult older","h":[78,58],"po":"2026-05-15","u":"2026-06-11","st":"2026-06","ag":"18–75"},{"n":"NCT07590336","t":"68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma","s":"rec","p":"phase1phase2","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"hcc"]],"po":"2026-05-15","u":"2026-10-21","st":"2026-06","ag":"18 and over"},{"n":"NCT07590531","t":"AMT-116 in Combination With AK112 in Patients With Lung Cancer","s":"rec","p":"phase1phase2","d":[4],"c":[0,23],"a":"adult older","h":[53,44],"po":"2026-05-15","u":"2026-08-10","st":"2026-06","ag":"18–75"},{"n":"NCT07591090","t":"A Phase II Study of AK146D1 Combined With AK112 in Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"a":"adult older","h":[9],"po":"2026-05-15","u":"2026-07-22","st":"2026-07","ag":"18–75"},{"n":"NCT07594340","t":"HAIC vs. TACE Combined With Sintilimab and Bevacizumab for Intermediate HCC (Beyond Up-To-Seven)","s":"rec","p":"phase3","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"hcc"]],"po":"2026-05-18","u":"2026-05-22","st":"2026-05","ag":"18 and over"},{"n":"NCT07595172","t":"NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer","s":"rec","p":"phase1phase2","d":[5],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"panc"]],"po":"2026-05-19","u":"2026-05-19","st":"2026-04","ag":"18–75"},{"n":"NCT07595770","t":"Adebrelimab Combined With Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"escc"]],"po":"2026-05-19","u":"2026-05-19","st":"2026-05","ag":"18–75"},{"n":"NCT07596121","t":"Serplulimab Monotherapy in Elderly Patients With NSCLC and PD-L1 TPS ≥ 50%","s":"rec","p":"phase2","d":[4],"c":[39],"lc":[39],"a":"older","h":[122],"l":[[122,"lung"]],"po":"2026-05-19","u":"2026-05-19","st":"2026-05","ag":"65 and over"},{"n":"NCT07598578","t":"An Open-label, Single-arm, Multicenter Phase II Clinical Study of Azacitidine, Chidamide Combined With PD-1 Monoclonal Antibody in the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma.","s":"rec","p":"earlyphase1","d":[19],"c":[4],"lc":[4],"a":"adult older","h":[187],"l":[[187,"lymph"]],"po":"2026-05-20","u":"2026-05-20","st":"2026-06","ag":"18–75"},{"n":"NCT07600125","t":"Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract Cancers","s":"rec","p":"na","d":[3],"c":[52,26,60,39],"lc":[39],"a":"adult older","h":[131,210,211,151],"l":[[131,"gc"]],"po":"2026-05-20","u":"2026-08-11","st":"2026-08","ag":"18 and over"},{"n":"NCT07600164","t":"Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer","s":"rec","p":"phase4","d":[6],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"breast"]],"po":"2026-05-20","u":"2026-07-13","st":"2026-07","ag":"18 and over"},{"n":"NCT07601178","t":"QUEEN-APPLE: A Single-Arm, Multicenter, Prospective Phase II Clinical Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Anlotinib Hydrochloride and Nab-Paclitaxel as First-Line Treatment for Advanced Triple-Negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[28],"lc":[28],"a":"adult older","h":[127],"l":[[127,"breast"]],"po":"2026-05-22","u":"2026-05-22","st":"2026-04","ag":"18–75"},{"n":"NCT07602907","t":"Metronomic Oral Paclitaxel Monotherapy for Advanced HER2-Negative Breast Cancer: A Two-Stage Dose-Finding and Expansion Study","s":"rec","p":"phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"breast"]],"po":"2026-05-22","u":"2026-08-11","st":"2026-08","ag":"18 and over"},{"n":"NCT07603479","t":"JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma","s":"rec","p":"phase1","d":[19],"c":[2],"a":"adult older","h":[38],"po":"2026-05-22","u":"2026-08-11","st":"2026-06","ag":"18 and over"},{"n":"NCT07604311","t":"Efficacy and Safety of Nefecon on Prevention of Relapse of IgA Nephropathy","s":"rec","p":"phase4","d":[46],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"iga"]],"po":"2026-05-22","u":"2026-09-02","st":"2026-06","ag":"18–75"},{"n":"NCT07604987","t":"R-PMDT Regimen in Newly Diagnosed PCNSL","s":"rec","p":"phase2","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"lymph"]],"po":"2026-05-22","u":"2026-05-22","st":"2026-05","ag":"18 and over"},{"n":"NCT07606937","t":"A Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma.","s":"rec","p":"earlyphase1","d":[19],"c":[2,0,5,30],"a":"adult older","h":[53,123,74,58],"po":"2026-05-26","u":"2026-06-05","st":"2026-06","ag":"18 and over"},{"n":"NCT07608003","t":"Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:","s":"rec","p":"na","d":[7],"c":[8],"lc":[8],"a":"child adult older","h":[11],"l":[[11,"glioma"]],"po":"2026-05-27","u":"2026-11-17","st":"2026-05","ag":"Not stated"},{"n":"NCT07608978","t":"Efficacy and Safety of Polatuzumab Vedotin in Combination With Zanubrutinib, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma of the MCD/BN2/N1 Subtypes","s":"rec","p":"phase2","d":[19],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"lymph"]],"po":"2026-05-27","u":"2026-05-27","st":"2026-06","ag":"18 and over"},{"n":"NCT07609121","t":"Hypofractionated Chemoradiotherapy With Tislelizumab and Surufatinib for Unresectable Stage III NSCLC","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2026-05-27","u":"2026-07-01","st":"2026-06","ag":"18–75"},{"n":"NCT07609823","t":"A Study of Lacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLL","s":"rec","p":"phase2","d":[19],"c":[28],"a":"adult older","h":[78],"po":"2026-05-27","u":"2026-07-30","st":"2026-07","ag":"18 and over"},{"n":"NCT07609862","t":"A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies","s":"rec","p":"phase1phase2","d":[19],"c":[30],"a":"adult older","h":[69],"po":"2026-05-27","u":"2026-07-30","st":"2026-07","ag":"18 and over"},{"n":"NCT07610720","t":"Dalpiciclib, Anti-HER2 Therapy, and Endocrine Therapy for Hormone-Receptor-Positive, HER2-Positive Metastatic Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[53],"l":[[53,"breast"]],"po":"2026-05-28","u":"2026-05-28","st":"2026-06","ag":"18–75"},{"n":"NCT07610798","t":"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations","s":"rec","p":"phase1phase2","d":[4,5],"c":[0],"a":"adult older","h":[53],"po":"2026-05-28","u":"2026-06-10","st":"2026-06","ag":"18 and over"},{"n":"NCT07612722","t":"Sub-lobectomy vs Lobectomy in IIA-IIIB NSCLC After Neoadjuvant IO+Chemo","s":"rec","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"lung"]],"po":"2026-05-29","u":"2026-05-29","st":"2026-05","ag":"18–75"},{"n":"NCT07613996","t":"Impact of Hyperemic State on Angio-IMR Performance","s":"rec","p":"na","d":[31],"c":[0,5],"lc":[5],"a":"adult older","h":[6,49],"l":[[6,"cad"]],"po":"2026-05-29","u":"2026-05-29","st":"2026-05","ag":"18 and over"},{"n":"NCT07614230","t":"SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes","s":"rec","p":"phase4","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"cad"]],"po":"2026-05-29","u":"2026-05-29","st":"2026-01","ag":"18–78"},{"n":"NCT07614477","t":"Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases","s":"rec","p":"phase2","d":[46],"c":[2,30],"a":"adult older","h":[29,59],"po":"2026-05-29","u":"2026-08-05","st":"2026-05","ag":"18–75"},{"n":"NCT07615374","t":"Laparoscopic-endoscopic Surgery Assisted Sentinel Lymph Node Navigation Surgery for Early Gastric Cancer","s":"rec","p":"na","d":[3],"c":[15],"lc":[15],"a":"child adult older","h":[27],"l":[[27,"gc"]],"po":"2026-05-29","u":"2026-09-14","st":"2026-05","ag":"Not stated"},{"n":"NCT07616089","t":"Phase I Study of FXS0683 in the Treatment of Blood Tumors","s":"rec","p":"phase1","d":[16,19],"c":[30],"a":"adult older","h":[69],"po":"2026-05-29","u":"2026-10-14","st":"2026-06","ag":"18 and over"},{"n":"NCT07616427","t":"Fovinaciclib Plus Aromatase Inhibitors and Dual HER2 Blockade in a Response-Adapted Neoadjuvant Strategy for HR-Positive/HER2-Positive Early Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[23,28],"lc":[23],"a":"adult older","x":"female","h":[54,78],"l":[[54,"breast"]],"po":"2026-06-01","u":"2026-06-01","st":"2026-05","ag":"18–75"},{"n":"NCT07616440","t":"Pilot Study on the Clinical Efficacy of Focused Ultrasound-Mediated Targeted Drug Delivery System Combined With Neoadjuvant Therapy for HER2-Positive Breast Cancer","s":"rec","p":"na","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2026-06-01","u":"2026-06-04","st":"2026-06","ag":"18–70"},{"n":"NCT07616453","t":"Efficacy and Safety of Culmerciclib Plus Aromatase Inhibitors in a Response-Adapted Neoadjuvant Strategy for Highly Proliferative ER-Positive/HER2-Negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2026-06-01","u":"2026-06-01","st":"2026-05","ag":"18–75"},{"n":"NCT07617844","t":"Multimodal mAgnetic Resonance imaGIng in Cardiovascular Disease","s":"rec","p":"na","d":[31],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"cad"]],"po":"2026-06-01","u":"2026-07-28","st":"2026-01","ag":"18 and over"},{"n":"NCT07620275","t":"Safety and Efficacy of KSVCBD Injection in Multiple Myeloma Expressing CD19 and/or BCMA","s":"rec","p":"phase1","d":[15],"c":[2,30],"lc":[2],"a":"adult older","h":[26,89,69],"l":[[26,"mm"]],"po":"2026-06-02","u":"2026-09-15","st":"2026-09","ag":"18–75"},{"n":"NCT07620314","t":"Safety and Efficacy of KSVCBD Injection in B-cell Non-Hodgkin's Lymphoma Expressing CD19 and/or BCMA","s":"rec","p":"phase1","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2026-06-02","u":"2026-07-20","st":"2026-07","ag":"18–75"},{"n":"NCT07621484","t":"HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[212],"l":[[212,"gc"]],"po":"2026-06-02","u":"2026-10-22","st":"2026-07","ag":"18–75"},{"n":"NCT07622186","t":"A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)","s":"rec","p":"phase2","d":[4],"c":[2,15,8,22,1,16,0,57,23,24,27,47,9,28,10,11,12,30,39,7,38,20],"a":"adult older","h":[40,53,57,58,78,44,25,111,74,45,13,47,143,37,30,135,167,50,138,170,8,116,84,86],"po":"2026-06-03","u":"2026-09-02","st":"2026-07","ag":"18–75"},{"n":"NCT07622342","t":"A Phase II Study of SHR-2173 Injection in Patients With Myasthenia Gravis","s":"rec","p":"phase2","d":[27],"c":[8,5],"a":"adult older","h":[103,11],"po":"2026-06-03","u":"2026-10-22","st":"2026-08","ag":"18–75"},{"n":"NCT07622706","t":"Firmonertinib in Perioperative Treatment of Resectable Stage II-IIIB EGFR-mutated Lung Adenocarcinoma","s":"rec","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"lung"]],"po":"2026-06-03","u":"2026-10-27","st":"2026-09","ag":"18 and over"},{"n":"NCT07622836","t":"A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer.","s":"rec","p":"na","d":[6],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"breast"]],"po":"2026-06-03","u":"2026-06-03","st":"2026-06","ag":"18–75"},{"n":"NCT07623356","t":"A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Non-Small Cell Lung Cancer","s":"rec","p":"phase1phase2","d":[4],"c":[5],"a":"adult older","h":[65],"po":"2026-06-03","u":"2026-07-29","st":"2026-07","ag":"18–75"},{"n":"NCT07623577","t":"Sac-TMT Combined With Bevacizumab in TNBC With Brain Metastases","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2026-06-03","u":"2026-06-03","st":"2026-01","ag":"18 and over"},{"n":"NCT07623798","t":"A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003","s":"rec","p":"phase3","d":[15],"c":[5],"a":"adult older","h":[6],"po":"2026-06-03","u":"2026-09-17","st":"2026-06","ag":"18 and over"},{"n":"NCT07623850","t":"A Phase I Study of JLM019 Injection","s":"rec","p":"phase1","d":[19],"c":[2],"a":"adult older","h":[38],"po":"2026-06-03","u":"2026-06-03","st":"2026-01","ag":"18 and over"},{"n":"NCT07625423","t":"Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors","s":"rec","p":"phase1","d":[0],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"npc"]],"po":"2026-06-04","u":"2026-09-02","st":"2026-03","ag":"18–65"},{"n":"NCT07626177","t":"Association Between Screening Behaviors and Lung Cancer Spectrum","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"child adult older","h":[9],"l":[[9,"lung"]],"po":"2026-06-04","u":"2026-06-04","st":"2026-05","ag":"Not stated"},{"n":"NCT07627347","t":"Efficacy and Safety of Anlotinib Combined With Bemocizumab for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma(ESCC)","s":"rec","p":"na","d":[1],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"escc"]],"po":"2026-06-04","u":"2026-06-04","st":"2026-05","ag":"18–70"},{"n":"NCT07628738","t":"A Prospective Clinical Study on Reduced-intensity Radiotherapy for Stage I/II Low-risk Nasal-type NK/T-cell Lymphoma Achieving Complete Remission After Chemotherapy","s":"rec","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2026-06-05","u":"2026-06-09","st":"2026-07","ag":"18–75"},{"n":"NCT07629817","t":"Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy","s":"rec","p":"phase3","d":[1],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"escc"]],"po":"2026-06-05","u":"2026-07-31","st":"2026-06","ag":"18–75"},{"n":"NCT07629947","t":"Peripheral Blood Versus Bone Marrow Plus Peripheral Blood Grafts for Haploidentical Transplantation in Severe Aplastic Anemia","s":"rec","p":"na","d":[17],"c":[2],"lc":[2],"a":"adult","h":[48],"l":[[48,"aa"]],"po":"2026-06-05","u":"2026-09-16","st":"2026-06","ag":"18–40"},{"n":"NCT07632118","t":"Radiotherapy With GX Regimen as Adjuvant Therapy for High-risk Patients Following Pancreatic Cancer Surgery","s":"rec","p":"phase3","d":[5],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"panc"]],"po":"2026-06-08","u":"2026-06-08","st":"2026-05","ag":"18–75"},{"n":"NCT07634471","t":"A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)","s":"rec","p":"phase2phase3","d":[19],"c":[2,5],"a":"adult older","h":[74,9],"po":"2026-06-08","u":"2026-11-13","st":"2026-06","ag":"18 and over"},{"n":"NCT07635407","t":"QFR-Guided Virtual Stenting for Preprocedural Physiological Optimization of Percutaneous Coronary Intervention: A Randomized Controlled Trial","s":"rec","p":"na","d":[31],"c":[2],"a":"adult older","h":[213],"po":"2026-06-09","u":"2026-07-06","st":"2026-06","ag":"18 and over"},{"n":"NCT07635836","t":"Comparison of Double-tract and Tubular Gastric Anastomosis in Proximal Gastric Cancer","s":"rec","p":"na","d":[3],"c":[27],"lc":[27],"a":"adult older","h":[124],"l":[[124,"gc"]],"po":"2026-06-09","u":"2026-06-09","st":"2026-05","ag":"18–75"},{"n":"NCT07637448","t":"EGFR-TKIs Plus PD-1 in EGFR-Mutant Advanced NSCLC","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"lung"]],"po":"2026-06-09","u":"2026-06-09","st":"2026-05","ag":"18 and over"},{"n":"NCT07638683","t":"A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).","s":"rec","p":"phase2","d":[15],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"mm"]],"po":"2026-06-10","u":"2026-08-03","st":"2026-05","ag":"18 and over"},{"n":"NCT07638852","t":"Study of Radiotherapy Combined With Cisplatin/Carboplatin, Adebrelimab and Bevacizumab in the Treatment of TNBC-BM.","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2026-06-10","u":"2026-09-10","st":"2026-02","ag":"18–70"},{"n":"NCT07638891","t":"A Study of HDM2020 in Patients With Advanced Sq-NSCLC","s":"rec","p":"phase1","d":[4],"c":[0],"a":"adult older","h":[43],"po":"2026-06-10","u":"2026-06-10","st":"2026-04","ag":"18–75"},{"n":"NCT07639138","t":"Lenalidomide Plus Targeted Therapy and Immunotherapy for Refractory HCC","s":"rec","p":"phase2","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"hcc"]],"po":"2026-06-10","u":"2026-09-21","st":"2026-08","ag":"18–75"},{"n":"NCT07640295","t":"Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations","s":"rec","p":"phase1phase2","d":[5],"c":[2,8,23,24,28,5,12,13,20],"a":"adult older","h":[123,78,12,25,74,45,44,133,37,100,13,84],"po":"2026-06-10","u":"2026-08-27","st":"2026-07","ag":"18 and over"},{"n":"NCT07640789","t":"A Study Comparing BL-B01D1 in Combination With Osimertinib Versus Osimertinib Alone in Patients With Locally Advanced, Unresectable EGFR-mutated Non-small Cell Lung Cancer(Stage III) Whose Disease Has Not Progressed Following Definitive Platinum-based Chemoradiation Therapy(PANKU-Lung08)","s":"rec","p":"phase3","d":[4],"c":[27],"a":"adult older","h":[199],"po":"2026-06-11","u":"2026-09-10","st":"2026-08","ag":"18–75"},{"n":"NCT07641023","t":"Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC","s":"rec","p":"phase1phase2","d":[4],"c":[21],"a":"adult older","h":[126],"po":"2026-06-11","u":"2026-06-11","st":"2026-03","ag":"18–75"},{"n":"NCT07642024","t":"A Study of BL-B01D1 in Combination With Osimertinib as Perioperative Therapy in Patients With EGFR-mutated Resectable Non-small Cell Lung Cancer(PANKU-Lung09)","s":"rec","p":"phase2phase3","d":[4],"c":[5],"a":"adult older","h":[56,65],"po":"2026-06-11","u":"2026-08-03","st":"2026-07","ag":"18–75"},{"n":"NCT07645222","t":"PHASE 1b STUDY OF HS-20122 COMBINED THERAPY IN NSCLC","s":"rec","p":"phase1","d":[4],"c":[0],"a":"adult older","h":[53],"po":"2026-06-12","u":"2026-07-06","st":"2026-06","ag":"18–75"},{"n":"NCT07647016","t":"Trastuzumab Deruxtecan Plus ivonescImab for Hormone Receptor-positive HER2 Negative Advanced Breast Cancer Study","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2026-06-15","u":"2026-06-15","st":"2026-04","ag":"18 and over"},{"n":"NCT07647029","t":"A Clinical Study on Prophylactic RespOnse To hEtrombopag for Secondary Prevention in Anti-Cancer Therapy-induced Thrombocytopeniae","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2026-06-15","u":"2026-11-02","st":"2026-07","ag":"18 and over"},{"n":"NCT07647263","t":"Trastuzumab Rezetecan Neoadjuvant Therapy in THP-Insensitive HER2-Positive Early Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[4],"lc":[4],"a":"adult older","x":"female","h":[5],"l":[[5,"breast"]],"po":"2026-06-15","u":"2026-06-15","st":"2026-03","ag":"18 and over"},{"n":"NCT07648823","t":"Dosimetry, Safety, and Efficacy Study of [177Lu]Lu-XT771 in Patients With Recurrent Glioblastoma","s":"rec","p":"earlyphase1","d":[7],"c":[2],"lc":[2],"a":"adult older","h":[102,38],"l":[[102,"glioma"]],"po":"2026-06-15","u":"2026-06-16","st":"2026-06","ag":"18–80"},{"n":"NCT07648914","t":"A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+/HER2- Breast Cancer After Failure of Prior Endocrine Therapy(PANKU-Breast03)","s":"rec","p":"phase3","d":[6],"c":[2],"a":"adult older","h":[23],"po":"2026-06-15","u":"2026-07-23","st":"2026-07","ag":"18 and over"},{"n":"NCT07649928","t":"A Study of Dose Escalation of ES502 in Patients With Advanced Pancreatic Cancer","s":"rec","p":"earlyphase1","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"panc"]],"po":"2026-06-16","u":"2026-06-16","st":"2026-05","ag":"18 and over"},{"n":"NCT07651644","t":"Two-component Radiology-guided Autonomous Cascade Engine (TRACE)","s":"rec","p":"na","d":[3],"c":[11],"lc":[11],"a":"child adult older","h":[18],"l":[[18,"gc"]],"po":"2026-06-16","u":"2026-06-16","st":"2026-06","ag":"Not stated"},{"n":"NCT07652281","t":"A Clinical Study of SHR-5421 in Patients With Multiple Myeloma","s":"rec","p":"phase1","d":[15],"c":[2],"a":"adult older","h":[48],"po":"2026-06-17","u":"2026-07-30","st":"2026-07","ag":"18 and over"},{"n":"NCT07652905","t":"CM336 Plus Isa-VR in Newly Diagnosed Primary Plasma Cell Leukemia","s":"rec","p":"phase2","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2026-06-17","u":"2026-09-18","st":"2026-09","ag":"18–75"},{"n":"NCT07654400","t":"A Study of BL-M14D1 in Combination With Atezolizumab in Patients With Extensive-stage Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[5],"a":"adult older","h":[65],"po":"2026-06-17","u":"2026-11-02","st":"2026-07","ag":"18 and over"},{"n":"NCT07655622","t":"Vebreltinib Plus Furmonertinib in Patients With EGFR-mutated Advanced Non-small Cell Lung Cancer and High PD-L1 Expression","s":"rec","p":"phase1phase2","d":[4],"c":[9],"lc":[9],"a":"adult older","h":[80],"l":[[80,"lung"]],"po":"2026-06-18","u":"2026-06-18","st":"2026-07","ag":"18–75"},{"n":"NCT07655869","t":"[177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma","s":"rec","p":"earlyphase1","d":[7],"c":[2],"lc":[2],"a":"adult older","h":[102,38],"l":[[102,"glioma"]],"po":"2026-06-18","u":"2026-06-18","st":"2026-06","ag":"18 and over"},{"n":"NCT07657676","t":"Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity","s":"rec","p":"phase4","d":[31],"c":[2],"a":"adult older","h":[213],"po":"2026-06-18","u":"2026-10-13","st":"2026-09","ag":"18 and over"},{"n":"NCT07658183","t":"A Clinical Trial Comparing the Efficacy and Safety of Different Doses of BL0175 Injection in Treating Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"a":"adult older","x":"female","h":[9],"po":"2026-06-18","u":"2026-10-21","st":"2026-09","ag":"18 and over"},{"n":"NCT07658833","t":"TACE and/or HAIC Combined With Molecular-targeted Therapy and Immunotherapy for HCC","s":"rec","p":"na","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"hcc"]],"po":"2026-06-22","u":"2026-06-22","st":"2026-07","ag":"18–75"},{"n":"NCT07660939","t":"GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders","s":"rec","p":"phase1","d":[15],"c":[2],"lc":[2],"a":"adult older","h":[29],"l":[[29,"mm"]],"po":"2026-06-22","u":"2026-09-28","st":"2026-06","ag":"18–80"},{"n":"NCT07661537","t":"A Clinical Study of SHR-3079 in B-cell Non-Hodgkin Lymphoma","s":"rec","p":"phase1","d":[19],"c":[2,0],"a":"adult older","h":[53,74],"po":"2026-06-22","u":"2026-08-07","st":"2026-07","ag":"18 and over"},{"n":"NCT07661771","t":"Individualized Primary Clinical Target Volume Based on Margin Expansion for Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[8,44,63,0,21,46],"lc":[0],"a":"adult older","h":[53,11,13,106,198,134,130],"l":[[53,"npc"]],"po":"2026-06-22","u":"2026-08-19","st":"2026-07","ag":"18–65"},{"n":"NCT07662317","t":"Construction of a Prospective Cohort Database for the Perioperative Period of Cardiac Surgery","s":"rec","p":"na","d":[31],"c":[23],"lc":[23],"a":"child adult older","h":[54],"l":[[54,"cad"]],"po":"2026-06-23","u":"2026-06-23","st":"2026-06","ag":"Not stated"},{"n":"NCT07662395","t":"SCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer","s":"rec","p":"phase2phase3","d":[4],"c":[0],"a":"adult older","h":[43],"po":"2026-06-23","u":"2026-06-23","st":"2026-05","ag":"18 and over"},{"n":"NCT07663253","t":"Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients","s":"rec","p":"na","d":[15],"c":[2,22,0,47,10,40,5,13,39,20],"lc":[5],"a":"adult older","h":[6,38,36,37,53,110,98,15,131,201],"l":[[6,"mm"]],"po":"2026-06-23","u":"2026-06-23","st":"2026-06","ag":"18 and over"},{"n":"NCT07668037","t":"Characterization of Multi-Omics Landscapes and AI Pathological Prediction Model for Long-Term Survival in NSCLC Immunotherapy","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2026-06-25","u":"2026-06-25","st":"2026-05","ag":"18 and over"},{"n":"NCT07668752","t":"A Study to Evaluate GFH375 Versus Docetaxel in Participants With Non-Small Cell Lung Cancer With KRAS G12D Mutation","s":"rec","p":"phase3","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2026-06-25","u":"2026-08-10","st":"2026-07","ag":"18 and over"},{"n":"NCT07670286","t":"Spatial Multi-omics and Intelligent Early Warning of Pancreatic Cancer Cachexia","s":"rec","p":"na","d":[5],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"panc"]],"po":"2026-06-26","u":"2026-06-26","st":"2026-04","ag":"18 and over"},{"n":"NCT07672223","t":"A Study of SYS6010 Plus Anti-PD-(L)-1 Monoclonal Antibody as Adjuvant Therapy in Non-small Cell Lung Cancer (NSCLC)","s":"rec","p":"phase3","d":[4],"c":[5],"a":"adult older","h":[42,56],"po":"2026-06-26","u":"2026-11-12","st":"2026-07","ag":"18–75"},{"n":"NCT07673887","t":"A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer","s":"rec","p":"phase3","d":[3],"c":[0],"a":"adult older","h":[53],"po":"2026-06-29","u":"2026-11-09","st":"2026-07","ag":"18 and over"},{"n":"NCT07676383","t":"Precision Navigation to Improve Community Cancer Screening Participation","s":"rec","p":"na","d":[4,6],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2026-06-30","u":"2026-09-18","st":"2026-08","ag":"45–74"},{"n":"NCT07677774","t":"GPC3-Targeted PET/CT in Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"hcc"]],"po":"2026-07-01","u":"2026-09-10","st":"2026-05","ag":"18–90"},{"n":"NCT07677787","t":"DLL3-Targeted PET/CT in Small Cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"lung"]],"po":"2026-07-01","u":"2026-07-01","st":"2026-05","ag":"18–80"},{"n":"NCT07678229","t":"BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL","s":"rec","p":"phase3","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lymph"]],"po":"2026-07-01","u":"2026-08-13","st":"2026-08","ag":"18–70"},{"n":"NCT07678593","t":"A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation","s":"rec","p":"phase1phase2","d":[5],"c":[2,22,0,23,5,11,13,39,20],"a":"adult older","h":[38,9,40,12,111,118,25,99,82],"po":"2026-07-01","u":"2026-10-05","st":"2026-09","ag":"18 and over"},{"n":"NCT07678684","t":"A Study of HF1K16 Combined With Bevacizumab in Patients With Recurrent or Progressive Glioma","s":"rec","p":"phase2","d":[7],"c":[5],"a":"adult older","h":[103],"po":"2026-07-01","u":"2026-07-10","st":"2026-06","ag":"18–75"},{"n":"NCT07678957","t":"A Study Comparing BL-M07D1 With DS-8201 in Patients With HR-Positive, HER2-Low Expressing Recurrent/Metastatic Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[2],"a":"adult older","x":"female","h":[23],"po":"2026-07-01","u":"2026-09-14","st":"2026-08","ag":"18–75"},{"n":"NCT07680933","t":"Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL)","s":"rec","p":"phase2","d":[19],"c":[31],"lc":[31],"a":"adult older","h":[64],"l":[[64,"lymph"]],"po":"2026-07-02","u":"2026-07-02","st":"2026-03","ag":"18–80"},{"n":"NCT07681245","t":"Label-free Femtosecond Laser Imaging Combined With the Fast Lung Artificial Intelligence Model for Rapid Intraoperative Diagnosis of Lung Surgical Specimens: A Multicentre, Prospective, Parallel-workflow, Non-inferiority Study.","s":"rec","p":"na","d":[4],"c":[2,5],"lc":[5],"a":"adult older","h":[42,139,161,162],"l":[[42,"lung"]],"po":"2026-07-02","u":"2026-10-26","st":"2026-07","ag":"18–90"},{"n":"NCT07683221","t":"SBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally Advanced Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[27],"lc":[27],"a":"adult older","h":[57],"l":[[57,"panc"]],"po":"2026-07-06","u":"2026-10-13","st":"2026-08","ag":"18–75"},{"n":"NCT07683845","t":"Patient-Derived Organoid-on-a-Chip Model for Personalized Prediction of Chemotherapy Efficacy in Pancreatic Cancer","s":"rec","p":"na","d":[5],"c":[5],"a":"adult older","h":[123],"po":"2026-07-06","u":"2026-07-06","st":"2026-02","ag":"18–75"},{"n":"NCT07687459","t":"Study Evaluation Rentosertib (INS018_055) Administered Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF)","s":"rec","p":"phase3","d":[37],"c":[2,15,8,22,16,0,6,23,17,65,27,47,9,28,10,67,61,5,11,18,12,30,34,37,13,39,7,31,68,69,20],"a":"adult older","h":[40,60,132,10,38,98,89,25,59,156,56,70,7,81,143,92,11,64,182,124,97,12,186,169,68,214,15,16,215,185,205,39,216,217,218,82,219,207,220,221,222,22,223,224,225],"po":"2026-07-07","u":"2026-10-13","st":"2026-09","ag":"40 and over"},{"n":"NCT07689643","t":"Safety and Preliminary Efficacy of [177Lu]Lu-RTX-2358 Combined With Immune Checkpoint Inhibitors in Patients With FAP-positive Metastatic Non-Small Cell Lung Cancer","s":"rec","p":"earlyphase1","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lung"]],"po":"2026-07-08","u":"2026-07-14","st":"2026-04","ag":"18 and over"},{"n":"NCT07689851","t":"Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[2,21,12],"a":"adult older","h":[23,84,106],"po":"2026-07-08","u":"2026-07-08","st":"2026-07","ag":"18–75"},{"n":"NCT07695259","t":"Olaparib+Trastuzumab+Pertuzumab Neoadjuvant for Elderly HER2+ Breast Cancer","s":"rec","p":"phase4","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[44],"l":[[44,"breast"]],"po":"2026-07-10","u":"2026-07-10","st":"2026-05","ag":"60 and over"},{"n":"NCT07696832","t":"Efficacy and Safety of Ivonescimab Monotherapy as First-Line Treatment for PD-L1-Positive, Driver Gene-Negative, Locally Advanced or Metastatic NSCLC: A Multicenter, Prospective, Real-World Cohort Study","s":"rec","p":"na","d":[4],"c":[0],"a":"adult older","h":[43],"po":"2026-07-10","u":"2026-10-21","st":"2026-01","ag":"18 and over"},{"n":"NCT07697443","t":"Clinical Trial of TQB3126 for Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Breast Cancer Subjects","s":"rec","p":"phase1phase2","d":[6],"c":[8,22,0,70,30,13],"a":"adult older","h":[58,99,133,47,20,226],"po":"2026-07-13","u":"2026-10-20","st":"2026-09","ag":"18–75"},{"n":"NCT07697586","t":"SKB264 in Combination With SKB118 for Non-Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[5],"a":"adult older","h":[65],"po":"2026-07-13","u":"2026-08-12","st":"2026-08","ag":"18–75"},{"n":"NCT07697859","t":"PD-1 Inhibitors Combined With Local Therapy at Different Timings in Oligometastatic ESCC","s":"rec","p":"na","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"escc"]],"po":"2026-07-13","u":"2026-07-13","st":"2026-07","ag":"18 and over"},{"n":"NCT07698366","t":"Breast Ultrasound Screening in Elderly Women: A Multicenter Cluster Randomized Trial","s":"rec","p":"na","d":[6],"c":[28],"lc":[28],"a":"older","x":"female","h":[78],"l":[[78,"breast"]],"po":"2026-07-13","u":"2026-09-28","st":"2026-09","ag":"65–80"},{"n":"NCT07700667","t":"SKB500 Combinations in Patients With Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[15,22,1,16,24,47,36,9,28,10,43,11,18,71,12,30,39,20],"a":"adult older","h":[24,25,40,125,47,58,37,78,30,127,87,111,45,18,80,84,227,50,135,178,138],"po":"2026-07-14","u":"2026-10-20","st":"2026-08","ag":"18–75"},{"n":"NCT07700979","t":"Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma","s":"rec","p":"phase3","d":[3],"c":[2,0,5],"a":"adult older","h":[74,6,39,43],"po":"2026-07-14","u":"2026-09-29","st":"2026-09","ag":"18 and over"},{"n":"NCT07702708","t":"Pre-Treatment DCE-MRI AI Models Predict Neoadjuvant Chemotherapy Response in HR+/HER2- Breast Cancer","s":"rec","p":"na","d":[6],"c":[16,56],"lc":[16],"a":"adult older","x":"female","h":[30,228,148],"l":[[30,"breast"]],"po":"2026-07-14","u":"2026-07-14","st":"2026-06","ag":"18 and over"},{"n":"NCT07705243","t":"Efficacy and Safety of Becotatug Vedotin (MRG003) Combined With Anti-PD1 as Maintenance Therapy for Recurrent and Metastatic Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"npc"]],"po":"2026-07-15","u":"2026-07-15","st":"2026-07","ag":"18–75"},{"n":"NCT07706985","t":"Efficacy and Safety of TPC Induction Chemotherapy Combined With Nimotuzumab and Toripalimab \"Immune Sandwich\" Regimen Versus Full-Course Immunotherapy for Locally Advanced Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"npc"]],"po":"2026-07-16","u":"2026-07-16","st":"2026-07","ag":"18–70"},{"n":"NCT07707531","t":"A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and Pancreatic Cancer","s":"rec","p":"earlyphase1","d":[3,5],"c":[5],"lc":[5],"a":"adult older","h":[103],"l":[[103,"gc"]],"po":"2026-07-16","u":"2026-07-16","st":"2026-06","ag":"18 and over"},{"n":"NCT07707895","t":"DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers","s":"rec","p":"phase1phase2","d":[4],"c":[10,5],"a":"adult older","h":[42,56,50],"po":"2026-07-16","u":"2026-11-12","st":"2026-11","ag":"18 and over"},{"n":"NCT07708012","t":"Clinical Study on Using Laparoscopic Sentinel Lymph Node Navigation Combined With Dual Endoscopy Surgery for Early Gastric Cancer","s":"rec","p":"na","d":[3],"c":[26],"lc":[26],"a":"adult older","h":[55],"l":[[55,"gc"]],"po":"2026-07-16","u":"2026-10-06","st":"2026-01","ag":"18–80"},{"n":"NCT07709585","t":"Befotertinib Plus Chemotherapy With an MRD-guided Adaptive Strategy for Treatment Escalation and Response Optimization in EGFR-mutated NSCLC Patients","s":"rec","p":"phase2","d":[4],"c":[0],"a":"adult older","h":[107],"po":"2026-07-16","u":"2026-11-04","st":"2026-11","ag":"18 and over"},{"n":"NCT07710690","t":"A Clinical Trial Evaluating the Tolerability, Safety, and Preliminary Efficacy of NRG-103 Injection in Patients With Recurrent or Progressive High-grade Glioma","s":"rec","p":"phase1","d":[7],"c":[5,13,39],"a":"adult older","h":[103,133,122],"po":"2026-07-17","u":"2026-07-17","st":"2026-07","ag":"18 and over"},{"n":"NCT07714512","t":"Phase I/II Study of Anti-CD38 Monoclonal Antibody in Refractory Severe Aplastic Anemia","s":"rec","p":"phase1phase2","d":[17],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"aa"]],"po":"2026-07-20","u":"2026-09-21","st":"2026-06","ag":"18 and over"},{"n":"NCT07714980","t":"TEAS Timing for Gastrectomy Recovery (TEAS-TIME Trial)","s":"rec","p":"na","d":[3],"c":[2,26,42,72,19],"lc":[26],"a":"adult older","h":[55,28,48,229,114,151],"l":[[55,"gc"]],"po":"2026-07-20","u":"2026-11-03","st":"2026-07","ag":"18–80"},{"n":"NCT07719556","t":"Orelabrutinib Combined With Obinutuzumab and Short-Course Venetoclax in Patients With Treatment-Naïve Mantle Cell Lymphoma (MCL)","s":"rec","p":"phase2","d":[19],"c":[49,28],"lc":[28],"a":"adult older","h":[78,230],"l":[[78,"lymph"]],"po":"2026-07-22","u":"2026-07-22","st":"2026-07","ag":"18 and over"},{"n":"NCT07721753","t":"Exergames-acceptance and Commitment Therapy(e-ACT) for Breast Cancer Depression and Anxiety: A Randomized Controlled Trial","s":"rec","p":"na","d":[6],"c":[14],"a":"adult older","x":"female","h":[21],"po":"2026-07-23","u":"2026-07-23","st":"2026-03","ag":"18 and over"},{"n":"NCT07726342","t":"SMP-656 for HER2-Positive Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[2,8,22,0,23,17,27,28,11,18,13,39,20],"a":"adult older","h":[23,53,111,24,74,12,133,57,18,47,13,82,92,31,120],"po":"2026-07-24","u":"2026-10-15","st":"2026-08","ag":"18 and over"},{"n":"NCT07727083","t":"Clinical and Biological Cohort Study of EBV-Positive T/NK-Cell Lymphoproliferative Diseases","s":"rec","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lymph"]],"po":"2026-07-27","u":"2026-08-13","st":"2026-08","ag":"18 and over"},{"n":"NCT07729956","t":"A Study of BL-B01D1 Plus an Anti-PD-1 Antibody Versus Nab-paclitaxel Plus an Anti-PD-1 Antibody in Patients With Previously Untreated, Locally Advanced, Inoperable or Metastatic Triple-Negative Breast Cancer Whose Tumors Express PD-L1 (PANKU-Breast04)","s":"rec","p":"phase3","d":[6],"c":[5],"a":"adult older","x":"female","h":[9],"po":"2026-07-28","u":"2026-09-30","st":"2026-09","ag":"18–75"},{"n":"NCT07732491","t":"Culmerciclib in HR+/HER2+ Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[53],"l":[[53,"breast"]],"po":"2026-07-29","u":"2026-07-29","st":"2026-08","ag":"18 and over"},{"n":"NCT07733830","t":"Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC","s":"rec","p":"phase2","d":[1],"c":[2,22,11,12,30,20],"lc":[30],"a":"adult older","h":[58,23,74,47,37,18,84],"l":[[58,"escc"]],"po":"2026-07-29","u":"2026-07-29","st":"2026-07","ag":"18–75"},{"n":"NCT07738341","t":"GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ)","s":"rec","p":"phase1phase2","d":[6],"c":[2],"a":"adult older","h":[23],"po":"2026-07-31","u":"2026-11-18","st":"2026-07","ag":"18 and over"},{"n":"NCT07739186","t":"A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06)","s":"rec","p":"phase2phase3","d":[4],"c":[0],"a":"adult older","h":[53,132],"po":"2026-07-31","u":"2026-11-12","st":"2026-10","ag":"18 and over"},{"n":"NCT07739199","t":"A Study Comparing BL-B01D1 in Combination With PD-1/VEGF Bispecific Antibody Versus Chemotherapy in Combination With PD-1/VEGF Bispecific Antibody in First-line Patients With Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer(PANKU-Lung05)","s":"rec","p":"phase2phase3","d":[4],"c":[0,13],"a":"adult older","h":[53,12],"po":"2026-07-31","u":"2026-11-12","st":"2026-10","ag":"18 and over"},{"n":"NCT07739485","t":"Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study","s":"rec","p":"phase1phase2","d":[6],"c":[41],"lc":[41],"a":"adult older","x":"female","h":[137],"l":[[137,"breast"]],"po":"2026-07-31","u":"2026-08-04","st":"2026-07","ag":"18–70"},{"n":"NCT07739511","t":"Paclitaxel Oral Solution in HER2-Positive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study","s":"rec","p":"phase1phase2","d":[6],"c":[41],"lc":[41],"a":"adult older","x":"female","h":[137],"l":[[137,"breast"]],"po":"2026-07-31","u":"2026-08-04","st":"2026-07","ag":"18–70"},{"n":"NCT07739758","t":"A Study of YL201 in Combination With Serplulimab in Participants With Treatment-naïve Extensive-stage Small Cell Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[0,11],"a":"adult older","h":[53,18],"po":"2026-07-31","u":"2026-08-24","st":"2026-08","ag":"18 and over"},{"n":"NCT07739966","t":"A Study of DS-3939a in Participants With Solid Tumors","s":"rec","p":"phase1phase2","d":[4],"c":[2,15,8,0,23,24,27,5,29,30,13,20],"a":"adult older","h":[57,58,44,45,46,13,37,61,49,65,19,138,66],"po":"2026-07-31","u":"2026-11-10","st":"2026-10","ag":"18 and over"},{"n":"NCT07742345","t":"Clinical Study of Coronary Extension Catheter","s":"rec","p":"na","d":[31],"c":[2],"a":"adult older","h":[39],"po":"2026-08-03","u":"2026-08-03","st":"2026-06","ag":"18 and over"},{"n":"NCT07743944","t":"A Real-world Study Observing Treatment Patterns and Clinical Results for Patients in China With Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer.","s":"rec","p":"na","d":[6],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"breast"]],"po":"2026-08-04","u":"2026-08-04","st":"2026-08","ag":"18 and over"},{"n":"NCT07744256","t":"Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)","s":"rec","p":"phase1phase2","d":[4],"c":[21],"a":"adult older","h":[126],"po":"2026-08-04","u":"2026-08-04","st":"2026-03","ag":"18–75"},{"n":"NCT07744529","t":"Amivantamab Combined With Intrathecal Pemetrexed for LM From EGFR-Mutated Lung Adenocarcinoma","s":"rec","p":"phase1phase2","d":[4],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lung"]],"po":"2026-08-04","u":"2026-08-04","st":"2026-05","ag":"18 and over"},{"n":"NCT07744698","t":"Metronomic Oral Paclitaxel Plus PD-1/ PD-L1 Inhibitor Maintenance in Advanced Lung Cancer (PULSE Study)","s":"rec","p":"phase4","d":[4],"c":[17],"a":"adult older","h":[231,88],"l":[[231,"lung"]],"po":"2026-08-04","u":"2026-08-04","st":"2026-07","ag":"18–75"},{"n":"NCT07745881","t":"Analgesic Effects of Retro-superior Costotransverse Ligament Space Block for Video-assisted Thoracoscopic Surgery","s":"rec","p":"na","d":[4],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"lung"]],"po":"2026-08-04","u":"2026-08-06","st":"2026-08","ag":"18–80"},{"n":"NCT07746323","t":"Effect of Modified Arm Positioning on Shoulder Pain After Thoracoscopic Lobectomy","s":"rec","p":"na","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[232],"l":[[232,"lung"]],"po":"2026-08-05","u":"2026-08-05","st":"2026-05","ag":"18 and over"},{"n":"NCT07747688","t":"Retrospective Analysis of Early Gastric Cancer Patients Based on Prospective Clinical Dataset","s":"rec","p":"na","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[39],"l":[[39,"gc"]],"po":"2026-08-05","u":"2026-08-05","st":"2026-05","ag":"18–90"},{"n":"NCT07749365","t":"Hypofractionated Radiotherapy Plus GM-CSF, Pomalidomide and Glofitamab for Newly Diagnosed PCNS-DLBCL","s":"rec","p":"phase2","d":[19],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"lymph"]],"po":"2026-08-06","u":"2026-08-06","st":"2026-07","ag":"18 and over"},{"n":"NCT07751341","t":"A Clinical Study of SHR-9839 as Monotherapy or in Combination With Chemotherapy Plus Adebrelimab Versus Chemotherapy Plus Adebrelimab in Patients With Advanced Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[2,20],"a":"adult older","h":[74,25],"po":"2026-08-07","u":"2026-09-16","st":"2026-09","ag":"18–75"},{"n":"NCT07751536","t":"ctDNA-driven Adaptive Proton Craniospinal Irradiation in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis After Resistance to Third-Generation TKIs in the Consolidation Phase","s":"rec","p":"na","d":[4],"c":[17],"a":"adult older","h":[68,88],"po":"2026-08-07","u":"2026-08-07","st":"2026-08","ag":"18–75"},{"n":"NCT07753226","t":"A Study of SI-B036 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors","s":"rec","p":"phase1","d":[6],"c":[2],"a":"adult older","h":[23],"po":"2026-08-07","u":"2026-09-10","st":"2026-08","ag":"18–75"},{"n":"NCT07754812","t":"Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment for Older Adults With NSCLC","s":"rec","p":"phase4","d":[4],"c":[0,23,5],"lc":[5],"a":"older","h":[56,43,44],"l":[[56,"lung"]],"po":"2026-08-10","u":"2026-08-10","st":"2026-06","ag":"70 and over"},{"n":"NCT07757230","t":"A Phase II Study of SSGJ-612 Plus a HER2-Targeted ADC in HR-Positive, HER2-Low or HER2-Ultralow Expression Metastatic Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[0],"a":"adult older","h":[53],"po":"2026-08-11","u":"2026-10-14","st":"2026-09","ag":"18–75"},{"n":"NCT07759856","t":"NK Cells Plus ICI for SCLC Maintenance","s":"rec","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[233],"l":[[233,"lung"]],"po":"2026-08-12","u":"2026-08-12","st":"2026-08","ag":"18 and over"},{"n":"NCT07760012","t":"68Ga-SorB PET/CT Imaging in Patients With Solid Tumors","s":"rec","p":"na","d":[2,4,5,6],"c":[2],"lc":[2],"a":"adult older","h":[115],"l":[[115,"hcc"]],"po":"2026-08-12","u":"2026-10-15","st":"2026-08","ag":"18 and over"},{"n":"NCT07760454","t":"A Clinical Study of CT0596 CAR-T in Relapsed/Refractory Multiple Myeloma","s":"rec","p":"phase1phase2","d":[15],"c":[5,4],"a":"adult older","h":[5,41],"po":"2026-08-12","u":"2026-09-17","st":"2026-09","ag":"18 and over"},{"n":"NCT07762872","t":"A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSD","s":"rec","p":"na","d":[25],"c":[2],"lc":[2],"a":"adult older","h":[71],"l":[[71,"nmosd"]],"po":"2026-08-13","u":"2026-08-13","st":"2026-07","ag":"18 and over"},{"n":"NCT07763301","t":"YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies","s":"rec","p":"phase1","d":[5],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"panc"]],"po":"2026-08-13","u":"2026-08-13","st":"2026-08","ag":"18–75"},{"n":"NCT07763587","t":"Analysis of Multimodal Psychosomatic Comorbidity Burden in Breast Cancer and Benefit Evaluation of Acupuncture Collaborative Management Regimen","s":"rec","p":"na","d":[6],"c":[30],"lc":[30],"a":"adult older","x":"female","h":[191,58],"l":[[191,"breast"]],"po":"2026-08-13","u":"2026-09-16","st":"2026-08","ag":"18–70"},{"n":"NCT07764081","t":"Progression, Management, and Clinical Outcomes of Coronary Artery Aneurysms","s":"rec","p":"na","d":[31],"c":[28],"lc":[28],"a":"adult older","h":[78,119],"l":[[78,"cad"]],"po":"2026-08-13","u":"2026-08-13","st":"2026-07","ag":"18–80"},{"n":"NCT07764094","t":"Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery Disease","s":"rec","p":"na","d":[31],"c":[28,31],"lc":[28],"a":"adult older","h":[78,234,119],"l":[[78,"cad"]],"po":"2026-08-13","u":"2026-08-28","st":"2026-09","ag":"18–80"},{"n":"NCT07766434","t":"A Prospective Multicenter Real-World Registry of Quantitative Flow Ratio-Guided Coronary REvascularization and QuAlity evaLuation","s":"rec","p":"na","d":[31],"c":[2],"a":"adult older","h":[213],"po":"2026-08-14","u":"2026-09-24","st":"2026-08","ag":"18 and over"},{"n":"NCT07767630","t":"Safety, Tolerability, and Preliminary Efficacy of [211At]MABG in Patients With Relapsed or Refractory Neuroblastoma","s":"rec","p":"earlyphase1","d":[13],"c":[22],"lc":[22],"a":"child adult older","h":[40],"l":[[40,"nb"]],"po":"2026-08-17","u":"2026-08-21","st":"2026-07","ag":"1–100"},{"n":"NCT07768124","t":"Acupoint Application for Chemotherapy-Induced Nausea and Vomiting in Lung Cancer","s":"rec","p":"na","d":[4],"c":[1],"lc":[1],"a":"adult older","h":[235],"l":[[235,"lung"]],"po":"2026-08-17","u":"2026-08-17","st":"2026-07","ag":"18–75"},{"n":"NCT07769008","t":"CCTA-Based vs CAG-Based CABG: A Multicenter Pragmatic Non-Inferiority Trial","s":"rec","p":"na","d":[31],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"cad"]],"po":"2026-08-17","u":"2026-10-27","st":"2026-08","ag":"18 and over"},{"n":"NCT07773818","t":"Establishment of a Multi-omics Prediction Model for Early Triple-negative Breast Cancer Based on UPGRADE-TNBC Study","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2026-08-19","u":"2026-08-19","st":"2026-08","ag":"18–75"},{"n":"NCT07773870","t":"Cold-Region Exposure and Cardiac Remodeling After PCI","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"cad"]],"po":"2026-08-19","u":"2026-08-19","st":"2026-06","ag":"18–80"},{"n":"NCT07774533","t":"68Ga-B7-H3 Nanobody ImmunoPET in Osteosarcoma","s":"rec","p":"earlyphase1","d":[11],"c":[2],"lc":[2],"a":"child adult older","h":[29],"l":[[29,"os"]],"po":"2026-08-19","u":"2026-08-19","st":"2026-04","ag":"10–80"},{"n":"NCT07774572","t":"Exploration of Circular RNA in B-cell Hematologic Malignancies","s":"rec","p":"phase1","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2026-08-19","u":"2026-08-19","st":"2026-05","ag":"18 and over"},{"n":"NCT07775508","t":"In Vivo CD19/CD20 CAR T-Cell Therapy for Relapsed/Refractory B-Cell Lymphoma","s":"rec","p":"phase1","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2026-08-20","u":"2026-08-20","st":"2026-06","ag":"18–75"},{"n":"NCT07776067","t":"CT Imaging and Clinical Features to Predict Outcomes in Patients With Gastric Cancer","s":"rec","p":"na","d":[3],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"gc"]],"po":"2026-08-20","u":"2026-08-31","st":"2026-04","ag":"18 and over"},{"n":"NCT07776080","t":"Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus","s":"rec","p":"phase2","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"hcc"]],"po":"2026-08-20","u":"2026-09-15","st":"2026-10","ag":"18–75"},{"n":"NCT07778212","t":"Orelabrutinib Combined With Pola-R-CHP as First-Line Treatment for Patients With Intermediate- to High-Risk DLBCL","s":"rec","p":"na","d":[19],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"lymph"]],"po":"2026-08-21","u":"2026-08-21","st":"2026-08","ag":"18 and over"},{"n":"NCT07778316","t":"Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)","s":"rec","p":"phase3","d":[4],"c":[2,5],"a":"adult older","h":[56,74,89],"po":"2026-08-21","u":"2026-09-17","st":"2026-08","ag":"18–99"},{"n":"NCT07779018","t":"CD19/CD22 CAR-T Consolidation in R/R Aggressive B-Cell Lymphoma After Second-Line Therapy","s":"rec","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2026-08-21","u":"2026-08-21","st":"2026-04","ag":"18–85"},{"n":"NCT07781358","t":"Becotatug Vedotin Combined With a PD-1 Inhibitor in the Treatment of Locally Advanced Recurrent Nasopharyngeal Carcinoma.","s":"rec","p":"phase2","d":[0],"c":[5],"lc":[5],"a":"adult older","h":[236],"l":[[236,"npc"]],"po":"2026-08-24","u":"2026-08-24","st":"2026-08","ag":"18–80"},{"n":"NCT07781579","t":"5T MRI and Metabolomics-Based Hemorrhage Risk Prediction in Moyamoya Disease","s":"rec","p":"na","d":[28],"c":[2],"lc":[2],"a":"child adult older","h":[94],"l":[[94,"moyamoya"]],"po":"2026-08-24","u":"2026-08-24","st":"2026-02","ag":"Not stated"},{"n":"NCT07782944","t":"CD38 Targeted -PET/ CT for Multiple Myeloma","s":"rec","p":"na","d":[15,19],"c":[57],"lc":[57],"a":"adult older","h":[170],"l":[[170,"mm"]],"po":"2026-08-24","u":"2026-08-24","st":"2026-07","ag":"18 and over"},{"n":"NCT07783971","t":"Study on the Microbial Environment of Non-small Cell Lung Cancer Based on Mycogenomics and Its Clinical Relevance","s":"rec","p":"na","d":[4],"a":"adult older","h":[237],"l":[[237,"lung"]],"po":"2026-08-25","u":"2026-08-25","st":"2026-08","ag":"30–80"},{"n":"NCT07784374","t":"A Phase II Study of GFH375 Combined With GFS202A or GFH276 Versus GFH375 in Patients With Previously Treated Locally Advanced Unresectable or Metastatic Pancreatic Cancer Harboring KRAS G12D Mutation","s":"rec","p":"phase2","d":[5],"c":[5],"a":"adult older","h":[123],"po":"2026-08-25","u":"2026-10-02","st":"2026-08","ag":"18–80"},{"n":"NCT07787273","t":"Interferon Gamma Plus Camrelizumab as Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[17],"a":"adult older","h":[112],"po":"2026-08-26","u":"2026-08-26","st":"2026-03","ag":"18 and over"},{"n":"NCT07788118","t":"A Phase Ib/II Exploratory Clinical Trial of Memory-Enhanced 7×19-THEMIS CAR-T Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lymph"]],"po":"2026-08-26","u":"2026-08-26","st":"2026-09","ag":"18–75"},{"n":"NCT07788196","t":"A Clinical Study Comparing Anti-HER2 Therapy Combined With Chemotherapy to Chemotherapy Alone as Adjuvant Therapy Following Surgery for Stage IB-II Gastric Cancer With High HER2 Expression.","s":"rec","p":"phase2","d":[3],"c":[39],"lc":[39],"a":"adult older","h":[131],"l":[[131,"gc"]],"po":"2026-08-26","u":"2026-08-26","st":"2026-07","ag":"18 and over"},{"n":"NCT07789184","t":"Radical Surgery Versus Non-Surgery in Gastric Cancer Patients With Peritoneal Metastasis After Successful Conversion Therapy","s":"rec","p":"phase3","d":[3],"c":[2,15,1,52,0,23,27,9,28,26,5,30,34,13,39],"a":"adult older","h":[74,78,26,70,60,44,55,53,14,9,58,111,113,54,80,36,75,82,27,121,127,220,193,210,72],"po":"2026-08-27","u":"2026-10-16","st":"2026-12","ag":"18–70"},{"n":"NCT07793695","t":"Oral Zinc Supplementation Combined With Targeted Immunotherapy for Unresectable or Advanced Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[17],"lc":[17],"a":"adult older","h":[68],"l":[[68,"hcc"]],"po":"2026-08-28","u":"2026-09-21","st":"2026-09","ag":"18–75"},{"n":"NCT07795437","t":"GPC3-Targeted PET Imaging of 18F-X12 in Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[29],"l":[[29,"hcc"]],"po":"2026-08-31","u":"2026-09-02","st":"2026-08","ag":"18 and over"},{"n":"NCT07796789","t":"Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for Chemoradiotherapy-Related Anorexia in Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[8,16,0],"lc":[0],"a":"adult older","h":[53,30,13],"l":[[53,"npc"]],"po":"2026-09-01","u":"2026-10-15","st":"2026-09","ag":"18–70"},{"n":"NCT07796880","t":"Neoadjuvant Culmerciclib Combined With Endocrine Therapy for Hormone Receptor-Positive， Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2026-09-01","u":"2026-09-15","st":"2026-09","ag":"18–70"},{"n":"NCT07797218","t":"Neoadjuvant Pyrotinib-to-pertuzumab in HER2+ eBC","s":"rec","p":"phase3","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[123],"l":[[123,"breast"]],"po":"2026-09-01","u":"2026-09-01","st":"2026-07","ag":"18–70"},{"n":"NCT07798947","t":"A Phase II Clinical Study of SHR-7787 Injection Combined With SHR-1316 Injection in Patients With LS-SCLC","s":"rec","p":"phase2","d":[4],"c":[27],"a":"adult older","h":[199],"po":"2026-09-02","u":"2026-10-19","st":"2026-10","ag":"18–75"},{"n":"NCT07799922","t":"IRE After Targeted Immunotherapy in HCC With Portal Vein Tumor Thrombus","s":"rec","p":"na","d":[2],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"hcc"]],"po":"2026-09-02","u":"2026-09-02","st":"2026-05","ag":"18–75"},{"n":"NCT07799935","t":"IRE After Chemotherapy for Locally Advanced Pancreatic Cancer","s":"rec","p":"na","d":[5],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"panc"]],"po":"2026-09-02","u":"2026-09-02","st":"2026-05","ag":"18–75"},{"n":"NCT07801287","t":"Iparomlimab/Tuvonralimab Plus SBRT and Lenvatinib for Perioperative Treatment of Potentially Resectable Intermediate-Stage HCC","s":"rec","p":"phase2","d":[2],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"hcc"]],"po":"2026-09-03","u":"2026-09-03","st":"2026-09","ag":"18 and over"},{"n":"NCT07802184","t":"GnP Combined With SHR-1701 and Apatinib as First-Line Treatment for Metastatic PDAC","s":"rec","p":"phase1phase2","d":[5],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"panc"]],"po":"2026-09-03","u":"2026-11-09","st":"2026-09","ag":"18–75"},{"n":"NCT07802821","t":"A Study Comparing QLC5508 in Combination With QL2107 Versus Tislelizumab Plus Platinum-based Chemotherapy in Participants Wih Treatment-naïve Extensive-Stage Small Cell Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[5],"a":"adult older","h":[65],"po":"2026-09-03","u":"2026-10-30","st":"2026-10","ag":"18 and over"},{"n":"NCT07806058","t":"An Open-Label, Multicenter, Phase IB/II Clinical Study of HRS-7172 in Combination With Antitumor Therapy in Participants With Solid Tumors","s":"rec","p":"phase1phase2","d":[5],"c":[5],"a":"adult older","h":[9],"po":"2026-09-08","u":"2026-10-26","st":"2026-10","ag":"18–70"},{"n":"NCT07806604","t":"Real World Study of Icotinib in Adjuvant Post Surgical Treatment for Stage IA2 High Risk to IB EGFR Mutant Non Small Cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[2,5],"a":"adult older","h":[56,74],"po":"2026-09-08","u":"2026-09-08","st":"2026-09","ag":"18 and over"},{"n":"NCT07807696","t":"Olive Oil Before Lung Cancer Surgery to Prevent Chylothorax","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2026-09-08","u":"2026-09-08","st":"2026-03","ag":"18–80"},{"n":"NCT07808827","t":"A Randomized, Open-Label, Multicenter Phase III Clinical Study of JS203 Plus Chemotherapy Versus Rituximab Plus Chemotherapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma","s":"rec","p":"phase3","d":[19],"c":[2],"a":"adult older","h":[74],"po":"2026-09-09","u":"2026-10-14","st":"2026-10","ag":"18–75"},{"n":"NCT07809763","t":"Wireless Wearable Home Prehabilitation for Older Adults With NSCLC","s":"rec","p":"na","d":[4],"c":[22],"lc":[22],"a":"older","h":[40],"l":[[40,"lung"]],"po":"2026-09-09","u":"2026-09-09","st":"2026-09","ag":"65–85"},{"n":"NCT07811687","t":"Effect of Laparoscopic Hepatectomy Combined With Splenectomy on Hepatic Functional Reserve and Immune Function","s":"rec","p":"na","d":[2],"c":[32],"lc":[32],"a":"adult older","h":[63],"l":[[63,"hcc"]],"po":"2026-09-10","u":"2026-09-10","st":"2026-08","ag":"18–80"},{"n":"NCT07811752","t":"Sacituzumab Govitecan Combined With Tislelizumab for Locally Advanced/Metastatic Esophageal Cancer","s":"rec","p":"phase2","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"escc"]],"po":"2026-09-10","u":"2026-09-10","st":"2026-07","ag":"18 and over"},{"n":"NCT07817056","t":"Risk-Stratified Management of Inavolisib-Induced Hyperglycemia and Patient Adherence","s":"rec","p":"na","d":[6],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"breast"]],"po":"2026-09-14","u":"2026-09-14","st":"2026-04","ag":"18 and over"},{"n":"NCT07817082","t":"Phase II Study of SHR-A1811 for Ultra-Low HER2 Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[30],"lc":[30],"a":"adult older","x":"female","h":[58],"l":[[58,"breast"]],"po":"2026-09-14","u":"2026-09-14","st":"2026-09","ag":"18–75"},{"n":"NCT07819656","t":"Dynamic Risk Prediction of Severe Myelosuppression in Nasopharyngeal Carcinoma","s":"rec","p":"na","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"npc"]],"po":"2026-09-15","u":"2026-09-15","st":"2026-08","ag":"18 and over"},{"n":"NCT07820254","t":"Inspiratory Flow Rate Capability in Pulmonary Fibrosis Patients","s":"rec","p":"na","d":[37],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"ipf"]],"po":"2026-09-15","u":"2026-09-15","st":"2026-01","ag":"18–80"},{"n":"NCT07822100","t":"To Assess the Efficacy and Safety of Utilizing Galactose-deficient IgA1 Biomarker Changes to Guide Pathogenic IgA-targeted Therapeutic Strategies","s":"rec","p":"na","d":[46],"c":[2],"lc":[2],"a":"adult older","h":[29],"l":[[29,"iga"]],"po":"2026-09-16","u":"2026-09-16","st":"2026-08","ag":"18–75"},{"n":"NCT07822711","t":"Effects of Different Stiffness Settings During Robotic Isokinetic Training in Children With SMA","s":"rec","p":"na","d":[40],"c":[2],"lc":[2],"a":"child","h":[115],"l":[[115,"sma"]],"po":"2026-09-16","u":"2026-11-17","st":"2026-10","ag":"6–12"},{"n":"NCT07822776","t":"Efgartigimod in Anti-NMDA Receptor Encephalitis.","s":"rec","p":"phase2","d":[34],"c":[2],"lc":[2],"a":"adult older","h":[161],"l":[[161,"nmdae"]],"po":"2026-09-16","u":"2026-09-16","st":"2026-06","ag":"18 and over"},{"n":"NCT07823829","t":"A Phase I/II Trial of CT1190B in Patients With Relapsed/Refractory Large B-Cell Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[5,13],"a":"adult older","h":[123,36,162],"po":"2026-09-16","u":"2026-10-01","st":"2026-09","ag":"18–75"},{"n":"NCT07823855","t":"SIB Accelerated Hyperfractionated RT for High-Proliferation NSCLC","s":"rec","p":"na","d":[4],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lung"]],"po":"2026-09-16","u":"2026-09-16","st":"2026-06","ag":"18 and over"},{"n":"NCT07824882","t":"A Phase II Study of HS-20093 Injection Combined With Adebrelimab Versus HS-20093 Injection in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations","s":"rec","p":"phase2","d":[4],"c":[13],"a":"adult older","h":[36],"po":"2026-09-17","u":"2026-10-23","st":"2026-10","ag":"18 and over"},{"n":"NCT07829848","t":"Response-Adapted Omission of Nodal Boost In N3 Breast Cancer After Neoadjuvant Systemic Therapy","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2026-09-21","u":"2026-09-23","st":"2026-09","ag":"18–75"},{"n":"NCT07830342","t":"A Clinical Study of HS-IT101 Injection in Patients With Advanced Non-Small Cell Lung Cancer(FASTIL-Lung02)","s":"rec","p":"phase1","d":[4],"c":[5],"a":"adult older","h":[56],"po":"2026-09-21","u":"2026-10-14","st":"2026-09","ag":"18–75"},{"n":"NCT07832279","t":"1-Week Versus 3-Week PBI","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2026-09-21","u":"2026-09-25","st":"2026-10","ag":"18–75"},{"n":"NCT07833085","t":"CAIX-targeted PET/CT in Solid Tumors","s":"rec","p":"na","d":[4,6],"c":[13],"lc":[13],"a":"adult older","h":[133],"l":[[133,"lung"]],"po":"2026-09-22","u":"2026-10-13","st":"2026-09","ag":"18 and over"},{"n":"NCT07835087","t":"Image-Guided Platform-Assisted Sentinel Lymph Node Retrieval in Early Gastric Cancer","s":"rec","p":"na","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[39],"l":[[39,"gc"]],"po":"2026-09-22","u":"2026-09-22","st":"2026-08","ag":"18–80"},{"n":"NCT07835139","t":"Hypofractionated vs. Conventionally Fractionated Postmastectomy Radiotherapy After Implant-Based Reconstruction","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2026-09-22","u":"2026-09-22","st":"2026-10","ag":"18 and over"},{"n":"NCT07835178","t":"Post-Marketing Clinical Study of High-Pressure Cutting Balloon","s":"rec","p":"na","d":[31],"c":[39],"a":"adult older","h":[111],"po":"2026-09-22","u":"2026-09-22","st":"2026-09","ag":"18 and over"},{"n":"NCT07838714","t":"Dual-Targeted Umbilical Cord Blood CAR-T Cells Against CD19 and CD22 for the Treatment of Relapsed or Refractory Acute B-Cell Lymphoblastic Leukemia","s":"rec","p":"phase1","d":[16],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"ball"]],"po":"2026-09-24","u":"2026-09-25","st":"2026-05","ag":"18–75"},{"n":"NCT07839247","t":"Zanubrutinib Plus Lenalidomide for Frail Elderly Patients With Newly Diagnosed PCNSL","s":"rec","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"older","h":[102],"l":[[102,"lymph"]],"po":"2026-09-24","u":"2026-11-10","st":"2026-09","ag":"70 and over"},{"n":"NCT07840092","t":"Biomarker Validation for Treatment Efficacy and Recurrence Prediction in Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"hcc"]],"po":"2026-09-24","u":"2026-09-24","st":"2026-10","ag":"18 and over"},{"n":"NCT07842835","t":"Registry of an Integrated Longitudinal Multimodal Biospecimen Biobank for Primary CNS Lymphoma in China","s":"rec","p":"na","d":[19],"c":[2,27],"a":"adult older","h":[113,102],"po":"2026-09-25","u":"2026-11-10","st":"2026-10","ag":"18–100"},{"n":"NCT07843940","t":"A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)","s":"rec","p":"phase1phase2","d":[4],"c":[22,24,5],"a":"adult older","h":[42,45,47],"po":"2026-09-28","u":"2026-11-10","st":"2026-10","ag":"18 and over"},{"n":"NCT07844941","t":"Artificial Intelligence (AI)-Based Personalized Exercise Coaching for Patients With Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[123],"l":[[123,"breast"]],"po":"2026-09-28","u":"2026-09-28","st":"2026-07","ag":"18–70"},{"n":"NCT07846462","t":"Aspirin 50mg vs 100mg Combined With P2Y12 Inhibitor After PCI","s":"rec","p":"na","d":[31],"c":[15],"lc":[15],"a":"adult older","h":[27],"l":[[27,"cad"]],"po":"2026-09-29","u":"2026-10-01","st":"2026-03","ag":"18–85"},{"n":"NCT07848243","t":"Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes","s":"rec","p":"phase2","d":[4,6],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"lung"]],"po":"2026-09-29","u":"2026-09-29","st":"2026-02","ag":"18 and over"},{"n":"NCT07848750","t":"InstaSure™ Non-Invasive Finger-Press Test for Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[2],"a":"adult older","h":[153],"po":"2026-09-30","u":"2026-09-30","st":"2026-06","ag":"18 and over"},{"n":"NCT07849608","t":"Silent Evaluation of DeepTRG for Assessing Tumor Response After Preoperative Treatment in Stomach and Gastroesophageal Junction Cancer","s":"rec","p":"na","d":[3],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"gc"]],"po":"2026-09-30","u":"2026-09-30","st":"2026-09","ag":"18 and over"},{"n":"NCT07851363","t":"Rapid Diagnosis and Treatment Response Monitoring of Primary CNS Lymphoma Using CSF ctDNA Liquid Biopsy","s":"rec","p":"na","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[102],"l":[[102,"lymph"]],"po":"2026-10-01","u":"2026-10-01","st":"2026-01","ag":"18–75"},{"n":"NCT07853261","t":"Impact of Stepwise Pressure-Increasing NC Balloon Post-Dilation on Stent Expansion","s":"rec","p":"na","d":[31],"c":[15],"lc":[15],"a":"adult older","h":[27],"l":[[27,"cad"]],"po":"2026-10-01","u":"2026-10-01","st":"2026-01","ag":"18 and over"},{"n":"NCT07854652","t":"BEBT-908 in MEF2D-Rearranged Relapsed/Refractory or MRD-Positive B-Cell Precursor Acute Lymphoblastic Leukemia","s":"rec","p":"phase1","d":[16],"c":[4],"lc":[4],"a":"child adult older","h":[5],"l":[[5,"ball"]],"po":"2026-10-02","u":"2026-11-16","st":"2026-09","ag":"14–75"},{"n":"NCT07855640","t":"Anti-PD-1 in Combination With Systemic Chemotherapy With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites","s":"rec","p":"na","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"gc"]],"po":"2026-10-02","u":"2026-10-02","st":"2026-07","ag":"18–75"},{"n":"NCT07855965","t":"Multicenter, Single-Arm, Prospective Phase II Study of Neoadjuvant Cryo-Thermal Ablation Combined With Toripalimab and Chemotherapy for Resectable Stage IB-IIIB Non-Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[22,73,51],"lc":[22],"a":"adult older","h":[40,238,47,146],"l":[[40,"lung"]],"po":"2026-10-02","u":"2026-10-02","st":"2026-09","ag":"18–80"},{"n":"NCT07857668","t":"LECS Combined With LSNNS for Early Gastric Cancer (LENS Trial)","s":"rec","p":"na","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"gc"]],"po":"2026-10-05","u":"2026-10-05","st":"2026-08","ag":"20–80"},{"n":"NCT07858630","t":"Radiotherapy Target Volume Delineation in Locally Advanced Esophageal Cancer in the Immunotherapy Era","s":"rec","p":"na","d":[1],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"escc"]],"po":"2026-10-05","u":"2026-10-05","st":"2026-08","ag":"18–80"},{"n":"NCT07863141","t":"A Phase II Study of Anlotinib + PD-1 Inhibitor vs. PD-1 Inhibitor Maintenance After First-Line Chemoimmunotherapy in Advanced ESCC (Esophageal Squamous Cell Carcinoma)","s":"rec","p":"phase2","d":[1],"c":[0],"lc":[0],"a":"adult older","h":[49],"l":[[49,"escc"]],"po":"2026-10-07","u":"2026-10-07","st":"2026-10","ag":"18–75"},{"n":"NCT07863167","t":"An Open, Multicenter Phase II Clinical Trial of SHR-A2009 Combined With Other Anti-tumor Therapies for Perioperative Treatment of Resectable Non-small Cell Lung Cancer.","s":"rec","p":"phase2","d":[4],"c":[0],"a":"adult older","h":[43],"po":"2026-10-07","u":"2026-11-18","st":"2026-10","ag":"18–70"},{"n":"NCT07863999","t":"Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Combined With Monoclonal Antibody in Locally Advanced NSCLC","s":"rec","p":"phase3","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56,121,139,212,162],"l":[[56,"lung"]],"po":"2026-10-07","u":"2026-10-07","st":"2026-05","ag":"18 and over"},{"n":"NCT07864701","t":"Study of JMBI-001 in Patients With MYC-Positive Advanced Cancers","s":"rec","p":"phase1phase2","d":[19],"c":[2],"a":"adult older","h":[74],"po":"2026-10-08","u":"2026-10-15","st":"2026-10","ag":"18–75"},{"n":"NCT07874581","t":"Effectiveness and Safety of MRG003 (Becotatug Vedotin) in Relapsed SCLC","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2026-10-15","u":"2026-10-15","st":"2026-10","ag":"18 and over"},{"n":"NCT07876557","t":"A Clinical Study to Evaluate the Efficacy and Safety of JS212 Monotherapy or Combination Therapy in Recurrent or Metastatic Triple-negative Breast Cancer(TNBC)","s":"rec","p":"phase2","d":[6],"c":[2,15,8,22,16,0,41,24,27,33,9,28,26,11,18,12,42,13,58,20],"a":"adult older","h":[78,53,45,118,25,43,26,55,57,27,37,18,143,13,19,48,142,30,172,98,137,114,175,84,239],"po":"2026-10-15","u":"2026-11-05","st":"2026-10","ag":"18–70"},{"n":"NCT07878351","t":"Prospective ctDNA Testing in Large B-Cell Lymphoma","s":"rec","p":"na","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[48,161],"l":[[48,"lymph"]],"po":"2026-10-16","u":"2026-10-16","st":"2026-10","ag":"18 and over"},{"n":"NCT07880353","t":"Real-World Outcomes of Sevabertinib in HER2-Mutant Advanced NSCLC: A Bidirectional Cohort Study","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lung"]],"po":"2026-10-19","u":"2026-11-05","st":"2026-10","ag":"18 and over"},{"n":"NCT07880600","t":"Pre-Treatment Breast DCE-MRI AI Model to Predict Neoadjuvant Chemotherapy Benefit in Locally Advanced Triple-Negative Breast Cancer","s":"rec","p":"na","d":[6],"c":[16,56],"lc":[16],"a":"adult older","x":"female","h":[30,228,148],"l":[[30,"breast"]],"po":"2026-10-19","u":"2026-10-19","st":"2026-10","ag":"18 and over"},{"n":"NCT07882641","t":"BEX101 in B-cell Non-Hodgkin's Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2026-10-20","u":"2026-10-22","st":"2026-10","ag":"18–75"},{"n":"NCT07886047","t":"Propranolol Hydrochloride Combined With Adebrelimab and Platinum-Based Chemotherapy in Small Cell Lung Cancer","s":"rec","p":"phase1","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[10,11,13,20],"l":[[10,"lung"]],"po":"2026-10-21","u":"2026-10-21","st":"2026-05","ag":"18–75"},{"n":"NCT07886229","t":"Propranolol Hydrochloride Combined With Toripalimab and Platinum-based Chemotherapy in Resectable Non-Small Cell Lung Cancer","s":"rec","p":"phase1","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[10,11,13,20],"l":[[10,"lung"]],"po":"2026-10-21","u":"2026-10-21","st":"2026-06","ag":"18–75"},{"n":"NCT07889531","t":"Efficacy and Safety of Ischemic Preconditioning Therapy Versus Optimal Medical Therapy in Reducing the Recurrence of Ischemic Events in Symptomatic Moyamoya Disease","s":"rec","p":"na","d":[28],"c":[2],"lc":[2],"a":"adult older","h":[102],"l":[[102,"moyamoya"]],"po":"2026-10-22","u":"2026-10-28","st":"2026-10","ag":"18–70"},{"n":"NCT07892573","t":"Becotatug Vedotin Plus Anti-PD-1 and S-1 in Patients With EGFR-Positive Advanced Pancreatic Cancer Who Have Failed at Least One Line of Standard Therapy","s":"rec","p":"na","d":[5],"c":[61],"lc":[61],"a":"adult older","h":[215],"l":[[215,"panc"]],"po":"2026-10-23","u":"2026-10-23","st":"2026-10","ag":"18–85"},{"n":"NCT07892833","t":"Becotatug Vedotin in Combination With Immunotherapy and Multimodality Radiotherapy for Esophageal Squamous Cell Carcinoma in the Second-line or Later Setting","s":"rec","p":"phase2","d":[1],"c":[55],"lc":[55],"a":"adult older","h":[164],"l":[[164,"escc"]],"po":"2026-10-23","u":"2026-10-23","st":"2026-05","ag":"18–80"},{"n":"NCT07894107","t":"Development and Validation of Risk Prediction Models for Stroke and Cognitive Impairment in Moyamoya Disease and Moyamoya Syndrome","s":"rec","p":"na","d":[28],"c":[2,22,23,9,5,4,13,20],"lc":[2],"a":"child adult older","h":[102,26,103,133,54,40,25,38,71,14,92,5,76],"l":[[102,"moyamoya"]],"po":"2026-10-26","u":"2026-10-26","st":"2026-08","ag":"12–70"},{"n":"NCT07894458","t":"MRD-Guided Postoperative Surveillance and Adaptive Treatment for Resectable Lung Cancer","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"lung"]],"po":"2026-10-26","u":"2026-10-26","st":"2026-08","ag":"18–85"},{"n":"NCT07900516","t":"A Prospective, Phase II, Exploratory Study Protocol of a Chemotherapy Sensitivity-based Culmerciclib Combination Regimen in Neoadjuvant Therapy for HR+/HER2- Breast Cancer.","s":"rec","p":"phase2","d":[6],"c":[28],"lc":[28],"a":"adult older","x":"female","h":[78],"l":[[78,"breast"]],"po":"2026-10-28","u":"2026-10-28","st":"2026-08","ag":"18–75"},{"n":"NCT07905066","t":"Hemophagocytic Lymphohistiocytosis After Allogeneic Stem Cell Transplantation","s":"rec","p":"na","d":[18],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"hlh"]],"po":"2026-10-29","u":"2026-10-29","st":"2026-10","ag":"18 and over"},{"n":"NCT07905937","t":"Exploration of Whole-Brain Radiotherapy Combined With PD-1 Inhibitors on Brain Injury","s":"rec","p":"na","d":[4],"c":[41],"lc":[41],"a":"adult older","h":[137],"l":[[137,"lung"]],"po":"2026-10-30","u":"2026-10-30","st":"2026-06","ag":"18–75"},{"n":"NCT07908888","t":"Efficacy and Safety of Polatuzumab Vedotin, Rituximab Combined With Reduced-dose Cyclophosphamide, Doxorubicin and Prednisone Regimen in the Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma: A Multicenter, Single-arm, Prospective Study","s":"rec","p":"phase4","d":[19],"c":[15],"lc":[15],"a":"older","h":[27],"l":[[27,"lymph"]],"po":"2026-11-02","u":"2026-11-02","st":"2026-10","ag":"65 and over"},{"n":"NCT07910708","t":"GN001 for Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and B-Cell Acute Lymphoblastic Leukemia","s":"rec","p":"phase1","d":[16,19],"c":[74],"lc":[74],"a":"adult older","h":[240],"l":[[240,"ball"]],"po":"2026-11-02","u":"2026-11-02","st":"2026-08","ag":"18–75"},{"n":"NCT07912190","t":"ePRO in Advanced Lung Cancer: Emotional Distress, Symptom Burden, Brain Metastasis","s":"rec","p":"na","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"lung"]],"po":"2026-11-03","u":"2026-11-03","st":"2026-01","ag":"18 and over"},{"n":"NCT07914556","t":"Phase 1 Study of 6MW5311 in Adults With Relapsed or Refractory Blood Cancers","s":"rec","p":"phase1","d":[15],"c":[5],"a":"adult older","h":[123],"po":"2026-11-03","u":"2026-11-03","st":"2026-09","ag":"18 and over"},{"n":"NCT07914764","t":"68Ga-labeled Cholecystokinin Receptor (CCK2R) Targeted Molecular Probes in Early Tumor Diagnosis","s":"rec","p":"na","d":[3,4],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"gc"]],"po":"2026-11-04","u":"2026-11-04","st":"2026-08","ag":"18–75"},{"n":"NCT07929909","t":"A Phase I Clinical Study of YN003 in the Treatment of Glioma","s":"rec","p":"phase1","d":[7],"c":[2],"a":"adult older","h":[241,100],"po":"2026-11-10","u":"2026-11-10","st":"2026-10","ag":"18–70"},{"n":"NCT07933653","t":"Thalidomide for Preventing Radiation-Induced Dermatitis in Breast Cancer Patients","s":"rec","p":"na","d":[6],"c":[10],"lc":[10],"a":"adult older","x":"female","h":[15],"l":[[15,"breast"]],"po":"2026-11-12","u":"2026-11-12","st":"2026-11","ag":"18–70"},{"n":"NCT07933952","t":"Liver Metastasis in Pancreatic Ductal Adenocarcinoma: Regulatory Mechanisms and Clinical Significance","s":"rec","p":"na","d":[5],"c":[28],"lc":[28],"a":"adult older","h":[242],"l":[[242,"panc"]],"po":"2026-11-12","u":"2026-11-12","st":"2026-10","ag":"18–80"},{"n":"NCT07935187","t":"Cardiopulmonary Exercise Active Health Cohort Study","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[115],"l":[[115,"cad"]],"po":"2026-11-13","u":"2026-11-13","st":"2026-05","ag":"18–80"},{"n":"NCT07940231","t":"Prospective Study of Intraoperative Brain Tumor Photographs for Pathological and Molecular Classification","s":"rec","p":"na","d":[7],"c":[2],"lc":[2],"a":"adult older","h":[102],"l":[[102,"glioma"]],"po":"2026-11-16","u":"2026-11-16","st":"2026-07","ag":"18 and over"},{"n":"NCT07941063","t":"Multimodal Ultrasound for Lymphoma Classification and Treatment Response Prediction","s":"rec","p":"na","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2026-11-17","u":"2026-11-17","st":"2026-01","ag":"18 and over"},{"n":"NCT07941128","t":"Pragmatic AI-Assisted Lung Cancer Translational Study","s":"rec","p":"na","d":[4],"c":[23,20],"lc":[23],"a":"adult older","h":[82,92],"l":[[82,"lung"]],"po":"2026-11-17","u":"2026-11-17","st":"2026-08","ag":"18 and over"},{"n":"NCT05321316","t":"Nectin-4 Specific LMW PET Probe Imaging in Multiple Solid Tumors","s":"rec","p":"na","d":[4,5,6],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"lung"]],"po":"2022-04-11","u":"2026-11-18","st":"2025-05","ag":"18–75"},{"n":"NCT05798845","t":"The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2023-04-05","u":"2026-03-11","st":"2025-02","ag":"18–75"},{"n":"NCT06014060","t":"24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized Trial","s":"rec","p":"na","d":[31],"c":[2],"a":"adult older","h":[213],"po":"2023-08-28","u":"2025-07-18","st":"2025-06","ag":"18–75"},{"n":"NCT06095154","t":"CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[16],"lc":[16],"a":"adult older","h":[30],"l":[[30,"npc"]],"po":"2023-10-23","u":"2025-03-13","st":"2025-01","ag":"18–70"},{"n":"NCT06160492","t":"5-Aminolevulinic Acid for Photodynamic Diagnosis of Malignant Glioma","s":"rec","p":"phase3","d":[7],"c":[0],"a":"adult older","h":[53],"po":"2023-12-07","u":"2026-10-27","st":"2025-04","ag":"18–75"},{"n":"NCT06232083","t":"A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)","s":"rec","p":"phase1","d":[4],"c":[17],"lc":[17],"a":"adult older","h":[68],"l":[[68,"lung"]],"po":"2024-01-30","u":"2025-07-09","st":"2025-09","ag":"18–75"},{"n":"NCT06296745","t":"Intrathecal Pemetrexed for Leptomeningeal Metastasis From Lung Adenocarcinoma That Progressed After Osimertinib.","s":"rec","p":"phase2","d":[4],"c":[3],"lc":[3],"a":"adult older","h":[4],"l":[[4,"lung"]],"po":"2024-03-06","u":"2026-01-30","st":"2025-09","ag":"18–75"},{"n":"NCT06314594","t":"Protocol for a Randomized Controlled Trial of a Clinician-Supervised Home-School-Hospital-Linked Digital Health Platform-Supported Conservative Management Pathway for AIS","s":"rec","p":"na","d":[33],"c":[23],"a":"child","h":[183],"po":"2024-03-18","u":"2026-10-27","st":"2025-03","ag":"12–16"},{"n":"NCT06348797","t":"Phase I Clinical Study of α-PD-L1/DLL3 CAR-T in Patients With R/R SCLC","s":"rec","p":"phase1","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"lung"]],"po":"2024-04-05","u":"2026-07-21","st":"2025-04","ag":"18–70"},{"n":"NCT06356688","t":"A Clinical Study on the Efficacy and Safety of Paclitaxel Polymeric Micelles and Cisplatin Combined With Cadonilimab as a Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"escc"]],"po":"2024-04-10","u":"2025-08-08","st":"2025-04","ag":"18–75"},{"n":"NCT06451198","t":"IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome","s":"rec","p":"phase4","d":[31],"c":[5],"lc":[5],"a":"older","h":[6],"l":[[6,"cad"]],"po":"2024-06-11","u":"2026-03-12","st":"2025-05","ag":"65 and over"},{"n":"NCT06481735","t":"TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALL","s":"rec","p":"phase1phase2","d":[16],"c":[2,30],"lc":[2],"a":"child adult older","h":[26,69,233,38],"l":[[26,"ball"]],"po":"2024-07-01","u":"2026-05-08","st":"2025-02","ag":"16–70"},{"n":"NCT06487624","t":"An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors","s":"rec","p":"phase1","d":[19],"c":[0,23,19],"a":"adult older","h":[46,28,0],"po":"2024-07-05","u":"2026-04-13","st":"2025-04","ag":"18 and over"},{"n":"NCT06514508","t":"Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients","s":"rec","p":"phase3","d":[15],"c":[2],"a":"adult older","h":[48],"po":"2024-07-23","u":"2026-09-14","st":"2025-12","ag":"18–78"},{"n":"NCT06519591","t":"Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal Metastasis","s":"rec","p":"phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"gc"]],"po":"2024-07-25","u":"2026-07-29","st":"2025-02","ag":"18 and over"},{"n":"NCT06568939","t":"A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)","s":"rec","p":"phase2","d":[4],"c":[16,24,25,9,10,34,13,39,20],"a":"adult older","h":[12,111,45,14,37,30,50,72,51],"po":"2024-08-23","u":"2026-10-22","st":"2025-01","ag":"18 and over"},{"n":"NCT06570447","t":"Glofitamab Combination With Chidamide in Patients With Recurrent/Refractory DLBCL","s":"rec","p":"phase2","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lymph"]],"po":"2024-08-26","u":"2026-08-03","st":"2025-02","ag":"18 and over"},{"n":"NCT06585072","t":"Pancreatic Cancer and Diabetes Mellitus","s":"rec","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[212],"l":[[212,"panc"]],"po":"2024-09-05","u":"2025-07-01","st":"2025-01","ag":"18 and over"},{"n":"NCT06618313","t":"One Trial to Evaluate the Safety, Tolerability and Efficacy of JCXH-213 in Patients With r/r B-NHL","s":"rec","p":"na","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[3],"l":[[3,"lymph"]],"po":"2024-10-01","u":"2025-06-03","st":"2025-03","ag":"18 and over"},{"n":"NCT06620809","t":"The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders","s":"rec","p":"phase1","d":[25],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"nmosd"]],"po":"2024-10-01","u":"2026-09-21","st":"2025-03","ag":"18–65"},{"n":"NCT06637150","t":"Dalpicilib-Enhanced vs. Standard Endocrine Therapy in ER+ HER2- Early Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2024-10-15","u":"2026-09-29","st":"2025-01","ag":"18–70"},{"n":"NCT06642792","t":"A Study of AK129 With or Without AK117 in PD(L)1-refractory Classic Hodgkin Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[2],"a":"adult older","h":[74],"po":"2024-10-15","u":"2025-02-11","st":"2025-01","ag":"18 and over"},{"n":"NCT06644781","t":"A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)","s":"rec","p":"phase3","d":[1],"c":[48,2,15,22,16,23,24,17,27,75,25,36,10,43,11,30,13,7,14,32,20],"a":"adult older","h":[74,40,125,57,47,44,58,37,30,87,150,45,46,63,18,12,21,27,83,50,136,243,19,31,244,67,88,138],"po":"2024-10-16","u":"2026-10-26","st":"2025-03","ag":"18 and over"},{"n":"NCT06663748","t":"ARX788 in HER2-positive Metastatic Breast Cancer Patients","s":"rec","p":"phase2","d":[6],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"breast"]],"po":"2024-10-29","u":"2026-10-16","st":"2025-06","ag":"18–75"},{"n":"NCT06674252","t":"A Study on the Improvement of Postoperative Symptoms and Survival Benefits of Modified Bufei Decoction in Elderly Patients With Lung Cancer Undergoing Radical Surgery","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"older","h":[74],"l":[[74,"lung"]],"po":"2024-11-05","u":"2026-01-27","st":"2025-06","ag":"65 and over"},{"n":"NCT06676982","t":"Clinical Trial of Autologous CD19 CAR-T Cells (CNCT19) Therapy for Advanced Hepatocellular Carcinoma","s":"rec","p":"phase1","d":[2],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"hcc"]],"po":"2024-11-06","u":"2025-12-15","st":"2025-01","ag":"18–80"},{"n":"NCT06679036","t":"A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer Patients","s":"rec","p":"phase1phase2","d":[6],"c":[24,20],"a":"adult older","x":"female","h":[45,37],"po":"2024-11-07","u":"2026-03-02","st":"2025-01","ag":"18–75"},{"n":"NCT06685887","t":"A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal Metastasis","s":"rec","p":"phase2","d":[3],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"gc"]],"po":"2024-11-13","u":"2025-04-11","st":"2025-02","ag":"18–75"},{"n":"NCT06686459","t":"A Phase II Clinical Trial of Artificial Intelligence-assisted One-stop Radiotherapy for Breast Cancer After Breast-conserving Surgery","s":"rec","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[53],"l":[[53,"breast"]],"po":"2024-11-13","u":"2025-07-01","st":"2025-04","ag":"18–70"},{"n":"NCT06687408","t":"Sleeve Lobectomy for Lung Cancer in Minimally Invasive Surgical Techniques","s":"rec","p":"na","d":[4],"c":[23,5],"lc":[23],"a":"adult older","h":[54,42,82],"l":[[54,"lung"]],"po":"2024-11-13","u":"2026-04-24","st":"2025-03","ag":"18 and over"},{"n":"NCT06688435","t":"A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia Gravis","s":"rec","p":"phase1","d":[27],"c":[27],"a":"adult older","h":[124],"po":"2024-11-14","u":"2026-08-12","st":"2025-03","ag":"18–65"},{"n":"NCT06689917","t":"JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia","s":"rec","p":"na","d":[16,19],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"ball"]],"po":"2024-11-15","u":"2025-07-08","st":"2025-01","ag":"18–75"},{"n":"NCT06697184","t":"A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.","s":"rec","p":"phase1phase2","d":[19],"c":[2,0,4],"a":"adult older","h":[5,115,70],"po":"2024-11-20","u":"2026-10-26","st":"2025-01","ag":"18 and over"},{"n":"NCT06703255","t":"A Phase 2 Study of HX301 in Patients with High-grade Giloma","s":"rec","p":"phase1phase2","d":[7],"c":[2],"a":"adult older","h":[102],"po":"2024-11-25","u":"2025-01-15","st":"2025-01","ag":"18 and over"},{"n":"NCT06712316","t":"Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)","s":"rec","p":"phase2phase3","d":[4],"c":[2,55,15,8,1,23,27,5,43,18,4,29,13,32],"a":"adult older","h":[42,56,38,44,5,13,133,164,82,61,94,83,125,63,138,39,20,66,175,178],"po":"2024-12-02","u":"2026-11-02","st":"2025-01","ag":"18 and over"},{"n":"NCT06712355","t":"Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[2,55,15,1,16,0,23,24,17,27,25,9,5,43,18,4,12,29,37,13,38,14,32,20],"a":"adult older","h":[23,42,57,43,38,44,5,12,45,133,14,164,81,37,61,30,68,83,125,63,138,39,66,175,84,21,86,178,67],"po":"2024-12-02","u":"2026-10-14","st":"2025-02","ag":"18 and over"},{"n":"NCT06712862","t":"A Clinical Study of Evaluating Myocardial Viability in Ischemic Heart Disease with Integrated 18F-FDG PET/MR","s":"rec","p":"na","d":[31],"c":[5],"lc":[5],"a":"child adult older","h":[65],"l":[[65,"cad"]],"po":"2024-12-02","u":"2024-12-02","st":"2025-12","ag":"Up to 80"},{"n":"NCT06717113","t":"A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma","s":"rec","p":"earlyphase1","d":[15],"c":[2],"lc":[2],"a":"adult older","h":[29],"l":[[29,"mm"]],"po":"2024-12-04","u":"2025-06-06","st":"2025-04","ag":"18–80"},{"n":"NCT06717347","t":"A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)","s":"rec","p":"phase3","d":[19],"c":[2,15,22,1,16,0,41,17,27,9,10,40,5,12,30,13,7],"a":"adult older","h":[40,53,74,69,9,115,8,110,27,2,47,0,30,57,116,137,50,19,84,88],"po":"2024-12-05","u":"2026-11-13","st":"2025-01","ag":"18 and over"},{"n":"NCT06730256","t":"A Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/ Refractory Plasma Cell Leukemia","s":"rec","p":"earlyphase1","d":[15],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"mm"]],"po":"2024-12-12","u":"2025-10-01","st":"2025-07","ag":"18 and over"},{"n":"NCT06731140","t":"Reverse HER2-negative Immune Resistant Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2024-12-12","u":"2025-11-17","st":"2025-02","ag":"18–70"},{"n":"NCT06731478","t":"Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer","s":"rec","p":"phase3","d":[3],"c":[2,49,16,23,24,17,27,33,25,5,11,4,12,30,34,13,39,7,31,58,20],"a":"adult older","h":[74,195,25,9,58,111,45,46,82,18,30,57,187,8,115,145,172,19,84,101,72,67,88],"po":"2024-12-12","u":"2026-08-10","st":"2025-02","ag":"18 and over"},{"n":"NCT06737913","t":"HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[0,20],"lc":[0],"a":"adult older","h":[53,37],"l":[[53,"hcc"]],"po":"2024-12-17","u":"2026-09-25","st":"2025-01","ag":"18 and over"},{"n":"NCT06738160","t":"The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2024-12-17","u":"2026-09-11","st":"2025-02","ag":"18–80"},{"n":"NCT06738966","t":"A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer","s":"rec","p":"phase1","d":[6],"c":[15,27],"a":"adult older","h":[27,83],"po":"2024-12-18","u":"2026-01-13","st":"2025-03","ag":"18 and over"},{"n":"NCT06741020","t":"Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma","s":"rec","p":"phase1phase2","d":[2],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"hcc"]],"po":"2024-12-18","u":"2025-05-23","st":"2025-03","ag":"18–75"},{"n":"NCT06741540","t":"Effects of TDCS Intervention on Neoadjuvant Chemotherapy in Breast Cancer Patients with Mild to Moderate Depression","s":"rec","p":"na","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2024-12-19","u":"2025-02-07","st":"2025-01","ag":"18–65"},{"n":"NCT06742892","t":"A Phase II Clinical Study to Evaluate HLX43 in Patients With Locally Advanced or Metastatic HCC Failed or Intolerance to Standard Therapy","s":"rec","p":"phase2","d":[2],"c":[8],"a":"adult older","h":[13],"po":"2024-12-19","u":"2025-03-10","st":"2025-03","ag":"18–75"},{"n":"NCT06742996","t":"A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)","s":"rec","p":"phase3","d":[19],"c":[2,22,1,0,23,24,25,9,28,26,5,11,37,13,31,20],"a":"adult older","h":[25,74,78,46,36,12,64,9,45,55,79,70,81,98,116,18,67],"po":"2024-12-19","u":"2026-10-29","st":"2025-03","ag":"18 and over"},{"n":"NCT06743477","t":"A Clinical Study of Ultra-transplantation for the Treatment of Major Thalassemia Scheme","s":"rec","p":"na","d":[20],"c":[47],"lc":[47],"a":"child","h":[217],"l":[[217,"bthal"]],"po":"2024-12-20","u":"2025-09-02","st":"2025-08","ag":"7–12"},{"n":"NCT06743503","t":"UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell Malignancies","s":"rec","p":"phase1","d":[19],"c":[28,30],"a":"adult older","h":[78,69],"po":"2024-12-20","u":"2025-09-18","st":"2025-04","ag":"18 and over"},{"n":"NCT06743945","t":"POLA-R-CHP in the First-line Treatment of Transformed DLBCL","s":"rec","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lymph"]],"po":"2024-12-20","u":"2025-02-25","st":"2025-02","ag":"18–80"},{"n":"NCT06749899","t":"QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.","s":"rec","p":"phase3","d":[0],"c":[8,22,44,63,16,0,41,28,10,5,30,13,7,46],"lc":[0],"a":"adult older","h":[53,30,11,13,50,236,8,47,127,16,12,36,58,198,134,130,245,246],"l":[[53,"npc"]],"po":"2024-12-27","u":"2025-05-22","st":"2025-05","ag":"18–65"},{"n":"NCT06752239","t":"Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC","s":"rec","p":"phase3","d":[0],"c":[9],"lc":[9],"a":"adult older","h":[116],"l":[[116,"npc"]],"po":"2024-12-30","u":"2025-04-10","st":"2025-01","ag":"18–70"},{"n":"NCT06752811","t":"Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer","s":"rec","p":"phase3","d":[5],"c":[28,5],"a":"adult older","h":[9,78],"po":"2024-12-31","u":"2026-11-18","st":"2025-02","ag":"18–75"},{"n":"NCT06753747","t":"A Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase1phase2","d":[1],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"escc"]],"po":"2024-12-31","u":"2025-12-03","st":"2025-09","ag":"18–75"},{"n":"NCT06754930","t":"A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC","s":"rec","p":"phase1phase2","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2025-01-01","u":"2025-04-17","st":"2025-02","ag":"18–75"},{"n":"NCT06756932","t":"BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer","s":"rec","p":"phase1","d":[6],"c":[0,23,5,30,20],"a":"adult older","h":[9,58,99,25,82],"po":"2025-01-03","u":"2026-09-14","st":"2025-02","ag":"18 and over"},{"n":"NCT06757634","t":"Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)","s":"rec","p":"phase3","d":[6],"c":[2,8,23,27,36,9,28,61,11,30,42,39,14,32,20],"a":"adult older","h":[23,58,74,54,25,11,143,13,127,113,114,63,215,87,247,239,21],"po":"2025-01-03","u":"2026-10-09","st":"2025-07","ag":"18 and over"},{"n":"NCT06758037","t":"Clinical Study of HiR+X Therapy for Newly Diagnosed Elderly Patients With DLBCL Intolerant to Chemotherapy","s":"rec","p":"phase2","d":[19],"c":[61],"lc":[61],"a":"older","h":[182],"l":[[182,"lymph"]],"po":"2025-01-03","u":"2025-03-18","st":"2025-01","ag":"70–100"},{"n":"NCT06758401","t":"This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.","s":"rec","p":"phase3","d":[4],"c":[2,8,49,22,16,0,23,24,17,27,25,36,9,28,10,5,29,30,37,13,39,31,20],"a":"adult older","h":[40,42,57,9,78,12,111,74,45,59,13,47,14,81,37,70,82,61,30,83,64,145,19,50,66,87,88,51],"po":"2025-01-03","u":"2026-11-12","st":"2025-07","ag":"18 and over"},{"n":"NCT06758544","t":"A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer","s":"rec","p":"phase1phase2","d":[5],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"panc"]],"po":"2025-01-03","u":"2025-08-17","st":"2025-03","ag":"18–75"},{"n":"NCT06758700","t":"Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2025-01-06","u":"2025-12-05","st":"2025-02","ag":"18–75"},{"n":"NCT06758713","t":"Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies","s":"rec","p":"phase1","d":[15,19],"c":[0],"lc":[0],"a":"adult older","h":[248],"l":[[248,"mm"]],"po":"2025-01-06","u":"2025-01-06","st":"2025-01","ag":"18–75"},{"n":"NCT06760039","t":"Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL","s":"rec","p":"phase1phase2","d":[19],"c":[2,16,33,9,45,59],"lc":[59],"a":"adult older","h":[171,161,30,116,129,73],"l":[[171,"lymph"]],"po":"2025-01-06","u":"2025-04-03","st":"2025-01","ag":"18–80"},{"n":"NCT06760819","t":"A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)","s":"rec","p":"phase2","d":[3],"c":[2,8,23,5],"a":"adult older","h":[74,6,9,82,29,13],"po":"2025-01-07","u":"2026-11-04","st":"2025-02","ag":"18 and over"},{"n":"NCT06762782","t":"Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery","s":"rec","p":"phase2","d":[2],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"hcc"]],"po":"2025-01-08","u":"2025-01-08","st":"2025-02","ag":"18–80"},{"n":"NCT06763848","t":"Protein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum Disorder","s":"rec","p":"na","d":[25],"c":[0],"lc":[0],"a":"adult older","h":[209],"l":[[209,"nmosd"]],"po":"2025-01-08","u":"2025-04-30","st":"2025-04","ag":"18–65"},{"n":"NCT06764017","t":"CHiR Therapy for Elderly DLBCL Intolerant to Chemo","s":"rec","p":"phase2","d":[19],"c":[61],"lc":[61],"a":"older","h":[182],"l":[[182,"lymph"]],"po":"2025-01-08","u":"2025-03-19","st":"2025-02","ag":"70–100"},{"n":"NCT06764082","t":"Nutritional Intervention for Biliary Atresia","s":"rec","p":"na","d":[30],"c":[13],"lc":[13],"a":"child","h":[36],"l":[[36,"ba"]],"po":"2025-01-08","u":"2025-12-22","st":"2025-02","ag":"1 day–3 months"},{"n":"NCT06764238","t":"Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol","s":"rec","p":"phase2phase3","d":[16],"c":[8,22,1,16,0,41,17,27,9,28,10,26,5,21,4,30,13,39],"lc":[30],"a":"child adult","h":[69,70,36,11,137,140,31,12,249,203,20,124,1,250,251,252,253,254,255,96,55,76,256,257,258],"l":[[69,"ball"]],"po":"2025-01-08","u":"2026-07-23","st":"2025-01","ag":"1 month–18"},{"n":"NCT06765499","t":"The Study Evaluating the Improvement of Nutritional Status and Frailty With Silkworm Pupa Powder Among Patients With Motor Neuron Disease","s":"rec","p":"na","d":[39],"c":[23],"a":"adult older","h":[185],"po":"2025-01-09","u":"2025-05-04","st":"2025-03","ag":"18–80"},{"n":"NCT06766305","t":"QL1706 Combined With SOX Used in Theperioperative Treatment","s":"rec","p":"phase1phase2","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"gc"]],"po":"2025-01-09","u":"2025-06-17","st":"2025-03","ag":"18–75"},{"n":"NCT06766643","t":"Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer","s":"rec","p":"phase2","d":[2],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"hcc"]],"po":"2025-01-09","u":"2025-01-09","st":"2025-01","ag":"18–75"},{"n":"NCT06767527","t":"AK112 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/ Metastatic Triple-negative Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[2],"a":"adult older","h":[23],"po":"2025-01-10","u":"2026-03-16","st":"2025-02","ag":"18–75"},{"n":"NCT06768307","t":"Assessment of Adebelizumab Combined With Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"lung"]],"po":"2025-01-10","u":"2026-08-17","st":"2025-01","ag":"18 and over"},{"n":"NCT06769113","t":"A Phase II Clinical Study to Evaluate HLX43 in Patients With Recurrent/Metastatic ESCC Failed or Intolerance to Standard Therapy","s":"rec","p":"phase2","d":[1],"c":[27],"a":"adult older","h":[57],"po":"2025-01-10","u":"2026-05-18","st":"2025-01","ag":"18–75"},{"n":"NCT06769295","t":"A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLC","s":"rec","p":"phase2","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"lung"]],"po":"2025-01-10","u":"2025-01-10","st":"2025-02","ag":"18–75"},{"n":"NCT06769425","t":"HS-10502 Combination Treatment in Patients With Advanced Solid Tumors","s":"rec","p":"phase1","d":[3,6],"c":[5],"a":"adult older","h":[9],"po":"2025-01-10","u":"2025-06-24","st":"2025-05","ag":"18 and over"},{"n":"NCT06769971","t":"Phase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in Patients with ES-SCLC","s":"rec","p":"phase2","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"lung"]],"po":"2025-01-10","u":"2025-01-10","st":"2025-02","ag":"18–75"},{"n":"NCT06770439","t":"IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"panc"]],"po":"2025-01-13","u":"2025-09-23","st":"2025-04","ag":"18 and over"},{"n":"NCT06770452","t":"HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients","s":"rec","p":"phase2","d":[5],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"panc"]],"po":"2025-01-13","u":"2026-06-03","st":"2025-03","ag":"18–75"},{"n":"NCT06771960","t":"Association Between RVT and Prognosis After Neoadjuvant Targeted Therapy in EGFR NSCLC","s":"rec","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"lung"]],"po":"2025-01-13","u":"2025-02-21","st":"2025-02","ag":"18–80"},{"n":"NCT06772623","t":"Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations","s":"rec","p":"phase1phase2","d":[4],"c":[8,22,16,9,28,5,12,13,39,20],"a":"adult older","h":[40,42,56,12,111,13,14,37,60,30,176],"po":"2025-01-13","u":"2026-11-19","st":"2025-03","ag":"18 and over"},{"n":"NCT06772935","t":"Electroacupuncture Treatment of Peripheral Neuropathy After Taxane Chemotherapy for Breast Cancer","s":"rec","p":"na","d":[6],"c":[62],"lc":[62],"a":"adult older","x":"female","h":[192],"l":[[192,"breast"]],"po":"2025-01-14","u":"2025-01-14","st":"2025-06","ag":"18–75"},{"n":"NCT06773312","t":"BC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma.","s":"rec","p":"phase1","d":[3],"c":[2],"a":"adult older","h":[74],"po":"2025-01-14","u":"2025-03-10","st":"2025-02","ag":"18–75"},{"n":"NCT06773481","t":"BC008-1A Injection for Recurrent CNS WHO G4 Glioma","s":"rec","p":"phase1","d":[7],"c":[2],"a":"adult older","h":[102],"po":"2025-01-14","u":"2025-07-09","st":"2025-04","ag":"18 and over"},{"n":"NCT06773507","t":"Phase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors","s":"rec","p":"phase1","d":[4],"c":[30],"a":"adult older","h":[58],"po":"2025-01-14","u":"2025-07-09","st":"2025-05","ag":"18 and over"},{"n":"NCT06775743","t":"ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2025-01-15","u":"2026-03-11","st":"2025-01","ag":"18 and over"},{"n":"NCT06776588","t":"Study on the Diagnosis of Ground-glass Lung Cancer by Microwave Ablation Combined With Puncture Biopsy","s":"rec","p":"na","d":[4],"a":"adult older","h":[259],"l":[[259,"lung"]],"po":"2025-01-15","u":"2025-11-24","st":"2025-01","ag":"18–75"},{"n":"NCT06776952","t":"A Randomized, Double-blind, Multicenter Phase III Study of XNW5004 Tablets in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma","s":"rec","p":"phase3","d":[19],"c":[2],"a":"child","h":[39],"po":"2025-01-15","u":"2026-01-09","st":"2025-04","ag":"18 days–70 days"},{"n":"NCT06780098","t":"Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)","s":"rec","p":"phase2","d":[4],"c":[2,1,16,28,10,5,20],"a":"adult older","h":[42,56,74,37,60,30,2,50],"po":"2025-01-17","u":"2026-11-13","st":"2025-05","ag":"18 and over"},{"n":"NCT06780111","t":"Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)","s":"rec","p":"phase1phase2","d":[1],"c":[2,17,9,7,31,20],"a":"adult older","h":[74,37,14,8,101,31],"po":"2025-01-17","u":"2026-11-13","st":"2025-07","ag":"18 and over"},{"n":"NCT06780137","t":"A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)","s":"rec","p":"phase1phase2","d":[4],"c":[2,22,16,23,28,5],"a":"adult older","h":[40,42,56,74,46,60,30],"po":"2025-01-17","u":"2026-10-06","st":"2025-02","ag":"18 and over"},{"n":"NCT06784921","t":"To Investigate the Real-world Efficacy and Safety of Sacituzumab Govitecan for HER2 Negative Metastatic Breast Cancer Patients in China.","s":"rec","p":"na","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[44],"l":[[44,"breast"]],"po":"2025-01-20","u":"2026-01-16","st":"2025-02","ag":"18–75"},{"n":"NCT06787339","t":"Capecitabine in Low Risk Triple Negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2025-01-22","u":"2026-09-28","st":"2025-01","ag":"18 and over"},{"n":"NCT06788002","t":"LDRT and Chemoimmunotherapy in NPC With Liver Metastasis","s":"rec","p":"phase2","d":[0],"c":[8],"lc":[8],"a":"adult older","h":[13,11,20],"l":[[13,"npc"]],"po":"2025-01-22","u":"2026-07-07","st":"2025-01","ag":"18–70"},{"n":"NCT06789679","t":"Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"panc"]],"po":"2025-01-23","u":"2025-01-30","st":"2025-01","ag":"18 and over"},{"n":"NCT06790693","t":"A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[2,8,22,0,23,24,27,47,10,30,34,39,38],"a":"adult older","h":[40,58,53,45,44,38,57,97,50,135,13,72,98,144,86],"po":"2025-01-24","u":"2026-11-04","st":"2025-04","ag":"18 and over"},{"n":"NCT06791538","t":"Robotic Versus Laparoscopic Radical Surgery for Locally Advanced Gastric Cancer","s":"rec","p":"na","d":[3],"c":[1],"lc":[1],"a":"adult older","h":[193],"l":[[193,"gc"]],"po":"2025-01-24","u":"2025-06-08","st":"2025-02","ag":"18–75"},{"n":"NCT06791681","t":"A Study of ESO-T01 in Treating Relapsed/ Refractory Multiple Myeloma","s":"rec","p":"earlyphase1","d":[15],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"mm"]],"po":"2025-01-24","u":"2025-02-11","st":"2025-01","ag":"18 and over"},{"n":"NCT06792253","t":"Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma","s":"rec","p":"phase3","d":[19],"c":[2],"a":"adult older","h":[23],"po":"2025-01-24","u":"2026-08-19","st":"2025-01","ag":"18–75"},{"n":"NCT06792552","t":"A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors","s":"rec","p":"phase1","d":[4],"c":[2,8,0,27,5,11,18],"a":"adult older","h":[53,9,26,24,13,18,199],"po":"2025-01-24","u":"2026-08-17","st":"2025-02","ag":"18 and over"},{"n":"NCT06792799","t":"Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease","s":"rec","p":"earlyphase1","d":[46],"c":[23],"lc":[23],"a":"child adult older","h":[179],"l":[[179,"iga"]],"po":"2025-01-27","u":"2025-12-01","st":"2025-01","ag":"3 and over"},{"n":"NCT06793189","t":"MZL-IPI Risk-adapted Targeted Therapy in Untreated MZL","s":"rec","p":"phase2","d":[19],"c":[2,5,11],"lc":[5],"a":"adult older","h":[123,115,118],"l":[[123,"lymph"]],"po":"2025-01-27","u":"2026-03-24","st":"2025-01","ag":"18 and over"},{"n":"NCT06793215","t":"A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[2,55,8,22,0,23,24,17,27,47,9,40,5,43,13],"a":"adult older","h":[40,56,57,9,74,45,10,46,13,14,164,82,135,49,68,125,65,19,260],"po":"2025-01-27","u":"2026-11-05","st":"2025-10","ag":"18 and over"},{"n":"NCT06793241","t":"Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia","s":"rec","p":"earlyphase1","d":[16],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"ball"]],"po":"2025-01-27","u":"2025-01-27","st":"2025-01","ag":"18 and over"},{"n":"NCT06793332","t":"BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2025-01-27","u":"2026-11-06","st":"2025-02","ag":"18–70"},{"n":"NCT06793449","t":"BCMA CAR-T Versus ASCT in Transplant-eligible Patients With Multiple Myeloma","s":"rec","p":"phase2","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2025-01-27","u":"2025-08-03","st":"2025-02","ag":"18–70"},{"n":"NCT06793475","t":"Aponermin-Based Bridging Therapy Prior to CAR-T Infusion in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease","s":"rec","p":"na","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2025-01-27","u":"2025-08-14","st":"2025-04","ag":"18 and over"},{"n":"NCT06793917","t":"Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma","s":"rec","p":"phase3","d":[3],"c":[16],"lc":[16],"a":"adult older","h":[30],"l":[[30,"gc"]],"po":"2025-01-27","u":"2025-07-20","st":"2025-06","ag":"18–70"},{"n":"NCT06796764","t":"COMBO Endoscopy Oropharyngeal Airway Reduces Hypoxia During Sedated Gastrointestinal Endoscopy in Obese Patients: A Multicenter, Randomized, Controlled Clinical Trial","s":"rec","p":"na","d":[3],"c":[23],"a":"adult older","h":[44,46],"po":"2025-01-28","u":"2025-09-10","st":"2025-04","ag":"18–70"},{"n":"NCT06796803","t":"Camrelizumab Combined With Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC) as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma(HCC)","s":"rec","p":"phase2phase3","d":[2],"c":[24,5],"lc":[5],"a":"adult older","h":[6,45],"l":[[6,"hcc"]],"po":"2025-01-28","u":"2026-07-17","st":"2025-02","ag":"18–75"},{"n":"NCT06801834","t":"Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[2,15,22,1,16,0,23,24,25,9,28,5,21,12,30,13,39,7,14,32,20],"a":"adult older","h":[42,53,58,9,44,12,111,74,45,36,46,127,54,47,80,14,37,82,140,2,49,63,65,106,138,8,84,21,67],"po":"2025-01-30","u":"2026-10-20","st":"2025-04","ag":"18 and over"},{"n":"NCT06802055","t":"Efficacy and Safety of Sirolimus With or Without Cyclosporin A in Chinese Patients With Aplastic Anemia Refractory/Intolerant to Cyclosporin A","s":"rec","p":"phase2","d":[17],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"aa"]],"po":"2025-01-30","u":"2025-06-04","st":"2025-01","ag":"18 and over"},{"n":"NCT06802757","t":"Posaconazole Plus PD-1 Inhibitors and Chemotherapy vs PD-1 Inhibitors and Chemotherapy in Neoadjuvant Therapy for Triple Negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[27],"lc":[27],"a":"adult older","x":"female","h":[57],"l":[[57,"breast"]],"po":"2025-01-31","u":"2026-11-04","st":"2025-04","ag":"18–70"},{"n":"NCT06802835","t":"EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma","s":"rec","p":"phase1phase2","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2025-01-31","u":"2026-05-11","st":"2025-07","ag":"18–75"},{"n":"NCT06803693","t":"Efficacy and Safety of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL","s":"rec","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2025-01-31","u":"2025-12-08","st":"2025-04","ag":"18–75"},{"n":"NCT06809764","t":"Clinical Effectiveness and Safety of Trastuzumab Deruxtecan (T-DXd) in Chinese Patients With HER2m NSCLC (RERUN)","s":"rec","p":"na","d":[4],"c":[2,16,0,23,17,27,9,28,10,40,26,5,11,21,18,13,7,20],"a":"adult older","h":[23,56,44,25,6,110,74,118,24,55,54,14,37,220,60,61,30,49,123,115,106,19,50,261,95,8,116,102,88,199],"po":"2025-02-05","u":"2026-08-18","st":"2025-02","ag":"18 and over"},{"n":"NCT06810804","t":"A Phase IIa Study to Evaluate NBQ72S","s":"rec","p":"phase2","d":[6],"c":[2],"a":"adult older","x":"female","h":[23],"po":"2025-02-06","u":"2026-04-13","st":"2025-04","ag":"18 and over"},{"n":"NCT06811844","t":"Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC","s":"rec","p":"phase2","d":[0],"c":[6,7],"lc":[7],"a":"adult older","h":[8,7],"l":[[8,"npc"]],"po":"2025-02-06","u":"2025-07-01","st":"2025-02","ag":"18–65"},{"n":"NCT06811870","t":"A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Breast Cancer Patients","s":"rec","p":"phase1phase2","d":[6],"c":[0],"lc":[0],"a":"adult","x":"female","h":[43],"l":[[43,"breast"]],"po":"2025-02-06","u":"2025-04-01","st":"2025-02","ag":"18–60"},{"n":"NCT06812039","t":"HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence","s":"rec","p":"phase2","d":[2],"c":[16,5,30],"lc":[5],"a":"adult older","h":[9,58,30],"l":[[9,"hcc"]],"po":"2025-02-06","u":"2025-02-06","st":"2025-01","ag":"18–75"},{"n":"NCT06816823","t":"CAR-NK Cells (CL-NK-001) in Pancreatic Cancer","s":"rec","p":"phase1","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[177],"l":[[177,"panc"]],"po":"2025-02-10","u":"2025-06-04","st":"2025-04","ag":"18–70"},{"n":"NCT06817954","t":"To Evaluate the Effectiveness and Safety of Mastectomy Combined With Immediate Breast Reconstruction in Breast Cancer (NJMU-Reconstruction Cohort)","s":"rec","p":"na","d":[6],"c":[28],"lc":[28],"a":"adult older","x":"female","h":[78],"l":[[78,"breast"]],"po":"2025-02-10","u":"2026-05-01","st":"2025-01","ag":"18–75"},{"n":"NCT06818149","t":"Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung Cancer","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2025-02-10","u":"2025-02-10","st":"2025-01","ag":"18 and over"},{"n":"NCT06818331","t":"Evaluation of Clinical Efficacy and Safety of Specific Mode Electroacupuncture Stimulation for Paclitaxel Across BBB Delivery in Patients With Postoperative Recurrence of Malignant Glioma: A Single-arm Trial","s":"rec","p":"phase2","d":[7],"c":[23],"a":"adult older","h":[262,263],"l":[[262,"glioma"]],"po":"2025-02-10","u":"2025-06-04","st":"2025-02","ag":"18–70"},{"n":"NCT06819826","t":"A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria","s":"rec","p":"phase3","d":[46],"c":[0],"a":"adult older","h":[43],"po":"2025-02-11","u":"2025-02-17","st":"2025-02","ag":"18 and over"},{"n":"NCT06820268","t":"A Study of XS-04 in Patients With Relapsed or Refractory Hematologic Malignancies","s":"rec","p":"phase1","d":[19],"c":[2,0,18,13],"a":"adult older","h":[53,74,12,175],"po":"2025-02-11","u":"2026-09-25","st":"2025-01","ag":"18–75"},{"n":"NCT06820970","t":"CRIC Combined With MFT for Cardiovascular Adverse Events in Patients With Incomplete Revascularization of CAD","s":"rec","p":"na","d":[31],"c":[20],"a":"adult older","h":[264],"po":"2025-02-11","u":"2026-04-06","st":"2025-08","ag":"18 and over"},{"n":"NCT06821503","t":"Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C","s":"rec","p":"phase1phase2","d":[5],"c":[2,24,9,28,5,11,30,39,20],"a":"adult older","h":[38,58,111,118,23,25,74,14,45,202,127,265],"po":"2025-02-12","u":"2026-03-10","st":"2025-04","ag":"18 and over"},{"n":"NCT06822400","t":"Investigation of Tetralogy of Fallot in Neonates","s":"rec","p":"na","d":[32],"c":[2,22,5,21,4],"lc":[2],"a":"child","h":[109,250,76,249,203],"l":[[109,"chd"]],"po":"2025-02-12","u":"2026-10-13","st":"2025-03","ag":"1 minute–6 months"},{"n":"NCT06822868","t":"A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma","s":"rec","p":"phase1","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[3],"l":[[3,"lymph"]],"po":"2025-02-12","u":"2025-02-12","st":"2025-02","ag":"18–75"},{"n":"NCT06822894","t":"Clinical Implications of Three-vessel Ultrasonic Flow Ratio Measurement in Patients With Coronary Artery Disease","s":"rec","p":"na","d":[31],"c":[2],"a":"adult older","h":[213],"po":"2025-02-12","u":"2026-02-12","st":"2025-06","ag":"18 and over"},{"n":"NCT06826118","t":"Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma","s":"rec","p":"phase2","d":[19],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"lymph"]],"po":"2025-02-13","u":"2025-02-13","st":"2025-02","ag":"18 and over"},{"n":"NCT06827236","t":"A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer","s":"rec","p":"phase1phase2","d":[6],"c":[55,15,22,1,10,5,39],"a":"adult older","h":[9,79,164,97,50,47,98,138],"po":"2025-02-14","u":"2026-11-10","st":"2025-04","ag":"18 and over"},{"n":"NCT06827717","t":"Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma","s":"rec","p":"phase2","d":[14],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"ewing"]],"po":"2025-02-14","u":"2025-05-31","st":"2025-04","ag":"18–75"},{"n":"NCT06828328","t":"A Study of GC203 TIL in PDCA (RJ)","s":"rec","p":"earlyphase1","d":[5],"c":[5],"a":"adult older","h":[123],"po":"2025-02-14","u":"2026-08-05","st":"2025-02","ag":"18–70"},{"n":"NCT06829212","t":"Research on Wireless Brain Implant System for General Control of External Devices","s":"rec","p":"na","d":[39],"c":[5],"a":"adult older","h":[103],"po":"2025-02-17","u":"2025-03-13","st":"2025-03","ag":"18–80"},{"n":"NCT06829459","t":"A Study to Evaluate the Efficacy and Safety of Glumetinib Combined With Osimertinib Mesylate Versus Platinum-based Doublet Chemotherapy in Non-Small Cell Lung Cancer Patients After Resistance to EGFR-TKIs","s":"rec","p":"phase3","d":[4],"c":[2],"a":"adult older","h":[23],"po":"2025-02-17","u":"2025-04-08","st":"2025-04","ag":"18 and over"},{"n":"NCT06829524","t":"HANDLE-a Real World Study on Satralizumab in NMOSD","s":"rec","p":"na","d":[25],"c":[5],"lc":[5],"a":"child adult older","h":[103],"l":[[103,"nmosd"]],"po":"2025-02-17","u":"2026-09-18","st":"2025-03","ag":"12 and over"},{"n":"NCT06829771","t":"Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[2,55,15,16,0,24,33,73,56,5,12,30,13,39,31,19,20],"a":"adult older","h":[53,74,58,64,9,37,45,27,238,111,28,30,228,19,164,84,73],"po":"2025-02-17","u":"2026-01-30","st":"2025-04","ag":"18–80"},{"n":"NCT06830018","t":"Nanocrystalline Megestrol for First-line Treatment of Advanced Gastric or Colorectal Cancer With Cancer-related Fatigue","s":"rec","p":"na","d":[3],"c":[11],"a":"adult older","h":[118],"po":"2025-02-17","u":"2025-02-17","st":"2025-01","ag":"18–75"},{"n":"NCT06830031","t":"Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma","s":"rec","p":"phase1","d":[19],"c":[30],"a":"adult older","h":[69],"po":"2025-02-17","u":"2026-09-11","st":"2025-03","ag":"18–75"},{"n":"NCT06830083","t":"Hypofractionated Radiation Fractionation in Breast Cancer Patients With Implant-Based Reconstruction","s":"rec","p":"na","d":[6],"c":[28],"lc":[28],"a":"adult older","x":"female","h":[78],"l":[[78,"breast"]],"po":"2025-02-17","u":"2025-02-17","st":"2025-01","ag":"18–65"},{"n":"NCT06830889","t":"A Study of BL-M07D1 Versus T-DM1 in the Adjuvant Treatment of HER2-positive Breast Cancer With Residual Invasive Cancer After Neoadjuvant Therapy","s":"rec","p":"phase3","d":[6],"c":[28,5],"a":"adult older","x":"female","h":[9,78],"po":"2025-02-17","u":"2026-01-22","st":"2025-06","ag":"18–75"},{"n":"NCT06831357","t":"Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma Using Whole Slide Imaging and MRI","s":"rec","p":"na","d":[0],"c":[0],"lc":[0],"a":"child adult older","h":[53],"l":[[53,"npc"]],"po":"2025-02-18","u":"2025-02-25","st":"2025-02","ag":"Not stated"},{"n":"NCT06831773","t":"Clinical Study of Carbon Ion Radiotherapy for High-grade Glioma","s":"rec","p":"na","d":[7],"c":[76],"lc":[76],"a":"child adult older","h":[266],"l":[[266,"glioma"]],"po":"2025-02-18","u":"2025-02-18","st":"2025-02","ag":"14–80"},{"n":"NCT06832202","t":"A Phase II Study of HLX22 in Combination With Trastuzumab Deruxtecan in HER2-low, Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer Patients","s":"rec","p":"phase2","d":[6],"c":[5],"a":"adult older","h":[9],"po":"2025-02-18","u":"2025-06-15","st":"2025-04","ag":"18 and over"},{"n":"NCT06832267","t":"Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) Regimen As First-line Therapy for PCNS DLBCL","s":"rec","p":"na","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"lymph"]],"po":"2025-02-18","u":"2025-02-18","st":"2025-02","ag":"18–75"},{"n":"NCT06833983","t":"To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia A","s":"rec","p":"phase3","d":[21],"c":[2,8,0,17,27,47,33,9,28,77,30,13,20],"a":"adult older","x":"male","h":[69,38,70,60,68,11,12,142,37,83,267,216,268],"po":"2025-02-19","u":"2025-12-09","st":"2025-03","ag":"18–65"},{"n":"NCT06834529","t":"CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[2],"a":"child adult older","h":[26],"po":"2025-02-19","u":"2025-02-19","st":"2025-01","ag":"14–75"},{"n":"NCT06838208","t":"Tislelizumab Combined With Chemotherapy and Relayed Radiotherapy in First-line Treatment of ES-SCLC","s":"rec","p":"phase2","d":[4],"c":[17],"a":"adult older","h":[231,88],"l":[[231,"lung"]],"po":"2025-02-20","u":"2025-09-24","st":"2025-02","ag":"18 and over"},{"n":"NCT06838832","t":"Novel Allogenic CD19-targeting CAR-γδT Cell Therapy (QH103E) in r/r NHL","s":"rec","p":"phase1phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2025-02-21","u":"2025-07-30","st":"2025-07","ag":"18–75"},{"n":"NCT06839066","t":"A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal Carcinoma Failed or Intolerance to Second-line Therapy","s":"rec","p":"phase2","d":[0],"c":[8,22,44,16,78,0,23,10,21,13,46],"a":"adult older","h":[53,30,11,50,40,47,44,12,36,106,134,269,130,270],"po":"2025-02-21","u":"2025-11-24","st":"2025-04","ag":"18 and over"},{"n":"NCT06839105","t":"A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies","s":"rec","p":"phase1","d":[4],"c":[15,8,16,0,23,24,47,36,9,5,11,13],"a":"adult older","h":[42,53,44,45,118,13,27,14,30,135,18,19,87],"po":"2025-02-21","u":"2026-07-02","st":"2025-02","ag":"18 and over"},{"n":"NCT06839547","t":"A Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tumor Drug as a Radiosensitizer in Patients With Advanced Breast Cancer Brain Metastasis.","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"breast"]],"po":"2025-02-21","u":"2026-06-10","st":"2025-03","ag":"18 and over"},{"n":"NCT06839560","t":"Evaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With VEX Metronomic Chemotherapy and Concurrent or Delayed Radiotherapy in Patients With Advanced HER2-Negative Breast Cancer With Brain Metastasis","s":"rec","p":"phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"breast"]],"po":"2025-02-21","u":"2026-06-10","st":"2025-03","ag":"18 and over"},{"n":"NCT06840067","t":"Clinical Study of Carbon Ion Radiotherapy for Pancreatic Cancer.","s":"rec","p":"na","d":[5],"c":[76],"lc":[76],"a":"adult older","h":[266],"l":[[266,"panc"]],"po":"2025-02-21","u":"2025-03-25","st":"2025-03","ag":"18–80"},{"n":"NCT06840704","t":"Immunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13,11,20],"l":[[13,"lung"]],"po":"2025-02-21","u":"2026-04-02","st":"2025-02","ag":"18 and over"},{"n":"NCT06841172","t":"Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC","s":"rec","p":"phase3","d":[2],"c":[27],"lc":[27],"a":"adult older","h":[57],"l":[[57,"hcc"]],"po":"2025-02-24","u":"2026-10-13","st":"2025-07","ag":"18–75"},{"n":"NCT06841354","t":"A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)","s":"rec","p":"phase3","d":[6],"c":[55,15,8,22,1,0,23,27,28,10,12,29,34,13,39,7,38,31,20],"a":"adult older","h":[78,53,111,36,79,44,54,164,27,37,46,50,47,13,8,72,83,66,84,86,101],"po":"2025-02-24","u":"2026-11-17","st":"2025-03","ag":"18 and over"},{"n":"NCT06843005","t":"Serial Coronary CTA-based Plaque Progression Detection for Management of Coronary Heart Disease","s":"rec","p":"na","d":[31],"c":[28],"lc":[28],"a":"adult older","h":[93],"l":[[93,"cad"]],"po":"2025-02-24","u":"2026-03-24","st":"2025-02","ag":"18–80"},{"n":"NCT06843889","t":"A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"escc"]],"po":"2025-02-25","u":"2025-04-16","st":"2025-04","ag":"18–75"},{"n":"NCT06844357","t":"A Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver Cancer.","s":"rec","p":"phase2phase3","d":[2],"c":[28],"a":"adult older","h":[120],"po":"2025-02-25","u":"2025-04-06","st":"2025-03","ag":"18 and over"},{"n":"NCT06844422","t":"Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND)","s":"rec","p":"phase1phase2","d":[5],"c":[27],"lc":[27],"a":"adult older","h":[57],"l":[[57,"panc"]],"po":"2025-02-25","u":"2026-04-28","st":"2025-02","ag":"18–75"},{"n":"NCT06845410","t":"Clinical Features, Current Treatment and Clinical Outcomes in Patients With INR-CAD: a Cohort Study","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"cad"]],"po":"2025-02-25","u":"2025-11-19","st":"2025-04","ag":"18 and over"},{"n":"NCT06846437","t":"JSKN003 Versus Trastuzumab Emtansine (T-DM1) for HER2-Positive, Advanced Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[5],"a":"adult older","h":[9],"po":"2025-02-26","u":"2025-03-24","st":"2025-02","ag":"18 and over"},{"n":"NCT06846489","t":"Acalabrutinib Plus Rituximab for the Treatment of Elderly or Low- to Intermediate-Risk Younger Untreated Mantle Cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2025-02-26","u":"2025-06-03","st":"2025-04","ag":"18 and over"},{"n":"NCT06846762","t":"DREAM Study: DNA/RNA-NGS Co-Testing in Driver-Negative, Treatment-Resistant NSCLC","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"child adult older","h":[42],"l":[[42,"lung"]],"po":"2025-02-26","u":"2025-02-26","st":"2025-03","ag":"Not stated"},{"n":"NCT06846996","t":"Real-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in China","s":"rec","p":"na","d":[3],"c":[2,15,16,0,6,23,28,5,43,11,12,29,30,31,20],"a":"adult older","h":[74,6,23,60,44,25,123,9,58,37,54,38,49,39,82,27,18,30,7,29,127,125,43,95,64,66,62,107,89,84,139,194],"po":"2025-02-26","u":"2026-08-18","st":"2025-02","ag":"18 and over"},{"n":"NCT06847555","t":"Phase I-II Clinical Study of Taurine for External Use in the Prevention and Treatment of Acute Radiation Skin Injury","s":"rec","p":"phase1phase2","d":[6],"c":[27],"lc":[27],"a":"adult older","x":"female","h":[57],"l":[[57,"breast"]],"po":"2025-02-26","u":"2025-02-26","st":"2025-05","ag":"18 and over"},{"n":"NCT06848699","t":"A Phase Ib/II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Patients With Advanced/Metastatic Solid Tumors","s":"rec","p":"phase1phase2","d":[4],"c":[8,1,27],"a":"adult older","h":[57,13,167],"po":"2025-02-27","u":"2025-11-17","st":"2025-02","ag":"18–75"},{"n":"NCT06849167","t":"Immunotherapy Combined with Hypofractionated Concurrent Chemoradiotherapy Followed by Immunotherapy in LA-NSCLC","s":"rec","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"lung"]],"po":"2025-02-27","u":"2025-02-27","st":"2025-03","ag":"18–70"},{"n":"NCT06849609","t":"A Study to Evaluate the Tolerability, Safety and Efficacy of VGN-R13 in Patients with ALS","s":"rec","p":"earlyphase1","d":[39],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"als"]],"po":"2025-02-27","u":"2025-03-17","st":"2025-01","ag":"18 and over"},{"n":"NCT06850285","t":"CD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma","s":"rec","p":"na","d":[19],"c":[12],"lc":[12],"a":"child adult older","h":[22],"l":[[22,"lymph"]],"po":"2025-02-27","u":"2025-02-27","st":"2025-09","ag":"15–80"},{"n":"NCT06851247","t":"GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma.","s":"rec","p":"phase2","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2025-02-28","u":"2025-02-28","st":"2025-01","ag":"18–65"},{"n":"NCT06851299","t":"The Clinical Study of the Efficacy and Safety of Trop2-ADC Monotherapy or Combination Immunotherapy Strategy in the Treatment of Advanced Triple-negative Breast Cancer.","s":"rec","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2025-02-28","u":"2025-02-28","st":"2025-03","ag":"18–70"},{"n":"NCT06852807","t":"18F-mFBG PET Imaging in the Evaluation of Neuroblastoma","s":"rec","p":"na","d":[13],"c":[23],"lc":[23],"a":"child adult","h":[46],"l":[[46,"nb"]],"po":"2025-02-28","u":"2025-08-08","st":"2025-02","ag":"Up to 18"},{"n":"NCT06853678","t":"Second-line Immunotherapy for ES-SCLC","s":"rec","p":"na","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2025-03-03","u":"2025-03-03","st":"2025-02","ag":"18 and over"},{"n":"NCT06854445","t":"Clinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[8,52,23,24,27,33,73,9,28,10,18,4,12,13,54,39,7,20],"a":"adult older","h":[25,46,5,8,37,45,24,238,60,155,133,10,111,57,13,116,50,19,84,271,73],"po":"2025-03-03","u":"2025-03-24","st":"2025-03","ag":"18 and over"},{"n":"NCT06855771","t":"A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)","s":"rec","p":"phase2","d":[4],"c":[2,23,27,25,9,10,29,7],"a":"adult older","h":[57,14,82,61,50,66,8,51],"po":"2025-03-04","u":"2026-09-18","st":"2025-09","ag":"18 and over"},{"n":"NCT06855810","t":"Newly-diagnosed Pediatric T-cell ALL Protocol","s":"rec","p":"phase2phase3","d":[19],"c":[8,22,1,16,0,41,17,27,26,5,30,13],"lc":[30],"a":"child adult","h":[69,36,12,140,124,55,70,31,11,20,252,137,76,250],"l":[[69,"lymph"]],"po":"2025-03-04","u":"2025-08-26","st":"2025-03","ag":"1 month–18"},{"n":"NCT06855823","t":"A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL","s":"rec","p":"phase1phase2","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2025-03-04","u":"2025-03-04","st":"2025-01","ag":"18–80"},{"n":"NCT06856200","t":"A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[272],"l":[[272,"breast"]],"po":"2025-03-04","u":"2025-03-04","st":"2025-02","ag":"18 and over"},{"n":"NCT06858813","t":"A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)","s":"rec","p":"phase1","d":[2,4],"c":[0,5],"a":"adult older","h":[6,70],"po":"2025-03-05","u":"2026-09-22","st":"2025-04","ag":"18 and over"},{"n":"NCT06860490","t":"HAIC Combined With Sintilimab Plus Bevacizumab Biosimilar for Advanced Hepatocellular Carcinoma (TASK-03)","s":"rec","p":"phase2","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"hcc"]],"po":"2025-03-06","u":"2026-04-21","st":"2025-03","ag":"18 and over"},{"n":"NCT06860529","t":"Serplulimab Combined With Chemotherapy for Early-stage HR+/HER2- Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"breast"]],"po":"2025-03-06","u":"2026-10-22","st":"2025-04","ag":"18 and over"},{"n":"NCT06861114","t":"Exploring the Value of Urine Proteomics-based Dynamic Surveillance for Early Recurrence After Radical Surgery for Hepatocellular Carcinoma: a Prospective Cohort Study","s":"rec","p":"na","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[0],"l":[[0,"hcc"]],"po":"2025-03-06","u":"2025-03-06","st":"2025-02","ag":"18–75"},{"n":"NCT06861543","t":"The Purpose of This Study is to Evaluate the Safety, Tolerability and Efficacy of TMT101 Injection Monotherapy in Patients With Advanced Pancreatic Cancer or Non-small Cell Lung Cancer(NSCLC)","s":"rec","p":"phase1","d":[4,5],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"lung"]],"po":"2025-03-06","u":"2025-08-11","st":"2025-03","ag":"18 and over"},{"n":"NCT06861998","t":"Preoperative Sleep Intervention on Postoperative Delirium in Infants and Toddlers Undergoing Congenital Heart Surgery","s":"rec","p":"na","d":[32],"c":[2],"lc":[2],"a":"child","h":[213],"l":[[213,"chd"]],"po":"2025-03-06","u":"2025-05-28","st":"2025-04","ag":"1 day–3"},{"n":"NCT06862869","t":"Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy","s":"rec","p":"na","d":[4],"c":[2,8,22,1,52,16,0,23,24,17,35,27,33,9,28,40,5,21,18,12,29,13,60,39,58,45,64],"a":"adult older","h":[42,56,78,44,6,110,12,45,36,24,113,127,13,54,79,14,60,30,97,68,155,98,29,185,106,195,211,66,172,273,129,95,71,84,85],"po":"2025-03-06","u":"2026-11-05","st":"2025-04","ag":"18 and over"},{"n":"NCT06863545","t":"Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography","s":"rec","p":"na","d":[31],"c":[23],"lc":[23],"a":"adult older","h":[54,274,275],"l":[[54,"cad"]],"po":"2025-03-07","u":"2026-02-06","st":"2025-04","ag":"18 and over"},{"n":"NCT06864624","t":"Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC","s":"rec","p":"phase2","d":[4],"c":[8,39,58],"lc":[39],"a":"adult older","h":[122,10,172],"l":[[122,"lung"]],"po":"2025-03-07","u":"2025-07-25","st":"2025-02","ag":"18 and over"},{"n":"NCT06867536","t":"Hypofractionation Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse B-cell Lymphoma With Baseline High Tumor Burden","s":"rec","p":"phase2","d":[19],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lymph"]],"po":"2025-03-10","u":"2026-05-15","st":"2025-04","ag":"18–75"},{"n":"NCT06868485","t":"A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[16,5,30,13],"a":"adult older","h":[56,58,12,30,65],"po":"2025-03-11","u":"2026-11-10","st":"2025-08","ag":"18 and over"},{"n":"NCT06868732","t":"Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC","s":"rec","p":"phase1","d":[4],"c":[0],"a":"adult older","h":[53],"po":"2025-03-11","u":"2026-03-30","st":"2025-04","ag":"18–75"},{"n":"NCT06869213","t":"A Single-arm, Open, Single-center Exploratory Study of Adebrelimab (SHR-1316) in Combination With Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Esophageal Squamous Carcinoma","s":"rec","p":"phase2","d":[1],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"escc"]],"po":"2025-03-11","u":"2025-10-02","st":"2025-03","ag":"18–75"},{"n":"NCT06869239","t":"Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"lung"]],"po":"2025-03-11","u":"2025-03-11","st":"2025-02","ag":"18–75"},{"n":"NCT06870435","t":"Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas","s":"rec","p":"na","d":[0],"c":[59],"lc":[59],"a":"adult older","h":[171],"l":[[171,"npc"]],"po":"2025-03-11","u":"2025-03-11","st":"2025-01","ag":"30–69"},{"n":"NCT06873659","t":"SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors","s":"rec","p":"phase1","d":[3],"c":[2,0,23,27,33,28,5,39],"a":"adult older","h":[74,78,6,23,44,53,111,142,57],"po":"2025-03-13","u":"2025-09-03","st":"2025-02","ag":"18–75"},{"n":"NCT06874933","t":"Neoadjuvant Chemotherapy in Combination With Anlotinib and Benmelstobart for HR+/HER2- Breast Cancer (NEOTORCH-BREAST03)","s":"rec","p":"phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[46,44,54],"l":[[46,"breast"]],"po":"2025-03-13","u":"2025-08-12","st":"2025-05","ag":"18–75"},{"n":"NCT06874946","t":"Nanobody-Based Anti-CD5 CAR-T for Relapsed/Refractory T-ALL/NHL","s":"rec","p":"phase1phase2","d":[19],"c":[2],"lc":[2],"a":"child adult older","h":[48],"l":[[48,"lymph"]],"po":"2025-03-13","u":"2026-05-07","st":"2025-02","ag":"3–70"},{"n":"NCT06875310","t":"A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)","s":"rec","p":"phase3","d":[4],"c":[2,55,15,8,22,1,16,0,23,24,17,27,25,9,28,10,5,43,11,21,18,4,12,29,30,13,7,14,32],"a":"adult older","h":[40,42,57,38,44,5,132,74,45,118,36,24,46,59,13,47,27,80,164,143,82,140,60,61,2,49,68,18,125,63,65,106,168,50,66,8,84,21,51],"po":"2025-03-13","u":"2026-11-17","st":"2025-04","ag":"18 and over"},{"n":"NCT06877299","t":"Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"lung"]],"po":"2025-03-14","u":"2026-01-02","st":"2025-07","ag":"18–75"},{"n":"NCT06879379","t":"KPD Consolidation After ASCT in NDMM Patients","s":"rec","p":"phase2phase3","d":[15],"c":[2,5],"lc":[2],"a":"adult older","h":[48,212],"l":[[48,"mm"]],"po":"2025-03-17","u":"2025-03-17","st":"2025-03","ag":"18 and over"},{"n":"NCT06879431","t":"Preoperative Sleep Intervention on Postoperative Delirium in School-aged Children Undergoing Congenital Heart Surgery","s":"rec","p":"na","d":[32],"c":[2],"lc":[2],"a":"child","h":[213],"l":[[213,"chd"]],"po":"2025-03-17","u":"2025-05-31","st":"2025-04","ag":"6–12"},{"n":"NCT06880393","t":"BCMA CAR-T for Dynamic High-risk Multiple Myeloma","s":"rec","p":"phase2","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2025-03-17","u":"2025-08-03","st":"2025-03","ag":"18–75"},{"n":"NCT06881511","t":"Exploratory Study on the Efficacy of Betaine Hydrochloride in Treating Autoimmune Gastritis","s":"rec","p":"na","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"gc"]],"po":"2025-03-18","u":"2025-03-30","st":"2025-01","ag":"18–80"},{"n":"NCT06882057","t":"Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol","s":"rec","p":"phase2phase3","d":[16],"c":[8,22,1,16,0,41,17,27,9,28,10,26,5,4,30,13,39],"lc":[30],"a":"child adult","h":[69,70,36,11,137,140,31,12,203,20,124,1,250,251,252,253,254,255,96,55,76,256,257,258],"l":[[69,"ball"]],"po":"2025-03-18","u":"2025-08-26","st":"2025-03","ag":"1–18"},{"n":"NCT06883526","t":"Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[23],"a":"adult older","h":[46],"po":"2025-03-19","u":"2026-01-05","st":"2025-05","ag":"18 and over"},{"n":"NCT06885957","t":"Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD","s":"rec","p":"na","d":[25],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"nmosd"]],"po":"2025-03-20","u":"2025-09-08","st":"2025-07","ag":"18–65"},{"n":"NCT06889688","t":"Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in Advanced Triple-Negative Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[8,0,41,5,13],"lc":[0],"a":"adult older","x":"female","h":[99,12,11,137,177],"l":[[99,"breast"]],"po":"2025-03-21","u":"2026-04-23","st":"2025-02","ag":"18–70"},{"n":"NCT06890065","t":"JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia","s":"rec","p":"na","d":[16,19],"c":[20],"a":"adult older","h":[25],"po":"2025-03-21","u":"2025-05-15","st":"2025-03","ag":"18–75"},{"n":"NCT06890494","t":"Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell Leukemia","s":"rec","p":"earlyphase1","d":[16],"c":[2],"lc":[2],"a":"adult older","h":[3],"l":[[3,"ball"]],"po":"2025-03-24","u":"2026-03-10","st":"2025-01","ag":"18–70"},{"n":"NCT06890598","t":"Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[48,2,8,22,1,63,0,23,24,27,36,10,5,43,21,4,29,30,13,39],"a":"adult older","h":[40,23,42,57,58,9,43,44,5,132,11,111,74,45,36,13,54,47,48,183,166,83,125,62,106,19,168,50,66,87,198,150],"po":"2025-03-24","u":"2026-11-04","st":"2025-03","ag":"18 and over"},{"n":"NCT06891742","t":"Phase I Study of OriC902 in Treatment of Advanced HCC","s":"rec","p":"phase1","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[74,3],"l":[[74,"hcc"]],"po":"2025-03-24","u":"2025-03-24","st":"2025-02","ag":"18–75"},{"n":"NCT06891833","t":"A Study of BL-M07D1 With or Without Pertuzumab Versus Docetaxel + Carboplatin + Trastuzumab + Pertuzumab in Neoadjuvant Therapy for HER2-Positive Breast Cancer","s":"rec","p":"phase2phase3","d":[6],"c":[48,55,8,22,1,16,0,6,23,24,17,27,36,9,10,5,21,18,12,30,39,20],"a":"adult older","x":"female","h":[9,58,45,99,111,24,79,44,164,57,10,140,46,50,47,13,68,7,14,92,106,144,87,84,150,88],"po":"2025-03-24","u":"2026-10-27","st":"2025-06","ag":"18–75"},{"n":"NCT06892093","t":"Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients","s":"rec","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2025-03-24","u":"2026-06-17","st":"2025-08","ag":"18 and over"},{"n":"NCT06892548","t":"A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer","s":"rec","p":"phase1phase2","d":[4],"c":[2,15,22,16,0,23,17,27,25,9,28,10,39,7,38,14,31,68,20],"a":"adult older","h":[40,57,44,111,74,46,80,14,37,82,140,30,83,101,50,138,95,8,276,116,214,21,86,67,88],"po":"2025-03-24","u":"2026-08-26","st":"2025-05","ag":"18 and over"},{"n":"NCT06893133","t":"ctDNA-MRD Monitoring After Resection in Gastric Cancer","s":"rec","p":"na","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"gc"]],"po":"2025-03-25","u":"2026-04-21","st":"2025-04","ag":"18 and over"},{"n":"NCT06893887","t":"Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[28],"lc":[28],"a":"adult older","h":[105],"l":[[105,"hcc"]],"po":"2025-03-25","u":"2026-10-01","st":"2025-05","ag":"18 and over"},{"n":"NCT06895031","t":"Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS","s":"rec","p":"phase2","d":[4,5],"c":[2],"a":"adult older","h":[74],"po":"2025-03-26","u":"2026-03-06","st":"2025-03","ag":"18–75"},{"n":"NCT06895538","t":"Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy","s":"rec","p":"phase2phase3","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[29],"l":[[29,"lymph"]],"po":"2025-03-26","u":"2026-08-05","st":"2025-05","ag":"18 and over"},{"n":"NCT06896422","t":"Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC","s":"rec","p":"phase1","d":[4],"c":[20],"lc":[20],"a":"adult older","h":[25],"l":[[25,"lung"]],"po":"2025-03-26","u":"2025-08-07","st":"2025-06","ag":"18 and over"},{"n":"NCT06897046","t":"Perioperative Study of Iparomlimab and Tuvonralimab in Resectable NSCLC","s":"rec","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2025-03-26","u":"2025-08-01","st":"2025-07","ag":"18 and over"},{"n":"NCT06898385","t":"A Phase I Clinical Study of IX001 TCR-T Injection in the Treatment of Advanced Pancreatic Cancer Patients With KRAS G12V Mutation","s":"rec","p":"phase1","d":[5],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"panc"]],"po":"2025-03-27","u":"2026-01-08","st":"2025-03","ag":"18–75"},{"n":"NCT06898398","t":"TACE Combined Surgery for the Resectable Huge HCC","s":"rec","p":"na","d":[2],"c":[2],"a":"adult older","h":[26],"po":"2025-03-27","u":"2025-04-03","st":"2025-01","ag":"18–75"},{"n":"NCT06899126","t":"Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[2,15,8,22,1,0,23,24,17,27,25,9,28,5,11,12,30,13,38,20],"a":"adult older","h":[40,78,12,74,45,118,36,59,13,47,27,80,14,37,70,82,2,68,18,62,65,19,138,31,84,86,67,199],"po":"2025-03-27","u":"2026-11-18","st":"2025-10","ag":"18 and over"},{"n":"NCT06900647","t":"Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer","s":"rec","p":"phase1","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[53],"l":[[53,"breast"]],"po":"2025-03-28","u":"2025-04-02","st":"2025-01","ag":"18 and over"},{"n":"NCT06901531","t":"A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer","s":"rec","p":"phase3","d":[3],"c":[2,22,16,23,24,17,5,18,30,13,62,20],"a":"adult older","h":[123,37,45,46,41,38,59,148,192,47,19,175,88],"po":"2025-03-30","u":"2026-11-05","st":"2025-05","ag":"18 and over"},{"n":"NCT06901817","t":"A Study of the Safety and Efficacy of Pemetrexed Combined with Nivolumab Via Intraventricular Injection for the Treatment of Refractory Non-squamous Non-small Cell Lung Cancer with Leptomeningeal Metastases","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2025-03-30","u":"2025-03-30","st":"2025-03","ag":"18 and over"},{"n":"NCT06902051","t":"Study on the Use of Lateral Decubitus Position in Left Breast Cancer Patients Undergoing Adjuvant Radiotherapy","s":"rec","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[70],"l":[[70,"breast"]],"po":"2025-03-30","u":"2025-05-11","st":"2025-04","ag":"18–70"},{"n":"NCT06902350","t":"Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors","s":"rec","p":"phase1","d":[4,7],"c":[2,15],"a":"adult older","h":[138,102],"po":"2025-03-30","u":"2025-05-25","st":"2025-05","ag":"18 and over"},{"n":"NCT06902389","t":"A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma","s":"rec","p":"phase1phase2","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[277],"l":[[277,"hcc"]],"po":"2025-03-30","u":"2025-09-03","st":"2025-07","ag":"18–75"},{"n":"NCT06903117","t":"Anti-CEA CAR-T for Advanced CEA-Positive Lung Carcinoma","s":"rec","p":"phase1","d":[4],"c":[5],"a":"adult older","h":[212],"po":"2025-03-30","u":"2025-04-03","st":"2025-03","ag":"18 and over"},{"n":"NCT06903377","t":"Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer","s":"rec","p":"phase1phase2","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2025-03-30","u":"2026-01-05","st":"2025-05","ag":"18–75"},{"n":"NCT06904183","t":"Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"hcc"]],"po":"2025-04-01","u":"2026-08-11","st":"2025-04","ag":"18–75"},{"n":"NCT06904196","t":"Lenvatinib Plus SIRT vs Lenvatinib in TACE-Refractory HCC","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"hcc"]],"po":"2025-04-01","u":"2025-04-29","st":"2025-04","ag":"18–75"},{"n":"NCT06905561","t":"Topical Diclofenac for Prevention of Radiation-induced Dermatitis","s":"rec","p":"na","d":[6],"c":[6],"lc":[6],"a":"adult older","h":[7],"l":[[7,"breast"]],"po":"2025-04-01","u":"2026-04-03","st":"2025-02","ag":"18–75"},{"n":"NCT06907615","t":"A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)","s":"rec","p":"phase2","d":[4],"c":[2],"a":"adult older","h":[23],"po":"2025-04-02","u":"2026-10-01","st":"2025-06","ag":"18 and over"},{"n":"NCT06908382","t":"Neoadjuvant QL1706 Therapy for ESCC","s":"rec","p":"phase2","d":[1],"c":[27],"lc":[27],"a":"adult older","h":[113],"l":[[113,"escc"]],"po":"2025-04-03","u":"2025-04-18","st":"2025-04","ag":"18–75"},{"n":"NCT06908668","t":"Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"breast"]],"po":"2025-04-03","u":"2026-06-10","st":"2025-03","ag":"18–70"},{"n":"NCT06909474","t":"Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies","s":"rec","p":"phase1","d":[19],"c":[13],"a":"adult older","h":[36],"po":"2025-04-03","u":"2025-04-03","st":"2025-03","ag":"18–75"},{"n":"NCT06909604","t":"Al18F-HER2-BCH PET in Breast Patients Treated With ADC Therapy","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"breast"]],"po":"2025-04-03","u":"2026-05-13","st":"2025-01","ag":"18 and over"},{"n":"NCT06909708","t":"SIRT Versus cTACE for Unresectable HCC (CHANCE2506)","s":"rec","p":"na","d":[2],"c":[28],"lc":[28],"a":"adult older","h":[120],"l":[[120,"hcc"]],"po":"2025-04-03","u":"2025-04-09","st":"2025-04","ag":"18 and over"},{"n":"NCT06911502","t":"A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)","s":"rec","p":"phase3","d":[19],"c":[2,0,27,13],"a":"adult older","h":[53,74,12,57],"po":"2025-04-04","u":"2026-05-20","st":"2025-07","ag":"18 and over"},{"n":"NCT06912074","t":"Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"escc"]],"po":"2025-04-04","u":"2025-11-17","st":"2025-04","ag":"18–80"},{"n":"NCT06912698","t":"Reduced Dose Radiotherapy vs Standard Dose Radiotherapy for Early Stage Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2025-04-06","u":"2025-04-22","st":"2025-05","ag":"18–70"},{"n":"NCT06912711","t":"TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma","s":"rec","p":"phase2","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2025-04-06","u":"2025-05-21","st":"2025-05","ag":"18–65"},{"n":"NCT06914037","t":"A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies","s":"rec","p":"phase1","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lymph"]],"po":"2025-04-06","u":"2025-04-06","st":"2025-03","ag":"18–70"},{"n":"NCT06914427","t":"PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique","s":"rec","p":"na","d":[4,7],"c":[39],"lc":[39],"a":"adult older","h":[131],"l":[[131,"lung"]],"po":"2025-04-06","u":"2026-11-10","st":"2025-04","ag":"18–75"},{"n":"NCT06914440","t":"Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[39],"lc":[39],"a":"adult older","x":"female","h":[131],"l":[[131,"breast"]],"po":"2025-04-06","u":"2026-08-14","st":"2025-06","ag":"18–75"},{"n":"NCT06914713","t":"Jin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPF","s":"rec","p":"na","d":[37],"c":[20],"a":"adult older","h":[34],"po":"2025-04-06","u":"2026-10-16","st":"2025-09","ag":"40–85"},{"n":"NCT06915389","t":"Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients","s":"rec","p":"na","d":[3],"c":[62],"lc":[62],"a":"adult older","h":[279],"l":[[279,"gc"]],"po":"2025-04-08","u":"2025-04-08","st":"2025-02","ag":"18–80"},{"n":"NCT06916338","t":"Clinical Study of 18F-Labeled FAPI-04 in PET Imaging of Breast Cancer","s":"rec","p":"na","d":[6],"c":[26],"lc":[26],"a":"adult older","h":[55],"l":[[55,"breast"]],"po":"2025-04-08","u":"2025-04-29","st":"2025-04","ag":"18–75"},{"n":"NCT06916637","t":"Clinical Study on the Application of 18F-HER2 Affibody PET Imaging in HER2-Expressing Breast Cancer","s":"rec","p":"na","d":[6],"c":[26],"lc":[26],"a":"adult older","h":[55],"l":[[55,"breast"]],"po":"2025-04-08","u":"2026-09-17","st":"2025-04","ag":"18–75"},{"n":"NCT06924398","t":"Postoperative EGFR-TKI Therapy forContralateral Pulmonary Nodules in Patients With EGFR-Mutant NSCLC（ARMOR2501）","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2025-04-11","u":"2025-06-10","st":"2025-04","ag":"18–75"},{"n":"NCT06925243","t":"Neoadjuvant Apatinib Combined With Sintilimab and Perioperative SOX Versus Neoadjuvant Sintilimab Combined With Perioperative SOX for Intestinal Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma","s":"rec","p":"phase3","d":[3],"c":[0,33],"a":"adult older","h":[195,53,141,142],"po":"2025-04-13","u":"2025-04-22","st":"2025-04","ag":"18–75"},{"n":"NCT06925464","t":"CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas","s":"rec","p":"phase1phase2","d":[19],"c":[2,5],"lc":[2],"a":"child adult older","h":[3,123],"l":[[3,"lymph"]],"po":"2025-04-13","u":"2025-05-13","st":"2025-04","ag":"14–70"},{"n":"NCT06926140","t":"Acupuncture Combined With PD-1/PD-L1 Inhibitors for Advanced Lung Cancer","s":"rec","p":"na","d":[4],"c":[2,17],"lc":[2],"a":"adult older","h":[280,112],"l":[[280,"lung"]],"po":"2025-04-13","u":"2025-07-24","st":"2025-06","ag":"18–75"},{"n":"NCT06926283","t":"A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors","s":"rec","p":"phase1","d":[14],"c":[2,8,23],"a":"adult older","h":[48,13,29,183],"po":"2025-04-13","u":"2026-09-23","st":"2025-05","ag":"18–75"},{"n":"NCT06926790","t":"Neoadjuvant Nivolumab Plus Ipilimumab in Resectable NSCLC (GALAXY 3)","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[132],"l":[[132,"lung"]],"po":"2025-04-15","u":"2026-11-09","st":"2025-06","ag":"18–80"},{"n":"NCT06926868","t":"A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)","s":"rec","p":"phase2phase3","d":[6],"c":[48,2,22,16,0,23,17,27,47,33,9,10,26,11,12,30,13,38,20],"a":"adult older","h":[23,58,53,74,25,133,55,37,18,140,46,50,135,68,19,142,30,31,98,116,84,86,150,199],"po":"2025-04-15","u":"2026-11-19","st":"2025-09","ag":"18 and over"},{"n":"NCT06927180","t":"SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC","s":"rec","p":"phase2","d":[6],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"breast"]],"po":"2025-04-15","u":"2025-06-23","st":"2025-04","ag":"18–70"},{"n":"NCT06927986","t":"Phase III Trial of SYS6010 Versus Platinum-based Chemotherapy for EGFR-mutated NSCLC（SYNSTAR01）","s":"rec","p":"phase3","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2025-04-15","u":"2026-07-01","st":"2025-03","ag":"18–75"},{"n":"NCT06928389","t":"Ivonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[5],"a":"adult older","h":[65],"po":"2025-04-15","u":"2026-04-09","st":"2025-07","ag":"18–75"},{"n":"NCT06929936","t":"Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally Advanced or Metastatic NSCLC","s":"rec","p":"phase2","d":[4],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"lung"]],"po":"2025-04-16","u":"2025-06-08","st":"2025-05","ag":"18 and over"},{"n":"NCT06930794","t":"A Study of Vebreltinib and Platinum-Containing Double Agents in Subjects With MET-Positive","s":"rec","p":"phase3","d":[4],"c":[2,0],"a":"adult older","h":[23,43],"po":"2025-04-16","u":"2026-05-01","st":"2025-07","ag":"18 and over"},{"n":"NCT06930807","t":"Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"lung"]],"po":"2025-04-16","u":"2025-04-16","st":"2025-03","ag":"18 and over"},{"n":"NCT06932874","t":"Metformin Hydrochloride Sustained-release Tablets (Ⅲ) in Patients With Type 2 Diabetes Mellitus Complicated With Coronary Heart Disease","s":"rec","p":"phase4","d":[31],"c":[2],"a":"adult older","h":[213],"po":"2025-04-17","u":"2025-04-30","st":"2025-03","ag":"30–75"},{"n":"NCT06933394","t":"Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma","s":"rec","p":"phase2","d":[13],"c":[0],"lc":[0],"a":"child adult","h":[99],"l":[[99,"nb"]],"po":"2025-04-18","u":"2025-04-18","st":"2025-05","ag":"18 months–18"},{"n":"NCT06936046","t":"Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression","s":"rec","p":"phase2","d":[7],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"glioma"]],"po":"2025-04-20","u":"2025-04-20","st":"2025-01","ag":"18 and over"},{"n":"NCT06936111","t":"REsiduAL rISk Under Intensive Lipid-lowering Therapy In Coronary Heart Disease","s":"rec","p":"na","d":[31],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"cad"]],"po":"2025-04-20","u":"2026-02-03","st":"2025-07","ag":"18–75"},{"n":"NCT06936930","t":"Reproductive and Mental Health of Patients With Aplastic Anemia","s":"rec","p":"na","d":[17],"c":[30],"lc":[30],"a":"adult","h":[69],"l":[[69,"aa"]],"po":"2025-04-20","u":"2026-11-12","st":"2025-03","ag":"18–40"},{"n":"NCT06937112","t":"18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis","s":"rec","p":"na","d":[4,5],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"lung"]],"po":"2025-04-22","u":"2025-04-22","st":"2025-04","ag":"18–75"},{"n":"NCT06938282","t":"An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"panc"]],"po":"2025-04-22","u":"2026-08-26","st":"2025-06","ag":"18 and over"},{"n":"NCT06938360","t":"Clinical Efficacy and Safety Assessment of Breast-Conserving Surgery for Central Breast Cancer: A Prospective Randomized Controlled Trial","s":"rec","p":"na","d":[6],"c":[39],"lc":[39],"a":"adult older","x":"female","h":[131],"l":[[131,"breast"]],"po":"2025-04-22","u":"2025-04-22","st":"2025-02","ag":"18–70"},{"n":"NCT06938373","t":"Development and Application of Accurate Detection Technology Based on Multimodal Data of Breast Cancer Comobid Depression","s":"rec","p":"na","d":[6],"c":[8],"lc":[8],"a":"adult older","h":[11],"l":[[11,"breast"]],"po":"2025-04-22","u":"2025-04-22","st":"2025-03","ag":"18–80"},{"n":"NCT06938880","t":"Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors","s":"rec","p":"phase1phase2","d":[2],"c":[0],"a":"adult older","h":[53],"po":"2025-04-22","u":"2026-01-05","st":"2025-05","ag":"18–75"},{"n":"NCT06939127","t":"Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB NSCLC","s":"rec","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2025-04-22","u":"2025-04-22","st":"2025-04","ag":"18–75"},{"n":"NCT06939166","t":"Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases","s":"rec","p":"earlyphase1","d":[25,27],"c":[30],"lc":[30],"a":"adult older","h":[281],"l":[[281,"nmosd"]],"po":"2025-04-22","u":"2025-12-15","st":"2025-06","ag":"18 and over"},{"n":"NCT06940102","t":"Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors","s":"rec","p":"na","d":[2,3],"c":[11],"a":"adult older","h":[18],"po":"2025-04-23","u":"2025-04-23","st":"2025-03","ag":"18 and over"},{"n":"NCT06940960","t":"JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia","s":"rec","p":"na","d":[16,19],"c":[45],"lc":[45],"a":"child adult older","h":[129],"l":[[129,"ball"]],"po":"2025-04-23","u":"2025-06-10","st":"2025-05","ag":"12–75"},{"n":"NCT06941948","t":"Sleep Disorders and Tumor Immune Microenvironment","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"lung"]],"po":"2025-04-24","u":"2025-04-24","st":"2025-05","ag":"18–70"},{"n":"NCT06942143","t":"An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors","s":"rec","p":"phase1","d":[4],"c":[0],"a":"adult older","h":[53],"po":"2025-04-24","u":"2025-09-03","st":"2025-05","ag":"18–75"},{"n":"NCT06942234","t":"Study of JSKN016 Combination Therapy in Inoperable Locally Advanced or Metastatic HER2-Negative Breast Cancer","s":"rec","p":"phase1phase2","d":[6],"c":[5],"a":"adult older","h":[9],"po":"2025-04-24","u":"2025-09-17","st":"2025-06","ag":"18–75"},{"n":"NCT06943235","t":"Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2025-04-24","u":"2026-02-11","st":"2025-04","ag":"18–80"},{"n":"NCT06943820","t":"AK129 Combination Therapy for Advanced Solid Tumors","s":"rec","p":"phase1phase2","d":[4],"c":[11],"a":"adult older","h":[18],"po":"2025-04-24","u":"2025-06-03","st":"2025-05","ag":"18–75"},{"n":"NCT06943872","t":"A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)","s":"rec","p":"phase3","d":[19],"c":[2,8,22,1,16,0,23,24,65,27,9,28,10,26,5,11,18,30,13,60,7,32],"a":"adult older","h":[40,36,113,140,69,9,8,118,45,55,79,70,11,136,6,0,186,116,180,189,82,120,50,18,148,63,205,62],"po":"2025-04-24","u":"2026-10-23","st":"2025-06","ag":"18 and over"},{"n":"NCT06944106","t":"A Study on Ivonescimab Plus Chemotherapy as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"panc"]],"po":"2025-04-25","u":"2025-05-31","st":"2025-03","ag":"18–75"},{"n":"NCT06945718","t":"Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Extended Lymphadenectomy Beyond D2 for Locally Advanced Gastric Cancer (FUGES-30)","s":"rec","p":"na","d":[3],"c":[16],"lc":[16],"a":"adult older","h":[140],"l":[[140,"gc"]],"po":"2025-04-25","u":"2026-11-17","st":"2025-05","ag":"18–75"},{"n":"NCT06946901","t":"The Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Peritoneal Metastatic Pancreatic Cancer, a Phase II Clinical Trial","s":"rec","p":"phase2","d":[5],"c":[8,5],"lc":[5],"a":"adult older","h":[6,10],"l":[[6,"panc"]],"po":"2025-04-27","u":"2025-04-27","st":"2025-04","ag":"18–80"},{"n":"NCT06946927","t":"A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation","s":"rec","p":"phase1","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"lung"]],"po":"2025-04-27","u":"2025-07-01","st":"2025-06","ag":"18–75"},{"n":"NCT06947291","t":"Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors","s":"rec","p":"phase2","d":[3],"c":[23],"a":"adult older","h":[44],"po":"2025-04-27","u":"2025-09-08","st":"2025-06","ag":"18 and over"},{"n":"NCT06947694","t":"A Study on Exploring the Abscopal Effect Induced by Different Radioimmunotherapy Combination Patterns in the Treatment of Non-Small Cell Lung Cancer With Multiple Metastases","s":"rec","p":"phase2","d":[4],"c":[1],"lc":[1],"a":"adult older","h":[167],"l":[[167,"lung"]],"po":"2025-04-27","u":"2025-07-22","st":"2025-07","ag":"18–75"},{"n":"NCT06947967","t":"Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype","s":"rec","p":"phase3","d":[19],"c":[0],"a":"adult older","h":[53],"po":"2025-04-27","u":"2026-10-21","st":"2025-08","ag":"18–80"},{"n":"NCT06948981","t":"GT719 Injection for the Treatment of Recurrent/Refractory CD19 Positive Adult B-cell Malignancies","s":"rec","p":"phase1phase2","d":[19],"c":[30],"a":"adult older","h":[69],"po":"2025-04-29","u":"2026-09-18","st":"2025-04","ag":"18–75"},{"n":"NCT06949033","t":"Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma","s":"rec","p":"phase3","d":[3],"c":[0,33],"a":"adult older","h":[195,53,141,142],"po":"2025-04-29","u":"2025-07-10","st":"2025-05","ag":"18–75"},{"n":"NCT06949150","t":"Combined Coronary CT Angiography and CT Perfusion in Coronary Artery Disease (CoroFusion)","s":"rec","p":"na","d":[31],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"cad"]],"po":"2025-04-29","u":"2025-04-29","st":"2025-01","ag":"18 and over"},{"n":"NCT06950827","t":"Textbook Outcomes of Right Hemihepatectomy in Patients With Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"hcc"]],"po":"2025-04-30","u":"2025-04-30","st":"2025-04","ag":"18 and over"},{"n":"NCT06951464","t":"A Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC","s":"rec","p":"phase2","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"lung"]],"po":"2025-04-30","u":"2025-07-23","st":"2025-06","ag":"18–75"},{"n":"NCT06951997","t":"QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"panc"]],"po":"2025-04-30","u":"2026-01-26","st":"2025-03","ag":"18–75"},{"n":"NCT06952075","t":"GR1803 Injection in Patients With RRMM","s":"rec","p":"phase2","d":[15],"c":[30],"a":"adult older","h":[69],"po":"2025-04-30","u":"2025-04-30","st":"2025-04","ag":"18 and over"},{"n":"NCT06952920","t":"Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[62],"lc":[62],"a":"adult older","h":[192],"l":[[192,"breast"]],"po":"2025-05-01","u":"2026-07-10","st":"2025-08","ag":"18–75"},{"n":"NCT06953843","t":"Study on the Optimal Combination Pattern of the Combined Treatment of Radiotherapy and Immunotherapy for the Abscopal Effect in Non-Small Cell Lung Cancer (NSCLC) With Multiple Metastases","s":"rec","p":"phase2","d":[4],"c":[1],"lc":[1],"a":"adult older","h":[167],"l":[[167,"lung"]],"po":"2025-05-01","u":"2025-07-14","st":"2025-07","ag":"18–75"},{"n":"NCT06953999","t":"A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer","s":"rec","p":"phase3","d":[5],"c":[23,24,5],"a":"adult older","h":[9,45,44],"po":"2025-05-01","u":"2026-03-04","st":"2025-06","ag":"18–75"},{"n":"NCT06954116","t":"Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence","s":"rec","p":"phase2","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2025-05-01","u":"2026-09-18","st":"2025-08","ag":"18–75"},{"n":"NCT06954246","t":"A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[5],"a":"adult older","h":[65],"po":"2025-05-01","u":"2025-06-18","st":"2025-06","ag":"18 and over"},{"n":"NCT06954467","t":"JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[2,8,24,17,9,5,11,20],"a":"adult older","h":[6,25,23,68,38,14,118,45,65,123,13],"po":"2025-05-01","u":"2025-07-02","st":"2025-05","ag":"18 and over"},{"n":"NCT06955988","t":"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AST2303 Tablets (ABK3376 Tablets) in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer","s":"rec","p":"phase1","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2025-05-02","u":"2026-08-13","st":"2025-03","ag":"18 and over"},{"n":"NCT06957886","t":"A Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With HER2-low Recurrent/Metastatic Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[8,0],"a":"adult older","x":"female","h":[99,13],"po":"2025-05-06","u":"2026-01-21","st":"2025-05","ag":"18–75"},{"n":"NCT06958705","t":"Venetoclax as Consolidation in CLL Patients Treated With BTK Inhibitor Monotherapy","s":"rec","p":"phase2","d":[19],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"lymph"]],"po":"2025-05-06","u":"2025-11-25","st":"2025-12","ag":"18–80"},{"n":"NCT06959173","t":"Organoid-guided Personalized Treatment of Pleural Effusion","s":"rec","p":"na","d":[4],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"lung"]],"po":"2025-05-06","u":"2025-05-06","st":"2025-02","ag":"18 and over"},{"n":"NCT06959524","t":"AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions","s":"rec","p":"na","d":[31],"c":[2,0,13,39],"a":"adult older","h":[213,109,111,49,282],"po":"2025-05-06","u":"2026-10-20","st":"2025-08","ag":"18 and over"},{"n":"NCT06959732","t":"Zanubrutinib Combined With G-CVP in Previously Untreated FL","s":"rec","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lymph"]],"po":"2025-05-07","u":"2025-05-07","st":"2025-01","ag":"18–80"},{"n":"NCT06961669","t":"Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma","s":"rec","p":"na","d":[15,16,19],"c":[17],"lc":[17],"a":"child adult older","h":[68],"l":[[68,"mm"]],"po":"2025-05-08","u":"2025-05-29","st":"2025-04","ag":"3 and over"},{"n":"NCT06962267","t":"A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type)","s":"rec","p":"phase2","d":[5],"c":[2],"a":"adult older","h":[38],"po":"2025-05-08","u":"2025-05-08","st":"2025-04","ag":"18–75"},{"n":"NCT06962865","t":"A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC","s":"rec","p":"phase2","d":[4],"c":[2,15,8,22,1,16,0,57,23,24,27,47,25,18,12,30,37,13,38,19,20],"a":"adult older","h":[57,25,12,26,45,10,24,47,81,82,61,30,2,135,83,138,169,170,174,95,84,86,152],"po":"2025-05-08","u":"2025-07-16","st":"2025-06","ag":"18–75"},{"n":"NCT06963827","t":"A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy","s":"rec","p":"phase3","d":[46],"c":[79,2,8,22,0,23,27,9,28,40,61,5,21,60,7,59],"a":"adult older","h":[29,40,49,98,43,41,243,20,123,120,171,14,182,124,54,110,126,283,100,211],"po":"2025-05-09","u":"2026-11-04","st":"2025-07","ag":"18 and over"},{"n":"NCT06964568","t":"CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC","s":"rec","p":"phase3","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"escc"]],"po":"2025-05-09","u":"2026-04-17","st":"2025-02","ag":"18 and over"},{"n":"NCT06964906","t":"Neoadjuvant High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab and Chemotherapy for ER-Positive /HER2-Negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2025-05-11","u":"2026-07-14","st":"2025-03","ag":"18–75"},{"n":"NCT06966141","t":"A Real World Study of Sacituzumab Govitecan","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2025-05-11","u":"2026-11-02","st":"2025-02","ag":"18 and over"},{"n":"NCT06966440","t":"Adjuvant Pancreatic Therapy Guided by MRD","s":"rec","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"panc"]],"po":"2025-05-11","u":"2025-07-15","st":"2025-06","ag":"18–75"},{"n":"NCT06966700","t":"A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)","s":"rec","p":"phase3","d":[6],"c":[2,15,8,23,24,17,27,28,10,5,34,13,39,7,20],"a":"adult older","h":[9,78,45,111,74,44,54,12,11,57,27,37,183,16,50,13,8,60,72,83,88],"po":"2025-05-13","u":"2026-11-17","st":"2025-06","ag":"18 and over"},{"n":"NCT06967038","t":"Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's Syndrome","s":"rec","p":"phase1phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[162],"l":[[162,"lymph"]],"po":"2025-05-13","u":"2025-05-13","st":"2025-02","ag":"18–70"},{"n":"NCT06967103","t":"QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"breast"]],"po":"2025-05-13","u":"2026-01-08","st":"2025-09","ag":"18 and over"},{"n":"NCT06968221","t":"Bovine Reinforcement in Stomach, Colorectal and Lung Operation","s":"rec","p":"phase3","d":[3,4],"c":[5],"a":"adult older","h":[41],"po":"2025-05-13","u":"2025-05-15","st":"2025-05","ag":"18–75"},{"n":"NCT06969014","t":"Transbronchial MWA for Pulmonary Tumors","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2025-05-13","u":"2025-07-18","st":"2025-05","ag":"18 and over"},{"n":"NCT06969612","t":"A Study on the Efficacy and Safety of Golidocitinib Combined With Tislelizumab and Chemotherapy as First-line Treatment for Advanced NSCLC","s":"rec","p":"phase1","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"lung"]],"po":"2025-05-14","u":"2025-06-06","st":"2025-05","ag":"18 and over"},{"n":"NCT06970912","t":"ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[48],"l":[[48,"breast"]],"po":"2025-05-14","u":"2026-07-13","st":"2025-08","ag":"18–75"},{"n":"NCT06971094","t":"Safety and Efficacy Evaluation of GC101 Gene Therapy Via Intrathecal (IT) Injectionin the Treatment of Patients With Type 2 Spinal Muscular Atrophy (SMA) - Phase III","s":"rec","p":"phase3","d":[40],"c":[2,21,4,13],"a":"child","h":[26,249,29,251,203,284],"po":"2025-05-14","u":"2026-11-13","st":"2025-05","ag":"2–12"},{"n":"NCT06972602","t":"High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed","s":"rec","p":"earlyphase1","d":[9],"c":[5],"lc":[5],"a":"child","h":[236],"l":[[236,"rb"]],"po":"2025-05-15","u":"2025-05-15","st":"2025-04","ag":"1–12"},{"n":"NCT06973187","t":"A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","s":"rec","p":"phase3","d":[19],"c":[2,15,8,22,52,16,24,33,73,9,10,40,61,5,11,18,4,12,37,13,39,62,31,20],"a":"adult older","h":[38,5,12,140,64,37,110,24,27,41,238,155,15,80,143,81,98,13,182,142,97,22,196,192],"po":"2025-05-15","u":"2026-09-28","st":"2025-09","ag":"18 and over"},{"n":"NCT06974929","t":"A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast Cancer","s":"rec","p":"phase1phase2","d":[6],"c":[30],"a":"adult older","x":"female","h":[58],"po":"2025-05-16","u":"2026-06-12","st":"2025-05","ag":"18–75"},{"n":"NCT06976190","t":"A Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[0],"a":"adult older","h":[53],"po":"2025-05-16","u":"2026-08-31","st":"2025-05","ag":"18–75"},{"n":"NCT06976437","t":"A Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell Malignant Tumors","s":"rec","p":"earlyphase1","d":[15,19],"c":[49],"lc":[49],"a":"adult older","h":[285],"l":[[285,"mm"]],"po":"2025-05-16","u":"2025-07-10","st":"2025-05","ag":"18 and over"},{"n":"NCT06977074","t":"PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2025-05-16","u":"2026-11-18","st":"2025-05","ag":"18–75"},{"n":"NCT06977893","t":"Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)","s":"rec","p":"phase3","d":[6],"c":[23,24,17,9,5,34,39,20],"lc":[23],"a":"adult older","x":"female","h":[46,45,44,25,97,112,82,6,72,239],"l":[[46,"breast"]],"po":"2025-05-18","u":"2025-05-18","st":"2025-03","ag":"18–75"},{"n":"NCT06978647","t":"A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases","s":"rec","p":"phase1","d":[26],"c":[2],"a":"adult older","h":[26],"po":"2025-05-18","u":"2026-10-21","st":"2025-05","ag":"18–65"},{"n":"NCT06978933","t":"FGF19 Overexpression Combination Unified Study in HCC-19","s":"rec","p":"phase2","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"hcc"]],"po":"2025-05-18","u":"2025-05-18","st":"2025-04","ag":"18 and over"},{"n":"NCT06979895","t":"Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric Cancer","s":"rec","p":"na","d":[3],"c":[39],"lc":[39],"a":"adult older","h":[131,122],"l":[[131,"gc"]],"po":"2025-05-20","u":"2026-08-27","st":"2025-05","ag":"18–75"},{"n":"NCT06985485","t":"Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy","s":"rec","p":"phase2","d":[16],"c":[4],"lc":[4],"a":"child adult older","h":[5],"l":[[5,"ball"]],"po":"2025-05-22","u":"2026-03-24","st":"2025-05","ag":"15 and over"},{"n":"NCT06986785","t":"A Study of BL-B01D1 Monotherapy, BL-B01D1 in Combination With Lenvatinib, BL-B01D1 in Combination With PD-1 Monoclonal Antibody, and BL-B01D1 in Combination With PD-1 Monoclonal Antibody and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[5],"a":"adult older","h":[6],"po":"2025-05-23","u":"2026-06-10","st":"2025-06","ag":"18–75"},{"n":"NCT06987734","t":"Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With Resectable Stage II-IIIA Non-small-cell Lung Cancer Patients","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2025-05-23","u":"2025-06-26","st":"2025-06","ag":"18 and over"},{"n":"NCT06987916","t":"Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[5],"lc":[5],"a":"child adult older","h":[162],"l":[[162,"lymph"]],"po":"2025-05-23","u":"2025-06-05","st":"2025-04","ag":"2–75"},{"n":"NCT06988059","t":"A Study of CT0596 in Plasma Cell Leukemia","s":"rec","p":"earlyphase1","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2025-05-23","u":"2025-08-01","st":"2025-06","ag":"18 and over"},{"n":"NCT06988488","t":"A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma","s":"rec","p":"phase1phase2","d":[15],"c":[5],"lc":[5],"a":"adult older","h":[286],"l":[[286,"mm"]],"po":"2025-05-25","u":"2026-09-02","st":"2025-10","ag":"18 and over"},{"n":"NCT06989437","t":"A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue","s":"rec","p":"phase2phase3","d":[5],"c":[2,52,16,0,23,17,27,33,5,12,37,39,20],"a":"adult older","h":[38,123,6,111,81,195,23,43,124,25,121,82,68,155,176,30,100],"po":"2025-05-25","u":"2026-10-14","st":"2025-10","ag":"18 and over"},{"n":"NCT06991790","t":"Sacituzumab Govitecan + Toripalimab as First - Line Therapy for Advanced Triple - Negative Breast Cancer and Biomarker Exploration","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[74],"l":[[74,"breast"]],"po":"2025-05-28","u":"2025-05-28","st":"2025-05","ag":"18–75"},{"n":"NCT06992336","t":"Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy","s":"rec","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2025-05-28","u":"2026-10-23","st":"2025-04","ag":"18–70"},{"n":"NCT06992739","t":"Trilaciclib in Patients Receiving Sacituzumab Tirumotecan for EGFR-mutated, Advanced Non-Small Cell Lung Cancer (NSCLC)","s":"rec","p":"phase2","d":[4],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"lung"]],"po":"2025-05-28","u":"2026-04-14","st":"2025-12","ag":"18–75"},{"n":"NCT06992882","t":"A Randomized, Open-label, Multi-center Phase III Study Comparing the Efficacy of Oral Chemotherapy Combined With Trastuzumab Versus Paclitaxel Combined With Trastuzumab in the Adjuvant Treatment of HER2-positive, Lymph Node-negative Early Breast Cancer Patients(ORCHID-PLUS)","s":"rec","p":"phase3","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2025-05-28","u":"2025-07-18","st":"2025-07","ag":"18–70"},{"n":"NCT06993714","t":"3D-printed Biodegradable Breast Implants for Breast Restoration","s":"rec","p":"phase2","d":[6],"c":[39],"lc":[39],"a":"adult older","x":"female","h":[131],"l":[[131,"breast"]],"po":"2025-05-29","u":"2025-06-06","st":"2025-05","ag":"18–70"},{"n":"NCT06993844","t":"Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors","s":"rec","p":"phase1phase2","d":[6],"c":[16,0,27,5],"a":"adult older","h":[9,53,57,30],"po":"2025-05-29","u":"2026-10-13","st":"2025-06","ag":"18 and over"},{"n":"NCT06994507","t":"GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[2],"a":"adult older","x":"female","h":[26],"po":"2025-05-29","u":"2025-08-06","st":"2025-08","ag":"18–75"},{"n":"NCT06995105","t":"Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma","s":"rec","p":"phase1phase2","d":[2],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"hcc"]],"po":"2025-05-29","u":"2025-05-29","st":"2025-04","ag":"18–75"},{"n":"NCT06995118","t":"The Application of \"HUAXI Hole 1\" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast Reconstruction","s":"rec","p":"na","d":[6],"c":[15,22,16,0,9,20],"a":"adult older","x":"female","h":[40,25,27,140,47,189,287,239],"po":"2025-05-29","u":"2025-07-02","st":"2025-06","ag":"18–70"},{"n":"NCT06996132","t":"Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"lymph"]],"po":"2025-05-30","u":"2025-06-17","st":"2025-05","ag":"18–65"},{"n":"NCT07000617","t":"A Phase II Study of Dexamethasone, Azacitidine, Pegaspargase and Tislelizumab Plus Radiotherapy for Patients With Stage I/II Extranodal NK/T-cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[74,23],"l":[[74,"lymph"]],"po":"2025-06-03","u":"2025-06-03","st":"2025-03","ag":"18 and over"},{"n":"NCT07000643","t":"Phase III Non-Inferiority Trial of Proton Versus Photon Therapy for Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[27],"lc":[27],"a":"adult older","h":[57],"l":[[57,"npc"]],"po":"2025-06-03","u":"2025-06-03","st":"2025-05","ag":"18–75"},{"n":"NCT07001540","t":"Evaluation of the Efficacy and Safety of Polatuzumab Vedotin Combined With Rituximab, Gemcitabine, and Oxaliplatin (Pola-R-GemOx) as Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Ineligible for Autologous Transplantation","s":"rec","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lymph"]],"po":"2025-06-03","u":"2025-06-19","st":"2025-05","ag":"18 and over"},{"n":"NCT07002099","t":"Selinexor, High-dose Methotrexate, and Rituximab Combined With Radiotherapy for Newly Diagnosed, Transplant-ineligible Patients With Central Nervous System Lymphoma: An Open-label, Single-arm, Multicenter Phase II Study","s":"rec","p":"phase2","d":[19],"c":[4],"lc":[4],"a":"adult older","h":[187],"l":[[187,"lymph"]],"po":"2025-06-03","u":"2025-06-03","st":"2025-06","ag":"18 and over"},{"n":"NCT07002177","t":"A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC","s":"rec","p":"phase1phase2","d":[6],"c":[5],"a":"adult older","x":"female","h":[9],"po":"2025-06-03","u":"2026-01-07","st":"2025-06","ag":"18–75"},{"n":"NCT07003074","t":"A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[15,8,17,27,28,5,43,11,12,30,34,13],"a":"adult older","h":[9,58,133,27,18,13,68,72,84,160,88,199,288],"po":"2025-06-04","u":"2025-06-25","st":"2025-06","ag":"18–75"},{"n":"NCT07003321","t":"A Trial of HRS-4508 in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[5],"a":"adult older","h":[56],"po":"2025-06-04","u":"2025-12-18","st":"2025-09","ag":"18–80"},{"n":"NCT07003334","t":"Correlation of Psychological Distress and Immune Checkpoint Inhibitors in Gastric Cancer","s":"rec","p":"na","d":[3],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"gc"]],"po":"2025-06-04","u":"2025-06-04","st":"2025-01","ag":"18–75"},{"n":"NCT07003490","t":"Radical Resection With Contralateral Lymph Node Dissection for Clinical N3 NSCLC","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[121],"l":[[121,"lung"]],"po":"2025-06-04","u":"2025-06-19","st":"2025-01","ag":"18–75"},{"n":"NCT07003555","t":"Dual-target BCMA-CD19 CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration","s":"rec","p":"phase1","d":[15],"c":[2],"lc":[2],"a":"adult older","h":[3],"l":[[3,"mm"]],"po":"2025-06-04","u":"2025-11-26","st":"2025-05","ag":"18–75"},{"n":"NCT07003568","t":"Dual-target BCMA-GPRC5D CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration","s":"rec","p":"phase1","d":[15],"c":[2],"lc":[2],"a":"adult older","h":[3],"l":[[3,"mm"]],"po":"2025-06-04","u":"2025-11-26","st":"2025-05","ag":"18–75"},{"n":"NCT07003737","t":"Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation","s":"rec","p":"na","d":[16],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"ball"]],"po":"2025-06-04","u":"2026-09-02","st":"2025-02","ag":"18–65"},{"n":"NCT07005102","t":"A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer","s":"rec","p":"phase2phase3","d":[4],"c":[22,16,0,9,5,13],"a":"adult older","h":[40,42,132,12,14,30],"po":"2025-06-05","u":"2026-10-05","st":"2025-08","ag":"18 and over"},{"n":"NCT07006012","t":"RGL-305+ Lymphoma + Exploratory Clinical Study","s":"rec","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lymph"]],"po":"2025-06-05","u":"2026-03-24","st":"2025-04","ag":"18–75"},{"n":"NCT07006077","t":"Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[23],"a":"adult older","h":[185],"po":"2025-06-05","u":"2026-02-27","st":"2025-05","ag":"18–75"},{"n":"NCT07007182","t":"Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[27],"lc":[27],"a":"adult older","h":[57],"l":[[57,"gc"]],"po":"2025-06-05","u":"2026-10-15","st":"2025-10","ag":"18–75"},{"n":"NCT07008287","t":"Real-world Study of Taletrectinib for Advanced ROS1+ NSCLC With Brain Metastases","s":"rec","p":"na","d":[4],"c":[23],"a":"adult older","h":[44],"po":"2025-06-06","u":"2025-07-22","st":"2025-06","ag":"18 and over"},{"n":"NCT07008716","t":"Omitting CTV for Primary Tumor in LS-SCLC","s":"rec","p":"phase3","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2025-06-06","u":"2025-06-06","st":"2025-06","ag":"18–75"},{"n":"NCT07008885","t":"BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B-ALL","s":"rec","p":"phase1phase2","d":[16],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"ball"]],"po":"2025-06-06","u":"2025-06-25","st":"2025-06","ag":"18–70"},{"n":"NCT07008976","t":"Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[48,2,15,8,16,6,17,33,25,9,51,10,5,11,18,30,20],"a":"adult older","h":[9,58,24,27,37,18,112,50,13,7,29,142,30,116,146,150,67,138,88],"po":"2025-06-06","u":"2025-08-14","st":"2025-07","ag":"18–75"},{"n":"NCT07009002","t":"BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2025-06-06","u":"2025-06-25","st":"2025-06","ag":"18–70"},{"n":"NCT07010198","t":"Head-to-Head Comparison of Hepatocellular Cancer (HCC) Screening Strategies: A Prospective Population-Based Cohort Study in Zhongshan City","s":"rec","p":"na","d":[2],"c":[46],"lc":[46],"a":"adult older","h":[134],"l":[[134,"hcc"]],"po":"2025-06-08","u":"2025-06-08","st":"2025-03","ag":"35 and over"},{"n":"NCT07010237","t":"Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia","s":"rec","p":"phase2","d":[17],"c":[30],"lc":[30],"a":"older","h":[69],"l":[[69,"aa"]],"po":"2025-06-08","u":"2025-06-08","st":"2025-02","ag":"65 and over"},{"n":"NCT07010263","t":"A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy","s":"rec","p":"phase3","d":[4],"c":[48,2,15,8,1,16,0,24,35,27,25,9,28,10,5,11,18,12,30,37,13,39,14,58,20,64],"a":"adult older","h":[23,56,57,58,9,43,12,26,111,74,45,118,24,113,127,13,79,14,81,37,15,61,30,122,206,50,138,172,84,21,85,204,152,150,67],"po":"2025-06-08","u":"2026-03-05","st":"2025-06","ag":"18 and over"},{"n":"NCT07010939","t":"A Study of Treatment-Related Toxicities and Quality of Life After Local Therapy in Chinese Breast Cancer Patients","s":"rec","p":"na","d":[6],"c":[2,21,12],"a":"adult older","x":"female","h":[23,106,84],"po":"2025-06-08","u":"2025-09-12","st":"2025-04","ag":"18 and over"},{"n":"NCT07011056","t":"A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma","s":"rec","p":"phase3","d":[19],"c":[22],"a":"adult older","h":[40],"po":"2025-06-08","u":"2025-09-19","st":"2025-07","ag":"18 and over"},{"n":"NCT07012447","t":"Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations","s":"rec","p":"phase2","d":[3],"c":[4],"lc":[4],"a":"child adult older","h":[5],"l":[[5,"gc"]],"po":"2025-06-10","u":"2025-06-10","st":"2025-04","ag":"14 and over"},{"n":"NCT07012798","t":"FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"hcc"]],"po":"2025-06-10","u":"2026-05-13","st":"2025-09","ag":"18 and over"},{"n":"NCT07012980","t":"Glofitamab, Polatuzumab Vedotin and Zanubrutinib in First-line Elderly DLBCL","s":"rec","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"older","h":[6],"l":[[6,"lymph"]],"po":"2025-06-10","u":"2026-10-16","st":"2025-06","ag":"70 and over"},{"n":"NCT07014150","t":"Neoadjuvant Therapy of Iparomlimab and Tuvonralimab Combined With Lenvatinib for Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"hcc"]],"po":"2025-06-10","u":"2026-05-05","st":"2025-06","ag":"18–75"},{"n":"NCT07014202","t":"Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy","s":"rec","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2025-06-10","u":"2025-07-30","st":"2025-06","ag":"18 and over"},{"n":"NCT07014826","t":"A Trial of HRS-5965 Capsule in Primary IgA Nephropathy","s":"rec","p":"phase3","d":[46],"c":[2],"a":"adult older","h":[29],"po":"2025-06-11","u":"2026-11-18","st":"2025-06","ag":"18 and over"},{"n":"NCT07015580","t":"The Characteristics of Oral Microbiota in Chronic Pancreatitis and Autoimmune Pancreatitis","s":"rec","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"panc"]],"po":"2025-06-11","u":"2025-06-11","st":"2025-02","ag":"18 and over"},{"n":"NCT07018050","t":"Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple Myeloma","s":"rec","p":"phase2","d":[15],"c":[30],"a":"adult older","h":[69],"po":"2025-06-12","u":"2026-06-08","st":"2025-09","ag":"18 and over"},{"n":"NCT07018518","t":"PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma","s":"rec","p":"phase1","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"hcc"]],"po":"2025-06-12","u":"2025-06-22","st":"2025-06","ag":"18–75"},{"n":"NCT07019675","t":"A Study of SKB518 in Patients With Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[2,8,23,27,47,9,10,5,21,12,29,30,34,13,38,20],"a":"adult older","h":[23,56,58,44,25,13,135,16,106,19,50,66,72,116,84,86,199],"po":"2025-06-13","u":"2026-05-08","st":"2025-08","ag":"18–75"},{"n":"NCT07022197","t":"Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases","s":"rec","p":"phase1phase2","d":[25,27],"c":[30],"lc":[30],"a":"adult","h":[59],"l":[[59,"nmosd"]],"po":"2025-06-15","u":"2026-10-16","st":"2025-04","ag":"18–60"},{"n":"NCT07022223","t":"Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma","s":"rec","p":"phase2","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[54,44,185],"l":[[54,"lymph"]],"po":"2025-06-15","u":"2025-06-15","st":"2025-03","ag":"18 and over"},{"n":"NCT07022587","t":"Bioresorbable Sirolimus-eluting scaﬀold in de Novo Coronary Artery Lesions","s":"rec","p":"na","d":[31],"c":[39],"lc":[39],"a":"adult older","h":[131],"l":[[131,"cad"]],"po":"2025-06-15","u":"2026-02-13","st":"2025-12","ag":"18–75"},{"n":"NCT07022964","t":"CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas","s":"rec","p":"phase1phase2","d":[19],"c":[2,5],"lc":[2],"a":"child adult older","h":[3,123],"l":[[3,"lymph"]],"po":"2025-06-15","u":"2026-09-11","st":"2025-06","ag":"14–70"},{"n":"NCT07023315","t":"A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma","s":"rec","p":"phase3","d":[3],"c":[2,16,24,5,18],"a":"adult older","h":[74,6,24,45,30],"po":"2025-06-16","u":"2026-02-11","st":"2025-08","ag":"18–75"},{"n":"NCT07024173","t":"A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[8,0],"a":"adult older","x":"female","h":[53,13],"po":"2025-06-17","u":"2026-10-02","st":"2025-07","ag":"18–75"},{"n":"NCT07024433","t":"Tubeless Anesthesia in Preventing Lung Complications in Patients Undergoing Surgery for Early-Stage Lung Cancer","s":"rec","p":"na","d":[4],"c":[16],"lc":[16],"a":"adult older","h":[140],"l":[[140,"lung"]],"po":"2025-06-17","u":"2025-06-17","st":"2025-05","ag":"18–70"},{"n":"NCT07025018","t":"Phase I Study of HMPL-306 for the Treatment of Gliomas With IDH1 and/or IDH2 Mutations","s":"rec","p":"phase1","d":[7],"c":[5],"lc":[5],"a":"adult older","h":[103],"l":[[103,"glioma"]],"po":"2025-06-17","u":"2025-08-01","st":"2025-07","ag":"18 and over"},{"n":"NCT07025889","t":"IBI343 Combined With Sintilimab Plus Chemotherapy in Gastric Cancer","s":"rec","p":"phase1phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"gc"]],"po":"2025-06-18","u":"2026-08-18","st":"2025-06","ag":"18–75"},{"n":"NCT07026149","t":"Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer","s":"rec","p":"phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"gc"]],"po":"2025-06-18","u":"2025-06-18","st":"2025-06","ag":"18–75"},{"n":"NCT07026669","t":"A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2025-06-18","u":"2025-06-18","st":"2025-01","ag":"18 and over"},{"n":"NCT07029269","t":"Feasibility of Enhanced Recovery After Surgery Without Prophylactic Abdominal Drainage Tubes After Laparoscopic Distal Gastrectomy For Gastric Cancer","s":"rec","p":"phase3","d":[3],"c":[16,0,23,33,39],"a":"adult older","h":[140,195,44,53,111],"po":"2025-06-19","u":"2025-12-17","st":"2025-06","ag":"18–80"},{"n":"NCT07030894","t":"Nefecon and Ambrisentan in IgA Nephropathy","s":"rec","p":"phase4","d":[46],"c":[15],"lc":[15],"a":"adult older","h":[27],"l":[[27,"iga"]],"po":"2025-06-22","u":"2025-09-15","st":"2025-09","ag":"18–70"},{"n":"NCT07031531","t":"Effectiveness of an AI-Enabled Stratified Management System for Premature Coronary Artery Disease","s":"rec","p":"na","d":[31],"c":[2,23,17,36,73,28,18,39,32,20],"a":"adult","h":[213,78,54,111,238,68,289,63,97,87,290],"po":"2025-06-22","u":"2026-08-18","st":"2025-08","ag":"18–45"},{"n":"NCT07032961","t":"A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening","s":"rec","p":"na","d":[3],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"gc"]],"po":"2025-06-24","u":"2025-07-04","st":"2025-06","ag":"45 and over"},{"n":"NCT07034157","t":"A Real-World Study on Ultrasound-Based Screening and Integrated Therapeutic Strategies for Patients With Concomitant Coronary and Cervicocephalic Artery Stenosis","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[109],"l":[[109,"cad"]],"po":"2025-06-24","u":"2025-06-24","st":"2025-06","ag":"18 and over"},{"n":"NCT07034326","t":"Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer","s":"rec","p":"phase2phase3","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[191],"l":[[191,"lung"]],"po":"2025-06-24","u":"2025-06-24","st":"2025-01","ag":"18–80"},{"n":"NCT07034339","t":"Construction and Clinical Application of the Immune Map of Pancreatic Cancer Evolution","s":"rec","p":"na","d":[5],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"panc"]],"po":"2025-06-24","u":"2025-08-06","st":"2025-05","ag":"18–80"},{"n":"NCT07034391","t":"A Study Evaluating the Efficacy of PD-1 Inhibitor Combined With Denosumab and Chemotherapy in Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Patients With Driver Gene-Negative Status","s":"rec","p":"phase2","d":[4],"c":[11],"lc":[11],"a":"adult older","h":[118],"l":[[118,"lung"]],"po":"2025-06-24","u":"2025-06-24","st":"2025-05","ag":"18–75"},{"n":"NCT07035626","t":"A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)","s":"rec","p":"phase1phase2","d":[0],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"npc"]],"po":"2025-06-25","u":"2025-06-26","st":"2025-06","ag":"18–80"},{"n":"NCT07037199","t":"Efficacy and Safety of Trastuzumab Rezetecan Followed by CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2-Low/Ultra-Low Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2025-06-25","u":"2025-12-31","st":"2025-08","ag":"18 and over"},{"n":"NCT07037576","t":"Efficacy and Safety of Prepectoral Prosthesis Immediate One-Stage Breast Reconstruction Versus Two-Stage Expander/Prosthesis Reconstruction in Postoperative Adjuvant Radiotherapy Breast Cancer Patients: A Prospective, Single-Center, Cohort Study","s":"rec","p":"na","d":[6],"c":[20],"lc":[20],"a":"adult older","x":"female","h":[37],"l":[[37,"breast"]],"po":"2025-06-25","u":"2025-06-25","st":"2025-05","ag":"18–70"},{"n":"NCT07038096","t":"ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma","s":"rec","p":"phase1phase2","d":[4],"c":[0],"a":"adult older","h":[53],"po":"2025-06-26","u":"2026-01-05","st":"2025-09","ag":"18–70"},{"n":"NCT07038629","t":"Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC","s":"rec","p":"phase2","d":[1],"c":[30],"lc":[30],"a":"older","h":[58],"l":[[58,"escc"]],"po":"2025-06-26","u":"2026-05-20","st":"2025-09","ag":"70–90"},{"n":"NCT07039201","t":"A Study to Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC)","s":"rec","p":"na","d":[2],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"hcc"]],"po":"2025-06-26","u":"2026-01-22","st":"2025-06","ag":"18–75"},{"n":"NCT07039656","t":"Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Non-small Cell Lung Cancer With or Without Prior Neoadjuvant Therapy","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"lung"]],"po":"2025-06-26","u":"2025-08-07","st":"2025-01","ag":"18–75"},{"n":"NCT07040228","t":"A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer","s":"rec","p":"phase1phase2","d":[5],"c":[21],"lc":[21],"a":"adult older","h":[106],"l":[[106,"panc"]],"po":"2025-06-27","u":"2026-05-18","st":"2025-05","ag":"18–80"},{"n":"NCT07043725","t":"A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[48,2,55,15,8,22,1,0,41,24,17,80,27,33,25,36,73,70,9,28,10,61,56,5,43,11,18,12,29,30,34,42,37,13,39,14,19,20],"a":"adult older","h":[9,78,58,45,99,111,24,118,238,74,79,38,25,12,11,133,164,57,27,81,18,10,2,143,50,291,28,60,166,72,142,228,98,15,114,116,103,173,261,117,176,215,66,226,87,84,278,21,150,160,67,88],"po":"2025-06-29","u":"2026-11-02","st":"2025-09","ag":"18–75"},{"n":"NCT07045311","t":"JS207 Combination Therapy in Triple-negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[2,15,52,23,24,17,28,26,11,18,34,13,39,20],"a":"adult older","h":[78,45,111,118,54,26,55,27,37,18,127,19,48,72,155,175,247,88],"po":"2025-07-01","u":"2026-04-15","st":"2025-09","ag":"18–75"},{"n":"NCT07046455","t":"Trop-2 Targeted PET Probes in Advanced TNBC","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"breast"]],"po":"2025-07-01","u":"2025-07-01","st":"2025-03","ag":"18–75"},{"n":"NCT07047365","t":"TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[48,2,55,15,8,22,1,41,6,24,17,27,47,33,36,73,9,51,28,10,61,11,21,18,12,77,30,42,37,39,38,62,14,31,20],"a":"adult older","h":[58,45,24,238,25,26,11,164,57,27,37,18,2,97,143,50,135,13,68,127,131,7,60,142,113,31,192,98,126,114,116,188,146,196,117,215,292,87,84,86,21,150,101,138],"po":"2025-07-02","u":"2026-06-03","st":"2025-07","ag":"18–75"},{"n":"NCT07047586","t":"Lenvatinib Plus Tislelizumab Versus Lenvatinib Alone in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab","s":"rec","p":"phase2","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"hcc"]],"po":"2025-07-02","u":"2025-07-03","st":"2025-07","ag":"18 and over"},{"n":"NCT07049185","t":"QL1706 Plus Celecoxib in Advanced Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[2],"lc":[2],"a":"adult older","h":[74,3],"l":[[74,"escc"]],"po":"2025-07-03","u":"2026-11-02","st":"2025-09","ag":"18–75"},{"n":"NCT07052253","t":"A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC.","s":"rec","p":"phase2","d":[2],"c":[13],"a":"adult older","h":[12],"po":"2025-07-04","u":"2026-03-16","st":"2025-07","ag":"18–75"},{"n":"NCT07052669","t":"Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLC","s":"rec","p":"phase3","d":[4],"c":[1,0],"lc":[0],"a":"adult older","h":[53,79],"l":[[53,"lung"]],"po":"2025-07-06","u":"2025-07-23","st":"2025-07","ag":"18–75"},{"n":"NCT07053072","t":"PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma.","s":"rec","p":"phase1","d":[2],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"hcc"]],"po":"2025-07-08","u":"2026-10-13","st":"2025-10","ag":"18–70"},{"n":"NCT07053670","t":"A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG11001 )","s":"rec","p":"phase1","d":[19],"c":[5,13],"lc":[5],"a":"adult older","h":[162,36],"l":[[162,"lymph"]],"po":"2025-07-08","u":"2025-11-17","st":"2025-07","ag":"18–75"},{"n":"NCT07054086","t":"Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma","s":"rec","p":"na","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"escc"]],"po":"2025-07-08","u":"2025-07-08","st":"2025-03","ag":"18–75"},{"n":"NCT07056556","t":"A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors","s":"rec","p":"phase1","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2025-07-09","u":"2025-08-22","st":"2025-07","ag":"18 and over"},{"n":"NCT07057102","t":"Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2025-07-09","u":"2025-07-09","st":"2025-01","ag":"18 and over"},{"n":"NCT07057427","t":"Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"breast"]],"po":"2025-07-09","u":"2025-07-09","st":"2025-06","ag":"18–70"},{"n":"NCT07058103","t":"Tislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the Treatment of R/R AITL","s":"rec","p":"phase2","d":[19],"c":[31],"lc":[31],"a":"adult older","h":[64],"l":[[64,"lymph"]],"po":"2025-07-10","u":"2025-07-10","st":"2025-04","ag":"18 and over"},{"n":"NCT07058298","t":"GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103)","s":"rec","p":"earlyphase1","d":[27],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"mg"]],"po":"2025-07-10","u":"2025-09-08","st":"2025-07","ag":"18–75"},{"n":"NCT07058519","t":"A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2025-07-10","u":"2025-11-26","st":"2025-09","ag":"18 and over"},{"n":"NCT07058662","t":"A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy.","s":"rec","p":"phase1phase2","d":[43],"c":[2],"a":"child","x":"male","h":[38],"po":"2025-07-10","u":"2026-11-13","st":"2025-07","ag":"4–9"},{"n":"NCT07058948","t":"Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors","s":"rec","p":"phase2","d":[4],"c":[2,30],"lc":[30],"a":"adult older","h":[58,39],"l":[[58,"lung"]],"po":"2025-07-10","u":"2026-04-29","st":"2025-07","ag":"18 and over"},{"n":"NCT07059650","t":"DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)","s":"rec","p":"phase1phase2","d":[19],"c":[2,8,22,0,23,17,25,12,13,39,20],"a":"adult older","h":[40,53,12,54,115,37,43,111,0,13,84,67,88],"po":"2025-07-11","u":"2026-04-01","st":"2025-08","ag":"18 and over"},{"n":"NCT07059923","t":"Predicting Immunotherapy Response and Survival of Lung Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Lung)","s":"rec","p":"na","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lung"]],"po":"2025-07-11","u":"2025-07-11","st":"2025-07","ag":"18 and over"},{"n":"NCT07059936","t":"Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)","s":"rec","p":"na","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"hcc"]],"po":"2025-07-11","u":"2025-07-22","st":"2025-07","ag":"18 and over"},{"n":"NCT07060807","t":"A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)","s":"rec","p":"phase3","d":[6],"c":[2,15,8,22,1,0,23,17,9,28,10,29,34,39,7,38,20],"a":"adult older","h":[23,40,78,53,79,44,37,50,47,13,8,82,127,48,72,66,247,239,86,138,88],"po":"2025-07-11","u":"2026-11-03","st":"2025-07","ag":"18 and over"},{"n":"NCT07061535","t":"Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[8,23,27],"lc":[23],"a":"adult older","h":[54,57,44,46,13],"l":[[54,"lung"]],"po":"2025-07-11","u":"2026-09-15","st":"2025-07","ag":"18 and over"},{"n":"NCT07061704","t":"Oncolytic Virus in Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase1phase2","d":[1],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"escc"]],"po":"2025-07-11","u":"2025-12-08","st":"2025-08","ag":"18–80"},{"n":"NCT07062055","t":"BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + Surgery/SBRT for BCLC-C HCC With PVTT and/or Oligometastases","s":"rec","p":"phase2","d":[2],"c":[27],"lc":[27],"a":"adult older","h":[57],"l":[[57,"hcc"]],"po":"2025-07-14","u":"2026-10-15","st":"2025-07","ag":"18–70"},{"n":"NCT07062380","t":"AI-Based Prediction of HCC Recurrence Patterns After Resection (APAR)","s":"rec","p":"na","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2025-07-14","u":"2025-09-03","st":"2025-06","ag":"18–75"},{"n":"NCT07062965","t":"A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.","s":"rec","p":"phase3","d":[6],"c":[2,15,8,52,16,0,23,24,17,27,9,28,10,5,18,37,13,39],"a":"adult older","h":[9,53,45,36,74,44,54,43,70,57,27,81,97,140,50,13,82,19,60,155,175,239,88],"po":"2025-07-14","u":"2026-10-19","st":"2025-08","ag":"18 and over"},{"n":"NCT07063147","t":"TTE Improves Clinical Management of Stable Chest Pain","s":"rec","p":"na","d":[31],"c":[30],"lc":[30],"a":"adult older","h":[169],"l":[[169,"cad"]],"po":"2025-07-14","u":"2025-07-18","st":"2025-01","ag":"18 and over"},{"n":"NCT07063329","t":"Phase I/II Study of PLB1004 Combined With Platinum-based Doublet Chemotherapy in Patients With EGFR Mutation-positive","s":"rec","p":"phase1phase2","d":[4],"c":[5,20],"a":"adult older","h":[42,37],"po":"2025-07-14","u":"2026-10-28","st":"2025-08","ag":"18 and over"},{"n":"NCT07065409","t":"Treatment of Moyamoya Disease With iPSC-derived Exosomes","s":"rec","p":"phase1","d":[28],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"moyamoya"]],"po":"2025-07-15","u":"2025-10-01","st":"2025-05","ag":"18–75"},{"n":"NCT07066098","t":"A Multicenter Study of IBI343 Monotherapy Versus Placebo in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, Pancreatic Cancer(G-HOPE-002)","s":"rec","p":"phase3","d":[5],"c":[5],"a":"adult older","h":[9],"po":"2025-07-15","u":"2026-10-05","st":"2025-07","ag":"18 and over"},{"n":"NCT07066280","t":"Modulating the Skin Microbiome to Prevent Radiation Dermatitis in Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2025-07-15","u":"2025-07-15","st":"2025-04","ag":"18–70"},{"n":"NCT07066657","t":"A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors","s":"rec","p":"phase1","d":[3,5],"c":[2,8,1,23,24,5,13,20],"a":"adult older","h":[74,6,12,37,45,41,82,13,17],"po":"2025-07-15","u":"2026-08-13","st":"2025-07","ag":"18 and over"},{"n":"NCT07066813","t":"Staging Strategies and Their Association With Prognosis and Therapy in Lung Cancer With Cystic Airspaces","s":"rec","p":"na","d":[4],"c":[8],"lc":[8],"a":"child adult older","h":[10],"l":[[10,"lung"]],"po":"2025-07-15","u":"2026-09-04","st":"2025-06","ag":"Not stated"},{"n":"NCT07067346","t":"Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma","s":"rec","p":"earlyphase1","d":[13],"c":[22],"lc":[22],"a":"child adult older","h":[40],"l":[[40,"nb"]],"po":"2025-07-16","u":"2025-07-29","st":"2025-07","ag":"12 months and over"},{"n":"NCT07067905","t":"Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma","s":"rec","p":"earlyphase1","d":[7],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"glioma"]],"po":"2025-07-16","u":"2025-07-16","st":"2025-06","ag":"18 and over"},{"n":"NCT07067983","t":"Clinical Evaluation of GRAPE Model for Gastric Cancer Screening","s":"rec","p":"na","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"gc"]],"po":"2025-07-16","u":"2025-07-16","st":"2025-05","ag":"18–80"},{"n":"NCT07068165","t":"A Randomized Controlled Study of the Efficacy and Safety of Lenalidomide in the Treatment of Active IgG4-related Disease","s":"rec","p":"phase2phase3","d":[26],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"igg4"]],"po":"2025-07-16","u":"2025-12-30","st":"2025-07","ag":"18–75"},{"n":"NCT07068529","t":"Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Colorectal Cancer：MetBio-CRC","s":"rec","p":"na","d":[3],"c":[5],"a":"adult older","h":[123],"po":"2025-07-16","u":"2025-07-16","st":"2025-06","ag":"18 and over"},{"n":"NCT07069842","t":"The Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating Lymphocytes (TILs) and Histone H3K4me3 in the Tumor Microenvironment","s":"rec","p":"na","d":[3],"c":[81],"lc":[81],"a":"adult older","h":[293],"l":[[293,"gc"]],"po":"2025-07-17","u":"2025-07-17","st":"2025-01","ag":"18–75"},{"n":"NCT07070232","t":"A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors","s":"rec","p":"phase1phase2","d":[3],"c":[1,23,30,13],"a":"adult older","h":[58,54,82,2,19],"po":"2025-07-17","u":"2026-11-18","st":"2025-08","ag":"18 and over"},{"n":"NCT07070440","t":"DZD6008 Combination Therapy in Patients With Locally Advanced or Metastatic NSCLC With EGFR Mutation (TIAN-SHAN7)","s":"rec","p":"phase1phase2","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2025-07-17","u":"2026-08-31","st":"2025-07","ag":"18 and over"},{"n":"NCT07070479","t":"Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial","s":"rec","p":"phase2","d":[0],"c":[8,0,46,59],"a":"adult older","h":[53,11,171,43,134],"po":"2025-07-17","u":"2025-09-18","st":"2025-06","ag":"18–70"},{"n":"NCT07070518","t":"Study of GV20-0251 in Participants With Solid Tumor Malignancies","s":"rec","p":"phase1phase2","d":[2,4],"c":[2,5],"a":"adult older","h":[23,74,56],"po":"2025-07-17","u":"2025-12-03","st":"2025-07","ag":"18 and over"},{"n":"NCT07070648","t":"Study on Predicting Response to Standard First-Line Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using ctDNA Combined With PET","s":"rec","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lymph"]],"po":"2025-07-17","u":"2025-07-17","st":"2025-05","ag":"18 and over"},{"n":"NCT07071103","t":"Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors","s":"rec","p":"phase2","d":[4],"c":[43],"lc":[43],"a":"adult older","h":[125],"l":[[125,"lung"]],"po":"2025-07-17","u":"2025-11-20","st":"2025-09","ag":"18–80"},{"n":"NCT07071337","t":"A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy","s":"rec","p":"phase3","d":[6],"c":[2,0],"a":"adult older","h":[53,26],"po":"2025-07-17","u":"2026-05-08","st":"2025-07","ag":"18–75"},{"n":"NCT07072169","t":"A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (B-NHL)","s":"rec","p":"phase1","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2025-07-18","u":"2025-07-18","st":"2025-05","ag":"18–75"},{"n":"NCT07072494","t":"CD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patients With Acute B-ALL Ineligible for Allogeneic HSCT: A Clinical Study","s":"rec","p":"phase1phase2","d":[16],"c":[0],"lc":[0],"a":"child adult older","h":[0],"l":[[0,"ball"]],"po":"2025-07-18","u":"2025-07-18","st":"2025-07","ag":"14–80"},{"n":"NCT07073833","t":"The Safety, Tolerability, and Efficacy of IBR900 Cell Injection in Relapsed/Refractory B-cell Non Hodgkin Lymphoma","s":"rec","p":"phase1","d":[19],"c":[23,5],"a":"adult older","h":[123,46],"po":"2025-07-18","u":"2026-07-02","st":"2025-07","ag":"18 and over"},{"n":"NCT07074470","t":"Combination Regimen of Teniposide, PD-1 Monoclonal Antibody and Selinixor for Patients With Relapsed or Refractory PCNSL","s":"rec","p":"na","d":[19],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"lymph"]],"po":"2025-07-20","u":"2025-07-20","st":"2025-01","ag":"18–75"},{"n":"NCT07076979","t":"Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetBio-GC","s":"rec","p":"na","d":[3],"c":[5],"a":"adult older","h":[123],"po":"2025-07-22","u":"2025-07-22","st":"2025-06","ag":"18 and over"},{"n":"NCT07077356","t":"Application of mRNA Vaccine in Liver Transplantation for Hepatocellular Carcinoma","s":"rec","p":"phase1","d":[2],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"hcc"]],"po":"2025-07-22","u":"2025-07-22","st":"2025-08","ag":"18 and over"},{"n":"NCT07078136","t":"Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor Diagnosis","s":"rec","p":"na","d":[3,12],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"gc"]],"po":"2025-07-22","u":"2025-07-31","st":"2025-07","ag":"18 and over"},{"n":"NCT07078500","t":"Orelabrutinib Combined With Pola-R-CHP Regimen for the Treatment of Untreated Non-GCB Diffuse Large B-Cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lymph"]],"po":"2025-07-22","u":"2025-08-19","st":"2025-05","ag":"18–80"},{"n":"NCT07079150","t":"Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study","s":"rec","p":"na","d":[2],"c":[39],"lc":[39],"a":"adult older","h":[111],"l":[[111,"hcc"]],"po":"2025-07-22","u":"2025-07-22","st":"2025-01","ag":"18–70"},{"n":"NCT07079228","t":"A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer","s":"rec","p":"phase3","d":[5],"c":[2],"a":"adult older","h":[74],"po":"2025-07-22","u":"2025-09-23","st":"2025-09","ag":"18–75"},{"n":"NCT07079475","t":"Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)","s":"rec","p":"phase1phase2","d":[4],"c":[2,8,22,0,23,27,28,5,11,30],"a":"adult older","h":[40,42,57,58,44,132,118,13,47,60,61],"po":"2025-07-23","u":"2026-10-23","st":"2025-07","ag":"18 and over"},{"n":"NCT07080021","t":"A Cohort Study on ctDNA MRD in Neoadjuvant Therapy for Pancreatic Cancer","s":"rec","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"panc"]],"po":"2025-07-23","u":"2025-07-29","st":"2025-05","ag":"18–75"},{"n":"NCT07080619","t":"SC-101 in Subjects With Advanced NECTIN4-Amplified Cancers","s":"rec","p":"phase2","d":[6],"c":[5],"a":"adult older","h":[9],"po":"2025-07-23","u":"2026-10-29","st":"2025-08","ag":"18–75"},{"n":"NCT07082179","t":"A Prospective Phase II Clinical Study of Immunotherapy Combined With Chemotherapy for Stage III Unresectable Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[28],"lc":[28],"a":"adult older","h":[127],"l":[[127,"lung"]],"po":"2025-07-24","u":"2026-02-11","st":"2025-09","ag":"18–75"},{"n":"NCT07082192","t":"A Study to Evaluate the Efficacy and Safety of Different Doses of CB03-154 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)","s":"rec","p":"phase2phase3","d":[39],"c":[2],"a":"adult older","h":[115],"po":"2025-07-24","u":"2026-09-22","st":"2025-10","ag":"18–65"},{"n":"NCT07082686","t":"A Study to Evaluate the Efficacy and Safety of ICP-248 in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (APEX-06)","s":"rec","p":"phase2","d":[19],"c":[2,15,8,22,1,16,0,23,17,27,9,28,10,26,5,30,34,13,39,20],"a":"adult older","h":[40,53,25,78,46,113,12,140,69,9,115,124,37,55,27,43,2,79,92,98,112,57,14,13,97,50,72],"po":"2025-07-24","u":"2026-07-23","st":"2025-08","ag":"18 and over"},{"n":"NCT07082842","t":"Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF","s":"rec","p":"phase3","d":[37],"c":[2],"a":"adult older","h":[62],"po":"2025-07-24","u":"2026-04-21","st":"2025-10","ag":"40–80"},{"n":"NCT07084662","t":"Xinlikang Capsule for Chemotherapy-induced Fatigue and Immune Disorders in Diffuse Large B Lymphoma","s":"rec","p":"phase2phase3","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2025-07-24","u":"2025-11-26","st":"2025-09","ag":"18 and over"},{"n":"NCT07085234","t":"Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPC","s":"rec","p":"phase2","d":[0],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"npc"]],"po":"2025-07-25","u":"2025-07-25","st":"2025-07","ag":"18–65"},{"n":"NCT07085559","t":"Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research","s":"rec","p":"earlyphase1","d":[15],"c":[17],"lc":[17],"a":"adult older","h":[68],"l":[[68,"mm"]],"po":"2025-07-25","u":"2025-07-25","st":"2025-06","ag":"19–75"},{"n":"NCT07085988","t":"Effect of Nutritional Management on Patients With Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma","s":"rec","p":"phase2","d":[0],"c":[9],"lc":[9],"a":"adult older","h":[116],"l":[[116,"npc"]],"po":"2025-07-25","u":"2025-07-25","st":"2025-01","ag":"18 and over"},{"n":"NCT07086300","t":"Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC","s":"rec","p":"na","d":[4],"c":[30],"lc":[30],"a":"older","h":[191],"l":[[191,"lung"]],"po":"2025-07-25","u":"2025-07-25","st":"2025-07","ag":"65–100"},{"n":"NCT07086456","t":"Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2025-07-25","u":"2025-07-25","st":"2025-07","ag":"18–75"},{"n":"NCT07086469","t":"Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"escc"]],"po":"2025-07-25","u":"2025-11-17","st":"2025-07","ag":"18–80"},{"n":"NCT07087223","t":"Phase Ib/II Study of Vebreltinib With Furmonertinib in NSCLC Patients With c-Met Amplification After EGFR-TKI Failure","s":"rec","p":"phase1phase2","d":[4],"c":[2,52,18,30],"lc":[2],"a":"adult older","h":[74,58,38,48,61,155,115,175],"l":[[74,"lung"]],"po":"2025-07-25","u":"2025-07-25","st":"2025-04","ag":"18 and over"},{"n":"NCT07088263","t":"Adaptive Chemotherapy for the Treatment of Advanced Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[53],"l":[[53,"breast"]],"po":"2025-07-28","u":"2025-12-11","st":"2025-09","ag":"18–75"},{"n":"NCT07088354","t":"Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy","s":"rec","p":"na","d":[1],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"escc"]],"po":"2025-07-28","u":"2025-07-28","st":"2025-03","ag":"18 and over"},{"n":"NCT07089199","t":"Tislelizumab Combined With Anlotinib and Nab-paclitaxel in II-III Resectable Non-small Cell Lung Cancer : A Prospective, Single-Arm, Phase II Study","s":"rec","p":"phase2","d":[4],"c":[27],"lc":[27],"a":"adult older","h":[124],"l":[[124,"lung"]],"po":"2025-07-28","u":"2026-10-13","st":"2025-07","ag":"18–75"},{"n":"NCT07090499","t":"A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors","s":"rec","p":"phase1","d":[1,4,5],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"escc"]],"po":"2025-07-29","u":"2026-11-05","st":"2025-08","ag":"18 and over"},{"n":"NCT07091305","t":"A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2025-07-29","u":"2026-06-11","st":"2025-10","ag":"18–75"},{"n":"NCT07093073","t":"Clinical Study of U01（ssCART-19） in Patients With B-Cell Lymphoma","s":"rec","p":"phase1","d":[19],"c":[5],"a":"child adult older","h":[162],"po":"2025-07-30","u":"2026-05-06","st":"2025-01","ag":"2–75"},{"n":"NCT07093411","t":"Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma","s":"rec","p":"earlyphase1","d":[19],"c":[2,17,39,31],"lc":[2],"a":"adult older","h":[3,64,68,97],"l":[[3,"lymph"]],"po":"2025-07-30","u":"2025-08-20","st":"2025-08","ag":"18–75"},{"n":"NCT07093710","t":"Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2025-07-30","u":"2025-12-31","st":"2025-08","ag":"18 and over"},{"n":"NCT07093788","t":"Super High-pressure Balloon Versus Intravascular Lithotripsy to Prepare Severely Calcified Coronary Lesions","s":"rec","p":"na","d":[31],"c":[28],"lc":[28],"a":"adult older","h":[78,119],"l":[[78,"cad"]],"po":"2025-07-30","u":"2026-03-10","st":"2025-09","ag":"18–80"},{"n":"NCT07093814","t":"A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma","s":"rec","p":"phase1phase2","d":[7],"c":[2,0,23,17,27,10,21,39,59],"a":"adult older","h":[124,53,70,68,54,122,104,50,171,294],"po":"2025-07-30","u":"2026-10-29","st":"2025-09","ag":"18–70"},{"n":"NCT07095023","t":"Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast Cancer","s":"rec","p":"na","d":[6],"c":[2,0,41,43,21,37],"lc":[0],"a":"adult older","h":[99,74,125,81,137,126],"l":[[99,"breast"]],"po":"2025-07-31","u":"2026-04-29","st":"2025-08","ag":"18–75"},{"n":"NCT07096869","t":"Bioequivalence Study of Paclitaxel Protein-bound Particles for Injectable Suspension (Albumin-bound) in Breast Cancer Patients","s":"rec","p":"phase1","d":[6],"c":[15],"a":"adult older","h":[27],"po":"2025-07-31","u":"2025-07-31","st":"2025-06","ag":"18–75"},{"n":"NCT07096882","t":"SDTM001 Injection as Adjuvant Therapy for NSCLC Patients After Radical Surgical Resection","s":"rec","p":"phase1","d":[4],"c":[22],"a":"adult older","h":[40],"po":"2025-07-31","u":"2025-07-31","st":"2025-07","ag":"18–70"},{"n":"NCT07098026","t":"Shenqi Fuwei Mixture Combined With Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric Cancer","s":"rec","p":"na","d":[3],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"gc"]],"po":"2025-08-01","u":"2025-08-01","st":"2025-05","ag":"18–75"},{"n":"NCT07099274","t":"Lparomlimab and Tuvonralimab Injection in Combination With TACE and Lenvatinib in the Treatment of Second-Line Therapy for Unresectable Intermediate-to-Advanced Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"hcc"]],"po":"2025-08-01","u":"2025-08-29","st":"2025-08","ag":"18 and over"},{"n":"NCT07100067","t":"LCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma","s":"rec","p":"na","d":[15],"c":[2,30,13],"a":"adult older","h":[69,12,295],"po":"2025-08-03","u":"2025-12-29","st":"2025-09","ag":"18 and over"},{"n":"NCT07100080","t":"Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)","s":"rec","p":"phase2phase3","d":[4],"c":[16,12,13],"a":"adult older","h":[36,30,84],"po":"2025-08-03","u":"2026-11-12","st":"2025-11","ag":"18 and over"},{"n":"NCT07100106","t":"A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer","s":"rec","p":"phase1phase2","d":[6],"c":[16,27,10,5,30],"a":"adult older","h":[9,58,57,50,30],"po":"2025-08-03","u":"2026-10-26","st":"2025-10","ag":"18 and over"},{"n":"NCT07100392","t":"Tauroursodeoxycholic Acid (TUDCA) Plus Camrelizumab and Regorafenib in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab","s":"rec","p":"phase2","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"hcc"]],"po":"2025-08-03","u":"2025-08-17","st":"2025-08","ag":"18 and over"},{"n":"NCT07100405","t":"TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment","s":"rec","p":"na","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"hcc"]],"po":"2025-08-03","u":"2025-08-17","st":"2025-08","ag":"18 and over"},{"n":"NCT07100600","t":"Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases","s":"rec","p":"phase2","d":[6],"c":[20],"lc":[20],"a":"adult older","x":"female","h":[37],"l":[[37,"breast"]],"po":"2025-08-03","u":"2026-10-13","st":"2025-08","ag":"18 and over"},{"n":"NCT07101679","t":"A Study of GnP RegimenCombined With Serplulimab and Stereotactic Body Radiation Therapy as First-line Treatment for Locally Advanced Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"panc"]],"po":"2025-08-03","u":"2025-08-07","st":"2025-04","ag":"18–75"},{"n":"NCT07101705","t":"An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies","s":"rec","p":"earlyphase1","d":[15,19],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"mm"]],"po":"2025-08-03","u":"2026-07-21","st":"2025-09","ag":"18–75"},{"n":"NCT07101744","t":"Iparomlimab and Tuvonralimab Combined With Nimotuzumab in Recurrent or Metastatic NPC After First-line Treatment Failure: A Single-arm Phase IIa Clinical Trial","s":"rec","p":"phase2","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2025-08-03","u":"2026-01-23","st":"2025-10","ag":"18–70"},{"n":"NCT07101770","t":"A Prediction Model in Pregnant Women With Aplastic Anemia","s":"rec","p":"na","d":[17],"c":[2],"lc":[2],"a":"adult","x":"female","h":[48],"l":[[48,"aa"]],"po":"2025-08-03","u":"2025-12-01","st":"2025-11","ag":"20–50"},{"n":"NCT07102901","t":"Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma","s":"rec","p":"phase2","d":[3],"c":[24,20],"a":"adult older","h":[25,45],"po":"2025-08-05","u":"2025-09-10","st":"2025-09","ag":"18–75"},{"n":"NCT07103668","t":"A Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients","s":"rec","p":"phase3","d":[3],"c":[2],"a":"adult older","h":[26],"po":"2025-08-05","u":"2025-10-23","st":"2025-08","ag":"18 and over"},{"n":"NCT07104058","t":"A Study on the Effect of MRD Detected by FAPI PET / CT on the Recurrence of IgG4-RD","s":"rec","p":"na","d":[26],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"igg4"]],"po":"2025-08-05","u":"2025-08-05","st":"2025-05","ag":"18–75"},{"n":"NCT07104214","t":"Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy","s":"rec","p":"na","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"gc"]],"po":"2025-08-05","u":"2026-03-11","st":"2025-08","ag":"18 and over"},{"n":"NCT07105579","t":"Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia","s":"rec","p":"phase2","d":[16],"c":[23],"lc":[23],"a":"child adult older","h":[46],"l":[[46,"ball"]],"po":"2025-08-06","u":"2025-08-06","st":"2025-08","ag":"14–65"},{"n":"NCT07106671","t":"A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma","s":"rec","p":"phase2","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2025-08-06","u":"2025-08-06","st":"2025-08","ag":"18 and over"},{"n":"NCT07106684","t":"ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Primary Plasma Cell Leukemia","s":"rec","p":"phase2","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2025-08-06","u":"2026-10-27","st":"2025-08","ag":"18–70"},{"n":"NCT07106710","t":"ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Ultra-High-Risk Multiple Myeloma","s":"rec","p":"phase2","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2025-08-06","u":"2026-10-27","st":"2025-08","ag":"18–70"},{"n":"NCT07106723","t":"Clinical Study of the Safety and Efficacy of ASCT Combined With CD7-CART in the Treatment of CD7+ TCL","s":"rec","p":"phase2","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"lymph"]],"po":"2025-08-06","u":"2025-08-06","st":"2025-06","ag":"18–65"},{"n":"NCT07106736","t":"MRD-Adaptive Guided Immunotherapy With CAR-T for Transplant-Ineligible Patients With Multiple Myeloma","s":"rec","p":"phase2","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2025-08-06","u":"2026-10-27","st":"2025-08","ag":"18–75"},{"n":"NCT07106749","t":"CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies","s":"rec","p":"phase1","d":[16,19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"ball"]],"po":"2025-08-06","u":"2025-08-06","st":"2025-06","ag":"18–70"},{"n":"NCT07106827","t":"A Study of GV20-0251 in Advanced or Refractory Solid Tumors","s":"rec","p":"phase1","d":[2,4,5],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"hcc"]],"po":"2025-08-06","u":"2025-11-24","st":"2025-09","ag":"18 and over"},{"n":"NCT07109323","t":"Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM","s":"rec","p":"phase1phase2","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2025-08-07","u":"2025-08-07","st":"2025-03","ag":"18–70"},{"n":"NCT07109401","t":"Perioperative Immunotherapy for Resectable Limited-Stage SCLC","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2025-08-07","u":"2025-08-07","st":"2025-03","ag":"18–75"},{"n":"NCT07109518","t":"uCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies","s":"rec","p":"phase1","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"lymph"]],"po":"2025-08-07","u":"2025-09-03","st":"2025-06","ag":"18–70"},{"n":"NCT07109531","t":"ASKC202 Combined With Limertinib Versus Platinum-based Chemotherapy in Treatment of Locally Advanced or Metastatic NSCLC With MET Amplification/Overexpression After Failure of EGFR-TKI Therapy","s":"rec","p":"phase3","d":[4],"c":[5],"a":"adult older","h":[65],"po":"2025-08-07","u":"2026-08-19","st":"2025-08","ag":"18 and over"},{"n":"NCT07110064","t":"QL1706+Lenvatinib+AG Regimen as First-line Treatment for Advanced Metastatic Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[28],"lc":[28],"a":"adult older","h":[60],"l":[[60,"panc"]],"po":"2025-08-07","u":"2026-01-02","st":"2025-09","ag":"18 and over"},{"n":"NCT07110103","t":"Golidocitinib With PD-1 Inhibitors as Maintenance Treatment for Previously Untreated ES-SCLC","s":"rec","p":"phase2","d":[4],"c":[2,1],"lc":[2],"a":"adult older","h":[23,167],"l":[[23,"lung"]],"po":"2025-08-07","u":"2026-02-27","st":"2025-10","ag":"18 and over"},{"n":"NCT07110415","t":"Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction","s":"rec","p":"phase4","d":[31],"c":[2,15,22,1,52,82,0,41,23,24,83,27,33,28,10,61,26,5,43,11,21,18,30,39,19,58,84,59],"a":"adult older","h":[123,206,124,169,120,94,296,15,82,194,49,46,125,27,280,55,210,118,185,98,183,156,28,297,215,172,142,196,137,193,90,97,298,299,300,301,96,171,302,303,304],"po":"2025-08-07","u":"2025-11-25","st":"2025-11","ag":"40–80"},{"n":"NCT07110571","t":"A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer","s":"rec","p":"phase2","d":[3],"c":[23,18],"a":"adult older","h":[44,24],"po":"2025-08-07","u":"2026-01-09","st":"2025-08","ag":"18–70"},{"n":"NCT07111520","t":"A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)","s":"rec","p":"phase1phase2","d":[4],"c":[15,22,1,16,0,17,27,9,26,5,18,4,30,13,38,14,31,32],"a":"adult older","h":[40,58,5,132,55,27,80,14,112,30,2,83,63,65,19,101,31,175,21,222,86,88],"po":"2025-08-08","u":"2026-11-13","st":"2025-09","ag":"18 and over"},{"n":"NCT07111832","t":"A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[2,5],"a":"adult older","x":"female","h":[74,272],"po":"2025-08-08","u":"2025-12-18","st":"2025-08","ag":"18–75"},{"n":"NCT07113613","t":"Prospective Study on Exemption of Tumor Bed Boost Radiotherapy for pCR Patients After Breast Conserving Surgery With Neoadjuvant Therapy","s":"rec","p":"phase2","d":[6],"c":[28],"lc":[28],"a":"adult older","x":"female","h":[78],"l":[[78,"breast"]],"po":"2025-08-11","u":"2025-08-11","st":"2025-01","ag":"30–75"},{"n":"NCT07114315","t":"A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[5,30],"a":"adult older","h":[6,58],"po":"2025-08-11","u":"2026-03-03","st":"2025-09","ag":"18–80"},{"n":"NCT07114601","t":"A Study of LY4257496 in Participants With Cancer (OMNIRAY)","s":"rec","p":"phase1","d":[3,6],"c":[2,30],"a":"adult older","h":[58,38],"po":"2025-08-11","u":"2026-11-04","st":"2025-08","ag":"18 and over"},{"n":"NCT07115108","t":"Effectiveness of High-Energy Density Enteral Nutrition for Enhancing Physical Growth and Cognitive Brain Development in Infants With Congenital Heart Disease","s":"rec","p":"na","d":[32],"c":[5],"lc":[5],"a":"child","h":[76],"l":[[76,"chd"]],"po":"2025-08-11","u":"2026-05-13","st":"2025-10","ag":"0 months–6 months"},{"n":"NCT07116083","t":"µQFR for Branch Stenosis After Single Stent in Bifurcation Lesions","s":"rec","p":"na","d":[31],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"cad"]],"po":"2025-08-11","u":"2026-02-02","st":"2025-08","ag":"18 and over"},{"n":"NCT07117045","t":"Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer","s":"rec","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[177],"l":[[177,"panc"]],"po":"2025-08-12","u":"2025-08-12","st":"2025-08","ag":"50 and over"},{"n":"NCT07117630","t":"An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2025-08-12","u":"2026-07-13","st":"2025-09","ag":"18 and over"},{"n":"NCT07117864","t":"Exploration of the Safety and Efficacy of T-DXd Concurrent With Brain Radiotherapy in Patients With Brain Metastases HER2-positive/HER2-low Advanced Breast Cancer","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2025-08-12","u":"2025-08-12","st":"2025-07","ag":"18–75"},{"n":"NCT07117890","t":"Sunvozertinib Treatment in Untreated Advanced NSCLC With EGFR Uncommon Mutations","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2025-08-12","u":"2025-12-24","st":"2025-02","ag":"18 and over"},{"n":"NCT07118319","t":"The Safety, Tolerability and Preliminary Efficacy of Derived Motor Neuron Progenitor Cells (XS228CN) in Subjects With Amyotrophic Lateral Sclerosis","s":"rec","p":"phase1","d":[39],"c":[2],"a":"adult older","h":[115],"po":"2025-08-12","u":"2025-11-21","st":"2025-09","ag":"18–75"},{"n":"NCT07118930","t":"Study of Sivelestat Sodium in OPCABG","s":"rec","p":"phase2","d":[31],"c":[40],"lc":[40],"a":"adult older","h":[110],"l":[[110,"cad"]],"po":"2025-08-12","u":"2025-08-12","st":"2025-08","ag":"18–75"},{"n":"NCT07120282","t":"Study to Evaluate the Efficacy and Safety of Adjuvant Tislelizumab in High-Risk Stage I NSCLC","s":"rec","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2025-08-13","u":"2026-03-09","st":"2025-10","ag":"18 and over"},{"n":"NCT07120698","t":"Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung)","s":"rec","p":"phase2","d":[4],"c":[0],"a":"adult older","h":[43],"po":"2025-08-13","u":"2026-01-05","st":"2025-11","ag":"28–75"},{"n":"NCT07121413","t":"A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis","s":"rec","p":"phase2","d":[37],"c":[22,0,23,65,9,28,5,30,31,20],"a":"adult older","h":[60,132,98,59,56,92,14,64,65,185,205,139],"po":"2025-08-13","u":"2026-02-11","st":"2025-11","ag":"40 and over"},{"n":"NCT07122687","t":"IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[11],"a":"adult older","h":[18],"po":"2025-08-14","u":"2026-07-27","st":"2025-08","ag":"18–75"},{"n":"NCT07123545","t":"Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma","s":"rec","p":"phase1phase2","d":[2],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"hcc"]],"po":"2025-08-14","u":"2025-08-14","st":"2025-08","ag":"18–75"},{"n":"NCT07124754","t":"Multimodal Deep Learning for Lymph Node Metastasis Prediction and Physician Performance Assessment in T1 Gastric Cancer","s":"rec","p":"na","d":[3],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"gc"]],"po":"2025-08-15","u":"2025-08-15","st":"2025-01","ag":"18 and over"},{"n":"NCT07124936","t":"A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[2,15,8,22,16,0,23,27,47,9,10,11,4,12,13,39,20],"a":"adult older","h":[40,53,25,74,46,36,12,37,27,111,143,187,30,57,14,13,50,135,84],"po":"2025-08-15","u":"2025-08-15","st":"2025-07","ag":"18–75"},{"n":"NCT07125950","t":"SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"breast"]],"po":"2025-08-15","u":"2026-10-15","st":"2025-10","ag":"18 and over"},{"n":"NCT07126678","t":"Fixed-Duration Zanubrutinib, Bendamustine, and Obinutuzumab (ZBG) in Treatment-Naïve Advanced Stage Follicular Lymphoma","s":"rec","p":"na","d":[19],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"lymph"]],"po":"2025-08-17","u":"2025-08-17","st":"2025-07","ag":"18–75"},{"n":"NCT07127822","t":"Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[2,22,24,26,18,12,30,39,20],"lc":[2],"a":"adult older","h":[74,40,25,55,24,58,111,45,84],"l":[[74,"gc"]],"po":"2025-08-17","u":"2026-08-05","st":"2025-12","ag":"18 and over"},{"n":"NCT07130383","t":"A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors","s":"rec","p":"phase2","d":[6],"c":[5],"a":"adult older","h":[9],"po":"2025-08-19","u":"2026-10-09","st":"2025-09","ag":"18–75"},{"n":"NCT07131319","t":"SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC","s":"rec","p":"phase2phase3","d":[4],"c":[9],"lc":[9],"a":"adult older","h":[80],"l":[[80,"lung"]],"po":"2025-08-20","u":"2026-11-16","st":"2025-04","ag":"18–85"},{"n":"NCT07131514","t":"HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"panc"]],"po":"2025-08-20","u":"2026-05-27","st":"2025-08","ag":"18–80"},{"n":"NCT07134153","t":"Phase I/II Study of Intrathecal/Ommaya T-DXd in HER2-Expressing Breast Cancer With Leptomeningeal/Brain Metastases","s":"rec","p":"phase1phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2025-08-21","u":"2026-10-26","st":"2025-05","ag":"18 and over"},{"n":"NCT07134660","t":"Thoracic Surgery Intercostal Block Trial With Liposomal vs. Hydrochloride Bupivacaine","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2025-08-21","u":"2026-03-30","st":"2025-09","ag":"18–80"},{"n":"NCT07135856","t":"Sleeve Lobectomy Following Neoadjuvant Therapy in NSCLC","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2025-08-22","u":"2025-12-31","st":"2025-09","ag":"18 and over"},{"n":"NCT07136519","t":"Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma","s":"rec","p":"phase2","d":[0],"c":[45],"lc":[45],"a":"adult older","h":[129],"l":[[129,"npc"]],"po":"2025-08-22","u":"2026-10-29","st":"2025-07","ag":"18–65"},{"n":"NCT07137052","t":"Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinoma","s":"rec","p":"na","d":[0],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"npc"]],"po":"2025-08-22","u":"2026-08-27","st":"2025-08","ag":"18–70"},{"n":"NCT07138547","t":"GSL Synthetase Inhibitor Eliglustat Combined With CD30 Target Immunotherapy for the Treatment of of CD30+ Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2025-08-24","u":"2026-01-02","st":"2025-12","ag":"18–75"},{"n":"NCT07138755","t":"The Efficacy and Safety of the Combination of PD-1 With Chemotherapy and Adaptive Radiotherapy Strategy in the Treatment of Stage III Non-small Cell Lung Cancer Patients","s":"rec","p":"phase2","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[20,13],"l":[[20,"lung"]],"po":"2025-08-24","u":"2026-09-02","st":"2025-08","ag":"18–75"},{"n":"NCT07139418","t":"The Clinical Significance of Examining Metastatic Lymph Nodes in Individual Gastric Mesenteries in the Patients With Gastric Cancer Undergoing Gastrectomy","s":"rec","p":"na","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"gc"]],"po":"2025-08-24","u":"2026-03-11","st":"2025-10","ag":"18–85"},{"n":"NCT07139873","t":"A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)","s":"rec","p":"phase3","d":[19],"c":[28,30],"a":"adult older","h":[78,69],"po":"2025-08-24","u":"2026-06-03","st":"2025-09","ag":"18 and over"},{"n":"NCT07141056","t":"The Impact of Emotional Stress on Immunotherapy Outcomes in Liver Cancer Patients: A Multi-Cohort Study","s":"rec","p":"na","d":[2],"c":[57,45],"lc":[57],"a":"adult older","h":[170,129],"l":[[170,"hcc"]],"po":"2025-08-26","u":"2025-08-26","st":"2025-01","ag":"18 and over"},{"n":"NCT07141264","t":"Adebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance Therapy","s":"rec","p":"phase2","d":[4],"c":[39],"lc":[39],"a":"adult older","h":[122],"l":[[122,"lung"]],"po":"2025-08-26","u":"2025-12-30","st":"2025-08","ag":"18–75"},{"n":"NCT07142122","t":"Safety Comparison of Total Laparoscopic Proximal Gastrectomy With or Without Preservation of the Celiac Branch of the Vagus Nerve for Early Upper Gastric Cancer: A Randomized Controlled Clinical Trial","s":"rec","p":"na","d":[3],"c":[16],"lc":[16],"a":"adult older","h":[30],"l":[[30,"gc"]],"po":"2025-08-26","u":"2025-08-26","st":"2025-01","ag":"18–75"},{"n":"NCT07143045","t":"A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases","s":"rec","p":"na","d":[4],"c":[15,8,22,1,63,16,0,24,17,47,9,28,10,26,11,21,12,30,13,7,32,20],"a":"adult older","h":[58,43,11,12,45,118,55,13,47,27,14,37,15,112,30,2,135,63,106,50,8,276,198,22],"po":"2025-08-27","u":"2026-02-09","st":"2025-12","ag":"18 and over"},{"n":"NCT07144280","t":"A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)","s":"rec","p":"phase3","d":[4],"c":[2,8,49,22,1,16,0,23,24,17,27,9,28,10,5,29,13,39,31,20],"a":"adult older","h":[40,9,78,44,111,74,45,36,13,14,37,70,112,30,2,68,83,64,65,145,50,39,66],"po":"2025-08-27","u":"2026-11-05","st":"2025-09","ag":"18 and over"},{"n":"NCT07144735","t":"Allogeneic γδT Cells in Glioblastoma","s":"rec","p":"na","d":[7],"c":[2,20],"lc":[2],"a":"adult older","h":[115,200],"l":[[115,"glioma"]],"po":"2025-08-27","u":"2025-08-27","st":"2025-04","ag":"18–70"},{"n":"NCT07146061","t":"pCAD-POAF 3 Year Follow-up","s":"rec","p":"na","d":[31],"c":[2],"a":"adult older","h":[213],"po":"2025-08-28","u":"2026-10-01","st":"2025-08","ag":"18–85"},{"n":"NCT07147101","t":"Different First-line Immunotherapy for Advancer Hepatocellular Carcinoma: A Prospective Observational Study on Efficacy and Immune Microenvironment","s":"rec","p":"na","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"hcc"]],"po":"2025-08-28","u":"2026-04-21","st":"2025-09","ag":"18 and over"},{"n":"NCT07147335","t":"The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients","s":"rec","p":"na","d":[2],"c":[80],"lc":[80],"a":"adult older","h":[291],"l":[[291,"hcc"]],"po":"2025-08-29","u":"2025-08-29","st":"2025-05","ag":"18–75"},{"n":"NCT07148791","t":"Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease","s":"rec","p":"phase2","d":[26],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"igg4"]],"po":"2025-08-29","u":"2025-09-03","st":"2025-09","ag":"18–75"},{"n":"NCT07149675","t":"PBC Long-term Outcomes Study","s":"rec","p":"na","d":[50],"c":[2],"lc":[2],"a":"child adult older","h":[39],"l":[[39,"pbc"]],"po":"2025-09-02","u":"2025-09-02","st":"2025-05","ag":"Not stated"},{"n":"NCT07150208","t":"T-DXd With or Without Bevacizumab for HER2-low Breast Cancer With Brain Metastasis","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2025-09-02","u":"2026-09-25","st":"2025-10","ag":"18–70"},{"n":"NCT07150624","t":"The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine","s":"rec","p":"phase4","d":[2],"c":[17],"lc":[17],"a":"adult older","h":[68],"l":[[68,"hcc"]],"po":"2025-09-02","u":"2026-05-11","st":"2025-11","ag":"18–70"},{"n":"NCT07150663","t":"Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[13],"a":"adult older","h":[36],"po":"2025-09-02","u":"2025-09-08","st":"2025-08","ag":"18–85"},{"n":"NCT07152041","t":"Newly-diagnosed Pediatric Ph-positive B-ALL Protocol","s":"rec","p":"phase3","d":[16],"c":[8,22,1,16,0,41,27,9,28,26,5,21,4,30,13],"lc":[30],"a":"child adult","h":[69,70,36,137,140,12,249,203,20,124,1,250,49,251,252,253,255,55,76,256,257],"l":[[69,"ball"]],"po":"2025-09-03","u":"2025-09-03","st":"2025-03","ag":"1 month–18"},{"n":"NCT07152782","t":"T-DXd With or Without Neratinib for HER2 Positive Breast Cancer With Brain Metastasis","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2025-09-03","u":"2026-09-28","st":"2025-09","ag":"18–70"},{"n":"NCT07153068","t":"SupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies","s":"rec","p":"phase1phase2","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"lymph"]],"po":"2025-09-03","u":"2025-12-15","st":"2025-06","ag":"18–70"},{"n":"NCT07154069","t":"Adaptive Immunotherapy for Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2025-09-04","u":"2025-11-25","st":"2025-11","ag":"18–65"},{"n":"NCT07154082","t":"Apatinib Mesylate and Camrelizumab Combined With TACE as Neoadjuvant Therapy for Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2025-09-04","u":"2025-09-04","st":"2025-12","ag":"18–70"},{"n":"NCT07154264","t":"A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10)","s":"rec","p":"phase2","d":[19],"c":[2,15,8,49,22,0,23,17,9,40,11,13,68,20],"a":"adult older","h":[40,46,12,115,37,110,27,70,143,145,0,14,13,214,88],"po":"2025-09-04","u":"2026-06-22","st":"2025-09","ag":"18 and over"},{"n":"NCT07154355","t":"Community Exercise Treating Effect on Cardiopulmonary Disease Patients","s":"rec","p":"na","d":[31],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"cad"]],"po":"2025-09-04","u":"2025-09-04","st":"2025-01","ag":"18–85"},{"n":"NCT07154563","t":"Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast Cancer","s":"rec","p":"na","d":[6],"c":[47],"lc":[47],"a":"adult older","x":"female","h":[135],"l":[[135,"breast"]],"po":"2025-09-04","u":"2025-09-04","st":"2025-02","ag":"18–75"},{"n":"NCT07154706","t":"Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)","s":"rec","p":"phase3","d":[4],"c":[2,22,0,23,27,25,9,28,10,40,5,30,13,39,20],"a":"adult older","h":[40,56,53,44,25,132,6,111,74,36,14,48,60,65,50,169,67,260,199],"po":"2025-09-04","u":"2026-05-19","st":"2025-08","ag":"18 and over"},{"n":"NCT07155174","t":"A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[22,9,5,13,20],"a":"adult older","h":[40,56,12,14,37,65],"po":"2025-09-04","u":"2026-10-27","st":"2025-11","ag":"18 and over"},{"n":"NCT07155187","t":"A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer","s":"rec","p":"phase2phase3","d":[4],"c":[0,9,5,34],"a":"adult older","h":[56,43,14,72],"po":"2025-09-04","u":"2026-10-05","st":"2025-12","ag":"18 and over"},{"n":"NCT07156253","t":"Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors","s":"rec","p":"phase1","d":[6],"c":[5],"a":"adult older","h":[9],"po":"2025-09-05","u":"2025-09-05","st":"2025-08","ag":"18 and over"},{"n":"NCT07157969","t":"ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC","s":"rec","p":"phase2","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"hcc"]],"po":"2025-09-05","u":"2025-12-01","st":"2025-02","ag":"18 and over"},{"n":"NCT07159620","t":"Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients","s":"rec","p":"phase2","d":[19],"c":[4],"lc":[4],"a":"child adult older","h":[5],"l":[[5,"lymph"]],"po":"2025-09-08","u":"2026-10-16","st":"2025-09","ag":"14–75"},{"n":"NCT07162012","t":"Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma","s":"rec","p":"earlyphase1","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[121],"l":[[121,"lymph"]],"po":"2025-09-09","u":"2025-12-02","st":"2025-09","ag":"18–70"},{"n":"NCT07162298","t":"Dragon Boat Race Versus Family Unsupervised Training to Improve the Physical Function and Quality of Life in Breast Cancer Patients","s":"rec","p":"phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[46],"l":[[46,"breast"]],"po":"2025-09-09","u":"2025-09-09","st":"2025-04","ag":"18–75"},{"n":"NCT07162506","t":"dCRT vs. Surgery in Resectable ESCC Patients Achieving cCR/PR After Induction Chemoimmunotherapy","s":"rec","p":"phase2","d":[1],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"escc"]],"po":"2025-09-09","u":"2026-10-15","st":"2025-11","ag":"18–75"},{"n":"NCT07164170","t":"A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib","s":"rec","p":"phase2","d":[4],"c":[2,22,16,0,24,17,28,10,5,11,13,39,20],"a":"adult older","h":[40,23,42,56,111,74,45,118,36,37,112,30,49,120,50],"po":"2025-09-10","u":"2026-06-17","st":"2025-09","ag":"18 and over"},{"n":"NCT07165769","t":"Zanubrutinib, Obinutuzumab, and Lenalidomide (ZGR) in the Treatment of Newly Diagnosed Splenic B-cell Lymphoma With Prominent Nucleoli (SBLPN): A Prospective, Open-label, Single-arm Clinical Trial","s":"rec","p":"phase2","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"lymph"]],"po":"2025-09-10","u":"2025-12-18","st":"2025-09","ag":"18–80"},{"n":"NCT07165847","t":"Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)","s":"rec","p":"phase2","d":[3],"c":[1],"lc":[1],"a":"adult older","h":[17],"l":[[17,"gc"]],"po":"2025-09-10","u":"2025-09-10","st":"2025-07","ag":"18 and over"},{"n":"NCT07166003","t":"Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2025-09-10","u":"2025-09-10","st":"2025-04","ag":"18–79"},{"n":"NCT07166263","t":"Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer","s":"rec","p":"earlyphase1","d":[3],"c":[28],"a":"adult older","h":[60],"po":"2025-09-10","u":"2026-10-01","st":"2025-10","ag":"18 and over"},{"n":"NCT07167264","t":"PGHD-AI Intelligent Model for the Nutritional Assessment and Intervention of Patients After Radical Surgery for Pancreatic Cancer.","s":"rec","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[121],"l":[[121,"panc"]],"po":"2025-09-11","u":"2025-09-11","st":"2025-07","ag":"18–80"},{"n":"NCT07168317","t":"Tislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the Treatment of New Diagnosed AITL","s":"rec","p":"phase2","d":[19],"c":[31],"lc":[31],"a":"adult older","h":[64],"l":[[64,"lymph"]],"po":"2025-09-11","u":"2025-09-11","st":"2025-08","ag":"18 and over"},{"n":"NCT07168980","t":"Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents","s":"rec","p":"phase2phase3","d":[19],"c":[5],"a":"child adult","h":[91],"po":"2025-09-11","u":"2026-06-04","st":"2025-07","ag":"Up to 18"},{"n":"NCT07169201","t":"High-Resolution CT for Heart","s":"rec","p":"na","d":[31],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"cad"]],"po":"2025-09-11","u":"2026-03-17","st":"2025-09","ag":"18 and over"},{"n":"NCT07169500","t":"Clinical Study on the Safety and Efficacy of BCMA-CART±ASCT in Treating Young Multiple Myeloma Patients","s":"rec","p":"phase1phase2","d":[15],"c":[30],"lc":[30],"a":"adult","h":[69],"l":[[69,"mm"]],"po":"2025-09-11","u":"2026-03-02","st":"2025-03","ag":"18–50"},{"n":"NCT07169552","t":"HC010 in First-line PD-L1 Positive Advanced NSCLC Patients","s":"rec","p":"phase2","d":[4],"c":[5],"a":"adult older","h":[65],"po":"2025-09-11","u":"2025-12-17","st":"2025-12","ag":"18 and over"},{"n":"NCT07169994","t":"A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors","s":"rec","p":"phase1phase2","d":[4,6],"c":[48,22,16,0,24,17,36,70,9,28,5,11,12,30,38],"a":"adult older","h":[53,58,9,78,45,30,68,18,98,116,84,86,87,150,226],"po":"2025-09-12","u":"2025-09-12","st":"2025-09","ag":"18–75"},{"n":"NCT07170345","t":"Computer-Aided Diagnosis for Hepatocellular Carcinoma Microvascular Invasion","s":"rec","p":"na","d":[2],"c":[2,22,16,0,10,5,11,37,20,59],"a":"adult","h":[40,277,15,81,190,181,38,143,0,171,92,107,305],"po":"2025-09-12","u":"2025-09-12","st":"2025-09","ag":"18–18"},{"n":"NCT07171606","t":"A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients","s":"rec","p":"phase2","d":[4],"c":[5],"a":"adult older","h":[56],"po":"2025-09-12","u":"2025-12-18","st":"2025-10","ag":"18–75"},{"n":"NCT07173387","t":"Stereotactic Body Radiotherapy and NALIRIFOX for Locally Advanced Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[27],"lc":[27],"a":"adult older","h":[57],"l":[[57,"panc"]],"po":"2025-09-15","u":"2026-10-13","st":"2025-10","ag":"18–75"},{"n":"NCT07173751","t":"ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[17,27,33,25,9,12,13,39,20],"a":"adult older","h":[25,133,57,68,142,84,247,239,67],"po":"2025-09-15","u":"2026-10-30","st":"2025-10","ag":"18 and over"},{"n":"NCT07174336","t":"A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)","s":"rec","p":"phase3","d":[6],"c":[48,2,15,8,22,16,0,24,5,43,30,13],"a":"adult older","h":[9,58,53,45,36,74,43,12,125,11,27,140,98,150],"po":"2025-09-15","u":"2026-11-04","st":"2025-12","ag":"18 and over"},{"n":"NCT07174908","t":"A Phase 3 Study of IN10018 in Combination With D-1553 Versus Standard Therapy for First Line Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation","s":"rec","p":"phase3","d":[4],"c":[2,8,0,23,9,28,5,13,20],"a":"adult older","h":[42,44,25,12,74,127,13,14,37,49],"po":"2025-09-16","u":"2026-11-12","st":"2025-09","ag":"18–80"},{"n":"NCT07175155","t":"Combination of COMBO Endoscopy Oropharyngeal Airway and HFNC Oxygenation in Sedated Gastrointestinal Endoscopy for Morbidly Obese Patients","s":"rec","p":"na","d":[3],"c":[2,23,29],"lc":[23],"a":"adult older","h":[46,29,66],"l":[[46,"gc"]],"po":"2025-09-16","u":"2026-03-11","st":"2025-10","ag":"18 and over"},{"n":"NCT07175220","t":"Phase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Cancer Subjects","s":"rec","p":"phase2","d":[4],"c":[0],"a":"adult older","h":[53],"po":"2025-09-16","u":"2025-11-18","st":"2025-10","ag":"18–75"},{"n":"NCT07176624","t":"The PRE-VAIL Study","s":"rec","p":"na","d":[3],"c":[15],"lc":[15],"a":"adult older","h":[27],"l":[[27,"gc"]],"po":"2025-09-16","u":"2026-02-09","st":"2025-09","ag":"18 and over"},{"n":"NCT07176650","t":"Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma","s":"rec","p":"phase1","d":[2],"c":[2,55,15,22,16,0,6,23,24,17,9,28,10,5,11,18,30,13,39,20],"a":"adult older","h":[6,36,25,50,12,70,111,78,23,80,68,58,82,27,38,143,45,30,9,7,164,37,24,47,18,116,19],"po":"2025-09-16","u":"2026-03-16","st":"2025-11","ag":"18–65"},{"n":"NCT07177443","t":"Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"npc"]],"po":"2025-09-17","u":"2026-09-17","st":"2025-09","ag":"18–65"},{"n":"NCT07177794","t":"Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCC","s":"rec","p":"phase3","d":[1],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"escc"]],"po":"2025-09-17","u":"2026-04-21","st":"2025-09","ag":"18–75"},{"n":"NCT07178171","t":"A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC","s":"rec","p":"phase1","d":[6],"c":[39],"lc":[39],"a":"adult older","x":"female","h":[131],"l":[[131,"breast"]],"po":"2025-09-17","u":"2025-11-24","st":"2025-11","ag":"18–70"},{"n":"NCT07178795","t":"A Study of BL-M07D1 vs Pembrolizumab-platinum Chemotherapy in First-line Treatment of HER2-mutant Advanced or Metastatic Non-squamous NSCLC","s":"rec","p":"phase3","d":[4],"c":[0],"a":"adult older","h":[53],"po":"2025-09-17","u":"2025-11-17","st":"2025-09","ag":"18–75"},{"n":"NCT07179679","t":"A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell Tumors","s":"rec","p":"phase1","d":[15],"c":[50,1,0,9,51,28,5,4,39],"a":"adult older","h":[78,6,60,111,149,70,43,14,2,187,146],"po":"2025-09-18","u":"2025-12-11","st":"2025-12","ag":"18–75"},{"n":"NCT07179900","t":"Radiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"hcc"]],"po":"2025-09-18","u":"2026-08-03","st":"2025-03","ag":"18 and over"},{"n":"NCT07180056","t":"Adjuvant CDK4/6 Inhibitor Use in HR+/HER2- Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"breast"]],"po":"2025-09-18","u":"2025-11-19","st":"2025-08","ag":"18 and over"},{"n":"NCT07180082","t":"Continuous or Intermittent Pyrotinib for HER2-positive Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"breast"]],"po":"2025-09-18","u":"2025-11-18","st":"2025-08","ag":"18 and over"},{"n":"NCT07180160","t":"Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[41],"l":[[41,"breast"]],"po":"2025-09-18","u":"2025-11-18","st":"2025-09","ag":"18 and over"},{"n":"NCT07180264","t":"Trastuzumab Deruxtecan in Advanced Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"breast"]],"po":"2025-09-18","u":"2025-11-18","st":"2025-08","ag":"18 and over"},{"n":"NCT07181473","t":"A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors","s":"rec","p":"phase1","d":[4],"c":[23,5,13,20],"a":"adult older","h":[12,37,82,65],"po":"2025-09-18","u":"2026-01-12","st":"2025-08","ag":"18 and over"},{"n":"NCT07181499","t":"Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients With Resistance to Third-Generation EGFR-TKI","s":"rec","p":"phase2","d":[4],"c":[0,59],"a":"adult older","h":[53,171],"po":"2025-09-18","u":"2025-09-30","st":"2025-09","ag":"18 and over"},{"n":"NCT07181512","t":"Deep Learning CAD Screening on Chest CT","s":"rec","p":"na","d":[31],"c":[23,61],"a":"adult older","h":[182,275],"po":"2025-09-18","u":"2026-02-17","st":"2025-09","ag":"18 and over"},{"n":"NCT07182682","t":"A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical Surgery","s":"rec","p":"phase3","d":[4],"c":[2,15,8,22,16,0,23,24,17,27,47,28,10,5,11,12,29,30,13,39,31,20],"a":"adult older","h":[40,23,42,56,53,57,58,9,78,38,44,25,132,6,11,12,111,74,45,118,46,59,13,54,47,27,37,140,61,30,135,18,83,62,64,65,19,50,169,99,20,66,95,71,276,84,88],"po":"2025-09-19","u":"2025-12-15","st":"2025-12","ag":"18 and over"},{"n":"NCT07182721","t":"SKB264 Plus Inetetamab in HER2-Positive Metastatic Breast Cancer Patients Progressing After T-DXd Treatment","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2025-09-19","u":"2026-07-15","st":"2025-09","ag":"18 and over"},{"n":"NCT07183150","t":"The Possible Range of No.4sb Lymph Node Dissection of Locally Advanced Distal Gastric Cancer","s":"rec","p":"na","d":[3],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"gc"]],"po":"2025-09-19","u":"2025-09-19","st":"2025-08","ag":"18–80"},{"n":"NCT07185373","t":"Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL","s":"rec","p":"phase2phase3","d":[19],"c":[2,16,0,27,9,5,39,20],"lc":[5],"a":"adult older","h":[103,115,124,37,41,162,136,177,14,122,99,71],"l":[[103,"lymph"]],"po":"2025-09-22","u":"2026-08-19","st":"2025-10","ag":"18–75"},{"n":"NCT07185997","t":"Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations","s":"rec","p":"phase3","d":[4],"c":[2,8,22,1,52,63,16,0,23,24,17,65,27,47,25,36,9,28,10,40,26,5,43,11,18,12,30,42,13,14,20],"a":"adult older","h":[40,23,42,56,58,78,44,25,11,110,12,74,45,118,24,46,55,13,47,79,14,48,37,70,60,61,30,135,49,68,155,18,296,83,125,50,169,20,114,205,84,21,87,198,67],"po":"2025-09-22","u":"2026-11-02","st":"2025-12","ag":"18 and over"},{"n":"NCT07187440","t":"A Study of Agalsidase Alfa Enyzme Replacement Therapy in Chinese Children and Adults With Fabry Disease","s":"rec","p":"na","d":[41],"c":[2,22,16,23,24,17,28,43,21,18,4,12,30,39],"a":"child adult older","h":[29,40,5,38,68,186,78,97,115,169,32,111,60,54,160,184,206,223],"po":"2025-09-23","u":"2026-01-02","st":"2025-11","ag":"7 and over"},{"n":"NCT07188012","t":"Safety and Dystrophin Expression of SPOT-03 in Duchenne Muscular Dystrophy (DMD) Patients","s":"rec","p":"earlyphase1","d":[43],"c":[5],"a":"child","x":"male","h":[91],"po":"2025-09-23","u":"2026-11-05","st":"2025-08","ag":"2–7"},{"n":"NCT07188077","t":"Metabolic and Immunomic Differential Analysis of Primary Central Nervous System Diffuse Large B-Cell Lymphoma","s":"rec","p":"na","d":[19],"c":[16],"lc":[16],"a":"adult older","h":[136],"l":[[136,"lymph"]],"po":"2025-09-23","u":"2025-11-18","st":"2025-03","ag":"18–75"},{"n":"NCT07188103","t":"Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[17],"lc":[17],"a":"adult older","h":[68],"l":[[68,"escc"]],"po":"2025-09-23","u":"2025-09-23","st":"2025-07","ag":"18–80"},{"n":"NCT07188584","t":"Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer","s":"rec","p":"phase3","d":[0],"c":[59],"lc":[59],"a":"adult older","h":[171],"l":[[171,"npc"]],"po":"2025-09-23","u":"2025-12-09","st":"2025-08","ag":"18–70"},{"n":"NCT07188610","t":"PA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma","s":"rec","p":"phase2","d":[19],"c":[2,22,0,23,17,28,5,4,30,13,31,20],"a":"adult older","h":[40,53,25,78,46,5,12,64,69,115,37,43,162,48,68],"po":"2025-09-23","u":"2026-07-06","st":"2025-09","ag":"18 and over"},{"n":"NCT07189065","t":"A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[2,15,8,22,1,52,16,0,23,17,25,36,9,28,10,5,11,18,4,12,30,13,7,31,20],"a":"adult older","h":[25,46,5,12,54,161,64,69,9,115,8,37,24,27,43,79,155,70,47,15,10,44,92,68,143,30,14,13,116,127,50,18,306,22,19,84,87,67],"po":"2025-09-23","u":"2025-12-16","st":"2025-11","ag":"18 and over"},{"n":"NCT07189455","t":"Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2025-09-24","u":"2026-01-05","st":"2025-12","ag":"18–75"},{"n":"NCT07190248","t":"A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)","s":"rec","p":"phase3","d":[4],"c":[2,8,22,1,16,0,23,17,25,9,28,10,5,12,29,13,39,7,20],"a":"adult older","h":[40,42,56,38,44,11,111,74,36,46,13,47,37,82,60,30,2,49,0,136,19,50,66,95,8,116,84,88,51],"po":"2025-09-24","u":"2026-11-12","st":"2025-10","ag":"18 and over"},{"n":"NCT07191431","t":"A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma（SELINA）","s":"rec","p":"na","d":[19],"c":[5],"lc":[5],"a":"child adult older","h":[123],"l":[[123,"lymph"]],"po":"2025-09-24","u":"2025-09-24","st":"2025-09","ag":"14–80"},{"n":"NCT07192185","t":"Systemic Chemotherapy With FOLFOX Plus Atezolizumab & Bevacizumab for Patients With Advanced HCC Who Previously Received Atezolizumab & Bevacizumab","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"hcc"]],"po":"2025-09-25","u":"2025-09-25","st":"2025-09","ag":"18–75"},{"n":"NCT07193628","t":"B7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory Glioblastoma","s":"rec","p":"phase1","d":[7],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"glioma"]],"po":"2025-09-26","u":"2025-11-18","st":"2025-09","ag":"18–75"},{"n":"NCT07193641","t":"A Study on Using SFRT With Standard Treatment for Oligoprogressive NSCLC","s":"rec","p":"phase2","d":[4],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lung"]],"po":"2025-09-26","u":"2025-09-26","st":"2025-06","ag":"18 and over"},{"n":"NCT07193654","t":"Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread","s":"rec","p":"phase2","d":[7],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"glioma"]],"po":"2025-09-26","u":"2025-09-26","st":"2025-04","ag":"18–75"},{"n":"NCT07194005","t":"Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"gc"]],"po":"2025-09-26","u":"2025-09-26","st":"2025-09","ag":"18–70"},{"n":"NCT07195084","t":"To Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[17],"a":"adult older","h":[231,68],"l":[[231,"lung"]],"po":"2025-09-26","u":"2026-04-13","st":"2025-09","ag":"18 and over"},{"n":"NCT07198230","t":"Drug-Eluting Bead-Based Transarterial Chemoembolization (DEB-TACE) as a Local Salvage Therapy for Large Lesions in Relapsed and Refractory Diffuse Large B-Cell Lymphoma","s":"rec","p":"na","d":[19],"c":[16],"lc":[16],"a":"adult older","h":[136],"l":[[136,"lymph"]],"po":"2025-09-30","u":"2025-11-18","st":"2025-03","ag":"18–75"},{"n":"NCT07198256","t":"AI-assisted Diagnosis of Malignant Brain Tumors","s":"rec","p":"na","d":[7,19],"c":[23],"lc":[23],"a":"adult older","h":[54,44],"l":[[54,"glioma"]],"po":"2025-09-30","u":"2025-09-30","st":"2025-09","ag":"18–100"},{"n":"NCT07198659","t":"A Single-Arm Investigator-Initiated Tria (IIT) Evaluating the Safety and Preliminary Efficacy of Autologous Drug-Loaded Neutrophils (NeuMed) in Patients With Unresectable Pancreatic Cancer","s":"rec","p":"earlyphase1","d":[5],"c":[39],"lc":[39],"a":"adult older","h":[131],"l":[[131,"panc"]],"po":"2025-09-30","u":"2025-09-30","st":"2025-07","ag":"18–70"},{"n":"NCT07198841","t":"IBI351 Plus Cetuximab β in Untreated Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation","s":"rec","p":"phase2","d":[4],"c":[2,63,0,9,10,18],"a":"adult older","h":[43,26,24,80,14,50,198],"po":"2025-09-30","u":"2026-03-11","st":"2025-11","ag":"18–75"},{"n":"NCT07199296","t":"Orelabrutinib and Rituximab With Optional Autologous Hematopoietic Stem Cell Transplantation in MCL Treatment","s":"rec","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"child adult older","h":[123],"l":[[123,"lymph"]],"po":"2025-09-30","u":"2025-09-30","st":"2025-07","ag":"14 and over"},{"n":"NCT07199959","t":"Study on the Mechanism of Acquired Resistance of Entrectinib","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2025-09-30","u":"2025-09-30","st":"2025-01","ag":"18 and over"},{"n":"NCT07200375","t":"An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell Lymphoma","s":"rec","p":"na","d":[19],"c":[2,15,22,0,24,27,9,61,5,30,37,13,39,19,20],"a":"adult older","h":[40,123,23,36,58,12,115,37,45,27,43,80,48,111,28,81,57,182],"po":"2025-10-01","u":"2026-11-05","st":"2025-09","ag":"18 and over"},{"n":"NCT07202364","t":"A Study of YL202 in Patients With Advanced Solid Tumors","s":"rec","p":"phase2","d":[4],"c":[8],"a":"adult older","h":[13],"po":"2025-10-01","u":"2026-10-14","st":"2025-08","ag":"18 and over"},{"n":"NCT07203404","t":"A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.","s":"rec","p":"earlyphase1","d":[46],"c":[5],"a":"adult older","h":[6],"po":"2025-10-02","u":"2026-08-03","st":"2025-07","ag":"18–75"},{"n":"NCT07205315","t":"A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia","s":"rec","p":"earlyphase1","d":[16,19],"c":[30],"a":"adult older","h":[69],"po":"2025-10-03","u":"2026-07-20","st":"2025-09","ag":"18–75"},{"n":"NCT07206498","t":"A Study to Evaluate Safety and Efficacy of WSD0922-FU Combo With Osimertinib for NSCLC","s":"rec","p":"phase1phase2","d":[4],"c":[16,5,30],"a":"adult older","h":[58,30,65],"po":"2025-10-03","u":"2026-11-10","st":"2025-10","ag":"18 and over"},{"n":"NCT07207070","t":"A Randomised, Open-label, Multicentre Phase III Clinical Study to Evaluate the Efficacy and Safety of JS105 Combined With Dalpiciclib and Fulvestrant Compared With Dalpiciclib and Fulvestrant in Patients With PIK3CA-mutated, HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer.","s":"rec","p":"phase3","d":[6],"c":[20],"a":"adult older","h":[37],"po":"2025-10-03","u":"2025-12-30","st":"2025-11","ag":"18–75"},{"n":"NCT07208058","t":"A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis (Also Known as Macrophage Activation Syndrome [MAS])","s":"rec","p":"phase3","d":[18],"c":[2,0,23,9,5,11,18,13,20],"a":"child adult older","h":[39,46,12,38,48,14,99,25,41,118,186,76],"po":"2025-10-06","u":"2026-10-15","st":"2025-11","ag":"16–80"},{"n":"NCT07208773","t":"A Study of YL201 and Ivonescimab (AK112) in Advanced Solid Tumors","s":"rec","p":"phase1phase2","d":[4],"c":[0],"a":"adult older","h":[53],"po":"2025-10-06","u":"2026-06-18","st":"2025-10","ag":"18 and over"},{"n":"NCT07208981","t":"Orelabrutinib Combined With Zebetuzumab and Lenalidomide for the Treatment of Newly Diagnosed MZL","s":"rec","p":"phase2","d":[19],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"lymph"]],"po":"2025-10-06","u":"2025-10-06","st":"2025-08","ag":"18–75"},{"n":"NCT07209813","t":"GKL-006 Injection Plus TACE Versus TACE Alone in Patients With Unresectable Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[2,8,23,9,28,20],"a":"adult older","h":[26,25,120,10,44,116],"po":"2025-10-07","u":"2026-08-17","st":"2025-11","ag":"18–80"},{"n":"NCT07211529","t":"Intraoperative Paravertebral Block and Postoperative Complications","s":"rec","p":"na","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"lung"]],"po":"2025-10-08","u":"2025-10-08","st":"2025-03","ag":"18–80"},{"n":"NCT07212933","t":"The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial","s":"rec","p":"phase2","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"gc"]],"po":"2025-10-08","u":"2025-10-08","st":"2025-07","ag":"18–70"},{"n":"NCT07213791","t":"A Study of LY4337713 in Participants With FAP-Positive Solid Tumors","s":"rec","p":"phase1","d":[3,6],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"gc"]],"po":"2025-10-09","u":"2026-11-04","st":"2025-10","ag":"18 and over"},{"n":"NCT07215650","t":"Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)","s":"rec","p":"phase1","d":[27],"c":[15,22,16,0,41,5,12,30,20],"a":"adult older","h":[103,59,108,25,176,137,98,27,209,140],"po":"2025-10-10","u":"2026-09-02","st":"2025-09","ag":"18 and over"},{"n":"NCT07217301","t":"A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[2,8,22,1,16,0,23,24,17,27,47,73,9,28,5,11,18,30,37,39,14,31,20],"a":"adult older","h":[40,42,56,57,58,43,78,44,25,111,74,45,24,46,238,47,79,14,81,48,37,82,112,60,30,2,135,68,92,18,64,20,95,21,88],"po":"2025-10-15","u":"2026-11-02","st":"2025-11","ag":"18 and over"},{"n":"NCT07218146","t":"A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)","s":"rec","p":"phase3","d":[4],"c":[2,15,8,22,16,0,23,24,17,27,25,9,28,10,5,18,29,13,39,7,20],"a":"adult older","h":[23,56,57,43,44,25,111,74,45,24,13,47,37,60,30,68,19,50,138,66,8,116,67],"po":"2025-10-20","u":"2026-10-16","st":"2025-11","ag":"18 and over"},{"n":"NCT07222267","t":"An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors","s":"rec","p":"phase1","d":[6],"c":[2,8,1,23,24,28,5,30,7],"a":"adult older","h":[9,23,78,58,45,74,2,13,8,82],"po":"2025-10-29","u":"2026-11-12","st":"2025-12","ag":"18 and over"},{"n":"NCT07226999","t":"Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy and With Tarlatamab, Alone or With Chemotherapy, in Adult Participants With Extensive-Stage Small Cell Lung Cancer","s":"rec","p":"phase2phase3","d":[4],"c":[0,5],"a":"adult older","h":[9,43],"po":"2025-11-12","u":"2026-11-18","st":"2025-12","ag":"18 and over"},{"n":"NCT07227012","t":"Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.","s":"rec","p":"phase1phase2","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"hcc"]],"po":"2025-11-12","u":"2026-10-08","st":"2025-12","ag":"18 and over"},{"n":"NCT07229599","t":"A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer","s":"rec","p":"phase1phase2","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2025-11-17","u":"2025-11-17","st":"2025-05","ag":"18–75"},{"n":"NCT07229729","t":"A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[0],"a":"adult older","h":[43],"po":"2025-11-17","u":"2025-12-01","st":"2025-11","ag":"18–70"},{"n":"NCT07232420","t":"A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors","s":"rec","p":"phase1","d":[4],"c":[0],"a":"adult older","h":[53],"po":"2025-11-18","u":"2025-11-24","st":"2025-11","ag":"18 and over"},{"n":"NCT07232433","t":"Safety and Efficacy Evaluation of Cryoablation in the Treatment of Ground-Glass Nodules","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lung"]],"po":"2025-11-18","u":"2026-01-22","st":"2025-11","ag":"18 and over"},{"n":"NCT07232849","t":"A Trial of HRS-4508 Combined With Other Antitumor Therapies in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2025-11-18","u":"2025-12-12","st":"2025-12","ag":"18–75"},{"n":"NCT07232875","t":"HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer","s":"rec","p":"phase3","d":[5],"c":[5],"a":"adult older","h":[41],"po":"2025-11-18","u":"2026-10-26","st":"2025-11","ag":"18–75"},{"n":"NCT07233720","t":"Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma","s":"rec","p":"na","d":[19],"c":[20],"lc":[20],"a":"child adult older","h":[37],"l":[[37,"lymph"]],"po":"2025-11-18","u":"2025-11-18","st":"2025-11","ag":"Not stated"},{"n":"NCT07235410","t":"Deep Learning-Based Multidimensional Body Composition Mapping for Outcome Prediction in HCC Patients Undergoing TACE","s":"rec","p":"na","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"hcc"]],"po":"2025-11-19","u":"2025-11-19","st":"2025-11","ag":"18 and over"},{"n":"NCT07235930","t":"Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Advanced Pancreatic Cancer","s":"rec","p":"phase3","d":[5],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"panc"]],"po":"2025-11-19","u":"2025-11-19","st":"2025-11","ag":"18–75"},{"n":"NCT07238283","t":"Irinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer","s":"rec","p":"phase3","d":[5],"c":[2],"a":"adult older","h":[38],"po":"2025-11-20","u":"2025-12-09","st":"2025-12","ag":"18–75"},{"n":"NCT07238881","t":"Dalpiciclib Plus Camrelizumab for HCC Patients Who Have Previously Received ICI Treatment","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"hcc"]],"po":"2025-11-20","u":"2025-11-20","st":"2025-11","ag":"18–75"},{"n":"NCT07239245","t":"Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo","s":"rec","p":"phase2","d":[2],"c":[2,11,20],"lc":[2],"a":"adult older","h":[23,118,37],"l":[[23,"hcc"]],"po":"2025-11-20","u":"2025-11-25","st":"2025-11","ag":"18–75"},{"n":"NCT07239661","t":"Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC","s":"rec","p":"na","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[191],"l":[[191,"lung"]],"po":"2025-11-20","u":"2025-11-20","st":"2025-11","ag":"18 and over"},{"n":"NCT07240194","t":"The Efficacy and Safety of Glofitamab in Combination With PD-1 Antibody and Lenalidomide in Patients With Relapsed/Refractory Large B-cell Lymphoma (LBCL) With TP53 Aberrations: A Prospective, Multicenter, Phase II Clinical Study","s":"rec","p":"phase2","d":[19],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"lymph"]],"po":"2025-11-20","u":"2025-11-20","st":"2025-09","ag":"18 and over"},{"n":"NCT07240896","t":"A Clinical Study on the Treatment of Wilson Disease With ATP7B mRNA/LNP (DSL101)","s":"rec","p":"earlyphase1","d":[29],"c":[17],"a":"adult older","h":[112],"po":"2025-11-21","u":"2026-01-20","st":"2025-12","ag":"18 and over"},{"n":"NCT07241767","t":"A Phase II Clinical Study of FH-006 for Injection Combined With Other Anticancer Therapies in Subjects With Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[0],"a":"adult older","h":[53],"po":"2025-11-21","u":"2026-04-08","st":"2025-11","ag":"18–75"},{"n":"NCT07242417","t":"TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors","s":"rec","p":"earlyphase1","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[3],"l":[[3,"hcc"]],"po":"2025-11-21","u":"2026-01-21","st":"2025-12","ag":"18–75"},{"n":"NCT07243691","t":"Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[23],"lc":[23],"a":"adult older","h":[82],"l":[[82,"hcc"]],"po":"2025-11-24","u":"2025-11-24","st":"2025-12","ag":"18 and over"},{"n":"NCT07243873","t":"Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter Study","s":"rec","p":"na","d":[4],"c":[9,5,64],"lc":[5],"a":"adult older","h":[56,14,65,273],"l":[[56,"lung"]],"po":"2025-11-24","u":"2025-11-24","st":"2025-12","ag":"18–85"},{"n":"NCT07244016","t":"Clinical Study on Using TCR to Predict the Effect of Tislelizumab + Chemotherapy in the First-line Treatment of ES-SCLC","s":"rec","p":"na","d":[4],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"lung"]],"po":"2025-11-24","u":"2025-11-24","st":"2025-02","ag":"18 and over"},{"n":"NCT07244094","t":"A Study on Predicting the Risk of Distant Metastasis in Breast Cancer Using AI-Generated Spatial Pathological Maps","s":"rec","p":"na","d":[6],"c":[15,23],"lc":[23],"a":"adult older","x":"female","h":[54,138],"l":[[54,"breast"]],"po":"2025-11-24","u":"2026-02-17","st":"2025-11","ag":"18–95"},{"n":"NCT07244406","t":"Assessment of Senl_B19 CAR-T Cells in Relapsed/Refractory CD19+ B-ALL","s":"rec","p":"phase2","d":[16],"c":[2],"a":"child adult","h":[48],"po":"2025-11-24","u":"2025-11-24","st":"2025-01","ag":"3–25"},{"n":"NCT07244835","t":"A Study of DEG6498 in Participants With Solid Tumors","s":"rec","p":"phase1","d":[2],"c":[2,0],"a":"adult older","h":[53,74,3],"po":"2025-11-24","u":"2026-06-30","st":"2025-11","ag":"18 and over"},{"n":"NCT07245446","t":"A Study of Ivonescimab in First-Line ES-SCLC","s":"rec","p":"phase2","d":[4],"c":[2,5,39],"a":"adult older","h":[23,56,111],"po":"2025-11-24","u":"2025-11-24","st":"2025-10","ag":"18–75"},{"n":"NCT07248163","t":"Universal CAR-T Cell Therapy for NHL","s":"rec","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[162],"l":[[162,"lymph"]],"po":"2025-11-25","u":"2025-11-25","st":"2025-03","ag":"18 and over"},{"n":"NCT07248176","t":"Universal CAR-T Cell Therapy for MM","s":"rec","p":"na","d":[15],"c":[5],"lc":[5],"a":"adult older","h":[162],"l":[[162,"mm"]],"po":"2025-11-25","u":"2025-12-01","st":"2025-04","ag":"18 and over"},{"n":"NCT07249073","t":"CAR19-BCMA Dual-target CAR-T in the Treatment of Relapsed / Refractory Multiple Myeloma","s":"rec","p":"earlyphase1","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2025-11-25","u":"2025-11-25","st":"2025-03","ag":"18–70"},{"n":"NCT07250204","t":"A Study on Combined Low-pass Whole-genome and Methylome Testing of Bloody Nipple Discharge Specimens for Benign-Malignant Differentiation.","s":"rec","p":"na","d":[6],"c":[13],"lc":[13],"a":"adult older","h":[19],"l":[[19,"breast"]],"po":"2025-11-26","u":"2026-07-17","st":"2025-12","ag":"18 and over"},{"n":"NCT07250347","t":"AI-Assisted Detection and Staging of Gastric Cancer Using Contrast-Enhanced CT","s":"rec","p":"na","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"gc"]],"po":"2025-11-26","u":"2025-11-26","st":"2025-08","ag":"18–85"},{"n":"NCT07250386","t":"A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors","s":"rec","p":"phase1","d":[4,6],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lung"]],"po":"2025-11-26","u":"2025-11-26","st":"2025-10","ag":"18 and over"},{"n":"NCT07252739","t":"KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)","s":"rec","p":"phase2","d":[4],"c":[22,9,28,5],"a":"adult older","h":[40,6,14,60],"po":"2025-11-28","u":"2026-11-10","st":"2025-12","ag":"18 and over"},{"n":"NCT07252986","t":"Clinical Translation Research on a Multi-omics Breast Cancer Distant Metastasis Prediction Model Empowered by Artificial Intelligence","s":"rec","p":"na","d":[6],"c":[23],"lc":[23],"a":"child adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2025-11-28","u":"2026-03-03","st":"2025-12","ag":"Not stated"},{"n":"NCT07253129","t":"Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)","s":"rec","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[121],"l":[[121,"lymph"]],"po":"2025-11-28","u":"2025-12-23","st":"2025-12","ag":"18–70"},{"n":"NCT07253948","t":"Distribution Characteristics of Helicobacter Pylori","s":"rec","p":"na","d":[3],"c":[15],"lc":[15],"a":"adult older","h":[27],"l":[[27,"gc"]],"po":"2025-11-28","u":"2025-11-28","st":"2025-10","ag":"18–80"},{"n":"NCT07255404","t":"A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[2,22,0,23,47,9,5,11,13,20],"a":"adult older","h":[9,36,183,118,99,14,103,37,47,135,100],"po":"2025-12-01","u":"2026-07-28","st":"2025-12","ag":"18 and over"},{"n":"NCT07255963","t":"Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL","s":"rec","p":"phase2","d":[19],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"lymph"]],"po":"2025-12-01","u":"2025-12-01","st":"2025-11","ag":"18 and over"},{"n":"NCT07257458","t":"Application of Methylation Markers in Early Detection and MRD Monitoring of Lung Cancer","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[307],"l":[[307,"lung"]],"po":"2025-12-02","u":"2025-12-02","st":"2025-04","ag":"18–85"},{"n":"NCT07257471","t":"Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[307],"l":[[307,"lung"]],"po":"2025-12-02","u":"2025-12-02","st":"2025-06","ag":"18–85"},{"n":"NCT07257510","t":"Pomalidomide Plus Orelabrutinib and Zuberitamab in Untreated Mantle Cell Lymphoma","s":"rec","p":"na","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[115],"l":[[115,"lymph"]],"po":"2025-12-02","u":"2025-12-02","st":"2025-08","ag":"18–80"},{"n":"NCT07258108","t":"Sac-TMT Plus KL-A167 in PD-L1+, HR+/HER2- Metastatic Breast Cancer After CDK4/6 Inhibitors","s":"rec","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"breast"]],"po":"2025-12-02","u":"2026-05-08","st":"2025-11","ag":"18–75"},{"n":"NCT07258979","t":"A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.","s":"rec","p":"phase1phase2","d":[0],"c":[8,22,1,44,16,0,57,6,23,35,47,9,10,5,85,7],"a":"adult older","h":[53,30,13,50,9,170,95,8,47,7,44,116,2,135,14,269,130,308,85],"po":"2025-12-02","u":"2025-12-02","st":"2025-11","ag":"18–75"},{"n":"NCT07259070","t":"Multicenter, Single-Arm Exploratory Phase I Clinical Study (Assessment of Safety and Efficacy) of Fully Human BAFF-R Chimeric Antigen Receptor T-Cell Injection in Relapsed/Refractory BAFF-R-Positive B-Cell Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"lymph"]],"po":"2025-12-02","u":"2026-05-13","st":"2025-11","ag":"18–75"},{"n":"NCT07259278","t":"Intelligent Management Platform for Guiding Exercise Rehabilitation in Coronary Heart Disease Patients","s":"rec","p":"na","d":[31],"c":[2],"a":"adult older","h":[213],"po":"2025-12-02","u":"2025-12-02","st":"2025-12","ag":"18 and over"},{"n":"NCT07260591","t":"VSV-02 Compassionate Use in Advanced Solid Tumors","s":"rec","p":"phase1","d":[4,6],"c":[14],"lc":[14],"a":"adult older","h":[21],"l":[[21,"lung"]],"po":"2025-12-03","u":"2025-12-03","st":"2025-09","ag":"18 and over"},{"n":"NCT07260812","t":"KSV01 Injection for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma","s":"rec","p":"phase1","d":[19],"c":[13],"a":"adult older","h":[36],"po":"2025-12-03","u":"2026-10-26","st":"2025-09","ag":"18–65"},{"n":"NCT07261163","t":"Obinutuzumab, Zanubrutinib, and Lenalidomide in First-line Treatment of Mantle Cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"lymph"]],"po":"2025-12-03","u":"2026-05-13","st":"2025-12","ag":"18–80"},{"n":"NCT07262567","t":"Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer","s":"rec","p":"phase3","d":[5],"c":[2],"a":"adult older","h":[74],"po":"2025-12-03","u":"2026-08-14","st":"2025-12","ag":"18–80"},{"n":"NCT07263347","t":"DIEP Flap Breast Reconstruction: Perioperative Biomarkers and Outcomes","s":"rec","p":"na","d":[6],"c":[13],"lc":[13],"a":"adult older","x":"female","h":[19],"l":[[19,"breast"]],"po":"2025-12-04","u":"2026-04-03","st":"2025-12","ag":"18–70"},{"n":"NCT07263386","t":"A Phase II, Multicenter, Randomized, Controlled Clinical Study Comparing the Efficacy and Safety of Sintilimab Plus SOX Versus SOX Alone as Adjuvant Therapy for PD-L1-Positive, Stage pN3 Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"gc"]],"po":"2025-12-04","u":"2025-12-04","st":"2025-10","ag":"18–75"},{"n":"NCT07263425","t":"Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Trastuzumab in Breast Cancer With Leptomeningeal Metastasis","s":"rec","p":"phase2","d":[6],"c":[28],"lc":[28],"a":"adult older","x":"female","h":[78,288],"l":[[78,"breast"]],"po":"2025-12-04","u":"2025-12-04","st":"2025-10","ag":"18–75"},{"n":"NCT07263451","t":"Safety and Feasibility of IRE for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory Study","s":"rec","p":"na","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[46],"l":[[46,"breast"]],"po":"2025-12-04","u":"2025-12-22","st":"2025-12","ag":"18 and over"},{"n":"NCT07263711","t":"Prospective Real-World Study of Pathology AI for Glioma Molecular Prediction","s":"rec","p":"na","d":[7],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"glioma"]],"po":"2025-12-04","u":"2025-12-04","st":"2025-09","ag":"18–100"},{"n":"NCT07263919","t":"Perioperative Cadonilimab Combined With Neoadjuvant Chemotherapy in Resectable Esophageal Squamous Cell Carcinoma (ESCC)","s":"rec","p":"phase2","d":[1],"c":[39],"a":"adult older","h":[122],"po":"2025-12-04","u":"2025-12-31","st":"2025-12","ag":"18–75"},{"n":"NCT07264985","t":"Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib","s":"rec","p":"na","d":[6],"c":[13],"lc":[13],"a":"adult older","h":[19],"l":[[19,"breast"]],"po":"2025-12-04","u":"2026-07-16","st":"2025-12","ag":"18–75"},{"n":"NCT07264998","t":"Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea","s":"rec","p":"na","d":[6],"c":[13],"lc":[13],"a":"adult older","h":[19],"l":[[19,"breast"]],"po":"2025-12-04","u":"2026-04-03","st":"2025-12","ag":"18–75"},{"n":"NCT07266480","t":"Clinical Study of Adbelimumab in the Adjuvant Treatment of Esophageal Squamous Cell Carcinoma.","s":"rec","p":"phase2","d":[1],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"escc"]],"po":"2025-12-05","u":"2025-12-05","st":"2025-09","ag":"18 and over"},{"n":"NCT07267806","t":"Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC","s":"rec","p":"phase3","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"hcc"]],"po":"2025-12-05","u":"2025-12-16","st":"2025-10","ag":"18 and over"},{"n":"NCT07268131","t":"TITAN-HCC: Neoadjuvant and Adjuvant QL1706 With TACE in Resectable Hepatocellular Carcinoma Beyond Milan Criteria","s":"rec","p":"na","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[103],"l":[[103,"hcc"]],"po":"2025-12-05","u":"2026-07-31","st":"2025-12","ag":"18–75"},{"n":"NCT07270835","t":"Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma","s":"rec","p":"phase4","d":[18,19],"c":[4],"lc":[4],"a":"child adult older","h":[5],"l":[[5,"hlh"]],"po":"2025-12-08","u":"2025-12-08","st":"2025-11","ag":"14–80"},{"n":"NCT07270861","t":"Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study","s":"rec","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lymph"]],"po":"2025-12-08","u":"2026-03-24","st":"2025-11","ag":"18 and over"},{"n":"NCT07272499","t":"Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease","s":"rec","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"child adult older","h":[123],"l":[[123,"lymph"]],"po":"2025-12-09","u":"2026-07-28","st":"2025-09","ag":"14 and over"},{"n":"NCT07274852","t":"A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors","s":"rec","p":"phase1","d":[4,6],"c":[22],"a":"adult older","h":[40],"po":"2025-12-10","u":"2026-01-06","st":"2025-12","ag":"18 and over"},{"n":"NCT07275073","t":"JMT106 Injection in the Treatment of Advanced Solid Tumors","s":"rec","p":"phase1","d":[2],"c":[23],"a":"adult older","h":[46],"po":"2025-12-10","u":"2025-12-18","st":"2025-09","ag":"18 and over"},{"n":"NCT07277439","t":"Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma","s":"rec","p":"phase2","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"gc"]],"po":"2025-12-11","u":"2026-03-19","st":"2025-12","ag":"18–75"},{"n":"NCT07277686","t":"AI Facial Analysis Algorithm to Screening Coronary Artery Disease in High-Risk Community Population","s":"rec","p":"na","d":[31],"c":[2],"a":"adult older","h":[213],"po":"2025-12-11","u":"2026-01-06","st":"2025-12","ag":"18 and over"},{"n":"NCT07277764","t":"Induction High-Low Dose Radiotherapy Plus Anti-PD-1 Followed by Definitive Radiotherapy in Recurrent Nasopharyngeal Carcinoma (Single-Arm Phase II)","s":"rec","p":"phase2","d":[0],"c":[9],"lc":[9],"a":"adult older","h":[116],"l":[[116,"npc"]],"po":"2025-12-11","u":"2025-12-11","st":"2025-10","ag":"18–75"},{"n":"NCT07282184","t":"Multimodal Deep Learning for Postoperative Liver Cancer Risk Stratification and Intervention","s":"rec","p":"phase1phase2","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2025-12-15","u":"2025-12-18","st":"2025-10","ag":"18–75"},{"n":"NCT07282353","t":"A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA","s":"rec","p":"phase3","d":[50],"c":[86,2,15,8,22,1,16,23,24,17,25,9,28,10,26,5,11,21,71,29,30,39,7,45,20],"a":"adult older","h":[41,39,40,27,59,181,55,309,112,15,111,14,66,118,62,31,90,11,129,78,126,92,68,123,166,310,178,190,233,311,312,152,313,314,315],"po":"2025-12-15","u":"2026-11-12","st":"2025-12","ag":"18–75"},{"n":"NCT07283796","t":"A Study to Assess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma","s":"rec","p":"phase1","d":[19],"c":[30],"a":"adult older","h":[69],"po":"2025-12-16","u":"2025-12-19","st":"2025-08","ag":"18 and over"},{"n":"NCT07284836","t":"Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Advanced Breast Cancer Patients With Liver Metastases After Failure of Standard Therapy","s":"rec","p":"phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[44],"l":[[44,"breast"]],"po":"2025-12-16","u":"2025-12-16","st":"2025-02","ag":"18–70"},{"n":"NCT07284927","t":"Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies","s":"rec","p":"phase1","d":[19],"c":[4],"a":"adult older","h":[5],"po":"2025-12-16","u":"2025-12-16","st":"2025-12","ag":"18–70"},{"n":"NCT07285382","t":"Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[52,26],"a":"adult older","x":"female","h":[55,155],"po":"2025-12-16","u":"2025-12-16","st":"2025-06","ag":"18–75"},{"n":"NCT07285850","t":"The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD","s":"rec","p":"phase2phase3","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[277],"l":[[277,"hcc"]],"po":"2025-12-16","u":"2025-12-16","st":"2025-10","ag":"18 and over"},{"n":"NCT07287228","t":"The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic Anemia","s":"rec","p":"phase1phase2","d":[17],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"aa"]],"po":"2025-12-17","u":"2026-11-06","st":"2025-12","ag":"18 and over"},{"n":"NCT07289997","t":"Iparomlimab and Tuvonralimab Combined With Apatinib and Irinotecan Hydrochloride for the Treatment of Advanced Alpha-fetoprotein-producing Gastric Cancer (AFPGC)","s":"rec","p":"phase2","d":[3],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"gc"]],"po":"2025-12-17","u":"2025-12-17","st":"2025-09","ag":"18 and over"},{"n":"NCT07290010","t":"The Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line Treatment for Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"escc"]],"po":"2025-12-17","u":"2025-12-17","st":"2025-09","ag":"18 and over"},{"n":"NCT07291921","t":"To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study)","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"lung"]],"po":"2025-12-18","u":"2026-03-03","st":"2025-05","ag":"18–85"},{"n":"NCT07294625","t":"A Clinical Study to Evaluate LVIVO-TaVec200 for the Treatment of Relapsed/Refractory Multiple Myeloma","s":"rec","p":"earlyphase1","d":[15],"c":[28,5,39,31,20],"lc":[28],"a":"adult older","h":[78,64,123,37,97],"l":[[78,"mm"]],"po":"2025-12-19","u":"2025-12-19","st":"2025-12","ag":"18 and over"},{"n":"NCT07294638","t":"Novel Humanized Ferritin-Based NIR Fluorescent Probe for Identifying Sentinel Lymph Node Metastasis in Early Gastric Cancer","s":"rec","p":"na","d":[3],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"gc"]],"po":"2025-12-19","u":"2025-12-19","st":"2025-07","ag":"18 and over"},{"n":"NCT07294664","t":"PDL1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[20],"lc":[20],"a":"adult older","h":[25],"l":[[25,"gc"]],"po":"2025-12-19","u":"2026-09-01","st":"2025-06","ag":"18 and over"},{"n":"NCT07296458","t":"FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy","s":"rec","p":"phase3","d":[50],"c":[0,39],"lc":[39],"a":"adult older","h":[131,99],"l":[[131,"pbc"]],"po":"2025-12-22","u":"2026-11-02","st":"2025-12","ag":"18–75"},{"n":"NCT07296627","t":"Real-world Immuno-therapy in Chinese Newly Diagnosed Multiple Myeloma Patients","s":"rec","p":"na","d":[15],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"mm"]],"po":"2025-12-22","u":"2025-12-22","st":"2025-07","ag":"18 and over"},{"n":"NCT07297329","t":"A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant","s":"rec","p":"phase3","d":[15],"c":[2],"a":"adult older","h":[89],"po":"2025-12-22","u":"2026-01-29","st":"2025-12","ag":"18 and over"},{"n":"NCT07298200","t":"Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer","s":"rec","p":"phase1","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[60],"l":[[60,"gc"]],"po":"2025-12-23","u":"2026-02-25","st":"2025-12","ag":"18–70"},{"n":"NCT07299149","t":"Zanubrutinib, Obinutuzumab Combined With Lenalidomide (ZGR) for the Treatment of Untreated Follicular Lymphoma","s":"rec","p":"phase2","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"lymph"]],"po":"2025-12-23","u":"2026-05-13","st":"2025-12","ag":"18–90"},{"n":"NCT07301411","t":"Exploratory Trial of Navigational Bronchoscopy-Guided Cryoablation in Lung Cancer Treatment","s":"rec","p":"na","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2025-12-24","u":"2025-12-24","st":"2025-11","ag":"18–80"},{"n":"NCT07301814","t":"Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors","s":"rec","p":"na","d":[3,5],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"gc"]],"po":"2025-12-24","u":"2025-12-24","st":"2025-09","ag":"18 and over"},{"n":"NCT07303023","t":"Individualized Neck Cervical Irradiation Prophylaxis Trial of NPC","s":"rec","p":"phase3","d":[0],"c":[22,1,23,5],"a":"adult older","h":[9,236,47,44,2,316],"po":"2025-12-24","u":"2025-12-24","st":"2025-09","ag":"18–70"},{"n":"NCT07304739","t":"Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients With Brain Parenchymal and Leptomeningeal Metastases","s":"rec","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2025-12-26","u":"2025-12-26","st":"2025-12","ag":"18–75"},{"n":"NCT07304934","t":"A Prospective Multicenter Study of the TuFEst-LN Model for Axillary Lymph Node Status Assessment in Breast Cancer","s":"rec","p":"na","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2025-12-26","u":"2026-08-10","st":"2025-08","ag":"18 and over"},{"n":"NCT07305116","t":"CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease","s":"rec","p":"phase1","d":[46],"c":[23],"lc":[23],"a":"child adult older","h":[179],"l":[[179,"iga"]],"po":"2025-12-26","u":"2026-02-03","st":"2025-12","ag":"3 and over"},{"n":"NCT07305337","t":"Randomised Controlled Trial of Artificial Intelligence-assisted Health Education","s":"rec","p":"na","d":[15,19],"c":[13],"lc":[13],"a":"adult older","h":[133],"l":[[133,"mm"]],"po":"2025-12-26","u":"2025-12-26","st":"2025-06","ag":"18–90"},{"n":"NCT07306273","t":"IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy","s":"rec","p":"phase2","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"panc"]],"po":"2025-12-29","u":"2025-12-29","st":"2025-12","ag":"18 and over"},{"n":"NCT07306286","t":"Cryoablation Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy","s":"rec","p":"phase2","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"panc"]],"po":"2025-12-29","u":"2025-12-29","st":"2025-12","ag":"18 and over"},{"n":"NCT07306299","t":"A Phase I Clinical Trial of a mRNA Vaccine for Recurrent or Progressive High-grade Glioma","s":"rec","p":"phase1","d":[7],"c":[23],"lc":[23],"a":"child adult older","h":[54],"l":[[54,"glioma"]],"po":"2025-12-29","u":"2025-12-29","st":"2025-12","ag":"16 and over"},{"n":"NCT07307560","t":"High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients","s":"rec","p":"na","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"gc"]],"po":"2025-12-29","u":"2026-05-04","st":"2025-12","ag":"18 and over"},{"n":"NCT07309952","t":"Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2025-12-30","u":"2026-04-30","st":"2025-12","ag":"18–75"},{"n":"NCT07311772","t":"Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid","s":"rec","p":"phase3","d":[0],"c":[2,8,49,22,16,0,23,47,10,5,43,87,59],"a":"adult older","h":[53,30,11,13,50,40,23,236,95,44,171,135,125,201,317,145],"po":"2025-12-31","u":"2026-05-07","st":"2025-12","ag":"18–75"},{"n":"NCT07312188","t":"A Study of F182112 in the Treatment of Patients With Relapsed or Refractory Multiple Myeloma","s":"rec","p":"phase2","d":[15],"c":[30],"a":"adult older","h":[69],"po":"2025-12-31","u":"2025-12-31","st":"2025-07","ag":"18 and over"},{"n":"NCT07312318","t":"AI-Driven Dynamic Prediction of Non-Target Lesion Progression After PCI: A Chinese Multicenter Cohort Study","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[62],"l":[[62,"cad"]],"po":"2025-12-31","u":"2025-12-31","st":"2025-09","ag":"18 and over"},{"n":"NCT07312422","t":"LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study","s":"rec","p":"phase1phase2","d":[5],"c":[23],"lc":[23],"a":"adult older","h":[183],"l":[[183,"panc"]],"po":"2025-12-31","u":"2026-01-26","st":"2025-09","ag":"18–75"},{"n":"NCT07315854","t":"Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer","s":"rec","p":"phase2","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[39],"l":[[39,"gc"]],"po":"2026-01-02","u":"2026-01-06","st":"2025-11","ag":"18–80"},{"n":"NCT07316452","t":"Risk Prediction of Disease Progression in Early-Onset Coronary Atherosclerosis","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult","h":[318],"l":[[318,"cad"]],"po":"2026-01-05","u":"2026-01-05","st":"2025-01","ag":"18–45"},{"n":"NCT07317414","t":"β-alanine in the Treatment of Advanced Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[2,28,31],"lc":[2],"a":"adult older","h":[38,78,64],"l":[[38,"hcc"]],"po":"2026-01-05","u":"2026-01-05","st":"2025-12","ag":"18–75"},{"n":"NCT07317609","t":"Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02)","s":"rec","p":"phase1","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"escc"]],"po":"2026-01-05","u":"2026-01-05","st":"2025-07","ag":"18 and over"},{"n":"NCT07318155","t":"A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease","s":"rec","p":"phase2","d":[31],"c":[2],"a":"adult older","h":[213],"po":"2026-01-05","u":"2026-04-29","st":"2025-03","ag":"18–75"},{"n":"NCT07319897","t":"68Ga-BCMA PET/CT in Multiple Myeloma","s":"rec","p":"phase2phase3","d":[15],"c":[2,15,18],"lc":[2],"a":"adult older","h":[29,27,186],"l":[[29,"mm"]],"po":"2026-01-06","u":"2026-06-22","st":"2025-12","ag":"18–80"},{"n":"NCT07321145","t":"A Retrospective Analysis of Robot-Assisted Versus Endoscopic Breast-Conserving Surgery for Breast Cancer","s":"rec","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[75],"l":[[75,"breast"]],"po":"2026-01-06","u":"2026-01-06","st":"2025-06","ag":"18–80"},{"n":"NCT07321301","t":"Polymer-lipid Particle-delivered CAR1920 mRNA CAR-T Therapy for Relapsed/Refractory B-cell Lymphoma/Leukemia","s":"rec","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"child adult older","h":[26],"l":[[26,"lymph"]],"po":"2026-01-07","u":"2026-01-07","st":"2025-09","ag":"14–85"},{"n":"NCT07322783","t":"Osimertinib Combined With Savolitinib in the Treatment of NSCLC With Low Copy Number MET Amplification","s":"rec","p":"phase2","d":[4],"c":[26],"lc":[26],"a":"adult older","h":[319],"l":[[319,"lung"]],"po":"2026-01-07","u":"2026-01-07","st":"2025-01","ag":"18–80"},{"n":"NCT07322848","t":"DEB-TACE vs cTACE in HCC After TIPS","s":"rec","p":"phase3","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[49],"l":[[49,"hcc"]],"po":"2026-01-07","u":"2026-05-01","st":"2025-12","ag":"18–75"},{"n":"NCT07324304","t":"NWRD06 DNA Plasmid for HCC After Curative Resection.","s":"rec","p":"phase2","d":[2],"c":[2,23,24],"a":"adult older","h":[26,82,181,38,45],"po":"2026-01-07","u":"2026-01-07","st":"2025-12","ag":"18–65"},{"n":"NCT07325630","t":"Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"gc"]],"po":"2026-01-08","u":"2026-01-08","st":"2025-11","ag":"18–75"},{"n":"NCT07326137","t":"A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain","s":"rec","p":"na","d":[5],"c":[13],"lc":[13],"a":"child adult older","h":[36],"l":[[36,"panc"]],"po":"2026-01-08","u":"2026-02-11","st":"2025-12","ag":"Not stated"},{"n":"NCT07327034","t":"ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression","s":"rec","p":"phase2","d":[2],"c":[2,15,8,22,1,16,78,0,57,23,17,27,9,28,10,40,5,11,30,13,39,31,58,20],"a":"adult older","h":[6,40,53,36,25,50,12,111,78,41,112,80,68,58,27,54,170,99,38,79,118,57,30,9,44,37,64,100,31,172,2,270,13,18,116,19,138,260,105],"po":"2026-01-08","u":"2026-01-08","st":"2025-06","ag":"18 and over"},{"n":"NCT07327788","t":"QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"hcc"]],"po":"2026-01-08","u":"2026-01-13","st":"2025-12","ag":"18 and over"},{"n":"NCT07328841","t":"Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy","s":"rec","p":"phase3","d":[0],"c":[8,0,10,43,13,87,46,59],"a":"adult older","h":[53,11,13,96,171,125,36,134,317,320],"po":"2026-01-09","u":"2026-01-09","st":"2025-11","ag":"18–70"},{"n":"NCT07328854","t":"40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[8,22,16,0,23,47,10,43,87,46,59],"a":"adult older","h":[53,30,11,13,50,40,95,44,171,135,125,201,134,317],"po":"2026-01-09","u":"2026-01-09","st":"2025-11","ag":"18–75"},{"n":"NCT07330037","t":"TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant Chemoimmunotherapy","s":"rec","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"child adult older","h":[58],"l":[[58,"lung"]],"po":"2026-01-09","u":"2026-01-09","st":"2025-12","ag":"17–75"},{"n":"NCT07330050","t":"WAST Cell-Docetaxel Combination Therapy in PD-1 Inhibitor-Resistant Advanced NSCLC","s":"rec","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2026-01-09","u":"2026-01-09","st":"2025-12","ag":"18–75"},{"n":"NCT07330544","t":"A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of Hormone Receptor (HR) -Positive, Human Epidermal Growth Factor Receptor-2 (HER-2) -Negative Advanced Breast Cancer That Relapsed or Progressed After Endocrine Therapy","s":"rec","p":"phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[44],"l":[[44,"breast"]],"po":"2026-01-09","u":"2026-01-09","st":"2025-11","ag":"18 and over"},{"n":"NCT07330596","t":"QL1706 Combined With Chemotherapy in the Treatment of Immune-mediated NSCLC","s":"rec","p":"phase2","d":[4],"a":"adult older","h":[231],"l":[[231,"lung"]],"po":"2026-01-09","u":"2026-01-09","st":"2025-10","ag":"18–75"},{"n":"NCT07331532","t":"68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors","s":"rec","p":"na","d":[4,5,6],"c":[2],"lc":[2],"a":"adult older","h":[29],"l":[[29,"lung"]],"po":"2026-01-12","u":"2026-01-20","st":"2025-06","ag":"18–80"},{"n":"NCT07331883","t":"Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma (CLEAR-2)","s":"rec","p":"phase2","d":[2],"c":[15,5],"lc":[5],"a":"adult older","h":[123,103,147],"l":[[123,"hcc"]],"po":"2026-01-12","u":"2026-03-27","st":"2025-11","ag":"18–75"},{"n":"NCT07332780","t":"Effect of Adenotonsillectomy on Spinal Curve Magnitude in Children With Sleep-Disordered Breathing","s":"rec","p":"na","d":[33],"c":[37],"lc":[37],"a":"child","h":[188],"l":[[188,"scol"]],"po":"2026-01-12","u":"2026-05-15","st":"2025-07","ag":"6–15"},{"n":"NCT07335991","t":"Effect of Vitamin A Supplementation on Idiopathic Scoliosis","s":"rec","p":"na","d":[33],"c":[37],"lc":[37],"a":"child","h":[188],"l":[[188,"scol"]],"po":"2026-01-13","u":"2026-05-15","st":"2025-05","ag":"6–15"},{"n":"NCT07337421","t":"Efcacy and Safety of Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With mFOLFOX in Hepatocellular Carcinoma With High-risk Recurrence Factors","s":"rec","p":"phase2","d":[2],"c":[32],"lc":[32],"a":"adult older","h":[63],"l":[[63,"hcc"]],"po":"2026-01-13","u":"2026-01-13","st":"2025-09","ag":"18–75"},{"n":"NCT07337460","t":"Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors","s":"rec","p":"phase2","d":[2],"c":[32],"lc":[32],"a":"adult older","h":[63],"l":[[63,"hcc"]],"po":"2026-01-13","u":"2026-01-13","st":"2025-11","ag":"18–75"},{"n":"NCT07337785","t":"CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases","s":"rec","p":"earlyphase1","d":[27],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"mg"]],"po":"2026-01-13","u":"2026-05-12","st":"2025-12","ag":"18–70"},{"n":"NCT07339345","t":"Prospective Single-Arm Clinical Trial of GO Regimen for HLH.","s":"rec","p":"phase2phase3","d":[18],"c":[2],"lc":[2],"a":"child adult older","h":[39],"l":[[39,"hlh"]],"po":"2026-01-14","u":"2026-01-14","st":"2025-06","ag":"14–70"},{"n":"NCT07339488","t":"Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[43],"lc":[43],"a":"adult older","h":[125],"l":[[125,"escc"]],"po":"2026-01-14","u":"2026-10-05","st":"2025-12","ag":"18–75"},{"n":"NCT07339644","t":"Functional Lung Avoidance Radiotherapy Guided by 4DCT Pulmonary Ventilation Function Imaging: A Prospective Single-arm Clinical Study","s":"rec","p":"na","d":[4],"c":[1],"lc":[1],"a":"adult older","h":[166],"l":[[166,"lung"]],"po":"2026-01-14","u":"2026-02-09","st":"2025-10","ag":"18–85"},{"n":"NCT07340398","t":"Neoadjuvant Trastuzumab-rezetecan Plus Pertuzumab or Nab-Paclitaxel, Carboplatin, Trastuzumab, and Pyrotinib After Suboptimal Response to Neoadjuvant Dual HER2-Targeted Therapy Combined With Chemotherapy in HER2-Positive Early Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2026-01-14","u":"2026-01-21","st":"2025-12","ag":"18–75"},{"n":"NCT07340424","t":"A Prospective, Open-label, Single-arm, Exploratory Clinical Trial to Evaluate the Safety and Tolerability of 225Ac-TR2205 Injection in Patients With Triple-negative Breast Cancer.","s":"rec","p":"earlyphase1","d":[6],"c":[27],"lc":[27],"a":"adult older","x":"female","h":[199],"l":[[199,"breast"]],"po":"2026-01-14","u":"2026-01-14","st":"2025-05","ag":"18 and over"},{"n":"NCT07340515","t":"Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial","s":"rec","p":"phase3","d":[0],"c":[27],"lc":[27],"a":"adult older","h":[57],"l":[[57,"npc"]],"po":"2026-01-14","u":"2026-01-14","st":"2025-12","ag":"18–70"},{"n":"NCT07350850","t":"A Multicenter, Prospective Clinical Trial With a Concurrent Control Evaluating Methotrexate Combined With Rituximab,Sintilimab and Pirtobrutinib vs. Investigator-Selected Standard of Care in Treatment-Naive PCNSL","s":"rec","p":"phase2","d":[19],"c":[15,16,13],"lc":[13],"a":"adult older","h":[36,136,147],"l":[[36,"lymph"]],"po":"2026-01-20","u":"2026-06-02","st":"2025-12","ag":"18 and over"},{"n":"NCT07350928","t":"Observation of the Effect of Preoperative Use of Dexmedetomidine Hydrochloride Nasal Spray on Optimizing Awake Sedation During Breast-Conserving Surgery for Breast Cancer and Postoperative Awake Status","s":"rec","p":"phase3","d":[6],"c":[30],"lc":[30],"a":"adult older","x":"female","h":[58],"l":[[58,"breast"]],"po":"2026-01-20","u":"2026-01-20","st":"2025-03","ag":"20–70"},{"n":"NCT07351487","t":"Neoadjuvant Chemotherapy Combined With Sintilimab and Bevacizumab for TNBC (NEOTORCH-BREAST07)","s":"rec","p":"phase2","d":[6],"c":[23,17,5],"lc":[23],"a":"adult older","x":"female","h":[46,112,6],"l":[[46,"breast"]],"po":"2026-01-20","u":"2026-01-20","st":"2025-09","ag":"18–75"},{"n":"NCT07353684","t":"Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[39],"l":[[39,"gc"]],"po":"2026-01-20","u":"2026-04-22","st":"2025-05","ag":"18–75"},{"n":"NCT07355699","t":"Application of Orelabrutinib With or Without CD20 Monoclonal Antibody in Previously Untreated Marginal Zone Lymphoma","s":"rec","p":"phase4","d":[19],"c":[2,11],"lc":[2],"a":"adult older","h":[161,38,118],"l":[[161,"lymph"]],"po":"2026-01-21","u":"2026-01-21","st":"2025-11","ag":"18 and over"},{"n":"NCT07358182","t":"Efficacy and Safety of Trastuzumab-rezetecan in HER2-Expressing Breast Cancer","s":"rec","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"breast"]],"po":"2026-01-22","u":"2026-01-22","st":"2025-06","ag":"18 and over"},{"n":"NCT07359014","t":"Novel CD19/BCMA Dual-Targeted CAR-T Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma","s":"rec","p":"na","d":[15],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"mm"]],"po":"2026-01-22","u":"2026-01-22","st":"2025-11","ag":"18–75"},{"n":"NCT07359040","t":"Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"child adult older","h":[48],"l":[[48,"lung"]],"po":"2026-01-22","u":"2026-06-03","st":"2025-07","ag":"Not stated"},{"n":"NCT07359586","t":"Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia","s":"rec","p":"na","d":[2,3,5],"c":[23],"lc":[23],"a":"child adult older","h":[46],"l":[[46,"hcc"]],"po":"2026-01-22","u":"2026-01-22","st":"2025-11","ag":"Not stated"},{"n":"NCT07361237","t":"A Phase l Clinical Study to Evalute the Safety,Tolerability,Pharmacokinetic Characteristics,and Preliminary Anti-tumor Efficacy of HJ-004-02 Tablets in Patients With Non-squamous Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutations","s":"rec","p":"phase1","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[65],"l":[[65,"lung"]],"po":"2026-01-22","u":"2026-01-22","st":"2025-12","ag":"18–75"},{"n":"NCT07362459","t":"A Study to Evaluate the Safety and Tolerability of SCTB14 as First-Line Therapy in Non-Small Cell Lung Cancer.","s":"rec","p":"phase3","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2026-01-23","u":"2026-01-23","st":"2025-12","ag":"18 and over"},{"n":"NCT07362914","t":"Corticosteroids for Doxorubicin Liposome-Induced Hand-Foot-Skin Reactions","s":"rec","p":"phase3","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2026-01-23","u":"2026-01-23","st":"2025-03","ag":"18–70"},{"n":"NCT07362940","t":"A Phase Ⅰ/Ⅱa Clinical Study of GEN-725 in Combination With Dositinib","s":"rec","p":"phase1phase2","d":[4],"c":[2,8,27,7,20],"a":"adult older","h":[57,74,13,37,8],"po":"2026-01-23","u":"2026-01-23","st":"2025-11","ag":"18–75"},{"n":"NCT07363538","t":"Multicenter Randomized Controlled Trial (RCT) and Efficacy Evaluation System Study on Surgical Innovation Strategies for Neonatal Complex Congenital Heart Disease","s":"rec","p":"na","d":[32],"c":[2,8,22,1,0,23,28,26,5,13,39,20],"lc":[20],"a":"child","h":[321,213,91,250,10,12,252,1,179,253,131,322],"l":[[321,"chd"]],"po":"2026-01-23","u":"2026-01-23","st":"2025-12","ag":"Up to 7 days"},{"n":"NCT07366528","t":"Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer","s":"rec","p":"phase3","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[123,9,41,296],"l":[[123,"gc"]],"po":"2026-01-26","u":"2026-01-26","st":"2025-12","ag":"18–80"},{"n":"NCT07369895","t":"Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma","s":"rec","p":"phase1","d":[15],"c":[0],"a":"adult older","h":[53],"po":"2026-01-27","u":"2026-01-27","st":"2025-10","ag":"18–75"},{"n":"NCT07371208","t":"Multicenter, Phase II Clinical Study of Sacituzumab Tirumotecan (Sac-TMT) in Combination With KL-A167 for Neoadjuvant Treatment of Triple-Negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"breast"]],"po":"2026-01-27","u":"2026-01-27","st":"2025-12","ag":"18–65"},{"n":"NCT07371663","t":"An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors","s":"rec","p":"phase1phase2","d":[3,4],"c":[2,23,20],"a":"adult older","h":[74,44,37],"po":"2026-01-28","u":"2026-01-28","st":"2025-12","ag":"18 and over"},{"n":"NCT07371923","t":"Application of Zanubrutinib-based Combination Regimens in the Treatment of Newly-diagnosed Diffuse Large B-cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[161],"l":[[161,"lymph"]],"po":"2026-01-28","u":"2026-01-28","st":"2025-11","ag":"18 and over"},{"n":"NCT07372365","t":"Orelabrutinib as Consolidation and Maintenance Therapy in Treatment-Naïve MZL.","s":"rec","p":"phase2","d":[19],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"lymph"]],"po":"2026-01-28","u":"2026-01-28","st":"2025-10","ag":"18 and over"},{"n":"NCT07373964","t":"A Prospective, Single-Arm, Single-Center Phase II Study Evaluating the Efficacy and Safety of Chidamide Combined With PD-L1 Inhibitor, Carboplatin, and Etoposide as First-Line Treatment in Patients With Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)","s":"rec","p":"phase2","d":[4],"c":[11],"lc":[11],"a":"adult older","h":[118],"l":[[118,"lung"]],"po":"2026-01-28","u":"2026-01-28","st":"2025-10","ag":"18–75"},{"n":"NCT07375316","t":"A ctDNA-guided Phase II Trial of Osimertinib in Combination With Sacituzumab Tirumotecan in EGFR-mutated Advanced NSCLC Patients With Positive ctDNA After lead-in Osimertinib Monotherapy","s":"rec","p":"phase2","d":[4],"c":[0,43,21],"a":"adult older","h":[43,125,126],"po":"2026-01-29","u":"2026-05-26","st":"2025-12","ag":"18 and over"},{"n":"NCT07376642","t":"A Phase I/IIa, Open-label, Single-center, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of IMV101 as a Single Agent in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma","s":"rec","p":"earlyphase1","d":[19],"c":[2,23],"a":"adult older","h":[23,46],"po":"2026-01-29","u":"2026-03-30","st":"2025-12","ag":"18 and over"},{"n":"NCT07376707","t":"A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors","s":"rec","p":"phase1","d":[2,4],"c":[5],"a":"adult older","h":[9],"po":"2026-01-29","u":"2026-01-29","st":"2025-06","ag":"18 and over"},{"n":"NCT07377279","t":"Acupuncture and Compression for the Prevention of CIPN in Breast Cancer Patients","s":"rec","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"breast"]],"po":"2026-01-29","u":"2026-02-02","st":"2025-09","ag":"18–70"},{"n":"NCT07377305","t":"Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder (NMOSD)","s":"rec","p":"na","d":[25],"c":[39],"lc":[39],"a":"adult older","h":[122],"l":[[122,"nmosd"]],"po":"2026-01-29","u":"2026-01-29","st":"2025-12","ag":"18–75"},{"n":"NCT07378137","t":"Comparing the Components of Composite Endpoints for Healthcare Providers and Patients","s":"rec","p":"na","d":[31],"c":[39],"lc":[39],"a":"adult older","h":[131],"l":[[131,"cad"]],"po":"2026-01-30","u":"2026-01-30","st":"2025-08","ag":"18 and over"},{"n":"NCT07378163","t":"Study on the Preferences for PCI Implantation Devices Among Doctors and Patients","s":"rec","p":"na","d":[31],"c":[39],"lc":[39],"a":"adult older","h":[131],"l":[[131,"cad"]],"po":"2026-01-30","u":"2026-01-30","st":"2025-08","ag":"18 and over"},{"n":"NCT07381829","t":"A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer","s":"rec","p":"phase1","d":[4],"c":[0],"a":"adult older","h":[53],"po":"2026-02-02","u":"2026-02-02","st":"2025-10","ag":"18–75"},{"n":"NCT07388771","t":"Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC）","s":"rec","p":"na","d":[4],"c":[23,13],"a":"adult older","h":[36,82],"po":"2026-02-05","u":"2026-03-19","st":"2025-12","ag":"18 and over"},{"n":"NCT07391839","t":"MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.","s":"rec","p":"phase1","d":[2],"c":[16,0,23,17,27,28,5,20],"a":"adult older","h":[6,68,136,57,120,52,44,37],"po":"2026-02-06","u":"2026-02-06","st":"2025-08","ag":"18–80"},{"n":"NCT07392346","t":"Safety and Efficacy of Fruquintinib Plus Nab-Paclitaxel and Iparomlimab and Tuvonralimab Injection in the Second-Line Treatment for Immunotherapy-experienced Advanced Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"gc"]],"po":"2026-02-06","u":"2026-02-11","st":"2025-12","ag":"18 and over"},{"n":"NCT07394218","t":"ctDNA-guided Treatment Decision-making","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2026-02-06","u":"2026-02-06","st":"2025-12","ag":"18–75"},{"n":"NCT07394387","t":"Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer.","s":"rec","p":"phase2","d":[6],"c":[28],"lc":[28],"a":"adult older","x":"female","h":[78],"l":[[78,"breast"]],"po":"2026-02-06","u":"2026-05-15","st":"2025-01","ag":"18–70"},{"n":"NCT07401537","t":"Efficacy and Safety of Extended-Dose Interval Immunotherapy Versus Standard-Dose Interval Immunotherapy for Advanced Triple-Negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"breast"]],"po":"2026-02-10","u":"2026-02-10","st":"2025-12","ag":"18–70"},{"n":"NCT07405372","t":"Construction and Application of an IDH Mutation-Targeted PET/MRI Imaging Framework for Precision Diagnosis of Gliomas","s":"rec","p":"na","d":[7],"c":[1],"lc":[1],"a":"adult older","h":[17],"l":[[17,"glioma"]],"po":"2026-02-12","u":"2026-02-24","st":"2025-12","ag":"18 and over"},{"n":"NCT07407439","t":"Real-world Studies of CDK4/6 Inhibitors","s":"rec","p":"na","d":[6],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"breast"]],"po":"2026-02-12","u":"2026-02-12","st":"2025-06","ag":"18 and over"},{"n":"NCT07411118","t":"RCT of EFTR Versus STER for GIST Treatment","s":"rec","p":"na","d":[3,12],"c":[5],"a":"adult older","h":[6],"po":"2026-02-13","u":"2026-02-13","st":"2025-02","ag":"18–75"},{"n":"NCT07411443","t":"AI-Enhanced Imaging in Population Breast Cancer Screening","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2026-02-13","u":"2026-02-13","st":"2025-01","ag":"35–69"},{"n":"NCT07413809","t":"Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen","s":"rec","p":"phase3","d":[15],"c":[61],"lc":[61],"a":"adult older","h":[323],"l":[[323,"mm"]],"po":"2026-02-17","u":"2026-02-17","st":"2025-10","ag":"18–65"},{"n":"NCT07417800","t":"Construction and Clinical Validation of a Predictive Model for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma Based on Whole-Slide Digital Pathological Images and Deep Learning","s":"rec","p":"na","d":[2],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"hcc"]],"po":"2026-02-18","u":"2026-06-10","st":"2025-11","ag":"18 and over"},{"n":"NCT07424703","t":"Effect of Bright Light Therapy on Idiopathic Scoliosis","s":"rec","p":"na","d":[33],"c":[37],"lc":[37],"a":"child","h":[188],"l":[[188,"scol"]],"po":"2026-02-20","u":"2026-05-19","st":"2025-09","ag":"10–15"},{"n":"NCT07425795","t":"Tislelizumab Combined With Chemotherapy Followed by Thoracic Consolidation Radiotherapy in the First-line Treatment of Extensive Stage Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[1],"lc":[1],"a":"adult older","h":[2],"l":[[2,"lung"]],"po":"2026-02-23","u":"2026-02-23","st":"2025-10","ag":"18–75"},{"n":"NCT07435454","t":"Exploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[28],"lc":[28],"a":"older","h":[127],"l":[[127,"escc"]],"po":"2026-02-27","u":"2026-02-27","st":"2025-12","ag":"70 and over"},{"n":"NCT07436845","t":"Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy","s":"rec","p":"na","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"hcc"]],"po":"2026-02-27","u":"2026-02-27","st":"2025-12","ag":"18 and over"},{"n":"NCT07439133","t":"Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR)","s":"rec","p":"phase3","d":[31],"c":[2,30],"a":"adult older","h":[109,38,324,161],"po":"2026-02-27","u":"2026-03-03","st":"2025-11","ag":"18–80"},{"n":"NCT07441291","t":"CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT","s":"rec","p":"phase3","d":[16],"c":[2],"lc":[2],"a":"child adult older","h":[48],"l":[[48,"ball"]],"po":"2026-02-27","u":"2026-02-27","st":"2025-11","ag":"3–79"},{"n":"NCT07443397","t":"Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients.","s":"rec","p":"phase3","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2026-03-02","u":"2026-03-02","st":"2025-08","ag":"18–80"},{"n":"NCT07448324","t":"Orelabrutinib Combined With Rituximab ± Lenalidomide in Response-Adapted Stratified Therapy for Untreated MZL","s":"rec","p":"phase2","d":[19],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"lymph"]],"po":"2026-03-04","u":"2026-03-04","st":"2025-04","ag":"18 and over"},{"n":"NCT07450391","t":"EBV-AST Cell Injection for EBV-Associated Lymphoproliferative Disorders","s":"rec","p":"phase1phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2026-03-04","u":"2026-03-04","st":"2025-06","ag":"18–70"},{"n":"NCT07455188","t":"A Study on the Efficacy and Safety of Switching Between Two Targeted Strategies, HP+Chemotherapy and HPy+Chemotherapy, After Treatment Progression in HER-2 Positive Advanced or Metastatic Breast Cancer","s":"rec","p":"na","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[44],"l":[[44,"breast"]],"po":"2026-03-06","u":"2026-03-06","st":"2025-03","ag":"18 and over"},{"n":"NCT07460362","t":"Glofitamab Combined With Lenalidomide in High Risk Patients With Relapsed or Refractory Mantle Cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[115],"l":[[115,"lymph"]],"po":"2026-03-10","u":"2026-03-10","st":"2025-08","ag":"18–80"},{"n":"NCT07463664","t":"Clinical Outcomes of Drug-Coated Balloons in the Treatment of Patients With Coronary De Novo Chronic Total Occlusion Lesions","s":"rec","p":"na","d":[31],"c":[2,36,14,20],"lc":[20],"a":"adult older","h":[25,213,87,34,325],"l":[[25,"cad"]],"po":"2026-03-11","u":"2026-03-11","st":"2025-04","ag":"18–80"},{"n":"NCT07464912","t":"A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)","s":"rec","p":"phase3","d":[37],"c":[2],"a":"adult older","h":[62],"po":"2026-03-11","u":"2026-03-11","st":"2025-12","ag":"40–80"},{"n":"NCT07466602","t":"cfDNA Methylation for Liver Cancer Recurrence Detection","s":"rec","p":"na","d":[2],"c":[13],"a":"adult older","h":[36],"po":"2026-03-12","u":"2026-03-23","st":"2025-09","ag":"18 and over"},{"n":"NCT07467330","t":"Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment","s":"rec","p":"phase3","d":[6],"c":[16],"lc":[16],"a":"adult older","x":"female","h":[30],"l":[[30,"breast"]],"po":"2026-03-12","u":"2026-03-12","st":"2025-11","ag":"18 and over"},{"n":"NCT07469267","t":"Level I-II Axillary Irradiation in Breast Cancer With Sentinel-Node Macro-metastases","s":"rec","p":"na","d":[6],"c":[8,41,23,24,27,61,5,18,30,13],"lc":[5],"a":"adult older","x":"female","h":[9,58,45,24,36,44,54,133,57,121,13,117,215],"l":[[9,"breast"]],"po":"2026-03-13","u":"2026-03-13","st":"2025-10","ag":"18 and over"},{"n":"NCT07470996","t":"T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-NR","s":"rec","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[121],"l":[[121,"lymph"]],"po":"2026-03-13","u":"2026-03-13","st":"2025-10","ag":"18–70"},{"n":"NCT07481058","t":"KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer","s":"rec","p":"phase2","d":[1],"c":[2],"a":"adult older","h":[23],"po":"2026-03-18","u":"2026-03-20","st":"2025-12","ag":"18–75"},{"n":"NCT07488728","t":"Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-Associated Hemophagocytic Lymphohistiocytosis","s":"rec","p":"na","d":[18],"c":[2],"lc":[2],"a":"child adult","h":[284],"l":[[284,"hlh"]],"po":"2026-03-23","u":"2026-03-23","st":"2025-10","ag":"Up to 18"},{"n":"NCT07489534","t":"Study of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal Dysfunction","s":"rec","p":"phase2","d":[15],"c":[2],"lc":[2],"a":"child adult older","h":[26],"l":[[26,"mm"]],"po":"2026-03-24","u":"2026-03-24","st":"2025-09","ag":"14 and over"},{"n":"NCT07489989","t":"Enhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor Combination.","s":"rec","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2026-03-24","u":"2026-03-24","st":"2025-05","ag":"18–85"},{"n":"NCT07492394","t":"Dalpiciclib With or Without Entinostat and Letrozole in HR+/HER2- Early Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[18],"lc":[18],"a":"adult older","x":"female","h":[24],"l":[[24,"breast"]],"po":"2026-03-25","u":"2026-04-02","st":"2025-09","ag":"18–75"},{"n":"NCT07495215","t":"A Clinical Study on the Safety, Tolerability and Efficacy of Neoantigen-based Personalized mRNA Therapy iNeo-Vac-R01 Plus PD-1 Inhibitor in Adjuvant Treatment of Liver Cancer Post Radical Resection","s":"rec","p":"phase1phase2","d":[2],"c":[23],"lc":[23],"a":"adult older","h":[82],"l":[[82,"hcc"]],"po":"2026-03-27","u":"2026-03-27","st":"2025-09","ag":"18–75"},{"n":"NCT07497165","t":"Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma","s":"rec","p":"na","d":[15],"c":[12],"lc":[12],"a":"adult older","h":[22],"l":[[22,"mm"]],"po":"2026-03-27","u":"2026-03-27","st":"2025-11","ag":"18–75"},{"n":"NCT07498855","t":"Robustness Evaluation of Deep Inspiration Breath-Hold (DIBH) Plans in Internal Mammary Irradiation","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[123],"l":[[123,"breast"]],"po":"2026-03-27","u":"2026-03-27","st":"2025-10","ag":"18 and over"},{"n":"NCT07498933","t":"FAP-targeted PET/NIR in Lung Malignant Tumors","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"lung"]],"po":"2026-03-27","u":"2026-04-01","st":"2025-06","ag":"18–70"},{"n":"NCT07499284","t":"A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic Anemia","s":"rec","p":"na","d":[17],"c":[23,4,31],"lc":[4],"a":"child adult older","h":[5,275,64],"l":[[5,"aa"]],"po":"2026-03-30","u":"2026-03-30","st":"2025-10","ag":"14 and over"},{"n":"NCT07508605","t":"Efficacy and Safety of CD19/CD20 CAR/TRuC-T in Relapsed/Refractory B-Cell Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[21],"lc":[21],"a":"adult older","h":[326],"l":[[326,"lymph"]],"po":"2026-04-02","u":"2026-04-02","st":"2025-01","ag":"18–75"},{"n":"NCT07508852","t":"68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer","s":"rec","p":"phase1phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[29],"l":[[29,"lung"]],"po":"2026-04-02","u":"2026-06-18","st":"2025-10","ag":"18 and over"},{"n":"NCT07509086","t":"IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia","s":"rec","p":"phase2","d":[15],"c":[15],"lc":[15],"a":"adult older","h":[27],"l":[[27,"mm"]],"po":"2026-04-03","u":"2026-04-03","st":"2025-12","ag":"18–80"},{"n":"NCT07510321","t":"FL-261 Imaging for Cancer Diagnosis and Staging","s":"rec","p":"na","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lung"]],"po":"2026-04-03","u":"2026-04-03","st":"2025-11","ag":"18 and over"},{"n":"NCT07523880","t":"Multi-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD","s":"rec","p":"na","d":[31],"c":[2,20],"a":"adult older","h":[213,264],"po":"2026-04-13","u":"2026-04-13","st":"2025-08","ag":"18 and over"},{"n":"NCT07524998","t":"A Chinese Multicenter Study on Surgical Techniques and Outcomes Across the Lifespan in Congenital Heart Disease","s":"rec","p":"na","d":[32],"c":[2],"a":"child adult older","h":[213],"po":"2026-04-13","u":"2026-04-13","st":"2025-02","ag":"Not stated"},{"n":"NCT07530094","t":"Short-Course Definitive Chemoradiotherapy Combined With Adjuvant or Concurrent Plus Adjuvant Camrelizumab for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[28],"a":"adult older","h":[127],"po":"2026-04-15","u":"2026-04-15","st":"2025-12","ag":"18–75"},{"n":"NCT07532434","t":"A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[115],"l":[[115,"breast"]],"po":"2026-04-15","u":"2026-04-15","st":"2025-09","ag":"18 and over"},{"n":"NCT07534033","t":"Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[0],"l":[[0,"lung"]],"po":"2026-04-16","u":"2026-10-29","st":"2025-12","ag":"18–80"},{"n":"NCT07538128","t":"Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma","s":"rec","p":"earlyphase1","d":[7],"c":[5],"lc":[5],"a":"adult older","h":[103],"l":[[103,"glioma"]],"po":"2026-04-20","u":"2026-04-20","st":"2025-01","ag":"18 and over"},{"n":"NCT07542002","t":"Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors：A Prospective Exploratory Study","s":"rec","p":"phase2","d":[5],"c":[61],"lc":[61],"a":"adult older","h":[215],"l":[[215,"panc"]],"po":"2026-04-21","u":"2026-04-21","st":"2025-03","ag":"18–75"},{"n":"NCT07548762","t":"Endoscopic Skin-Sparing vs. Conventional Mastectomy for Wound Complications in BC","s":"rec","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2026-04-23","u":"2026-04-23","st":"2025-12","ag":"18–75"},{"n":"NCT07559097","t":"Exploration of the Application of Methotrexate-loaded Drug Vesicles in Intrathecal Injection for Meningeal Metastasis of Lung Cancer","s":"rec","p":"phase1phase2","d":[4],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"lung"]],"po":"2026-04-30","u":"2026-04-30","st":"2025-09","ag":"18 and over"},{"n":"NCT07559864","t":"Comparing Regorafenib Combined With Envafolimab to Physician's Choice in Patients With Metastatic Gastrointestinal Stromal Tumors Harboring KIT Exon 17 Mutations Refractory to Standard Treatment","s":"rec","p":"phase2","d":[12],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"gist"]],"po":"2026-04-30","u":"2026-04-30","st":"2025-07","ag":"18 and over"},{"n":"NCT07561814","t":"A Study on a Predictive Model for Efficacy and Prognosis of Pancreatic Carcinoma Based on Multimodal Data","s":"rec","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"panc"]],"po":"2026-05-01","u":"2026-07-02","st":"2025-12","ag":"18 and over"},{"n":"NCT07564453","t":"Full-course Immunotherapy Combined With Chemotherapy in Newly Diagnosed B-cell Acute Lymphoblastic Leukemia","s":"rec","p":"phase2","d":[16],"c":[4],"lc":[4],"a":"child adult older","h":[5],"l":[[5,"ball"]],"po":"2026-05-04","u":"2026-05-04","st":"2025-04","ag":"15–65"},{"n":"NCT07574749","t":"Molecular Subtyping of Breast Cancer-derived Small Extracellular Vesicles (sEVs) to Predict Therapeutic Efficacy","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2026-05-08","u":"2026-05-08","st":"2025-04","ag":"18–75"},{"n":"NCT07578064","t":"A Randomized, Self-controlled Post-marketing Clinical Study on the Comparison of Shengbai Oral Liquid and Leucogen Tablets in the Treatment of Moderate Neutropenia Caused by Anti-tumor Drugs in Breast Cancer Patients","s":"rec","p":"phase4","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2026-05-11","u":"2026-05-11","st":"2025-08","ag":"18–80"},{"n":"NCT07578675","t":"Brain Cognitive Network Abnormalities in Anemia Patients Using fNIRS","s":"rec","p":"na","d":[17],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"aa"]],"po":"2026-05-11","u":"2026-09-18","st":"2025-10","ag":"18–65"},{"n":"NCT07581821","t":"Sintilimab Combined With Anlotinib and Taxane-Based Chemotherap for Recurrent/Metastatic Nasopharyngeal Carcinoma","s":"rec","p":"phase2","d":[0],"c":[59],"lc":[59],"a":"adult older","h":[171],"l":[[171,"npc"]],"po":"2026-05-12","u":"2026-05-12","st":"2025-09","ag":"18–65"},{"n":"NCT07585981","t":"Early Application of Budesonide Enteric-coated Capsules in the Treatment of Primary IgA Nephropathy.","s":"rec","p":"na","d":[46],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"iga"]],"po":"2026-05-14","u":"2026-05-14","st":"2025-10","ag":"18 and over"},{"n":"NCT07586384","t":"Single-port Versus Conventional Laparoscopic Surgery for Radical Proximal Gastric Cancer: A Randomized Controlled Trial","s":"rec","p":"na","d":[3],"c":[37],"lc":[37],"a":"adult older","h":[81],"l":[[81,"gc"]],"po":"2026-05-14","u":"2026-05-14","st":"2025-11","ag":"18–80"},{"n":"NCT07586813","t":"Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors","s":"rec","p":"phase2","d":[5],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"panc"]],"po":"2026-05-14","u":"2026-05-14","st":"2025-12","ag":"18 and over"},{"n":"NCT07586826","t":"Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors","s":"rec","p":"phase2","d":[4,6],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"lung"]],"po":"2026-05-14","u":"2026-05-14","st":"2025-12","ag":"18 and over"},{"n":"NCT07588737","t":"Multimodal AI-Guided Recovery Management After Lung Cancer Surgery","s":"rec","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[132],"l":[[132,"lung"]],"po":"2026-05-15","u":"2026-05-15","st":"2025-03","ag":"18–80"},{"n":"NCT07594964","t":"To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors","s":"rec","p":"phase1","d":[2,3,5],"c":[2],"a":"adult older","h":[38,74],"po":"2026-05-19","u":"2026-05-19","st":"2025-08","ag":"18–70"},{"n":"NCT07595237","t":"A IIT Study of 177Lu-DOTA-SNA040","s":"rec","p":"earlyphase1","d":[3,5],"c":[5],"a":"adult older","h":[9],"po":"2026-05-19","u":"2026-08-21","st":"2025-11","ag":"18–75"},{"n":"NCT07596693","t":"KXV01 Injection in Patients With Advanced Solid Tumor (Including Osteosarcoma and Sarcoma)","s":"rec","p":"phase1","d":[11],"c":[5],"a":"adult older","h":[202],"po":"2026-05-19","u":"2026-05-19","st":"2025-12","ag":"18–70"},{"n":"NCT07597772","t":"Preliminary Trial of SNA014 for Pancreatic Cancer","s":"rec","p":"earlyphase1","d":[5],"c":[30],"a":"adult older","h":[58],"po":"2026-05-19","u":"2026-05-19","st":"2025-10","ag":"18–75"},{"n":"NCT07600268","t":"Efficacy of Stereotactic Body Radiotherapy (SBRT) Combined With Maintenance Therapy Compared to Maintenance Therapy Alone in Advanced Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[27],"lc":[27],"a":"adult older","h":[57],"l":[[57,"panc"]],"po":"2026-05-20","u":"2026-05-20","st":"2025-08","ag":"18–70"},{"n":"NCT07608081","t":"The Value of Time-Dependent Diffusion MRI and Magnetic Resonance Elastography in the Precise Diagnosis and Efficacy Assessment of Breast Cancer","s":"rec","p":"na","d":[6],"c":[47],"lc":[47],"a":"adult older","x":"female","h":[135],"l":[[135,"breast"]],"po":"2026-05-27","u":"2026-05-27","st":"2025-10","ag":"18–80"},{"n":"NCT07610616","t":"Study on the Mechanism of ADC Drug Evaluation Based on Immune Co-culture of Lung Cancer Organoids","s":"rec","p":"na","d":[4],"c":[0],"a":"adult older","h":[132],"po":"2026-05-28","u":"2026-05-28","st":"2025-12","ag":"18–100"},{"n":"NCT07612774","t":"CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS","s":"rec","p":"phase4","d":[31],"c":[22,39],"lc":[22],"a":"adult older","h":[40,122],"l":[[40,"cad"]],"po":"2026-05-29","u":"2026-10-07","st":"2025-11","ag":"40–75"},{"n":"NCT07612891","t":"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumor","s":"rec","p":"phase1phase2","d":[6],"c":[5],"a":"adult older","h":[9],"po":"2026-05-29","u":"2026-05-29","st":"2025-07","ag":"18 and over"},{"n":"NCT07616700","t":"A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA Nephropathy","s":"rec","p":"phase2","d":[46],"c":[2],"a":"child adult older","h":[29],"po":"2026-06-01","u":"2026-06-01","st":"2025-08","ag":"Not stated"},{"n":"NCT07617246","t":"The Efficacy and Safety of Fosrolapitant and Palonosetron Hydrochloride for Injection in Preventing Nausea and Vomiting Caused by Multi-cycle Immunotherapy and Chemotherapy in Patients With Esophageal Cancer and Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lung"]],"po":"2026-06-01","u":"2026-06-01","st":"2025-11","ag":"18 and over"},{"n":"NCT07622797","t":"Exploratory Clinical Study of Camrelizumab Combined With Concurrent Chemoradiotherapy as an Organ-preserving Strategy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[36],"lc":[36],"a":"adult older","h":[87],"l":[[87,"escc"]],"po":"2026-06-03","u":"2026-06-03","st":"2025-11","ag":"18 and over"},{"n":"NCT07626736","t":"Evaluating the Efficacy and Safety of AI Localization Models in Multidisciplinary Team Care for NSCLC","s":"rec","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"lung"]],"po":"2026-06-04","u":"2026-06-04","st":"2025-12","ag":"18 and over"},{"n":"NCT07652138","t":"Safety and Efficacy of RN1201 Injection as First-Line Treatment for Newly Diagnosed Multiple Myeloma","s":"rec","p":"phase1","d":[15],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"mm"]],"po":"2026-06-16","u":"2026-06-16","st":"2025-07","ag":"18–70"},{"n":"NCT07653893","t":"A Phase II Observational Clinical Study on the Relationship Between Cerebrospinal Fluid Drug Concentration and Efficacy of Trastuzumab Deruxtecan in Central Nervous System Metastatic Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2026-06-17","u":"2026-06-17","st":"2025-06","ag":"18 and over"},{"n":"NCT07655024","t":"TAIC FOLFOX for Locally Advanced G/GEJA","s":"rec","p":"phase2","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[280],"l":[[280,"gc"]],"po":"2026-06-17","u":"2026-06-17","st":"2025-11","ag":"18 and over"},{"n":"NCT07657130","t":"Optimal Application Timing of ADC Drugs for Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[11],"lc":[11],"a":"adult older","x":"female","h":[18],"l":[[18,"breast"]],"po":"2026-06-18","u":"2026-06-18","st":"2025-07","ag":"18–75"},{"n":"NCT07657624","t":"Modifiable Risk Factors for Cognitive Dysfunction in Patients With Coronary Heart Disease","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[109],"l":[[109,"cad"]],"po":"2026-06-18","u":"2026-07-15","st":"2025-06","ag":"18 and over"},{"n":"NCT07662733","t":"Effectiveness of Perioperative Percutaneous Acupuncture on Postoperative Sleep Disturbances and Chronic Pain in Patients Undergoing Video-Assisted Thoracoscopic Lung Cancer Resection: A Prospective, Randomized, Single-Blind, Superiority Controlled Trial","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[121],"l":[[121,"lung"]],"po":"2026-06-23","u":"2026-06-23","st":"2025-06","ag":"18–75"},{"n":"NCT07670026","t":"Intensified Adjuvant Therapy for High-Risk Newly Diagnosed Glioblastoma With Subtotal Resection or Short-Term Progression","s":"rec","p":"phase2","d":[7],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"glioma"]],"po":"2026-06-25","u":"2026-06-25","st":"2025-12","ag":"18 and over"},{"n":"NCT07673029","t":"A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[48,2,55,15,8,22,1,52,16,0,41,23,24,17,27,47,25,36,70,9,10,26,56,5,43,11,18,12,30,42,13,39,14,31,19,20],"a":"adult older","h":[9,40,58,53,45,99,111,24,118,36,44,54,25,12,26,133,164,55,57,27,41,37,18,2,97,16,112,50,135,13,82,19,28,155,30,228,114,261,117,175,226,87,84,239,21,150,160,67,101,327,88],"po":"2026-06-29","u":"2026-06-29","st":"2025-01","ag":"18–75"},{"n":"NCT07692750","t":"IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer","s":"rec","p":"phase1phase2","d":[5],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"panc"]],"po":"2026-07-09","u":"2026-07-09","st":"2025-04","ag":"18 and over"},{"n":"NCT07708194","t":"Entinostat Plus Pyrotinib and Endocrine Therapy in Advanced Triple-Positive Breast Cancer After Trastuzumab Failure","s":"rec","p":"phase1phase2","d":[6],"c":[30],"lc":[30],"a":"adult older","x":"female","h":[58],"l":[[58,"breast"]],"po":"2026-07-16","u":"2026-07-16","st":"2025-06","ag":"18–75"},{"n":"NCT07725783","t":"Prospective Evaluation of Dynamic Serum ProGRP for Treatment Response Monitoring in Ewing Sarcoma","s":"rec","p":"na","d":[14],"c":[2],"lc":[2],"a":"child adult","h":[48],"l":[[48,"ewing"]],"po":"2026-07-24","u":"2026-07-24","st":"2025-09","ag":"10–60"},{"n":"NCT07742332","t":"Targeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLC","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2026-08-03","u":"2026-08-03","st":"2025-11","ag":"18 and over"},{"n":"NCT07748325","t":"Adjuvant Immune Checkpoint Inhibitor Versus Observation After Neoadjuvant Immunochemotherapy and Surgery in High-Risk NSCLC","s":"rec","p":"phase2","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"lung"]],"po":"2026-08-05","u":"2026-08-05","st":"2025-01","ag":"18–75"},{"n":"NCT07754890","t":"Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"lymph"]],"po":"2026-08-10","u":"2026-08-12","st":"2025-08","ag":"18–75"},{"n":"NCT07757165","t":"The Necessity of Surgery in Patients With mGC Achieving Radiological Response After Conversion Therapy","s":"rec","p":"phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"gc"]],"po":"2026-08-11","u":"2026-08-11","st":"2025-11","ag":"18–75"},{"n":"NCT07763054","t":"Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients","s":"rec","p":"na","d":[15,16,19],"c":[6],"lc":[6],"a":"adult older","h":[328],"l":[[328,"mm"]],"po":"2026-08-13","u":"2026-08-13","st":"2025-08","ag":"18–75"},{"n":"NCT07767305","t":"Efficacy of Kinesio Taping Versus Compression Therapy on Breast Lymphedema Induced by Radiotherapy After Breast-Conserving Surgery","s":"rec","p":"na","d":[6],"c":[77],"lc":[77],"a":"adult older","h":[292],"l":[[292,"breast"]],"po":"2026-08-17","u":"2026-08-17","st":"2025-10","ag":"18 and over"},{"n":"NCT07769827","t":"Peg IFNα-2b Therapy for Unresectable Mid to Late Stage HBV-HCC","s":"rec","p":"na","d":[2],"c":[28],"lc":[28],"a":"adult older","h":[93],"l":[[93,"hcc"]],"po":"2026-08-18","u":"2026-08-18","st":"2025-12","ag":"18 and over"},{"n":"NCT07770113","t":"A Random, Non-controlled, Open Clinical Study of Apatinib Mesylate Combined With Albumin-bound Paclitaxel ± Adebrelimab in Treating Advanced Second-line Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[36,20],"lc":[20],"a":"adult older","h":[25,87],"l":[[25,"gc"]],"po":"2026-08-18","u":"2026-08-18","st":"2025-06","ag":"18–80"},{"n":"NCT07775820","t":"PD-L1 Inhibitor Rechallenge After Immunotherapy-Related Pneumonitis in Patients With Lung Cancer","s":"rec","p":"na","d":[4],"c":[0,9,21,37],"lc":[0],"a":"adult older","h":[70,132,80,81,168],"l":[[70,"lung"]],"po":"2026-08-20","u":"2026-08-20","st":"2025-10","ag":"18 and over"},{"n":"NCT07796113","t":"Adebrelimab With Famitinib and Chemotherapy as Neoadjuvant Therapy for ESCC","s":"rec","p":"phase2","d":[1],"c":[39],"lc":[39],"a":"adult older","h":[111],"l":[[111,"escc"]],"po":"2026-08-31","u":"2026-08-31","st":"2025-10","ag":"18–75"},{"n":"NCT07801430","t":"Station 4L Lymph Node Dissection Versus No Dissection in Clinical Stage I Solid Nodule-Type Invasive NSCLC","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2026-09-03","u":"2026-09-09","st":"2025-12","ag":"18–75"},{"n":"NCT07806292","t":"Anlotinib + Benmelstobart + HAIC in Unresectable HCC: A Phase II Study","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"hcc"]],"po":"2026-09-08","u":"2026-09-08","st":"2025-04","ag":"18–75"},{"n":"NCT07810088","t":"Dalpiciclib Combined With Aromatase Inhibitors and Olmesartan as the First-line Treatment for HR+/HER2- Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[13],"lc":[13],"a":"adult older","x":"female","h":[12],"l":[[12,"breast"]],"po":"2026-09-09","u":"2026-09-09","st":"2025-06","ag":"18–75"},{"n":"NCT07815223","t":"A Phase II Study of Tislelizumab Plus Anlotinib Consolidation After Chemoradiotherapy in LS-SCLC","s":"rec","p":"phase2","d":[4],"c":[19],"lc":[19],"a":"adult older","h":[28],"l":[[28,"lung"]],"po":"2026-09-11","u":"2026-09-11","st":"2025-11","ag":"18–75"},{"n":"NCT07820423","t":"Multimodal AI Predicts High-risk Pathology in Lung Cancer Associated With Cystic Airspaces","s":"rec","p":"na","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[10],"l":[[10,"lung"]],"po":"2026-09-15","u":"2026-09-15","st":"2025-05","ag":"18 and over"},{"n":"NCT07822737","t":"PCCT-Defined High-Risk Plaque and Future Coronary Events: The PREDICT Study","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[89],"l":[[89,"cad"]],"po":"2026-09-16","u":"2026-09-16","st":"2025-01","ag":"18 and over"},{"n":"NCT07823049","t":"Study of XNW28012 in Subjects With Metastatic Pancreatic Cancer Who Received Prior Systemic Therapy","s":"rec","p":"phase3","d":[5],"c":[2,15,8,49,22,1,16,0,23,24,17,9,28,5,11,12,30,13,39,32,58,20],"a":"child adult older","h":[38,9,40,6,58,12,36,60,118,25,99,74,140,82,14,27,45,44,63,97,98,65,172,145,37,39,116,2,127,18,176,30,100,13,84,88],"po":"2026-09-16","u":"2026-09-16","st":"2025-07","ag":"Not stated"},{"n":"NCT07824479","t":"Predicting Efficacy of Preoperative Immunotherapy in Advanced Gastric Cancer","s":"rec","p":"na","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"gc"]],"po":"2026-09-17","u":"2026-09-17","st":"2025-06","ag":"18–80"},{"n":"NCT07832006","t":"Irreversible Electroporation Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"hcc"]],"po":"2026-09-21","u":"2026-09-21","st":"2025-04","ag":"18–75"},{"n":"NCT07837739","t":"Adjuvant EGFR-TKI Therapy After Surgery for EGFR-Mutant High-Risk Stage IA2-IIB NSCLC","s":"rec","p":"na","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"lung"]],"po":"2026-09-23","u":"2026-09-23","st":"2025-07","ag":"18–75"},{"n":"NCT07867392","t":"Neoadjuvant Iparomlimab and Tuvonralimab With Nab-P-SOX in Locally Advanced Gastric or Gastroesophageal Junction Cancer","s":"rec","p":"phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"gc"]],"po":"2026-10-09","u":"2026-10-13","st":"2025-02","ag":"18–75"},{"n":"NCT07883499","t":"Prospective Study Protocol for Multiparametric PCCT Assessment of Early Ventricular Outcomes After CABG","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"cad"]],"po":"2026-10-20","u":"2026-10-20","st":"2025-10","ag":"18–100"},{"n":"NCT07895277","t":"Longitudinal AI-Assisted Management of Indeterminate Pulmonary Nodules","s":"rec","p":"na","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lung"]],"po":"2026-10-26","u":"2026-10-26","st":"2025-01","ag":"35 and over"},{"n":"NCT07896668","t":"Pucotenlimab and Anlotinib in Combination With Chemotherapy","s":"rec","p":"phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"breast"]],"po":"2026-10-27","u":"2026-10-27","st":"2025-09","ag":"18 and over"},{"n":"NCT07920224","t":"Candonilimab Combined With Fruquintinib and Paclitaxel Albumin-Bound as Second-Line Treatment for Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma","s":"rec","p":"phase2","d":[3],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"gc"]],"po":"2026-11-05","u":"2026-11-05","st":"2025-07","ag":"18–75"},{"n":"NCT07934537","t":"Efficacy and Safety of Chidamide Combined With PD-1 Inhibitor as Maintenance Therapy Following CAR-T Cell Treatment With TP53-Mutated Large B-Cell Lymphoma (LBCL)","s":"rec","p":"phase4","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[162],"l":[[162,"lymph"]],"po":"2026-11-13","u":"2026-11-16","st":"2025-10","ag":"18–70"},{"n":"NCT07947043","t":"Exploratory Clinical Study of Autologous Tumor-Infiltrating Lymphocytes (TIL) Injection","s":"rec","p":"phase1","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"lung"]],"po":"2026-11-18","u":"2026-11-18","st":"2025-04","ag":"18–75"},{"n":"NCT04535843","t":"Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China","s":"rec","p":"na","d":[27],"c":[5],"lc":[5],"a":"child adult older","h":[103,76],"l":[[103,"mg"]],"po":"2020-09-02","u":"2025-05-28","st":"2024-02","ag":"0–90"},{"n":"NCT04744506","t":"Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy","s":"rec","p":"na","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2021-02-09","u":"2025-02-12","st":"2024-11","ag":"18–85"},{"n":"NCT05266846","t":"Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK","s":"rec","p":"phase2","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2022-03-04","u":"2024-05-30","st":"2024-05","ag":"18 and over"},{"n":"NCT05578053","t":"Efficacy and Safety of Dalpiciclib in Hormone Receptor-positive Advanced Breast Cancer","s":"rec","p":"na","d":[6],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"breast"]],"po":"2022-10-13","u":"2025-09-11","st":"2024-09","ag":"18 and over"},{"n":"NCT05613452","t":"Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[316],"l":[[316,"lung"]],"po":"2022-11-14","u":"2025-06-13","st":"2024-09","ag":"18–80"},{"n":"NCT05745350","t":"First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC","s":"rec","p":"phase2","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lung"]],"po":"2023-02-27","u":"2025-02-11","st":"2024-03","ag":"18 and over"},{"n":"NCT05812287","t":"Exploring the Difference Between Gastric Cardia Cancer and Non-cardia Gastric Cancer Based on Multiomics","s":"rec","p":"na","d":[3],"c":[27],"lc":[27],"a":"adult older","h":[124],"l":[[124,"gc"]],"po":"2023-04-13","u":"2026-09-08","st":"2024-03","ag":"18–75"},{"n":"NCT05824520","t":"Coronary CT-Derived FFR-Guided Strategy Versus Medical Therapy","s":"rec","p":"na","d":[31],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"cad"]],"po":"2023-04-21","u":"2026-02-02","st":"2024-10","ag":"18 and over"},{"n":"NCT05831085","t":"Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease","s":"rec","p":"na","d":[31],"c":[2,23],"a":"adult older","h":[213,54],"po":"2023-04-26","u":"2026-06-24","st":"2024-06","ag":"20 and over"},{"n":"NCT05892289","t":"Feasibility and Safety of Robotic Assisted Proximal Gastrectomy With Double-flap Technique for Proximal Early Gastric Cancer","s":"rec","p":"na","d":[3],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"gc"]],"po":"2023-06-07","u":"2025-05-25","st":"2024-06","ag":"20–80"},{"n":"NCT05941741","t":"IC Plus Low-dose Radiation Plus Cadonilimab in LANPC","s":"rec","p":"phase3","d":[0],"c":[0,9,10],"lc":[0],"a":"adult older","h":[53,15,116],"l":[[53,"npc"]],"po":"2023-07-12","u":"2026-05-11","st":"2024-01","ag":"18–70"},{"n":"NCT05956587","t":"A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors","s":"rec","p":"phase2","d":[0,4],"c":[1,16,0,23,25,88,36,9,30,13,39,20],"a":"adult older","h":[53,30,99,44,2,49,80,12,133,111,37,59,329,67,87],"po":"2023-07-21","u":"2025-09-26","st":"2024-01","ag":"18–75"},{"n":"NCT05979818","t":"Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer","s":"rec","p":"phase1","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[10],"l":[[10,"lung"]],"po":"2023-08-07","u":"2026-11-19","st":"2024-11","ag":"18–75"},{"n":"NCT05990556","t":"Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients","s":"rec","p":"na","d":[7],"c":[0],"lc":[0],"a":"adult older","h":[49],"l":[[49,"glioma"]],"po":"2023-08-14","u":"2024-07-24","st":"2024-05","ag":"18–70"},{"n":"NCT05997693","t":"One-Month DAPT in CABG Patients","s":"rec","p":"phase3","d":[31],"c":[2,15,5],"a":"adult older","h":[109,123,330],"po":"2023-08-18","u":"2025-12-22","st":"2024-08","ag":"18 and over"},{"n":"NCT06020430","t":"Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy","s":"rec","p":"na","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[19],"l":[[19,"lung"]],"po":"2023-08-31","u":"2024-03-15","st":"2024-02","ag":"18–75"},{"n":"NCT06032052","t":"Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients","s":"rec","p":"phase2","d":[4],"c":[13],"lc":[13],"a":"older","h":[19],"l":[[19,"lung"]],"po":"2023-09-11","u":"2024-03-15","st":"2024-02","ag":"65 and over"},{"n":"NCT06037733","t":"Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy","s":"rec","p":"na","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[19],"l":[[19,"lung"]],"po":"2023-09-14","u":"2024-03-15","st":"2024-03","ag":"18–75"},{"n":"NCT06060782","t":"Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine","s":"rec","p":"phase1","d":[16,19],"c":[59],"lc":[59],"a":"adult older","h":[171],"l":[[171,"ball"]],"po":"2023-09-29","u":"2025-03-06","st":"2024-03","ag":"18–65"},{"n":"NCT06083207","t":"A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma","s":"rec","p":"phase1phase2","d":[15],"c":[2,28,10,5,4,30,13,39,31],"a":"adult older","h":[64,5,38,59,78,6,36,15,111],"po":"2023-10-13","u":"2024-12-13","st":"2024-07","ag":"18 and over"},{"n":"NCT06087510","t":"Different Dose Esketamine and Dexmedetomidine for Supplemental Analgesia and Longterm Outcomes","s":"rec","p":"phase4","d":[33],"c":[2],"lc":[2],"a":"adult older","h":[29],"l":[[29,"scol"]],"po":"2023-10-17","u":"2025-07-30","st":"2024-01","ag":"18 and over"},{"n":"NCT06102824","t":"Organoid-based Functional Precision Therapy for Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"breast"]],"po":"2023-10-26","u":"2024-11-25","st":"2024-10","ag":"18–80"},{"n":"NCT06109454","t":"Observation on the Therapeutic Effect of Huaier Granules in the Adjuvant Treatment of Non-small Cell Lung Cancer After Radical Surgery","s":"rec","p":"na","d":[4],"c":[11],"lc":[11],"a":"adult older","h":[18],"l":[[18,"lung"]],"po":"2023-10-31","u":"2024-05-10","st":"2024-03","ag":"18–75"},{"n":"NCT06111638","t":"Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs","s":"rec","p":"phase2phase3","d":[21],"c":[2,8,22,0,41,47,4,30,13,39],"a":"adult older","x":"male","h":[69,38,70,5,11,12,267,137,98,331],"po":"2023-11-01","u":"2026-03-17","st":"2024-01","ag":"18 and over"},{"n":"NCT06121505","t":"Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[22,1,51,13],"lc":[22],"a":"adult older","h":[40,12,47,166,146],"l":[[40,"lung"]],"po":"2023-11-08","u":"2025-12-17","st":"2024-03","ag":"18–75"},{"n":"NCT06122389","t":"SHR2554 Clinical Study of Chidamide in the Treatment of T-cell Lymphoma","s":"rec","p":"phase3","d":[19],"c":[2],"a":"adult older","h":[74],"po":"2023-11-08","u":"2026-01-08","st":"2024-02","ag":"18–70"},{"n":"NCT06123494","t":"SHR-A1811 for Subjects With Her2-positive Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on or After First-line Anti-HER2 Therapy-containing Regimen","s":"rec","p":"phase3","d":[3],"c":[5],"a":"adult older","h":[65],"po":"2023-11-08","u":"2024-01-16","st":"2024-01","ag":"18–75"},{"n":"NCT06127303","t":"Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42,6,332],"l":[[42,"lung"]],"po":"2023-11-13","u":"2025-09-05","st":"2024-04","ag":"18–75"},{"n":"NCT06128252","t":"Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer","s":"rec","p":"na","d":[3],"c":[1,28,5,11,34,13,39],"lc":[39],"a":"adult older","h":[122,60,118,9,131,36,144,193,97,167,17,72],"l":[[122,"gc"]],"po":"2023-11-13","u":"2026-06-09","st":"2024-09","ag":"18–75"},{"n":"NCT06128837","t":"Study of LY01610 in Patients With Recurrent Small Cell Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[2],"a":"adult older","h":[23],"po":"2023-11-13","u":"2024-03-15","st":"2024-03","ag":"18 and over"},{"n":"NCT06134960","t":"NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor","s":"rec","p":"phase1","d":[3,5],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"gc"]],"po":"2023-11-18","u":"2026-09-14","st":"2024-11","ag":"18–75"},{"n":"NCT06149130","t":"Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR+/HER2 - Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[13],"lc":[13],"a":"adult older","x":"female","h":[36],"l":[[36,"breast"]],"po":"2023-11-28","u":"2024-04-15","st":"2024-01","ag":"18–75"},{"n":"NCT06157996","t":"Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscore","s":"rec","p":"phase2","d":[3],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"gc"]],"po":"2023-12-06","u":"2025-05-30","st":"2024-06","ag":"18 and over"},{"n":"NCT06172478","t":"A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors","s":"rec","p":"phase2","d":[3,4,5,6],"c":[22,0],"a":"adult older","h":[40,53],"po":"2023-12-15","u":"2026-11-17","st":"2024-02","ag":"18 and over"},{"n":"NCT06176027","t":"Azacytidine Plus CAOLD Regimen in Relapsed/Refractory Peripheral T-Cell Lymphomas","s":"rec","p":"phase1phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2023-12-19","u":"2024-10-29","st":"2024-10","ag":"18 and over"},{"n":"NCT06176534","t":"Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial","s":"rec","p":"phase2","d":[6],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"breast"]],"po":"2023-12-19","u":"2024-08-20","st":"2024-01","ag":"18 and over"},{"n":"NCT06179069","t":"A Study of ZL-1310 in Subjects With Small Cell Lung Cancer","s":"rec","p":"phase1","d":[4],"c":[2,8,22,0,24,17,9,28,5,11,13,39,7,20],"a":"adult older","h":[43,6,12,111,74,45,13,47,80,37,112,60,18,8],"po":"2023-12-21","u":"2026-10-16","st":"2024-01","ag":"18 and over"},{"n":"NCT06179524","t":"CAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALL","s":"rec","p":"phase2","d":[16],"c":[30],"a":"child adult","h":[69],"po":"2023-12-22","u":"2025-01-13","st":"2024-01","ag":"Up to 25"},{"n":"NCT06182657","t":"The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC","s":"rec","p":"na","d":[0],"c":[9],"lc":[9],"a":"adult older","h":[116],"l":[[116,"npc"]],"po":"2023-12-27","u":"2024-02-08","st":"2024-01","ag":"18 and over"},{"n":"NCT06194656","t":"Clinical Trial of SIBP-03 in Patients With Head and Neck Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[0],"c":[5],"a":"adult older","h":[65],"po":"2024-01-08","u":"2026-01-16","st":"2024-09","ag":"18–75"},{"n":"NCT06194734","t":"A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer","s":"rec","p":"phase3","d":[1],"c":[2],"a":"adult older","h":[23],"po":"2024-01-08","u":"2024-03-07","st":"2024-02","ag":"18–75"},{"n":"NCT06195189","t":"Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure：Phase I/II","s":"rec","p":"phase1phase2","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"lung"]],"po":"2024-01-08","u":"2026-05-08","st":"2024-02","ag":"18–80"},{"n":"NCT06196294","t":"GPC3/Mesothelin-CAR-γδT Cells Against Cancers","s":"rec","p":"phase1","d":[4,5],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"lung"]],"po":"2024-01-09","u":"2024-06-26","st":"2024-05","ag":"18–75"},{"n":"NCT06196697","t":"AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer","s":"rec","p":"phase2","d":[3],"c":[24],"lc":[24],"a":"adult older","h":[333],"l":[[333,"gc"]],"po":"2024-01-09","u":"2024-06-27","st":"2024-04","ag":"18–75"},{"n":"NCT06197581","t":"Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2024-01-09","u":"2024-08-21","st":"2024-01","ag":"18–70"},{"n":"NCT06197776","t":"Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC","s":"rec","p":"na","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2024-01-09","u":"2026-05-11","st":"2024-07","ag":"18–70"},{"n":"NCT06198868","t":"MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC","s":"rec","p":"na","d":[4],"c":[28],"lc":[28],"a":"adult older","h":[127],"l":[[127,"lung"]],"po":"2024-01-10","u":"2024-01-12","st":"2024-02","ag":"18 and over"},{"n":"NCT06200168","t":"Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[62],"lc":[62],"a":"adult older","h":[192],"l":[[192,"breast"]],"po":"2024-01-10","u":"2025-04-02","st":"2024-01","ag":"18–75"},{"n":"NCT06203210","t":"A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[2,8,22,1,23,24,27,25,9,5,11,30,34,13,38,19,20],"a":"adult older","h":[40,57,58,9,44,12,74,45,36,46,13,47,80,37,61,2,18,62,28,19,72,86,67],"po":"2024-01-12","u":"2026-08-06","st":"2024-05","ag":"18 and over"},{"n":"NCT06206174","t":"TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies","s":"rec","p":"phase1phase2","d":[19],"c":[30],"a":"adult older","h":[69],"po":"2024-01-16","u":"2024-04-10","st":"2024-03","ag":"18 and over"},{"n":"NCT06207552","t":"Evaluation of the Safety, Tolerability and Efficacy of a Gene Therapy Drug for the Treatment of Pediatric Fabry Disease","s":"rec","p":"earlyphase1","d":[41],"c":[5],"lc":[5],"a":"child adult","h":[76],"l":[[76,"fabry"]],"po":"2024-01-17","u":"2024-07-09","st":"2024-02","ag":"7–18"},{"n":"NCT06210776","t":"A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)","s":"rec","p":"na","d":[6],"c":[2,22,63,16,0,23,24,17,47,36,9,28,40,26,5,43,11,21,12,77,30,34,42,39,14,31,58,20,59],"a":"adult older","h":[9,78,58,45,99,111,44,54,25,26,125,110,37,18,97,135,47,60,29,72,92,30,172,95,98,114,115,116,106,64,171,198,292,177,87,84,247,21,319,3,88],"po":"2024-01-18","u":"2026-01-12","st":"2024-01","ag":"18 and over"},{"n":"NCT06210815","t":"A Study of HLX42 in Advanced/Metastatic Solid Tumors","s":"rec","p":"phase1","d":[4],"c":[0],"a":"adult older","h":[43],"po":"2024-01-18","u":"2025-09-22","st":"2024-03","ag":"18–75"},{"n":"NCT06214195","t":"The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity","s":"rec","p":"phase3","d":[6],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"breast"]],"po":"2024-01-19","u":"2024-01-19","st":"2024-01","ag":"18 and over"},{"n":"NCT06215326","t":"Short-term Effects of Preoperative Exercise in Moderate-to-high Perioperative Risk Lung Cancer Patients","s":"rec","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"lung"]],"po":"2024-01-22","u":"2026-08-03","st":"2024-01","ag":"18 and over"},{"n":"NCT06215495","t":"A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial","s":"rec","p":"na","d":[7],"c":[0],"lc":[0],"a":"adult older","h":[0],"l":[[0,"glioma"]],"po":"2024-01-22","u":"2024-03-15","st":"2024-02","ag":"18–65"},{"n":"NCT06215651","t":"Cadonilimab and Lenvatinib for Conversion Therapy in Unresectable Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"hcc"]],"po":"2024-01-22","u":"2024-04-01","st":"2024-03","ag":"18–75"},{"n":"NCT06216847","t":"Clinical Outcomes of Patients With Coronary Artery Disease","s":"rec","p":"na","d":[31],"c":[11],"lc":[11],"a":"adult older","h":[128],"l":[[128,"cad"]],"po":"2024-01-22","u":"2025-09-10","st":"2024-02","ag":"18 and over"},{"n":"NCT06217757","t":"Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC","s":"rec","p":"phase1phase2","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"lung"]],"po":"2024-01-22","u":"2026-05-05","st":"2024-04","ag":"18–75"},{"n":"NCT06219356","t":"A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas","s":"rec","p":"phase1","d":[19],"c":[2,8,0,23,9,5,11,12,13,7,20],"a":"adult older","h":[53,74,46,12,9,115,8,37,143,13,116,84],"po":"2024-01-23","u":"2025-08-19","st":"2024-01","ag":"18 and over"},{"n":"NCT06221748","t":"DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy","s":"rec","p":"phase2phase3","d":[3],"c":[2,8,22,24,27,47,26,5,13,7,31,20],"a":"adult older","h":[74,40,25,55,123,45,57,8,13,19,135,101],"po":"2024-01-24","u":"2024-04-03","st":"2024-02","ag":"18–75"},{"n":"NCT06228079","t":"Adjuvant vs Surgery Only in Early-stage Recurrent NPC","s":"rec","p":"phase3","d":[0],"c":[16,10,5,21],"lc":[5],"a":"adult older","h":[236,96,140,104,6,202,177],"l":[[236,"npc"]],"po":"2024-01-29","u":"2025-07-04","st":"2024-06","ag":"18–75"},{"n":"NCT06228794","t":"The Prognostic Value of CPCs Quantified by Flow Cytometry in Patients With Multiple Myeloma: a Prospective, Multicenter Clinical Trial","s":"rec","p":"na","d":[15],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"mm"]],"po":"2024-01-29","u":"2025-05-21","st":"2024-04","ag":"18–80"},{"n":"NCT06228963","t":"Orelabrutinib in the Treatment of HP-positive Gastric MALT Lymphoma","s":"rec","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lymph"]],"po":"2024-01-29","u":"2024-02-23","st":"2024-03","ag":"18 and over"},{"n":"NCT06230055","t":"Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With Leptomeningeal Metastasis","s":"rec","p":"phase4","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2024-01-29","u":"2025-11-25","st":"2024-01","ag":"18 and over"},{"n":"NCT06232096","t":"A Study of MBS314 in Participants With Relapsed/Refractory Multiple Myeloma.","s":"rec","p":"phase1phase2","d":[15],"c":[30],"a":"adult older","h":[69],"po":"2024-01-30","u":"2024-03-15","st":"2024-02","ag":"18 and over"},{"n":"NCT06232395","t":"Early Detection and Post-operative Monitoring of Gastric Cancer","s":"rec","p":"na","d":[3],"c":[5],"a":"adult older","h":[9],"po":"2024-01-30","u":"2025-06-06","st":"2024-02","ag":"18 and over"},{"n":"NCT06235203","t":"Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC","s":"rec","p":"phase3","d":[0],"c":[16,10,5,21],"lc":[5],"a":"adult older","h":[236,96,140,104,6,202,177],"l":[[236,"npc"]],"po":"2024-01-31","u":"2025-06-03","st":"2024-07","ag":"18–75"},{"n":"NCT06235931","t":"A Clinical Study of Darcilil Combined With AI Combined With Pyrrotinib in the Treatment of TPBC","s":"rec","p":"na","d":[6],"c":[4],"lc":[4],"a":"older","x":"female","h":[187],"l":[[187,"breast"]],"po":"2024-02-01","u":"2024-02-01","st":"2024-02","ag":"65 and over"},{"n":"NCT06238908","t":"Safety and Efficacy Study of NGGT003 in Hemophilia A Patients","s":"rec","p":"earlyphase1","d":[21],"c":[30],"lc":[30],"a":"adult older","x":"male","h":[69],"l":[[69,"ha"]],"po":"2024-02-02","u":"2025-02-21","st":"2024-01","ag":"18 and over"},{"n":"NCT06239727","t":"Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response","s":"rec","p":"phase3","d":[0],"c":[8,22,1,44,63,16,0,41,6,23,9,28,10,43,30,13,39,7,45],"lc":[0],"a":"adult older","h":[53,30,11,13,50,40,8,47,7,44,129,116,2,127,12,125,36,58,198,111,130,245],"l":[[53,"npc"]],"po":"2024-02-02","u":"2026-03-06","st":"2024-03","ag":"18–65"},{"n":"NCT06241326","t":"Immunotherapy for Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"hcc"]],"po":"2024-02-05","u":"2024-04-10","st":"2024-03","ag":"18 and over"},{"n":"NCT06241521","t":"Myasthenia Gravis Registry in China","s":"rec","p":"na","d":[27],"c":[2,15,8,22,1,0,9,5,4,30,39,31,20],"lc":[5],"a":"child adult older","h":[103,49,59,11,122,40,71,64,94,79,5,38,25,14,27,209],"l":[[103,"mg"]],"po":"2024-02-05","u":"2024-02-05","st":"2024-02","ag":"Not stated"},{"n":"NCT06241599","t":"A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)","s":"rec","p":"phase2phase3","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2024-02-05","u":"2024-02-05","st":"2024-02","ag":"18–75"},{"n":"NCT06241612","t":"Individualized Elective Neck Irradiation in NPC Patients","s":"rec","p":"phase3","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2024-02-05","u":"2025-09-17","st":"2024-04","ag":"18–70"},{"n":"NCT06243003","t":"WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases","s":"rec","p":"phase1phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2024-02-05","u":"2024-02-07","st":"2024-01","ag":"18 and over"},{"n":"NCT06244225","t":"HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"hcc"]],"po":"2024-02-06","u":"2024-02-06","st":"2024-01","ag":"18 and over"},{"n":"NCT06244264","t":"The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis","s":"rec","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"lung"]],"po":"2024-02-06","u":"2024-07-12","st":"2024-03","ag":"18–75"},{"n":"NCT06244368","t":"GVM±R in Patients With Relapsed or Refractory Aggressive NHL.","s":"rec","p":"phase2","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"lymph"]],"po":"2024-02-06","u":"2025-05-14","st":"2024-01","ag":"18–65"},{"n":"NCT06249438","t":"A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy","s":"rec","p":"phase1","d":[25,27],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"nmosd"]],"po":"2024-02-08","u":"2025-07-25","st":"2024-03","ag":"18–70"},{"n":"NCT06250959","t":"RDC-Blinatumomab Versus hyperCVAD for Ph-negative B-ALL.","s":"rec","p":"phase2","d":[16],"c":[4],"lc":[4],"a":"child adult older","h":[5],"l":[[5,"ball"]],"po":"2024-02-09","u":"2024-04-04","st":"2024-02","ag":"15–65"},{"n":"NCT06253962","t":"Carotid Atherosclerosis in Predicting Coronary Artery Disease","s":"rec","p":"na","d":[31],"c":[5],"lc":[5],"a":"child adult older","h":[6],"l":[[6,"cad"]],"po":"2024-02-12","u":"2024-02-12","st":"2024-02","ag":"14–90"},{"n":"NCT06254690","t":"The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase II Clinical Study","s":"rec","p":"phase2","d":[6],"c":[28],"lc":[28],"a":"adult older","x":"female","h":[78,288],"l":[[78,"breast"]],"po":"2024-02-12","u":"2024-02-12","st":"2024-01","ag":"18–70"},{"n":"NCT06255210","t":"Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON)","s":"rec","p":"phase2","d":[13],"c":[5],"lc":[5],"a":"adult older","h":[236],"l":[[236,"nb"]],"po":"2024-02-13","u":"2024-02-13","st":"2024-03","ag":"18 and over"},{"n":"NCT06255392","t":"Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2024-02-13","u":"2025-08-15","st":"2024-06","ag":"18–70"},{"n":"NCT06256237","t":"Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 Trial","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2024-02-13","u":"2024-05-29","st":"2024-04","ag":"18 and over"},{"n":"NCT06258642","t":"Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2024-02-14","u":"2025-08-20","st":"2024-04","ag":"18–75"},{"n":"NCT06265350","t":"Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases","s":"rec","p":"na","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"hcc"]],"po":"2024-02-20","u":"2024-02-20","st":"2024-02","ag":"18–75"},{"n":"NCT06267183","t":"A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.","s":"rec","p":"earlyphase1","d":[37],"c":[5],"a":"adult","h":[334],"po":"2024-02-20","u":"2026-08-14","st":"2024-01","ag":"18–45"},{"n":"NCT06269211","t":"Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1 Positive Expression","s":"rec","p":"phase2","d":[4],"c":[0,5],"lc":[5],"a":"adult older","h":[123,43],"l":[[123,"lung"]],"po":"2024-02-21","u":"2024-11-18","st":"2024-04","ag":"18 and over"},{"n":"NCT06272214","t":"Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy","s":"rec","p":"phase2","d":[1],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"escc"]],"po":"2024-02-22","u":"2024-07-16","st":"2024-03","ag":"18–75"},{"n":"NCT06276868","t":"Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[20],"lc":[20],"a":"adult older","x":"female","h":[37],"l":[[37,"breast"]],"po":"2024-02-26","u":"2024-12-17","st":"2024-01","ag":"18–70"},{"n":"NCT06277050","t":"Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[78,9],"lc":[9],"a":"adult older","h":[116,270,335],"l":[[116,"npc"]],"po":"2024-02-26","u":"2026-05-15","st":"2024-03","ag":"18–70"},{"n":"NCT06277531","t":"Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)","s":"rec","p":"na","d":[5],"c":[2],"lc":[2],"a":"adult older","h":[115,100],"l":[[115,"panc"]],"po":"2024-02-26","u":"2025-05-28","st":"2024-03","ag":"18–85"},{"n":"NCT06278454","t":"Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases","s":"rec","p":"phase1","d":[5],"c":[1,5,4,30,20],"a":"adult older","h":[177,121,187,37,59,2],"po":"2024-02-26","u":"2026-06-10","st":"2024-01","ag":"18–80"},{"n":"NCT06279026","t":"UTAA17 Injection in the Treatment of Relapsed/Refractory Multiple Myeloma","s":"rec","p":"na","d":[15],"c":[4],"a":"adult older","h":[187],"po":"2024-02-26","u":"2024-02-26","st":"2024-04","ag":"18 and over"},{"n":"NCT06280105","t":"A Trial of Cadonilimab Plus Regorafenib in Patients With Hepatocellular Carcinoma Who Failed Camrelizumab Combined With Apatinib","s":"rec","p":"phase2","d":[2],"c":[16],"lc":[16],"a":"adult older","h":[190],"l":[[190,"hcc"]],"po":"2024-02-28","u":"2025-05-15","st":"2024-03","ag":"18–75"},{"n":"NCT06280313","t":"Impact of Splenectomy on the Efficacy of Targeted Therapy and Immunotherapy in Unresectable HCC Patients With Cirrhotic Portal Hypertension","s":"rec","p":"na","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2024-02-28","u":"2025-08-15","st":"2024-03","ag":"18–75"},{"n":"NCT06280378","t":"β-Thalassemia Treatment With KL003 Cell Injection","s":"rec","p":"phase1phase2","d":[20],"c":[5,30],"a":"child adult","h":[69,123],"po":"2024-02-28","u":"2026-11-02","st":"2024-04","ag":"3–35"},{"n":"NCT06282796","t":"Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy","s":"rec","p":"na","d":[6],"c":[16,11],"lc":[11],"a":"adult older","x":"female","h":[118,18,30],"l":[[118,"breast"]],"po":"2024-02-28","u":"2024-02-28","st":"2024-01","ag":"18–80"},{"n":"NCT06283719","t":"Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer","s":"rec","p":"phase1phase2","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2024-02-28","u":"2026-10-19","st":"2024-09","ag":"18–75"},{"n":"NCT06285279","t":"The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases","s":"rec","p":"phase1","d":[26],"c":[28],"lc":[28],"a":"adult older","h":[93],"l":[[93,"igg4"]],"po":"2024-02-29","u":"2026-07-06","st":"2024-03","ag":"18–65"},{"n":"NCT06287788","t":"A Mucosal Contouring Method Based on Swallowing-induced Breakthrough Pain for Radiation-induced Oropharyngeal Mucositis","s":"rec","p":"na","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"npc"]],"po":"2024-03-01","u":"2024-03-01","st":"2024-03","ag":"18 and over"},{"n":"NCT06295926","t":"Serplulimab Combined With CCRT for LS-SCLC.","s":"rec","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"lung"]],"po":"2024-03-06","u":"2024-07-22","st":"2024-04","ag":"18 and over"},{"n":"NCT06300177","t":"D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure","s":"rec","p":"phase3","d":[4],"c":[48,2,15,8,49,22,1,16,0,57,6,23,24,17,27,47,33,36,9,28,10,40,5,11,18,12,30,34,42,37,13,60,39,7,14,31,45,20,64],"a":"adult older","h":[23,42,57,58,11,26,111,74,118,36,10,24,46,127,13,54,133,14,81,143,37,15,140,61,30,2,135,122,68,123,166,136,92,7,206,98,115,64,145,195,101,138,211,170,99,20,129,193,72,114,8,71,175,116,84,21,216,204,336,87,150,178,260],"po":"2024-03-08","u":"2024-04-26","st":"2024-03","ag":"18 and over"},{"n":"NCT06300879","t":"A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique","s":"rec","p":"na","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[103],"l":[[103,"gc"]],"po":"2024-03-08","u":"2025-05-02","st":"2024-01","ag":"18–75"},{"n":"NCT06301165","t":"TPC Versus GP Induction Chemotherapy for Nasopharyngeal Carcinoma","s":"rec","p":"phase2","d":[0],"c":[44,63,0,21,13],"a":"adult older","h":[53,95,99,12,126,198,132,130],"po":"2024-03-08","u":"2024-07-08","st":"2024-03","ag":"18–65"},{"n":"NCT06301399","t":"Rituximab Combined With Prior Therapy in Advanced Hepatocellular Carcinoma: Efficacy & Safety Study","s":"rec","p":"phase2","d":[2],"c":[30],"lc":[30],"a":"child adult older","h":[58],"l":[[58,"hcc"]],"po":"2024-03-08","u":"2024-11-20","st":"2024-03","ag":"17–79"},{"n":"NCT06301438","t":"Dalpiciclib in HR+/HER2- ABC","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"breast"]],"po":"2024-03-08","u":"2026-02-03","st":"2024-05","ag":"18 and over"},{"n":"NCT06304350","t":"Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[5],"a":"adult older","h":[121],"po":"2024-03-12","u":"2024-03-13","st":"2024-02","ag":"18–75"},{"n":"NCT06304441","t":"Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[337],"l":[[337,"lung"]],"po":"2024-03-12","u":"2025-09-29","st":"2024-04","ag":"18–75"},{"n":"NCT06306456","t":"A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC","s":"rec","p":"phase1phase2","d":[4],"c":[8,17,28,5,29,20],"a":"adult older","h":[56,25,13,60,66,31],"po":"2024-03-12","u":"2024-07-08","st":"2024-03","ag":"18 and over"},{"n":"NCT06306755","t":"Effectiveness of Risk-based Sequential Screening for Esophageal and Gastric Cancer","s":"rec","p":"na","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"gc"]],"po":"2024-03-12","u":"2025-01-24","st":"2024-06","ag":"50–69"},{"n":"NCT06307314","t":"Plasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis","s":"rec","p":"na","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"npc"]],"po":"2024-03-12","u":"2024-03-12","st":"2024-02","ag":"18 and over"},{"n":"NCT06307600","t":"The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia","s":"rec","p":"earlyphase1","d":[16,19],"c":[17,13],"lc":[17],"a":"child adult older","h":[68,12],"l":[[68,"ball"]],"po":"2024-03-13","u":"2025-01-23","st":"2024-03","ag":"3–70"},{"n":"NCT06307925","t":"A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors","s":"rec","p":"phase1","d":[2],"c":[0],"a":"adult older","h":[53],"po":"2024-03-13","u":"2025-05-13","st":"2024-03","ag":"18–75"},{"n":"NCT06308328","t":"A Real-world Observational Study of a Mucosal Contouring Method for Radiation-induced Oropharyngeal Mucositis","s":"rec","p":"na","d":[0],"c":[22,0,5,85,21,59],"lc":[0],"a":"adult older","h":[70,53,9,95,99,47,171,49,126,308],"l":[[70,"npc"]],"po":"2024-03-13","u":"2024-03-13","st":"2024-04","ag":"18 and over"},{"n":"NCT06309485","t":"Phase 2 Study of WGI-0301 for Advanced HCC","s":"rec","p":"phase2","d":[2],"c":[8,22,23,24,9,13],"a":"adult older","h":[40,36,82,45,44,13,116],"po":"2024-03-13","u":"2026-09-11","st":"2024-07","ag":"18 and over"},{"n":"NCT06311929","t":"Precision Adjuvant Therapy After Surgery for Hepatocellular Carcinoma","s":"rec","p":"phase4","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2024-03-15","u":"2024-05-07","st":"2024-04","ag":"18–75"},{"n":"NCT06311981","t":"Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"older","h":[316],"l":[[316,"lung"]],"po":"2024-03-15","u":"2025-06-13","st":"2024-08","ag":"75 and over"},{"n":"NCT06312137","t":"A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)","s":"rec","p":"phase3","d":[4],"c":[2,15,8,22,16,0,23,27,9,5,4,29,13,39,20],"a":"adult older","h":[56,57,38,44,5,132,6,11,12,74,46,13,47,27,14,48,37,70,82,30,122,19,66],"po":"2024-03-15","u":"2026-11-10","st":"2024-04","ag":"18 and over"},{"n":"NCT06313086","t":"DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[5],"a":"adult older","h":[9],"po":"2024-03-15","u":"2024-05-10","st":"2024-03","ag":"18 and over"},{"n":"NCT06313190","t":"Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402)","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"hcc"]],"po":"2024-03-15","u":"2024-11-18","st":"2024-04","ag":"18–75"},{"n":"NCT06313450","t":"De-escalated Radiotherapy for Primary Tumor After Neoadjuvant Therapy With Toripalimab Plus Chemotherapy for Nasopharyngeal Carcinoma","s":"rec","p":"na","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2024-03-15","u":"2024-03-19","st":"2024-03","ag":"18–70"},{"n":"NCT06313463","t":"Study Of Capecitabine Combined With Camrelizumab For Non-pCR TNBC With TLS After Neoadjuvant Chemoterapy","s":"rec","p":"phase3","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2024-03-15","u":"2024-03-15","st":"2024-03","ag":"18–80"},{"n":"NCT06313567","t":"Metronomic Capecitabine in Stage III Gastric Cancer","s":"rec","p":"phase3","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"gc"]],"po":"2024-03-15","u":"2024-07-08","st":"2024-03","ag":"18–80"},{"n":"NCT06313957","t":"A Study of LUCAR-20SP in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma","s":"rec","p":"phase1","d":[19],"c":[2,20],"lc":[2],"a":"adult older","h":[74,37],"l":[[74,"lymph"]],"po":"2024-03-15","u":"2025-03-25","st":"2024-03","ag":"18 and over"},{"n":"NCT06314295","t":"Automated Echocardiographic Detection of Coronary Artery Disease Using Artificial Intelligence Methods","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[94],"l":[[94,"cad"]],"po":"2024-03-18","u":"2025-11-21","st":"2024-03","ag":"18–90"},{"n":"NCT06314334","t":"Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[23,5],"a":"adult older","h":[9,236,44,90],"po":"2024-03-18","u":"2026-04-09","st":"2024-03","ag":"18–75"},{"n":"NCT06314906","t":"Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[33],"lc":[33],"a":"adult older","h":[195],"l":[[195,"breast"]],"po":"2024-03-18","u":"2024-03-21","st":"2024-03","ag":"18–75"},{"n":"NCT06319157","t":"Minimal Access Versus Conventional Latissimus Dorsi Flap Harvest for Breast Reconstruction","s":"rec","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2024-03-19","u":"2024-03-19","st":"2024-03","ag":"18–70"},{"n":"NCT06321289","t":"Allogeneic TRAC Locus-inserted CD19-targeting STAR T Cell Therapy in r/r B-NHL","s":"rec","p":"phase1phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2024-03-20","u":"2024-03-25","st":"2024-03","ag":"18–75"},{"n":"NCT06321939","t":"Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma","s":"rec","p":"na","d":[0],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"npc"]],"po":"2024-03-20","u":"2024-03-20","st":"2024-01","ag":"18 and over"},{"n":"NCT06323239","t":"SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma","s":"rec","p":"phase2","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2024-03-21","u":"2026-05-11","st":"2024-07","ag":"18–75"},{"n":"NCT06323525","t":"TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2024-03-21","u":"2025-05-25","st":"2024-04","ag":"18–70"},{"n":"NCT06324357","t":"Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread","s":"rec","p":"phase1phase2","d":[3,6],"c":[15,23,24,28,5,30,20],"a":"adult older","h":[78,9,58,37,45,82,27],"po":"2024-03-21","u":"2026-11-16","st":"2024-06","ag":"18 and over"},{"n":"NCT06326736","t":"Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer","s":"rec","p":"earlyphase1","d":[5],"c":[28],"lc":[28],"a":"adult older","h":[93],"l":[[93,"panc"]],"po":"2024-03-22","u":"2024-03-22","st":"2024-04","ag":"18–75"},{"n":"NCT06327451","t":"Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma","s":"rec","p":"phase2","d":[7],"c":[30],"lc":[30],"a":"adult","h":[59],"l":[[59,"glioma"]],"po":"2024-03-25","u":"2024-03-25","st":"2024-04","ag":"18–60"},{"n":"NCT06330337","t":"Effect of Electroacupuncture Combined With Paclitaxel Clinical Efficacy of Patients With Recurrence of High-grade Glioma","s":"rec","p":"phase3","d":[7],"c":[23],"a":"adult older","h":[262,263],"l":[[262,"glioma"]],"po":"2024-03-26","u":"2024-03-26","st":"2024-04","ag":"18–70"},{"n":"NCT06332430","t":"Intratumoral CAN2109 in Subjects With Solid Tumors","s":"rec","p":"phase1","d":[19],"c":[0],"a":"adult older","h":[99],"po":"2024-03-27","u":"2024-12-19","st":"2024-05","ag":"18 and over"},{"n":"NCT06338293","t":"Effects of Inclisiran Combined With Statins on the Morphology of Coronary Vulnerable Plaques","s":"rec","p":"phase4","d":[31],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"cad"]],"po":"2024-03-29","u":"2025-02-14","st":"2024-03","ag":"18–80"},{"n":"NCT06338683","t":"Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer","s":"rec","p":"phase3","d":[3,4],"c":[62],"lc":[62],"a":"adult older","h":[279],"l":[[279,"gc"]],"po":"2024-03-29","u":"2024-03-29","st":"2024-03","ag":"18–80"},{"n":"NCT06339619","t":"Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and Oteracil Potassium Capsules for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"escc"]],"po":"2024-04-01","u":"2026-06-04","st":"2024-03","ag":"18–75"},{"n":"NCT06340204","t":"Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma","s":"rec","p":"phase1","d":[14],"c":[2,27],"lc":[2],"a":"child adult","h":[48,338,57],"l":[[48,"ewing"]],"po":"2024-04-01","u":"2024-04-03","st":"2024-03","ag":"8–40"},{"n":"NCT06340230","t":"SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in HR Positive/HER2 Low Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[11],"lc":[11],"a":"adult older","x":"female","h":[143],"l":[[143,"breast"]],"po":"2024-04-01","u":"2024-12-04","st":"2024-08","ag":"18–75"},{"n":"NCT06341556","t":"A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lymph"]],"po":"2024-04-02","u":"2024-09-04","st":"2024-05","ag":"18 and over"},{"n":"NCT06341595","t":"Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM","s":"rec","p":"phase2","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"gc"]],"po":"2024-04-02","u":"2024-04-02","st":"2024-04","ag":"18–75"},{"n":"NCT06342167","t":"Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[48,16,29,30,14,58],"a":"adult older","h":[58,30,150,66,21,172],"po":"2024-04-02","u":"2026-10-07","st":"2024-03","ag":"18–80"},{"n":"NCT06343090","t":"Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients","s":"rec","p":"na","d":[16],"c":[2],"lc":[2],"a":"child adult older","h":[3],"l":[[3,"ball"]],"po":"2024-04-02","u":"2026-03-10","st":"2024-04","ag":"1–70"},{"n":"NCT06344156","t":"Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer","s":"rec","p":"phase1","d":[5],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"panc"]],"po":"2024-04-03","u":"2025-02-28","st":"2024-04","ag":"18–75"},{"n":"NCT06345729","t":"A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)","s":"rec","p":"phase3","d":[4],"c":[2,8,22,1,16,0,23,24,17,27,25,9,28,5,4,12,29,34,37,13,60,39,7,20],"a":"adult older","h":[40,42,53,57,9,38,5,132,6,111,74,45,36,10,46,13,47,80,14,81,37,70,82,60,61,30,2,122,19,180,66,72,8,84,88,51],"po":"2024-04-03","u":"2026-11-12","st":"2024-05","ag":"18 and over"},{"n":"NCT06346093","t":"Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer","s":"rec","p":"na","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[177],"l":[[177,"gc"]],"po":"2024-04-03","u":"2025-06-10","st":"2024-04","ag":"18 and over"},{"n":"NCT06346912","t":"CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL","s":"rec","p":"earlyphase1","d":[16,19],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"ball"]],"po":"2024-04-04","u":"2024-05-14","st":"2024-05","ag":"18 and over"},{"n":"NCT06348927","t":"Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR-Sensitive Mutations Combined With Co-Mutations Advanced NSCLC","s":"rec","p":"phase2","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2024-04-05","u":"2024-09-19","st":"2024-07","ag":"18 and over"},{"n":"NCT06349317","t":"Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTT","s":"rec","p":"phase2","d":[2],"c":[16],"lc":[16],"a":"adult older","h":[190],"l":[[190,"hcc"]],"po":"2024-04-05","u":"2025-09-29","st":"2024-04","ag":"18–75"},{"n":"NCT06349889","t":"Adebrelimab and Chemoradiotherapy in High-risk LANPC","s":"rec","p":"phase2","d":[0],"c":[22,0,7],"lc":[0],"a":"adult older","h":[53,40,70,8],"l":[[53,"npc"]],"po":"2024-04-05","u":"2025-01-15","st":"2024-07","ag":"18–65"},{"n":"NCT06349980","t":"A Study to Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 with or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients.","s":"rec","p":"phase2","d":[2],"c":[5],"a":"adult older","h":[6],"po":"2024-04-05","u":"2024-12-18","st":"2024-08","ag":"18 and over"},{"n":"NCT06352008","t":"To Evaluate the Efficacy and Safety of Anlotinib Hydrochloride Capsule in Postoperative Non-pCR Patients With Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2024-04-08","u":"2025-11-20","st":"2024-07","ag":"18 and over"},{"n":"NCT06353126","t":"DEB-TACE Prior to Liver Transplantation in the Treatment of HCC","s":"rec","p":"phase4","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"hcc"]],"po":"2024-04-08","u":"2024-10-18","st":"2024-10","ag":"18–75"},{"n":"NCT06353646","t":"XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer","s":"rec","p":"na","d":[5],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"panc"]],"po":"2024-04-09","u":"2026-02-13","st":"2024-03","ag":"18–75"},{"n":"NCT06354140","t":"PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY","s":"rec","p":"phase2","d":[1],"c":[1],"lc":[1],"a":"adult older","h":[17],"l":[[17,"escc"]],"po":"2024-04-09","u":"2024-07-17","st":"2024-05","ag":"18–75"},{"n":"NCT06355609","t":"Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR Mutant Advanced NSCLC-RW","s":"rec","p":"phase2","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2024-04-09","u":"2024-09-20","st":"2024-07","ag":"18 and over"},{"n":"NCT06355739","t":"CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+","s":"rec","p":"na","d":[16,19],"c":[30],"lc":[30],"a":"child adult","h":[69],"l":[[69,"ball"]],"po":"2024-04-09","u":"2024-04-09","st":"2024-02","ag":"3–18"},{"n":"NCT06359275","t":"PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients","s":"rec","p":"phase2","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"panc"]],"po":"2024-04-11","u":"2024-06-25","st":"2024-06","ag":"18–75"},{"n":"NCT06360042","t":"Anti-PD-1/PD-L1 Combined With Anti-angiogenic Agents as First-line Treatment for Unresectable HCC","s":"rec","p":"phase2","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"hcc"]],"po":"2024-04-11","u":"2024-04-22","st":"2024-01","ag":"18 and over"},{"n":"NCT06361589","t":"Real World Study of Lolatinib for Advanced ALK+ NSCLC Patients","s":"rec","p":"na","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[47],"l":[[47,"lung"]],"po":"2024-04-12","u":"2024-04-12","st":"2024-05","ag":"18 and over"},{"n":"NCT06361888","t":"A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer","s":"rec","p":"phase2phase3","d":[5],"c":[2,8,22,1,16,0,6,23,24,17,27,47,25,9,28,10,5,11,21,4,30,37,13,39,7,20],"a":"adult older","h":[38,40,123,6,58,12,36,54,60,111,81,183,118,43,25,5,74,15,14,45,11,44,68,103,115,339,8,37,57,7,116,2,127,19,18,30,47,135,13,152,106],"po":"2024-04-12","u":"2026-09-17","st":"2024-05","ag":"18–75"},{"n":"NCT06363006","t":"Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer","s":"rec","p":"phase1","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"hcc"]],"po":"2024-04-12","u":"2024-04-12","st":"2024-03","ag":"18–75"},{"n":"NCT06363734","t":"Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II Trial","s":"rec","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2024-04-12","u":"2024-04-16","st":"2024-04","ag":"18–75"},{"n":"NCT06363994","t":"A Global Phase 3 Study of Orelabrutinib+BR Vs.BR in Pts with TN MCL","s":"rec","p":"phase3","d":[19],"c":[2,55,15,8,49,22,1,16,0,23,17,27,36,9,28,61,5,11,18,12,30,34,13,39,20],"a":"adult older","h":[40,53,74,58,113,12,54,140,103,115,37,118,24,27,43,79,60,92,143,145,98,112,14,13,182,97,131,72,164,84,87],"po":"2024-04-12","u":"2024-12-27","st":"2024-05","ag":"60 and over"},{"n":"NCT06365671","t":"CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors","s":"rec","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2024-04-15","u":"2026-01-06","st":"2024-04","ag":"18 and over"},{"n":"NCT06367088","t":"Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"breast"]],"po":"2024-04-16","u":"2025-05-20","st":"2024-05","ag":"18–70"},{"n":"NCT06371040","t":"Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis","s":"rec","p":"phase1","d":[27],"c":[39],"lc":[39],"a":"adult older","h":[122],"l":[[122,"mg"]],"po":"2024-04-17","u":"2025-09-15","st":"2024-07","ag":"18–80"},{"n":"NCT06371157","t":"A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma","s":"rec","p":"phase3","d":[2],"c":[8,23,28,20],"a":"adult older","h":[120,44,37,13],"po":"2024-04-17","u":"2025-03-12","st":"2024-08","ag":"18–75"},{"n":"NCT06371274","t":"A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.","s":"rec","p":"na","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[46],"l":[[46,"breast"]],"po":"2024-04-17","u":"2025-08-12","st":"2024-10","ag":"18 and over"},{"n":"NCT06375044","t":"Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma","s":"rec","p":"phase1","d":[15],"c":[2,16,0,23,28,30,20],"a":"adult older","h":[46,89,69,37,60,53,136],"po":"2024-04-19","u":"2026-08-28","st":"2024-05","ag":"18 and over"},{"n":"NCT06375187","t":"A Study of GC203 TIL in Advanced Malignant Solid Tumors","s":"rec","p":"phase1","d":[4,6],"c":[5],"a":"adult older","h":[9],"po":"2024-04-19","u":"2025-12-11","st":"2024-05","ag":"18–75"},{"n":"NCT06375473","t":"Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients","s":"rec","p":"na","d":[5],"c":[2,17,10,61,5,13,20],"lc":[2],"a":"adult older","h":[38,9,12,25,15,215,92,88],"l":[[38,"panc"]],"po":"2024-04-19","u":"2026-01-06","st":"2024-04","ag":"18–100"},{"n":"NCT06375733","t":"A Study of GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCL","s":"rec","p":"phase1phase2","d":[19],"c":[10,20],"a":"adult older","h":[37,50],"po":"2024-04-19","u":"2025-08-12","st":"2024-03","ag":"18 and over"},{"n":"NCT06376721","t":"Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[161],"l":[[161,"lymph"]],"po":"2024-04-19","u":"2024-04-19","st":"2024-04","ag":"18–75"},{"n":"NCT06378138","t":"ICP-248 in Combination With Orelabrutinib in Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (APEX-03)","s":"rec","p":"phase2phase3","d":[19],"c":[2,55,15,8,22,1,52,16,0,23,17,89,27,33,36,9,28,10,5,11,18,12,30,34,13,39,7,68,20,64],"a":"adult older","h":[40,53,78,46,36,58,113,12,140,103,69,115,8,124,37,24,27,43,79,155,70,15,167,10,92,68,143,340,98,112,273,57,14,13,185,214,97,141,184,72,164,84,87],"po":"2024-04-22","u":"2025-11-21","st":"2024-05","ag":"18–80"},{"n":"NCT06379087","t":"Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC","s":"rec","p":"phase2","d":[4],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"lung"]],"po":"2024-04-23","u":"2025-07-10","st":"2024-05","ag":"18–75"},{"n":"NCT06382103","t":"Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy","s":"rec","p":"na","d":[2],"c":[5],"lc":[5],"a":"child adult older","h":[6],"l":[[6,"hcc"]],"po":"2024-04-24","u":"2025-03-26","st":"2024-05","ag":"Not stated"},{"n":"NCT06383208","t":"Cardiovascular-Renal Adverse Prognosis Assessment System for Coronary Heart Disease With Chronic Kidney Disease Based on Metabolomics","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[62],"l":[[62,"cad"]],"po":"2024-04-25","u":"2024-04-25","st":"2024-04","ag":"18–80"},{"n":"NCT06383728","t":"Neoadjuvant Targeted Therapy in Patients With Resectable EGFR-mutated Lung Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[132],"l":[[132,"lung"]],"po":"2024-04-25","u":"2024-05-09","st":"2024-04","ag":"18–75"},{"n":"NCT06383767","t":"A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[2],"a":"adult older","h":[23],"po":"2024-04-25","u":"2025-06-19","st":"2024-07","ag":"18 and over"},{"n":"NCT06385067","t":"Treatment of Primary Coronary Artery Vascular Lesions With Biolimus Coated Coronary Balloon Dilation Catheter","s":"rec","p":"na","d":[31],"c":[10],"a":"adult older","h":[15],"po":"2024-04-25","u":"2026-10-27","st":"2024-05","ag":"18 and over"},{"n":"NCT06385652","t":"PET Imaging Study of 68Ga-NB381 in Multiple Myeloma","s":"rec","p":"earlyphase1","d":[15],"c":[2],"lc":[2],"a":"adult older","h":[29],"l":[[29,"mm"]],"po":"2024-04-26","u":"2026-04-16","st":"2024-04","ag":"18–90"},{"n":"NCT06385730","t":"Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS)","s":"rec","p":"phase2","d":[1],"c":[5],"lc":[5],"a":"older","h":[42],"l":[[42,"escc"]],"po":"2024-04-26","u":"2024-07-01","st":"2024-06","ag":"76 and over"},{"n":"NCT06385990","t":"Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy","s":"rec","p":"phase2","d":[6],"c":[8],"lc":[8],"a":"adult older","x":"female","h":[13],"l":[[13,"breast"]],"po":"2024-04-26","u":"2024-04-26","st":"2024-03","ag":"18–70"},{"n":"NCT06387121","t":"Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL","s":"rec","p":"phase2","d":[16,19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"ball"]],"po":"2024-04-26","u":"2025-12-17","st":"2024-04","ag":"18 and over"},{"n":"NCT06387628","t":"LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2024-04-29","u":"2024-08-02","st":"2024-07","ag":"18–75"},{"n":"NCT06388031","t":"ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI","s":"rec","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"lung"]],"po":"2024-04-29","u":"2024-11-07","st":"2024-08","ag":"18–80"},{"n":"NCT06389201","t":"Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients","s":"rec","p":"na","d":[0],"c":[40],"lc":[40],"a":"adult older","h":[110],"l":[[110,"npc"]],"po":"2024-04-29","u":"2025-02-18","st":"2024-08","ag":"20–70"},{"n":"NCT06389305","t":"CIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic Impact on Patients With Early CAR-T Cell Dysfunction","s":"rec","p":"na","d":[16],"c":[2],"lc":[2],"a":"child adult","h":[3],"l":[[3,"ball"]],"po":"2024-04-29","u":"2026-02-25","st":"2024-05","ag":"1–39"},{"n":"NCT06389422","t":"Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis","s":"rec","p":"phase2","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"hcc"]],"po":"2024-04-29","u":"2024-04-29","st":"2024-05","ag":"18–90"},{"n":"NCT06391736","t":"Evaluation of the Safety and Efficacy of Late-onset Pompe Disease Gene Therapy Drug","s":"rec","p":"phase1phase2","d":[42],"c":[2],"a":"child adult older","h":[26],"po":"2024-04-30","u":"2026-11-13","st":"2024-04","ag":"6 and over"},{"n":"NCT06392217","t":"clinIcal Efficacy and Safety of Incadronate in Breast Cancer With Bone Metastases","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2024-04-30","u":"2026-11-02","st":"2024-03","ag":"18 and over"},{"n":"NCT06393361","t":"Chidamide Decitabine Plus Anti-PD-1 Antibody for Patients With R/R cHL Who Are Transplant-ineligible or Refused Transplant.","s":"rec","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2024-05-01","u":"2026-01-02","st":"2024-06","ag":"18–75"},{"n":"NCT06393985","t":"Decitabine, Venetoclax and Blinatumomab for Maintenance Following HSCT in Patients With Ph-Negative B-ALL","s":"rec","p":"phase2","d":[16],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"ball"]],"po":"2024-05-01","u":"2024-11-19","st":"2024-04","ag":"18–65"},{"n":"NCT06395870","t":"Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma","s":"rec","p":"phase1","d":[19],"c":[17,30],"lc":[30],"a":"adult older","h":[58,68],"l":[[58,"lymph"]],"po":"2024-05-02","u":"2024-11-06","st":"2024-05","ag":"18–75"},{"n":"NCT06397222","t":"Sintilimab Plus Bevacizumab and SIRT for Intermediate-advanced HCC","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"hcc"]],"po":"2024-05-02","u":"2024-05-07","st":"2024-05","ag":"18–75"},{"n":"NCT06397235","t":"DEB-TACE+RALOX-HAIC vs DEB-TACE for Large HCC","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"hcc"]],"po":"2024-05-02","u":"2025-02-20","st":"2024-05","ag":"18–75"},{"n":"NCT06401005","t":"SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC)","s":"rec","p":"phase2","d":[6],"c":[13],"lc":[13],"a":"adult older","x":"female","h":[19],"l":[[19,"breast"]],"po":"2024-05-06","u":"2024-12-02","st":"2024-11","ag":"18 and over"},{"n":"NCT06402435","t":"SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[13],"lc":[13],"a":"adult older","x":"female","h":[19],"l":[[19,"breast"]],"po":"2024-05-07","u":"2025-07-02","st":"2024-11","ag":"18 and over"},{"n":"NCT06403735","t":"A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors","s":"rec","p":"phase1","d":[4,5],"c":[24,47,9,5],"a":"adult older","h":[45,135,65,116],"po":"2024-05-08","u":"2024-05-08","st":"2024-04","ag":"18 and over"},{"n":"NCT06404697","t":"Boost Irradiation to the Supraclavicular Area Among High Risk cN3c Breast Cancer Patients","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[123],"l":[[123,"breast"]],"po":"2024-05-08","u":"2024-05-08","st":"2024-05","ag":"18 and over"},{"n":"NCT06405113","t":"FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[49],"lc":[49],"a":"adult older","h":[230],"l":[[230,"gc"]],"po":"2024-05-08","u":"2025-02-20","st":"2024-06","ag":"18–80"},{"n":"NCT06406634","t":"Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"hcc"]],"po":"2024-05-09","u":"2024-05-09","st":"2024-05","ag":"18–75"},{"n":"NCT06407947","t":"Study of CT071 Injection in High Risk Newly Diagnosed Multiple Myeloma","s":"rec","p":"earlyphase1","d":[15],"c":[5],"lc":[5],"a":"adult older","h":[212],"l":[[212,"mm"]],"po":"2024-05-09","u":"2024-06-12","st":"2024-06","ag":"18 and over"},{"n":"NCT06408584","t":"Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab","s":"rec","p":"na","d":[1],"c":[17],"lc":[17],"a":"adult older","h":[68],"l":[[68,"escc"]],"po":"2024-05-10","u":"2024-05-21","st":"2024-03","ag":"18 and over"},{"n":"NCT06409702","t":"Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection","s":"rec","p":"phase4","d":[15],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"mm"]],"po":"2024-05-10","u":"2025-06-12","st":"2024-06","ag":"18 and over"},{"n":"NCT06411678","t":"Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer","s":"rec","p":"earlyphase1","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[38],"l":[[38,"breast"]],"po":"2024-05-13","u":"2026-09-21","st":"2024-05","ag":"18–70"},{"n":"NCT06413342","t":"Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[23],"lc":[23],"a":"older","h":[44],"l":[[44,"escc"]],"po":"2024-05-14","u":"2024-07-16","st":"2024-06","ag":"70–85"},{"n":"NCT06413654","t":"A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)","s":"rec","p":"phase2phase3","d":[25],"c":[2,8,22,16,0,23,24,17,27,47,11,18,12,30,37,13,7,20],"a":"adult older","h":[209,102,59,36,186,26,25,10,161,124,98,54,118,11,81,176,136,49,92,31,201,206,29,8,99,68,243],"po":"2024-05-14","u":"2026-05-05","st":"2024-07","ag":"18 and over"},{"n":"NCT06415669","t":"A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcinoma","s":"rec","p":"phase2","d":[3],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"gc"]],"po":"2024-05-16","u":"2024-05-29","st":"2024-05","ag":"18–75"},{"n":"NCT06416410","t":"JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C Mutation","s":"rec","p":"phase3","d":[4],"c":[2,8,22,16,0,23,24,27,25,28,10,26,5,11,21,12,29,30,13,60,39,20],"a":"adult older","h":[40,23,56,57,58,9,78,12,111,74,45,118,36,46,55,13,37,30,49,18,115,106,19,50,211,66,84,102,51],"po":"2024-05-16","u":"2026-08-13","st":"2024-08","ag":"18 and over"},{"n":"NCT06417008","t":"A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer","s":"rec","p":"phase2phase3","d":[4],"c":[23,30],"a":"adult older","h":[58,44],"po":"2024-05-16","u":"2025-08-01","st":"2024-05","ag":"18–75"},{"n":"NCT06417892","t":"Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ Adenocarcinoma","s":"rec","p":"na","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"gc"]],"po":"2024-05-16","u":"2026-07-28","st":"2024-04","ag":"18 and over"},{"n":"NCT06418594","t":"Adebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain Metastasis","s":"rec","p":"phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[26],"l":[[26,"breast"]],"po":"2024-05-17","u":"2024-12-10","st":"2024-10","ag":"18 and over"},{"n":"NCT06418659","t":"A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients","s":"rec","p":"earlyphase1","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[212],"l":[[212,"hcc"]],"po":"2024-05-17","u":"2025-04-24","st":"2024-10","ag":"18 and over"},{"n":"NCT06421298","t":"A Prospective, Single-arm, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Tafolecimab and Sintilimab Combined With Chemotherapy in Patients With Advanced or Metastatic Driver Gene-negative Non-small Cell Lung Cancer After Failure of First-line Immunotherapy.","s":"rec","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[61],"l":[[61,"lung"]],"po":"2024-05-20","u":"2024-05-20","st":"2024-05","ag":"18–75"},{"n":"NCT06421376","t":"Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer","s":"rec","p":"phase2","d":[1],"c":[48,2,14],"lc":[2],"a":"adult older","h":[23,150,21],"l":[[23,"escc"]],"po":"2024-05-20","u":"2025-05-30","st":"2024-05","ag":"18–80"},{"n":"NCT06421831","t":"Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients","s":"rec","p":"phase1phase2","d":[40],"c":[2],"a":"child adult older","h":[102],"po":"2024-05-20","u":"2026-11-17","st":"2024-05","ag":"2 and over"},{"n":"NCT06421948","t":"Linperlisib Combined With Chidamide in Patients With PTCL","s":"rec","p":"phase1phase2","d":[19],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"lymph"]],"po":"2024-05-20","u":"2025-12-05","st":"2024-05","ag":"18–80"},{"n":"NCT06422143","t":"Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]","s":"rec","p":"phase3","d":[4],"c":[2,15,8,22,16,0,23,24,9,5,29,34,37,13,7,32,20],"a":"adult older","h":[40,56,38,44,132,74,45,36,10,46,47,27,80,14,81,37,70,82,30,63,65,66,72,8],"po":"2024-05-20","u":"2026-11-17","st":"2024-06","ag":"18 and over"},{"n":"NCT06424301","t":"Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma","s":"rec","p":"earlyphase1","d":[9],"c":[5],"lc":[5],"a":"child adult older","h":[236],"l":[[236,"rb"]],"po":"2024-05-22","u":"2025-06-26","st":"2024-12","ag":"6 months and over"},{"n":"NCT06424665","t":"A Study of FZ-AD005 in Patients With Advanced Solid Tumors","s":"rec","p":"phase1","d":[4],"c":[8,23,5],"a":"adult older","h":[44,13,65],"po":"2024-05-22","u":"2026-03-04","st":"2024-07","ag":"18–75"},{"n":"NCT06424899","t":"A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC","s":"rec","p":"phase2","d":[4],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"lung"]],"po":"2024-05-22","u":"2024-05-22","st":"2024-05","ag":"18–75"},{"n":"NCT06425120","t":"Effect of Xuesaitong Soft Capsules on Major Risk Factors in Patients With Coronary Heart Disease","s":"rec","p":"phase4","d":[31],"c":[2,40],"a":"adult older","h":[213,110],"po":"2024-05-22","u":"2025-09-08","st":"2024-06","ag":"18 and over"},{"n":"NCT06425874","t":"The Impact of Socioeconomic Determinants on the Patient Reported Outcomes in Young Breast Cancer Patients After Breast Surgery","s":"rec","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult","x":"female","h":[99],"l":[[99,"breast"]],"po":"2024-05-22","u":"2026-11-19","st":"2024-02","ag":"18–50"},{"n":"NCT06426511","t":"ctDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLC","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2024-05-23","u":"2026-04-23","st":"2024-12","ag":"18–75"},{"n":"NCT06427239","t":"Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma","s":"rec","p":"phase1phase2","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"panc"]],"po":"2024-05-23","u":"2026-05-26","st":"2024-06","ag":"18–75"},{"n":"NCT06427447","t":"Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC)","s":"rec","p":"phase3","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[177],"l":[[177,"panc"]],"po":"2024-05-23","u":"2025-02-04","st":"2024-08","ag":"18–75"},{"n":"NCT06427460","t":"Central-boost Ablative Radiation Therapy for Solid Tumors (CBART)","s":"rec","p":"phase2","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[177],"l":[[177,"panc"]],"po":"2024-05-23","u":"2024-05-23","st":"2024-05","ag":"18–75"},{"n":"NCT06427941","t":"A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors","s":"rec","p":"phase1phase2","d":[2,3,4],"c":[8,22,1,16,0,23,24,17,9,10,18,37,13,31],"a":"adult older","h":[46,36,50,12,70,80,81,68,190,45,0,64,2,24,47,13],"po":"2024-05-24","u":"2026-09-16","st":"2024-07","ag":"18 and over"},{"n":"NCT06428409","t":"A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)","s":"rec","p":"phase1phase2","d":[5],"c":[2,8,22,16,5,13],"a":"adult older","h":[40,41,12,74,341,13],"po":"2024-05-24","u":"2026-10-29","st":"2024-06","ag":"18 and over"},{"n":"NCT06429696","t":"PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for Extensive-stage Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"lung"]],"po":"2024-05-28","u":"2025-05-28","st":"2024-07","ag":"18–75"},{"n":"NCT06429891","t":"Research on Early Diagnosis and Clinical Transformation of Nuclide Probe Based on Bioorthogonal-gastric Cancer Mucin Target Visualization","s":"rec","p":"na","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"gc"]],"po":"2024-05-28","u":"2024-08-22","st":"2024-08","ag":"18–70"},{"n":"NCT06430437","t":"A Study of SHR-A1811 in First-line Treatment of Patients With Advanced or Metastatic Non-small Cell Lung Cancer With HER2 Mutations","s":"rec","p":"phase3","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2024-05-28","u":"2026-01-21","st":"2024-07","ag":"18–75"},{"n":"NCT06430658","t":"Neoadjuvant Comprehensive Treatment for Unresectable Esophageal Cancer","s":"rec","p":"phase2","d":[1],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"escc"]],"po":"2024-05-28","u":"2024-12-27","st":"2024-04","ag":"18–75"},{"n":"NCT06430983","t":"Recurrent Liver Cancer: Reconceptualization and Reevaluation","s":"rec","p":"na","d":[2],"c":[28],"lc":[28],"a":"adult older","h":[242],"l":[[242,"hcc"]],"po":"2024-05-28","u":"2024-12-12","st":"2024-07","ag":"18–75"},{"n":"NCT06431685","t":"Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer","s":"rec","p":"phase1","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"lung"]],"po":"2024-05-28","u":"2026-05-08","st":"2024-04","ag":"18–75"},{"n":"NCT06433609","t":"Study of ADCs Combined With Adebrelimab in HER2-negative Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","h":[3],"l":[[3,"breast"]],"po":"2024-05-30","u":"2026-07-14","st":"2024-08","ag":"18–75"},{"n":"NCT06435260","t":"Hypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"panc"]],"po":"2024-05-30","u":"2026-07-06","st":"2024-08","ag":"18–75"},{"n":"NCT06436677","t":"A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma","s":"rec","p":"na","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[29,74,115],"l":[[29,"lymph"]],"po":"2024-05-31","u":"2024-05-31","st":"2024-05","ag":"18–75"},{"n":"NCT06437509","t":"A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Extensive-stage Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[5],"a":"adult older","h":[65],"po":"2024-05-31","u":"2026-07-23","st":"2024-06","ag":"18–75"},{"n":"NCT06437522","t":"A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors","s":"rec","p":"phase2","d":[0],"c":[5],"a":"adult older","h":[9],"po":"2024-05-31","u":"2026-07-23","st":"2024-06","ag":"18–75"},{"n":"NCT06437977","t":"Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH)","s":"rec","p":"phase3","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2024-05-31","u":"2026-05-13","st":"2024-09","ag":"18–75"},{"n":"NCT06438627","t":"Efficacy and Safety of TPC+Apatinib+Camrelizumab vs GP+ Camrelizumab for High-Risk Nasopharyngeal Carcinoma: A Phase 3 Trial","s":"rec","p":"phase3","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"npc"]],"po":"2024-06-03","u":"2024-07-16","st":"2024-05","ag":"18–65"},{"n":"NCT06439771","t":"A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of YL202 in Patients With BC","s":"rec","p":"phase2","d":[6],"c":[5],"a":"adult older","x":"female","h":[9],"po":"2024-06-03","u":"2026-10-14","st":"2024-04","ag":"18–75"},{"n":"NCT06440057","t":"Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma.","s":"rec","p":"phase1phase2","d":[4],"c":[2],"a":"adult older","h":[26],"po":"2024-06-03","u":"2024-12-16","st":"2024-08","ag":"18–75"},{"n":"NCT06440954","t":"Efficacy and Resistance Mechanisms of IP in NSCLC With Leptomeningeal Metastases","s":"rec","p":"phase2","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2024-06-04","u":"2024-06-04","st":"2024-05","ag":"18 and over"},{"n":"NCT06445088","t":"Diagnostic Accuracy of EBV C Promoter Methylation Kit in Nasopharyngeal Carcinoma","s":"rec","p":"na","d":[0],"c":[16,0,10,87,46],"lc":[0],"a":"child adult older","h":[53,30,15,134,317],"l":[[53,"npc"]],"po":"2024-06-06","u":"2024-06-25","st":"2024-05","ag":"Not stated"},{"n":"NCT06445517","t":"Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma","s":"rec","p":"phase1","d":[19],"c":[2,9,5,30],"a":"adult older","h":[123,74,58,14],"po":"2024-06-06","u":"2026-07-24","st":"2024-04","ag":"18 and over"},{"n":"NCT06445803","t":"CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL","s":"rec","p":"phase1","d":[16,19],"c":[9,5],"a":"adult older","h":[14,9],"po":"2024-06-06","u":"2024-06-06","st":"2024-05","ag":"18 and over"},{"n":"NCT06445881","t":"Efficacy and Safety of Modified Si Jun Zi Tang in Perioperative NSCLC Treatment","s":"rec","p":"phase2","d":[4],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"lung"]],"po":"2024-06-06","u":"2024-06-06","st":"2024-06","ag":"18–75"},{"n":"NCT06446154","t":"Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"hcc"]],"po":"2024-06-06","u":"2024-12-31","st":"2024-12","ag":"18 and over"},{"n":"NCT06446726","t":"Low-dose Radiation Combined With Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"escc"]],"po":"2024-06-06","u":"2025-06-06","st":"2024-06","ag":"18–75"},{"n":"NCT06447597","t":"A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.","s":"rec","p":"phase2phase3","d":[27],"c":[2,15,8,22,0,23,27,9,5,13,39,64],"a":"adult older","h":[103,11,122,220,29,98,273,216,70,27,16,46],"po":"2024-06-07","u":"2026-08-14","st":"2024-07","ag":"18–70"},{"n":"NCT06449885","t":"A Cohort Study in Newly Diagnosed MZL","s":"rec","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lymph"]],"po":"2024-06-10","u":"2025-11-19","st":"2024-05","ag":"18 and over"},{"n":"NCT06450067","t":"Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia","s":"rec","p":"na","d":[16],"c":[2,22,0,27,5,30,13,31,20],"a":"adult older","h":[48,69,12,64,124,40,0,37,162,115],"po":"2024-06-10","u":"2024-09-19","st":"2024-06","ag":"18 and over"},{"n":"NCT06452277","t":"A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)","s":"rec","p":"phase3","d":[4],"c":[2,15,8,22,16,0,23,24,27,25,28,5,29,13,7],"a":"adult older","h":[40,23,42,57,78,44,132,6,26,74,45,13,47,82,60,30,94,19,138,66,8,51],"po":"2024-06-11","u":"2026-11-04","st":"2024-08","ag":"18 and over"},{"n":"NCT06452602","t":"Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.","s":"rec","p":"phase2","d":[1],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"escc"]],"po":"2024-06-11","u":"2026-02-27","st":"2024-06","ag":"18–75"},{"n":"NCT06452706","t":"The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[23,24,5,34,13,39],"a":"adult older","h":[45,111,123,133,183,72],"po":"2024-06-11","u":"2024-11-19","st":"2024-11","ag":"18–75"},{"n":"NCT06454448","t":"Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer","s":"rec","p":"phase1phase2","d":[5],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"panc"]],"po":"2024-06-12","u":"2024-06-28","st":"2024-06","ag":"18–75"},{"n":"NCT06454578","t":"Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection","s":"rec","p":"phase2","d":[2],"c":[27],"lc":[27],"a":"adult older","h":[124],"l":[[124,"hcc"]],"po":"2024-06-12","u":"2024-08-01","st":"2024-07","ag":"18 and over"},{"n":"NCT06454968","t":"Orelabrutinib Combined With Obinutuzumab and Lenalidomide (OGL Regimen) as First-line Treatment for Marginal Zone Lymphoma.","s":"rec","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"lymph"]],"po":"2024-06-12","u":"2024-06-18","st":"2024-06","ag":"18 and over"},{"n":"NCT06455410","t":"GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma","s":"rec","p":"phase2","d":[0],"c":[63,0,88,10,43,21],"lc":[0],"a":"adult older","h":[99,50,95,0,125,106,198,342],"l":[[99,"npc"]],"po":"2024-06-12","u":"2024-06-25","st":"2024-06","ag":"18–65"},{"n":"NCT06458894","t":"Research on Building and Application of Internet-based Home Pre-rehabilitation Model for Lung Surgery Patients.","s":"rec","p":"na","d":[4],"c":[23],"lc":[23],"a":"adult older","h":[343],"l":[[343,"lung"]],"po":"2024-06-14","u":"2025-02-17","st":"2024-08","ag":"60–99"},{"n":"NCT06461156","t":"A Study of HS-10504 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)","s":"rec","p":"phase1","d":[4],"c":[0],"a":"adult older","h":[132],"po":"2024-06-14","u":"2026-08-31","st":"2024-06","ag":"18 and over"},{"n":"NCT06461624","t":"Clinical Trial of Autologous GPC3 CAR-T Cells (CBG166) Therapy for Advanced Hepatocellular Carcinoma","s":"rec","p":"phase1","d":[2],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"hcc"]],"po":"2024-06-17","u":"2024-11-06","st":"2024-07","ag":"18–70"},{"n":"NCT06461910","t":"Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma","s":"rec","p":"phase2","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"gc"]],"po":"2024-06-17","u":"2026-03-03","st":"2024-06","ag":"18–75"},{"n":"NCT06463392","t":"Deep Learning-based sbORN Diagnostic Model","s":"rec","p":"na","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"npc"]],"po":"2024-06-17","u":"2024-10-01","st":"2024-07","ag":"18 and over"},{"n":"NCT06463587","t":"Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)","s":"rec","p":"phase3","d":[27],"c":[2,55,15,8,22,0,5,11,18,13,20,64],"a":"adult older","h":[103,11,36,40,71,38,108,143,344,92,273,147,27,164],"po":"2024-06-18","u":"2026-11-17","st":"2024-06","ag":"18 and over"},{"n":"NCT06463834","t":"A Study of Sintilimab Combined With Chemotherapy for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[16],"lc":[16],"a":"adult older","h":[30],"l":[[30,"escc"]],"po":"2024-06-18","u":"2024-06-18","st":"2024-03","ag":"18–75"},{"n":"NCT06464861","t":"Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma","s":"rec","p":"phase1","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lymph"]],"po":"2024-06-18","u":"2025-02-07","st":"2024-06","ag":"18–75"},{"n":"NCT06464913","t":"Randomized Phase II Trial: Chest Wall RT Omission After Prosthetic Reconstruction","s":"rec","p":"phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2024-06-18","u":"2024-10-15","st":"2024-09","ag":"18–70"},{"n":"NCT06464978","t":"Stapler Reinforcement Patches Compared to Standard Staplers in Gastrojejunostomy","s":"rec","p":"na","d":[3],"c":[51],"lc":[51],"a":"adult older","h":[345],"l":[[345,"gc"]],"po":"2024-06-18","u":"2026-03-31","st":"2024-05","ag":"18–85"},{"n":"NCT06465069","t":"A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors","s":"rec","p":"phase1","d":[1,4,5,6],"c":[2,0,5],"a":"adult older","h":[53,74,41],"po":"2024-06-18","u":"2026-11-04","st":"2024-07","ag":"18 and over"},{"n":"NCT06465550","t":"A Phase 1 Study of Gene-modified Autologous Hematopoietic Stem Cell (BD211) Treating β-thalassemia Major","s":"rec","p":"phase1","d":[20],"c":[0,10,5],"a":"child adult","h":[15,99,123],"po":"2024-06-20","u":"2024-06-24","st":"2024-01","ag":"3–35"},{"n":"NCT06467500","t":"A Prospective, Open-label, Single-center, Single-arm Phase II Clinical Study of Cadonilimab (AK104) Combined With Monotherapy Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer With Negative Driver Genes and Failed Immunotherapy","s":"rec","p":"phase2","d":[4],"c":[68],"lc":[68],"a":"adult older","h":[214],"l":[[214,"lung"]],"po":"2024-06-21","u":"2024-06-21","st":"2024-03","ag":"18–75"},{"n":"NCT06467617","t":"Adebrelimab Plus Chemo and Recaticimab in Perioperative Treatment of Resectable NSCLC","s":"rec","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[61],"l":[[61,"lung"]],"po":"2024-06-21","u":"2024-12-16","st":"2024-08","ag":"18–75"},{"n":"NCT06467786","t":"Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer","s":"rec","p":"phase4","d":[4],"c":[39],"lc":[39],"a":"adult older","h":[122],"l":[[122,"lung"]],"po":"2024-06-21","u":"2024-06-21","st":"2024-03","ag":"18 and over"},{"n":"NCT06467799","t":"Neoadjuvant HAIC and PD-1 Plus Adjuvant PD-1 for High-risk Recurrent HCC","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"hcc"]],"po":"2024-06-21","u":"2025-09-29","st":"2024-09","ag":"18–75"},{"n":"NCT06468280","t":"Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"gc"]],"po":"2024-06-21","u":"2026-01-21","st":"2024-11","ag":"18–79"},{"n":"NCT06469944","t":"Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)","s":"rec","p":"phase1phase2","d":[3],"c":[2,16,23,9,5,34,7,20],"a":"adult older","h":[74,14,9,37,82,8,341,72],"po":"2024-06-24","u":"2026-11-13","st":"2024-09","ag":"18 and over"},{"n":"NCT06470256","t":"Palliative Hepatectomy Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma","s":"rec","p":"phase1","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2024-06-24","u":"2024-06-24","st":"2024-06","ag":"18–75"},{"n":"NCT06471205","t":"A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Unresectable Locally Advanced or Recurrent Metastatic Triple-negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"a":"adult older","h":[9],"po":"2024-06-24","u":"2026-07-23","st":"2024-08","ag":"18–75"},{"n":"NCT06471738","t":"Combination of Zanubrutinib, Rituximab and Venetoclax in Patients With Previously Untreated Follicular Lymphoma","s":"rec","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2024-06-24","u":"2026-07-20","st":"2024-07","ag":"18 and over"},{"n":"NCT06472713","t":"Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPC","s":"rec","p":"phase2","d":[0],"c":[59],"lc":[59],"a":"adult older","h":[171],"l":[[171,"npc"]],"po":"2024-06-25","u":"2025-01-13","st":"2024-07","ag":"18–70"},{"n":"NCT06473961","t":"A Phase Ib Study of GC101 in NSCLC","s":"rec","p":"phase1","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2024-06-25","u":"2026-08-05","st":"2024-10","ag":"18–70"},{"n":"NCT06474520","t":"Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)","s":"rec","p":"na","d":[25],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"nmosd"]],"po":"2024-06-25","u":"2024-09-20","st":"2024-08","ag":"18 and over"},{"n":"NCT06475209","t":"Adebrelimab + Apatinib in SCLC Maintenance Therapy","s":"rec","p":"phase2","d":[4],"c":[39],"lc":[39],"a":"adult older","h":[122],"l":[[122,"lung"]],"po":"2024-06-26","u":"2024-06-26","st":"2024-06","ag":"18–75"},{"n":"NCT06475300","t":"A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors","s":"rec","p":"phase2","d":[0,4],"c":[0],"a":"adult older","h":[53],"po":"2024-06-26","u":"2026-07-23","st":"2024-06","ag":"18 and over"},{"n":"NCT06478108","t":"Interventional Software for Multi-immunotherapy of Solid Tumors","s":"rec","p":"phase2phase3","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"lung"]],"po":"2024-06-27","u":"2024-06-27","st":"2024-04","ag":"18–75"},{"n":"NCT06478225","t":"Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer","s":"rec","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"panc"]],"po":"2024-06-27","u":"2024-06-27","st":"2024-05","ag":"18–75"},{"n":"NCT06478472","t":"Prospective Clinical Study of Orelabrutinib in Combination With Rituximab (OR) for Primary Marginal Zone Lymphoma (MZL) That Failed or Not Suitable for Local Therapy","s":"rec","p":"na","d":[19],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"lymph"]],"po":"2024-06-27","u":"2024-07-29","st":"2024-06","ag":"18 and over"},{"n":"NCT06478927","t":"Backline Treatment of Advanced Hepatocellular Carcinoma With Palbociclib","s":"rec","p":"na","d":[2],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"hcc"]],"po":"2024-06-27","u":"2024-06-27","st":"2024-01","ag":"18–75"},{"n":"NCT06479356","t":"CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[30],"a":"adult older","h":[58],"po":"2024-06-28","u":"2024-08-21","st":"2024-08","ag":"18 and over"},{"n":"NCT06479616","t":"A Long-term Follow-up Study in Participants Who Received CS-101","s":"rec","p":"na","d":[20],"c":[5],"lc":[5],"a":"child","h":[76],"l":[[76,"bthal"]],"po":"2024-06-28","u":"2026-10-26","st":"2024-06","ag":"3–17"},{"n":"NCT06480864","t":"Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Stage Small Cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[11],"lc":[11],"a":"adult older","h":[118],"l":[[118,"lung"]],"po":"2024-06-28","u":"2025-01-06","st":"2024-08","ag":"18 and over"},{"n":"NCT06481228","t":"Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL","s":"rec","p":"na","d":[16],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"ball"]],"po":"2024-07-01","u":"2026-03-02","st":"2024-06","ag":"18 and over"},{"n":"NCT06481241","t":"Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALL","s":"rec","p":"na","d":[16],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"ball"]],"po":"2024-07-01","u":"2026-03-02","st":"2024-06","ag":"18 and over"},{"n":"NCT06481826","t":"Glofitamab in Chinese Patients With R/R DLBCL","s":"rec","p":"na","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"lymph"]],"po":"2024-07-01","u":"2026-03-27","st":"2024-01","ag":"18–80"},{"n":"NCT06482801","t":"Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"hcc"]],"po":"2024-07-01","u":"2024-07-01","st":"2024-06","ag":"18–75"},{"n":"NCT06482905","t":"Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.","s":"rec","p":"phase1","d":[7],"c":[2],"a":"adult older","h":[102],"po":"2024-07-01","u":"2026-03-24","st":"2024-09","ag":"18–75"},{"n":"NCT06483282","t":"A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"lung"]],"po":"2024-07-03","u":"2026-09-11","st":"2024-06","ag":"18–75"},{"n":"NCT06483295","t":"Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet Platform","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2024-07-03","u":"2025-05-28","st":"2024-03","ag":"18–80"},{"n":"NCT06483347","t":"Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"lung"]],"po":"2024-07-03","u":"2024-07-03","st":"2024-04","ag":"18–75"},{"n":"NCT06484777","t":"A Clinical Study of SHR-9539 in Patients With Multiple Myeloma","s":"rec","p":"phase1","d":[15],"c":[22],"a":"adult older","h":[40],"po":"2024-07-03","u":"2026-04-16","st":"2024-08","ag":"18 and over"},{"n":"NCT06484816","t":"TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies","s":"rec","p":"phase1","d":[4],"c":[23],"a":"adult older","h":[82],"po":"2024-07-03","u":"2025-02-24","st":"2024-07","ag":"18 and over"},{"n":"NCT06484829","t":"Purinostat Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma","s":"rec","p":"phase1phase2","d":[15],"c":[22],"a":"adult older","h":[40],"po":"2024-07-03","u":"2025-04-02","st":"2024-03","ag":"18–75"},{"n":"NCT06484985","t":"Study of AXT-1003 in Subjects With Advanced Malignant Tumors.","s":"rec","p":"phase1","d":[19],"c":[2,16,0,5],"a":"adult older","h":[53,74,9,30],"po":"2024-07-03","u":"2026-01-28","st":"2024-09","ag":"18 and over"},{"n":"NCT06485466","t":"TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma","s":"rec","p":"phase3","d":[2],"c":[22],"lc":[22],"a":"adult older","h":[47],"l":[[47,"hcc"]],"po":"2024-07-03","u":"2026-04-14","st":"2024-08","ag":"18–80"},{"n":"NCT06485544","t":"Neoadjuvant Adebrelimab in Resectable SCLC: A Randomized Trial","s":"rec","p":"phase2","d":[4],"c":[39],"lc":[39],"a":"adult older","h":[122],"l":[[122,"lung"]],"po":"2024-07-03","u":"2024-07-03","st":"2024-07","ag":"18–75"},{"n":"NCT06486337","t":"CMOP±R in the Treatment of Untreated Non-Hodgkin's Lymphoma","s":"rec","p":"phase2","d":[19],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"lymph"]],"po":"2024-07-03","u":"2026-09-09","st":"2024-07","ag":"18–75"},{"n":"NCT06487429","t":"Short Course Radiotherapy With Sequential Disitamab Vedotin Combined With S-1 and Sintilimab as Whole Course Neoadjuvant Therapy for HER2 Expressed Locally Progressive Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"gc"]],"po":"2024-07-05","u":"2024-07-05","st":"2024-05","ag":"18–75"},{"n":"NCT06489080","t":"Survival and cArdiovascular eVents in Patients With Acute Myocardial Infarction","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[29],"l":[[29,"cad"]],"po":"2024-07-05","u":"2024-07-05","st":"2024-03","ag":"18 and over"},{"n":"NCT06489119","t":"Single-cell Multi-omics Analyses of OCT-diagnosed Plaque Subtypes in Coronary Artery Disease (MOOP-CAD)","s":"rec","p":"na","d":[31],"c":[15,24],"lc":[24],"a":"adult older","h":[206,147],"l":[[206,"cad"]],"po":"2024-07-05","u":"2025-09-15","st":"2024-07","ag":"18–85"},{"n":"NCT06489197","t":"AK112 Combined With Chemotherapy as the First-line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients","s":"rec","p":"phase2","d":[1],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"escc"]],"po":"2024-07-05","u":"2025-01-22","st":"2024-11","ag":"18–75"},{"n":"NCT06489808","t":"Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL","s":"rec","p":"phase2","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"lymph"]],"po":"2024-07-08","u":"2024-07-08","st":"2024-05","ag":"18 and over"},{"n":"NCT06491472","t":"Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"panc"]],"po":"2024-07-09","u":"2024-07-09","st":"2024-07","ag":"18 and over"},{"n":"NCT06492005","t":"A Clinical Study of 9MW2821 (and PD-1 Inhibitor) in Locally Advanced or Metastatic Triple-Negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"a":"adult older","h":[9],"po":"2024-07-09","u":"2025-01-10","st":"2024-07","ag":"18–75"},{"n":"NCT06492395","t":"Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT","s":"rec","p":"phase3","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"hcc"]],"po":"2024-07-09","u":"2025-01-29","st":"2024-08","ag":"18–75"},{"n":"NCT06492408","t":"Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma.","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"hcc"]],"po":"2024-07-09","u":"2024-07-09","st":"2024-07","ag":"18–75"},{"n":"NCT06492421","t":"Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"lung"]],"po":"2024-07-09","u":"2024-07-09","st":"2024-07","ag":"18–75"},{"n":"NCT06493864","t":"A Study of BL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors","s":"rec","p":"phase1","d":[6],"c":[5],"a":"adult older","h":[9],"po":"2024-07-10","u":"2025-09-18","st":"2024-08","ag":"18–75"},{"n":"NCT06494371","t":"A Study of LCAR-HL30 in Subjects With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma","s":"rec","p":"phase1","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2024-07-10","u":"2024-07-10","st":"2024-07","ag":"18–75"},{"n":"NCT06494514","t":"NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer","s":"rec","p":"na","d":[5],"c":[28],"lc":[28],"a":"adult older","h":[60],"l":[[60,"panc"]],"po":"2024-07-10","u":"2024-07-10","st":"2024-04","ag":"18 and over"},{"n":"NCT06495515","t":"Dalpiciclib Plus Toremifene for First-line Advanced HR Positive and HER2 Negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[30],"lc":[30],"a":"adult older","x":"female","h":[58],"l":[[58,"breast"]],"po":"2024-07-10","u":"2026-09-17","st":"2024-08","ag":"18–75"},{"n":"NCT06496048","t":"Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC","s":"rec","p":"phase3","d":[4],"c":[15],"a":"adult older","h":[138],"po":"2024-07-11","u":"2024-12-12","st":"2024-09","ag":"18 and over"},{"n":"NCT06496308","t":"Bendamustine and Rituximab With or Without Orelabrutinib in MCL Treatment","s":"rec","p":"phase3","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2024-07-11","u":"2024-07-11","st":"2024-07","ag":"18–80"},{"n":"NCT06496373","t":"Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer","s":"rec","p":"earlyphase1","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"panc"]],"po":"2024-07-11","u":"2025-11-17","st":"2024-07","ag":"18 and over"},{"n":"NCT06496490","t":"A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality","s":"rec","p":"phase2","d":[4],"c":[2,15,8,22,63,16,0,24,35,9,10,5,30,39,20,64],"a":"adult older","h":[53,58,9,111,74,45,13,47,14,37,30,98,50,138,85,204,198],"po":"2024-07-11","u":"2025-11-20","st":"2024-08","ag":"18–75"},{"n":"NCT06497361","t":"Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease","s":"rec","p":"earlyphase1","d":[26],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"igg4"]],"po":"2024-07-11","u":"2024-07-11","st":"2024-07","ag":"18 and over"},{"n":"NCT06497387","t":"Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease","s":"rec","p":"earlyphase1","d":[26],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"igg4"]],"po":"2024-07-11","u":"2024-07-11","st":"2024-07","ag":"18 and over"},{"n":"NCT06497530","t":"Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC","s":"rec","p":"phase2","d":[4],"c":[0],"a":"adult older","h":[132],"po":"2024-07-11","u":"2026-06-08","st":"2024-12","ag":"18 and over"},{"n":"NCT06497738","t":"A Prospective Study Comparing DRd With VRd-lite in Elderly Newly Diagnosed Multiple Myeloma","s":"rec","p":"na","d":[15],"c":[49,28,40],"lc":[28],"a":"older","h":[78,110,230],"l":[[78,"mm"]],"po":"2024-07-12","u":"2025-08-17","st":"2024-05","ag":"65 and over"},{"n":"NCT06498089","t":"A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis","s":"rec","p":"phase4","d":[35],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"takayasu"]],"po":"2024-07-12","u":"2024-10-17","st":"2024-06","ag":"18–65"},{"n":"NCT06498154","t":"Eliminating Breast Surgery for Breast Cancer Patients With Clinical Complete Response to Neoadjuvant Systemic Therapy","s":"rec","p":"phase2","d":[6],"c":[30],"lc":[30],"a":"adult older","x":"female","h":[58],"l":[[58,"breast"]],"po":"2024-07-12","u":"2025-12-19","st":"2024-07","ag":"18–70"},{"n":"NCT06498622","t":"Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab","s":"rec","p":"phase2","d":[2],"c":[17],"lc":[17],"a":"adult older","h":[68],"l":[[68,"hcc"]],"po":"2024-07-12","u":"2024-07-12","st":"2024-07","ag":"18–80"},{"n":"NCT06500052","t":"A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors","s":"rec","p":"phase1","d":[3,5],"c":[0],"a":"adult older","h":[53],"po":"2024-07-15","u":"2025-09-18","st":"2024-07","ag":"18–75"},{"n":"NCT06500208","t":"Neoadjuvant Adebrelimab and Chemotherapy in High-rish ER+/HER2- BC","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[123],"l":[[123,"breast"]],"po":"2024-07-15","u":"2025-06-26","st":"2024-11","ag":"18–65"},{"n":"NCT06500312","t":"Decoding the Association of Imaging and Tumor Microenvironment in Lung Cancer Using Radiogenomic Approach（Radiogenomics-Lung）","s":"rec","p":"na","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lung"]],"po":"2024-07-15","u":"2025-01-13","st":"2024-07","ag":"18 and over"},{"n":"NCT06501391","t":"Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Stable Brain Metastasis","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2024-07-15","u":"2024-08-28","st":"2024-07","ag":"18 and over"},{"n":"NCT06502015","t":"Biomarkers in Autoimmune Disease of Nervous System","s":"rec","p":"na","d":[25,27],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"nmosd"]],"po":"2024-07-15","u":"2026-07-29","st":"2024-07","ag":"18 and over"},{"n":"NCT06502613","t":"Idiopathic Scoliosis New Onset and Melatonin Phase Delay in Children","s":"rec","p":"na","d":[33],"c":[37],"lc":[37],"a":"child","h":[188],"l":[[188,"scol"]],"po":"2024-07-16","u":"2024-07-16","st":"2024-08","ag":"6–15"},{"n":"NCT06503263","t":"Zanubrutinib and Lenalidomide as Maintenance Therapy in DLBCL","s":"rec","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"child adult older","h":[26],"l":[[26,"lymph"]],"po":"2024-07-16","u":"2024-09-19","st":"2024-08","ag":"14 and over"},{"n":"NCT06503744","t":"Transthoracic vs Transbronchial Radiofrequency Ablation for Lung Cancer","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2024-07-16","u":"2026-04-13","st":"2024-01","ag":"18 and over"},{"n":"NCT06503783","t":"A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Negative Breast Cancer and Other Solid Tumors","s":"rec","p":"phase1","d":[6],"c":[24,5],"a":"adult older","h":[9,45],"po":"2024-07-16","u":"2026-01-21","st":"2024-08","ag":"18–75"},{"n":"NCT06504732","t":"To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer","s":"rec","p":"phase2phase3","d":[3],"c":[24,11],"a":"adult older","h":[118,45],"po":"2024-07-17","u":"2026-06-05","st":"2024-08","ag":"18–75"},{"n":"NCT06504940","t":"Optimize Study - Orelabrutinib Combined With BR/G in Untreated Marginal Zone Lymphoma (MZL)","s":"rec","p":"phase2","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"lymph"]],"po":"2024-07-17","u":"2026-02-27","st":"2024-06","ag":"18 and over"},{"n":"NCT06505824","t":"A Study of BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors","s":"rec","p":"phase1","d":[4],"c":[5],"a":"adult older","h":[65],"po":"2024-07-17","u":"2026-11-02","st":"2024-08","ag":"18–75"},{"n":"NCT06506292","t":"A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)","s":"rec","p":"phase2","d":[3],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"gc"]],"po":"2024-07-17","u":"2024-07-17","st":"2024-07","ag":"18–75"},{"n":"NCT06507514","t":"Blinatumomab and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL","s":"rec","p":"phase1","d":[16],"c":[4],"lc":[4],"a":"child adult older","h":[5],"l":[[5,"ball"]],"po":"2024-07-18","u":"2025-11-21","st":"2024-04","ag":"15–65"},{"n":"NCT06507683","t":"Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GIST","s":"rec","p":"na","d":[12],"c":[1],"lc":[1],"a":"adult older","h":[79],"l":[[79,"gist"]],"po":"2024-07-18","u":"2024-07-18","st":"2024-05","ag":"18–75"},{"n":"NCT06508983","t":"A Clinical Study Comparing SG301 Plus Pomalidomide and Dexamethasone to Placebo Plus Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients","s":"rec","p":"phase3","d":[15],"c":[2,0,23,4,30,13,39,20],"a":"adult older","h":[89,12,5,37,97,53,58,54,189],"po":"2024-07-19","u":"2026-07-10","st":"2024-06","ag":"18–75"},{"n":"NCT06509009","t":"Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma","s":"rec","p":"phase2","d":[0],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"npc"]],"po":"2024-07-19","u":"2025-09-19","st":"2024-08","ag":"18–75"},{"n":"NCT06509568","t":"Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma（CRIS-2 Trial）","s":"rec","p":"phase2","d":[1],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"escc"]],"po":"2024-07-19","u":"2025-08-29","st":"2024-08","ag":"18–75"},{"n":"NCT06510010","t":"Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[0],"lc":[0],"a":"adult older","h":[75],"l":[[75,"gc"]],"po":"2024-07-19","u":"2026-08-06","st":"2024-12","ag":"18–75"},{"n":"NCT06510283","t":"Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis","s":"rec","p":"phase2","d":[34],"c":[2],"lc":[2],"a":"child adult older","h":[161],"l":[[161,"nmdae"]],"po":"2024-07-19","u":"2024-11-20","st":"2024-12","ag":"14 and over"},{"n":"NCT06510660","t":"Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC","s":"rec","p":"phase2","d":[1],"c":[16],"lc":[16],"a":"adult older","h":[140],"l":[[140,"escc"]],"po":"2024-07-19","u":"2026-10-29","st":"2024-04","ag":"18–70"},{"n":"NCT06512051","t":"A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer","s":"rec","p":"phase1phase2","d":[4],"c":[2],"a":"adult older","h":[26],"po":"2024-07-22","u":"2025-12-23","st":"2024-07","ag":"18–70"},{"n":"NCT06512571","t":"CVI Alterations in FD: a Prospective, Multicenter, Observational Cohort Study","s":"rec","p":"na","d":[41],"c":[2],"a":"adult older","h":[213],"po":"2024-07-22","u":"2025-03-26","st":"2024-12","ag":"18 and over"},{"n":"NCT06514027","t":"Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion Mutations","s":"rec","p":"phase2","d":[4],"c":[0],"a":"adult older","h":[53],"po":"2024-07-23","u":"2026-08-18","st":"2024-08","ag":"18 and over"},{"n":"NCT06514118","t":"Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[26],"lc":[26],"a":"adult older","h":[319],"l":[[319,"lung"]],"po":"2024-07-23","u":"2024-07-23","st":"2024-04","ag":"18–80"},{"n":"NCT06515314","t":"HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors","s":"rec","p":"phase1","d":[2],"c":[5],"a":"adult older","h":[6],"po":"2024-07-23","u":"2025-12-02","st":"2024-10","ag":"18–75"},{"n":"NCT06515587","t":"Clinical Study of Lewis Antigen Assay Combined With CA19-9 Assay to Assess Prognosis in Patients With Pancreatic Cancer","s":"rec","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[121],"l":[[121,"panc"]],"po":"2024-07-23","u":"2025-05-14","st":"2024-08","ag":"18–75"},{"n":"NCT06516133","t":"Online Adaptive Radiotherapy for Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2024-07-23","u":"2024-07-23","st":"2024-05","ag":"18–70"},{"n":"NCT06516289","t":"Neoadjuvant Treatment of gBRCA-Mutated HER2-Negative Breast Cancer With HRS-1167 and Famitinib ± Camrelizumab","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2024-07-23","u":"2024-12-12","st":"2024-09","ag":"18–70"},{"n":"NCT06517004","t":"An Open-label, Single-arm Study of JWCAR201 in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma","s":"rec","p":"phase1","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lymph"]],"po":"2024-07-24","u":"2024-07-24","st":"2024-07","ag":"18 and over"},{"n":"NCT06517511","t":"Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial)","s":"rec","p":"phase2","d":[19],"c":[0,5],"lc":[0],"a":"adult older","h":[53,9],"l":[[53,"lymph"]],"po":"2024-07-24","u":"2026-02-12","st":"2024-08","ag":"18–80"},{"n":"NCT06517953","t":"Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2024-07-24","u":"2024-07-25","st":"2024-07","ag":"18 and over"},{"n":"NCT06518135","t":"Axillary Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With Initial cN1 Breast Cancer","s":"rec","p":"na","d":[6],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"breast"]],"po":"2024-07-24","u":"2024-12-17","st":"2024-04","ag":"18–70"},{"n":"NCT06518655","t":"Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath","s":"rec","p":"na","d":[4],"c":[2,22,63,0,5,13],"a":"adult older","h":[42,38,132,47,16,320,198],"po":"2024-07-24","u":"2025-12-24","st":"2024-06","ag":"18–80"},{"n":"NCT06519526","t":"Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lymph"]],"po":"2024-07-25","u":"2026-03-24","st":"2024-08","ag":"18–70"},{"n":"NCT06519578","t":"Prospective Real-World Study of HAIC With Raltitrexed or 5-Fluorouracil for the Treatment of Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"hcc"]],"po":"2024-07-25","u":"2024-08-07","st":"2024-08","ag":"18–75"},{"n":"NCT06520163","t":"Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma","s":"rec","p":"phase3","d":[19],"c":[23,61,37],"lc":[61],"a":"adult older","h":[323,46,81,185],"l":[[323,"lymph"]],"po":"2024-07-25","u":"2025-12-04","st":"2024-08","ag":"18–75"},{"n":"NCT06520176","t":"Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients","s":"rec","p":"phase3","d":[15],"c":[23,61,29,37],"lc":[61],"a":"adult older","h":[323,46,81,66,188,346,347],"l":[[323,"mm"]],"po":"2024-07-25","u":"2024-07-25","st":"2024-08","ag":"18–75"},{"n":"NCT06520904","t":"Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography","s":"rec","p":"phase4","d":[31],"c":[34],"lc":[34],"a":"adult older","h":[207],"l":[[207,"cad"]],"po":"2024-07-25","u":"2024-08-19","st":"2024-07","ag":"18–65"},{"n":"NCT06521255","t":"Evaluate the Safety and Efficacy of Tafasitamab and Lenalidomide in Combination With Gemcitabine and Oxaliplatin Versus Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma","s":"rec","p":"phase3","d":[19],"c":[2,15,8,22,1,0,23,27,9,5,4,30,34,37,13,20],"a":"adult older","h":[53,123,46,12,37,27,43,79,233,187,81,98,57,14,13,116,185,94,72],"po":"2024-07-25","u":"2024-07-25","st":"2024-05","ag":"18 and over"},{"n":"NCT06522555","t":"The Efficacy and Safety of Pola-ZR2 Versus ZR2 in the Treatment of Old Patients With de Novo Diffuse Large B-cell Lymphoma","s":"rec","p":"phase3","d":[19],"c":[5],"lc":[5],"a":"older","h":[123],"l":[[123,"lymph"]],"po":"2024-07-26","u":"2024-08-05","st":"2024-07","ag":"70 and over"},{"n":"NCT06523673","t":"Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lung"]],"po":"2024-07-26","u":"2024-08-30","st":"2024-09","ag":"18 and over"},{"n":"NCT06527898","t":"Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer","s":"rec","p":"phase1phase2","d":[4],"c":[17],"lc":[17],"a":"adult older","h":[68],"l":[[68,"lung"]],"po":"2024-07-30","u":"2024-09-19","st":"2024-07","ag":"18–70"},{"n":"NCT06528418","t":"Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath","s":"rec","p":"na","d":[4],"c":[0],"a":"adult older","h":[132],"po":"2024-07-30","u":"2025-03-26","st":"2024-06","ag":"18–100"},{"n":"NCT06528847","t":"Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2024-07-30","u":"2024-07-31","st":"2024-06","ag":"18–74"},{"n":"NCT06529614","t":"An In-situ Detection for MicroRNA","s":"rec","p":"na","d":[6],"c":[13],"lc":[13],"a":"adult older","x":"female","h":[36],"l":[[36,"breast"]],"po":"2024-07-31","u":"2025-10-06","st":"2024-07","ag":"18–75"},{"n":"NCT06530251","t":"A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)","s":"rec","p":"phase1phase2","d":[2],"c":[2,27],"a":"adult older","h":[23,57],"po":"2024-07-31","u":"2026-03-04","st":"2024-09","ag":"18–75"},{"n":"NCT06530550","t":"PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas","s":"rec","p":"phase2","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"lymph"]],"po":"2024-07-31","u":"2025-08-12","st":"2024-08","ag":"18 and over"},{"n":"NCT06531278","t":"Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety","s":"rec","p":"phase2","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[121],"l":[[121,"panc"]],"po":"2024-07-31","u":"2024-07-31","st":"2024-07","ag":"18–75"},{"n":"NCT06531486","t":"A Phase I Study of XS-02 Capsules in Patients With Advanced Solid Tumors","s":"rec","p":"phase1","d":[6,11],"c":[2],"a":"adult older","h":[23],"po":"2024-08-01","u":"2026-10-26","st":"2024-08","ag":"18–75"},{"n":"NCT06532006","t":"A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer","s":"rec","p":"phase3","d":[3],"c":[2,55,15,8,49,22,1,16,0,23,24,17,33,36,9,28,26,5,18,12,30,34,7,62,31,58,20],"a":"adult older","h":[74,78,40,23,60,25,55,24,14,9,112,58,37,141,45,46,41,38,142,75,82,27,30,79,8,164,13,145,98,172,31,192,87,84,101,72],"po":"2024-08-01","u":"2026-02-27","st":"2024-11","ag":"18 and over"},{"n":"NCT06532591","t":"Neoadjuvant/Adjuvant Cadonilimab Plus Chemotherapy in Patients With Resectable PD-L1 Negative NSCLC","s":"rec","p":"phase2","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[47],"l":[[47,"lung"]],"po":"2024-08-01","u":"2024-12-20","st":"2024-08","ag":"18–70"},{"n":"NCT06532617","t":"Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[121],"l":[[121,"panc"]],"po":"2024-08-01","u":"2025-05-14","st":"2024-09","ag":"18–80"},{"n":"NCT06533267","t":"Endoscopic Surgery vs. Intensity Modulated Radiotherapy for Stage I Nasopharyngeal Carcinoma.","s":"rec","p":"na","d":[0],"c":[59],"lc":[59],"a":"adult older","h":[171],"l":[[171,"npc"]],"po":"2024-08-01","u":"2024-08-01","st":"2024-03","ag":"18–75"},{"n":"NCT06533384","t":"PARPi or Capecitabine Combined With PD-1 Inhibitors as Adjuvant Therapy in High-risk TNBC","s":"rec","p":"phase3","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[43],"l":[[43,"breast"]],"po":"2024-08-01","u":"2024-11-04","st":"2024-08","ag":"18–70"},{"n":"NCT06534463","t":"Registry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE)","s":"rec","p":"na","d":[19],"c":[5],"lc":[5],"a":"child adult older","h":[123],"l":[[123,"lymph"]],"po":"2024-08-02","u":"2024-12-03","st":"2024-08","ag":"14 and over"},{"n":"NCT06534762","t":"Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study","s":"rec","p":"phase2","d":[4,5,6,19],"c":[23],"lc":[23],"a":"adult older","h":[183],"l":[[183,"lung"]],"po":"2024-08-02","u":"2024-08-02","st":"2024-07","ag":"18–65"},{"n":"NCT06536868","t":"Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC","s":"rec","p":"phase2","d":[4],"c":[12],"lc":[12],"a":"adult older","h":[184,22],"l":[[184,"lung"]],"po":"2024-08-05","u":"2026-04-24","st":"2024-08","ag":"18–80"},{"n":"NCT06537908","t":"Anti-PD-1/PD-L1 Antibodies Plus Anti-VEGF Antibody Treatment in Patients With Advanced-Stage HCC","s":"rec","p":"na","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"hcc"]],"po":"2024-08-05","u":"2025-12-15","st":"2024-08","ag":"18–90"},{"n":"NCT06538896","t":"Tislelizumab Combined with Nab-Paclitaxel for First-Line Treatment of Advanced Triple-Negative Breast Cancer with Bone Metastasis，an Exploratory, Single-Arm, Multicenter Phase II Clinical Study","s":"rec","p":"phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[44],"l":[[44,"breast"]],"po":"2024-08-06","u":"2024-11-26","st":"2024-08","ag":"18–70"},{"n":"NCT06539182","t":"DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)","s":"rec","p":"phase2","d":[19],"c":[28],"a":"adult older","h":[78],"po":"2024-08-06","u":"2026-06-02","st":"2024-04","ag":"18 and over"},{"n":"NCT06539624","t":"Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease","s":"rec","p":"na","d":[41],"c":[23,5],"lc":[23],"a":"child adult older","h":[179,91],"l":[[179,"fabry"]],"po":"2024-08-06","u":"2026-02-27","st":"2024-10","ag":"7 and over"},{"n":"NCT06539832","t":"Intestinal Flora and Immunity in Monoclonal Gammopathy Patients","s":"rec","p":"na","d":[15],"c":[0],"lc":[0],"a":"adult older","h":[0],"l":[[0,"mm"]],"po":"2024-08-06","u":"2024-09-19","st":"2024-05","ag":"45 and over"},{"n":"NCT06541327","t":"Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection","s":"rec","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2024-08-07","u":"2024-08-19","st":"2024-05","ag":"18 and over"},{"n":"NCT06541340","t":"A New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive Jaundice","s":"rec","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"panc"]],"po":"2024-08-07","u":"2024-08-07","st":"2024-08","ag":"18–75"},{"n":"NCT06541626","t":"Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases","s":"rec","p":"na","d":[25],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"nmosd"]],"po":"2024-08-07","u":"2024-08-07","st":"2024-01","ag":"18–65"},{"n":"NCT06542120","t":"Research on Body Voice AI Recognition System for Children's Health Management","s":"rec","p":"na","d":[32],"c":[47,5,13],"lc":[5],"a":"child adult","h":[90,91,251,348],"l":[[90,"chd"]],"po":"2024-08-07","u":"2026-08-12","st":"2024-05","ag":"Up to 18"},{"n":"NCT06542159","t":"Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary Oligometastases","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2024-08-07","u":"2025-11-17","st":"2024-05","ag":"18 and over"},{"n":"NCT06542796","t":"Study on the Classification of Comprehensive Treatment Effect of Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"hcc"]],"po":"2024-08-07","u":"2025-02-10","st":"2024-09","ag":"18–75"},{"n":"NCT06543108","t":"Preliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PET/CT and PET/MR in Gastric Cancer","s":"rec","p":"na","d":[3],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"gc"]],"po":"2024-08-07","u":"2024-08-07","st":"2024-01","ag":"18–90"},{"n":"NCT06543992","t":"Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Methotrexate in Breast Cancer With Leptomeningeal Metastasis","s":"rec","p":"phase2","d":[6],"c":[28],"lc":[28],"a":"adult older","x":"female","h":[78,288],"l":[[78,"breast"]],"po":"2024-08-09","u":"2026-07-21","st":"2024-08","ag":"18–75"},{"n":"NCT06544083","t":"Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood","s":"rec","p":"na","d":[2],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"hcc"]],"po":"2024-08-09","u":"2026-05-27","st":"2024-02","ag":"18–75"},{"n":"NCT06547710","t":"Primary Tumor Resection for M1a Stage Lung Cancer","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2024-08-09","u":"2026-07-08","st":"2024-04","ag":"18–75"},{"n":"NCT06547736","t":"Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"panc"]],"po":"2024-08-09","u":"2026-01-05","st":"2024-10","ag":"18–75"},{"n":"NCT06548711","t":"Effect of Transcutaneous Acupoint Electrical Stimulation (TAES) on Postoperative Cough in Lung Cancer","s":"rec","p":"na","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[191],"l":[[191,"lung"]],"po":"2024-08-12","u":"2025-09-08","st":"2024-04","ag":"18–80"},{"n":"NCT06550921","t":"Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[2],"a":"adult older","h":[26],"po":"2024-08-13","u":"2024-08-13","st":"2024-08","ag":"18–75"},{"n":"NCT06553352","t":"Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular Lymphoma","s":"rec","p":"phase2","d":[19],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"lymph"]],"po":"2024-08-14","u":"2024-09-03","st":"2024-03","ag":"18 and over"},{"n":"NCT06554561","t":"A Study of Pomadomide in Combination With Rituximab and Methotrexate for Newly-diagnosed Primary Central Nervous System Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lymph"]],"po":"2024-08-15","u":"2024-08-15","st":"2024-08","ag":"18–75"},{"n":"NCT06554600","t":"A Study of Zanubrutinib in Combination With Polatuzumab Vedotin, Bendamustine and Rituximab in the Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lymph"]],"po":"2024-08-15","u":"2024-08-15","st":"2024-08","ag":"18–75"},{"n":"NCT06554613","t":"Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLC","s":"rec","p":"phase2","d":[4],"c":[9],"lc":[9],"a":"adult older","h":[80],"l":[[80,"lung"]],"po":"2024-08-15","u":"2026-05-05","st":"2024-07","ag":"18–75"},{"n":"NCT06554626","t":"Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL","s":"rec","p":"phase2","d":[16],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"ball"]],"po":"2024-08-15","u":"2024-08-15","st":"2024-08","ag":"40 and over"},{"n":"NCT06555068","t":"A Trial of HRS-6209 in Combination With Other Antitumor Therapies in Breast Cancer Patients or HRS-9813 as Monotherapy in Patients With Advanced Solid Tumors","s":"rec","p":"phase1phase2","d":[6],"c":[5],"a":"adult older","x":"female","h":[9],"po":"2024-08-15","u":"2026-10-22","st":"2024-08","ag":"18–75"},{"n":"NCT06555471","t":"A Single-arm, Phase II Exploratory Study of Sintilimab in Combination With Chemoradiotherapy in Elderly Patients With Locally Advanced Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[28],"lc":[28],"a":"older","h":[78],"l":[[78,"gc"]],"po":"2024-08-15","u":"2024-08-15","st":"2024-08","ag":"75 and over"},{"n":"NCT06556199","t":"A Study of Selinexor in Combination With Temozolomide and Anti-PD-1 Antibody in Patients With Relapsed/Refractory Primary Central Nervous System Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lymph"]],"po":"2024-08-15","u":"2025-07-31","st":"2024-08","ag":"18–75"},{"n":"NCT06556394","t":"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RAG-17 in Subjects With Amyotrophic Lateral Sclerosis (ALS) With Superoxide Dismutase Type 1 (SOD1) Gene Mutation","s":"rec","p":"phase1","d":[39],"c":[2,22,23],"a":"adult older","h":[40,54,102],"po":"2024-08-16","u":"2025-01-08","st":"2024-12","ag":"18 and over"},{"n":"NCT06559371","t":"68Ga FAPI PET/CT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[123],"l":[[123,"breast"]],"po":"2024-08-19","u":"2025-12-29","st":"2024-08","ag":"18 and over"},{"n":"NCT06559696","t":"Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy","s":"rec","p":"phase3","d":[6],"c":[16],"lc":[16],"a":"adult older","x":"female","h":[140],"l":[[140,"breast"]],"po":"2024-08-19","u":"2026-10-29","st":"2024-07","ag":"18–75"},{"n":"NCT06560528","t":"Disitamab Vedotin Combined With Tislelizumab and Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Cancer With HER2 Overexpression","s":"rec","p":"phase2","d":[3],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"gc"]],"po":"2024-08-19","u":"2024-08-19","st":"2024-09","ag":"18–75"},{"n":"NCT06561178","t":"Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401)","s":"rec","p":"na","d":[1],"c":[0],"lc":[0],"a":"child adult older","h":[53],"l":[[53,"escc"]],"po":"2024-08-19","u":"2024-08-29","st":"2024-08","ag":"Not stated"},{"n":"NCT06561386","t":"A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%","s":"rec","p":"phase3","d":[4],"c":[2,8,22,1,16,0,23,24,27,9,10,5,11,12,29,30,14],"a":"adult older","h":[42,57,58,43,44,132,6,74,45,46,13,47,14,82,30,2,49,18,50,66,84,21,178],"po":"2024-08-20","u":"2026-11-09","st":"2024-10","ag":"18 and over"},{"n":"NCT06561399","t":"Triple Therapy Sequential Radiotherapy in Unresectable HCC (TALENP003)","s":"rec","p":"na","d":[2],"c":[16],"lc":[16],"a":"adult older","h":[148,190,136],"l":[[148,"hcc"]],"po":"2024-08-20","u":"2024-08-20","st":"2024-08","ag":"18–75"},{"n":"NCT06561620","t":"Befotertinib Adjuvant Therapy in Stage IA2-IB NSCLC Patients","s":"rec","p":"phase4","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2024-08-20","u":"2024-08-22","st":"2024-05","ag":"18–75"},{"n":"NCT06562920","t":"Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"lung"]],"po":"2024-08-20","u":"2024-08-20","st":"2024-07","ag":"18–75"},{"n":"NCT06563245","t":"Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment","s":"rec","p":"phase2phase3","d":[19],"c":[5],"a":"child adult","h":[91],"po":"2024-08-20","u":"2026-03-19","st":"2024-09","ag":"2–35"},{"n":"NCT06563869","t":"Sintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase3","d":[1],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"escc"]],"po":"2024-08-21","u":"2024-08-21","st":"2024-02","ag":"18–75"},{"n":"NCT06563947","t":"Oral Fecal Microbiota Transplantation in Advanced Hepatocellular Carcinoma After Progression on ICI-TKI Therapy","s":"rec","p":"phase2","d":[2],"c":[21],"lc":[21],"a":"adult older","h":[312],"l":[[312,"hcc"]],"po":"2024-08-21","u":"2026-09-10","st":"2024-09","ag":"18–75"},{"n":"NCT06563999","t":"Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2024-08-21","u":"2026-04-21","st":"2024-11","ag":"18–75"},{"n":"NCT06564272","t":"A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma","s":"rec","p":"phase2","d":[14],"c":[2],"a":"child adult","h":[284],"po":"2024-08-21","u":"2024-08-23","st":"2024-09","ag":"12–18"},{"n":"NCT06564324","t":"A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients","s":"rec","p":"phase3","d":[4],"c":[2,8,22,1,0,23,17,27,47,25,9,28,10,5,11,18,4,12,30,13,39,7,20],"a":"adult older","h":[40,23,56,58,78,44,25,5,132,6,111,74,118,36,24,13,14,37,82,112,2,135,65,50,8,84,67,199],"po":"2024-08-21","u":"2026-04-13","st":"2024-11","ag":"18 and over"},{"n":"NCT06566586","t":"A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[8,0,24,65,33,73,9,10,5,12,30,34,13,39,20],"a":"adult older","h":[53,36,58,37,45,238,162,92,14,13,97,50,72,205,84,73],"po":"2024-08-22","u":"2024-11-20","st":"2024-11","ag":"18–75"},{"n":"NCT06566807","t":"Oxygen Study-Orelabrutinib Combined With Obinutuzumab(O2) for First-Line Treatment of Marginal Zone Lymphoma","s":"rec","p":"phase2","d":[19],"c":[89],"lc":[89],"a":"adult older","h":[340],"l":[[340,"lymph"]],"po":"2024-08-22","u":"2024-08-22","st":"2024-08","ag":"18 and over"},{"n":"NCT06567015","t":"Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs","s":"rec","p":"phase1phase2","d":[4],"c":[5,30],"a":"adult older","h":[58,65],"po":"2024-08-22","u":"2026-09-02","st":"2024-09","ag":"18 and over"},{"n":"NCT06567353","t":"A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[123],"l":[[123,"breast"]],"po":"2024-08-22","u":"2025-03-14","st":"2024-12","ag":"18–75"},{"n":"NCT06567938","t":"Intravascular Ultrasound-Guided PCI in Patients With Chronic Kidney Disease","s":"rec","p":"na","d":[31],"c":[39],"lc":[39],"a":"adult older","h":[111],"l":[[111,"cad"]],"po":"2024-08-23","u":"2024-08-23","st":"2024-07","ag":"18 and over"},{"n":"NCT06568705","t":"Hypofractionated Online Adaptive Radiotherapy of Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[38],"l":[[38,"breast"]],"po":"2024-08-23","u":"2026-10-20","st":"2024-09","ag":"35–70"},{"n":"NCT06569485","t":"A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma Patients","s":"rec","p":"phase2","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2024-08-26","u":"2024-08-26","st":"2024-05","ag":"18 and over"},{"n":"NCT06569498","t":"Neoadjuvant Triple Therapy for Resectable HCC","s":"rec","p":"na","d":[2],"c":[16,7],"lc":[16],"a":"adult older","h":[148,190,136,243,8],"l":[[148,"hcc"]],"po":"2024-08-26","u":"2024-10-15","st":"2024-09","ag":"18–75"},{"n":"NCT06572267","t":"Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease","s":"rec","p":"phase2","d":[31],"c":[39],"lc":[39],"a":"adult older","h":[131],"l":[[131,"cad"]],"po":"2024-08-27","u":"2026-01-23","st":"2024-10","ag":"18 and over"},{"n":"NCT06572319","t":"Disitamab Vedotin Plus Trastuzumab in Patients With HER2 Positive GC/GEJ Patiens","s":"rec","p":"phase1phase2","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"gc"]],"po":"2024-08-27","u":"2024-08-27","st":"2024-09","ag":"18–75"},{"n":"NCT06572540","t":"Transthoracic vs Transbronchial Cryoablation for Early-stage Peripheral Lung Cancer","s":"rec","p":"na","d":[4],"c":[22,0,23,5,20],"a":"adult older","h":[40,42,132,82,92],"po":"2024-08-27","u":"2025-07-18","st":"2024-09","ag":"18 and over"},{"n":"NCT06572813","t":"Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer","s":"rec","p":"phase1phase2","d":[5],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"panc"]],"po":"2024-08-27","u":"2025-01-10","st":"2024-11","ag":"18–75"},{"n":"NCT06574347","t":"Vebreltinib Plus PLB1004 as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC.","s":"rec","p":"phase2","d":[4],"c":[0],"a":"adult older","h":[43],"po":"2024-08-27","u":"2025-05-21","st":"2024-08","ag":"18 and over"},{"n":"NCT06574568","t":"A Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma","s":"rec","p":"phase1","d":[15],"c":[2,0,23,24,27,12,20],"a":"adult older","h":[46,89,37,53,45,349,57,99,84],"po":"2024-08-28","u":"2026-02-05","st":"2024-06","ag":"18–75"},{"n":"NCT06574698","t":"Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma","s":"rec","p":"na","d":[13],"c":[0],"lc":[0],"a":"child adult","h":[1],"l":[[1,"nb"]],"po":"2024-08-28","u":"2024-08-28","st":"2024-05","ag":"1–21"},{"n":"NCT06576973","t":"Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"escc"]],"po":"2024-08-29","u":"2025-12-02","st":"2024-08","ag":"18–75"},{"n":"NCT06577532","t":"Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors","s":"rec","p":"earlyphase1","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"panc"]],"po":"2024-08-29","u":"2025-05-21","st":"2024-09","ag":"18 and over"},{"n":"NCT06578052","t":"Irinotecan Liposome in Combination With Capecitabine","s":"rec","p":"na","d":[5],"c":[21],"lc":[21],"a":"adult older","h":[106],"l":[[106,"panc"]],"po":"2024-08-29","u":"2025-02-14","st":"2024-08","ag":"18–80"},{"n":"NCT06580301","t":"Study of YK012 in B-cell Acute Lymphoblastic Leukemia","s":"rec","p":"phase1phase2","d":[16],"c":[15,0,41,23,9,31],"a":"adult older","h":[46,99,137,53,64,43,14,27],"po":"2024-08-30","u":"2026-02-06","st":"2024-09","ag":"18–75"},{"n":"NCT06580574","t":"Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers","s":"rec","p":"phase2","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"gc"]],"po":"2024-08-30","u":"2026-05-15","st":"2024-09","ag":"18 and over"},{"n":"NCT06581081","t":"Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia","s":"rec","p":"na","d":[16],"c":[2],"lc":[2],"a":"child adult older","h":[48],"l":[[48,"ball"]],"po":"2024-08-30","u":"2025-03-12","st":"2024-10","ag":"12–65"},{"n":"NCT06581315","t":"Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"hcc"]],"po":"2024-09-03","u":"2024-09-03","st":"2024-08","ag":"18–75"},{"n":"NCT06581419","t":"A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors","s":"rec","p":"phase1phase2","d":[4],"c":[2],"a":"adult older","h":[23],"po":"2024-09-03","u":"2025-01-15","st":"2024-12","ag":"18–75"},{"n":"NCT06581640","t":"Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple Myeloma","s":"rec","p":"phase2","d":[15],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"mm"]],"po":"2024-09-03","u":"2024-09-25","st":"2024-09","ag":"18–80"},{"n":"NCT06582940","t":"Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2024-09-03","u":"2025-11-17","st":"2024-03","ag":"18–75"},{"n":"NCT06584227","t":"Adebrelimab and Chidamide for Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[28],"lc":[28],"a":"adult older","h":[93],"l":[[93,"panc"]],"po":"2024-09-04","u":"2025-12-08","st":"2024-09","ag":"18–75"},{"n":"NCT06587061","t":"HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"panc"]],"po":"2024-09-19","u":"2026-05-27","st":"2024-12","ag":"18–80"},{"n":"NCT06587789","t":"Ribociclib in Combination With Adjuvant Endocrine Therapy for Patients With Early High-risk HR+HER2- Breast Cancer","s":"rec","p":"na","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2024-09-19","u":"2024-11-21","st":"2024-01","ag":"18–80"},{"n":"NCT06592170","t":"Linperlisib Combination With Obinutuzumab Frontline Treatment of Marginal Zone Lymphoma Patients (MZL)","s":"rec","p":"phase1phase2","d":[19],"c":[15],"lc":[15],"a":"adult older","h":[27],"l":[[27,"lymph"]],"po":"2024-09-19","u":"2024-09-19","st":"2024-08","ag":"18 and over"},{"n":"NCT06594640","t":"R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"lymph"]],"po":"2024-09-19","u":"2026-06-10","st":"2024-05","ag":"18 and over"},{"n":"NCT06596018","t":"Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy","s":"rec","p":"phase1phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2024-09-19","u":"2025-12-30","st":"2024-12","ag":"18–75"},{"n":"NCT06596915","t":"Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors","s":"rec","p":"phase1","d":[4,5,6],"c":[2],"a":"adult older","h":[74],"po":"2024-09-19","u":"2026-10-13","st":"2024-09","ag":"18 and over"},{"n":"NCT06596954","t":"Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell Carcinoma","s":"rec","p":"na","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"escc"]],"po":"2024-09-19","u":"2026-08-11","st":"2024-06","ag":"18–80"},{"n":"NCT06597227","t":"Proximal Gastrectomy vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy","s":"rec","p":"na","d":[3],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"gc"]],"po":"2024-09-19","u":"2026-04-27","st":"2024-03","ag":"18–75"},{"n":"NCT06597526","t":"The Role of 18F-FDG&amp;68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.","s":"rec","p":"na","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"gc"]],"po":"2024-09-19","u":"2024-09-19","st":"2024-06","ag":"18 and over"},{"n":"NCT06598046","t":"A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined With Capecitabine in the Treatment of Active Brain Metastasis of TNBC","s":"rec","p":"phase2","d":[6],"c":[20],"lc":[20],"a":"adult older","x":"female","h":[37],"l":[[37,"breast"]],"po":"2024-09-19","u":"2026-10-13","st":"2024-06","ag":"18 and over"},{"n":"NCT06598306","t":"Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)","s":"rec","p":"phase1","d":[4],"c":[15,5],"a":"adult older","h":[56,138],"po":"2024-09-19","u":"2026-06-26","st":"2024-10","ag":"18 and over"},{"n":"NCT06598527","t":"Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumab Plus Platinum-based Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer: A Phase Ⅲ, Randomized, Multicenter, Prospective Study","s":"rec","p":"phase3","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2024-09-19","u":"2025-05-29","st":"2024-10","ag":"18–75"},{"n":"NCT06598722","t":"BCL-2 Inhibitors Combined with the HyperCVAD Regimen for Newly Diagnosed T-lymphoblastic Leukemia/lymphoma.","s":"rec","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult","h":[121],"l":[[121,"lymph"]],"po":"2024-09-19","u":"2024-09-24","st":"2024-08","ag":"18–60"},{"n":"NCT06598787","t":"A Study of BL-B01D1 in Patients With Recurrent Glioblastoma","s":"rec","p":"phase2","d":[7],"c":[2],"a":"adult older","h":[102],"po":"2024-09-19","u":"2025-05-07","st":"2024-10","ag":"18 and over"},{"n":"NCT06601010","t":"The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer.","s":"rec","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"panc"]],"po":"2024-09-19","u":"2024-12-11","st":"2024-09","ag":"18–75"},{"n":"NCT06601309","t":"Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC","s":"rec","p":"phase2","d":[1],"c":[16],"lc":[16],"a":"adult older","h":[140],"l":[[140,"escc"]],"po":"2024-09-19","u":"2026-10-29","st":"2024-07","ag":"18–75"},{"n":"NCT06601621","t":"Study on the Impact of Electroacupuncture Combined With Self-Acupressure on the Quality of Life of Patients With Early-Stage Breast Cancer Undergoing Chemotherapy","s":"rec","p":"na","d":[6],"c":[62],"lc":[62],"a":"adult older","h":[192],"l":[[192,"breast"]],"po":"2024-09-19","u":"2026-02-12","st":"2024-10","ag":"18–75"},{"n":"NCT06602011","t":"Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002)","s":"rec","p":"na","d":[2],"c":[16,7],"lc":[16],"a":"adult older","h":[148,190,136,243,8],"l":[[148,"hcc"]],"po":"2024-09-19","u":"2024-10-15","st":"2024-09","ag":"18–75"},{"n":"NCT06602037","t":"ImmunoPET Imaging of Pancreatic Cancer","s":"rec","p":"na","d":[3,5],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"gc"]],"po":"2024-09-19","u":"2025-12-29","st":"2024-11","ag":"18–70"},{"n":"NCT06602167","t":"Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated Hand-Foot Syndrome","s":"rec","p":"na","d":[6],"c":[62],"lc":[62],"a":"adult older","h":[192],"l":[[192,"breast"]],"po":"2024-09-19","u":"2024-12-12","st":"2024-10","ag":"18–85"},{"n":"NCT06602843","t":"Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy","s":"rec","p":"na","d":[1],"c":[17],"lc":[17],"a":"adult older","h":[68],"l":[[68,"escc"]],"po":"2024-09-19","u":"2024-09-19","st":"2024-01","ag":"18–75"},{"n":"NCT06607107","t":"mFOLFOX7 Plus Camrelizumab and Apatinib in BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan Criteria","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"hcc"]],"po":"2024-09-23","u":"2024-09-23","st":"2024-02","ag":"18–75"},{"n":"NCT06607419","t":"Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia","s":"rec","p":"phase2phase3","d":[16],"c":[17,5],"lc":[5],"a":"child adult","h":[91,254],"l":[[91,"ball"]],"po":"2024-09-23","u":"2024-09-23","st":"2024-05","ag":"1 month–18"},{"n":"NCT06607796","t":"Efficacy and Safety of Intratumoral Toluenesulfonamide (PTS) Injection in Stage IV Driver Gene-Negative NSCLC With/Without Chemoimmunotherapy","s":"rec","p":"phase3","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[132],"l":[[132,"lung"]],"po":"2024-09-23","u":"2024-09-25","st":"2024-03","ag":"18–75"},{"n":"NCT06608732","t":"Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission.","s":"rec","p":"phase2","d":[16],"c":[30],"lc":[30],"a":"child adult older","h":[69],"l":[[69,"ball"]],"po":"2024-09-23","u":"2024-11-05","st":"2024-08","ag":"16–70"},{"n":"NCT06609187","t":"A Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors","s":"rec","p":"phase1","d":[6],"c":[2],"a":"adult older","h":[23],"po":"2024-09-24","u":"2026-01-21","st":"2024-10","ag":"18 and over"},{"n":"NCT06609304","t":"Axicabtagene Ciloleucel for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma","s":"rec","p":"phase4","d":[19],"c":[20],"lc":[20],"a":"adult older","h":[25],"l":[[25,"lymph"]],"po":"2024-09-24","u":"2024-10-15","st":"2024-09","ag":"18–70"},{"n":"NCT06609850","t":"The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[2],"a":"adult older","h":[26],"po":"2024-09-24","u":"2024-12-03","st":"2024-10","ag":"18–75"},{"n":"NCT06609863","t":"dTACE-HAIC Combined With Bevacizumab and Atezolizumab for Huge Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[2],"a":"adult older","h":[26],"po":"2024-09-24","u":"2024-12-03","st":"2024-10","ag":"18–75"},{"n":"NCT06609876","t":"Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC","s":"rec","p":"na","d":[2],"c":[2],"a":"adult older","h":[26],"po":"2024-09-24","u":"2024-12-03","st":"2024-10","ag":"18–75"},{"n":"NCT06610734","t":"Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)","s":"rec","p":"phase2","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"lung"]],"po":"2024-09-24","u":"2026-02-09","st":"2024-12","ag":"18–75"},{"n":"NCT06610799","t":"Study of IBI363 in Patients with Advanced First-line Gastric Cancer","s":"rec","p":"phase1","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"gc"]],"po":"2024-09-24","u":"2024-11-20","st":"2024-10","ag":"18–75"},{"n":"NCT06611150","t":"Concurrent Nab-paclitaxel with Intensity-modulated Radiation Therapy in Patients with Stage III-IVa Nasopharyngeal Carcinoma","s":"rec","p":"phase1","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2024-09-24","u":"2024-09-27","st":"2024-08","ag":"18–70"},{"n":"NCT06611787","t":"A Comprehensive Registry Study of the Whole Life Cycle of Patients With CHD","s":"rec","p":"na","d":[32],"c":[2],"lc":[2],"a":"child adult older","h":[109],"l":[[109,"chd"]],"po":"2024-09-25","u":"2024-09-25","st":"2024-02","ag":"Not stated"},{"n":"NCT06611813","t":"Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)","s":"rec","p":"phase2","d":[6],"c":[23,24,17,5,34,20],"lc":[23],"a":"adult older","x":"female","h":[46,45,44,25,112,6,72],"l":[[46,"breast"]],"po":"2024-09-25","u":"2025-08-12","st":"2024-06","ag":"18–75"},{"n":"NCT06612840","t":"A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors","s":"rec","p":"phase1","d":[4],"c":[5],"a":"adult older","h":[65],"po":"2024-09-25","u":"2026-01-21","st":"2024-10","ag":"18 and over"},{"n":"NCT06613009","t":"Study of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer","s":"rec","p":"phase1","d":[4],"c":[8,16,23,17,27,9,20],"a":"adult older","h":[57,44,13,14,37,112,136],"po":"2024-09-25","u":"2025-02-11","st":"2024-12","ag":"18–75"},{"n":"NCT06615193","t":"A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor","s":"rec","p":"phase1","d":[19],"c":[23,27,9,4,30,31,20],"a":"adult older","h":[46,5,64,69,37,187,57,14],"po":"2024-09-26","u":"2024-09-26","st":"2024-08","ag":"18 and over"},{"n":"NCT06617416","t":"A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC","s":"rec","p":"phase3","d":[4],"c":[27],"a":"adult older","h":[199],"po":"2024-09-27","u":"2025-03-12","st":"2024-11","ag":"18 and over"},{"n":"NCT06618664","t":"A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma (KYLIN-02)","s":"rec","p":"phase3","d":[2],"c":[17],"a":"adult older","h":[68],"po":"2024-10-01","u":"2026-09-25","st":"2024-10","ag":"18 and over"},{"n":"NCT06621563","t":"Phase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid Tumors","s":"rec","p":"phase1","d":[4],"c":[30],"a":"adult older","h":[58],"po":"2024-10-01","u":"2025-04-09","st":"2024-12","ag":"18–75"},{"n":"NCT06622031","t":"TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT","s":"rec","p":"na","d":[2],"c":[2],"a":"adult older","h":[26],"po":"2024-10-01","u":"2025-01-13","st":"2024-10","ag":"18–75"},{"n":"NCT06623474","t":"Correlation Study of Lipid Metabolites as Markers of Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"hcc"]],"po":"2024-10-02","u":"2024-10-09","st":"2024-07","ag":"18–80"},{"n":"NCT06623487","t":"The Application Value of 68Ga-grazytracer PET in Immunotherapy for Stage III Non-small-cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lung"]],"po":"2024-10-02","u":"2024-10-02","st":"2024-07","ag":"18–75"},{"n":"NCT06627712","t":"SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC","s":"rec","p":"phase3","d":[6],"c":[22],"lc":[22],"a":"adult older","x":"female","h":[40],"l":[[40,"breast"]],"po":"2024-10-04","u":"2026-09-29","st":"2024-11","ag":"18–65"},{"n":"NCT06631391","t":"Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma.","s":"rec","p":"phase1","d":[13],"c":[0],"lc":[0],"a":"child adult","h":[53],"l":[[53,"nb"]],"po":"2024-10-08","u":"2025-02-20","st":"2024-11","ag":"1 day–18"},{"n":"NCT06632262","t":"A Phase 2 Clinical Study of ABSK061 and ABSK043","s":"rec","p":"phase2","d":[3,4],"c":[22,41,23,24,27,5,11,18,12,30,13,7,38,31,20],"a":"adult older","h":[40,6,118,24,58,37,45,36,18,183,8,137,64,86,84,176,199],"po":"2024-10-09","u":"2024-11-19","st":"2024-11","ag":"18 and over"},{"n":"NCT06632886","t":"AI-Assisted Non-Contrast CT for Multi-Cancer Screening","s":"rec","p":"na","d":[3,4,5,6],"c":[5],"lc":[5],"a":"adult older","h":[177],"l":[[177,"gc"]],"po":"2024-10-09","u":"2024-10-09","st":"2024-10","ag":"18 and over"},{"n":"NCT06633328","t":"CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia","s":"rec","p":"earlyphase1","d":[17],"c":[23],"lc":[23],"a":"child adult older","h":[46],"l":[[46,"aa"]],"po":"2024-10-09","u":"2024-10-09","st":"2024-10","ag":"Not stated"},{"n":"NCT06633341","t":"Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma","s":"rec","p":"earlyphase1","d":[19],"c":[23],"lc":[23],"a":"child adult older","h":[46],"l":[[46,"lymph"]],"po":"2024-10-09","u":"2024-10-09","st":"2024-10","ag":"Not stated"},{"n":"NCT06634589","t":"A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies","s":"rec","p":"phase1phase2","d":[19],"c":[16,23,4,37],"a":"adult older","h":[46,5,140,81],"po":"2024-10-10","u":"2026-09-11","st":"2024-11","ag":"18 and over"},{"n":"NCT06634966","t":"Segmentectomy for Solid-dominant Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2024-10-10","u":"2024-10-10","st":"2024-07","ag":"18–80"},{"n":"NCT06634979","t":"Selective Lymph Node Resection for Invasive Non-small Cell Lung Cancer With the CTR of 0.5-1 and the Diameter of ≤ 2 cm","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2024-10-10","u":"2025-08-12","st":"2024-05","ag":"18–80"},{"n":"NCT06636981","t":"All Trans Retinoic Acid Combined with Toripalimab+Chemotherapy for Locally Advanced Inoperable or Metastatic Triple Negative Breast Cancer：a Multi-center, Multi-cohort Phase II Trial","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2024-10-15","u":"2024-12-13","st":"2024-11","ag":"18 and over"},{"n":"NCT06637163","t":"Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC","s":"rec","p":"phase2","d":[1],"c":[23,5,43,11,30],"lc":[5],"a":"adult older","h":[6,125,44,58,18],"l":[[6,"escc"]],"po":"2024-10-15","u":"2025-04-17","st":"2024-10","ag":"18 and over"},{"n":"NCT06638866","t":"AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort","s":"rec","p":"na","d":[5],"c":[90,5],"lc":[5],"a":"adult older","h":[177,350],"l":[[177,"panc"]],"po":"2024-10-15","u":"2025-03-19","st":"2024-08","ag":"18 and over"},{"n":"NCT06640361","t":"A Study of Olverembatinib in SDH-deficient GIST.","s":"rec","p":"phase3","d":[12],"c":[0],"a":"child adult older","h":[53],"po":"2024-10-15","u":"2026-07-23","st":"2024-11","ag":"12 and over"},{"n":"NCT06641544","t":"The Efficacy and Safety of Different Combination Regimens of Inetetamab in First-line Treatment of HER2 Positive Metastatic Breast Cancer","s":"rec","p":"phase4","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2024-10-15","u":"2024-10-15","st":"2024-10","ag":"18–70"},{"n":"NCT06641609","t":"A Phase I Study of CFT8919 in Patients With Advanced NSCLC","s":"rec","p":"phase1","d":[4],"c":[23],"a":"adult older","h":[44],"po":"2024-10-15","u":"2026-09-04","st":"2024-11","ag":"18 and over"},{"n":"NCT06641713","t":"HAIC Compared With TACE in Huge Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[2],"a":"adult older","h":[26],"po":"2024-10-15","u":"2025-03-26","st":"2024-10","ag":"18–75"},{"n":"NCT06641895","t":"Evaluation of the Safety and Efficacy of BBM-D101 to Treat Patients with Duchenne Muscular Dystrophy","s":"rec","p":"earlyphase1","d":[43],"c":[5],"lc":[5],"a":"child","x":"male","h":[91],"l":[[91,"dmd"]],"po":"2024-10-15","u":"2025-03-25","st":"2024-07","ag":"4–8"},{"n":"NCT06644066","t":"Partial Pressure of Oxygen Control Method in Identification of Intersegmental Plane","s":"rec","p":"na","d":[4],"c":[39],"lc":[39],"a":"adult older","h":[122],"l":[[122,"lung"]],"po":"2024-10-16","u":"2025-01-07","st":"2024-05","ag":"18–75"},{"n":"NCT06644118","t":"A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)","s":"rec","p":"phase1","d":[15],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"mm"]],"po":"2024-10-16","u":"2024-11-08","st":"2024-10","ag":"18–75"},{"n":"NCT06644430","t":"Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular Carcinoma","s":"rec","p":"na","d":[2,4],"c":[2],"a":"adult older","h":[26],"po":"2024-10-16","u":"2026-10-23","st":"2024-10","ag":"18–80"},{"n":"NCT06644937","t":"Single-arm Clinical Trial of TACE in Combination With Icaritin as Adjuvant Therapy After Surgery in Patients With Hepatocellular Carcinoma at High Risk of Recurrence","s":"rec","p":"phase2phase3","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[0],"l":[[0,"hcc"]],"po":"2024-10-16","u":"2025-09-23","st":"2024-11","ag":"18–75"},{"n":"NCT06646588","t":"Fruquintinib in Combination With Tislelizumab Followed by Radiotherapy in Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"escc"]],"po":"2024-10-17","u":"2024-10-17","st":"2024-04","ag":"18 and over"},{"n":"NCT06647940","t":"Orelabrutinib in Combination with R-CHOP for CD5-positive DLBCL Patients（Rocket Trial）","s":"rec","p":"phase2","d":[19],"c":[0,33,43,59],"a":"adult older","h":[53,125,278,171,73],"po":"2024-10-18","u":"2024-10-22","st":"2024-11","ag":"18 and over"},{"n":"NCT06648317","t":"Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"lung"]],"po":"2024-10-18","u":"2024-11-25","st":"2024-11","ag":"18–75"},{"n":"NCT06649305","t":"A Prospective Multicenter Clinical Study： IntracOronary neaR-Infrared Spectroscopy and OptIcal Coherence Tomography for Evaluating Coronary vulNerable Plaque in Patients With diabeTes","s":"rec","p":"na","d":[31],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"cad"]],"po":"2024-10-18","u":"2026-02-12","st":"2024-10","ag":"18 and over"},{"n":"NCT06649331","t":"Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2024-10-18","u":"2026-09-03","st":"2024-10","ag":"18 and over"},{"n":"NCT06649565","t":"Prospective Validation and Application of an Artificial Intelligence-based Model for Evaluating the Efficacy of Breast Cancer Patients After Neoadjuvant Therapy","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2024-10-18","u":"2024-10-18","st":"2024-01","ag":"18 and over"},{"n":"NCT06650319","t":"A Clinical Study to Evaluate the Safety and Efficacy of LY-M003 Injection in Patients With Wilson Disease","s":"rec","p":"earlyphase1","d":[29],"c":[23],"lc":[23],"a":"child adult","h":[46],"l":[[46,"wilson"]],"po":"2024-10-21","u":"2026-01-23","st":"2024-09","ag":"10–60"},{"n":"NCT06650332","t":"Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients","s":"rec","p":"phase1phase2","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"gc"]],"po":"2024-10-21","u":"2024-10-21","st":"2024-07","ag":"18–75"},{"n":"NCT06650553","t":"Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study","s":"rec","p":"na","d":[17],"c":[12],"lc":[12],"a":"child adult older","h":[22],"l":[[22,"aa"]],"po":"2024-10-21","u":"2025-08-14","st":"2024-06","ag":"6–75"},{"n":"NCT06651853","t":"Large Fraction Radiation Therapy Combined With Lenalidomide, and Glofitamab in Refractory Relapsed DLBCL","s":"rec","p":"phase2","d":[19],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"lymph"]],"po":"2024-10-22","u":"2025-07-23","st":"2024-10","ag":"18 and over"},{"n":"NCT06652048","t":"High-dose Furmonertinib or Combined With Chemotherapy in EGFR-mutant Advanced NSCLC After Disease Progression on Third-generation EGFR-TKI","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2024-10-22","u":"2025-11-21","st":"2024-10","ag":"18 and over"},{"n":"NCT06652243","t":"Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma","s":"rec","p":"earlyphase1","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[121],"l":[[121,"hcc"]],"po":"2024-10-22","u":"2024-11-25","st":"2024-11","ag":"18–70"},{"n":"NCT06653062","t":"Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance","s":"rec","p":"na","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2024-10-22","u":"2024-12-30","st":"2024-11","ag":"18 and over"},{"n":"NCT06654596","t":"Efficacy and Safety of Telitacicept in IgAN","s":"rec","p":"na","d":[46],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"iga"]],"po":"2024-10-23","u":"2025-01-01","st":"2024-12","ag":"18–70"},{"n":"NCT06658080","t":"Drug Sensitivity of Hydrothorax and Ascite Organoids from Breast Cancer","s":"rec","p":"na","d":[6],"c":[23],"lc":[23],"a":"adult older","h":[54,44],"l":[[54,"breast"]],"po":"2024-10-26","u":"2025-01-07","st":"2024-11","ag":"18–70"},{"n":"NCT06659042","t":"Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2024-10-26","u":"2025-05-18","st":"2024-11","ag":"18 and over"},{"n":"NCT06660628","t":"Large Segmentation Radiotherapy ± Deep Inspiration Breath Hold(DIBH) for Left Breast Cancer","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[38],"l":[[38,"breast"]],"po":"2024-10-28","u":"2024-10-28","st":"2024-08","ag":"18–70"},{"n":"NCT06662006","t":"Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer Patients","s":"rec","p":"phase2","d":[5],"c":[28],"lc":[28],"a":"adult older","h":[60],"l":[[60,"panc"]],"po":"2024-10-28","u":"2026-02-06","st":"2024-03","ag":"18–75"},{"n":"NCT06662110","t":"IMmune Proteomics to Predict neoAdjuvant Chemotherapy and immunoTherapy Response in Gastric Cancer","s":"rec","p":"na","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"gc"]],"po":"2024-10-28","u":"2024-10-28","st":"2024-08","ag":"18–75"},{"n":"NCT06663059","t":"Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study","s":"rec","p":"phase2","d":[1],"c":[39],"lc":[39],"a":"adult older","h":[122],"l":[[122,"escc"]],"po":"2024-10-29","u":"2024-10-29","st":"2024-10","ag":"18–75"},{"n":"NCT06663306","t":"Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLC","s":"rec","p":"phase1","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2024-10-29","u":"2026-03-02","st":"2024-12","ag":"18 and over"},{"n":"NCT06664411","t":"Pola-ZR2P in Previously Untreated DLBCL","s":"rec","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"child adult older","h":[26],"l":[[26,"lymph"]],"po":"2024-10-29","u":"2025-08-19","st":"2024-09","ag":"14 and over"},{"n":"NCT06666270","t":"Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors","s":"rec","p":"phase1","d":[6],"c":[5,20],"a":"adult older","h":[9,37],"po":"2024-10-30","u":"2025-07-20","st":"2024-11","ag":"18 and over"},{"n":"NCT06667908","t":"A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)","s":"rec","p":"phase2","d":[4],"c":[0],"a":"adult older","h":[49],"po":"2024-10-31","u":"2026-11-03","st":"2024-12","ag":"18 and over"},{"n":"NCT06668103","t":"A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib","s":"rec","p":"phase2","d":[4],"c":[15,24,5,13],"a":"adult older","h":[42,12,45,138],"po":"2024-10-31","u":"2024-12-12","st":"2024-11","ag":"18 and over"},{"n":"NCT06671236","t":"Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases","s":"rec","p":"phase1","d":[39],"c":[20],"a":"adult older","h":[25],"po":"2024-11-04","u":"2025-09-25","st":"2024-11","ag":"18–70"},{"n":"NCT06671262","t":"Neoadjuvant Toripalimab and Radiotherapy Treatment in N+ HR+ Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2024-11-04","u":"2025-02-11","st":"2024-12","ag":"18–85"},{"n":"NCT06674096","t":"RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL","s":"rec","p":"phase2","d":[19],"c":[23],"lc":[23],"a":"older","h":[44],"l":[[44,"lymph"]],"po":"2024-11-05","u":"2024-11-18","st":"2024-11","ag":"65 and over"},{"n":"NCT06674343","t":"Furmonertinib 160mg as First-line Treatment in Locally Advanced or Metastatic NSCLC With EGFR Classical Mutations","s":"rec","p":"phase3","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"lung"]],"po":"2024-11-05","u":"2024-11-05","st":"2024-07","ag":"18 and over"},{"n":"NCT06675201","t":"Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"escc"]],"po":"2024-11-05","u":"2024-11-05","st":"2024-10","ag":"18–80"},{"n":"NCT06675214","t":"Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy.","s":"rec","p":"phase3","d":[0],"c":[59],"lc":[59],"a":"adult older","h":[171],"l":[[171,"npc"]],"po":"2024-11-05","u":"2024-11-05","st":"2024-07","ag":"18–65"},{"n":"NCT06676007","t":"A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy","s":"rec","p":"na","d":[46],"c":[22],"lc":[22],"a":"adult older","h":[98],"l":[[98,"iga"]],"po":"2024-11-06","u":"2026-01-15","st":"2024-10","ag":"18–75"},{"n":"NCT06676449","t":"TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC","s":"rec","p":"phase3","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"escc"]],"po":"2024-11-06","u":"2026-01-07","st":"2024-11","ag":"18–75"},{"n":"NCT06676722","t":"SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of Immunotherapy","s":"rec","p":"phase2","d":[0],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"npc"]],"po":"2024-11-06","u":"2025-07-01","st":"2024-11","ag":"18–75"},{"n":"NCT06677879","t":"A Prospective Cohort Study of Proton and Photon Therapy for Left-sided Breast Cancer.","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[316],"l":[[316,"breast"]],"po":"2024-11-07","u":"2025-05-30","st":"2024-08","ag":"18–80"},{"n":"NCT06678048","t":"Arsenous Acid for Refractory Triple-Negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[53],"l":[[53,"breast"]],"po":"2024-11-07","u":"2025-06-06","st":"2024-10","ag":"18–75"},{"n":"NCT06679244","t":"Application of a New Surgical Technique in Proximal Gastrectomy: a Prospective, Multicenter Randomized Controlled Study","s":"rec","p":"na","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[103,123,9],"l":[[103,"gc"]],"po":"2024-11-07","u":"2025-07-22","st":"2024-12","ag":"18–80"},{"n":"NCT06681506","t":"A New Cardiac Rehabilitation Treatment in the Application of Ischemic Heart Disease","s":"rec","p":"na","d":[31],"c":[5],"a":"adult older","h":[296],"po":"2024-11-08","u":"2024-11-08","st":"2024-01","ag":"18–85"},{"n":"NCT06682130","t":"Glofitamab Bridging ASCT for Patients With Relapsed or Refractory DLBCL","s":"rec","p":"phase2","d":[19],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"lymph"]],"po":"2024-11-12","u":"2025-07-14","st":"2024-11","ag":"18–70"},{"n":"NCT06682156","t":"Conversion to Carfilzomib Therapy in Bortezomib Intolerant Newly Diagnosed Multiple Myeloma(NDMM) Patients","s":"rec","p":"na","d":[15],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"mm"]],"po":"2024-11-12","u":"2024-11-12","st":"2024-09","ag":"18 and over"},{"n":"NCT06682195","t":"Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)","s":"rec","p":"phase2","d":[6],"c":[23,24,17,9,5,12,34,39,20],"lc":[23],"a":"adult older","x":"female","h":[46,45,44,25,97,112,82,6,72,84,239],"l":[[46,"breast"]],"po":"2024-11-12","u":"2026-01-14","st":"2024-10","ag":"18–70"},{"n":"NCT06683885","t":"A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[20],"lc":[20],"a":"older","h":[25],"l":[[25,"lymph"]],"po":"2024-11-12","u":"2024-11-12","st":"2024-11","ag":"65 and over"},{"n":"NCT06684418","t":"Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2024-11-12","u":"2025-01-20","st":"2024-12","ag":"18 and over"},{"n":"NCT06684600","t":"Study of Dalpiciclib Isethionate Plus Pyrotinib Maleate in the Treatment of Advanced Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"escc"]],"po":"2024-11-12","u":"2024-11-12","st":"2024-11","ag":"18–75"},{"n":"NCT06686108","t":"Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention","s":"rec","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"child adult","h":[121],"l":[[121,"lymph"]],"po":"2024-11-13","u":"2025-05-07","st":"2024-10","ag":"14–55"},{"n":"NCT06689540","t":"Mts105 for Advanced Hepatocellular Carcinoma","s":"rec","p":"phase1","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"hcc"]],"po":"2024-11-14","u":"2024-12-24","st":"2024-11","ag":"18 and over"},{"n":"NCT06690593","t":"Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy","s":"rec","p":"na","d":[15],"c":[0],"lc":[0],"a":"adult older","h":[0],"l":[[0,"mm"]],"po":"2024-11-15","u":"2024-12-27","st":"2024-12","ag":"45 and over"},{"n":"NCT06690645","t":"The Association of Psychological Stress with the Efficacy of Neoadjuvant Therapy in Breast Cancer","s":"rec","p":"na","d":[6],"c":[11],"lc":[11],"a":"adult older","x":"female","h":[143],"l":[[143,"breast"]],"po":"2024-11-15","u":"2024-11-15","st":"2024-11","ag":"18 and over"},{"n":"NCT06692972","t":"The Regression Pattern of Primary Lesions in Lung Cancer After Definitive Radiotherapy","s":"rec","p":"na","d":[4],"c":[2,13],"lc":[2],"a":"adult older","h":[62,16],"l":[[62,"lung"]],"po":"2024-11-18","u":"2025-02-27","st":"2024-12","ag":"18 and over"},{"n":"NCT06694636","t":"Intravascular Radiofrequency Ablation of Sympathetic Nerves for the Treatment of Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[28],"lc":[28],"a":"adult older","h":[120],"l":[[120,"hcc"]],"po":"2024-11-19","u":"2024-11-19","st":"2024-02","ag":"25–75"},{"n":"NCT06696833","t":"Allogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia","s":"rec","p":"earlyphase1","d":[16],"c":[4],"lc":[4],"a":"child adult older","h":[5],"l":[[5,"ball"]],"po":"2024-11-20","u":"2024-11-20","st":"2024-12","ag":"14 and over"},{"n":"NCT06696846","t":"CD70-CAR-NK Cell Therapy for T Cell Lymphoma and Acute Myeloid Leukemia","s":"rec","p":"phase1","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lymph"]],"po":"2024-11-20","u":"2026-04-30","st":"2024-12","ag":"18–75"},{"n":"NCT06697483","t":"Risk Stratification and MRD-driven Maintenance for MM After ASCT","s":"rec","p":"na","d":[15],"c":[2,24],"lc":[2],"a":"adult older","h":[48,38,196],"l":[[48,"mm"]],"po":"2024-11-20","u":"2024-11-25","st":"2024-12","ag":"18 and over"},{"n":"NCT06697938","t":"Neoadjuvant Chemoradiotherapy Compared to Neoadjuvant Chemotherapy for Luminal-Type Locally Advanced Breast Cancer: A Clinical Study","s":"rec","p":"na","d":[6],"c":[22],"lc":[22],"a":"adult older","h":[47],"l":[[47,"breast"]],"po":"2024-11-20","u":"2024-11-20","st":"2024-11","ag":"18–70"},{"n":"NCT06698679","t":"The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer","s":"rec","p":"na","d":[6],"c":[11],"lc":[11],"a":"adult older","x":"female","h":[143],"l":[[143,"breast"]],"po":"2024-11-21","u":"2024-11-21","st":"2024-11","ag":"18 and over"},{"n":"NCT06698692","t":"Trilaciclib for the Prevention of Chemoradiotherapy-Induced Myelosuppression in Esophageal Squamous Cell Carcinoma","s":"rec","p":"na","d":[1],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"escc"]],"po":"2024-11-21","u":"2024-11-21","st":"2024-04","ag":"18 and over"},{"n":"NCT06698965","t":"Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2024-11-21","u":"2024-11-21","st":"2024-10","ag":"18 and over"},{"n":"NCT06699979","t":"Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes","s":"rec","p":"na","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[10],"l":[[10,"lung"]],"po":"2024-11-21","u":"2026-07-07","st":"2024-08","ag":"18 and over"},{"n":"NCT06700395","t":"A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma","s":"rec","p":"phase1","d":[15],"c":[22,5],"a":"adult older","h":[40,6],"po":"2024-11-22","u":"2024-12-06","st":"2024-11","ag":"18–75"},{"n":"NCT06700798","t":"Orelabrutinib Combined With Rituximab Versus R-CVP in the Untreated MZL： A Randomized, Open Phase II Trial","s":"rec","p":"phase2","d":[19],"c":[9],"lc":[9],"a":"adult older","h":[14],"l":[[14,"lymph"]],"po":"2024-11-22","u":"2025-06-17","st":"2024-12","ag":"18 and over"},{"n":"NCT06702826","t":"Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases","s":"rec","p":"phase2","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[11],"l":[[11,"lung"]],"po":"2024-11-25","u":"2024-11-25","st":"2024-11","ag":"18–75"},{"n":"NCT06702891","t":"Integrative Analysis of Exosome-Mediated Single-Cell Transcriptomics and Proteomics in Gastric Cardia Cancer","s":"rec","p":"na","d":[3],"c":[27],"lc":[27],"a":"adult older","h":[124],"l":[[124,"gc"]],"po":"2024-11-25","u":"2026-09-03","st":"2024-12","ag":"18 and over"},{"n":"NCT06704555","t":"Radiotherapy Followed by Tiselizumab Combined With RCHOP in Previously Untreated Bulky Follicular Lymphoma","s":"rec","p":"phase2","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lymph"]],"po":"2024-11-26","u":"2024-11-26","st":"2024-12","ag":"18–70"},{"n":"NCT06705127","t":"Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC.","s":"rec","p":"phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"breast"]],"po":"2024-11-26","u":"2024-11-26","st":"2024-07","ag":"18–75"},{"n":"NCT06707233","t":"Y-90 SIRT for Unresectable HCC Larger Than 7cm","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"hcc"]],"po":"2024-11-27","u":"2025-01-28","st":"2024-12","ag":"18–75"},{"n":"NCT06707259","t":"Clinical Study of Cord Blood-derived IL-10/IL-15 CD19-CAR NK in the Treatment of Refractory/Relapsed B-cell NHL","s":"rec","p":"phase1","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lymph"]],"po":"2024-11-27","u":"2025-11-20","st":"2024-12","ag":"18–75"},{"n":"NCT06709417","t":"A Phase II Clinical Study of Sintilimab Combined with Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) (NICE-CS)","s":"rec","p":"phase2","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"escc"]],"po":"2024-11-29","u":"2024-11-29","st":"2024-11","ag":"20–75"},{"n":"NCT06711471","t":"Trifluridine/tipiracil (TAS-102), Bevacizumab, and Camrelizumab As Third-line or Later-line Therapy of Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"gc"]],"po":"2024-12-02","u":"2024-12-02","st":"2024-11","ag":"18 and over"},{"n":"NCT06713161","t":"Tumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic Status","s":"rec","p":"na","d":[6],"c":[47],"lc":[47],"a":"adult older","x":"female","h":[135],"l":[[135,"breast"]],"po":"2024-12-03","u":"2024-12-03","st":"2024-09","ag":"18–75"},{"n":"NCT06713421","t":"Effect of Premedication With Pronase on Mucosal Cleanliness During EGD","s":"rec","p":"na","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[177],"l":[[177,"gc"]],"po":"2024-12-03","u":"2025-02-25","st":"2024-12","ag":"18–70"},{"n":"NCT06714383","t":"Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma","s":"rec","p":"phase2","d":[11],"c":[2],"lc":[2],"a":"child adult older","h":[48],"l":[[48,"os"]],"po":"2024-12-03","u":"2024-12-03","st":"2024-11","ag":"14–70"},{"n":"NCT06714708","t":"Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC","s":"rec","p":"phase2","d":[4],"c":[17],"a":"adult older","h":[231,88],"l":[[231,"lung"]],"po":"2024-12-04","u":"2025-02-10","st":"2024-11","ag":"18 and over"},{"n":"NCT06715020","t":"Establishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular Imaging","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"breast"]],"po":"2024-12-04","u":"2026-08-11","st":"2024-12","ag":"18–75"},{"n":"NCT06715826","t":"Target-specific immunoPET Imaging of Breast Cancer","s":"rec","p":"phase1phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[41],"l":[[41,"breast"]],"po":"2024-12-04","u":"2026-01-27","st":"2024-09","ag":"18–75"},{"n":"NCT06715839","t":"Target-specific immunoPET Imaging of Digestive System Carcinoma","s":"rec","p":"na","d":[3,5],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"gc"]],"po":"2024-12-04","u":"2025-12-31","st":"2024-12","ag":"18–75"},{"n":"NCT06716073","t":"Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial","s":"rec","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2024-12-04","u":"2026-09-30","st":"2024-08","ag":"18–75"},{"n":"NCT06716164","t":"Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r B-NHL Clinical Research","s":"rec","p":"earlyphase1","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"lymph"]],"po":"2024-12-04","u":"2024-12-04","st":"2024-12","ag":"19–70"},{"n":"NCT06716658","t":"JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas","s":"rec","p":"phase2","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"lymph"]],"po":"2024-12-04","u":"2025-11-18","st":"2024-12","ag":"18 and over"},{"n":"NCT06718010","t":"The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2024-12-05","u":"2026-01-21","st":"2024-12","ag":"18 and over"},{"n":"NCT06718244","t":"Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1","s":"rec","p":"phase2","d":[16],"c":[5],"lc":[5],"a":"child adult older","h":[123],"l":[[123,"ball"]],"po":"2024-12-05","u":"2026-11-12","st":"2024-12","ag":"16–70"},{"n":"NCT06718270","t":"a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia","s":"rec","p":"earlyphase1","d":[15],"c":[5],"lc":[5],"a":"adult older","h":[212],"l":[[212,"mm"]],"po":"2024-12-05","u":"2024-12-12","st":"2024-12","ag":"18 and over"},{"n":"NCT06718309","t":"Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC","s":"rec","p":"phase2","d":[4],"c":[23],"a":"adult older","h":[351],"po":"2024-12-05","u":"2024-12-05","st":"2024-04","ag":"18 and over"},{"n":"NCT06718972","t":"A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China","s":"rec","p":"na","d":[4],"c":[0],"lc":[0],"a":"child adult older","h":[132],"l":[[132,"lung"]],"po":"2024-12-05","u":"2025-04-27","st":"2024-09","ag":"Not stated"},{"n":"NCT06719700","t":"Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2024-12-06","u":"2026-03-03","st":"2024-11","ag":"18–75"},{"n":"NCT06722911","t":"Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[23],"lc":[23],"a":"adult older","h":[183],"l":[[183,"panc"]],"po":"2024-12-09","u":"2024-12-09","st":"2024-11","ag":"18–75"},{"n":"NCT06725082","t":"Impact of Recombinant Humanized Type III Collagen on the Immediate and Long-term Effects of Breast Tumor Surgery","s":"rec","p":"phase1","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[48],"l":[[48,"breast"]],"po":"2024-12-10","u":"2024-12-10","st":"2024-12","ag":"18–80"},{"n":"NCT06725940","t":"GzmB-PET/CT to Evaluate Neoadjuvant Therapy Efficacy in Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"breast"]],"po":"2024-12-10","u":"2024-12-10","st":"2024-11","ag":"18–65"},{"n":"NCT06727669","t":"Longitudinal Cohort of Thrombosis and Hemostasis Diseases","s":"rec","p":"na","d":[21,23],"c":[2,1,20],"lc":[2],"a":"child adult older","h":[48,25,94,167,39],"l":[[48,"ha"]],"po":"2024-12-11","u":"2024-12-11","st":"2024-11","ag":"Not stated"},{"n":"NCT06728852","t":"Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical Study","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2024-12-11","u":"2024-12-11","st":"2024-12","ag":"18–70"},{"n":"NCT06728878","t":"Analysis of Lymph Node Metastasis and Tumor Deposit in the Short Gastric Mesentery Following Total Gastrectomy for Gastric Cancer","s":"rec","p":"na","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"gc"]],"po":"2024-12-11","u":"2025-09-02","st":"2024-05","ag":"18–85"},{"n":"NCT06728891","t":"Analysis of Tumor Deposit at the Fusion Site of the Right Gastric Mesentery and Left Gastric Mesentery in the Patients With Gastric Cancer Who Received Proximal Gastrectomy","s":"rec","p":"na","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"gc"]],"po":"2024-12-11","u":"2025-09-02","st":"2024-05","ag":"18–85"},{"n":"NCT06730295","t":"Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Centrally Located Early-stage Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2024-12-12","u":"2025-03-12","st":"2024-12","ag":"18 and over"},{"n":"NCT06730373","t":"First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)","s":"rec","p":"phase2","d":[3],"c":[27,25,26,19,20,91],"lc":[27],"a":"adult older","h":[124,25,55,113,28,352,336,67],"l":[[124,"gc"]],"po":"2024-12-12","u":"2026-09-15","st":"2024-10","ag":"18–75"},{"n":"NCT06732492","t":"RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies","s":"rec","p":"phase1","d":[19],"c":[13],"lc":[13],"a":"child adult older","h":[12],"l":[[12,"lymph"]],"po":"2024-12-13","u":"2024-12-13","st":"2024-10","ag":"3–70"},{"n":"NCT06733051","t":"Phase II Study of Golidocitinib and Benmelstobart in Patients with R/R ENKTL (JACKPOT50)","s":"rec","p":"phase2","d":[19],"c":[2,0],"lc":[0],"a":"adult older","h":[53,161],"l":[[53,"lymph"]],"po":"2024-12-13","u":"2025-02-10","st":"2024-01","ag":"18 and over"},{"n":"NCT06734182","t":"Neoadjuvant Envafolimab Plus Disitamab Vedotin and Carboplatin in Resectable HER2-Mutant Non-Small-Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"lung"]],"po":"2024-12-16","u":"2024-12-16","st":"2024-06","ag":"18–75"},{"n":"NCT06734520","t":"Clinical Study of Super Transplantation in the Treatment of Severe β-thalassemia","s":"rec","p":"na","d":[20],"c":[0],"lc":[0],"a":"child","h":[1],"l":[[1,"bthal"]],"po":"2024-12-16","u":"2024-12-16","st":"2024-10","ag":"7–10"},{"n":"NCT06734533","t":"Anlotinib-based Combination Therapy in Patients with Hormone Receptor-positive（HR+） Metastatic Breast Cancer(MBC) .","s":"rec","p":"na","d":[6],"c":[8],"lc":[8],"a":"adult older","x":"female","h":[13],"l":[[13,"breast"]],"po":"2024-12-16","u":"2024-12-16","st":"2024-12","ag":"18–75"},{"n":"NCT06734702","t":"Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2024-12-16","u":"2025-07-24","st":"2024-11","ag":"18–75"},{"n":"NCT06734871","t":"A Clinical Study Exploring CT1190B in the Treatment of Patients with Relapsed/refractory B-cell Non-Hodgkin Lymphoma","s":"rec","p":"phase1","d":[19],"c":[5],"a":"adult older","h":[162],"po":"2024-12-16","u":"2025-01-03","st":"2024-12","ag":"18–75"},{"n":"NCT06735131","t":"The Optimal Radioimmunotherapy Combinations for Advanced TNBC","s":"rec","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"child adult older","h":[53],"l":[[53,"breast"]],"po":"2024-12-16","u":"2025-12-03","st":"2024-12","ag":"Not stated"},{"n":"NCT06735495","t":"CD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic Tumors","s":"rec","p":"phase1phase2","d":[16,19],"c":[13],"lc":[13],"a":"child adult older","h":[12],"l":[[12,"ball"]],"po":"2024-12-16","u":"2024-12-16","st":"2024-11","ag":"3–75"},{"n":"NCT06736847","t":"Exploration of Lymph Node Metastasis and Tumor Deposit in the Posterior Gastric Mesentery for Distal Gastric Cancer","s":"rec","p":"na","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"gc"]],"po":"2024-12-17","u":"2025-09-02","st":"2024-05","ag":"18–85"},{"n":"NCT06739031","t":"Clinical Trial to Evaluate the Efficacy and Safety of Pulsed Electric Field Ablation Devices in the Treatment of Lung Tumors","s":"rec","p":"na","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2024-12-18","u":"2026-08-21","st":"2024-12","ag":"18 and over"},{"n":"NCT06739265","t":"Golidocitinib Plus CHOP in Newly Diagnosed PTCL","s":"rec","p":"phase1phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"lymph"]],"po":"2024-12-18","u":"2024-12-18","st":"2024-09","ag":"18–70"},{"n":"NCT06740955","t":"Hypofractionated Radiotherapy","s":"rec","p":"na","d":[7],"c":[15],"lc":[15],"a":"adult older","h":[27],"l":[[27,"glioma"]],"po":"2024-12-18","u":"2024-12-18","st":"2024-08","ag":"18–70"},{"n":"NCT06742021","t":"Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung Cancer","s":"rec","p":"na","d":[4],"c":[47],"lc":[47],"a":"adult older","h":[135],"l":[[135,"lung"]],"po":"2024-12-19","u":"2024-12-19","st":"2024-11","ag":"18–75"},{"n":"NCT06742411","t":"XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC","s":"rec","p":"phase1phase2","d":[3],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"gc"]],"po":"2024-12-19","u":"2025-05-07","st":"2024-12","ag":"18–75"},{"n":"NCT06742424","t":"PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCC","s":"rec","p":"phase2","d":[2],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"hcc"]],"po":"2024-12-19","u":"2024-12-19","st":"2024-10","ag":"18–75"},{"n":"NCT06742463","t":"VHAG in Treating R/R T-ALL/LBL","s":"rec","p":"phase2","d":[19],"c":[23],"lc":[23],"a":"child adult older","h":[46],"l":[[46,"lymph"]],"po":"2024-12-19","u":"2024-12-19","st":"2024-12","ag":"14–74"},{"n":"NCT06742502","t":"Sintilimab Plus Rituximab Followed by R-CHOP Regimen in Untreated PMBL","s":"rec","p":"phase2","d":[19],"c":[16],"a":"adult older","h":[30],"po":"2024-12-19","u":"2025-06-05","st":"2024-11","ag":"18–75"},{"n":"NCT06742515","t":"Blinatumomab Plus Reduced-dose Chemotherapy in Treating B-ALL","s":"rec","p":"phase2","d":[16],"c":[23],"lc":[23],"a":"child adult","h":[46],"l":[[46,"ball"]],"po":"2024-12-19","u":"2024-12-19","st":"2024-10","ag":"15–59"},{"n":"NCT06745687","t":"BCMA/CD3 BsAb in the Treatment of High-risk Smoldering Multiple Myeloma","s":"rec","p":"na","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2024-12-20","u":"2026-07-23","st":"2024-12","ag":"18–78"},{"n":"NCT06745830","t":"Lymph Node Pathologic Grading Strategy","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"child adult older","h":[9],"l":[[9,"lung"]],"po":"2024-12-20","u":"2024-12-20","st":"2024-04","ag":"Not stated"},{"n":"NCT06746194","t":"The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy","s":"rec","p":"na","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"hcc"]],"po":"2024-12-24","u":"2024-12-24","st":"2024-12","ag":"18–75"},{"n":"NCT06747728","t":"Bevacizumab Neoadjuvant Therapy for New High-grade Gliomas in the Brain","s":"rec","p":"na","d":[7],"c":[20],"lc":[20],"a":"adult older","h":[25],"l":[[25,"glioma"]],"po":"2024-12-24","u":"2024-12-24","st":"2024-03","ag":"18 and over"},{"n":"NCT06748352","t":"Safety and Efficacy of Traction Robot-assisted Endoscopic Submucosal Dissection for Early Gastric Cancer","s":"rec","p":"na","d":[3],"c":[27],"lc":[27],"a":"adult older","h":[124],"l":[[124,"gc"]],"po":"2024-12-27","u":"2024-12-27","st":"2024-12","ag":"18–80"},{"n":"NCT06748690","t":"MCB vs EUS-FNA for Preoperative Pathological Evaluation of Gastric SMT","s":"rec","p":"na","d":[3,12],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"gc"]],"po":"2024-12-27","u":"2026-04-16","st":"2024-01","ag":"18 and over"},{"n":"NCT06749691","t":"Liposomal Irinotecan and Apatinib in ES-SCLC","s":"rec","p":"phase2","d":[4],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lung"]],"po":"2024-12-27","u":"2024-12-27","st":"2024-12","ag":"18–75"},{"n":"NCT06749860","t":"Disitamab Vedotin in Combination with Tislelizumab and Bevacizumab in a Phase II Clinical Study of Locally Advanced or Metastatic Non-small Cell Lung Cancer with HER2 Mutation/amplification/expression","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2024-12-27","u":"2024-12-27","st":"2024-02","ag":"18 and over"},{"n":"NCT06749886","t":"An Exploratory Study of Tislelizumab in Combination with Chemotherapy in Immuno-experienced Patients with EGFR/ALK/ROS1-negative Advanced NSCLC in the Second-line Setting","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2024-12-27","u":"2024-12-27","st":"2024-11","ag":"18 and over"},{"n":"NCT06751134","t":"Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma","s":"rec","p":"phase1","d":[13],"c":[28],"lc":[28],"a":"child","h":[253],"l":[[253,"nb"]],"po":"2024-12-27","u":"2025-02-07","st":"2024-12","ag":"1–12"},{"n":"NCT06752785","t":"CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.","s":"rec","p":"phase1","d":[16],"c":[0],"lc":[0],"a":"child adult","h":[1],"l":[[1,"ball"]],"po":"2024-12-31","u":"2024-12-31","st":"2024-10","ag":"1–18"},{"n":"NCT06754267","t":"Venetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALL","s":"rec","p":"phase2","d":[16],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"ball"]],"po":"2024-12-31","u":"2024-12-31","st":"2024-12","ag":"18 and over"},{"n":"NCT06755151","t":"Fenofibrate in Primary Biliary Cholangitis: a Real World Study","s":"rec","p":"phase3","d":[50],"c":[39],"lc":[39],"a":"adult older","h":[131],"l":[[131,"pbc"]],"po":"2025-01-01","u":"2026-01-08","st":"2024-01","ag":"18–75"},{"n":"NCT06755541","t":"Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study","s":"rec","p":"phase3","d":[50],"c":[39],"lc":[39],"a":"adult older","h":[131],"l":[[131,"pbc"]],"po":"2025-01-01","u":"2026-01-08","st":"2024-01","ag":"18–75"},{"n":"NCT06755684","t":"Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2025-01-01","u":"2025-01-06","st":"2024-11","ag":"18 and over"},{"n":"NCT06755775","t":"PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma","s":"rec","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2025-01-01","u":"2025-01-01","st":"2024-07","ag":"18 and over"},{"n":"NCT06756217","t":"68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lung"]],"po":"2025-01-01","u":"2025-01-01","st":"2024-12","ag":"18–75"},{"n":"NCT06757153","t":"Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients","s":"rec","p":"earlyphase1","d":[7],"c":[13],"lc":[13],"a":"adult older","h":[133],"l":[[133,"glioma"]],"po":"2025-01-03","u":"2025-01-03","st":"2024-12","ag":"18 and over"},{"n":"NCT06757621","t":"Hypofractionated Postoperative Regional Nodal Irradiation for Patients With Intermediate-risk Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2025-01-03","u":"2025-01-03","st":"2024-10","ag":"45 and over"},{"n":"NCT06758115","t":"Central Motor Mechanisms in AIS Via HD-sEMG, EEG and Neuromuscular Coupling Analysis","s":"rec","p":"na","d":[33],"c":[23],"lc":[23],"a":"child adult","h":[275],"l":[[275,"scol"]],"po":"2025-01-03","u":"2025-01-03","st":"2024-01","ag":"10–18"},{"n":"NCT06759064","t":"Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites","s":"rec","p":"phase1phase2","d":[3],"c":[27],"lc":[27],"a":"adult older","h":[124],"l":[[124,"gc"]],"po":"2025-01-06","u":"2025-11-19","st":"2024-09","ag":"18–75"},{"n":"NCT06760364","t":"A Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic Cancer","s":"rec","p":"phase1","d":[5],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"panc"]],"po":"2025-01-06","u":"2025-04-10","st":"2024-12","ag":"18–70"},{"n":"NCT06760858","t":"A Prospective Cohort Study on the Treatment of Locally Advanced Gastric Cancer","s":"rec","p":"na","d":[3],"c":[1],"lc":[1],"a":"adult older","h":[193],"l":[[193,"gc"]],"po":"2025-01-07","u":"2025-01-07","st":"2024-12","ag":"18–80"},{"n":"NCT06761027","t":"mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer","s":"rec","p":"phase1phase2","d":[5],"c":[16],"lc":[16],"a":"adult older","h":[148,136],"l":[[148,"panc"]],"po":"2025-01-07","u":"2025-01-07","st":"2024-12","ag":"18–75"},{"n":"NCT06765564","t":"Clinical Study of Induced Pluripotent Stem Cells Derived Motor Neuron Precursor Cell Therapy for Amyotrophic Lateral Sclerosis (ALS)","s":"rec","p":"na","d":[39],"c":[5],"lc":[5],"a":"adult","h":[65,353],"l":[[65,"als"]],"po":"2025-01-09","u":"2025-01-09","st":"2024-03","ag":"18–60"},{"n":"NCT06767813","t":"Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms","s":"rec","p":"phase2","d":[5],"c":[28,5,4,37,20],"a":"adult older","h":[9,60,81,5,37],"po":"2025-01-10","u":"2025-09-19","st":"2024-03","ag":"18–75"},{"n":"NCT06768151","t":"A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer","s":"rec","p":"phase1","d":[4],"c":[13],"a":"adult older","h":[36],"po":"2025-01-10","u":"2025-01-10","st":"2024-12","ag":"18 and over"},{"n":"NCT06770296","t":"The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase I Clinical Study","s":"rec","p":"phase1","d":[6],"c":[28],"lc":[28],"a":"adult older","h":[78,288],"l":[[78,"breast"]],"po":"2025-01-13","u":"2025-01-13","st":"2024-11","ag":"18–75"},{"n":"NCT06771609","t":"Phase II Clinical Trial of PD-L1 in Combination With Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy With or Without Radiotherapy for Advanced Triple-negative Breast Cancer.","s":"rec","p":"phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"breast"]],"po":"2025-01-13","u":"2026-06-10","st":"2024-09","ag":"18 and over"},{"n":"NCT06772766","t":"A Multiple Ascending Dose Study of 9MW3011 in Patients With Non-transfusion-dependent β-thalassemia","s":"rec","p":"phase1","d":[20],"c":[6,10],"a":"adult older","h":[15,7],"po":"2025-01-14","u":"2025-01-14","st":"2024-12","ag":"18–65"},{"n":"NCT06773143","t":"Effect of Subanesthetic Dose of Esketamine on Sleep Quality","s":"rec","p":"na","d":[6],"c":[28],"lc":[28],"a":"adult older","x":"female","h":[78],"l":[[78,"breast"]],"po":"2025-01-14","u":"2025-02-10","st":"2024-12","ag":"18–65"},{"n":"NCT06775275","t":"A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[132],"l":[[132,"lung"]],"po":"2025-01-15","u":"2025-01-15","st":"2024-09","ag":"18–65"},{"n":"NCT06775678","t":"Spatial Fragmentation Combined With Low-dose Radiotherapy for Immunotherapy Combined With Chemotherapy-resistant Locally Advanced or Advanced Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2025-01-15","u":"2025-06-17","st":"2024-10","ag":"18 and over"},{"n":"NCT06776770","t":"A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer","s":"rec","p":"phase1phase2","d":[3],"c":[21],"lc":[21],"a":"adult older","h":[106],"l":[[106,"gc"]],"po":"2025-01-15","u":"2025-01-15","st":"2024-08","ag":"18 and over"},{"n":"NCT06776861","t":"A Prospective, Multicenter, Observational Cohort Study Assessing the Efficacy and Safety of Radiotherapy-sensitized Immunotherapy in Advanced Breast Cancer","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"breast"]],"po":"2025-01-15","u":"2026-06-09","st":"2024-09","ag":"18 and over"},{"n":"NCT06780826","t":"A Study on the Efficacy of Atezolizumab Combined with Chemotherapy","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2025-01-17","u":"2025-01-17","st":"2024-08","ag":"18 and over"},{"n":"NCT06781281","t":"NabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer.","s":"rec","p":"na","d":[6],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"breast"]],"po":"2025-01-17","u":"2025-06-23","st":"2024-12","ag":"18 and over"},{"n":"NCT06782685","t":"Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV","s":"rec","p":"phase1phase2","d":[5],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"panc"]],"po":"2025-01-20","u":"2025-01-20","st":"2024-06","ag":"18–75"},{"n":"NCT06783569","t":"A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors","s":"rec","p":"phase1","d":[3],"c":[24,11],"a":"adult older","h":[45,18],"po":"2025-01-20","u":"2025-09-09","st":"2024-12","ag":"18 and over"},{"n":"NCT06786026","t":"QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2025-01-22","u":"2025-02-06","st":"2024-10","ag":"18–75"},{"n":"NCT06786169","t":"The Relationship of Psychological Stress With Therapy Efficacy and Prognosis of Gastric Cancer","s":"rec","p":"na","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"gc"]],"po":"2025-01-22","u":"2025-01-22","st":"2024-09","ag":"18–80"},{"n":"NCT06787456","t":"\"Xijiang Project\" Screening Cohort for NPC","s":"rec","p":"na","d":[0],"c":[59],"lc":[59],"a":"adult older","h":[171],"l":[[171,"npc"]],"po":"2025-01-22","u":"2026-09-01","st":"2024-11","ag":"30–69"},{"n":"NCT06788548","t":"Fluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastric Cancer（IDEAL Stage 2b）","s":"rec","p":"na","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[39],"l":[[39,"gc"]],"po":"2025-01-23","u":"2026-08-21","st":"2024-02","ag":"18–80"},{"n":"NCT06791083","t":"Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[16],"lc":[16],"a":"adult older","h":[136],"l":[[136,"gc"]],"po":"2025-01-24","u":"2025-01-24","st":"2024-06","ag":"18–75"},{"n":"NCT06791148","t":"Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer","s":"rec","p":"phase2","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[60],"l":[[60,"gc"]],"po":"2025-01-24","u":"2025-01-24","st":"2024-07","ag":"18–75"},{"n":"NCT06793774","t":"Risk Evaluation by COronary Imaging and Artificial intelliGence Based fuNctIonal analyZing tEchniques - III","s":"rec","p":"na","d":[31],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"cad"]],"po":"2025-01-27","u":"2025-01-27","st":"2024-07","ag":"18 and over"},{"n":"NCT06793787","t":"Risk Evaluation by COronary Imaging and Artificial intelliGence Based fuNctIonal analyZing tEchniques - IV","s":"rec","p":"na","d":[31],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"cad"]],"po":"2025-01-27","u":"2025-01-27","st":"2024-07","ag":"18 and over"},{"n":"NCT06794008","t":"BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases","s":"rec","p":"phase2","d":[23,26,44],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"tt"]],"po":"2025-01-27","u":"2025-04-02","st":"2024-12","ag":"18–65"},{"n":"NCT06813365","t":"Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN2)","s":"rec","p":"phase1","d":[4],"c":[2],"a":"adult older","h":[38],"po":"2025-02-06","u":"2026-08-28","st":"2024-06","ag":"18 and over"},{"n":"NCT06817434","t":"Study on Evaluating the Effectiveness of Statins in the Treatment of Moyamoya Disease","s":"rec","p":"na","d":[28],"c":[2],"lc":[2],"a":"adult","h":[102],"l":[[102,"moyamoya"]],"po":"2025-02-10","u":"2025-02-10","st":"2024-12","ag":"18–60"},{"n":"NCT06817525","t":"Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBC","s":"rec","p":"phase2","d":[6],"c":[20],"lc":[20],"a":"adult older","x":"female","h":[37],"l":[[37,"breast"]],"po":"2025-02-10","u":"2025-12-05","st":"2024-11","ag":"18–65"},{"n":"NCT06818838","t":"A Clinical Study Evaluating LY-M001 Injection in the Treatment of Adult Patients With Type I Gaucher Disease","s":"rec","p":"phase1phase2","d":[47],"c":[0,12,30],"a":"adult","h":[189,22,69],"po":"2025-02-11","u":"2026-01-26","st":"2024-07","ag":"18–60"},{"n":"NCT06818916","t":"Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma","s":"rec","p":"na","d":[13],"c":[2],"lc":[2],"a":"child adult","h":[284],"l":[[284,"nb"]],"po":"2025-02-11","u":"2025-12-03","st":"2024-06","ag":"Up to 18"},{"n":"NCT06821048","t":"Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors","s":"rec","p":"phase1","d":[3,5],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"gc"]],"po":"2025-02-11","u":"2026-01-23","st":"2024-07","ag":"18 and over"},{"n":"NCT06824883","t":"Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"lymph"]],"po":"2025-02-13","u":"2025-02-13","st":"2024-05","ag":"18–75"},{"n":"NCT06826079","t":"Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor) in Patients With Locally Advanced Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"gc"]],"po":"2025-02-13","u":"2026-08-18","st":"2024-11","ag":"18–70"},{"n":"NCT06826885","t":"Safety and Efficacy of IMPT or IMRT for Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"breast"]],"po":"2025-02-14","u":"2025-02-14","st":"2024-12","ag":"18 and over"},{"n":"NCT06829147","t":"A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC)","s":"rec","p":"na","d":[0],"c":[0],"lc":[0],"a":"child adult older","h":[53],"l":[[53,"npc"]],"po":"2025-02-17","u":"2025-02-17","st":"2024-11","ag":"Not stated"},{"n":"NCT06832839","t":"Study on the Mechanism of Cognitive Impairment in Patients with Moyamoya Disease","s":"rec","p":"na","d":[28],"c":[2],"lc":[2],"a":"adult","h":[102],"l":[[102,"moyamoya"]],"po":"2025-02-18","u":"2025-02-18","st":"2024-12","ag":"18–60"},{"n":"NCT06832904","t":"Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05)","s":"rec","p":"phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[46],"l":[[46,"breast"]],"po":"2025-02-18","u":"2025-02-18","st":"2024-12","ag":"18–75"},{"n":"NCT06836505","t":"Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.","s":"rec","p":"phase1phase2","d":[13],"c":[44,0],"lc":[0],"a":"child adult","h":[53,354],"l":[[53,"nb"]],"po":"2025-02-20","u":"2025-02-26","st":"2024-12","ag":"1–50"},{"n":"NCT06843629","t":"Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors","s":"rec","p":"na","d":[4,5],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lung"]],"po":"2025-02-25","u":"2026-05-28","st":"2024-10","ag":"18–65"},{"n":"NCT06843707","t":"Establishing a Longitudinal Cohort Study of Lung Cancer Using Tissue and Peripheral Blood Metabolomics.","s":"rec","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[132],"l":[[132,"lung"]],"po":"2025-02-25","u":"2025-02-25","st":"2024-01","ag":"18–75"},{"n":"NCT06848569","t":"Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study","s":"rec","p":"phase2","d":[19],"c":[0],"lc":[0],"a":"child adult","h":[53],"l":[[53,"lymph"]],"po":"2025-02-27","u":"2025-02-27","st":"2024-10","ag":"1–18"},{"n":"NCT06849180","t":"Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data","s":"rec","p":"na","d":[2],"c":[28],"lc":[28],"a":"adult older","h":[120],"l":[[120,"hcc"]],"po":"2025-02-27","u":"2025-02-27","st":"2024-12","ag":"18 and over"},{"n":"NCT06849908","t":"Baricitinib in the Treatment of Intestinal Behçet's Syndrome","s":"rec","p":"phase2","d":[44],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"behcet"]],"po":"2025-02-27","u":"2026-09-21","st":"2024-11","ag":"18–65"},{"n":"NCT06851663","t":"Trop2-targeted immunoPET Imaging of Solid Tumors","s":"rec","p":"phase2phase3","d":[0,4],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"npc"]],"po":"2025-02-28","u":"2026-05-29","st":"2024-12","ag":"18–75"},{"n":"NCT06852638","t":"CD70-targeted immunoPET Imaging of Malignant Cancers","s":"rec","p":"phase2","d":[0,19],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"npc"]],"po":"2025-02-28","u":"2026-05-12","st":"2024-12","ag":"18–80"},{"n":"NCT06863506","t":"Phase II Clinical Study of Befotertinib in EGFR Non-classical Mutant NSCLC","s":"rec","p":"phase2","d":[4],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lung"]],"po":"2025-03-07","u":"2025-03-07","st":"2024-10","ag":"18 and over"},{"n":"NCT06864221","t":"Plasma Sphingolipid Metabolites and Radiotherapy Efficacy in Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"hcc"]],"po":"2025-03-07","u":"2025-03-12","st":"2024-09","ag":"18–80"},{"n":"NCT06867991","t":"Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis","s":"rec","p":"phase3","d":[34],"c":[49,20],"lc":[49],"a":"child adult older","h":[145,25],"l":[[145,"nmdae"]],"po":"2025-03-10","u":"2026-06-09","st":"2024-11","ag":"12 and over"},{"n":"NCT06868849","t":"A Study of JMT203 in Patients With Cancer Cachexia","s":"rec","p":"phase1phase2","d":[4,5],"c":[23],"a":"adult older","h":[82],"po":"2025-03-11","u":"2026-05-22","st":"2024-05","ag":"18 and over"},{"n":"NCT06869694","t":"Energy CT in Imaging and Diagnosis of Gastric Cancer","s":"rec","p":"na","d":[3],"c":[20],"lc":[20],"a":"adult older","h":[25],"l":[[25,"gc"]],"po":"2025-03-11","u":"2025-03-11","st":"2024-09","ag":"18 and over"},{"n":"NCT06873555","t":"A Study of DC05F01 in Chinese Patients With Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors","s":"rec","p":"phase1phase2","d":[4],"c":[55,8],"a":"adult older","h":[13,164],"po":"2025-03-12","u":"2026-09-16","st":"2024-09","ag":"18 and over"},{"n":"NCT06878625","t":"A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[30],"lc":[30],"a":"adult older","x":"female","h":[58],"l":[[58,"breast"]],"po":"2025-03-17","u":"2025-03-25","st":"2024-12","ag":"18–70"},{"n":"NCT06880575","t":"Seniors Integrated Longitudinal cardioVascular Evaluation of Coronary Heart Disease: a Multicenter, Prospective Registry in China (SILVER-China)","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"older","h":[94],"l":[[94,"cad"]],"po":"2025-03-17","u":"2025-03-17","st":"2024-11","ag":"75 and over"},{"n":"NCT06880913","t":"Nanobody-Based CD19/CD22 Tandem Dual CAR-T Therapy for R/R B-ALL","s":"rec","p":"phase1phase2","d":[16,19],"c":[2],"lc":[2],"a":"child adult older","h":[48],"l":[[48,"ball"]],"po":"2025-03-18","u":"2026-03-30","st":"2024-11","ag":"12–65"},{"n":"NCT06881043","t":"The Safety and Efficacy of Robotic Assisted Surgery Using Vessel Sealer Extend in Locally Advanced Gastric Cancer","s":"rec","p":"na","d":[3],"c":[15],"lc":[15],"a":"adult older","h":[27],"l":[[27,"gc"]],"po":"2025-03-18","u":"2026-08-31","st":"2024-11","ag":"18–75"},{"n":"NCT06891157","t":"Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes","s":"rec","p":"phase2","d":[19],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"lymph"]],"po":"2025-03-24","u":"2025-03-24","st":"2024-08","ag":"18 and over"},{"n":"NCT06891651","t":"21-gene in Elder Breast Cancer Patients With Lymph Node Metastasis","s":"rec","p":"na","d":[6],"c":[27],"lc":[27],"a":"older","x":"female","h":[124],"l":[[124,"breast"]],"po":"2025-03-24","u":"2025-03-24","st":"2024-12","ag":"65 and over"},{"n":"NCT06895447","t":"Robotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Therapy","s":"rec","p":"phase2","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"gc"]],"po":"2025-03-26","u":"2025-07-01","st":"2024-11","ag":"18–80"},{"n":"NCT06900049","t":"Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular Dystrophy","s":"rec","p":"earlyphase1","d":[43],"c":[5],"lc":[5],"a":"child","x":"male","h":[91],"l":[[91,"dmd"]],"po":"2025-03-28","u":"2025-04-02","st":"2024-10","ag":"4–8"},{"n":"NCT06906432","t":"Mechanisms of Brain-Heart Injury of Post-Intracranial Hemorrhage","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[102],"l":[[102,"cad"]],"po":"2025-04-02","u":"2025-04-02","st":"2024-08","ag":"18–80"},{"n":"NCT06907602","t":"Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2phase3","d":[1],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"escc"]],"po":"2025-04-02","u":"2025-04-02","st":"2024-01","ag":"18 and over"},{"n":"NCT06911528","t":"Application of EndoScell Intraoperative Cellular Probing Technology for Early-Stage Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2025-04-04","u":"2025-04-04","st":"2024-01","ag":"18 and over"},{"n":"NCT06911606","t":"Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC)","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"lung"]],"po":"2025-04-04","u":"2025-04-04","st":"2024-05","ag":"18–75"},{"n":"NCT06911710","t":"The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors","s":"rec","p":"phase1phase2","d":[15,16,19],"c":[30],"lc":[30],"a":"adult older","h":[59],"l":[[59,"mm"]],"po":"2025-04-04","u":"2025-04-04","st":"2024-11","ag":"18 and over"},{"n":"NCT06918262","t":"Observational Clinical Study on Role of MRD in Predicting Local Therapy in Oligometastatic Breast Cancer","s":"rec","p":"na","d":[6],"c":[15],"lc":[15],"a":"child adult older","h":[27],"l":[[27,"breast"]],"po":"2025-04-09","u":"2025-04-09","st":"2024-01","ag":"Not stated"},{"n":"NCT06926179","t":"Safety, Efficacy, and Survival Outcomes of Neoadjuvant/Induction Immunotherapy in Surgical and Radiotherapeutic Management of Non-Small Cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[2,47],"lc":[2],"a":"adult older","h":[74,135,115],"l":[[74,"lung"]],"po":"2025-04-13","u":"2025-04-16","st":"2024-12","ag":"18 and over"},{"n":"NCT06927466","t":"A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.","s":"rec","p":"phase1","d":[16],"c":[2,9,5,4,13,31],"a":"child adult","h":[48,91,36,203,64,14],"po":"2025-04-15","u":"2026-08-17","st":"2024-09","ag":"3–25"},{"n":"NCT06929949","t":"The Effect of Different Digestive Tract Reconstruction Methods on Postoperative Quality of Life After Proximal Gastrectomy","s":"rec","p":"na","d":[3],"c":[15],"lc":[15],"a":"adult older","h":[27],"l":[[27,"gc"]],"po":"2025-04-16","u":"2026-08-28","st":"2024-11","ag":"18–75"},{"n":"NCT06930573","t":"A Study of AK112, a PD-1/ VEGF Bispecific Antibody, for Resectable Hepatocellular Carcinoma With High Recurrence Risk","s":"rec","p":"phase4","d":[2],"c":[20],"lc":[20],"a":"adult older","h":[25],"l":[[25,"hcc"]],"po":"2025-04-16","u":"2025-04-16","st":"2024-12","ag":"18–75"},{"n":"NCT06937567","t":"CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors","s":"rec","p":"earlyphase1","d":[3,5],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"gc"]],"po":"2025-04-22","u":"2026-05-26","st":"2024-12","ag":"18–70"},{"n":"NCT06950086","t":"Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors","s":"rec","p":"phase1phase2","d":[6],"c":[5],"a":"adult older","h":[9],"po":"2025-04-29","u":"2025-04-29","st":"2024-01","ag":"18 and over"},{"n":"NCT06956001","t":"Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q Mutation","s":"rec","p":"phase3","d":[4],"c":[2,27],"a":"adult older","h":[23,57],"po":"2025-05-02","u":"2026-08-13","st":"2024-11","ag":"18 and over"},{"n":"NCT06958627","t":"The Impact of Intelligent Patient Management Model on Medication Adherence of Pyrotinib Compared to Traditional Patient Management Model: a Prospective, Multicenter, Randomized Controlled Clinical Study","s":"rec","p":"phase2phase3","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2025-05-06","u":"2025-05-06","st":"2024-04","ag":"18 and over"},{"n":"NCT06970639","t":"A Study Evaluating Furmonertinib Plus Platinum-based Doublet Chemotherapy Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Sensitizing Mutation-Positive Non-squamous Non-Small Cell Lung Cancer (NSCLC) and Brain Metastases","s":"rec","p":"phase3","d":[4],"c":[0],"a":"adult older","h":[43],"po":"2025-05-14","u":"2026-08-13","st":"2024-09","ag":"18 and over"},{"n":"NCT06971523","t":"A Phase I/II Clinical Study of CTS3497 in Patients With MTAP Deficient Malignacies","s":"rec","p":"phase1phase2","d":[19],"c":[2],"a":"adult older","h":[74],"po":"2025-05-14","u":"2025-05-14","st":"2024-12","ag":"18 and over"},{"n":"NCT06973811","t":"ZR-MTX for PIOL Phase II Trial","s":"rec","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"lymph"]],"po":"2025-05-15","u":"2026-09-04","st":"2024-10","ag":"18–75"},{"n":"NCT06975384","t":"The Associations of Sleep Disturbance With Therapy Efficacy and Prognosis of Lung Cancer","s":"rec","p":"na","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[10],"l":[[10,"lung"]],"po":"2025-05-16","u":"2025-05-16","st":"2024-11","ag":"18 and over"},{"n":"NCT06988579","t":"The Impact of AI Assistance on Radiologist Performance and Healthcare Costs in LDCT-Based Lung Cancer Screening","s":"rec","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[132],"l":[[132,"lung"]],"po":"2025-05-25","u":"2025-06-26","st":"2024-07","ag":"40–74"},{"n":"NCT06988943","t":"Early Intervention Strategies for Lung Cancer","s":"rec","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[132],"l":[[132,"lung"]],"po":"2025-05-25","u":"2025-05-30","st":"2024-06","ag":"40–74"},{"n":"NCT06988956","t":"Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[28],"lc":[28],"a":"older","h":[78],"l":[[78,"escc"]],"po":"2025-05-25","u":"2025-05-25","st":"2024-03","ag":"75 and over"},{"n":"NCT06992622","t":"Zhejiang Adolescent Spine and Vision Health Cohort: A Longitudinal Database Analysis","s":"rec","p":"na","d":[33],"c":[37],"lc":[37],"a":"child","h":[188],"l":[[188,"scol"]],"po":"2025-05-28","u":"2025-05-28","st":"2024-09","ag":"6–17"},{"n":"NCT06999031","t":"A Study to Evaluate CG-105-12 in Patients With Relapsed/Refractory Multiple Myeloma","s":"rec","p":"earlyphase1","d":[15],"c":[9],"lc":[9],"a":"adult older","h":[14],"l":[[14,"mm"]],"po":"2025-05-31","u":"2025-05-31","st":"2024-09","ag":"18–75"},{"n":"NCT07007832","t":"Bile Omics for Diagnosing Indeterminate Biliary Strictures","s":"rec","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[121],"l":[[121,"panc"]],"po":"2025-06-06","u":"2025-06-11","st":"2024-01","ag":"18–90"},{"n":"NCT07012720","t":"Research on the Potential Mechanisms Underlying the Efficacy Differences in Specific Neoadjuvant Treatment Regimens for Different Subtypes of Breast Cancer","s":"rec","p":"na","d":[6],"c":[39],"lc":[39],"a":"adult older","x":"female","h":[131],"l":[[131,"breast"]],"po":"2025-06-10","u":"2025-06-10","st":"2024-04","ag":"25–75"},{"n":"NCT07016126","t":"D-BACE in Combination With Chemotherapy and Camrelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"lung"]],"po":"2025-06-11","u":"2026-10-26","st":"2024-12","ag":"18–75"},{"n":"NCT07016724","t":"Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer","s":"rec","p":"phase2","d":[1],"c":[20],"lc":[20],"a":"adult older","h":[25],"l":[[25,"escc"]],"po":"2025-06-12","u":"2025-06-12","st":"2024-08","ag":"18–75"},{"n":"NCT07019233","t":"A Study of the Effect of Real-time Pressure Controllers on Subjective and Objective Symptoms of Peripheral Neuropathy Induced by Albumin Paclitaxel","s":"rec","p":"na","d":[6],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"breast"]],"po":"2025-06-13","u":"2025-06-13","st":"2024-09","ag":"18–75"},{"n":"NCT07026110","t":"Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"lung"]],"po":"2025-06-18","u":"2025-06-18","st":"2024-12","ag":"18–80"},{"n":"NCT07026240","t":"Post-operative Monitoring of Gastric Cancer","s":"rec","p":"na","d":[3],"c":[5],"a":"adult older","h":[9],"po":"2025-06-18","u":"2025-06-18","st":"2024-02","ag":"18 and over"},{"n":"NCT07028970","t":"Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection","s":"rec","p":"na","d":[15],"c":[2,30,13,20],"a":"child adult older","h":[69,59,36,37,29],"po":"2025-06-19","u":"2025-06-19","st":"2024-12","ag":"Not stated"},{"n":"NCT07037537","t":"Evaluation of the Effectiveness and Safety of Laparoscopic Assisted Mastectomy With Preservation of Nipple and Areola, Immediate One-step Breast Reconstruction With Pectoral Muscle Prosthesis and Patch, and Simultaneous Autologous Fat Transplantation","s":"rec","p":"na","d":[6],"c":[20],"lc":[20],"a":"adult older","x":"female","h":[37],"l":[[37,"breast"]],"po":"2025-06-25","u":"2025-06-25","st":"2024-10","ag":"18–70"},{"n":"NCT07046689","t":"PET/CT for Trop2 ADC Response Evaluation Cancers","s":"rec","p":"na","d":[6],"c":[7],"lc":[7],"a":"adult older","x":"female","h":[8],"l":[[8,"breast"]],"po":"2025-07-01","u":"2025-07-15","st":"2024-11","ag":"18 and over"},{"n":"NCT07054879","t":"CtDNA-guided Maintenance Therapy in Pancreatic Cancer","s":"rec","p":"na","d":[5],"c":[28],"lc":[28],"a":"adult older","h":[60],"l":[[60,"panc"]],"po":"2025-07-08","u":"2025-07-08","st":"2024-11","ag":"18 and over"},{"n":"NCT07056010","t":"Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion Immunochemotherapy","s":"rec","p":"na","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"gc"]],"po":"2025-07-09","u":"2025-07-09","st":"2024-11","ag":"18–80"},{"n":"NCT07059741","t":"Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL","s":"rec","p":"na","d":[19],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"lymph"]],"po":"2025-07-11","u":"2025-07-11","st":"2024-12","ag":"18 and over"},{"n":"NCT07065435","t":"RC48 Plus Bevacizumab or Pyrotinib in HER2-Positive Metastatic Breast Cancer After T-DXd Failure: A Phase II Study","s":"rec","p":"phase2","d":[6],"c":[28],"lc":[28],"a":"adult older","x":"female","h":[78],"l":[[78,"breast"]],"po":"2025-07-15","u":"2025-07-15","st":"2024-01","ag":"18–75"},{"n":"NCT07070362","t":"Digital Early Warning System for Acute Lung Injury in Liver Surgery","s":"rec","p":"na","d":[2],"c":[2,1],"a":"adult older","h":[193,100],"po":"2025-07-17","u":"2026-08-17","st":"2024-11","ag":"18 and over"},{"n":"NCT07072208","t":"Pomalidomide, Rituximab and Orelabrutinib Combined With Polatuzumab Vedotin in the Treatment of Newly Diagnosed Elderly Patients With DLBCL","s":"rec","p":"na","d":[19],"c":[4],"lc":[4],"a":"older","h":[5],"l":[[5,"lymph"]],"po":"2025-07-18","u":"2025-07-18","st":"2024-11","ag":"70 and over"},{"n":"NCT07072221","t":"Bendamustine Combined With Chidamide and Lenalidomide for Relapsed and Refractory PTCL Patients","s":"rec","p":"na","d":[19],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"lymph"]],"po":"2025-07-18","u":"2025-07-18","st":"2024-11","ag":"18 and over"},{"n":"NCT07074457","t":"Chidamide Combined With Brentuximab Vedotin Regimen for CD30+ PTCL Patients","s":"rec","p":"na","d":[19],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"lymph"]],"po":"2025-07-20","u":"2025-07-20","st":"2024-11","ag":"18–75"},{"n":"NCT07085182","t":"Tislelizumab Combined With sCRT in Stage IIIB/C-IV Non-Squamous Non-Small Cell Lung Cancer：A Prospective, Single-Arm, Phase II Study","s":"rec","p":"phase2","d":[4],"c":[91],"lc":[91],"a":"adult older","h":[355],"l":[[355,"lung"]],"po":"2025-07-25","u":"2025-07-25","st":"2024-01","ag":"18–75"},{"n":"NCT07101237","t":"An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer.","s":"rec","p":"na","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"hcc"]],"po":"2025-08-03","u":"2025-08-03","st":"2024-08","ag":"18–70"},{"n":"NCT07119463","t":"Effect of Goal-Oriented Albumin Infusion on Postoperative Complication Management in Gastric Cancer Surgery","s":"rec","p":"phase2","d":[3],"c":[15],"lc":[15],"a":"adult older","h":[27],"l":[[27,"gc"]],"po":"2025-08-13","u":"2025-08-13","st":"2024-10","ag":"18–80"},{"n":"NCT07131670","t":"Symptoms Burden in Lung Cancer Patients Undergoing Definitive Chemoradiotherapy: Insights From Electronic Patient-Reported Outcomes","s":"rec","p":"na","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"lung"]],"po":"2025-08-20","u":"2025-08-20","st":"2024-06","ag":"18 and over"},{"n":"NCT07133984","t":"STICH3C Cardiac Magnetic Resonance Observational Study","s":"rec","p":"na","d":[31],"c":[5],"a":"adult older","h":[123],"po":"2025-08-21","u":"2026-09-21","st":"2024-03","ag":"18 and over"},{"n":"NCT07135661","t":"Ultra-Hypofractionated vs. Moderately Hypofractionated Proton Therapy for Early Breast Cancer After Lumpectomy","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[316],"l":[[316,"breast"]],"po":"2025-08-22","u":"2025-08-22","st":"2024-10","ag":"40 and over"},{"n":"NCT07149688","t":"Village-Based Management of Chronic Cardiovascular Disease in Qu Jiang Elderly Population Registry: The BOUQUET Cohort Study","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[109],"l":[[109,"cad"]],"po":"2025-09-02","u":"2025-09-02","st":"2024-03","ag":"60 and over"},{"n":"NCT07155954","t":"Value of Super-resolution Ultrasonography in Differentiating Benign and Malignant Lymph Nodes","s":"rec","p":"na","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[115],"l":[[115,"lymph"]],"po":"2025-09-04","u":"2025-09-04","st":"2024-10","ag":"18 and over"},{"n":"NCT07180368","t":"Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients","s":"rec","p":"na","d":[31],"c":[39],"lc":[39],"a":"older","h":[131],"l":[[131,"cad"]],"po":"2025-09-18","u":"2025-09-18","st":"2024-10","ag":"65 and over"},{"n":"NCT07195500","t":"Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma","s":"rec","p":"na","d":[13],"c":[28],"lc":[28],"a":"child adult older","h":[78,119],"l":[[78,"nb"]],"po":"2025-09-26","u":"2025-09-26","st":"2024-12","ag":"6 months and over"},{"n":"NCT07195799","t":"Linperlisib Combination With Cyclophosphamide, Prednisone, and Thalidomide (CPT) in R/R NHL","s":"rec","p":"phase2","d":[19],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"lymph"]],"po":"2025-09-29","u":"2025-09-29","st":"2024-12","ag":"18 and over"},{"n":"NCT07234162","t":"A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19)","s":"rec","p":"phase3","d":[19],"c":[2,15,8,22,1,16,0,23,24,17,27,33,25,28,10,5,11,12,30,37,13,39,7,20],"a":"adult older","h":[53,123,25,46,36,58,12,161,115,8,37,45,27,43,79,60,162,31,133,44,111,143,30,81,98,57,13,142,94,50,19,84,67,88,73],"po":"2025-11-18","u":"2026-06-08","st":"2024-05","ag":"18 and over"},{"n":"NCT07236203","t":"Predictive Factors for the Efficacy of CD19 CAR-T Therapy in Relapsed/Refractory Large B-Cell Lymphoma: A Clinical Study","s":"rec","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lymph"]],"po":"2025-11-19","u":"2025-11-19","st":"2024-02","ag":"18 and over"},{"n":"NCT07239063","t":"Validation of High-Throughput Large-Format Tissue Preprocessing for Lung and Colorectal Cancer","s":"rec","p":"na","d":[4],"c":[0],"lc":[0],"a":"child adult older","h":[70],"l":[[70,"lung"]],"po":"2025-11-20","u":"2026-02-10","st":"2024-10","ag":"Not stated"},{"n":"NCT07251868","t":"Evaluation of Trop-2 ADC in Breast Cancer Patients With Brain Metastases: A Real-World Study","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"breast"]],"po":"2025-11-26","u":"2025-11-26","st":"2024-08","ag":"18 and over"},{"n":"NCT07309185","t":"Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy","s":"rec","p":"phase2","d":[3],"c":[27],"lc":[27],"a":"adult older","h":[57],"l":[[57,"gc"]],"po":"2025-12-30","u":"2025-12-30","st":"2024-07","ag":"18–75"},{"n":"NCT07334431","t":"Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer","s":"rec","p":"phase1phase2","d":[3],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"gc"]],"po":"2026-01-12","u":"2026-01-12","st":"2024-02","ag":"18–75"},{"n":"NCT07335081","t":"ctDNA in HER2+ EBC Neoadjuvant Treatment","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[123],"l":[[123,"breast"]],"po":"2026-01-12","u":"2026-03-24","st":"2024-02","ag":"18–70"},{"n":"NCT07394959","t":"Hydration Guided by Remote Dielectric Sensing (ReDS) System for Preventing Acute Kidney Injury in Elderly Patients With Renal Insufficiency for Coronary Angiography and Intervention","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"cad"]],"po":"2026-02-06","u":"2026-02-06","st":"2024-09","ag":"60 and over"},{"n":"NCT07399210","t":"Noninvasive Detection of Lung Nodule Malignancy Using cfDNA Fragmentomics","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2026-02-10","u":"2026-02-10","st":"2024-08","ag":"18 and over"},{"n":"NCT07400354","t":"The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut Microbiota","s":"rec","p":"na","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"gc"]],"po":"2026-02-10","u":"2026-02-10","st":"2024-03","ag":"18 and over"},{"n":"NCT07430579","t":"Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma","s":"rec","p":"na","d":[1],"c":[27],"lc":[27],"a":"adult older","h":[356,124],"l":[[356,"escc"]],"po":"2026-02-24","u":"2026-02-24","st":"2024-12","ag":"18–80"},{"n":"NCT07433283","t":"Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor","s":"rec","p":"phase1phase2","d":[4,5],"c":[2,8,22,1,16,6,24,5,20],"a":"adult older","h":[40,9,38,25,45,13,79,30,7],"po":"2026-02-25","u":"2026-02-25","st":"2024-11","ag":"18–80"},{"n":"NCT07437404","t":"Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.","s":"rec","p":"phase3","d":[21],"c":[2],"a":"child","x":"male","h":[284],"po":"2026-02-27","u":"2026-02-27","st":"2024-04","ag":"Up to 6"},{"n":"NCT07437898","t":"Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study","s":"rec","p":"phase2","d":[1],"c":[92],"lc":[92],"a":"adult older","h":[357],"l":[[357,"escc"]],"po":"2026-02-27","u":"2026-02-27","st":"2024-09","ag":"18–75"},{"n":"NCT07439991","t":"Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery","s":"rec","p":"na","d":[4],"c":[15],"lc":[15],"a":"adult older","h":[27],"l":[[27,"lung"]],"po":"2026-02-27","u":"2026-02-27","st":"2024-11","ag":"18 and over"},{"n":"NCT07444281","t":"An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With GPC3+ Advanced/Metastatic Squamous Cell Lung Cancer","s":"rec","p":"phase1","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2026-03-02","u":"2026-03-03","st":"2024-12","ag":"18–75"},{"n":"NCT07446452","t":"Disitamab Vedotin Plus Bevacizumab in HER2-Low Metastatic Breast Cancer After T-DXd Failure: A Phase II Study","s":"rec","p":"phase2","d":[6],"c":[28],"lc":[28],"a":"adult older","x":"female","h":[78],"l":[[78,"breast"]],"po":"2026-03-03","u":"2026-03-03","st":"2024-01","ag":"18–75"},{"n":"NCT07463300","t":"A Hierarchical Multi-modal AI Framework for Pathological and Genetic Subtyping of Lung Cancer Based on PET/CT Imaging","s":"rec","p":"na","d":[4],"c":[22,23,11,13,32],"lc":[23],"a":"adult older","h":[54,40,44,118,36,133,63,275],"l":[[54,"lung"]],"po":"2026-03-11","u":"2026-03-11","st":"2024-08","ag":"18 and over"},{"n":"NCT07517354","t":"Family-Based Moyamoya Susceptibility and Early Detection","s":"rec","p":"na","d":[28],"c":[2],"lc":[2],"a":"child adult older","h":[102,94],"l":[[102,"moyamoya"]],"po":"2026-04-08","u":"2026-04-08","st":"2024-11","ag":"Not stated"},{"n":"NCT07547787","t":"A Long-term Follow-up Study of Subjects Enrolled in Clinical Trials of Cadonilimab (AK104)","s":"rec","p":"na","d":[3],"c":[2],"a":"child adult older","h":[74],"po":"2026-04-23","u":"2026-04-23","st":"2024-12","ag":"Not stated"},{"n":"NCT07584889","t":"Efficacy and Safety of CD19-CAR.p40-T in Patients With Relapsed/Refractory CD19-Positive Hematologic Malignancies","s":"rec","p":"phase1phase2","d":[16,19],"c":[21],"lc":[21],"a":"adult older","h":[326],"l":[[326,"ball"]],"po":"2026-05-13","u":"2026-05-13","st":"2024-04","ag":"18–75"},{"n":"NCT07599371","t":"A Prospective, Single-arm Clinical Study on the Safety and Efficacy of Ivoximab Combined With Temozolomide in the Treatment of Relapsed/Refractory Glioma","s":"rec","p":"phase1phase2","d":[7],"c":[20],"lc":[20],"a":"adult older","h":[25],"l":[[25,"glioma"]],"po":"2026-05-20","u":"2026-05-20","st":"2024-10","ag":"18–85"},{"n":"NCT07632664","t":"Clinical Study of a New Treatment Model for Elderly Lung Cancer Patients","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"older","h":[48],"l":[[48,"lung"]],"po":"2026-06-08","u":"2026-07-15","st":"2024-08","ag":"65 and over"},{"n":"NCT07635342","t":"Pyrotinib Plus Trastuzumab and Chemotherapy for HER2-Positive Early Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[18],"lc":[18],"a":"adult older","x":"female","h":[24],"l":[[24,"breast"]],"po":"2026-06-09","u":"2026-06-09","st":"2024-04","ag":"18–65"},{"n":"NCT07644832","t":"An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency","s":"rec","p":"phase1phase2","d":[21],"c":[8,17,27,33,12,39,20],"a":"adult older","h":[184,68,11,142,83,358,359],"po":"2026-06-12","u":"2026-06-12","st":"2024-05","ag":"18–65"},{"n":"NCT07648069","t":"Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusion in the Treatment of Advanced Sarcoma","s":"rec","p":"phase1","d":[11],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"os"]],"po":"2026-06-15","u":"2026-06-15","st":"2024-09","ag":"18–70"},{"n":"NCT07653984","t":"Cohort Study on Neuroimmune Diseases in the Reproductive Age","s":"rec","p":"na","d":[25,27],"c":[0],"lc":[0],"a":"adult","x":"female","h":[209],"l":[[209,"nmosd"]],"po":"2026-06-17","u":"2026-06-17","st":"2024-04","ag":"20–55"},{"n":"NCT07657494","t":"Predictive Value of Tumor Microenvironment PET/CT for Response and Prognosis in Aggressive Lymphoma","s":"rec","p":"na","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[360],"l":[[360,"lymph"]],"po":"2026-06-18","u":"2026-10-07","st":"2024-07","ag":"18 and over"},{"n":"NCT07659119","t":"Assessment of CT-FFR in Patients With CCS: A Prospective Multicenter Cohort Study","s":"rec","p":"na","d":[31],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"cad"]],"po":"2026-06-22","u":"2026-08-12","st":"2024-09","ag":"18 and over"},{"n":"NCT07660419","t":"Effect of Mobile-Based Home Cardiac Rehabilitation on Coronary Plaque","s":"rec","p":"na","d":[31],"c":[2],"a":"adult older","h":[213],"po":"2026-06-22","u":"2026-06-22","st":"2024-12","ag":"18–70"},{"n":"NCT07677878","t":"Blinatumomab Combined With Low-dose DLI as Maintenance Therapy After Transplantation for B-ALL","s":"rec","p":"phase1","d":[16],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"ball"]],"po":"2026-07-01","u":"2026-07-01","st":"2024-12","ag":"18–70"},{"n":"NCT07699185","t":"Neoadjuvant Cardonilizumab Combined With Neoadjuvant Chemoradiotherapy Can Resect Locally Advanced Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"escc"]],"po":"2026-07-13","u":"2026-07-13","st":"2024-01","ag":"18–75"},{"n":"NCT07724496","t":"Helicobacter Pylori Infection Status and Pathological Features for Predicting Gastric Cancer Biological Behavior and Prognosis: A Real-World Observational Study","s":"rec","p":"na","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"gc"]],"po":"2026-07-24","u":"2026-07-24","st":"2024-01","ag":"18–80"},{"n":"NCT07773064","t":"Identification for High Risk of Coronary Heart Disease Based on Quantitative Analysis of Fundus Vessels and Metabolic Molecules","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[94,39],"l":[[94,"cad"]],"po":"2026-08-19","u":"2026-08-20","st":"2024-05","ag":"18–100"},{"n":"NCT07795645","t":"Validating a Medical AI Fine-Tuning Platform for Major Diseases","s":"rec","p":"na","d":[3,31],"c":[2],"lc":[2],"a":"adult older","h":[39],"l":[[39,"gc"]],"po":"2026-08-31","u":"2026-08-31","st":"2024-11","ag":"18 and over"},{"n":"NCT07838415","t":"Multimodalomics-based Construction of Spatiotemporal Characteristics of Dynamic Liver Cancer Microenvironment to Characterize the Clinical Application of Immune Mechanisms in Liver Cancer","s":"rec","p":"na","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2026-09-24","u":"2026-09-24","st":"2024-10","ag":"18–80"},{"n":"NCT07898293","t":"TEAS for Gastrectomy Recovery","s":"rec","p":"na","d":[3],"c":[26,42,19],"lc":[26],"a":"adult older","h":[55,28,114],"l":[[55,"gc"]],"po":"2026-10-27","u":"2026-11-02","st":"2024-10","ag":"18–80"},{"n":"NCT07899099","t":"Mecapegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Advanced Breast Cancer","s":"rec","p":"na","d":[6],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"breast"]],"po":"2026-10-27","u":"2026-10-27","st":"2024-10","ag":"18 and over"},{"n":"NCT07907211","t":"Aspirin vs. Rivaroxaban for Thromboprophylaxis in Multiple Myeloma","s":"rec","p":"phase4","d":[15],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"mm"]],"po":"2026-10-30","u":"2026-10-30","st":"2024-02","ag":"18–70"},{"n":"NCT07923214","t":"A Phase I Study of CG-7321 Monotherapy or Combination Therapy in Advanced Solid Tumors","s":"rec","p":"phase1","d":[3,6],"c":[22,16,5],"a":"adult older","h":[40,9,30],"po":"2026-11-06","u":"2026-11-13","st":"2024-07","ag":"18 and over"},{"n":"NCT07925125","t":"Artificial Intelligence-Assisted 4D Dynamic Long-Axial PET Imaging for the Detection of Early Pancreatic Cancer Lesions","s":"rec","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"panc"]],"po":"2026-11-09","u":"2026-11-09","st":"2024-11","ag":"18–75"},{"n":"NCT03734952","t":"Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma With Neoadjuvant Chemoradiotherapy","s":"rec","p":"na","d":[1],"c":[16],"lc":[16],"a":"adult older","h":[140],"l":[[140,"escc"]],"po":"2018-11-08","u":"2023-09-25","st":"2023-05","ag":"18–65"},{"n":"NCT04124120","t":"Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women","s":"rec","p":"na","d":[31],"c":[2,15,5],"a":"adult older","x":"female","h":[213,123,330],"po":"2019-10-11","u":"2026-04-01","st":"2023-04","ag":"18 and over"},{"n":"NCT04960839","t":"Prophylactic Irradiation to the Contralateral Breast for BCAs Patients","s":"rec","p":"na","d":[6],"c":[23,9,5],"lc":[23],"a":"adult older","x":"female","h":[54,46,82,116,361,274],"l":[[54,"breast"]],"po":"2021-07-14","u":"2021-07-14","st":"2023-01","ag":"30–70"},{"n":"NCT05191485","t":"Shared Decision Making in Patients With Lung Cancer","s":"rec","p":"na","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[47],"l":[[47,"lung"]],"po":"2022-01-13","u":"2026-04-30","st":"2023-02","ag":"18 and over"},{"n":"NCT05212454","t":"Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks","s":"rec","p":"phase3","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2022-01-28","u":"2023-04-25","st":"2023-03","ag":"18–70"},{"n":"NCT05303519","t":"SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)","s":"rec","p":"phase3","d":[7],"c":[2,8,22,16,0,5],"a":"adult older","h":[102,40,11,103,53,38,136,241,71],"po":"2022-03-31","u":"2026-11-17","st":"2023-06","ag":"18 and over"},{"n":"NCT05319639","t":"Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab","s":"rec","p":"phase1phase2","d":[3],"c":[16],"lc":[16],"a":"adult older","h":[30],"l":[[30,"gc"]],"po":"2022-04-08","u":"2025-02-27","st":"2023-02","ag":"18–75"},{"n":"NCT05319730","t":"A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)","s":"rec","p":"phase1phase2","d":[1],"c":[2,23,17,5,7,14,20],"a":"adult older","h":[74,44,37,42,68,8,21],"po":"2022-04-08","u":"2026-10-07","st":"2023-05","ag":"18 and over"},{"n":"NCT05427370","t":"The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)","s":"rec","p":"na","d":[31],"c":[5],"a":"adult older","h":[123],"po":"2022-06-22","u":"2026-10-19","st":"2023-06","ag":"18 and over"},{"n":"NCT05475613","t":"Downstaging Protocol Containing Immunotherapy for HCC Beyond the Milan Criteria Before Liver Transplantation","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"hcc"]],"po":"2022-07-27","u":"2024-11-29","st":"2023-06","ag":"18–75"},{"n":"NCT05489289","t":"A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative Resection","s":"rec","p":"phase3","d":[2],"c":[5],"a":"adult older","h":[6],"po":"2022-08-05","u":"2025-03-12","st":"2023-01","ag":"18–75"},{"n":"NCT05494502","t":"Impact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer Patients","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","h":[29,74],"l":[[29,"breast"]],"po":"2022-08-10","u":"2025-07-31","st":"2023-05","ag":"18–85"},{"n":"NCT05535413","t":"UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases","s":"rec","p":"phase1phase2","d":[6],"c":[8],"lc":[8],"a":"adult older","x":"female","h":[13],"l":[[13,"breast"]],"po":"2022-09-10","u":"2025-04-25","st":"2023-01","ag":"18–70"},{"n":"NCT05565807","t":"Safety and Efficacy Study of An Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma","s":"rec","p":"phase1phase2","d":[15],"c":[2,23],"a":"adult older","h":[46,89,115],"po":"2022-10-04","u":"2025-08-15","st":"2023-02","ag":"18 and over"},{"n":"NCT05577091","t":"Tris-CAR-T Cell Therapy for Recurrent Glioblastoma","s":"rec","p":"phase1","d":[7],"c":[2],"lc":[2],"a":"adult older","h":[102],"l":[[102,"glioma"]],"po":"2022-10-13","u":"2024-04-12","st":"2023-09","ag":"18–70"},{"n":"NCT05593458","t":"Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1","s":"rec","p":"phase3","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"gc"]],"po":"2022-10-25","u":"2026-06-11","st":"2023-03","ag":"18–75"},{"n":"NCT05596630","t":"Stereotactic Body Radiation Therapy for the Safety and Prognosis of Small Intrahepatic Recurrent HCC","s":"rec","p":"na","d":[2],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"hcc"]],"po":"2022-10-27","u":"2025-02-10","st":"2023-05","ag":"18–80"},{"n":"NCT05613478","t":"Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of Hepatocellular Carcinoma","s":"rec","p":"phase3","d":[2],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"hcc"]],"po":"2022-11-14","u":"2024-12-31","st":"2023-01","ag":"18 and over"},{"n":"NCT05623267","t":"Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT","s":"rec","p":"phase2phase3","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2022-11-21","u":"2023-08-07","st":"2023-07","ag":"18 and over"},{"n":"NCT05631886","t":"Combination of CAR-DC Vaccine and ICIs in Malignant Tumors","s":"rec","p":"phase1","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2022-11-30","u":"2023-08-28","st":"2023-07","ag":"18–75"},{"n":"NCT05635487","t":"A Study of SHR-A1811 Monotherapy or Combined With Pyrotinib Maleate as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients","s":"rec","p":"phase2","d":[6],"c":[11],"lc":[11],"a":"adult older","x":"female","h":[143],"l":[[143,"breast"]],"po":"2022-12-02","u":"2024-07-05","st":"2023-03","ag":"18–75"},{"n":"NCT05638867","t":"NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI","s":"rec","p":"phase4","d":[31],"c":[2],"a":"adult older","h":[213],"po":"2022-12-06","u":"2026-08-11","st":"2023-11","ag":"18–75"},{"n":"NCT05646862","t":"A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy","s":"rec","p":"phase3","d":[6],"c":[15,22,1,0,23,27,9,28,30,13],"a":"adult older","h":[58,53,79,44,54,43,12,57,27,47,82,127,19,80],"po":"2022-12-12","u":"2026-10-26","st":"2023-06","ag":"18 and over"},{"n":"NCT05667506","t":"A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)","s":"rec","p":"phase1phase2","d":[16],"c":[1,0,17,9,28,30,13,31],"a":"child adult","h":[69,70,31,12,64,1,14,252,253],"po":"2022-12-28","u":"2025-08-12","st":"2023-02","ag":"3–18"},{"n":"NCT05669222","t":"The FAVOR V AMI Trial","s":"rec","p":"na","d":[31],"c":[2],"a":"adult older","h":[213],"po":"2022-12-30","u":"2026-09-24","st":"2023-01","ag":"18 and over"},{"n":"NCT05671822","t":"Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[5],"a":"adult older","h":[6],"po":"2023-01-05","u":"2026-02-12","st":"2023-03","ag":"18–75"},{"n":"NCT05672043","t":"Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China","s":"rec","p":"na","d":[7],"c":[2],"lc":[2],"a":"child adult","h":[102],"l":[[102,"glioma"]],"po":"2023-01-05","u":"2023-01-05","st":"2023-01","ag":"0–18"},{"n":"NCT05675813","t":"Genotype-guided Treatment in Newly Diagnosed PTCL","s":"rec","p":"phase1phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2023-01-09","u":"2024-01-08","st":"2023-02","ag":"18–75"},{"n":"NCT05681260","t":"Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)","s":"rec","p":"phase3","d":[19],"c":[22,5],"a":"child adult","h":[91,250],"po":"2023-01-12","u":"2026-03-19","st":"2023-02","ag":"12 months–18"},{"n":"NCT05686447","t":"Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis","s":"rec","p":"na","d":[15],"c":[0],"lc":[0],"a":"child adult older","h":[0],"l":[[0,"mm"]],"po":"2023-01-17","u":"2025-04-06","st":"2023-01","ag":"Not stated"},{"n":"NCT05687357","t":"Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ Adenocarcinoma","s":"rec","p":"phase2","d":[3],"c":[28,12,13],"lc":[28],"a":"adult older","h":[60,36,84],"l":[[60,"gc"]],"po":"2023-01-18","u":"2023-04-19","st":"2023-03","ag":"18–75"},{"n":"NCT05692674","t":"A Prospective Phase II Study for Adjuvant Hypofractionated Intensity-modulated Proton Radiotherapy for Post Operative Breast Cancer With Implantation Reconstruction","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[316],"l":[[316,"breast"]],"po":"2023-01-20","u":"2023-01-20","st":"2023-01","ag":"18–80"},{"n":"NCT05696626","t":"Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation","s":"rec","p":"phase3","d":[6],"c":[48,2,55,15,8,22,1,52,16,0,6,23,47,33,25,36,73,70,9,28,10,61,26,5,11,21,18,30,34,37,13,39,7,38,31,20],"a":"adult older","h":[9,40,78,58,99,111,24,238,74,79,44,38,25,43,12,11,164,55,27,37,81,183,18,10,97,140,46,50,135,47,8,82,275,131,7,19,60,72,155,142,30,98,126,90,116,64,103,0,215,226,87,239,86,150,67,101,231],"po":"2023-01-25","u":"2026-11-13","st":"2023-10","ag":"18 and over"},{"n":"NCT05698147","t":"Selinexor in Combination With MTX+Ritu to Treat R/R CNSL","s":"rec","p":"phase1phase2","d":[19],"c":[2,16,17,5,20],"a":"adult older","h":[25,103,102,136,112],"po":"2023-01-26","u":"2025-09-16","st":"2023-08","ag":"18–75"},{"n":"NCT05699655","t":"Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 Vs Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer","s":"rec","p":"phase2phase3","d":[3],"c":[16],"lc":[16],"a":"adult older","h":[30],"l":[[30,"gc"]],"po":"2023-01-26","u":"2024-05-01","st":"2023-05","ag":"18–75"},{"n":"NCT05701306","t":"APG-115 Alone or in Combination With APG-2575 in Recurrent or Refractory Neuroblastoma or Solid Tumors","s":"rec","p":"phase1phase2","d":[13],"c":[0,30,13],"a":"child adult older","h":[58,36,53],"po":"2023-01-27","u":"2026-08-21","st":"2023-02","ag":"5 and over"},{"n":"NCT05704166","t":"PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients","s":"rec","p":"phase2","d":[6],"c":[16],"lc":[16],"a":"adult older","x":"female","h":[140],"l":[[140,"breast"]],"po":"2023-01-30","u":"2026-10-29","st":"2023-03","ag":"18–75"},{"n":"NCT05717699","t":"Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma","s":"rec","p":"phase1","d":[7],"c":[2],"a":"child adult","h":[241],"po":"2023-02-08","u":"2024-02-28","st":"2023-01","ag":"1–18"},{"n":"NCT05717712","t":"Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma","s":"rec","p":"phase1","d":[7],"c":[2],"a":"child adult","h":[241],"po":"2023-02-08","u":"2024-02-28","st":"2023-01","ag":"1–18"},{"n":"NCT05717803","t":"Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)","s":"rec","p":"phase3","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2023-02-08","u":"2024-06-03","st":"2023-02","ag":"18–80"},{"n":"NCT05722275","t":"Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics","s":"rec","p":"na","d":[3],"c":[2,16,0,47,12,20],"a":"adult older","h":[74,140,70,25,53,37,43,95,135,84],"po":"2023-02-10","u":"2023-02-14","st":"2023-01","ag":"18 and over"},{"n":"NCT05737953","t":"Construction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid Samples","s":"rec","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[177],"l":[[177,"panc"]],"po":"2023-02-21","u":"2025-02-11","st":"2023-03","ag":"18 and over"},{"n":"NCT05738434","t":"Camrelizumab in Combination With Apatinib Mesylate Plus Short-course Chemotherapy for Advanced ESCC","s":"rec","p":"phase2","d":[1],"c":[20],"lc":[20],"a":"adult older","h":[25],"l":[[25,"escc"]],"po":"2023-02-22","u":"2024-11-21","st":"2023-03","ag":"18–75"},{"n":"NCT05738980","t":"Prevention of Postoperative Recurrence of Hepatocellular Carcinoma by Blocking RAK Cells With Anti-TIM-3","s":"rec","p":"na","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[94],"l":[[94,"hcc"]],"po":"2023-02-22","u":"2023-02-22","st":"2023-02","ag":"18–75"},{"n":"NCT05741359","t":"The Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin Lymphoma","s":"rec","p":"phase1","d":[19],"c":[23,13],"a":"adult older","h":[46,12],"po":"2023-02-23","u":"2025-11-25","st":"2023-04","ag":"18 and over"},{"n":"NCT05744687","t":"Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer","s":"rec","p":"phase2phase3","d":[6],"c":[48,2,15,16,0,36,58],"a":"adult older","x":"female","h":[53,74,30,172,156,87,150],"po":"2023-02-27","u":"2025-08-17","st":"2023-04","ag":"18–75"},{"n":"NCT05749588","t":"FUSCC Refractory TNBC Platform Study (FUTURE2.0)","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2023-03-01","u":"2026-04-16","st":"2023-03","ag":"18 and over"},{"n":"NCT05749822","t":"Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis","s":"rec","p":"phase2phase3","d":[50],"c":[2,8,22,0,47,28,11,30,39,93,20],"lc":[39],"a":"adult older","h":[131,38,267,59,118,11,99,78,92,98,311,362],"l":[[131,"pbc"]],"po":"2023-03-01","u":"2026-01-08","st":"2023-02","ag":"18–75"},{"n":"NCT05751343","t":"Atezolizumab and Bevacizumab Plus TACE-HAIC for Unresectable Advanced HCC: a Phase 2 Clinical Trial","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"hcc"]],"po":"2023-03-02","u":"2025-11-18","st":"2023-03","ag":"18–75"},{"n":"NCT05751733","t":"Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST","s":"rec","p":"na","d":[12],"c":[8],"lc":[8],"a":"adult older","h":[11],"l":[[11,"gist"]],"po":"2023-03-02","u":"2023-03-02","st":"2023-02","ag":"18 and over"},{"n":"NCT05751967","t":"Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis","s":"rec","p":"phase3","d":[50],"c":[22,0,33,28,11,30,39],"lc":[39],"a":"adult older","h":[131,59,118,60,99,98,195],"l":[[131,"pbc"]],"po":"2023-03-02","u":"2026-01-08","st":"2023-02","ag":"18–75"},{"n":"NCT05754203","t":"Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC","s":"rec","p":"na","d":[4],"c":[1],"lc":[1],"a":"adult older","h":[167],"l":[[167,"lung"]],"po":"2023-03-03","u":"2025-07-14","st":"2023-08","ag":"18–75"},{"n":"NCT05759546","t":"PARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2023-03-08","u":"2024-02-06","st":"2023-02","ag":"18–75"},{"n":"NCT05759793","t":"A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia","s":"rec","p":"phase1","d":[15],"c":[5],"a":"adult older","h":[123],"po":"2023-03-08","u":"2025-05-20","st":"2023-03","ag":"18–75"},{"n":"NCT05760378","t":"Famitinib in Combination With Camrelizumab and TPC in The First-line Treatment of Immunomodulatory Locally Advanced or Metastatic TNBC.","s":"rec","p":"phase3","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2023-03-08","u":"2024-02-06","st":"2023-03","ag":"18–70"},{"n":"NCT05760612","t":"Adjuvant Trastuzumab Plus Neratinib in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Neoadjuvant Trastuzumab Plus Pertuzumab","s":"rec","p":"phase3","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2023-03-08","u":"2025-09-25","st":"2023-03","ag":"18–70"},{"n":"NCT05762510","t":"A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]","s":"rec","p":"earlyphase1","d":[20],"c":[10],"lc":[10],"a":"child adult","h":[15],"l":[[15,"bthal"]],"po":"2023-03-09","u":"2023-05-09","st":"2023-02","ag":"5–35"},{"n":"NCT05765877","t":"Neoadjuvant WX-0593 in Resectable ALK-positive or ROS1-positive Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[27],"lc":[27],"a":"adult older","h":[57],"l":[[57,"lung"]],"po":"2023-03-13","u":"2025-06-12","st":"2023-03","ag":"18 and over"},{"n":"NCT05766800","t":"Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2023-03-13","u":"2024-09-19","st":"2023-03","ag":"18 and over"},{"n":"NCT05768529","t":"Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[8,5,4],"a":"adult older","h":[123,5,20],"po":"2023-03-14","u":"2026-10-02","st":"2023-03","ag":"18–70"},{"n":"NCT05769010","t":"Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain Metastases","s":"rec","p":"phase2","d":[6],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"breast"]],"po":"2023-03-15","u":"2026-04-01","st":"2023-03","ag":"18–75"},{"n":"NCT05775042","t":"Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy","s":"rec","p":"phase2","d":[46],"c":[2],"a":"adult older","h":[29],"po":"2023-03-20","u":"2024-10-15","st":"2023-05","ag":"18–75"},{"n":"NCT05777278","t":"Savolitinib Plus Docetaxel as 2L in EGFR/ALK/ROS1/MET ex14m-wildtype NSCLC With MET Overexpression","s":"rec","p":"phase1phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[132],"l":[[132,"lung"]],"po":"2023-03-21","u":"2023-10-10","st":"2023-07","ag":"18 and over"},{"n":"NCT05779917","t":"Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers","s":"rec","p":"phase1","d":[5],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"panc"]],"po":"2023-03-22","u":"2024-06-25","st":"2023-03","ag":"18–75"},{"n":"NCT05786924","t":"Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies","s":"rec","p":"phase1phase2","d":[4],"c":[2,27,5,4],"a":"adult older","h":[57,6,74,187],"po":"2023-03-28","u":"2026-11-17","st":"2023-04","ag":"18 and over"},{"n":"NCT05789082","t":"A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation","s":"rec","p":"phase1phase2","d":[4],"c":[8,24,5],"a":"adult older","h":[56,45,13],"po":"2023-03-29","u":"2026-11-05","st":"2023-06","ag":"18 and over"},{"n":"NCT05795335","t":"CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"breast"]],"po":"2023-04-03","u":"2023-05-16","st":"2023-04","ag":"18 and over"},{"n":"NCT05800002","t":"IVUS-guided DES Implantation in Coronary Calcification","s":"rec","p":"na","d":[31],"c":[28],"lc":[28],"a":"adult older","h":[78,119],"l":[[78,"cad"]],"po":"2023-04-05","u":"2024-11-15","st":"2023-04","ag":"18 and over"},{"n":"NCT05800223","t":"Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2023-04-05","u":"2023-04-05","st":"2023-01","ag":"18–75"},{"n":"NCT05800340","t":"Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"lung"]],"po":"2023-04-05","u":"2023-04-05","st":"2023-04","ag":"18 and over"},{"n":"NCT05800977","t":"A Study of C-CAR039 (Prizloncabtagene Autoleucel) in Patients With Relapsed/Refractory Large B-Cell Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[2,1,0,23,9,28,5,30,20],"a":"adult older","h":[123,25,74,78,46,58,69,115,37,43,2,0,116,3],"po":"2023-04-06","u":"2025-12-31","st":"2023-02","ag":"18 and over"},{"n":"NCT05802394","t":"The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic Cancer","s":"rec","p":"na","d":[5],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"panc"]],"po":"2023-04-06","u":"2023-04-12","st":"2023-02","ag":"18 and over"},{"n":"NCT05802407","t":"The Value of Molecular Residual Disease Monitoring Based on ctDNA in Resected Pancreatic Cancer","s":"rec","p":"na","d":[5],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"panc"]],"po":"2023-04-06","u":"2023-04-12","st":"2023-02","ag":"18 and over"},{"n":"NCT05806060","t":"Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2023-04-10","u":"2026-03-25","st":"2023-04","ag":"18–70"},{"n":"NCT05806099","t":"A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of MBS303 in B-Cell NHL","s":"rec","p":"phase1phase2","d":[19],"c":[2],"a":"adult older","h":[74],"po":"2023-04-10","u":"2024-11-20","st":"2023-06","ag":"18 and over"},{"n":"NCT05806580","t":"Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma","s":"rec","p":"phase4","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2023-04-10","u":"2024-10-23","st":"2023-05","ag":"18 and over"},{"n":"NCT05813015","t":"Study of Comparing of With and Without Sequential Therapy of S-1","s":"rec","p":"phase3","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"gc"]],"po":"2023-04-14","u":"2023-04-14","st":"2023-01","ag":"18–75"},{"n":"NCT05824169","t":"Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients","s":"rec","p":"phase1phase2","d":[40],"c":[2,11,4],"a":"child","h":[26,143,203],"po":"2023-04-21","u":"2026-11-17","st":"2023-02","ag":"0 months–6 months"},{"n":"NCT05825443","t":"Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"lung"]],"po":"2023-04-24","u":"2023-04-25","st":"2023-04","ag":"18–80"},{"n":"NCT05830123","t":"ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas","s":"rec","p":"phase2","d":[11],"c":[2,8,0,23,5,30,20],"a":"adult older","h":[48,202,49,121,53,37,58,54,26,13,44],"po":"2023-04-26","u":"2024-08-23","st":"2023-06","ag":"18 and over"},{"n":"NCT05830812","t":"Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma","s":"rec","p":"na","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lung"]],"po":"2023-04-26","u":"2024-09-19","st":"2023-01","ag":"20–80"},{"n":"NCT05831865","t":"Frontline of ASCT in High-risk DLBCL","s":"rec","p":"na","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"lymph"]],"po":"2023-04-26","u":"2023-05-06","st":"2023-05","ag":"18–70"},{"n":"NCT05831878","t":"RC48-ADC in HER2-low Advanced Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[41],"l":[[41,"breast"]],"po":"2023-04-26","u":"2026-05-13","st":"2023-05","ag":"18 and over"},{"n":"NCT05833594","t":"Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma","s":"rec","p":"na","d":[1],"c":[17],"lc":[17],"a":"adult older","h":[68],"l":[[68,"escc"]],"po":"2023-04-27","u":"2023-12-26","st":"2023-07","ag":"18–85"},{"n":"NCT05833893","t":"Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"child adult older","h":[26],"l":[[26,"lymph"]],"po":"2023-04-27","u":"2023-04-27","st":"2023-05","ag":"14 and over"},{"n":"NCT05834764","t":"Pyrotinib in Women With High-risk in Early Stage Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[28],"lc":[28],"a":"adult older","x":"female","h":[78],"l":[[78,"breast"]],"po":"2023-04-28","u":"2023-04-28","st":"2023-04","ag":"18–75"},{"n":"NCT05835570","t":"Integrin αvβ6-targeted PET in Malignant Tumors","s":"rec","p":"na","d":[4,6],"c":[13],"lc":[13],"a":"adult older","h":[133],"l":[[133,"lung"]],"po":"2023-04-28","u":"2025-04-30","st":"2023-01","ag":"18–85"},{"n":"NCT05842707","t":"Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[5],"a":"adult older","h":[162],"po":"2023-05-06","u":"2023-05-06","st":"2023-01","ag":"18–75"},{"n":"NCT05845723","t":"Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome","s":"rec","p":"phase2","d":[44],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"behcet"]],"po":"2023-05-06","u":"2024-08-19","st":"2023-06","ag":"18–65"},{"n":"NCT05847855","t":"Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors","s":"rec","p":"na","d":[5],"c":[22,5],"lc":[5],"a":"adult older","h":[9,40],"l":[[9,"panc"]],"po":"2023-05-08","u":"2026-03-25","st":"2023-02","ag":"18 and over"},{"n":"NCT05848310","t":"Preoperative Serum FGF19 in the Prognosis of Biliary Atresia","s":"rec","p":"na","d":[30],"c":[5],"lc":[5],"a":"child adult older","h":[76],"l":[[76,"ba"]],"po":"2023-05-08","u":"2026-03-27","st":"2023-10","ag":"Not stated"},{"n":"NCT05851677","t":"Disitamab Vedotin (RC48-ADC) in Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"child adult older","h":[41],"l":[[41,"breast"]],"po":"2023-05-10","u":"2025-09-17","st":"2023-06","ag":"Not stated"},{"n":"NCT05854849","t":"Gemcitabine and Camrelizumab Plus Apatinib Versus Cisplatin in First-line Treatment of RM-NPC","s":"rec","p":"phase3","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2023-05-11","u":"2023-05-11","st":"2023-05","ag":"18–75"},{"n":"NCT05857800","t":"Exploring the Neo-Adjuvant Therapy Effects on Lung Cancer Through Monitoring and Assessment of Tumor Environment","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2023-05-15","u":"2023-06-08","st":"2023-05","ag":"18 and over"},{"n":"NCT05859750","t":"A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[2,0,23,27,5,13],"a":"adult older","h":[38,177,12,53,183,44,57],"po":"2023-05-16","u":"2024-12-16","st":"2023-05","ag":"18–75"},{"n":"NCT05860400","t":"Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"cad"]],"po":"2023-05-16","u":"2025-11-19","st":"2023-05","ag":"18 and over"},{"n":"NCT05860465","t":"Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer","s":"rec","p":"phase2phase3","d":[6],"c":[48,2,55,15,16,0,23,24,47,36,28,11,18,30,39,58],"a":"adult older","x":"female","h":[78,58,53,45,111,24,118,44,38,164,135,127,30,172,87,150,138],"po":"2023-05-16","u":"2026-01-14","st":"2023-09","ag":"18–75"},{"n":"NCT05860868","t":"Two Cycles VS Three Cycles Induction Chemotherapy in T1-4N2-3 Locally Advanced Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[49],"l":[[49,"npc"]],"po":"2023-05-16","u":"2023-05-16","st":"2023-05","ag":"18–65"},{"n":"NCT05861271","t":"Adjuvant Pyrotinib and Capecitabine For HER2 Positive Micro Invasive Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2023-05-16","u":"2024-03-22","st":"2023-06","ag":"18–70"},{"n":"NCT05862064","t":"A Multi-center, Randomized, Open-label, Phase III Study Comparing PD-1 Inhibitor Combined With Antivascular Therapy and Anthracycline/Taxane-based Adjuvant Chemotherapy Versus Anthracycline/Taxane-based Adjuvant Chemotherapy Alone in Patients With Operable Triple-negative Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2023-05-17","u":"2025-07-16","st":"2023-06","ag":"18–70"},{"n":"NCT05862337","t":"Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.","s":"rec","p":"phase3","d":[2],"c":[2,55,15,8,49,22,1,52,16,0,6,23,17,27,33,73,9,51,10,40,61,5,11,29,30,34,37,39,20],"a":"adult older","h":[40,277,209,25,50,110,111,11,23,112,238,80,81,68,58,190,82,181,38,143,57,30,0,7,39,363,142,195,20,164,146,37,215,311,155,66,202,2,48,207,145,13,122,18,138,260],"po":"2023-05-17","u":"2023-05-17","st":"2023-05","ag":"18–75"},{"n":"NCT05869474","t":"Implantation of iodine125-Seeds Combined With Chemotherapy in the Treatment of Metastatic Pancreatic Carcinoma","s":"rec","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[177],"l":[[177,"panc"]],"po":"2023-05-22","u":"2023-08-04","st":"2023-08","ag":"18–80"},{"n":"NCT05870969","t":"Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)","s":"rec","p":"na","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"hcc"]],"po":"2023-05-23","u":"2023-05-23","st":"2023-03","ag":"18–75"},{"n":"NCT05872347","t":"Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.","s":"rec","p":"phase2","d":[6],"c":[48,2,55,15,0,23,24,17,36,28,10,18,30,34,13,38,58,20],"a":"adult older","x":"female","h":[78,58,53,45,24,74,44,38,12,164,27,37,112,50,68,72,172,87,86,150,138],"po":"2023-05-24","u":"2026-05-05","st":"2023-09","ag":"18–75"},{"n":"NCT05876065","t":"Capecitabine and Cyclophosphamide (XC) as Maintenance Therapy for Advanced Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[41],"l":[[41,"breast"]],"po":"2023-05-25","u":"2026-08-19","st":"2023-06","ag":"18 and over"},{"n":"NCT05877872","t":"Reduced-target Resection After Induction Chemotherapy in Resectable Recurrent Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2023-05-26","u":"2023-05-26","st":"2023-05","ag":"18–75"},{"n":"NCT05882058","t":"DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers","s":"rec","p":"phase2","d":[4],"c":[22,23,27,9,5],"a":"adult older","h":[40,42,124,80,82],"po":"2023-05-31","u":"2026-07-23","st":"2023-10","ag":"18 and over"},{"n":"NCT05883852","t":"EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2023-06-01","u":"2023-06-27","st":"2023-06","ag":"18–70"},{"n":"NCT05884983","t":"Screening Effect of Dual-energy CT Combined With Nasopharyngeal Endoscopy for Screening Nasopharyngeal Carcinoma","s":"rec","p":"na","d":[0],"c":[46],"lc":[46],"a":"adult older","h":[134],"l":[[134,"npc"]],"po":"2023-06-01","u":"2025-08-15","st":"2023-02","ag":"30–69"},{"n":"NCT05886439","t":"LK101 Combined With PD-1 or PD-L1 Monoclonal Antibody in the Treatment of Lung Cancer","s":"rec","p":"phase1phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2023-06-02","u":"2025-12-08","st":"2023-05","ag":"18 and over"},{"n":"NCT05888870","t":"ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor","s":"rec","p":"phase4","d":[21],"c":[30],"lc":[30],"a":"child adult older","h":[69],"l":[[69,"ha"]],"po":"2023-06-05","u":"2025-02-24","st":"2023-11","ag":"14–65"},{"n":"NCT05891093","t":"Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)","s":"rec","p":"phase3","d":[6],"c":[2,22,1,16,0,40,61,5,11,39,32],"lc":[5],"a":"adult older","x":"female","h":[9,40,53,111,118,74,43,110,18,2,140,202,63,215],"l":[[9,"breast"]],"po":"2023-06-06","u":"2024-02-08","st":"2023-06","ag":"18–70"},{"n":"NCT05891561","t":"Short-course Trastuzumab, Pertuzumab with Taxanes in the Adjuvant Treatment of Early HER2-positive Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[123],"l":[[123,"breast"]],"po":"2023-06-07","u":"2024-11-27","st":"2023-11","ag":"18–75"},{"n":"NCT05892354","t":"Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy","s":"rec","p":"na","d":[0],"c":[16,0,57,6,23,88,9,10,87],"lc":[10],"a":"adult older","h":[15,30,170,95,7,44,43,80,14,148,165,183,342,317],"l":[[15,"npc"]],"po":"2023-06-07","u":"2024-08-07","st":"2023-06","ag":"18–70"},{"n":"NCT05892718","t":"A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors","s":"rec","p":"phase1","d":[19],"c":[23],"a":"adult older","h":[185],"po":"2023-06-07","u":"2026-02-04","st":"2023-10","ag":"18 and over"},{"n":"NCT05894239","t":"A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[2,15,22,16,23,27,36,9,10,18,30,13],"a":"adult older","h":[58,74,44,12,57,27,50,47,19,30,98,80,175,87],"po":"2023-06-08","u":"2026-11-13","st":"2023-09","ag":"18 and over"},{"n":"NCT05894369","t":"Influence Mechanism of Tumor Microenvironment Changes on Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma","s":"rec","p":"na","d":[1],"c":[13],"lc":[13],"a":"adult older","h":[16],"l":[[16,"escc"]],"po":"2023-06-08","u":"2024-11-25","st":"2023-05","ag":"18–80"},{"n":"NCT05899621","t":"A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL","s":"rec","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2023-06-12","u":"2023-06-12","st":"2023-06","ag":"18 and over"},{"n":"NCT05901428","t":"TCb vs EC-T in High Risk ER+/HER2- Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2023-06-13","u":"2026-09-28","st":"2023-06","ag":"18–70"},{"n":"NCT05904964","t":"Disitamab Vedotin (RC48) in Hormone Receptor Positive, HER2-low Metastatic Breast Cancer (the Rosy Trial)","s":"rec","p":"phase3","d":[6],"c":[0,43],"lc":[0],"a":"adult older","h":[99,125],"l":[[99,"breast"]],"po":"2023-06-15","u":"2023-06-22","st":"2023-07","ag":"18–70"},{"n":"NCT05909332","t":"Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)","s":"rec","p":"phase3","d":[6],"c":[2,22,1,16,0,40,61,5,11,39,32],"lc":[5],"a":"adult older","x":"female","h":[9,40,53,111,118,74,43,110,18,2,140,202,63,215],"l":[[9,"breast"]],"po":"2023-06-18","u":"2026-01-21","st":"2023-06","ag":"18–70"},{"n":"NCT05910398","t":"Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"breast"]],"po":"2023-06-18","u":"2025-11-18","st":"2023-06","ag":"18 and over"},{"n":"NCT05911217","t":"A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer","s":"rec","p":"phase1","d":[5],"c":[2,8,23,5,13,39,20],"a":"adult older","h":[9,123,12,111,183,74,363,37],"po":"2023-06-20","u":"2026-10-21","st":"2023-07","ag":"18–79"},{"n":"NCT05911958","t":"A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[20],"lc":[20],"a":"adult older","x":"female","h":[37],"l":[[37,"breast"]],"po":"2023-06-22","u":"2024-11-04","st":"2023-07","ag":"18–70"},{"n":"NCT05913089","t":"A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[2,16,5,12,30,42],"a":"adult older","h":[42,74,59,140,61,89,169,114,84],"po":"2023-06-22","u":"2023-06-29","st":"2023-06","ag":"18–80"},{"n":"NCT05916261","t":"Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer","s":"rec","p":"earlyphase1","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"panc"]],"po":"2023-06-23","u":"2023-10-26","st":"2023-04","ag":"18 and over"},{"n":"NCT05917431","t":"Phase 2 Study of SBRT Plus Tislelizumab and Regorafenib in Unresectable or Oligometastatic HCC","s":"rec","p":"phase2","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"hcc"]],"po":"2023-06-23","u":"2023-06-23","st":"2023-06","ag":"18 and over"},{"n":"NCT05918094","t":"Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma","s":"rec","p":"phase3","d":[3],"c":[22,52,0,24,9,5,13,20],"lc":[0],"a":"adult older","h":[53,40,14,123,37,45,36,155],"l":[[53,"gc"]],"po":"2023-06-26","u":"2024-01-26","st":"2023-04","ag":"18–75"},{"n":"NCT05918328","t":"Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC","s":"rec","p":"phase2","d":[6],"c":[20],"lc":[20],"a":"adult older","x":"female","h":[37],"l":[[37,"breast"]],"po":"2023-06-26","u":"2025-03-07","st":"2023-05","ag":"18–65"},{"n":"NCT05919030","t":"A Study of Chemoradiation in Combination with Tislelizumab As First Line Treatment in Participants with Advanced Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase3","d":[1],"c":[13],"lc":[13],"a":"adult older","h":[16],"l":[[16,"escc"]],"po":"2023-06-26","u":"2024-11-14","st":"2023-07","ag":"18 and over"},{"n":"NCT05920356","t":"A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)","s":"rec","p":"phase3","d":[4],"c":[48,2,55,15,8,22,1,16,0,23,24,17,27,47,25,36,9,28,10,40,5,43,18,12,29,30,42,13,39,7,38,20],"a":"adult older","h":[40,58,9,43,38,44,25,11,12,111,74,45,36,10,46,13,47,14,164,37,82,140,60,61,30,2,135,148,125,50,138,66,114,95,8,175,116,84,222,86,87,152,150,260,199],"po":"2023-06-27","u":"2026-11-13","st":"2023-11","ag":"18–100"},{"n":"NCT05920863","t":"Lenvatinib Combined with Tislelizumab and TACE Applied As Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma with High-risk Recurrence Factors","s":"rec","p":"phase2","d":[2],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"hcc"]],"po":"2023-06-27","u":"2025-02-11","st":"2023-07","ag":"18–75"},{"n":"NCT05923489","t":"Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients","s":"rec","p":"na","d":[31],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"cad"]],"po":"2023-06-28","u":"2026-08-21","st":"2023-10","ag":"18 and over"},{"n":"NCT05923905","t":"Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients","s":"rec","p":"phase4","d":[39],"c":[2],"lc":[2],"a":"adult older","h":[115],"l":[[115,"als"]],"po":"2023-06-28","u":"2023-11-22","st":"2023-01","ag":"18–80"},{"n":"NCT05924841","t":"A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Extensive Stage Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[15],"a":"adult older","h":[138],"po":"2023-06-29","u":"2026-08-27","st":"2023-11","ag":"18–75"},{"n":"NCT05925309","t":"Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy","s":"rec","p":"na","d":[30],"c":[5],"lc":[5],"a":"child","h":[76],"l":[[76,"ba"]],"po":"2023-06-29","u":"2026-05-15","st":"2023-07","ag":"14 days–90 days"},{"n":"NCT05926726","t":"GPC3-directed CAR-T in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"hcc"]],"po":"2023-07-03","u":"2023-07-03","st":"2023-01","ag":"18–75"},{"n":"NCT05931263","t":"A Randomized Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL","s":"rec","p":"phase3","d":[19],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"lymph"]],"po":"2023-07-05","u":"2023-07-05","st":"2023-06","ag":"18–65"},{"n":"NCT05933967","t":"A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With Double Expression Diffuse Large B-cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[27],"lc":[27],"a":"adult older","h":[57],"l":[[57,"lymph"]],"po":"2023-07-06","u":"2023-08-15","st":"2023-06","ag":"18–70"},{"n":"NCT05934331","t":"A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study","s":"rec","p":"phase2","d":[3],"c":[5],"a":"adult older","h":[65],"po":"2023-07-06","u":"2026-10-19","st":"2023-07","ag":"18–80"},{"n":"NCT05935150","t":"Omission of SLNB in CN0 Early Breast Cancer","s":"rec","p":"na","d":[6],"c":[28],"lc":[28],"a":"adult older","x":"female","h":[78],"l":[[78,"breast"]],"po":"2023-07-07","u":"2024-10-15","st":"2023-06","ag":"18–70"},{"n":"NCT05937438","t":"Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma","s":"rec","p":"phase1phase2","d":[1],"c":[17],"lc":[17],"a":"adult older","h":[68],"l":[[68,"escc"]],"po":"2023-07-10","u":"2025-01-29","st":"2023-09","ag":"18–75"},{"n":"NCT05938309","t":"A Cohort Study on the Safety of Laparoscopic Resection of 5cm or Larger Gastric Gastrointestinal Stromal Tumors","s":"rec","p":"na","d":[3,12],"c":[16],"lc":[16],"a":"adult older","h":[140],"l":[[140,"gc"]],"po":"2023-07-10","u":"2023-07-10","st":"2023-05","ag":"18–75"},{"n":"NCT05939063","t":"LRAMPS Versus LDP in Selected Early-stage Left-sided Pancreatic Cancer","s":"rec","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"panc"]],"po":"2023-07-11","u":"2023-11-24","st":"2023-10","ag":"18–80"},{"n":"NCT05939830","t":"Omission of ALND in Breast Cancer Patients With Axillary pCR","s":"rec","p":"na","d":[6],"c":[28],"lc":[28],"a":"adult older","x":"female","h":[78],"l":[[78,"breast"]],"po":"2023-07-11","u":"2024-12-30","st":"2023-09","ag":"18–70"},{"n":"NCT05940532","t":"A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC","s":"rec","p":"phase2","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2023-07-11","u":"2023-07-11","st":"2023-06","ag":"18–75"},{"n":"NCT05948033","t":"CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2023-07-17","u":"2023-07-17","st":"2023-07","ag":"18–75"},{"n":"NCT05949541","t":"Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2023-07-18","u":"2024-02-08","st":"2023-07","ag":"18–75"},{"n":"NCT05949931","t":"Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma","s":"rec","p":"phase2","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2023-07-18","u":"2026-05-01","st":"2023-10","ag":"18 and over"},{"n":"NCT05950945","t":"Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[2,16,23,17,27,47,9,26,5,39,20],"a":"adult older","h":[9,44,26,55,57,37,135,131,30,116,94,239,88],"po":"2023-07-18","u":"2026-06-12","st":"2023-12","ag":"18 and over"},{"n":"NCT05952661","t":"Minimally Residual of Esophageal Cancer 001","s":"rec","p":"na","d":[1],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"escc"]],"po":"2023-07-19","u":"2023-07-19","st":"2023-02","ag":"18–75"},{"n":"NCT05954897","t":"Lenvatinib, Tislelizumab Combined With RALOX Regimen HAIC in Advanced Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"hcc"]],"po":"2023-07-20","u":"2023-07-20","st":"2023-09","ag":"18 and over"},{"n":"NCT05956847","t":"The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric","s":"rec","p":"na","d":[3],"c":[39],"lc":[39],"a":"adult older","h":[131],"l":[[131,"gc"]],"po":"2023-07-21","u":"2023-08-29","st":"2023-08","ag":"18–80"},{"n":"NCT05958719","t":"Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"lymph"]],"po":"2023-07-25","u":"2024-12-30","st":"2023-03","ag":"18 and over"},{"n":"NCT05965024","t":"Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2023-07-28","u":"2024-02-21","st":"2023-10","ag":"18 and over"},{"n":"NCT05965115","t":"The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE Study","s":"rec","p":"na","d":[15],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"mm"]],"po":"2023-07-28","u":"2023-08-01","st":"2023-07","ag":"18 and over"},{"n":"NCT05965557","t":"Exploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2023-07-28","u":"2026-06-30","st":"2023-06","ag":"18–80"},{"n":"NCT05968053","t":"Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)","s":"rec","p":"na","d":[7],"c":[2],"lc":[2],"a":"adult older","h":[102],"l":[[102,"glioma"]],"po":"2023-08-01","u":"2025-01-23","st":"2023-09","ag":"18–80"},{"n":"NCT05969171","t":"A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"panc"]],"po":"2023-08-01","u":"2025-07-30","st":"2023-12","ag":"18–75"},{"n":"NCT05970198","t":"Helical Tomotherapy in Multiple Myeloma","s":"rec","p":"na","d":[15],"c":[13],"lc":[13],"a":"adult older","h":[133],"l":[[133,"mm"]],"po":"2023-08-01","u":"2023-08-01","st":"2023-06","ag":"18–75"},{"n":"NCT05970666","t":"Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"hcc"]],"po":"2023-08-01","u":"2024-02-28","st":"2023-11","ag":"18–75"},{"n":"NCT05975749","t":"Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"gc"]],"po":"2023-08-04","u":"2024-03-12","st":"2023-01","ag":"20–80"},{"n":"NCT05976412","t":"Regional Lymph Node Irradiation for High-risk pN0 Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[123],"l":[[123,"breast"]],"po":"2023-08-04","u":"2023-08-07","st":"2023-07","ag":"18 and over"},{"n":"NCT05976997","t":"Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL)","s":"rec","p":"phase2","d":[19],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lymph"]],"po":"2023-08-04","u":"2026-05-18","st":"2023-05","ag":"18–70"},{"n":"NCT05978193","t":"Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[42,123],"l":[[42,"escc"]],"po":"2023-08-07","u":"2026-01-22","st":"2023-01","ag":"18 and over"},{"n":"NCT05978284","t":"Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma","s":"rec","p":"phase1phase2","d":[4],"c":[20],"a":"adult older","h":[37],"po":"2023-08-07","u":"2026-01-05","st":"2023-10","ag":"18–75"},{"n":"NCT05979363","t":"A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd)-Based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With Primary Plasma Cell Leukemia","s":"rec","p":"phase2","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2023-08-07","u":"2026-11-04","st":"2023-08","ag":"18–75"},{"n":"NCT05981001","t":"Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer","s":"rec","p":"phase1phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2023-08-08","u":"2023-08-08","st":"2023-08","ag":"18–70"},{"n":"NCT05981014","t":"Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer","s":"rec","p":"phase1phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2023-08-08","u":"2023-08-08","st":"2023-08","ag":"18–70"},{"n":"NCT05983107","t":"Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2023-08-09","u":"2023-08-09","st":"2023-07","ag":"18–75"},{"n":"NCT05984342","t":"Adjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase1","d":[1],"c":[43],"lc":[43],"a":"adult older","h":[125],"l":[[125,"escc"]],"po":"2023-08-09","u":"2023-08-09","st":"2023-08","ag":"18–70"},{"n":"NCT05984511","t":"TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT","s":"rec","p":"na","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[209],"l":[[209,"hcc"]],"po":"2023-08-09","u":"2025-02-11","st":"2023-08","ag":"18–75"},{"n":"NCT05985798","t":"Sintilimab+Bevacizumab+TACE vs. Lenvatinib+TACE for Advanced HCC","s":"rec","p":"phase3","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"hcc"]],"po":"2023-08-14","u":"2023-08-14","st":"2023-08","ag":"18 and over"},{"n":"NCT05987826","t":"Study of Furmonertinib as Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢB EGFR Sensitive Mutant NSCLC","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"lung"]],"po":"2023-08-14","u":"2026-08-24","st":"2023-09","ag":"18–75"},{"n":"NCT05989542","t":"A Confirmatory Clinical Study in NSCLC Patients With MET Exon 14 Mutation (KUNPENG-2)","s":"rec","p":"phase3","d":[4],"c":[0],"a":"adult older","h":[43],"po":"2023-08-14","u":"2025-06-29","st":"2023-10","ag":"18 and over"},{"n":"NCT05990946","t":"Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer","s":"rec","p":"na","d":[4],"c":[46],"lc":[46],"a":"adult older","h":[134],"l":[[134,"lung"]],"po":"2023-08-14","u":"2026-09-04","st":"2023-12","ag":"18–75"},{"n":"NCT05994170","t":"Reducing High Risk Primary Tumor Clinical Target Volumes (CTVp1) in Non-metastatic Nasopharyngeal Carcinoma","s":"rec","p":"na","d":[0],"c":[46],"lc":[46],"a":"adult older","h":[134],"l":[[134,"npc"]],"po":"2023-08-16","u":"2023-08-16","st":"2023-08","ag":"18–70"},{"n":"NCT05994859","t":"SIRT for Potentially Resectable HCC","s":"rec","p":"na","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"hcc"]],"po":"2023-08-16","u":"2023-09-14","st":"2023-08","ag":"18–75"},{"n":"NCT05997719","t":"Exploring Cancer Evolution, Prognostic and Predictive Biomarkers in EGFR-mutant NSCLC","s":"rec","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2023-08-18","u":"2023-10-24","st":"2023-08","ag":"18 and over"},{"n":"NCT05999149","t":"A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)","s":"rec","p":"phase3","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2023-08-21","u":"2026-11-06","st":"2023-08","ag":"18–70"},{"n":"NCT06000917","t":"A Study of Neoadjuvant TCHpy（Pyrotinib ，Trastuzumab，Carboplatin and Paclitaxel）for ER+/HER2+ Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[13],"lc":[13],"a":"adult older","x":"female","h":[12],"l":[[12,"breast"]],"po":"2023-08-21","u":"2023-08-21","st":"2023-05","ag":"18–75"},{"n":"NCT06001086","t":"A Phase II Clinical Study of Treatment With Disitamb Vedotin Plus Pyrotinib in HER2-positive Early Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[28],"lc":[28],"a":"adult older","h":[78,288],"l":[[78,"breast"]],"po":"2023-08-21","u":"2023-12-20","st":"2023-11","ag":"18 and over"},{"n":"NCT06002711","t":"Multi-Dimensional MRI Spatial Heterogeneity Analysis for Predicting Key Genes and Prognosis of High-Grade Gliomas: A Multi-Center Study","s":"rec","p":"na","d":[7],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"glioma"]],"po":"2023-08-21","u":"2025-08-08","st":"2023-09","ag":"18–70"},{"n":"NCT06007248","t":"Disease Characteristics of IR-CAD: a Case-control Study","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult","h":[38],"l":[[38,"cad"]],"po":"2023-08-23","u":"2025-11-19","st":"2023-11","ag":"45–64"},{"n":"NCT06008054","t":"A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal Tumors","s":"rec","p":"phase2","d":[3],"c":[2],"a":"adult older","h":[74],"po":"2023-08-23","u":"2025-09-26","st":"2023-11","ag":"18–75"},{"n":"NCT06008288","t":"A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.","s":"rec","p":"phase2","d":[5],"c":[2,8,22,16,0,23,24,17,27,9,28,26,5,11,30,13,39,20],"a":"adult older","h":[38,40,46,78,177,58,12,111,53,183,55,118,23,25,99,74,14,45,44,363,103,37,57,127,19,30,100,13,88],"po":"2023-08-23","u":"2026-03-13","st":"2023-10","ag":"18 and over"},{"n":"NCT06010329","t":"A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC","s":"rec","p":"phase2","d":[4],"c":[2,22,0,23,24,27,9,28,5,13,20],"a":"adult older","h":[40,44,25,12,74,45,127,37,61,83,65,95,116],"po":"2023-08-24","u":"2026-11-02","st":"2023-12","ag":"18 and over"},{"n":"NCT06013618","t":"Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma","s":"rec","p":"phase2","d":[13],"c":[0],"lc":[0],"a":"child adult older","h":[53],"l":[[53,"nb"]],"po":"2023-08-28","u":"2025-06-17","st":"2023-06","ag":"12 months and over"},{"n":"NCT06014073","t":"TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL","s":"rec","p":"phase1phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2023-08-28","u":"2025-05-25","st":"2023-09","ag":"18–70"},{"n":"NCT06017895","t":"Doxepin Solution for Alleviation of Stubborn Breakthrough Pain Induced by Swallowing in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma","s":"rec","p":"na","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"npc"]],"po":"2023-08-30","u":"2026-06-23","st":"2023-10","ag":"18 and over"},{"n":"NCT06018363","t":"Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection","s":"rec","p":"phase1phase2","d":[7],"c":[4],"lc":[4],"a":"adult older","h":[364],"l":[[364,"glioma"]],"po":"2023-08-30","u":"2025-08-19","st":"2023-06","ag":"18–70"},{"n":"NCT06023212","t":"Tranexamic Acid Use for Bleeding Prevention in the Surgical Treatment of Metastatic Spinal Tumor in Lung Cancer Patients","s":"rec","p":"phase1phase2","d":[4],"c":[23],"lc":[23],"a":"child adult older","h":[54],"l":[[54,"lung"]],"po":"2023-09-05","u":"2025-02-10","st":"2023-12","ag":"10–80"},{"n":"NCT06023758","t":"Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC","s":"rec","p":"phase2","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"gc"]],"po":"2023-09-05","u":"2024-05-10","st":"2023-09","ag":"18–75"},{"n":"NCT06026488","t":"Real-World Study of DLBCL With Different Genetic Subtypes","s":"rec","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2023-09-07","u":"2024-12-19","st":"2023-10","ag":"18 and over"},{"n":"NCT06026878","t":"GNT Induction Treatment in Locally Advanced NPC","s":"rec","p":"phase3","d":[0],"c":[39],"lc":[39],"a":"adult older","h":[131],"l":[[131,"npc"]],"po":"2023-09-07","u":"2023-09-07","st":"2023-09","ag":"18–75"},{"n":"NCT06031181","t":"Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)","s":"rec","p":"phase3","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2023-09-11","u":"2023-12-13","st":"2023-03","ag":"18–80"},{"n":"NCT06031285","t":"Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"hcc"]],"po":"2023-09-11","u":"2025-07-23","st":"2023-09","ag":"18–75"},{"n":"NCT06033287","t":"Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC.","s":"rec","p":"na","d":[6],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"breast"]],"po":"2023-09-13","u":"2025-07-11","st":"2023-01","ag":"18 and over"},{"n":"NCT06035016","t":"Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast Cancer","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[38],"l":[[38,"breast"]],"po":"2023-09-13","u":"2023-09-13","st":"2023-06","ag":"18–75"},{"n":"NCT06035250","t":"AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy","s":"rec","p":"na","d":[3],"c":[2,8,16,0,47,10,26,5,11,4,30,20],"a":"adult older","h":[74,140,70,118,25,55,123,5,58,37,38,49,75,30,11,48,95,50,135],"po":"2023-09-13","u":"2023-09-28","st":"2023-09","ag":"18 and over"},{"n":"NCT06035679","t":"Pyrotinib Combined With Trastuzumab and Chemotherapy Neoadjuvant Therapy for HER2-positive Breast Cancer","s":"rec","p":"na","d":[6],"a":"adult older","x":"female","h":[365],"l":[[365,"breast"]],"po":"2023-09-13","u":"2025-03-12","st":"2023-08","ag":"18–75"},{"n":"NCT06039735","t":"Cardiac Toxicity and Prognostic Value of New Echocardiographic Indicators in the Treatment of Primary Multiple Myeloma","s":"rec","p":"na","d":[15],"c":[27],"lc":[27],"a":"adult older","h":[124],"l":[[124,"mm"]],"po":"2023-09-15","u":"2023-11-21","st":"2023-11","ag":"18–70"},{"n":"NCT06041477","t":"Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC","s":"rec","p":"phase3","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"hcc"]],"po":"2023-09-18","u":"2024-08-27","st":"2023-10","ag":"18–75"},{"n":"NCT06041659","t":"Functional Magnetic Resonance-Based Observations of Brain Networks in Moyamoya Disease Patients Under Anesthesia","s":"rec","p":"na","d":[28],"c":[2],"lc":[2],"a":"adult older","h":[102],"l":[[102,"moyamoya"]],"po":"2023-09-18","u":"2025-02-13","st":"2023-10","ag":"18–65"},{"n":"NCT06041776","t":"Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations","s":"rec","p":"phase3","d":[4],"c":[28,5],"a":"adult older","h":[42,127],"po":"2023-09-18","u":"2023-09-22","st":"2023-03","ag":"18 and over"},{"n":"NCT06042894","t":"A Study of SI-B003 or BL-B01D1+SI-B003 in Patients With Unresectable Locally Advanced or Recurrent Metastatic HER2 Negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"a":"adult older","x":"female","h":[9],"po":"2023-09-21","u":"2025-09-26","st":"2023-12","ag":"18–75"},{"n":"NCT06042998","t":"A Multicenter, RCT Study of the Clinical Efficacy of Robotic and Laparoscopic Gastrectomy in Neoadjuvant Gastric Cancer","s":"rec","p":"na","d":[3],"c":[26],"lc":[26],"a":"adult older","h":[55],"l":[[55,"gc"]],"po":"2023-09-21","u":"2023-09-21","st":"2023-07","ag":"18–75"},{"n":"NCT06043466","t":"A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors","s":"rec","p":"phase1","d":[3,4,5,6],"c":[23],"a":"adult older","h":[46,54],"po":"2023-09-21","u":"2023-09-21","st":"2023-08","ag":"18 and over"},{"n":"NCT06043973","t":"Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance","s":"rec","p":"phase3","d":[4],"c":[27],"lc":[27],"a":"adult older","h":[220],"l":[[220,"lung"]],"po":"2023-09-21","u":"2023-09-21","st":"2023-09","ag":"18–75"},{"n":"NCT06045091","t":"To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL","s":"rec","p":"earlyphase1","d":[15],"c":[5],"a":"adult older","h":[212],"po":"2023-09-21","u":"2023-09-21","st":"2023-07","ag":"18 and over"},{"n":"NCT06047197","t":"Phase I Clinical Trial of RC19D2 Cell Injection in the Treatment of Diffuse Large B-cell Lymphoma","s":"rec","p":"phase1","d":[19],"c":[30],"a":"adult older","h":[69],"po":"2023-09-21","u":"2024-08-27","st":"2023-09","ag":"18 and over"},{"n":"NCT06049290","t":"A Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma","s":"rec","p":"phase1phase2","d":[15],"c":[2,15,0,41,6,23,61,26,5,11,21,4,12,37,13,54,39,7,20],"a":"adult older","h":[46,12,5,48,37,27,97,53,25,137,8,143,81,182,286,7,104,151,271,22],"po":"2023-09-22","u":"2026-11-12","st":"2023-10","ag":"18 and over"},{"n":"NCT06050317","t":"Sintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[27],"lc":[27],"a":"adult older","h":[57],"l":[[57,"panc"]],"po":"2023-09-22","u":"2026-10-15","st":"2023-08","ag":"18–75"},{"n":"NCT06051617","t":"Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis","s":"rec","p":"phase3","d":[50],"c":[2,15,22,1,16,0,41,23,17,5,34,13,39,20],"a":"adult older","h":[131,41,39,40,27,153,181,46,12,112,209,111,92,207,166,190,117],"po":"2023-09-25","u":"2026-11-02","st":"2023-09","ag":"18 and over"},{"n":"NCT06052098","t":"Transbronchial vs Transthoracic Ablation for Early-stage Peripheral Lung Cancer","s":"rec","p":"na","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2023-09-25","u":"2023-12-06","st":"2023-10","ag":"18 and over"},{"n":"NCT06054906","t":"Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[103],"l":[[103,"gc"]],"po":"2023-09-26","u":"2026-11-10","st":"2023-10","ag":"18 and over"},{"n":"NCT06056115","t":"Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic","s":"rec","p":"na","d":[4],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"lung"]],"po":"2023-09-28","u":"2023-09-28","st":"2023-05","ag":"18–75"},{"n":"NCT06056336","t":"Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"escc"]],"po":"2023-09-28","u":"2023-09-28","st":"2023-09","ag":"18–75"},{"n":"NCT06057402","t":"Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)","s":"rec","p":"phase4","d":[15],"c":[2,0,23,27],"a":"adult older","h":[46,53,115,113],"po":"2023-09-28","u":"2026-07-01","st":"2023-10","ag":"18 and over"},{"n":"NCT06060769","t":"Study on the Quantitative Assessment of the Risk of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Using Multi-parameter Magnetic Resonance Imaging","s":"rec","p":"na","d":[2],"c":[59],"lc":[59],"a":"adult older","h":[171],"l":[[171,"hcc"]],"po":"2023-09-29","u":"2023-09-29","st":"2023-09","ag":"18 and over"},{"n":"NCT06064812","t":"A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.","s":"rec","p":"phase1phase2","d":[6],"c":[15,22,0,23,17,27,36,28,10,5,11,30,13,20],"a":"adult older","x":"female","h":[9,78,58,53,118,44,25,57,27,37,18,50,47,82,19,31,87,138],"po":"2023-10-03","u":"2026-02-10","st":"2023-09","ag":"18 and over"},{"n":"NCT06066203","t":"A Study of GNC-035 in Relapsed or Refractory Non-Hodgkin 's Lymphoma and Other Hematological Malignancies","s":"rec","p":"phase1phase2","d":[19],"c":[2],"a":"adult older","h":[74],"po":"2023-10-04","u":"2026-08-27","st":"2023-11","ag":"18–75"},{"n":"NCT06069830","t":"PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma","s":"rec","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2023-10-06","u":"2026-01-27","st":"2023-12","ag":"18 and over"},{"n":"NCT06079983","t":"JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects","s":"rec","p":"phase3","d":[6],"c":[48,2,15,8,22,1,52,16,0,41,23,24,17,80,27,47,33,25,36,70,9,28,26,5,43,11,18,4,12,30,34,13,39,7,38,62,14,31,45,20,64],"a":"adult older","h":[9,23,40,58,53,45,99,111,118,74,79,44,54,25,43,12,125,11,133,55,57,27,37,18,97,140,112,46,135,47,13,8,68,291,127,72,155,142,30,31,192,129,98,137,148,187,116,64,117,273,175,226,87,84,86,21,150,67,101,288],"po":"2023-10-12","u":"2025-09-12","st":"2023-12","ag":"18 and over"},{"n":"NCT06080776","t":"SH-1028 Tablets Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB NSCLC With Sensitizing EGFR Mutations","s":"rec","p":"phase3","d":[4],"c":[5],"a":"adult older","h":[56],"po":"2023-10-12","u":"2023-10-12","st":"2023-05","ag":"18–75"},{"n":"NCT06081647","t":"The Efficacy and Safety of the COMBO Endoscopy Oropharyngeal Airway in Gastrointestinal Endoscopy Procedure","s":"rec","p":"na","d":[3],"c":[23,27,9,28,5],"lc":[5],"a":"adult","h":[41,78,14,9,46,220,90,162],"l":[[41,"gc"]],"po":"2023-10-13","u":"2025-06-25","st":"2023-12","ag":"18–60"},{"n":"NCT06081959","t":"Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[2],"a":"adult older","h":[23],"po":"2023-10-13","u":"2026-05-08","st":"2023-10","ag":"18–75"},{"n":"NCT06082102","t":"Efficacy and Safety of Orelabrutinib Combined With Rituximab Versus Lenalidomide Combined With Rituximab in Patients With Relapsed/Refractory Marginal Zone Lymphoma","s":"rec","p":"phase3","d":[19],"c":[2,55,8,22,52,0,23,9,26,5,11,13,39,19,20],"a":"adult older","h":[40,53,46,12,161,9,37,118,55,102,155,92,28,14,13,116,97,164],"po":"2023-10-13","u":"2025-09-15","st":"2023-12","ag":"18 and over"},{"n":"NCT06084936","t":"A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma","s":"rec","p":"phase3","d":[19],"c":[2,15,22,1,16,0,10,5,11,37,20],"a":"adult older","h":[40,53,25,161,9,37,118,27,2,30,81,50],"po":"2023-10-16","u":"2026-11-05","st":"2023-10","ag":"18 and over"},{"n":"NCT06090539","t":"A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas","s":"rec","p":"phase1phase2","d":[19],"c":[2,0,9],"a":"adult older","h":[53,74,14],"po":"2023-10-19","u":"2026-10-23","st":"2023-12","ag":"18 and over"},{"n":"NCT06092957","t":"Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy","s":"rec","p":"phase3","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2023-10-23","u":"2023-12-15","st":"2023-10","ag":"18–70"},{"n":"NCT06095583","t":"Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)","s":"rec","p":"phase3","d":[4],"c":[48,2,15,8,22,1,0,23,24,17,27,9,26,5,11,21,12,29,30,13,7,58,20],"a":"adult older","h":[23,53,57,58,9,11,74,45,118,55,13,54,47,80,133,14,37,2,68,18,19,138,66,172,126,8,84,150],"po":"2023-10-23","u":"2026-07-27","st":"2023-11","ag":"18 and over"},{"n":"NCT06102837","t":"Tumor Vaccines for Solid Tumors","s":"rec","p":"na","d":[7],"c":[5],"lc":[5],"a":"child adult older","h":[103],"l":[[103,"glioma"]],"po":"2023-10-26","u":"2023-10-26","st":"2023-10","ag":"Not stated"},{"n":"NCT06104085","t":"99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[38],"l":[[38,"breast"]],"po":"2023-10-27","u":"2023-10-27","st":"2023-09","ag":"18–80"},{"n":"NCT06107673","t":"Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）","s":"rec","p":"phase2","d":[6],"c":[18],"lc":[18],"a":"adult older","x":"female","h":[24],"l":[[24,"breast"]],"po":"2023-10-30","u":"2025-12-11","st":"2023-09","ag":"18–75"},{"n":"NCT06107686","t":"A Study of YL202 in Selected Patients With Advanced Solid Tumors","s":"rec","p":"phase2","d":[6],"c":[2,15,8,22,1,0,57,23,24,17,27,70,9,10,26,5,43,11,4,12,29,34,42,13,39,38,31,20],"a":"adult older","h":[40,53,45,111,118,36,74,79,44,54,25,12,125,11,55,57,37,18,112,121,50,47,147,49,193,19,166,72,31,332,187,114,115,170,116,64,103,0,83,75,226,84,86,101,366],"po":"2023-10-30","u":"2025-11-26","st":"2023-12","ag":"18–75"},{"n":"NCT06109558","t":"The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC","s":"rec","p":"phase1phase2","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2023-10-31","u":"2024-05-30","st":"2023-12","ag":"18 and over"},{"n":"NCT06111274","t":"A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[22,24,5,13],"a":"adult older","h":[40,41,12,45,65],"po":"2023-11-01","u":"2024-04-11","st":"2023-10","ag":"18–75"},{"n":"NCT06114225","t":"Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial","s":"rec","p":"phase2","d":[11],"c":[5],"lc":[5],"a":"child adult older","h":[123],"l":[[123,"os"]],"po":"2023-11-02","u":"2023-11-02","st":"2023-06","ag":"10–65"},{"n":"NCT06119581","t":"A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[2,8,49,22,16,0,6,23,24,27,25,9,5,29,30,34,13,39,38,68,45],"a":"adult older","h":[40,23,42,57,58,44,132,12,111,74,45,36,46,13,47,14,82,30,16,7,83,145,66,129,72,214,86,51],"po":"2023-11-07","u":"2026-11-04","st":"2023-12","ag":"18 and over"},{"n":"NCT06120166","t":"Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research","s":"rec","p":"earlyphase1","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"lymph"]],"po":"2023-11-07","u":"2025-09-19","st":"2023-11","ag":"18 and over"},{"n":"NCT06120283","t":"BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors","s":"rec","p":"phase1","d":[6],"c":[2,16,0,24,9,5,11],"a":"adult older","h":[9,45,99,74,18,14,30],"po":"2023-11-07","u":"2026-10-15","st":"2023-12","ag":"18 and over"},{"n":"NCT06121557","t":"Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer","s":"rec","p":"phase1","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2023-11-08","u":"2023-11-08","st":"2023-11","ag":"18–70"},{"n":"NCT06121570","t":"Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer","s":"rec","p":"phase1","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2023-11-08","u":"2023-11-08","st":"2023-11","ag":"18–70"},{"n":"NCT06121700","t":"Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer","s":"rec","p":"phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"gc"]],"po":"2023-11-08","u":"2023-11-08","st":"2023-01","ag":"18–75"},{"n":"NCT06123754","t":"Phase III Study of Envafolimab Versus Placebo Plus Chemotherapy in Resectable Stage III NSCLC","s":"rec","p":"phase3","d":[4],"c":[30],"a":"adult older","h":[58],"po":"2023-11-09","u":"2026-03-25","st":"2023-11","ag":"18 and over"},{"n":"NCT06125041","t":"Adebelizumab Combined With Chemotherapy and Radiotherapy Treat ES-SCLC","s":"rec","p":"phase2","d":[4],"c":[27],"lc":[27],"a":"adult older","h":[220],"l":[[220,"lung"]],"po":"2023-11-09","u":"2023-11-09","st":"2023-10","ag":"18–75"},{"n":"NCT06125327","t":"SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)","s":"rec","p":"phase2phase3","d":[37],"c":[2],"a":"adult older","h":[38],"po":"2023-11-09","u":"2024-11-19","st":"2023-06","ag":"40–80"},{"n":"NCT06126406","t":"Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors","s":"rec","p":"phase1","d":[3,5],"c":[54],"a":"adult older","h":[271],"po":"2023-11-13","u":"2023-11-13","st":"2023-11","ag":"18 and over"},{"n":"NCT06131840","t":"A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors","s":"rec","p":"phase1","d":[3,4,5],"c":[0,5],"a":"adult older","h":[9,75],"po":"2023-11-14","u":"2026-07-22","st":"2023-11","ag":"18 and over"},{"n":"NCT06134284","t":"Clinical Study of OR for Second-line Treatment of Refractory MZL","s":"rec","p":"phase4","d":[19],"c":[23,61],"a":"adult older","h":[54,182],"po":"2023-11-18","u":"2024-06-11","st":"2023-01","ag":"18–80"},{"n":"NCT06135922","t":"Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection","s":"rec","p":"phase1","d":[18],"c":[2],"lc":[2],"a":"child adult","h":[26],"l":[[26,"hlh"]],"po":"2023-11-18","u":"2023-11-18","st":"2023-08","ag":"1–60"},{"n":"NCT06136351","t":"A Study of the Zanubrutinib Given in Combination With Bendamustine and Rituximab in (Elderly or TP53 Alterations or Chemotherapy Intolerance) Patients With Newly Diagnosed Mantle Cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2023-11-18","u":"2023-11-29","st":"2023-11","ag":"18 and over"},{"n":"NCT06136364","t":"CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study","s":"rec","p":"phase1","d":[19],"c":[5],"a":"adult older","h":[123],"po":"2023-11-18","u":"2023-11-18","st":"2023-08","ag":"18–75"},{"n":"NCT06136559","t":"A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)","s":"rec","p":"phase3","d":[19],"c":[2,15,8,22,1,0,41,6,23,17,27,9,28,10,12,30,34,13,31,20],"a":"adult older","h":[40,53,78,46,36,58,12,29,64,69,115,37,27,2,70,10,44,57,14,13,116,137,50,72,7,84,88],"po":"2023-11-18","u":"2026-11-17","st":"2023-12","ag":"18 and over"},{"n":"NCT06138340","t":"The Effects of Anesthetics on Brain Network Connectivity in Patients With Supratentorial Glioma","s":"rec","p":"na","d":[7],"c":[2],"lc":[2],"a":"adult older","h":[102],"l":[[102,"glioma"]],"po":"2023-11-18","u":"2025-02-14","st":"2023-08","ag":"18 and over"},{"n":"NCT06139042","t":"Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers","s":"rec","p":"na","d":[5],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"panc"]],"po":"2023-11-18","u":"2025-02-10","st":"2023-11","ag":"40–75"},{"n":"NCT06140966","t":"Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma","s":"rec","p":"phase2","d":[15],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"mm"]],"po":"2023-11-21","u":"2025-04-16","st":"2023-10","ag":"18–70"},{"n":"NCT06141226","t":"Phase II Clinical Trial to Evaluate the Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Capsule and Chemotherapy in the Treatment of Immunoresistant Advanced Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2023-11-21","u":"2024-09-19","st":"2023-04","ag":"18–75"},{"n":"NCT06142058","t":"RecistTM Criteria in Evaluating the Efficacy of Targeted Therapy for NSCLC","s":"rec","p":"na","d":[4],"c":[1],"lc":[1],"a":"adult older","h":[367],"l":[[367,"lung"]],"po":"2023-11-21","u":"2023-11-21","st":"2023-11","ag":"18 and over"},{"n":"NCT06145893","t":"A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease","s":"rec","p":"phase3","d":[44],"c":[2,0,57,23,25,9,5,21,18,4,12,37,7,31],"a":"adult older","h":[48,46,29,99,81,39,184,170,8,32,209,5,14,64,368,71,186,162,115,152],"po":"2023-11-24","u":"2025-04-08","st":"2023-11","ag":"18–75"},{"n":"NCT06147570","t":"A Study of HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2023-11-27","u":"2023-11-27","st":"2023-09","ag":"18 and over"},{"n":"NCT06151080","t":"Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL","s":"rec","p":"phase2","d":[19],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"lymph"]],"po":"2023-11-30","u":"2025-02-19","st":"2023-11","ag":"18–70"},{"n":"NCT06151106","t":"Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"lymph"]],"po":"2023-11-30","u":"2025-02-19","st":"2023-11","ag":"18–75"},{"n":"NCT06155305","t":"Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer","s":"rec","p":"na","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2023-12-04","u":"2025-01-07","st":"2023-12","ag":"18–70"},{"n":"NCT06155383","t":"Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.","s":"rec","p":"phase2","d":[3],"c":[2,22,16,0,24,27,47,7,20],"a":"adult older","h":[74,70,37,45,30,57,8,43,47,135],"po":"2023-12-04","u":"2023-12-14","st":"2023-11","ag":"18 and over"},{"n":"NCT06156150","t":"The Role of B7-H4 in Tumor Vaccine","s":"rec","p":"na","d":[7],"c":[5],"lc":[5],"a":"adult older","h":[103],"l":[[103,"glioma"]],"po":"2023-12-05","u":"2023-12-05","st":"2023-11","ag":"18–80"},{"n":"NCT06157060","t":"Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Longitudinal Monitoring MRD Based on ctDNA","s":"rec","p":"na","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[0,53,95,107],"l":[[0,"hcc"]],"po":"2023-12-05","u":"2026-03-20","st":"2023-11","ag":"18–75"},{"n":"NCT06158269","t":"DVRd in the Treatment of Patients With Newly Diagnosed Double-hit Multiple Myeloma","s":"rec","p":"phase2","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2023-12-06","u":"2023-12-06","st":"2023-12","ag":"18–70"},{"n":"NCT06158386","t":"Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma","s":"rec","p":"phase2","d":[19],"c":[7],"lc":[7],"a":"adult older","x":"female","h":[8],"l":[[8,"lymph"]],"po":"2023-12-06","u":"2025-02-19","st":"2023-11","ag":"18 and over"},{"n":"NCT06158399","t":"AZA Combined With RCHOP in P53-mutated DLBCL.","s":"rec","p":"phase2","d":[19],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"lymph"]],"po":"2023-12-06","u":"2025-02-19","st":"2023-11","ag":"18–70"},{"n":"NCT06158412","t":"All-trans Retinoic Acid in Combination With a KPD Regimen for the Treatment of Refractory/Relapsed Multiple Myeloma","s":"rec","p":"phase2","d":[15],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"mm"]],"po":"2023-12-06","u":"2025-02-19","st":"2023-11","ag":"18 and over"},{"n":"NCT06158919","t":"A Study of PD-1 Inhibitors Combined With Fruquintinib and Chemotherapy in First-line Treatment of HER2-negative Advanced G/GEJ Cancer","s":"rec","p":"na","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"gc"]],"po":"2023-12-06","u":"2023-12-06","st":"2023-11","ag":"18–80"},{"n":"NCT06161207","t":"3D-4K-ICG Laparoscopic Gastrectomy for Gastric Cancer","s":"rec","p":"phase3","d":[3],"c":[16],"lc":[16],"a":"adult older","h":[140],"l":[[140,"gc"]],"po":"2023-12-07","u":"2024-06-24","st":"2023-01","ag":"18–75"},{"n":"NCT06161610","t":"Recurrent High Grade Glioma Treated by LITT","s":"rec","p":"na","d":[7],"c":[2,15,0,27,5,13,20],"lc":[2],"a":"adult older","h":[102,103,124,25,36,27,49,100],"l":[[102,"glioma"]],"po":"2023-12-08","u":"2024-11-29","st":"2023-09","ag":"18 and over"},{"n":"NCT06162338","t":"A Study of the Safety and Preliminary Efficacy of LY-M001 Injection in the Treatment of Adult Patients With Gaucher Disease Type I","s":"rec","p":"na","d":[47],"c":[23],"lc":[23],"a":"adult","h":[46],"l":[[46,"gauch"]],"po":"2023-12-08","u":"2025-02-14","st":"2023-11","ag":"18–60"},{"n":"NCT06164769","t":"Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery","s":"rec","p":"na","d":[5],"c":[23],"lc":[23],"a":"child adult older","h":[54],"l":[[54,"panc"]],"po":"2023-12-11","u":"2025-06-02","st":"2023-03","ag":"14–70"},{"n":"NCT06165900","t":"Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC","s":"rec","p":"phase2","d":[6],"c":[11],"lc":[11],"a":"adult older","x":"female","h":[143],"l":[[143,"breast"]],"po":"2023-12-12","u":"2024-01-03","st":"2023-09","ag":"18–75"},{"n":"NCT06166147","t":"A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection","s":"rec","p":"na","d":[5],"c":[5],"a":"adult older","h":[9,121,139],"po":"2023-12-12","u":"2024-09-19","st":"2023-12","ag":"40–75"},{"n":"NCT06167694","t":"Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast Cancer","s":"rec","p":"phase1phase2","d":[6],"c":[2,0],"a":"adult older","x":"female","h":[53,26],"po":"2023-12-12","u":"2026-01-09","st":"2023-12","ag":"18–75"},{"n":"NCT06168032","t":"COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"lung"]],"po":"2023-12-13","u":"2023-12-13","st":"2023-12","ag":"18 and over"},{"n":"NCT06170489","t":"A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL)","s":"rec","p":"phase3","d":[19],"c":[2],"a":"adult older","h":[74],"po":"2023-12-14","u":"2025-02-28","st":"2023-12","ag":"18 and over"},{"n":"NCT06170788","t":"Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)","s":"rec","p":"phase3","d":[4],"c":[2,8,22,16,0,23,24,17,27,9,5,18,29,13,60,7,38,31,45,20],"a":"adult older","h":[40,57,38,132,12,74,45,36,10,46,47,80,14,37,70,82,30,83,64,19,186,180,66,129,8,31,116,177,86],"po":"2023-12-14","u":"2026-11-03","st":"2023-12","ag":"18 and over"},{"n":"NCT06172205","t":"Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC","s":"rec","p":"phase3","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"hcc"]],"po":"2023-12-15","u":"2025-12-03","st":"2023-07","ag":"18–75"},{"n":"NCT06173986","t":"Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer","s":"rec","p":"phase1phase2","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"escc"]],"po":"2023-12-18","u":"2023-12-18","st":"2023-01","ag":"18–75"},{"n":"NCT06176729","t":"Pola-R2 in Newly Diagnosed Non-fit Elderly DLBCL Patients","s":"rec","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"older","h":[38],"l":[[38,"lymph"]],"po":"2023-12-20","u":"2023-12-20","st":"2023-10","ag":"70 and over"},{"n":"NCT06177041","t":"M108 Plus CAPOX Versus Placebo Plus CAPOX as First-line Treatment for Claudin (CLDN) 18.2-Positive, HER2-Negative, PD-L1 CPS<5, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma.","s":"rec","p":"phase3","d":[3],"c":[2],"a":"adult older","h":[74],"po":"2023-12-20","u":"2024-02-28","st":"2023-12","ag":"18–75"},{"n":"NCT06177301","t":"Tislelizumab Plus GX Versus Tislelizumab Plus GP in the Treatment of R/M NPC","s":"rec","p":"phase3","d":[0],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"npc"]],"po":"2023-12-20","u":"2025-08-14","st":"2023-12","ag":"18–75"},{"n":"NCT06178159","t":"DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"a":"adult older","h":[9],"po":"2023-12-20","u":"2025-10-01","st":"2023-11","ag":"18 and over"},{"n":"NCT06180174","t":"Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma","s":"rec","p":"phase1","d":[19],"c":[2],"a":"adult older","h":[74],"po":"2023-12-22","u":"2023-12-28","st":"2023-12","ag":"18 and over"},{"n":"NCT06182696","t":"OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM","s":"rec","p":"phase1phase2","d":[15],"c":[2,23,28,5,13],"a":"adult older","h":[46,12,78,162,3],"po":"2023-12-27","u":"2024-05-31","st":"2023-10","ag":"18–75"},{"n":"NCT06187961","t":"HAIC, Lenvatinib, and Cadonilimab as Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2024-01-03","u":"2026-08-26","st":"2023-12","ag":"18 and over"},{"n":"NCT06190067","t":"Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma","s":"rec","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2024-01-05","u":"2024-01-30","st":"2023-10","ag":"18 and over"},{"n":"NCT06190301","t":"RCT on Intralesional Rituximab Injection Versus ISRT in Ocular Adnexal MALT Lymphoma","s":"rec","p":"na","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[369],"l":[[369,"lymph"]],"po":"2024-01-05","u":"2026-04-20","st":"2023-12","ag":"18–75"},{"n":"NCT06190639","t":"A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC","s":"rec","p":"phase2","d":[1],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"escc"]],"po":"2024-01-05","u":"2024-01-05","st":"2023-10","ag":"18 and over"},{"n":"NCT06190665","t":"DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCC","s":"rec","p":"na","d":[2],"c":[2,28],"lc":[28],"a":"adult older","h":[120,29],"l":[[120,"hcc"]],"po":"2024-01-05","u":"2024-01-12","st":"2023-12","ag":"18–80"},{"n":"NCT06192849","t":"To Assess the Efficacy and Safety of Furmonertinib in Patients With Epidermal Growth Factor Receptor 20ins Mutation Positive Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy","s":"rec","p":"phase2","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[47],"l":[[47,"lung"]],"po":"2024-01-05","u":"2024-01-05","st":"2023-12","ag":"18 and over"},{"n":"NCT06196255","t":"Safety and Efficacy of Anti-FcRL5 CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma (R/R MM)","s":"rec","p":"phase1phase2","d":[15],"c":[31],"lc":[31],"a":"adult older","h":[64],"l":[[64,"mm"]],"po":"2024-01-09","u":"2024-01-09","st":"2023-12","ag":"18–70"},{"n":"NCT06199895","t":"Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer","s":"rec","p":"phase2","d":[3,4,5,6],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"gc"]],"po":"2024-01-10","u":"2025-06-03","st":"2023-11","ag":"18 and over"},{"n":"NCT06201065","t":"FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind Trial","s":"rec","p":"phase3","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"hcc"]],"po":"2024-01-11","u":"2024-01-11","st":"2023-12","ag":"18–75"},{"n":"NCT06203327","t":"Atrophic Gastritis Predicts the Risk of Gastric Cancer","s":"rec","p":"na","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"gc"]],"po":"2024-01-12","u":"2024-12-30","st":"2023-12","ag":"18–70"},{"n":"NCT06203652","t":"The Pathogenesis and Prognostic Factors of Lymphoma","s":"rec","p":"na","d":[19],"c":[5],"lc":[5],"a":"child adult older","h":[6],"l":[[6,"lymph"]],"po":"2024-01-12","u":"2024-01-12","st":"2023-06","ag":"Not stated"},{"n":"NCT06205927","t":"Randomized Study of Carbon Ion Boost in Hypoxic Lesions for Locally Advanced Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[316],"l":[[316,"lung"]],"po":"2024-01-16","u":"2025-06-17","st":"2023-12","ag":"18–80"},{"n":"NCT06216782","t":"Exploring the Frontiers of Neoadjuvant Therapy for Lung Cancer: a Prospective Observational Real-world Study","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2024-01-22","u":"2024-01-22","st":"2023-12","ag":"18 and over"},{"n":"NCT06219096","t":"Application of ICG@HSA Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection","s":"rec","p":"na","d":[2],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"hcc"]],"po":"2024-01-23","u":"2024-01-23","st":"2023-12","ag":"18–75"},{"n":"NCT06220552","t":"The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma","s":"rec","p":"phase2","d":[7],"c":[59],"lc":[59],"a":"adult older","h":[171],"l":[[171,"glioma"]],"po":"2024-01-24","u":"2024-01-24","st":"2023-12","ag":"18 and over"},{"n":"NCT06227117","t":"Neoadjuvant Study of DV in Combination Toripalimab or Sequence Chemotherapy in HR-negative, HER2 Low-expressing Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[8,23,5,30],"a":"adult older","h":[9,58,44,11,13],"po":"2024-01-26","u":"2024-03-19","st":"2023-07","ag":"18 and over"},{"n":"NCT06230445","t":"Effects of Digital Therapeutic in Whole Process Management of Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2024-01-30","u":"2024-02-26","st":"2023-06","ag":"18–70"},{"n":"NCT06246162","t":"Mitoxantrone Hydrochloride Liposome Combination Regimen in the Treatment of High-risk/Extramedullary Multiple Myeloma","s":"rec","p":"phase1phase2","d":[15],"c":[40],"lc":[40],"a":"adult older","h":[110],"l":[[110,"mm"]],"po":"2024-02-07","u":"2024-02-07","st":"2023-11","ag":"18–70"},{"n":"NCT06252792","t":"Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma","s":"rec","p":"na","d":[15],"c":[15],"lc":[15],"a":"adult older","h":[27],"l":[[27,"mm"]],"po":"2024-02-12","u":"2026-04-03","st":"2023-06","ag":"18 and over"},{"n":"NCT06254560","t":"Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness","s":"rec","p":"phase2","d":[17],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"aa"]],"po":"2024-02-12","u":"2024-02-12","st":"2023-02","ag":"18–70"},{"n":"NCT06272149","t":"An Exploratory Clinical Trial of VGN-R08b in Patients With Type II Gaucher Disease","s":"rec","p":"earlyphase1","d":[47],"c":[5],"lc":[5],"a":"child","h":[90],"l":[[90,"gauch"]],"po":"2024-02-22","u":"2024-02-22","st":"2023-03","ag":"0 months–24 months"},{"n":"NCT06276283","t":"DZD9008 In Combination With Bevacizumab in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutation (WU-KONG29)","s":"rec","p":"phase2","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2024-02-23","u":"2025-06-19","st":"2023-02","ag":"18 and over"},{"n":"NCT06277024","t":"A Study on the Safety and Efficacy of the Combination of Candenizumab, Lenvatinib, and SOX Regimen in the Treatment of HER2 Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Patients","s":"rec","p":"na","d":[3],"c":[16],"lc":[16],"a":"adult older","h":[140],"l":[[140,"gc"]],"po":"2024-02-26","u":"2024-02-26","st":"2023-01","ag":"18–75"},{"n":"NCT06278870","t":"Disitamab Vedotin + Pyrotinib Versus THP in the First-line Treatment for HER2+ Advanced Breast Cancer Clinical Trial","s":"rec","p":"phase3","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2024-02-26","u":"2024-02-26","st":"2023-09","ag":"18–75"},{"n":"NCT06282497","t":"Xerostomia-optimised IMRT Versus Standard IMRT in NPC","s":"rec","p":"na","d":[0],"c":[46],"lc":[46],"a":"adult older","h":[134],"l":[[134,"npc"]],"po":"2024-02-28","u":"2024-05-01","st":"2023-10","ag":"18–70"},{"n":"NCT06286150","t":"Efficacy and Safety of Single-port Surgical Robot System in Thoraic Surgery","s":"rec","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[132],"l":[[132,"lung"]],"po":"2024-02-29","u":"2024-02-29","st":"2023-09","ag":"18–75"},{"n":"NCT06286267","t":"AI-Assisted System for Accurate Diagnosis and Prognosis of Breast Phyllodes Tumors","s":"rec","p":"na","d":[6],"c":[0],"lc":[0],"a":"child adult older","x":"female","h":[99,53],"l":[[99,"breast"]],"po":"2024-02-29","u":"2024-02-29","st":"2023-03","ag":"Not stated"},{"n":"NCT06307080","t":"Clinical Study of Multimodal Ablation Remodeling Immunosensitized PD-1 in the Treatment of Pancreatic Cancer With Liver Metastasis","s":"rec","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[121],"l":[[121,"panc"]],"po":"2024-03-12","u":"2025-07-09","st":"2023-10","ag":"18–70"},{"n":"NCT06327594","t":"Assessment System of Sarcopenia in Lung Cancer Patients","s":"rec","p":"na","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"lung"]],"po":"2024-03-25","u":"2024-03-25","st":"2023-11","ag":"40–100"},{"n":"NCT06339775","t":"Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation","s":"rec","p":"phase4","d":[16],"c":[20],"lc":[20],"a":"child adult older","h":[25],"l":[[25,"ball"]],"po":"2024-04-01","u":"2024-04-01","st":"2023-09","ag":"Up to 65"},{"n":"NCT06341894","t":"Efficacy and Safety of Dalpiciclib With Endocrine Therapy as Adjuvant Treatment in HR+/ HER2- Early Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[28],"lc":[28],"a":"adult older","x":"female","h":[78],"l":[[78,"breast"]],"po":"2024-04-02","u":"2024-04-02","st":"2023-11","ag":"18–75"},{"n":"NCT06343064","t":"Vebreltinib Plus PLB1004 in EGFR-mutated, Advanced NSCLC With MET Amplification or MET Overexpression Following EGFR-TKI","s":"rec","p":"phase1phase2","d":[4],"c":[5],"a":"adult older","h":[56],"po":"2024-04-02","u":"2025-05-21","st":"2023-06","ag":"18 and over"},{"n":"NCT06354218","t":"Serplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age","s":"rec","p":"phase2","d":[1],"c":[28],"lc":[28],"a":"older","h":[78],"l":[[78,"escc"]],"po":"2024-04-09","u":"2024-04-09","st":"2023-12","ag":"75 and over"},{"n":"NCT06358222","t":"Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2024-04-10","u":"2025-05-18","st":"2023-12","ag":"18–75"},{"n":"NCT06371482","t":"Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01)","s":"rec","p":"phase2","d":[4],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"lung"]],"po":"2024-04-17","u":"2024-06-17","st":"2023-06","ag":"18–75"},{"n":"NCT06383520","t":"Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular Carcinoma","s":"rec","p":"earlyphase1","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"hcc"]],"po":"2024-04-25","u":"2025-05-14","st":"2023-09","ag":"18–65"},{"n":"NCT06399926","t":"Efficacy and Safety of Intraventricule Pemetrexed Disodium Administered Via Ommaya Reservoir","s":"rec","p":"na","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[11],"l":[[11,"lung"]],"po":"2024-05-06","u":"2024-05-06","st":"2023-10","ag":"18 and over"},{"n":"NCT06410651","t":"Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"escc"]],"po":"2024-05-13","u":"2024-05-13","st":"2023-03","ag":"18–80"},{"n":"NCT06413212","t":"Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing","s":"rec","p":"na","d":[3,4,6],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"gc"]],"po":"2024-05-14","u":"2025-06-04","st":"2023-08","ag":"18 and over"},{"n":"NCT06429839","t":"Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients","s":"rec","p":"phase2","d":[1],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"escc"]],"po":"2024-05-28","u":"2024-05-28","st":"2023-03","ag":"18–80"},{"n":"NCT06431100","t":"a Single-arm, Single-center, Open Clinical Study","s":"rec","p":"na","d":[3,4,6],"c":[20],"a":"adult older","h":[25],"po":"2024-05-28","u":"2024-05-28","st":"2023-07","ag":"18–75"},{"n":"NCT06451211","t":"Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"gc"]],"po":"2024-06-11","u":"2024-06-11","st":"2023-05","ag":"18–75"},{"n":"NCT06463717","t":"Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not","s":"rec","p":"na","d":[15],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"mm"]],"po":"2024-06-18","u":"2024-06-24","st":"2023-12","ag":"18–70"},{"n":"NCT06503276","t":"The Treatment of Ocular Adnexal Extranodal Marginal Zone B-cell Lymphoma by Orelabrutinib and Radiotherapy","s":"rec","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[332],"l":[[332,"lymph"]],"po":"2024-07-16","u":"2024-07-22","st":"2023-11","ag":"18–75"},{"n":"NCT06508307","t":"A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors","s":"rec","p":"phase1","d":[2,3,4,5,6],"c":[20],"a":"adult older","h":[37],"po":"2024-07-18","u":"2025-08-21","st":"2023-04","ag":"18–75"},{"n":"NCT06512207","t":"A Study on the Efficacy of Androgen Deprivation Therapy Combined With Anti-PD-1 Therapy in Advanced Lung Cancer","s":"rec","p":"na","d":[4],"c":[20],"a":"adult older","x":"male","h":[25],"po":"2024-07-22","u":"2025-09-09","st":"2023-12","ag":"60 and over"},{"n":"NCT06534489","t":"Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lung"]],"po":"2024-08-02","u":"2024-08-02","st":"2023-08","ag":"18–75"},{"n":"NCT06559761","t":"Image Driven Hepatocellular Carcinoma Invasiveness Evaluation Research","s":"rec","p":"na","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"hcc"]],"po":"2024-08-19","u":"2024-08-19","st":"2023-01","ag":"18–80"},{"n":"NCT06560827","t":"CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection","s":"rec","p":"phase1","d":[2],"c":[2,8,22,16,0,23,5,11,30,13,20],"a":"adult older","h":[6,40,53,36,25,23,58,190,82,54,118,363,47,18],"po":"2024-08-19","u":"2024-08-19","st":"2023-10","ag":"18–75"},{"n":"NCT06588231","t":"Effect of Individualized Exercise in Elderly Patients With Coronary Heart Disease","s":"rec","p":"na","d":[31],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"cad"]],"po":"2024-09-19","u":"2024-12-31","st":"2023-10","ag":"60–75"},{"n":"NCT06605521","t":"To Evaluate the Efficacy and Safety of Ipsilateral Supraclavicular Lymph Node Dissection for Breast Cancer Patients","s":"rec","p":"na","d":[6],"c":[20],"lc":[20],"a":"adult older","x":"female","h":[37],"l":[[37,"breast"]],"po":"2024-09-20","u":"2024-09-20","st":"2023-04","ag":"18–80"},{"n":"NCT06678282","t":"JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia","s":"rec","p":"na","d":[16,19],"c":[20],"a":"adult older","h":[25],"po":"2024-11-07","u":"2024-11-07","st":"2023-09","ag":"18–75"},{"n":"NCT06688760","t":"Surgery Alone Verus Sugery Combined with Dose-reduced Radiotherapy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma","s":"rec","p":"na","d":[0],"c":[0,59],"a":"adult older","h":[171,320],"po":"2024-11-14","u":"2024-11-14","st":"2023-11","ag":"18–70"},{"n":"NCT06693973","t":"An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma","s":"rec","p":"earlyphase1","d":[19],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lymph"]],"po":"2024-11-19","u":"2024-11-19","st":"2023-12","ag":"18 and over"},{"n":"NCT06697535","t":"A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)","s":"rec","p":"phase2","d":[25],"c":[8],"a":"adult older","h":[11],"po":"2024-11-20","u":"2024-11-20","st":"2023-05","ag":"18–65"},{"n":"NCT06702683","t":"The Correlation Between Blood Concentration of Sintilimab and Efficacy and Adverse Reactions in Patients with Advanced Gastric Cancer","s":"rec","p":"na","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[120],"l":[[120,"gc"]],"po":"2024-11-25","u":"2024-11-25","st":"2023-02","ag":"18 and over"},{"n":"NCT06718205","t":"Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[20],"lc":[20],"a":"adult older","h":[25],"l":[[25,"escc"]],"po":"2024-12-05","u":"2024-12-05","st":"2023-03","ag":"18–75"},{"n":"NCT06730503","t":"Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2024-12-12","u":"2024-12-12","st":"2023-10","ag":"18 and over"},{"n":"NCT06735105","t":"Study on the Value of Three DWI Scanning Sequences in Staging of Gastric Cancer","s":"rec","p":"na","d":[3],"c":[47],"lc":[47],"a":"adult older","h":[135],"l":[[135,"gc"]],"po":"2024-12-16","u":"2024-12-16","st":"2023-12","ag":"18–80"},{"n":"NCT06746701","t":"Study on the Treatment of Hepatitis B Virus(HBV) Infected Individuals With Peginterferon α-2b Combined With NA.","s":"rec","p":"na","d":[2],"c":[8,0,80],"lc":[8],"a":"adult older","h":[11,209,291],"l":[[11,"hcc"]],"po":"2024-12-24","u":"2024-12-24","st":"2023-05","ag":"18–65"},{"n":"NCT06756321","t":"A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy","s":"rec","p":"earlyphase1","d":[19],"c":[40],"lc":[40],"a":"adult older","h":[110],"l":[[110,"lymph"]],"po":"2025-01-03","u":"2025-01-03","st":"2023-09","ag":"18–70"},{"n":"NCT06760052","t":"Longitudinal Data Registry of Plasma Cell Dyscrasia","s":"rec","p":"na","d":[15],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"mm"]],"po":"2025-01-06","u":"2026-08-03","st":"2023-03","ag":"19–99"},{"n":"NCT06774222","t":"A Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRG","s":"rec","p":"phase2","d":[3],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"gc"]],"po":"2025-01-14","u":"2025-01-14","st":"2023-09","ag":"18–75"},{"n":"NCT06783816","t":"A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors","s":"rec","p":"na","d":[15,19],"c":[12],"lc":[12],"a":"child adult older","h":[22],"l":[[22,"mm"]],"po":"2025-01-20","u":"2025-01-20","st":"2023-12","ag":"Not stated"},{"n":"NCT06788353","t":"Prospective Collection of Therapeutic Efficacy and Safety Data in Patients with Unresectable Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[49],"l":[[49,"hcc"]],"po":"2025-01-23","u":"2025-01-23","st":"2023-03","ag":"18–75"},{"n":"NCT06790797","t":"Investigating the Biomarkers in Tumor and Peripheral Blood to Evaluate the Efficacy of Cancer Immunotherapy in Chest Cancer Patients","s":"rec","p":"na","d":[4],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"lung"]],"po":"2025-01-24","u":"2025-01-24","st":"2023-02","ag":"18–80"},{"n":"NCT06792162","t":"PD-1 Antibody Carilizumab Combined with Apatinib for Unresectable Stage III and IV DMMR Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[115],"l":[[115,"gc"]],"po":"2025-01-24","u":"2025-01-24","st":"2023-04","ag":"18 and over"},{"n":"NCT06799637","t":"Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments","s":"rec","p":"phase1phase2","d":[5],"c":[2,8,22,1,16,0,41,23,17,47,36,5,13],"a":"adult older","h":[38,9,40,46,99,137,68,10,98,39,2,19,30,135,13,87,31],"po":"2025-01-29","u":"2026-04-15","st":"2023-12","ag":"18 and over"},{"n":"NCT06876688","t":"Relma-cel Followed by Tislelizumab for the Treatment of Relapsed/Refractory CNS Large B-Cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[2,0,5,13,20],"lc":[5],"a":"adult older","h":[123,53,36,37,102,71],"l":[[123,"lymph"]],"po":"2025-03-14","u":"2025-03-14","st":"2023-11","ag":"18 and over"},{"n":"NCT06886347","t":"Metastatic Nasopharyngeal Carcinoma","s":"rec","p":"phase1","d":[0],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"npc"]],"po":"2025-03-20","u":"2025-03-20","st":"2023-07","ag":"18–75"},{"n":"NCT06904014","t":"Efficacy and Safety of Sintilimab Combined With Lenvatinib and HAIC for Neoadjuvant Therapy of Borderline Resectable HCC","s":"rec","p":"phase2","d":[2],"c":[27],"lc":[27],"a":"adult older","h":[57],"l":[[57,"hcc"]],"po":"2025-04-01","u":"2025-04-01","st":"2023-10","ag":"18–70"},{"n":"NCT06908291","t":"Photoacoustic/Ultrasound Imaging for Breast Nodule Diagnosis, Molecular Classification, and Neoadjuvant Chemotherapy Response Evaluation","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[38],"l":[[38,"breast"]],"po":"2025-04-03","u":"2025-04-03","st":"2023-06","ag":"18 and over"},{"n":"NCT07014410","t":"Pyrotinib Combined With Dalpiciclib Combined With Letrozole in ER-positive and HER2-positive Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[44],"l":[[44,"breast"]],"po":"2025-06-11","u":"2025-06-11","st":"2023-02","ag":"18–75"},{"n":"NCT07041320","t":"Oral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Non-small Cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[17],"lc":[17],"a":"older","h":[370],"l":[[370,"lung"]],"po":"2025-06-27","u":"2025-06-27","st":"2023-06","ag":"65 and over"},{"n":"NCT07070011","t":"Small Extracellular Vesicle miRNAs as Predictive Biomarkers for Immunochemotherapy Efficacy in Extensive-stage Small Cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2025-07-17","u":"2025-07-17","st":"2023-01","ag":"45–80"},{"n":"NCT07073755","t":"Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd","s":"rec","p":"na","d":[6],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"breast"]],"po":"2025-07-18","u":"2025-07-18","st":"2023-01","ag":"18 and over"},{"n":"NCT07097207","t":"Efficacy and Safety of CD19CD20-CAR.p40-T in B-cell Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[21],"lc":[21],"a":"adult older","h":[326],"l":[[326,"lymph"]],"po":"2025-07-31","u":"2025-07-31","st":"2023-10","ag":"18–75"},{"n":"NCT07145047","t":"Clinical Study of Oncolytic Virus in Glioblastoma","s":"rec","p":"phase1phase2","d":[7],"c":[94],"lc":[94],"a":"adult older","h":[371],"l":[[371,"glioma"]],"po":"2025-08-28","u":"2025-12-19","st":"2023-11","ag":"18–70"},{"n":"NCT07146425","t":"Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis","s":"rec","p":"na","d":[27],"c":[5],"lc":[5],"a":"adult older","h":[103],"l":[[103,"mg"]],"po":"2025-08-28","u":"2025-08-28","st":"2023-08","ag":"18 and over"},{"n":"NCT07205523","t":"High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)","s":"rec","p":"na","d":[15,17,19],"c":[62],"lc":[62],"a":"child adult older","h":[192],"l":[[192,"mm"]],"po":"2025-10-03","u":"2025-10-03","st":"2023-09","ag":"Not stated"},{"n":"NCT07266493","t":"Efficacy and Safety of Neoadjuvant Envafolimab Combined With Albumin-bound Paclitaxel and Carboplatin for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"escc"]],"po":"2025-12-05","u":"2025-12-05","st":"2023-12","ag":"18 and over"},{"n":"NCT07328945","t":"Patient-derived Tumor-like Cell Cluster Model-based Precision Treatment Strategy on Non-small Cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2026-01-09","u":"2026-01-09","st":"2023-12","ag":"18–80"},{"n":"NCT07549100","t":"Efficacy and Safety of Tislelizumab Plus Chemotherapy as Conversion Therapy in Unresectable Locally Advanced ESCC","s":"rec","p":"na","d":[1],"c":[27],"lc":[27],"a":"adult older","h":[113],"l":[[113,"escc"]],"po":"2026-04-23","u":"2026-04-23","st":"2023-05","ag":"18–75"},{"n":"NCT07638774","t":"The Efficacy of Compression/Ice Gloves/Socks in Patients With UTD1-induced Neuropathy.","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2026-06-10","u":"2026-06-10","st":"2023-03","ag":"18–75"},{"n":"NCT07920094","t":"Comparison of the Safety and Aesthetic Outcomes of a Novel Endoscopic-Assisted Breast-Conserving Surgery (SRRSHzb-EABCS) With Those of Conventional Breast-Conserving Surgery","s":"rec","p":"na","d":[6],"c":[23,95,61,29,37],"lc":[23],"a":"adult older","x":"female","h":[82,44,54,81,183,46,275,185,372,215,66],"l":[[82,"breast"]],"po":"2026-11-05","u":"2026-11-09","st":"2023-07","ag":"18–70"},{"n":"NCT03786003","t":"ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007)","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2018-12-24","u":"2023-07-21","st":"2022-02","ag":"18–75"},{"n":"NCT04088422","t":"Cell Free DNA in Mature B-cell Lymphoma","s":"rec","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2019-09-12","u":"2023-02-24","st":"2022-09","ag":"18 and over"},{"n":"NCT04527419","t":"SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009)","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2020-08-26","u":"2025-08-26","st":"2022-02","ag":"18–75"},{"n":"NCT04631770","t":"Mediastinal Lymph Node Dissection Versus Spared Mediastinal Lymph Node Dissection in Stage I GGN NSCLC","s":"rec","p":"na","d":[4],"c":[30],"lc":[30],"a":"child adult older","h":[58],"l":[[58,"lung"]],"po":"2020-11-17","u":"2023-09-28","st":"2022-05","ag":"Not stated"},{"n":"NCT04657861","t":"APRIL CAR-T Cell Therapy for Patients With BCMA/TACI Positive Relapsed and/or Refractory Multiple Myeloma","s":"rec","p":"earlyphase1","d":[15],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"mm"]],"po":"2020-12-08","u":"2022-05-09","st":"2022-05","ag":"18–75"},{"n":"NCT04728724","t":"Neoadjuvant Immunotherapy for Stage III Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2021-01-28","u":"2023-09-13","st":"2022-09","ag":"18–75"},{"n":"NCT04813705","t":"18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma","s":"rec","p":"phase2","d":[0],"c":[29],"lc":[29],"a":"adult older","h":[366],"l":[[366,"npc"]],"po":"2021-03-24","u":"2023-02-21","st":"2022-01","ag":"18–80"},{"n":"NCT04840264","t":"Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel Obstruction","s":"rec","p":"phase2","d":[3],"c":[0],"lc":[0],"a":"adult older","h":[75,43],"l":[[75,"gc"]],"po":"2021-04-09","u":"2026-07-13","st":"2022-01","ag":"18–75"},{"n":"NCT04928846","t":"A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)","s":"rec","p":"phase3","d":[4],"c":[2,15,8,22,1,52,16,0,23,24,17,65,27,47,25,9,28,10,40,5,43,11,18,12,29,30,34,13,39,7,45,20],"a":"adult older","h":[40,42,57,58,38,44,132,12,111,74,45,118,36,46,59,13,47,79,80,14,37,60,61,30,135,155,83,125,19,50,138,66,129,72,8,205,175,84,222,260,51],"po":"2021-06-16","u":"2026-10-29","st":"2022-03","ag":"18 and over"},{"n":"NCT04973293","t":"Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lung"]],"po":"2021-07-22","u":"2024-11-19","st":"2022-10","ag":"18–75"},{"n":"NCT04973306","t":"Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC","s":"rec","p":"phase2phase3","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"escc"]],"po":"2021-07-22","u":"2022-06-30","st":"2022-03","ag":"18–75"},{"n":"NCT05067348","t":"Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis","s":"rec","p":"phase2","d":[27],"c":[2,8,22,5,30,39],"lc":[39],"a":"adult older","h":[122,103,59,11,40,102],"l":[[122,"mg"]],"po":"2021-10-05","u":"2025-05-01","st":"2022-07","ag":"18–80"},{"n":"NCT05076682","t":"Reverse Triple Negative Immune Resistant Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2021-10-13","u":"2026-10-23","st":"2022-06","ag":"18–70"},{"n":"NCT05091424","t":"A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia","s":"rec","p":"phase1","d":[19],"c":[2,0,9,30],"a":"adult older","h":[69,70,48,14],"po":"2021-10-25","u":"2026-11-05","st":"2022-03","ag":"18 and over"},{"n":"NCT05139017","t":"A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)","s":"rec","p":"phase2phase3","d":[19],"c":[2,15,22,1,0,23,36,9,5,13,20],"a":"adult older","h":[40,53,74,46,12,9,37,27,2,47,44,0,14,116,87],"po":"2021-12-01","u":"2026-11-03","st":"2022-01","ag":"18 and over"},{"n":"NCT05145361","t":"Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)","s":"rec","p":"earlyphase1","d":[25],"c":[2,12,30,39],"a":"adult older","h":[102,59,122,176],"po":"2021-12-06","u":"2026-05-05","st":"2022-04","ag":"18 and over"},{"n":"NCT05147844","t":"Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma","s":"rec","p":"phase2","d":[0],"c":[1],"lc":[1],"a":"adult older","h":[167],"l":[[167,"npc"]],"po":"2021-12-07","u":"2025-07-14","st":"2022-03","ag":"18–75"},{"n":"NCT05150691","t":"A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors","s":"rec","p":"phase1phase2","d":[3],"c":[48,2,55,15,8,1,0,23,17,27,10,5,11,18,30,37,13,60,39,7,31,19,20],"a":"adult older","h":[74,23,118,44,25,12,58,37,111,46,54,81,49,27,18,11,79,57,28,8,164,83,180,13,68,296,31,64,2,50,99,150,175,138],"po":"2021-12-09","u":"2026-08-27","st":"2022-01","ag":"18 and over"},{"n":"NCT05155189","t":"A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma","s":"rec","p":"phase1","d":[2],"c":[23,20],"lc":[23],"a":"adult older","h":[46,25],"l":[[46,"hcc"]],"po":"2021-12-13","u":"2026-01-21","st":"2022-02","ag":"18–75"},{"n":"NCT05168566","t":"Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[2,55,15,8,22,0,23,24,25,28,5,11,13,20],"a":"adult older","h":[23,42,56,78,38,44,25,132,12,74,45,118,13,47,164,37,61,138,67],"po":"2021-12-23","u":"2026-11-16","st":"2022-09","ag":"18 and over"},{"n":"NCT05182944","t":"A Study of Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCC","s":"rec","p":"phase2","d":[1],"c":[20],"lc":[20],"a":"adult older","h":[25],"l":[[25,"escc"]],"po":"2022-01-10","u":"2022-05-11","st":"2022-01","ag":"18–80"},{"n":"NCT05192798","t":"Albumin-Bound Paclitaxel Combined With Antiangiogenic Agents in First-line Treatment of Relapsed or Metastatic TNBC","s":"rec","p":"phase2","d":[6],"c":[55],"lc":[55],"a":"adult older","x":"female","h":[164],"l":[[164,"breast"]],"po":"2022-01-14","u":"2026-09-04","st":"2022-01","ag":"18–80"},{"n":"NCT05201781","t":"A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel","s":"rec","p":"phase4","d":[15],"c":[2,22,16,0,23,28,5,39],"a":"adult older","h":[40,46,212,78,123,60,97,53,115,140],"po":"2022-01-21","u":"2026-11-03","st":"2022-03","ag":"18 and over"},{"n":"NCT05208762","t":"A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors","s":"rec","p":"phase1","d":[1,2,3,4,5,6],"c":[2,5],"a":"adult older","h":[74,65,39],"po":"2022-01-26","u":"2026-07-22","st":"2022-10","ag":"18 and over"},{"n":"NCT05214222","t":"Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"escc"]],"po":"2022-01-28","u":"2024-12-30","st":"2022-09","ag":"18–75"},{"n":"NCT05219721","t":"A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia","s":"rec","p":"phase1","d":[15],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"mm"]],"po":"2022-02-02","u":"2025-06-11","st":"2022-03","ag":"18–75"},{"n":"NCT05228951","t":"Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC","s":"rec","p":"phase2","d":[6],"c":[11],"lc":[11],"a":"adult older","x":"female","h":[143],"l":[[143,"breast"]],"po":"2022-02-08","u":"2022-09-13","st":"2022-02","ag":"18–75"},{"n":"NCT05241028","t":"Adjuvant Therapy of Ensartinib in Stage IB-IIIA ALK-positive Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"lung"]],"po":"2022-02-15","u":"2023-10-10","st":"2022-05","ag":"18–75"},{"n":"NCT05243797","t":"Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation","s":"rec","p":"phase3","d":[15],"c":[2,15,23,27,5,11,30,37,13,20],"a":"adult older","h":[46,89,69,36,37,27,29,143,81,124,286],"po":"2022-02-17","u":"2026-11-10","st":"2022-09","ag":"18 and over"},{"n":"NCT05252078","t":"Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients","s":"rec","p":"phase2","d":[1],"c":[9],"lc":[9],"a":"adult older","h":[116],"l":[[116,"escc"]],"po":"2022-02-23","u":"2022-12-16","st":"2022-06","ag":"18 and over"},{"n":"NCT05254743","t":"A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)","s":"rec","p":"phase3","d":[19],"c":[8,0,6,23,17,9,10,5,30,34,13],"a":"adult older","h":[53,36,12,54,9,70,31,10,68,13,116,59,50,72,7],"po":"2022-02-24","u":"2026-08-17","st":"2022-07","ag":"18 and over"},{"n":"NCT05257018","t":"R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse","s":"rec","p":"phase2","d":[19],"c":[34],"a":"adult older","h":[72],"po":"2022-02-25","u":"2026-04-02","st":"2022-02","ag":"18–75"},{"n":"NCT05262491","t":"A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor","s":"rec","p":"phase1","d":[3],"c":[2,22,23,27,9,30],"a":"adult older","h":[74,40,44,14,83,59],"po":"2022-03-02","u":"2026-08-27","st":"2022-02","ag":"18–75"},{"n":"NCT05263570","t":"The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer Patient With Standard Neoadjuvant Therapy in Real World.","s":"rec","p":"na","d":[6],"c":[11],"lc":[11],"a":"adult older","x":"female","h":[143],"l":[[143,"breast"]],"po":"2022-03-02","u":"2022-09-13","st":"2022-08","ag":"18 and over"},{"n":"NCT05271916","t":"First-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R Mutations","s":"rec","p":"phase1phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2022-03-09","u":"2023-04-19","st":"2022-10","ag":"18–75"},{"n":"NCT05284539","t":"Efficacy of Platinum-based Chemotherapy Plus Immune Checkpoint Inhibitors for EGFR/ALK/ROS1 Mutant Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2022-03-17","u":"2024-06-07","st":"2022-04","ag":"18 and over"},{"n":"NCT05286957","t":"MRD-guided Adjuvant Tislelizumab and Chemotherapy in Resected Stage IIA-IIIB NSCLC","s":"rec","p":"phase2","d":[4],"c":[20],"lc":[20],"a":"adult older","h":[25],"l":[[25,"lung"]],"po":"2022-03-18","u":"2023-03-17","st":"2022-06","ag":"18–80"},{"n":"NCT05288205","t":"Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation","s":"rec","p":"phase1phase2","d":[4,5],"c":[2,8,16,0,24,17,65,27,25,5,11,21,13,7,20],"a":"adult older","h":[23,57,9,11,12,74,45,118,36,124,13,37,61,30,16,49,0,68,115,106,8,205,102,51],"po":"2022-03-21","u":"2026-08-13","st":"2022-04","ag":"18 and over"},{"n":"NCT05294055","t":"Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma","s":"rec","p":"phase2","d":[15,19],"c":[2,17,27,30,20],"lc":[30],"a":"adult older","h":[69,59,37,58,115,57,68],"l":[[69,"mm"]],"po":"2022-03-24","u":"2025-05-13","st":"2022-04","ag":"18–65"},{"n":"NCT05294731","t":"Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader","s":"rec","p":"phase1phase2","d":[19],"c":[2,55,15,8,22,1,16,0,23,17,27,9,28,26,5,4,12,37,13,20],"a":"adult older","h":[40,123,78,46,5,12,140,115,37,27,43,167,10,68,81,57,14,164,89,84,319],"po":"2022-03-24","u":"2026-10-21","st":"2022-05","ag":"18 and over"},{"n":"NCT05296577","t":"Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[20],"lc":[20],"a":"adult older","x":"female","h":[37],"l":[[37,"breast"]],"po":"2022-03-25","u":"2026-10-16","st":"2022-03","ag":"18 and over"},{"n":"NCT05299424","t":"A Study of CM336 in Patients With Relapsed or Refractory Multiple Myeloma","s":"rec","p":"phase1phase2","d":[15],"c":[2],"a":"adult older","h":[115],"po":"2022-03-29","u":"2024-10-15","st":"2022-08","ag":"18 and over"},{"n":"NCT05305092","t":"Assessment of Brain Cognitive Impairment in Breast Cancer","s":"rec","p":"na","d":[6],"c":[39],"lc":[39],"a":"child adult older","x":"female","h":[122],"l":[[122,"breast"]],"po":"2022-03-31","u":"2022-07-13","st":"2022-05","ag":"Not stated"},{"n":"NCT05323201","t":"Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer","s":"rec","p":"phase1phase2","d":[2],"c":[31],"lc":[31],"a":"adult older","h":[64],"l":[[64,"hcc"]],"po":"2022-04-12","u":"2022-04-12","st":"2022-02","ag":"18–70"},{"n":"NCT05323929","t":"The Relationship Between Scar Formation and ESD Depth in Therapy for Gastric Carcinoma","s":"rec","p":"na","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"gc"]],"po":"2022-04-12","u":"2022-04-14","st":"2022-01","ag":"18–75"},{"n":"NCT05327517","t":"Surgery or Chemoradiotherapy for Cervical Esophageal Cancer","s":"rec","p":"na","d":[1],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"escc"]],"po":"2022-04-14","u":"2022-04-14","st":"2022-04","ag":"18–75"},{"n":"NCT05332756","t":"Long-term Outcomes of Conservative Management in Patients with Moyamoya Disease and Their First-degree Relatives (LAMORA)","s":"rec","p":"na","d":[28],"c":[2],"lc":[2],"a":"child adult","h":[102],"l":[[102,"moyamoya"]],"po":"2022-04-18","u":"2024-12-19","st":"2022-05","ag":"2–60"},{"n":"NCT05334277","t":"Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA","s":"rec","p":"phase2","d":[4],"c":[15,22,63,0,23,35,9,11,34,13,39,31,20],"a":"adult older","h":[53,25,12,111,46,54,27,14,70,49,122,18,98,64,275,72,95,85,198],"po":"2022-04-19","u":"2022-08-31","st":"2022-05","ag":"18 and over"},{"n":"NCT05334823","t":"A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents","s":"rec","p":"phase2","d":[16],"c":[2,8,22,1,23,9,28,21,4,30,13,20],"a":"child adult","h":[69,36,179,284,10,249,203,250,25,14,252,78],"po":"2022-04-19","u":"2026-09-15","st":"2022-01","ag":"3–21"},{"n":"NCT05337319","t":"Prospective Registry of the Current Status of Care for Patients With Coronary Artery Disease","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[109],"l":[[109,"cad"]],"po":"2022-04-20","u":"2022-05-26","st":"2022-01","ag":"18 and over"},{"n":"NCT05339568","t":"Patient's Whole Process Follow-up Management(HOPE-1)","s":"rec","p":"na","d":[4],"c":[27],"lc":[27],"a":"adult older","h":[220],"l":[[220,"lung"]],"po":"2022-04-21","u":"2022-09-08","st":"2022-05","ag":"18 and over"},{"n":"NCT05340491","t":"Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial","s":"rec","p":"phase3","d":[0],"c":[22,16,0,41,23,9,10,5,13,39,7],"lc":[0],"a":"adult older","h":[53,30,15,9,8,47,44,116,137,133,131],"l":[[53,"npc"]],"po":"2022-04-22","u":"2026-05-11","st":"2022-04","ag":"18–70"},{"n":"NCT05341141","t":"Effectiveness of Cryotherapy Combined With Compression Therapy for Preventing Chemotherapy-induced Peripheral Neuropathy","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[74],"l":[[74,"breast"]],"po":"2022-04-22","u":"2022-06-13","st":"2022-06","ag":"20–70"},{"n":"NCT05341492","t":"EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer","s":"rec","p":"earlyphase1","d":[4,6],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"lung"]],"po":"2022-04-22","u":"2024-06-25","st":"2022-05","ag":"18–75"},{"n":"NCT05341557","t":"A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma","s":"rec","p":"phase1","d":[19],"c":[30],"a":"adult older","h":[58,59],"po":"2022-04-22","u":"2025-01-27","st":"2022-08","ag":"18 and over"},{"n":"NCT05342792","t":"Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2022-04-25","u":"2022-04-25","st":"2022-04","ag":"18–65"},{"n":"NCT05345860","t":"Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast Cancer","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2022-04-26","u":"2022-04-26","st":"2022-03","ag":"18 and over"},{"n":"NCT05346510","t":"Prone Positioning CT Scan and Ultrasound Assessing Axillary Lymph Nodes in Patients With Breast Cancer Official Title: Evaluation of Axillary Lymph Nodes Using Prone Positioning Computed Tomography Scan and Ultrasound in Patients With Breast Cancer","s":"rec","p":"na","d":[6],"c":[11],"lc":[11],"a":"adult older","x":"female","h":[143],"l":[[143,"breast"]],"po":"2022-04-26","u":"2022-04-26","st":"2022-03","ag":"18–70"},{"n":"NCT05347524","t":"Detection of Peritoneal Metastasis of Gastric Cancer by Liquid Biopsy in Peripheral Blood: A Prospective Study","s":"rec","p":"na","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"gc"]],"po":"2022-04-26","u":"2022-04-26","st":"2022-03","ag":"18–74"},{"n":"NCT05351788","t":"SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer.","s":"rec","p":"phase2","d":[4],"c":[0],"a":"adult older","h":[53],"po":"2022-04-28","u":"2026-05-12","st":"2022-05","ag":"18–75"},{"n":"NCT05352035","t":"Multiomics Tumor Evolution Model of NSCLC","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"lung"]],"po":"2022-04-28","u":"2025-04-30","st":"2022-04","ag":"18 and over"},{"n":"NCT05352321","t":"Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal Carcinoma","s":"rec","p":"na","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53,320],"l":[[53,"npc"]],"po":"2022-04-28","u":"2022-07-01","st":"2022-06","ag":"18–70"},{"n":"NCT05357846","t":"PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)","s":"rec","p":"phase3","d":[1],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"escc"]],"po":"2022-05-03","u":"2026-04-30","st":"2022-11","ag":"18–70"},{"n":"NCT05360290","t":"CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[41],"l":[[41,"breast"]],"po":"2022-05-04","u":"2026-02-03","st":"2022-09","ag":"18–70"},{"n":"NCT05365581","t":"A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer","s":"rec","p":"phase1","d":[3,5],"c":[0,23,5,13,20],"a":"adult older","h":[53,123,12,37,46],"po":"2022-05-09","u":"2026-09-11","st":"2022-06","ag":"18 and over"},{"n":"NCT05369442","t":"Prognosis and Antiplatelet Strategies for Patients With PCI and High Bleeding Risk:A Study Protocol","s":"rec","p":"na","d":[31],"c":[22],"lc":[22],"a":"child adult older","h":[40],"l":[[40,"cad"]],"po":"2022-05-11","u":"2026-01-06","st":"2022-05","ag":"Not stated"},{"n":"NCT05377658","t":"AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"lung"]],"po":"2022-05-17","u":"2024-02-21","st":"2022-07","ag":"18–75"},{"n":"NCT05378334","t":"Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients","s":"rec","p":"na","d":[4],"c":[0],"a":"adult older","h":[107],"po":"2022-05-18","u":"2026-03-10","st":"2022-06","ag":"18–75"},{"n":"NCT05382728","t":"Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO)","s":"rec","p":"phase3","d":[4],"c":[8,5],"a":"adult older","h":[42,13],"po":"2022-05-19","u":"2024-01-30","st":"2022-06","ag":"18–80"},{"n":"NCT05392413","t":"Immune Indicator Model for Predicting Efficacy of PD-1 Monoclonal Antibody","s":"rec","p":"na","d":[1],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"escc"]],"po":"2022-05-26","u":"2022-07-06","st":"2022-08","ag":"18–75"},{"n":"NCT05397769","t":"Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial.","s":"rec","p":"phase2","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2022-05-31","u":"2022-08-10","st":"2022-06","ag":"18–65"},{"n":"NCT05398861","t":"Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[20],"lc":[20],"a":"adult older","x":"female","h":[37],"l":[[37,"breast"]],"po":"2022-06-01","u":"2026-04-16","st":"2022-08","ag":"18–70"},{"n":"NCT05408897","t":"Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD","s":"rec","p":"na","d":[12],"c":[2],"lc":[2],"a":"child adult older","h":[48],"l":[[48,"gist"]],"po":"2022-06-07","u":"2022-09-21","st":"2022-01","ag":"Not stated"},{"n":"NCT05409482","t":"A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[16],"lc":[16],"a":"adult older","h":[190],"l":[[190,"hcc"]],"po":"2022-06-08","u":"2025-05-13","st":"2022-08","ag":"18–75"},{"n":"NCT05420454","t":"A Study for the Neoadjuvant Treatment of Breast Cancer","s":"rec","p":"phase4","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2022-06-15","u":"2022-07-01","st":"2022-07","ag":"18 and over"},{"n":"NCT05420467","t":"A Study for the Adjuvant Treatment of Breast Cancer","s":"rec","p":"phase4","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2022-06-15","u":"2022-07-01","st":"2022-07","ag":"18 and over"},{"n":"NCT05424159","t":"Ablative Carbon Ion Radiotherapy With Pencil Beam Scanning for Locally Advanced Unresectable Pancreatic Cancer","s":"rec","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[316],"l":[[316,"panc"]],"po":"2022-06-21","u":"2023-12-07","st":"2022-07","ag":"18–80"},{"n":"NCT05427383","t":"KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy","s":"rec","p":"phase2phase3","d":[3],"c":[2],"a":"adult older","h":[26],"po":"2022-06-22","u":"2023-12-19","st":"2022-04","ag":"18 and over"},{"n":"NCT05430399","t":"Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[8],"a":"adult older","x":"female","h":[13],"po":"2022-06-24","u":"2023-07-13","st":"2022-06","ag":"18 and over"},{"n":"NCT05433467","t":"CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical Resection","s":"rec","p":"na","d":[2],"c":[32],"lc":[32],"a":"adult older","h":[63],"l":[[63,"hcc"]],"po":"2022-06-27","u":"2025-08-13","st":"2022-05","ag":"18 and over"},{"n":"NCT05437900","t":"INSIGHTFUL-FFR Clinical Trial","s":"rec","p":"phase4","d":[31],"c":[22,27,5],"a":"adult older","h":[6,40,124],"po":"2022-06-29","u":"2026-01-12","st":"2022-09","ag":"18–85"},{"n":"NCT05443841","t":"Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005)","s":"rec","p":"na","d":[1],"c":[17,40,5,18,96,30,39,20],"lc":[5],"a":"child adult older","h":[9,24,58,110,92,68,111,373,260],"l":[[9,"escc"]],"po":"2022-07-05","u":"2023-07-13","st":"2022-07","ag":"Not stated"},{"n":"NCT05444478","t":"Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[8],"a":"adult older","h":[363],"po":"2022-07-06","u":"2023-11-07","st":"2022-07","ag":"18–75"},{"n":"NCT05447169","t":"Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for Nasopharyngeal Carcinoma Screening","s":"rec","p":"na","d":[0],"c":[0],"lc":[0],"a":"adult","x":"male","h":[53],"l":[[53,"npc"]],"po":"2022-07-07","u":"2022-07-08","st":"2022-07","ag":"30–62"},{"n":"NCT05447702","t":"Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)","s":"rec","p":"phase2","d":[6],"c":[22],"lc":[22],"a":"adult older","x":"female","h":[40],"l":[[40,"breast"]],"po":"2022-07-07","u":"2023-05-22","st":"2022-11","ag":"18–75"},{"n":"NCT05450835","t":"OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap Method","s":"rec","p":"na","d":[3],"c":[15,8,0,43,11],"lc":[0],"a":"adult older","h":[70,118,75,27,125,43,20,108],"l":[[70,"gc"]],"po":"2022-07-11","u":"2025-05-31","st":"2022-09","ag":"18–75"},{"n":"NCT05454774","t":"A Study of FVIII Gene Therapy for Hemophilia A","s":"rec","p":"earlyphase1","d":[21],"c":[30],"lc":[30],"a":"adult older","x":"male","h":[69],"l":[[69,"ha"]],"po":"2022-07-12","u":"2025-02-21","st":"2022-07","ag":"18 and over"},{"n":"NCT05457049","t":"Adjuvant Therapy Omission for Resected NSCLC Patients With Longitudinal Undetectable MRD","s":"rec","p":"na","d":[4],"c":[63,0,43,46],"a":"adult older","h":[43,125,134,198],"po":"2022-07-13","u":"2026-09-16","st":"2022-08","ag":"18 and over"},{"n":"NCT05461664","t":"Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA","s":"rec","p":"na","d":[12],"c":[0],"lc":[0],"a":"adult older","h":[49],"l":[[49,"gist"]],"po":"2022-07-18","u":"2025-02-26","st":"2022-07","ag":"18 and over"},{"n":"NCT05461768","t":"A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2-Positive/Negative Breast Cancer and Other Solid Tumors","s":"rec","p":"phase1","d":[6],"c":[16,0,27,13,20],"a":"adult older","h":[99,25,133,30,83],"po":"2022-07-18","u":"2026-08-27","st":"2022-08","ag":"18–75"},{"n":"NCT05464875","t":"A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors","s":"rec","p":"na","d":[12],"c":[0],"lc":[0],"a":"adult older","h":[49],"l":[[49,"gist"]],"po":"2022-07-19","u":"2025-02-26","st":"2022-07","ag":"18 and over"},{"n":"NCT05470348","t":"A Study of BL-B01D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors","s":"rec","p":"phase1","d":[6],"c":[0,5],"a":"adult older","h":[9,43],"po":"2022-07-22","u":"2026-08-27","st":"2022-08","ag":"18–75"},{"n":"NCT05472558","t":"Clinical Study of Cord Blood-derived CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL","s":"rec","p":"phase1","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lymph"]],"po":"2022-07-25","u":"2025-03-04","st":"2022-07","ag":"18–75"},{"n":"NCT05475678","t":"Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[20],"lc":[20],"a":"adult older","x":"female","h":[37],"l":[[37,"breast"]],"po":"2022-07-27","u":"2025-01-23","st":"2022-12","ag":"18–70"},{"n":"NCT05482568","t":"A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer","s":"rec","p":"phase1phase2","d":[4],"c":[23,5],"a":"adult older","h":[42,44],"po":"2022-08-01","u":"2026-04-20","st":"2022-09","ag":"18–75"},{"n":"NCT05484908","t":"Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC","s":"rec","p":"na","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[209],"l":[[209,"hcc"]],"po":"2022-08-02","u":"2024-11-29","st":"2022-08","ag":"18–65"},{"n":"NCT05486650","t":"An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor Treatment","s":"rec","p":"na","d":[4],"c":[1],"lc":[1],"a":"adult older","h":[167],"l":[[167,"lung"]],"po":"2022-08-03","u":"2025-07-14","st":"2022-08","ag":"18–75"},{"n":"NCT05487170","t":"A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)","s":"rec","p":"phase1phase2","d":[19],"c":[2],"a":"adult older","h":[23,74],"po":"2022-08-04","u":"2025-03-04","st":"2022-07","ag":"18 and over"},{"n":"NCT05487391","t":"A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection.","s":"rec","p":"phase3","d":[4],"c":[5],"a":"adult older","h":[56],"po":"2022-08-04","u":"2024-10-15","st":"2022-12","ag":"18 and over"},{"n":"NCT05490472","t":"JAB-2485 Activity in Adult Patients With Advanced Solid Tumors","s":"rec","p":"phase1phase2","d":[4,6],"c":[2,15,27],"a":"adult older","h":[23,57,115,138],"po":"2022-08-05","u":"2026-01-09","st":"2022-12","ag":"18 and over"},{"n":"NCT05494021","t":"China Lung Cancer Screening (CLUS) Study Version 3.0","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2022-08-09","u":"2022-08-09","st":"2022-01","ag":"45–75"},{"n":"NCT05494060","t":"XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma","s":"rec","p":"phase2","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"gc"]],"po":"2022-08-09","u":"2023-11-07","st":"2022-03","ag":"18–75"},{"n":"NCT05494086","t":"Dual-Port Laparoscopic Distal Gastrectomy for Gastric Cancer","s":"rec","p":"na","d":[3],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"gc"]],"po":"2022-08-09","u":"2024-05-13","st":"2022-08","ag":"18–75"},{"n":"NCT05495152","t":"Adjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase3","d":[1],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"escc"]],"po":"2022-08-10","u":"2024-10-02","st":"2022-08","ag":"18–70"},{"n":"NCT05498064","t":"A Real World Study of Ensartinib in Advanced ALK-positive NSCLC","s":"rec","p":"na","d":[4,19],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"lung"]],"po":"2022-08-11","u":"2022-08-11","st":"2022-05","ag":"18 and over"},{"n":"NCT05498428","t":"A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[22,0,23,24,5,18,30,37,13,39,19],"a":"adult older","h":[40,9,12,111,45,46,59,47,81,82,49,28,175],"po":"2022-08-12","u":"2026-11-03","st":"2022-11","ag":"18 and over"},{"n":"NCT05503667","t":"Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2022-08-17","u":"2022-08-17","st":"2022-02","ag":"18 and over"},{"n":"NCT05504694","t":"Ofatumumab in AQP4-IgG Seropositive NMOSD","s":"rec","p":"phase1phase2","d":[25],"c":[39],"lc":[39],"a":"adult older","h":[122],"l":[[122,"nmosd"]],"po":"2022-08-17","u":"2026-01-30","st":"2022-06","ag":"18 and over"},{"n":"NCT05506410","t":"A Clinical Study of Hanlikang and BTK Inhibitors in the Treatment of Newly Diagnosed Mantle Cell Lymphoma","s":"rec","p":"na","d":[19],"c":[20],"lc":[20],"a":"adult older","h":[25],"l":[[25,"lymph"]],"po":"2022-08-18","u":"2022-08-18","st":"2022-08","ag":"18–90"},{"n":"NCT05507411","t":"Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC","s":"rec","p":"phase2","d":[1],"c":[23,61],"lc":[23],"a":"adult older","h":[44,46,215],"l":[[44,"escc"]],"po":"2022-08-19","u":"2022-08-19","st":"2022-08","ag":"18–75"},{"n":"NCT05508347","t":"Nituzumab (Taixinsheng ®） A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal Carcinoma","s":"rec","p":"phase2","d":[0],"c":[22],"lc":[22],"a":"adult older","h":[47],"l":[[47,"npc"]],"po":"2022-08-19","u":"2025-04-09","st":"2022-04","ag":"18–70"},{"n":"NCT05512286","t":"Patient-Reported Outcome and Safety Between Preoperative and Postmastectomy Radiotherapy in DIEP Flap Reconstruction","s":"rec","p":"na","d":[6],"c":[8,5,20],"lc":[5],"a":"adult older","x":"female","h":[103,37,13],"l":[[103,"breast"]],"po":"2022-08-23","u":"2024-11-25","st":"2022-08","ag":"18 and over"},{"n":"NCT05512351","t":"Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Oligodendroglioma","s":"rec","p":"phase2","d":[7],"c":[20],"lc":[20],"a":"adult older","h":[92],"l":[[92,"glioma"]],"po":"2022-08-23","u":"2022-09-27","st":"2022-12","ag":"18 and over"},{"n":"NCT05514275","t":"Radiotherapy Combined With Endostatin and Capecitabine for NPC","s":"rec","p":"phase2","d":[0],"c":[23,61],"lc":[23],"a":"adult older","h":[44,215,182],"l":[[44,"npc"]],"po":"2022-08-24","u":"2022-08-24","st":"2022-08","ag":"18–65"},{"n":"NCT05514327","t":"A Study of Ultra-fraction Radiotherapy Bridging CART in R/R DLBCL","s":"rec","p":"na","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"lymph"]],"po":"2022-08-24","u":"2026-03-24","st":"2022-09","ag":"18 and over"},{"n":"NCT05515315","t":"Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[16],"lc":[16],"a":"adult older","h":[341],"l":[[341,"escc"]],"po":"2022-08-25","u":"2024-02-07","st":"2022-05","ag":"18–70"},{"n":"NCT05518851","t":"TreAtments and outComes in paTients With prImary CutAneous Lymphoma","s":"rec","p":"na","d":[19],"c":[2,27],"lc":[2],"a":"child adult older","h":[29,115,124],"l":[[29,"lymph"]],"po":"2022-08-29","u":"2023-11-18","st":"2022-08","ag":"Not stated"},{"n":"NCT05521802","t":"A Study of C-CAR088 in Patients With Relapsed or Refractory Multiple Myeloma","s":"rec","p":"phase1phase2","d":[15],"c":[30],"a":"adult older","h":[69],"po":"2022-08-30","u":"2023-03-24","st":"2022-11","ag":"18 and over"},{"n":"NCT05525767","t":"Chemotherapy Combined With Bevacizumab Neoadjuvant Therapy for HER2-negative Breast Cancer","s":"rec","p":"phase4","d":[6],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"breast"]],"po":"2022-09-02","u":"2025-12-11","st":"2022-03","ag":"18 and over"},{"n":"NCT05527470","t":"Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[57,87],"a":"adult older","h":[170,317],"po":"2022-09-02","u":"2023-05-03","st":"2022-11","ag":"18–65"},{"n":"NCT05528055","t":"A Study to Investigate the Safety and Tolerability of SCR-6920 Capsule in Patients With Advanced Malignant Tumors","s":"rec","p":"phase1","d":[19],"c":[27],"a":"adult older","h":[57],"po":"2022-09-06","u":"2022-09-06","st":"2022-05","ag":"18–75"},{"n":"NCT05533775","t":"A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[22,10],"a":"child adult","h":[50,250],"po":"2022-09-09","u":"2026-11-05","st":"2022-11","ag":"6 months–30"},{"n":"NCT05536102","t":"The Effectiveness and Safety of XELOX and Tislelizumab + PLD for Resectable Gastric Cancer (LidingStudy)","s":"rec","p":"phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[121],"l":[[121,"gc"]],"po":"2022-09-10","u":"2023-03-09","st":"2022-09","ag":"18–75"},{"n":"NCT05536505","t":"Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC","s":"rec","p":"phase2","d":[4],"c":[2,1,63,16,0,23,17,26,5,21,13,7,46],"a":"adult older","h":[43,6,36,55,54,70,140,68,168,39,95,8,134,198,178],"po":"2022-09-13","u":"2022-09-14","st":"2022-09","ag":"18–80"},{"n":"NCT05537129","t":"Laparoscopic vs Open Total Gastrectomy for Gastric Cancer","s":"rec","p":"na","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"gc"]],"po":"2022-09-13","u":"2022-09-13","st":"2022-10","ag":"20–80"},{"n":"NCT05543330","t":"A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC","s":"rec","p":"phase1phase2","d":[4],"c":[23],"a":"adult older","h":[44],"po":"2022-09-16","u":"2026-07-08","st":"2022-09","ag":"18–75"},{"n":"NCT05549024","t":"68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients","s":"rec","p":"earlyphase1","d":[6],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"breast"]],"po":"2022-09-22","u":"2024-07-05","st":"2022-08","ag":"18 and over"},{"n":"NCT05552222","t":"A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma","s":"rec","p":"phase3","d":[15],"c":[2,15,8,49,22,1,16,0,23,24,27,9,28,10,5,11,21,30,37,13,39,7,20],"a":"adult older","h":[89,69,38,41,123,36,37,27,60,97,29,10,98,15,58,8,143,81,161,140,45,54,120,70,14,124,2,126,230],"po":"2022-09-23","u":"2026-11-03","st":"2022-10","ag":"18 and over"},{"n":"NCT05554939","t":"Allogenic CD19-targeting CAR-γδT Cell Therapy in R/R NHL","s":"rec","p":"phase1phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2022-09-26","u":"2026-09-15","st":"2022-12","ag":"18–75"},{"n":"NCT05562024","t":"TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma","s":"rec","p":"phase1","d":[13],"c":[27,30],"a":"child adult older","h":[58,57],"po":"2022-09-30","u":"2023-02-27","st":"2022-12","ag":"1 and over"},{"n":"NCT05571774","t":"Construction of a Database for TTP","s":"rec","p":"na","d":[23],"c":[4],"lc":[4],"a":"child adult older","h":[5],"l":[[5,"tt"]],"po":"2022-10-07","u":"2022-10-07","st":"2022-10","ag":"Not stated"},{"n":"NCT05575804","t":"GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer","s":"rec","p":"phase1phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2022-10-12","u":"2026-07-24","st":"2022-10","ag":"18–75"},{"n":"NCT05576389","t":"Fluzoparib Combined With Camrelizumab for Neoadjuvant Treatment of Embryogenic BRCA Mutation HER2 Negative Breast Cancer: an Open, Single Arm, Multicenter Study","s":"rec","p":"phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[48],"l":[[48,"breast"]],"po":"2022-10-12","u":"2026-07-21","st":"2022-10","ag":"18 and over"},{"n":"NCT05579132","t":"A Clinical Study of MK-1045 (CN201) in People With Precursor B-cell Acute Lymphoblastic Leukemia (MK-1045-002)","s":"rec","p":"phase1phase2","d":[16],"c":[22,1,0,23,30,13,31,20],"a":"child adult older","h":[69,70,36,179,12,167,64,250,37],"po":"2022-10-13","u":"2026-10-30","st":"2022-11","ag":"2 and over"},{"n":"NCT05579366","t":"Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)","s":"rec","p":"phase1phase2","d":[4,6],"c":[2,15,8,22,1,16,0,23,5,11,12,30,13],"a":"adult older","h":[23,58,9,44,36,13,47,30,2,18,65,138,99,84,184,361],"po":"2022-10-13","u":"2026-11-04","st":"2022-12","ag":"18 and over"},{"n":"NCT05582499","t":"Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2022-10-17","u":"2026-05-28","st":"2022-11","ag":"18–70"},{"n":"NCT05584267","t":"Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy","s":"rec","p":"phase2","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2022-10-18","u":"2024-05-30","st":"2022-12","ag":"18 and over"},{"n":"NCT05594095","t":"SNF Platform Study of HR+/ HER2-advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2022-10-26","u":"2024-10-04","st":"2022-12","ag":"18 and over"},{"n":"NCT05594797","t":"Human BCMA Targeted T Cells Injection（BCMA CAR-T）for Subjects With R/R MM","s":"rec","p":"phase2","d":[15],"c":[5,37],"a":"adult older","h":[212,81],"po":"2022-10-26","u":"2022-12-09","st":"2022-07","ag":"18–75"},{"n":"NCT05600660","t":"Orelabrutinib,Rituximab and Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma","s":"rec","p":"phase2","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lymph"]],"po":"2022-10-31","u":"2022-11-08","st":"2022-08","ag":"18–75"},{"n":"NCT05603078","t":"A Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer (BIRKIN)","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"child adult","x":"female","h":[23],"l":[[23,"breast"]],"po":"2022-11-02","u":"2022-11-02","st":"2022-06","ag":"Up to 55"},{"n":"NCT05608213","t":"Lenvatinib Plus I-125 Seed Brachytherapy vs. Lenvatinib for TACE-refractory HCC","s":"rec","p":"phase3","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"hcc"]],"po":"2022-11-08","u":"2022-11-08","st":"2022-11","ag":"18–75"},{"n":"NCT05611801","t":"A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B","s":"rec","p":"phase3","d":[21],"c":[2,30,13],"a":"child","x":"male","h":[284,69,36],"po":"2022-11-10","u":"2026-11-18","st":"2022-12","ag":"1–17"},{"n":"NCT05618041","t":"The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies","s":"rec","p":"na","d":[15,19],"c":[12],"a":"child adult older","h":[22],"po":"2022-11-16","u":"2025-06-24","st":"2022-09","ag":"14–75"},{"n":"NCT05618821","t":"Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Lymph Node Dissection for Remnant Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[16],"lc":[16],"a":"adult older","h":[140],"l":[[140,"gc"]],"po":"2022-11-16","u":"2022-11-16","st":"2022-06","ag":"18–75"},{"n":"NCT05619068","t":"The Evolution and Prognosis of Moyamoya Disease","s":"rec","p":"na","d":[28],"c":[2],"lc":[2],"a":"child adult","h":[26],"l":[[26,"moyamoya"]],"po":"2022-11-16","u":"2022-12-21","st":"2022-09","ag":"10–60"},{"n":"NCT05620680","t":"CD7 CAR-T Cells in T-cell Lymphoma/Leukemia","s":"rec","p":"na","d":[19],"c":[21],"lc":[21],"a":"adult older","h":[326],"l":[[326,"lymph"]],"po":"2022-11-17","u":"2022-11-17","st":"2022-10","ag":"18–75"},{"n":"NCT05620706","t":"Study of GPC-3 CAR-T Cells in Treating With Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[21],"lc":[21],"a":"adult older","h":[326],"l":[[326,"hcc"]],"po":"2022-11-17","u":"2022-11-22","st":"2022-11","ag":"40–70"},{"n":"NCT05620732","t":"Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T","s":"rec","p":"na","d":[3,5],"c":[21],"lc":[21],"a":"adult older","h":[326],"l":[[326,"gc"]],"po":"2022-11-17","u":"2022-11-22","st":"2022-10","ag":"18–75"},{"n":"NCT05621564","t":"Pre-operative Therapy in Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[41],"l":[[41,"breast"]],"po":"2022-11-18","u":"2026-08-04","st":"2022-11","ag":"18 and over"},{"n":"NCT05623020","t":"A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant","s":"rec","p":"phase3","d":[15],"c":[2,15,16,0,23,28,5,4,30,37,13],"a":"adult older","h":[46,69,5,36,27,60,53,115,81,140,70,286],"po":"2022-11-21","u":"2026-10-27","st":"2022-11","ag":"18 and over"},{"n":"NCT05623982","t":"A Study of GNC-038 Injection in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[2,26],"a":"adult older","h":[74,319],"po":"2022-11-21","u":"2026-08-27","st":"2022-09","ag":"18–75"},{"n":"NCT05626400","t":"Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL","s":"rec","p":"na","d":[19],"c":[97],"a":"child adult older","h":[374],"po":"2022-11-23","u":"2022-11-25","st":"2022-08","ag":"2–70"},{"n":"NCT05632380","t":"ASCT in Combination With C-CAR088 for Treating Patients With Ultra High-risk Multiple Myeloma (MM)","s":"rec","p":"phase1phase2","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2022-11-30","u":"2026-08-07","st":"2022-07","ag":"18–70"},{"n":"NCT05638594","t":"Pyrotinib Combined With Trastuzumab, Dalpiciclib, Letrozole Versus TCbHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HR +/HER2 + Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[11],"lc":[11],"a":"adult older","x":"female","h":[143],"l":[[143,"breast"]],"po":"2022-12-06","u":"2023-03-20","st":"2022-12","ag":"18–75"},{"n":"NCT05652192","t":"SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC","s":"rec","p":"phase2","d":[0],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"npc"]],"po":"2022-12-15","u":"2022-12-15","st":"2022-09","ag":"18–75"},{"n":"NCT05652920","t":"Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC","s":"rec","p":"phase1phase2","d":[2],"c":[2,15,8,22,23,5],"a":"adult older","h":[6,40,82,27,74,13],"po":"2022-12-15","u":"2024-04-03","st":"2022-12","ag":"18–70"},{"n":"NCT05653453","t":"Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer","s":"rec","p":"phase3","d":[5],"c":[24,5],"a":"adult older","h":[9,45,103],"po":"2022-12-16","u":"2025-03-24","st":"2022-12","ag":"18–75"},{"n":"NCT05657652","t":"CAV Regimen for R/R Ph- B-ALL","s":"rec","p":"na","d":[16],"c":[4],"lc":[4],"a":"child adult older","h":[5],"l":[[5,"ball"]],"po":"2022-12-20","u":"2025-12-29","st":"2022-10","ag":"15–70"},{"n":"NCT05659628","t":"CD19 CAR-T Expressing IL-7 and CCL19 Combined With Anti-PD1 in RR-DLBCL","s":"rec","p":"phase1","d":[19],"c":[23,61],"a":"adult older","h":[54,182],"po":"2022-12-21","u":"2022-12-21","st":"2022-12","ag":"18–75"},{"n":"NCT05660473","t":"Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia","s":"rec","p":"phase2","d":[19],"c":[30],"lc":[30],"a":"child adult","h":[69],"l":[[69,"lymph"]],"po":"2022-12-21","u":"2025-08-01","st":"2022-08","ag":"14–60"},{"n":"NCT05661786","t":"Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase","s":"rec","p":"na","d":[2],"c":[28],"lc":[28],"a":"adult older","h":[60],"l":[[60,"hcc"]],"po":"2022-12-22","u":"2022-12-22","st":"2022-12","ag":"18 and over"},{"n":"NCT05686434","t":"Osimertinib Therapy After Resection in High-risk Stage I EGFRm NSCLC (OSTAR)","s":"rec","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2023-01-17","u":"2023-01-17","st":"2022-10","ag":"18 and over"},{"n":"NCT05707819","t":"Sintilimab in Combination With Chemoradiotherapy in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma","s":"rec","p":"na","d":[0],"c":[10],"lc":[10],"a":"adult older","h":[50],"l":[[50,"npc"]],"po":"2023-02-01","u":"2023-02-01","st":"2022-07","ag":"18–70"},{"n":"NCT05717790","t":"Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma","s":"rec","p":"na","d":[0],"c":[0,57,88,87,46],"lc":[88],"a":"adult older","h":[342,170,278,317,329,375,376],"l":[[342,"npc"]],"po":"2023-02-08","u":"2023-02-08","st":"2022-12","ag":"18–70"},{"n":"NCT05722405","t":"Ixazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma","s":"rec","p":"phase4","d":[15],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"mm"]],"po":"2023-02-10","u":"2026-01-05","st":"2022-07","ag":"18–80"},{"n":"NCT05731258","t":"Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen","s":"rec","p":"na","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2023-02-16","u":"2023-02-16","st":"2022-05","ag":"18–75"},{"n":"NCT05761470","t":"Neoadjuvant Camrelizumab and Fluzoparib and Nab-paclitaxel in Early Breast Cancer With HRR Gene Mutation","s":"rec","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","h":[49],"l":[[49,"breast"]],"po":"2023-03-09","u":"2023-03-09","st":"2022-05","ag":"18–75"},{"n":"NCT05762900","t":"Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients","s":"rec","p":"phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2023-03-10","u":"2023-03-10","st":"2022-10","ag":"35 and over"},{"n":"NCT05789030","t":"Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement","s":"rec","p":"na","d":[26],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"igg4"]],"po":"2023-03-29","u":"2026-04-07","st":"2022-07","ag":"18–75"},{"n":"NCT05804916","t":"Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer","s":"rec","p":"phase2phase3","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[38],"l":[[38,"breast"]],"po":"2023-04-07","u":"2023-04-07","st":"2022-04","ag":"18–70"},{"n":"NCT05833659","t":"Comparison Between Prepectoral and Subpectoral Breast Reconstruction","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[39],"l":[[39,"breast"]],"po":"2023-04-27","u":"2023-04-27","st":"2022-03","ag":"18–70"},{"n":"NCT05846750","t":"Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Marginal Zone Lymphoma","s":"rec","p":"phase2","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"lymph"]],"po":"2023-05-06","u":"2023-07-19","st":"2022-11","ag":"18 and over"},{"n":"NCT05846763","t":"Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Follicular Lymphoma in Real World Study","s":"rec","p":"na","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"lymph"]],"po":"2023-05-06","u":"2023-05-23","st":"2022-11","ag":"18 and over"},{"n":"NCT05851014","t":"A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[55,15,8,22,1,63,16,0,6,23,17,27,47,25,9,28,10,61,5,11,37,13,39,58,20],"a":"adult older","h":[9,40,78,53,79,54,25,12,164,57,27,81,18,2,16,140,112,50,135,13,7,19,113,172,116,83,215,198,247,67,138,88],"po":"2023-05-09","u":"2023-05-09","st":"2022-01","ag":"18–75"},{"n":"NCT05856383","t":"Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC","s":"rec","p":"na","d":[6],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"breast"]],"po":"2023-05-12","u":"2023-05-12","st":"2022-03","ag":"18 and over"},{"n":"NCT05859659","t":"Clinical, patHOlogical and Imaging Project of nEuro-oncology (HOPE)","s":"rec","p":"na","d":[7],"c":[2],"lc":[2],"a":"adult older","h":[102],"l":[[102,"glioma"]],"po":"2023-05-16","u":"2026-03-09","st":"2022-01","ag":"18–90"},{"n":"NCT05871099","t":"Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not","s":"rec","p":"phase3","d":[3],"c":[26],"lc":[26],"a":"adult older","h":[55],"l":[[55,"gc"]],"po":"2023-05-23","u":"2026-03-06","st":"2022-11","ag":"18–80"},{"n":"NCT05887661","t":"Goal-directed LCVP Based on HP in Laparoscopic Hepatectomy","s":"rec","p":"na","d":[2],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"hcc"]],"po":"2023-06-05","u":"2026-11-12","st":"2022-05","ag":"18 and over"},{"n":"NCT05992597","t":"ZR2 Sequential Immunochemotherapy for Newly Treated MCL","s":"rec","p":"phase2","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"lymph"]],"po":"2023-08-15","u":"2023-09-21","st":"2022-08","ag":"18–75"},{"n":"NCT06001073","t":"Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics","s":"rec","p":"na","d":[31],"c":[39],"lc":[39],"a":"child adult older","h":[111],"l":[[111,"cad"]],"po":"2023-08-21","u":"2024-07-12","st":"2022-12","ag":"3–80"},{"n":"NCT06005870","t":"Zanubrutinib Combined With R-CHOP in the Treatment of Newly Diagnosed DLBCL With p53 Protein Expression","s":"rec","p":"phase2","d":[19],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lymph"]],"po":"2023-08-23","u":"2026-05-18","st":"2022-11","ag":"18–75"},{"n":"NCT06006650","t":"Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell","s":"rec","p":"phase2","d":[1],"c":[39],"lc":[39],"a":"adult older","h":[122],"l":[[122,"escc"]],"po":"2023-08-23","u":"2023-08-23","st":"2022-08","ag":"18–75"},{"n":"NCT06024187","t":"Cold Dissection Versus Electrocautery Dissection in Endoscopic Nipple-Sparing Mastectomy and Immediate Implant-Based Reconstruction: A Randomized Controlled Trial","s":"rec","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2023-09-06","u":"2025-02-13","st":"2022-11","ag":"18–75"},{"n":"NCT06081478","t":"CD19/CD22 Bispecific CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma or Acute Lymphoblastic Leukemia","s":"rec","p":"phase2","d":[16,19],"c":[2],"lc":[2],"a":"child adult older","h":[161],"l":[[161,"ball"]],"po":"2023-10-13","u":"2023-10-13","st":"2022-01","ag":"14–85"},{"n":"NCT06128148","t":"Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors","s":"rec","p":"phase1","d":[4],"c":[0],"a":"adult older","h":[53],"po":"2023-11-13","u":"2025-07-14","st":"2022-05","ag":"18 and over"},{"n":"NCT06173076","t":"A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis","s":"rec","p":"na","d":[7],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"glioma"]],"po":"2023-12-15","u":"2025-08-27","st":"2022-05","ag":"18–100"},{"n":"NCT06190782","t":"Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor","s":"rec","p":"phase3","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"escc"]],"po":"2024-01-05","u":"2024-05-02","st":"2022-09","ag":"18 and over"},{"n":"NCT06241807","t":"Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC","s":"rec","p":"phase2","d":[4],"c":[27],"lc":[27],"a":"adult older","h":[57],"l":[[57,"lung"]],"po":"2024-02-05","u":"2024-02-14","st":"2022-12","ag":"18–75"},{"n":"NCT06313983","t":"A Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[2],"a":"adult older","h":[74],"po":"2024-03-15","u":"2025-04-22","st":"2022-01","ag":"18 and over"},{"n":"NCT06404164","t":"Pulmonary Watershed Topographic Map Navigation for Lung Nodule Resection","s":"rec","p":"na","d":[4],"c":[0],"lc":[0],"a":"child adult older","h":[43],"l":[[43,"lung"]],"po":"2024-05-08","u":"2024-05-08","st":"2022-01","ag":"Not stated"},{"n":"NCT06529562","t":"Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose Chemoradiotherapy for Newly Diagnosed Operable Nasopharyngeal Carcinoma.","s":"rec","p":"na","d":[0],"c":[59],"lc":[59],"a":"adult older","h":[171],"l":[[171,"npc"]],"po":"2024-07-31","u":"2024-07-31","st":"2022-11","ag":"18–70"},{"n":"NCT06551220","t":"Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns","s":"rec","p":"na","d":[6],"c":[8,63,16,0,23,80,28,5,43,21,59],"a":"adult older","x":"female","h":[78,53,54,125,10,13,168,291,107,30,95,90,171,198,108],"po":"2024-08-13","u":"2026-05-22","st":"2022-10","ag":"18–80"},{"n":"NCT06595186","t":"JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)","s":"rec","p":"phase2","d":[7],"c":[2],"a":"adult older","h":[102],"po":"2024-09-19","u":"2024-09-19","st":"2022-10","ag":"18–75"},{"n":"NCT06615466","t":"Super-Hypofractionated Partial Breast Irradiation","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2024-09-26","u":"2024-09-26","st":"2022-04","ag":"45–74"},{"n":"NCT06706713","t":"Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[8,0],"a":"adult older","h":[43,13],"po":"2024-11-26","u":"2024-11-26","st":"2022-04","ag":"18 and over"},{"n":"NCT06717568","t":"3D Depth Camera-Based Assessment of Adolescent Idiopathic ScoliosisUsing a Depth Camera","s":"rec","p":"na","d":[33],"c":[23],"lc":[23],"a":"child adult","h":[275],"l":[[275,"scol"]],"po":"2024-12-05","u":"2024-12-05","st":"2022-01","ag":"10–18"},{"n":"NCT06727981","t":"First-Line and Neoadjuvant Immunotherapy for Gastric Cancer","s":"rec","p":"na","d":[3],"c":[27],"lc":[27],"a":"adult older","h":[124],"l":[[124,"gc"]],"po":"2024-12-11","u":"2024-12-11","st":"2022-01","ag":"18–100"},{"n":"NCT06768008","t":"An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Disease","s":"rec","p":"na","d":[32],"c":[2],"lc":[2],"a":"child","h":[109],"l":[[109,"chd"]],"po":"2025-01-10","u":"2025-01-10","st":"2022-01","ag":"1 day–28 days"},{"n":"NCT06775821","t":"Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer","s":"rec","p":"na","d":[4],"c":[47],"lc":[47],"a":"adult older","h":[201,135],"l":[[201,"lung"]],"po":"2025-01-15","u":"2025-01-15","st":"2022-10","ag":"20–90"},{"n":"NCT06822413","t":"Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis","s":"rec","p":"na","d":[2,3,5],"c":[23,9,5],"lc":[23],"a":"child adult older","h":[54,80,14,103],"l":[[54,"hcc"]],"po":"2025-02-12","u":"2025-04-24","st":"2022-09","ag":"Not stated"},{"n":"NCT06870942","t":"Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy","s":"rec","p":"phase2","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"hcc"]],"po":"2025-03-11","u":"2025-03-11","st":"2022-07","ag":"18–75"},{"n":"NCT06909877","t":"Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[22],"a":"adult older","h":[47],"po":"2025-04-04","u":"2026-01-30","st":"2022-07","ag":"18–75"},{"n":"NCT06946407","t":"Rituximab, Methotrexate, and Tepadina Induction Followed by Etoposide and Cytarabine Consolidation in Primary Central Nervous System Lymphoma","s":"rec","p":"na","d":[19],"c":[15],"lc":[15],"a":"child adult","h":[27],"l":[[27,"lymph"]],"po":"2025-04-27","u":"2025-04-27","st":"2022-12","ag":"Up to 60"},{"n":"NCT06954961","t":"A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[2,24],"a":"adult older","x":"female","h":[23,45],"po":"2025-05-02","u":"2026-03-31","st":"2022-09","ag":"18–75"},{"n":"NCT06998108","t":"Study of BEBT-209 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Patients With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Who Have Progressed After Prior Endocrine Therapy","s":"rec","p":"phase3","d":[6],"c":[2],"a":"adult older","x":"female","h":[23],"po":"2025-05-31","u":"2025-05-31","st":"2022-06","ag":"18 and over"},{"n":"NCT07014943","t":"High-Dose Gemcitabine, Busulfan, and Thiotepa Followed by ASCT in Primary Central Nervous System Lymphoma","s":"rec","p":"phase2","d":[19],"c":[22],"lc":[22],"a":"child adult older","h":[40],"l":[[40,"lymph"]],"po":"2025-06-11","u":"2025-06-11","st":"2022-01","ag":"16–70"},{"n":"NCT07045571","t":"MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer","s":"rec","p":"na","d":[5],"c":[5],"lc":[5],"a":"child adult older","h":[41],"l":[[41,"panc"]],"po":"2025-07-01","u":"2025-07-01","st":"2022-10","ag":"Not stated"},{"n":"NCT07064746","t":"Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma","s":"rec","p":"na","d":[13],"c":[28],"lc":[28],"a":"child adult","h":[78,119],"l":[[78,"nb"]],"po":"2025-07-15","u":"2025-07-21","st":"2022-07","ag":"Up to 18"},{"n":"NCT07066475","t":"A Registry-Based Cohort Study on the Clinical Outcomes of Spinal Cord Glioma Resection Via the Dorsolateral Sulcus Approach","s":"rec","p":"na","d":[7],"c":[2],"lc":[2],"a":"child adult older","h":[102],"l":[[102,"glioma"]],"po":"2025-07-15","u":"2025-07-23","st":"2022-01","ag":"3–75"},{"n":"NCT07179744","t":"Regional Radiotherapy Omission in Low-Risk Node Positive Breast Cancer","s":"rec","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2025-09-18","u":"2026-09-01","st":"2022-07","ag":"18–70"},{"n":"NCT07231068","t":"A Dose-escalation and Dose-expansion Phase I/Phase II Clinical Study of Dositinib Mesylate Tablets (90-1408) in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer With Positive EGFR Mutation","s":"rec","p":"phase1phase2","d":[4],"c":[2,0,20],"a":"adult older","h":[23,38,37,92,99],"po":"2025-11-17","u":"2025-11-17","st":"2022-10","ag":"18–75"},{"n":"NCT07327216","t":"Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[45],"lc":[45],"a":"adult older","h":[129],"l":[[129,"npc"]],"po":"2026-01-08","u":"2026-03-04","st":"2022-08","ag":"18–75"},{"n":"NCT07370077","t":"Research on Early Screening and Diagnosis of Pulmonary Nodules Based on Novel Non-invasive Technologies.","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"lung"]],"po":"2026-01-27","u":"2026-01-27","st":"2022-12","ag":"18 and over"},{"n":"NCT07516678","t":"Serial ctDNA and Molecular Residual Disease Monitoring in Neuroblastoma","s":"rec","p":"na","d":[13],"c":[0],"lc":[0],"a":"child adult older","h":[53],"l":[[53,"nb"]],"po":"2026-04-08","u":"2026-04-08","st":"2022-01","ag":"Not stated"},{"n":"NCT07632365","t":"Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer","s":"rec","p":"phase1phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2026-06-08","u":"2026-07-23","st":"2022-10","ag":"18 and over"},{"n":"NCT07841249","t":"Cardiorespiratory Fitness After Lobectomy Versus Sublobar Resection","s":"rec","p":"na","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"lung"]],"po":"2026-09-25","u":"2026-09-25","st":"2022-08","ag":"18 and over"},{"n":"NCT04136782","t":"Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer","s":"rec","p":"phase4","d":[6],"c":[15,24,11],"lc":[11],"a":"adult older","x":"female","h":[143,45,18,156],"l":[[143,"breast"]],"po":"2019-10-23","u":"2021-07-20","st":"2021-07","ag":"18–70"},{"n":"NCT04137653","t":"Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT","s":"rec","p":"phase3","d":[6],"c":[11],"lc":[11],"a":"adult older","x":"female","h":[143],"l":[[143,"breast"]],"po":"2019-10-24","u":"2021-07-20","st":"2021-07","ag":"18–70"},{"n":"NCT04146298","t":"Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer","s":"rec","p":"phase1phase2","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[177],"l":[[177,"panc"]],"po":"2019-10-31","u":"2025-12-24","st":"2021-10","ag":"18–75"},{"n":"NCT04415853","t":"Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer","s":"rec","p":"phase3","d":[1],"c":[2],"a":"adult older","h":[26],"po":"2020-06-04","u":"2026-09-28","st":"2021-01","ag":"18–80"},{"n":"NCT04436965","t":"Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition","s":"rec","p":"phase3","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2020-06-18","u":"2026-05-11","st":"2021-08","ag":"18–65"},{"n":"NCT04476485","t":"Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy","s":"rec","p":"na","d":[6],"c":[15,24,11],"lc":[11],"a":"adult older","x":"female","h":[143,45,18,156],"l":[[143,"breast"]],"po":"2020-07-20","u":"2021-07-20","st":"2021-07","ag":"18–70"},{"n":"NCT04478292","t":"A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy","s":"rec","p":"phase3","d":[8],"c":[5],"lc":[5],"a":"child adult","h":[91],"l":[[91,"hb"]],"po":"2020-07-20","u":"2026-05-04","st":"2021-03","ag":"Up to 18"},{"n":"NCT04483076","t":"Oxaliplatin Combined With S-1(SOX) Neoadjuvant Chemotherapy for Different Cycles in Patients With Gastric Cancer","s":"rec","p":"phase3","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"gc"]],"po":"2020-07-23","u":"2021-01-20","st":"2021-01","ag":"18–70"},{"n":"NCT04517266","t":"Evaluating Omitting of Internal Mammary Irradiation Among Early Stage Intermediate Risk (N1) Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[123],"l":[[123,"breast"]],"po":"2020-08-18","u":"2026-08-11","st":"2021-03","ag":"18–80"},{"n":"NCT04634552","t":"A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma","s":"rec","p":"phase2","d":[15],"c":[2,4,30,39],"a":"adult older","h":[69,5,97,111,115],"po":"2020-11-18","u":"2026-11-03","st":"2021-02","ag":"18 and over"},{"n":"NCT04662294","t":"CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases","s":"rec","p":"earlyphase1","d":[15,19],"c":[23],"lc":[23],"a":"child adult older","h":[46],"l":[[46,"mm"]],"po":"2020-12-10","u":"2021-11-04","st":"2021-11","ag":"Not stated"},{"n":"NCT04710758","t":"Multicenter Study on Laparoscopic Total Gastrectomy for Advanced Gastric Cancer","s":"rec","p":"na","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"gc"]],"po":"2021-01-15","u":"2025-09-22","st":"2021-01","ag":"18–75"},{"n":"NCT04722978","t":"Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[53],"l":[[53,"breast"]],"po":"2021-01-25","u":"2025-12-17","st":"2021-04","ag":"18–70"},{"n":"NCT04728841","t":"Gene Therapy for Chinese Hemophilia A","s":"rec","p":"na","d":[21],"c":[30],"lc":[30],"a":"adult older","x":"male","h":[69],"l":[[69,"ha"]],"po":"2021-01-28","u":"2025-08-01","st":"2021-03","ag":"18 and over"},{"n":"NCT04728893","t":"Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)","s":"rec","p":"phase2","d":[19],"c":[2,15,8,22,0,23,17,9,28,10,5,30,13,31,20],"a":"adult older","h":[40,53,78,46,12,103,64,69,9,115,37,27,10,68,14,13,50],"po":"2021-01-28","u":"2026-11-17","st":"2021-04","ag":"18 and over"},{"n":"NCT04737889","t":"Rituximab, Lenalidomide Combined With Methotrexate and Temozolomide For Primary Central Nervous System Lymphoma","s":"rec","p":"phase2","d":[19],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"lymph"]],"po":"2021-02-04","u":"2025-04-23","st":"2021-01","ag":"18–70"},{"n":"NCT04750122","t":"Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients","s":"rec","p":"phase1phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[48],"l":[[48,"breast"]],"po":"2021-02-11","u":"2021-04-01","st":"2021-03","ag":"18–75"},{"n":"NCT04777084","t":"The Efficacy and Safety of the Bispecific Anti-PD-1/PD-L1 Antibody IBI318 Combined with Lenvatinib in NSCLC.","s":"rec","p":"phase2","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2021-03-02","u":"2025-03-05","st":"2021-08","ag":"18–75"},{"n":"NCT04777942","t":"Neo-TACE-HAIC for High-risk BCLC A Stage HCC (NeoconceptA)","s":"rec","p":"na","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"hcc"]],"po":"2021-03-02","u":"2021-03-02","st":"2021-02","ag":"18–75"},{"n":"NCT04778956","t":"Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[63,0,46],"a":"adult older","h":[53,70,49,198,134,320],"po":"2021-03-03","u":"2021-03-04","st":"2021-03","ag":"18–70"},{"n":"NCT04790305","t":"Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer","s":"rec","p":"phase4","d":[6],"c":[2,15,8,1,16,0,17,27,28,61,26,5,11,18,4,13,39,32,20],"lc":[5],"a":"adult older","h":[9,23,78,24,124,43,12,133,55,18,10,97,16,112,13,68,5,107,19,60,166,92,30,377,63,156,215],"l":[[9,"breast"]],"po":"2021-03-10","u":"2024-06-27","st":"2021-06","ag":"18–70"},{"n":"NCT04794972","t":"A Study of GNC-039, a Tetra-specific Antibody, in Participants With Relapsed/Refractory or Metastatic Solid Tumors","s":"rec","p":"phase1","d":[7],"c":[2,22,0,21,39],"a":"adult older","h":[102,40,0,111,104],"po":"2021-03-12","u":"2026-08-27","st":"2021-04","ag":"18 and over"},{"n":"NCT04803318","t":"Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"hcc"]],"po":"2021-03-17","u":"2024-06-25","st":"2021-01","ag":"18–85"},{"n":"NCT04803539","t":"A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After Adjuvant Chemotherapy in TNBC","s":"rec","p":"phase2phase3","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2021-03-17","u":"2023-02-21","st":"2021-04","ag":"18–80"},{"n":"NCT04807673","t":"Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)","s":"rec","p":"phase3","d":[1],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"escc"]],"po":"2021-03-19","u":"2022-06-01","st":"2021-12","ag":"18–75"},{"n":"NCT04809025","t":"Comparation of Endoscopic Biopsy and Postoperative Specimen for the Molecular Diagnosis of Gastric Cancer","s":"rec","p":"na","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"gc"]],"po":"2021-03-22","u":"2025-09-29","st":"2021-05","ag":"18–75"},{"n":"NCT04829708","t":"Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy","s":"rec","p":"phase3","d":[4],"c":[27],"lc":[27],"a":"adult older","h":[57],"l":[[57,"lung"]],"po":"2021-04-02","u":"2021-04-29","st":"2021-04","ag":"18–75"},{"n":"NCT04836156","t":"Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for Human Epidermal Growth Factor Receptor 2 (HER2) Negative Early Breast Cancer Patients","s":"rec","p":"phase1phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[48],"l":[[48,"breast"]],"po":"2021-04-08","u":"2022-04-06","st":"2021-04","ag":"18–75"},{"n":"NCT04842812","t":"Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors","s":"rec","p":"phase1","d":[4,6],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"lung"]],"po":"2021-04-13","u":"2024-06-25","st":"2021-01","ag":"18–85"},{"n":"NCT04843215","t":"A Phase III Study Comparing Total and Partial Omentectomy for Patients With Advanced Gastric Cancer","s":"rec","p":"na","d":[3],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"gc"]],"po":"2021-04-13","u":"2021-05-10","st":"2021-01","ag":"18–70"},{"n":"NCT04850729","t":"Relationship Between Perioperative Treatment Efficacy and The Tumor Microenvironment for Locally Advanced Resectable Gastric Cancer.","s":"rec","p":"na","d":[3],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"gc"]],"po":"2021-04-20","u":"2025-05-30","st":"2021-05","ag":"18–75"},{"n":"NCT04853342","t":"To Assess the Efficacy and Safety of Furmonertinib Versus Placebo, in Patients With Epidermal Growth Factor Receptor Mutation Positive Stage II-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy","s":"rec","p":"phase3","d":[4],"c":[4],"a":"adult older","h":[5],"po":"2021-04-21","u":"2026-08-13","st":"2021-06","ag":"18–75"},{"n":"NCT04885374","t":"China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine","s":"rec","p":"na","d":[39],"c":[2],"a":"adult older","h":[378],"po":"2021-05-13","u":"2021-05-13","st":"2021-03","ag":"18 and over"},{"n":"NCT04886804","t":"Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)","s":"rec","p":"phase1","d":[4],"c":[2,15,16,0,23,24,10,5,13,7,20],"a":"adult older","h":[42,43,44,25,12,74,45,36,46,27,37,30,50,8],"po":"2021-05-14","u":"2026-11-12","st":"2021-07","ag":"18 and over"},{"n":"NCT04891016","t":"Toripalimab Plus FLOT in Locally Advanced Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"gc"]],"po":"2021-05-18","u":"2024-06-06","st":"2021-06","ag":"18–70"},{"n":"NCT04900818","t":"Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors","s":"rec","p":"phase1","d":[3,5],"c":[2,0,23,24,17,5,11,30,13,20],"a":"adult older","h":[74,6,118,58,37,45,75,82,31,19],"po":"2021-05-25","u":"2026-03-05","st":"2021-06","ag":"18 and over"},{"n":"NCT04903678","t":"Intrathecal Chemotherapy for Central Nervous System Metastasis in Retinoblastoma","s":"rec","p":"na","d":[9],"c":[5],"lc":[5],"a":"child adult older","h":[236],"l":[[236,"rb"]],"po":"2021-05-26","u":"2025-02-25","st":"2021-05","ag":"Not stated"},{"n":"NCT04905056","t":"A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"lung"]],"po":"2021-05-27","u":"2021-05-27","st":"2021-01","ag":"18–85"},{"n":"NCT04912843","t":"Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy","s":"rec","p":"phase2phase3","d":[57],"c":[2],"a":"child adult older","h":[161],"po":"2021-06-03","u":"2022-11-14","st":"2021-06","ag":"12–75"},{"n":"NCT04913285","t":"A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors","s":"rec","p":"phase1","d":[4],"c":[24,25,5],"a":"adult older","h":[56,45,67],"po":"2021-06-04","u":"2026-09-02","st":"2021-08","ag":"18 and over"},{"n":"NCT04922567","t":"Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lymph"]],"po":"2021-06-10","u":"2022-11-07","st":"2021-04","ag":"18–75"},{"n":"NCT04924075","t":"Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)","s":"rec","p":"phase2","d":[12],"c":[2],"a":"child adult older","h":[29],"po":"2021-06-11","u":"2026-11-13","st":"2021-08","ag":"12 and over"},{"n":"NCT04930432","t":"Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors","s":"rec","p":"phase1phase2","d":[4],"c":[2,55,15,8,22,1,52,16,0,23,24,17,27,47,33,9,28,10,40,26,5,43,11,21,18,4,12,29,30,42,37,13,39,7,31,19,20],"a":"adult older","h":[40,42,57,58,78,44,25,5,11,12,111,74,45,118,10,46,127,55,59,13,54,47,27,133,164,81,37,60,30,2,135,16,92,18,125,210,28,19,107,168,101,50,39,99,161,66,332,142,114,8,31,175,116,84,319,260],"po":"2021-06-18","u":"2026-02-10","st":"2021-09","ag":"18 and over"},{"n":"NCT04933669","t":"Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors","s":"rec","p":"phase2","d":[12],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"gist"]],"po":"2021-06-22","u":"2021-10-12","st":"2021-09","ag":"18–80"},{"n":"NCT04943913","t":"Study of GC101 TIL in Brain Glioma (Soochow2)","s":"rec","p":"earlyphase1","d":[7],"c":[4],"a":"adult older","h":[187],"po":"2021-06-29","u":"2026-08-05","st":"2021-05","ag":"18–75"},{"n":"NCT04944563","t":"Comparison of Segmentectomy Versus Lobectomy for Non-small Cell Lung Cancer ≤ 2 cm in the Middle Third of the Lung Field","s":"rec","p":"na","d":[4],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"lung"]],"po":"2021-06-29","u":"2022-04-05","st":"2021-07","ag":"18–75"},{"n":"NCT04944914","t":"Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For Oligometastatic Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2021-06-30","u":"2026-04-30","st":"2021-06","ag":"18–70"},{"n":"NCT04947280","t":"Single Arm Phase II Study of Fractionated Stereotatic Radiation Therapy (FSRT) for Bone Metastases in Breast Cancer","s":"rec","p":"phase1phase2","d":[6],"c":[5],"lc":[5],"a":"child adult older","h":[9],"l":[[9,"breast"]],"po":"2021-07-01","u":"2021-07-01","st":"2021-01","ag":"Not stated"},{"n":"NCT04947813","t":"Genotype-Phenotype Correlations in Patients With Alport Syndrome","s":"rec","p":"na","d":[45],"c":[5],"lc":[5],"a":"child adult older","h":[90],"l":[[90,"alport"]],"po":"2021-07-01","u":"2021-07-01","st":"2021-01","ag":"Not stated"},{"n":"NCT04951622","t":"A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis","s":"rec","p":"phase3","d":[27],"c":[2,15,8,22,16,0,23,27,5,30,39],"a":"adult older","h":[103,59,11,122,40,71,220,94,124,108,27,102,140,82],"po":"2021-07-07","u":"2026-11-05","st":"2021-07","ag":"18 and over"},{"n":"NCT04951635","t":"A Phase III Study to Assess the Effects of Almonertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer","s":"rec","p":"phase3","d":[4],"c":[27],"a":"adult older","h":[57],"po":"2021-07-07","u":"2022-06-16","st":"2021-03","ag":"18 and over"},{"n":"NCT04952272","t":"Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors","s":"rec","p":"phase1","d":[2,4],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"hcc"]],"po":"2021-07-07","u":"2024-06-26","st":"2021-03","ag":"18–80"},{"n":"NCT04961515","t":"Orelabrutinib, Sintilimab and Temozolomide in Relapsed or Refractory Central Nervous System Lymphoma","s":"rec","p":"phase2","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lymph"]],"po":"2021-07-14","u":"2025-07-31","st":"2021-07","ag":"18–75"},{"n":"NCT04973605","t":"A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma","s":"rec","p":"phase1phase2","d":[15],"c":[2,8,1,16,23,9,28,26,5,11,18,30,13,7,20],"a":"adult older","h":[46,89,69,12,59,78,6,48,37,25,8,115,140,118,14,186,2,151,13],"po":"2021-07-22","u":"2026-10-26","st":"2021-09","ag":"18 and over"},{"n":"NCT04976296","t":"MRD Monitoring in Lung Cancer After Resection","s":"rec","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"lung"]],"po":"2021-07-26","u":"2022-03-17","st":"2021-09","ag":"18 and over"},{"n":"NCT04980716","t":"Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients","s":"rec","p":"phase3","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2021-07-28","u":"2025-11-18","st":"2021-06","ag":"18–75"},{"n":"NCT04983121","t":"Efficacy and Safety of Pyrotinib Maleate Combined With ARX788 Neoadjuvant Treatment in Breast Cancer Patients","s":"rec","p":"phase2","d":[6],"c":[11],"lc":[11],"a":"adult older","x":"female","h":[143],"l":[[143,"breast"]],"po":"2021-07-30","u":"2022-09-13","st":"2021-08","ag":"18–75"},{"n":"NCT04989621","t":"Orelabrutinib Plus Rituximab Followed by Maintenance With Orelabrutinib for Relapsed and Refractory Follicular Lymphoma(RR FL)","s":"rec","p":"phase2","d":[19],"c":[0],"a":"adult older","h":[53,43,99],"po":"2021-08-04","u":"2026-04-23","st":"2021-08","ag":"18 and over"},{"n":"NCT04993690","t":"A Study of LP-168 in Participants With Relapse or Refractory B-Cell Lymphoma","s":"rec","p":"phase1","d":[19],"c":[2,0],"a":"adult older","h":[53,74,115],"po":"2021-08-06","u":"2026-09-14","st":"2021-07","ag":"18–80"},{"n":"NCT04996121","t":"A Study of XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid Tumors","s":"rec","p":"phase1phase2","d":[4],"c":[2],"a":"adult older","h":[23],"po":"2021-08-09","u":"2022-08-30","st":"2021-12","ag":"18 and over"},{"n":"NCT04997837","t":"Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma","s":"rec","p":"phase3","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"gc"]],"po":"2021-08-10","u":"2021-08-10","st":"2021-07","ag":"18 and over"},{"n":"NCT04999384","t":"First in Human, Dose Escalation Study of AN4005","s":"rec","p":"phase1","d":[19],"c":[2,24,13],"a":"adult older","h":[74,12,45],"po":"2021-08-10","u":"2025-11-18","st":"2021-09","ag":"18 and over"},{"n":"NCT05006716","t":"A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies","s":"rec","p":"phase1phase2","d":[19],"c":[2,0,5,30,37,68,20],"a":"adult older","h":[123,38,69,37,70,81,214],"po":"2021-08-16","u":"2026-10-05","st":"2021-09","ag":"18 and over"},{"n":"NCT05010863","t":"Gastric Cancer Marker Detection and Its Kit Development","s":"rec","p":"na","d":[3],"c":[37],"lc":[37],"a":"child adult older","h":[188],"l":[[188,"gc"]],"po":"2021-08-18","u":"2021-08-18","st":"2021-01","ag":"Not stated"},{"n":"NCT05011487","t":"Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLC","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2021-08-18","u":"2024-01-16","st":"2021-08","ag":"18–75"},{"n":"NCT05014464","t":"ALK Tyrosine Kinase Inhibitors in ALK-rearranged Advanced Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2021-08-20","u":"2024-09-20","st":"2021-11","ag":"18 and over"},{"n":"NCT05018520","t":"The Safety and Effectiveness of 4R-CHOP+4R vs 6R-CHOP+2R in Newly Diagnosed Patients With DLBCL in Low Risk","s":"rec","p":"phase3","d":[19],"c":[5],"lc":[5],"a":"child adult older","h":[123],"l":[[123,"lymph"]],"po":"2021-08-24","u":"2026-05-11","st":"2021-09","ag":"14–75"},{"n":"NCT05020236","t":"A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments","s":"rec","p":"phase3","d":[15],"c":[2,15,1,16,0,23,27,9,28,21,18,30,37,13,31,20],"a":"adult older","h":[46,69,64,38,36,37,27,60,53,115,81,140,113,70,43,14,186,2,104,295],"po":"2021-08-25","u":"2026-08-24","st":"2021-10","ag":"18 and over"},{"n":"NCT05024214","t":"Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors","s":"rec","p":"phase1phase2","d":[2,4],"c":[2,55,15,52,16,0,23,24,47,5,11,12,30,20,59],"a":"adult older","h":[6,26,25,58,82,27,143,45,0,140,171,164,210,18,94,138,135,176],"po":"2021-08-27","u":"2026-03-25","st":"2021-11","ag":"18 and over"},{"n":"NCT05032768","t":"The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2021-09-02","u":"2021-09-02","st":"2021-01","ag":"18–70"},{"n":"NCT05033392","t":"PD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer","s":"rec","p":"phase2","d":[3],"c":[21],"lc":[21],"a":"adult older","h":[168],"l":[[168,"gc"]],"po":"2021-09-02","u":"2025-02-05","st":"2021-09","ag":"18–79"},{"n":"NCT05035108","t":"The Treatment of Bioartificial Liver With hiHep Cells After Extensive Hepatectomy","s":"rec","p":"earlyphase1","d":[2],"c":[23],"lc":[23],"a":"adult older","h":[82],"l":[[82,"hcc"]],"po":"2021-09-05","u":"2025-06-26","st":"2021-09","ag":"30–80"},{"n":"NCT05035147","t":"Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer","s":"rec","p":"phase4","d":[5],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"panc"]],"po":"2021-09-05","u":"2021-09-21","st":"2021-03","ag":"18 and over"},{"n":"NCT05040555","t":"R-CDOP Regimen in the Treatment of Newly Diagnosed Non-Hodgkin's Lymphoma With High Tumor Burden","s":"rec","p":"na","d":[19],"c":[15],"a":"adult older","h":[27],"po":"2021-09-10","u":"2021-09-16","st":"2021-08","ag":"18–75"},{"n":"NCT05047510","t":"GPC3 Targeted Fluorescence Image Guided Surgery of Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[73,59],"a":"adult older","h":[238,305],"po":"2021-09-17","u":"2023-08-30","st":"2021-09","ag":"18–75"},{"n":"NCT05053802","t":"Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56,41,123,296,121,177],"l":[[56,"lung"]],"po":"2021-09-23","u":"2021-09-23","st":"2021-03","ag":"18–79"},{"n":"NCT05055908","t":"Efficacy and Biomarker Development for Lung Cancer Treated With Immune Checkpoint Inhibitors","s":"rec","p":"phase3","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2021-09-24","u":"2024-08-02","st":"2021-10","ag":"18 and over"},{"n":"NCT05057845","t":"Cryoablation Combined with Tislelizumab Plus Lenvatinib As Second-line or Later Therapy in Advanced Hepatocellular Carcinoma","s":"rec","p":"phase2","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"hcc"]],"po":"2021-09-27","u":"2025-02-27","st":"2021-09","ag":"18 and over"},{"n":"NCT05059379","t":"Medial vs. Entire Supraclavicular Lymph Node Radiation Therapy for Patients With Invasive Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2021-09-28","u":"2021-10-25","st":"2021-09","ag":"18–75"},{"n":"NCT05059951","t":"Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung Cancer","s":"rec","p":"na","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2021-09-28","u":"2024-06-04","st":"2021-10","ag":"18 and over"},{"n":"NCT05062005","t":"ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[49],"l":[[49,"npc"]],"po":"2021-09-30","u":"2021-09-30","st":"2021-09","ag":"18–65"},{"n":"NCT05062837","t":"Hepatectomy Combined With Camrelizumab and Apatinib in CNLC Stage IIIb HCC","s":"rec","p":"phase2phase3","d":[2],"c":[10],"lc":[10],"a":"adult older","h":[50],"l":[[50,"hcc"]],"po":"2021-09-30","u":"2026-10-08","st":"2021-06","ag":"18–75"},{"n":"NCT05063136","t":"Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[20],"lc":[20],"a":"adult older","x":"female","h":[37],"l":[[37,"breast"]],"po":"2021-09-30","u":"2024-11-04","st":"2021-09","ag":"18–70"},{"n":"NCT05069220","t":"18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor","s":"rec","p":"earlyphase1","d":[13],"c":[2],"lc":[2],"a":"child adult older","h":[38],"l":[[38,"nb"]],"po":"2021-10-06","u":"2024-03-01","st":"2021-09","ag":"1–80"},{"n":"NCT05072626","t":"High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia","s":"rec","p":"na","d":[30],"c":[5],"lc":[5],"a":"child","h":[76],"l":[[76,"ba"]],"po":"2021-10-11","u":"2026-04-03","st":"2021-10","ag":"Up to 3 months"},{"n":"NCT05088226","t":"Ruxolitinib and Chidamide Intensified Bu/CY Conditioning Regimen","s":"rec","p":"phase2","d":[16],"c":[2],"lc":[2],"a":"child adult older","h":[26],"l":[[26,"ball"]],"po":"2021-10-21","u":"2026-04-23","st":"2021-12","ag":"12–65"},{"n":"NCT05098197","t":"A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)","s":"rec","p":"earlyphase1","d":[5],"c":[5],"a":"adult older","h":[296],"po":"2021-10-28","u":"2025-12-11","st":"2021-09","ag":"18–75"},{"n":"NCT05099172","t":"First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)","s":"rec","p":"phase1phase2","d":[4],"c":[2,8,22,16,23,24,27,28,5,29],"a":"adult older","h":[40,42,57,44,74,45,124,13,82,60,30,94,66],"po":"2021-10-29","u":"2026-11-12","st":"2021-10","ag":"18 and over"},{"n":"NCT05104788","t":"A Study of Icotinib With Chemotherapy as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"lung"]],"po":"2021-11-03","u":"2021-11-03","st":"2021-10","ag":"18–75"},{"n":"NCT05126160","t":"Immune Score Based Radiomics in Nasopharyngeal Carcinoma","s":"rec","p":"na","d":[0],"c":[23,61,37,13],"lc":[23],"a":"adult older","h":[44,16,215,81,182],"l":[[44,"npc"]],"po":"2021-11-18","u":"2021-11-18","st":"2021-11","ag":"18–70"},{"n":"NCT05142475","t":"A Study of GC101 TIL in Advanced Breast Cancer (10hospital)","s":"rec","p":"earlyphase1","d":[6],"c":[5],"a":"adult older","h":[296],"po":"2021-12-02","u":"2025-12-11","st":"2021-11","ag":"18–75"},{"n":"NCT05145127","t":"Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors","s":"rec","p":"phase3","d":[21],"c":[2,0,41,9,30,13],"a":"child adult older","x":"male","h":[284,69,70,36,137,216],"po":"2021-12-06","u":"2026-10-26","st":"2021-11","ag":"1–74"},{"n":"NCT05147467","t":"Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL","s":"rec","p":"phase2","d":[19],"c":[0,6,23,9,4,13,20],"a":"adult older","h":[53,46,5,12,37,70,0,14,7],"po":"2021-12-07","u":"2026-03-27","st":"2021-12","ag":"18 and over"},{"n":"NCT05150145","t":"Radiotherapy or Observation of Liver Metastases in Small Cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[41],"lc":[41],"a":"adult older","h":[137],"l":[[137,"lung"]],"po":"2021-12-08","u":"2025-06-26","st":"2021-04","ag":"18–70"},{"n":"NCT05159193","t":"Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2021-12-16","u":"2024-02-02","st":"2021-12","ag":"18–70"},{"n":"NCT05187338","t":"Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors","s":"rec","p":"phase1phase2","d":[3,4,5,6],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"gc"]],"po":"2022-01-11","u":"2024-06-25","st":"2021-11","ag":"18–70"},{"n":"NCT05194982","t":"A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor","s":"rec","p":"phase1","d":[0],"c":[8,1,0,13],"a":"adult older","h":[53,13,2,16,12,278],"po":"2022-01-18","u":"2026-08-27","st":"2021-11","ag":"18–75"},{"n":"NCT05209620","t":"Orelabrutinib Combined With Pemetrexed For Relapsed/Refractory Central Nervous System Lymphoma","s":"rec","p":"phase2","d":[19],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"lymph"]],"po":"2022-01-26","u":"2025-04-23","st":"2021-12","ag":"18–75"},{"n":"NCT05218889","t":"Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer","s":"rec","p":"phase1phase2","d":[5],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"panc"]],"po":"2022-02-01","u":"2024-12-31","st":"2021-08","ag":"18–75"},{"n":"NCT05241119","t":"Axillary Lymph Node Treatment Guided by Naocarbon Tracing After Neoadjuvant Chemotherapy","s":"rec","p":"na","d":[6],"c":[11],"lc":[11],"a":"adult older","x":"female","h":[143,18],"l":[[143,"breast"]],"po":"2022-02-15","u":"2022-02-15","st":"2021-11","ag":"18–70"},{"n":"NCT05283993","t":"A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH","s":"rec","p":"na","d":[15],"c":[2],"lc":[2],"a":"child adult older","h":[29],"l":[[29,"mm"]],"po":"2022-03-17","u":"2026-09-16","st":"2021-07","ag":"Not stated"},{"n":"NCT05292742","t":"Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[16],"lc":[16],"a":"adult older","x":"female","h":[140],"l":[[140,"breast"]],"po":"2022-03-23","u":"2022-03-23","st":"2021-07","ag":"18–75"},{"n":"NCT05466565","t":"Antiviral Therapy for Patients With Liver Cancer After Surgery","s":"rec","p":"na","d":[2],"c":[8],"lc":[8],"a":"adult older","h":[11],"l":[[11,"hcc"]],"po":"2022-07-20","u":"2022-07-20","st":"2021-12","ag":"18–65"},{"n":"NCT05479409","t":"Neoadjuvant Radiation in Locally Advanced Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2022-07-29","u":"2026-06-26","st":"2021-03","ag":"18–70"},{"n":"NCT05508126","t":"Multi-parametric MRI and Dual-energy CT in Patients of Gastric Cancer","s":"rec","p":"na","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"gc"]],"po":"2022-08-19","u":"2024-10-15","st":"2021-11","ag":"18 and over"},{"n":"NCT05514769","t":"Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer","s":"rec","p":"na","d":[3],"c":[51],"lc":[51],"a":"adult older","h":[345],"l":[[345,"gc"]],"po":"2022-08-24","u":"2026-03-31","st":"2021-01","ag":"18–85"},{"n":"NCT05541367","t":"Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer","s":"rec","p":"na","d":[6],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"breast"]],"po":"2022-09-15","u":"2022-09-15","st":"2021-12","ag":"18 and over"},{"n":"NCT05552846","t":"Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lung"]],"po":"2022-09-23","u":"2026-08-12","st":"2021-01","ag":"18–80"},{"n":"NCT05559645","t":"Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15)","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"lung"]],"po":"2022-09-29","u":"2026-09-02","st":"2021-11","ag":"18 and over"},{"n":"NCT05598528","t":"Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)","s":"rec","p":"na","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[10],"l":[[10,"lung"]],"po":"2022-10-28","u":"2024-12-02","st":"2021-09","ag":"18 and over"},{"n":"NCT05728268","t":"Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index","s":"rec","p":"phase2","d":[6],"c":[43],"lc":[43],"a":"adult older","x":"female","h":[160],"l":[[160,"breast"]],"po":"2023-02-15","u":"2026-01-02","st":"2021-08","ag":"18–70"},{"n":"NCT05751018","t":"Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"lung"]],"po":"2023-03-02","u":"2025-12-02","st":"2021-12","ag":"18 and over"},{"n":"NCT05775419","t":"Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC","s":"rec","p":"na","d":[1],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"escc"]],"po":"2023-03-20","u":"2023-03-20","st":"2021-06","ag":"18–70"},{"n":"NCT06021678","t":"Safety and Efficacy of EX103 in Subjects with Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma","s":"rec","p":"phase1phase2","d":[19],"c":[27,30,20],"a":"adult older","h":[69,124,37],"po":"2023-09-01","u":"2025-02-27","st":"2021-11","ag":"18 and over"},{"n":"NCT06078930","t":"Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms","s":"rec","p":"na","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"gc"]],"po":"2023-10-12","u":"2025-06-04","st":"2021-06","ag":"18–90"},{"n":"NCT06099912","t":"Individualized Dynamic Frailty-tailored Therapy (DynaFiT) in Elderly Patients With NDMM","s":"rec","p":"na","d":[15],"c":[15],"lc":[15],"a":"older","h":[27],"l":[[27,"mm"]],"po":"2023-10-25","u":"2026-02-12","st":"2021-09","ag":"65 and over"},{"n":"NCT06189391","t":"A Study to Evaluate MK-1045 (CN201) in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (MK-1045-001/CN201-101)","s":"rec","p":"phase1","d":[19],"c":[2,15,22,0,27,9,5,18,30,7,20],"a":"adult older","h":[53,25,74,58,26,9,8,37,24,27,47,6,57,116,65],"po":"2024-01-03","u":"2026-10-29","st":"2021-03","ag":"18–75"},{"n":"NCT06234137","t":"A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrotinib in the Treatment of Local-advanced HER2-positive Breast Cancer","s":"rec","p":"na","d":[6],"c":[37],"lc":[37],"a":"adult older","x":"female","h":[81],"l":[[81,"breast"]],"po":"2024-01-31","u":"2024-01-31","st":"2021-11","ag":"18–75"},{"n":"NCT06333561","t":"HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[2],"a":"adult older","h":[26],"po":"2024-03-27","u":"2025-02-06","st":"2021-01","ag":"18–75"},{"n":"NCT06369181","t":"Neuroendocrine Transformation in RB1/TP53 Inactivated NSCLC","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2024-04-16","u":"2024-04-23","st":"2021-01","ag":"18 and over"},{"n":"NCT06725524","t":"A Study of JMT601 in Participants With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin Lymphoma","s":"rec","p":"phase1","d":[19],"c":[5],"a":"adult older","h":[123],"po":"2024-12-10","u":"2024-12-10","st":"2021-10","ag":"18–70"},{"n":"NCT06754059","t":"Pyrotinib Combined With Trastuzumab for Maintenance Therapy After First-line TH (P) Therapy for HER2+ABC","s":"rec","p":"na","d":[6],"c":[16],"lc":[16],"a":"adult older","x":"female","h":[379],"l":[[379,"breast"]],"po":"2024-12-31","u":"2025-01-01","st":"2021-06","ag":"18–70"},{"n":"NCT07080437","t":"An Observational Study on the Safety and Efficacy of Immunotherapy Combined With Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma","s":"rec","p":"na","d":[1],"c":[1],"lc":[1],"a":"older","h":[178],"l":[[178,"escc"]],"po":"2025-07-23","u":"2025-07-23","st":"2021-03","ag":"70 and over"},{"n":"NCT07198217","t":"Real World Study of Platinum Containing Dual Drug Chemotherapy Followed by Large Fractionated Radiotherapy Combined withTislelizumab in Stage IIIB/C-IV Non-small Cell Lung Cancer Patient","s":"rec","p":"phase2","d":[4],"c":[91],"lc":[91],"a":"adult older","h":[355],"l":[[355,"lung"]],"po":"2025-09-30","u":"2025-09-30","st":"2021-05","ag":"18–75"},{"n":"NCT07300449","t":"A Prospective Multicenter Clinical Study of SCCG Protocol and ctDNA 5hmc in Predicting the Chemotherapy Sensitivity and Monitoring the Recurrence and Metastasis of Hepatoblastoma in Children and Adolescents","s":"rec","p":"phase2","d":[8],"c":[0],"lc":[0],"a":"child adult","h":[53],"l":[[53,"hb"]],"po":"2025-12-23","u":"2025-12-23","st":"2021-06","ag":"Up to 18"},{"n":"NCT07320586","t":"Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[27],"lc":[27],"a":"adult older","h":[57],"l":[[57,"gc"]],"po":"2026-01-06","u":"2026-03-13","st":"2021-03","ag":"18–75"},{"n":"NCT07776301","t":"Application of CT-Linac-Based \"All-in-One\" One-Stop Radiotherapy in Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2026-08-20","u":"2026-08-20","st":"2021-08","ag":"18 and over"},{"n":"NCT03907826","t":"PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients","s":"rec","p":"phase3","d":[0],"c":[22,16,0,41,23,9,10,5,13,39,7],"lc":[0],"a":"adult older","h":[53,30,15,9,8,47,44,116,137,133,131],"l":[[53,"npc"]],"po":"2019-04-09","u":"2026-05-07","st":"2020-03","ag":"18–70"},{"n":"NCT03936153","t":"Study to Evaluate Efficacy and Safety of Oral Abexinostat in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)","s":"rec","p":"phase2","d":[19],"c":[2,22,16,23,33,25,5,18,13,31,20],"a":"adult older","h":[40,25,23,12,140,64,9,115,37,24,44,30,142,62,67],"po":"2019-05-03","u":"2025-04-10","st":"2020-01","ag":"18 and over"},{"n":"NCT03972956","t":"Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease","s":"rec","p":"na","d":[3],"c":[13],"lc":[13],"a":"adult older","h":[16],"l":[[16,"gc"]],"po":"2019-06-04","u":"2022-04-29","st":"2020-12","ag":"18–80"},{"n":"NCT04085900","t":"Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City","s":"rec","p":"na","d":[0],"c":[87,46],"lc":[46],"a":"adult older","h":[134,317],"l":[[134,"npc"]],"po":"2019-09-11","u":"2026-09-29","st":"2020-04","ag":"30–69"},{"n":"NCT04150744","t":"RFA Plus Carrizumab vs Carrizumab Alone for HCC","s":"rec","p":"phase2","d":[2],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"hcc"]],"po":"2019-11-05","u":"2020-07-08","st":"2020-08","ag":"18–75"},{"n":"NCT04158843","t":"Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometastasis","s":"rec","p":"na","d":[6],"c":[23],"a":"adult older","x":"female","h":[44,54],"po":"2019-11-12","u":"2020-05-12","st":"2020-05","ag":"18–75"},{"n":"NCT04209218","t":"Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[29],"l":[[29,"lung"]],"po":"2019-12-24","u":"2025-07-31","st":"2020-04","ag":"50–90"},{"n":"NCT04220047","t":"Effects of Left Atrial Appendage Resection and Marshall Ligament Amputation on Clinical Outcome in Patients Undergoing Off-pump Coronary Artery Bypass","s":"rec","p":"na","d":[31],"c":[2],"a":"adult older","h":[213],"po":"2020-01-07","u":"2021-01-20","st":"2020-04","ag":"18–80"},{"n":"NCT04227015","t":"A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy","s":"rec","p":"earlyphase1","d":[16,19],"c":[23],"lc":[23],"a":"child adult older","h":[46],"l":[[46,"ball"]],"po":"2020-01-13","u":"2020-12-28","st":"2020-01","ag":"3–70"},{"n":"NCT04255563","t":"Drug-coating Balloon Treatment in Coronary Artery Disease","s":"rec","p":"na","d":[31],"c":[28],"lc":[28],"a":"adult older","h":[78,119],"l":[[78,"cad"]],"po":"2020-02-05","u":"2024-11-15","st":"2020-02","ag":"18 and over"},{"n":"NCT04280822","t":"Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma","s":"rec","p":"phase3","d":[1],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"escc"]],"po":"2020-02-21","u":"2022-10-04","st":"2020-04","ag":"18–75"},{"n":"NCT04281641","t":"Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2020-02-24","u":"2020-05-04","st":"2020-04","ag":"18–70"},{"n":"NCT04295473","t":"Reduced Port Laparoscopic Gastrectomy for Gastric Cancer","s":"rec","p":"na","d":[3],"c":[51],"lc":[51],"a":"adult older","h":[345],"l":[[345,"gc"]],"po":"2020-03-04","u":"2026-11-16","st":"2020-03","ag":"18–90"},{"n":"NCT04300686","t":"A Pilot Study in Severe Patients With Takayasu Arteritis.","s":"rec","p":"phase4","d":[35],"c":[5],"lc":[5],"a":"child adult older","h":[6],"l":[[6,"takayasu"]],"po":"2020-03-09","u":"2021-08-10","st":"2020-03","ag":"14–100"},{"n":"NCT04316364","t":"A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC","s":"rec","p":"phase3","d":[4],"c":[2,22,0,23,28,5,20],"a":"adult older","h":[40,43,44,6,74,127,37],"po":"2020-03-20","u":"2021-11-04","st":"2020-07","ag":"18–70"},{"n":"NCT04322617","t":"Anlotinib Plus Immune Checkpoint Inhibitors for Lung Cancer","s":"rec","p":"phase2phase3","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2020-03-26","u":"2024-06-04","st":"2020-03","ag":"18 and over"},{"n":"NCT04322890","t":"Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation","s":"rec","p":"phase2","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2020-03-26","u":"2024-10-22","st":"2020-04","ag":"18 and over"},{"n":"NCT04324164","t":"Survival Outcome of EGFR-TKI in Uncommon EGFR Mutant Advanced NSCLC","s":"rec","p":"na","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2020-03-27","u":"2025-01-27","st":"2020-03","ag":"18 and over"},{"n":"NCT04365036","t":"A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL)","s":"rec","p":"phase3","d":[19],"c":[0],"a":"adult older","h":[43],"po":"2020-04-28","u":"2025-03-13","st":"2020-05","ag":"18–75"},{"n":"NCT04376866","t":"Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[10],"lc":[10],"a":"adult older","h":[50],"l":[[50,"npc"]],"po":"2020-05-06","u":"2021-07-20","st":"2020-06","ag":"18–65"},{"n":"NCT04390737","t":"Evaluate the Safety and Clinical Activity of HH2853","s":"rec","p":"phase1phase2","d":[19],"c":[2,8,22,0,23,17,28,10,5,11,12,30,13,20],"a":"adult older","h":[40,53,74,58,12,37,60,6,44,143,112,13,50,18,84],"po":"2020-05-15","u":"2026-01-30","st":"2020-09","ag":"18 and over"},{"n":"NCT04425265","t":"Plasma Radiofrequency Ablation at Low Temperature Versus Electrocautery Block Resection at High Frequency for Localized Recurrent Nasopharyngeal Carcinoma","s":"rec","p":"na","d":[0],"c":[0,59],"a":"adult older","h":[53,171],"po":"2020-06-11","u":"2026-05-08","st":"2020-06","ag":"18–70"},{"n":"NCT04437329","t":"Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[95],"l":[[95,"npc"]],"po":"2020-06-18","u":"2022-05-10","st":"2020-08","ag":"18–65"},{"n":"NCT04440436","t":"Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's Lymphoma(NHL) Patients","s":"rec","p":"phase1phase2","d":[19],"c":[2],"a":"adult older","h":[74],"po":"2020-06-19","u":"2020-12-08","st":"2020-06","ag":"18 and over"},{"n":"NCT04448522","t":"Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[0,85,87,46],"lc":[0],"a":"adult older","h":[53,134,317,308],"l":[[53,"npc"]],"po":"2020-06-26","u":"2020-09-28","st":"2020-08","ag":"18–70"},{"n":"NCT04453813","t":"Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[0,85,87,46,59],"a":"adult older","h":[53,171,134,317,308],"po":"2020-07-01","u":"2020-09-28","st":"2020-07","ag":"18–70"},{"n":"NCT04453826","t":"Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[0,85,87,46,59],"a":"adult older","h":[53,171,134,317,308],"po":"2020-07-01","u":"2020-09-28","st":"2020-09","ag":"18–70"},{"n":"NCT04481932","t":"Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[74],"l":[[74,"breast"]],"po":"2020-07-22","u":"2020-07-22","st":"2020-07","ag":"18–70"},{"n":"NCT04494503","t":"Study of APG2575 Single Agent and Combination Therapy in Patients With Relapsed/Refractory CLL/SLL","s":"rec","p":"phase1phase2","d":[19],"c":[2,15,8,1,0,41,23,9,28,10,5,18,4,30,13],"a":"adult older","h":[78,5,12,54,69,9,115,24,27,2,70,11,6,14,137,120,50],"po":"2020-07-31","u":"2025-04-16","st":"2020-08","ag":"18 and over"},{"n":"NCT04501523","t":"A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After NAC in TNBC","s":"rec","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2020-08-06","u":"2023-02-21","st":"2020-08","ag":"18–80"},{"n":"NCT04504526","t":"Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases","s":"rec","p":"earlyphase1","d":[15,19],"c":[16],"lc":[16],"a":"adult older","h":[136],"l":[[136,"mm"]],"po":"2020-08-07","u":"2026-07-21","st":"2020-08","ag":"18–80"},{"n":"NCT04519905","t":"Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)","s":"rec","p":"na","d":[1],"c":[28,5],"lc":[5],"a":"older","h":[139,127],"l":[[139,"escc"]],"po":"2020-08-20","u":"2021-11-02","st":"2020-01","ag":"76 and over"},{"n":"NCT04539977","t":"PD-L1 Antibody (TQB2450) Plus Chemotherapy for Previously Untreated Limited- Stage Small-cell Lung Cancer","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2020-09-07","u":"2023-05-09","st":"2020-09","ag":"18–75"},{"n":"NCT04544969","t":"Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC","s":"rec","p":"na","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2020-09-10","u":"2025-01-28","st":"2020-04","ag":"18–70"},{"n":"NCT04547673","t":"To Develop and Validate a Nasoendoscopic Intelligent Diagnostic System for Nasopharyngeal Carcinoma","s":"rec","p":"na","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[49,53],"l":[[49,"npc"]],"po":"2020-09-14","u":"2024-02-20","st":"2020-06","ag":"18 and over"},{"n":"NCT04557449","t":"Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors","s":"rec","p":"phase2","d":[4,6],"c":[2,23,13,39,20],"a":"adult older","h":[23,111,37,82,19],"po":"2020-09-21","u":"2026-11-10","st":"2020-09","ag":"18 and over"},{"n":"NCT04561557","t":"Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System","s":"rec","p":"earlyphase1","d":[25,27],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"nmosd"]],"po":"2020-09-23","u":"2024-10-30","st":"2020-09","ag":"18–75"},{"n":"NCT04573660","t":"Abbott Vascular Medical Device Registry","s":"rec","p":"na","d":[31],"c":[61,39],"a":"adult older","h":[111,182],"po":"2020-10-05","u":"2026-10-13","st":"2020-10","ag":"18 and over"},{"n":"NCT04576143","t":"Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer","s":"rec","p":"phase2phase3","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2020-10-06","u":"2021-08-12","st":"2020-09","ag":"18–70"},{"n":"NCT04586478","t":"Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma","s":"rec","p":"phase2","d":[19],"c":[2,22,1,0,23,27,5,30,13,20],"a":"adult older","h":[40,123,25,74,46,36,58,69,115,124,37,43,79,162,167,295],"po":"2020-10-14","u":"2025-02-07","st":"2020-10","ag":"18–75"},{"n":"NCT04606446","t":"Study of PF-07248144 in Advanced or Metastatic Solid Tumors","s":"rec","p":"phase2","d":[4,6],"c":[2,0,39],"a":"adult older","h":[53,111,74],"po":"2020-10-28","u":"2026-10-21","st":"2020-11","ag":"18 and over"},{"n":"NCT04613596","t":"Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7","s":"rec","p":"phase2phase3","d":[4],"c":[2,55,15,8,22,1,16,0,23,24,17,27,25,9,10,5,11,21,18,12,29,13,39,7,20],"a":"adult older","h":[40,23,42,57,9,44,132,12,111,74,45,24,46,13,47,27,14,164,143,37,70,30,68,168,50,66,8,84,178,67],"po":"2020-11-03","u":"2026-11-19","st":"2020-12","ag":"18 and over"},{"n":"NCT04615143","t":"Tislelizumab or Tislelizumab Combined With Lenvatinib Neo-adjuvant Treatment for Resectable RHCC","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[49],"l":[[49,"hcc"]],"po":"2020-11-04","u":"2025-01-09","st":"2020-12","ag":"18–75"},{"n":"NCT04645199","t":"National Longitudinal Cohort of Hematological Diseases","s":"rec","p":"na","d":[15,17,19,21],"c":[30],"lc":[30],"a":"child adult older","h":[69],"l":[[69,"mm"]],"po":"2020-11-27","u":"2026-02-12","st":"2020-12","ag":"Not stated"},{"n":"NCT04646759","t":"Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2020-11-30","u":"2020-11-30","st":"2020-10","ag":"18–80"},{"n":"NCT04650243","t":"Clinical Research of Tapering UDCA in PBC Patients With a Complete Response","s":"rec","p":"phase4","d":[50],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"pbc"]],"po":"2020-12-02","u":"2025-04-01","st":"2020-01","ag":"18 and over"},{"n":"NCT04661020","t":"CD19 CAR-T Therapy for Patients With Newly Diagnosed High-risk Large B-cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"lymph"]],"po":"2020-12-09","u":"2026-04-07","st":"2020-12","ag":"18 and over"},{"n":"NCT04665882","t":"Nomogram to Predict Breast Cancer Related Lymphedema","s":"rec","p":"na","d":[6],"c":[13],"lc":[13],"a":"adult older","x":"female","h":[133],"l":[[133,"breast"]],"po":"2020-12-14","u":"2020-12-16","st":"2020-12","ag":"18–80"},{"n":"NCT04688801","t":"Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer","s":"rec","p":"na","d":[3],"c":[27],"lc":[27],"a":"adult older","h":[356],"l":[[356,"gc"]],"po":"2020-12-30","u":"2022-11-16","st":"2020-07","ag":"25–80"},{"n":"NCT04743479","t":"Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)","s":"rec","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[177],"l":[[177,"panc"]],"po":"2021-02-08","u":"2023-09-01","st":"2020-12","ag":"50–75"},{"n":"NCT04770207","t":"Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs","s":"rec","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"hcc"]],"po":"2021-02-25","u":"2024-08-21","st":"2020-11","ag":"18–99"},{"n":"NCT04807881","t":"Phase Ib Clinical Study of Keynatinib","s":"rec","p":"phase1","d":[16,19],"c":[2,22,5],"a":"adult older","h":[40,9,115,23],"po":"2021-03-19","u":"2026-10-29","st":"2020-09","ag":"18 and over"},{"n":"NCT04858724","t":"The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA)","s":"rec","p":"na","d":[46],"c":[5],"lc":[5],"a":"child adult older","h":[123],"l":[[123,"iga"]],"po":"2021-04-26","u":"2026-08-18","st":"2020-12","ag":"Not stated"},{"n":"NCT05080010","t":"Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma","s":"rec","p":"phase3","d":[9],"c":[0],"lc":[0],"a":"child adult older","h":[369],"l":[[369,"rb"]],"po":"2021-10-15","u":"2021-10-15","st":"2020-11","ag":"Not stated"},{"n":"NCT05140746","t":"Prediction of Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric Cancer","s":"rec","p":"na","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"gc"]],"po":"2021-12-01","u":"2024-01-09","st":"2020-09","ag":"18–75"},{"n":"NCT05182957","t":"Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma","s":"rec","p":"phase2","d":[19],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"lymph"]],"po":"2022-01-10","u":"2026-05-01","st":"2020-01","ag":"18 and over"},{"n":"NCT05190848","t":"Correlation of Microbiome and Metabonomics With IgA Nephropathy","s":"rec","p":"na","d":[46],"c":[0],"lc":[0],"a":"child adult older","h":[43,49,99,209,248],"l":[[43,"iga"]],"po":"2022-01-13","u":"2026-09-14","st":"2020-05","ag":"16–65"},{"n":"NCT05200715","t":"AutoInflammatory Disease Alliance Registry (AIDA)","s":"rec","p":"na","d":[44],"c":[2,1],"a":"child adult older","h":[79,48],"po":"2022-01-21","u":"2025-07-10","st":"2020-08","ag":"Not stated"},{"n":"NCT05314114","t":"Selective Omission of Axillary Surgery in Triple-negative and HER2-positive Breast Cancer After NACT","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[74],"l":[[74,"breast"]],"po":"2022-04-06","u":"2022-04-18","st":"2020-07","ag":"18–70"},{"n":"NCT05360069","t":"Linear Stapler Versus Circular Stapler in Esophagojejunostomy","s":"rec","p":"na","d":[3],"c":[51],"lc":[51],"a":"adult older","h":[345],"l":[[345,"gc"]],"po":"2022-05-04","u":"2026-04-02","st":"2020-01","ag":"18–90"},{"n":"NCT05477979","t":"The Associations of Psychological Stress With Therapy Efficacy and Prognosis of Lung Cancer (STRESS-LUNG)","s":"rec","p":"na","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[10],"l":[[10,"lung"]],"po":"2022-07-28","u":"2025-02-25","st":"2020-06","ag":"18 and over"},{"n":"NCT05520788","t":"Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing","s":"rec","p":"na","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2022-08-30","u":"2025-02-11","st":"2020-05","ag":"18 and over"},{"n":"NCT05713994","t":"Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[56],"lc":[56],"a":"adult older","h":[228],"l":[[228,"hcc"]],"po":"2023-02-06","u":"2025-03-25","st":"2020-05","ag":"18 and over"},{"n":"NCT05740995","t":"Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma","s":"rec","p":"na","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"escc"]],"po":"2023-02-23","u":"2023-03-21","st":"2020-12","ag":"18–75"},{"n":"NCT05745532","t":"Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients","s":"rec","p":"earlyphase1","d":[20],"c":[21],"lc":[21],"a":"child","h":[249],"l":[[249,"bthal"]],"po":"2023-02-27","u":"2024-11-29","st":"2020-12","ag":"8–16"},{"n":"NCT06315933","t":"Anesthesia Neurodevelopmental Impact in Congenital Scoliosis Children","s":"rec","p":"na","d":[33],"c":[2],"lc":[2],"a":"child","h":[38],"l":[[38,"scol"]],"po":"2024-03-18","u":"2025-11-18","st":"2020-07","ag":"6–16"},{"n":"NCT06375798","t":"Clinical Study of Breast Conserving Surgery Combined With Intraoperative Radiotherapy for Early Breast Cancer","s":"rec","p":"na","d":[6],"c":[18],"lc":[18],"a":"adult older","x":"female","h":[24],"l":[[24,"breast"]],"po":"2024-04-19","u":"2025-09-15","st":"2020-11","ag":"55 and over"},{"n":"NCT06526442","t":"MRE for Diagnosis of Pancreatic Masses","s":"rec","p":"na","d":[5],"c":[11],"lc":[11],"a":"adult older","h":[143],"l":[[143,"panc"]],"po":"2024-07-29","u":"2026-02-13","st":"2020-10","ag":"18–80"},{"n":"NCT06849063","t":"Assessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRE","s":"rec","p":"na","d":[5],"c":[11],"lc":[11],"a":"adult older","h":[143],"l":[[143,"panc"]],"po":"2025-02-27","u":"2026-06-09","st":"2020-10","ag":"18–80"},{"n":"NCT03491605","t":"Surveillance and Tracking the Outcomes of Chronic Latent EBV Infection","s":"rec","p":"na","d":[18],"c":[13],"lc":[13],"a":"child adult older","h":[36],"l":[[36,"hlh"]],"po":"2018-04-09","u":"2021-02-10","st":"2019-07","ag":"Not stated"},{"n":"NCT03785743","t":"Comparing Laparoscopic and Open Surgery for Pancreatic Carcinoma","s":"rec","p":"na","d":[5],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"panc"]],"po":"2018-12-24","u":"2022-03-02","st":"2019-03","ag":"18–75"},{"n":"NCT03788512","t":"Coexistence of Cerebral and Coronary Atherosclerosis in Acute Ischemic Cerebrovascular Disease Patients Registry","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[71],"l":[[71,"cad"]],"po":"2018-12-27","u":"2022-01-11","st":"2019-01","ag":"18–85"},{"n":"NCT03829553","t":"Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment","s":"rec","p":"phase3","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[123],"l":[[123,"breast"]],"po":"2019-02-04","u":"2022-06-02","st":"2019-02","ag":"18–75"},{"n":"NCT03872661","t":"Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC","s":"rec","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2019-03-13","u":"2026-04-21","st":"2019-03","ag":"18–75"},{"n":"NCT03917043","t":"APG-2449 in Patients With Advanced Solid Tumors","s":"rec","p":"phase1","d":[4],"c":[2,16,0,13],"a":"adult older","h":[12,74,140,30,49],"po":"2019-04-16","u":"2026-07-23","st":"2019-05","ag":"18 and over"},{"n":"NCT03941561","t":"S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC）","s":"rec","p":"phase3","d":[3],"c":[17,9,54],"a":"adult older","h":[271,68,116],"po":"2019-05-08","u":"2019-05-31","st":"2019-01","ag":"18–75"},{"n":"NCT03949231","t":"Infusion of PD1/PDL1/CTLA4 Inhibitors Via Hepatic Arterial for Immunotherapy of Hepatocellular Carcinoma","s":"rec","p":"phase3","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"hcc"]],"po":"2019-05-14","u":"2024-06-26","st":"2019-01","ag":"18–80"},{"n":"NCT03964753","t":"Neoadjuvant Therapy With Nab-paclitaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase2","d":[1],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"escc"]],"po":"2019-05-28","u":"2023-10-10","st":"2019-04","ag":"18–75"},{"n":"NCT04008329","t":"A Registered Cohort Study on Amyotrophic Lateral Sclerosis","s":"rec","p":"na","d":[39],"c":[16],"lc":[16],"a":"child adult older","h":[136],"l":[[136,"als"]],"po":"2019-07-05","u":"2021-03-22","st":"2019-07","ag":"Not stated"},{"n":"NCT04010604","t":"A Registered Cohort Study on SMA","s":"rec","p":"na","d":[40],"c":[16],"lc":[16],"a":"child adult older","h":[136],"l":[[136,"sma"]],"po":"2019-07-08","u":"2019-09-23","st":"2019-07","ag":"1 week–70"},{"n":"NCT04012658","t":"A Registered Cohort Study on Wilson's Disease","s":"rec","p":"na","d":[29],"c":[16],"lc":[16],"a":"child adult older","h":[136],"l":[[136,"wilson"]],"po":"2019-07-09","u":"2019-09-23","st":"2019-07","ag":"Not stated"},{"n":"NCT04012671","t":"A Registered Cohort Study on Duchenne Muscular Dystrophy","s":"rec","p":"na","d":[43],"c":[16],"lc":[16],"a":"child adult older","h":[136],"l":[[136,"dmd"]],"po":"2019-07-09","u":"2021-03-22","st":"2019-07","ag":"2 and over"},{"n":"NCT04025450","t":"Comparation of Chidamide Plus VRD (Bortezomib, Lenalidomide, Dexamethasone) With VRD Regimen for Primary High-Risk Multiple Myeloma Patients","s":"rec","p":"phase1phase2","d":[15],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"mm"]],"po":"2019-07-19","u":"2019-07-19","st":"2019-07","ag":"18–80"},{"n":"NCT04043494","t":"International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma","s":"rec","p":"phase3","d":[19],"c":[8],"lc":[8],"a":"child adult","h":[380],"l":[[380,"lymph"]],"po":"2019-08-02","u":"2026-05-06","st":"2019-08","ag":"Up to 18"},{"n":"NCT04047953","t":"Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric Adenocarcinoma","s":"rec","p":"na","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"gc"]],"po":"2019-08-07","u":"2023-04-05","st":"2019-09","ag":"18–75"},{"n":"NCT04065321","t":"Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer","s":"rec","p":"na","d":[6],"c":[11],"lc":[11],"a":"adult","x":"female","h":[143,18],"l":[[143,"breast"]],"po":"2019-08-22","u":"2022-05-05","st":"2019-10","ag":"18–60"},{"n":"NCT04069884","t":"RecurIndex Guided Avoidance of Regional Nodal Irradiation for Node Positive Breast Cancer","s":"rec","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2019-08-28","u":"2025-09-22","st":"2019-08","ag":"18–70"},{"n":"NCT04072653","t":"Sentinel Node Biopsy Vs Observation After Axillary PET","s":"rec","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2019-08-28","u":"2020-07-13","st":"2019-09","ag":"18 and over"},{"n":"NCT04084496","t":"mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients","s":"rec","p":"phase2","d":[5],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"panc"]],"po":"2019-09-10","u":"2025-05-30","st":"2019-09","ag":"18–79"},{"n":"NCT04106830","t":"Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)","s":"rec","p":"na","d":[25],"c":[2],"lc":[2],"a":"child adult older","h":[102],"l":[[102,"nmosd"]],"po":"2019-09-27","u":"2026-06-15","st":"2019-01","ag":"16–75"},{"n":"NCT04135664","t":"Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carcinoma","s":"rec","p":"phase3","d":[1],"c":[9,5,30],"lc":[5],"a":"adult older","h":[42,6,58,177,123,14],"l":[[42,"escc"]],"po":"2019-10-22","u":"2019-10-22","st":"2019-09","ag":"18–75"},{"n":"NCT04138212","t":"Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)","s":"rec","p":"phase3","d":[1],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"escc"]],"po":"2019-10-24","u":"2022-08-09","st":"2019-10","ag":"18–70"},{"n":"NCT04138719","t":"Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[18],"lc":[18],"a":"adult older","x":"female","h":[24],"l":[[24,"breast"]],"po":"2019-10-24","u":"2025-09-11","st":"2019-11","ag":"18–70"},{"n":"NCT04143724","t":"Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia","s":"rec","p":"phase2","d":[20],"c":[22,0,10,21],"a":"child","h":[15,70,99,40,104],"po":"2019-10-29","u":"2026-07-10","st":"2019-11","ag":"6–17"},{"n":"NCT04159142","t":"Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer","s":"rec","p":"phase2","d":[6],"c":[18],"lc":[18],"a":"adult older","x":"female","h":[24],"l":[[24,"breast"]],"po":"2019-11-12","u":"2025-09-11","st":"2019-11","ag":"18–70"},{"n":"NCT04162353","t":"BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma","s":"rec","p":"phase1","d":[15,19],"c":[21],"a":"child adult older","h":[126],"po":"2019-11-14","u":"2025-09-16","st":"2019-07","ag":"Not stated"},{"n":"NCT04174079","t":"Study on Adjuvant Chemotherapy After Total Two-field Lymph Node Dissection of Thoracic Esophageal Squamous Cell Carcinoma","s":"rec","p":"na","d":[1],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"escc"]],"po":"2019-11-22","u":"2026-07-21","st":"2019-12","ag":"18–75"},{"n":"NCT04182984","t":"TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study","s":"rec","p":"na","d":[27],"c":[39],"lc":[39],"a":"adult older","h":[122],"l":[[122,"mg"]],"po":"2019-12-02","u":"2026-01-30","st":"2019-11","ag":"18–75"},{"n":"NCT04254263","t":"Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[41],"l":[[41,"breast"]],"po":"2020-02-05","u":"2025-09-11","st":"2019-12","ag":"18–70"},{"n":"NCT04263935","t":"Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma","s":"rec","p":"na","d":[19],"c":[20],"lc":[20],"a":"child adult older","h":[37],"l":[[37,"lymph"]],"po":"2020-02-11","u":"2025-04-23","st":"2019-01","ag":"Not stated"},{"n":"NCT04270591","t":"Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer","s":"rec","p":"phase1phase2","d":[4],"c":[2,15,8,22,0,23,24,17,27,9,28,5,11,18,30,13,20],"a":"adult older","h":[40,58,9,38,44,25,132,11,12,74,45,46,124,127,59,13,27,14,68,18,19,175,177],"po":"2020-02-17","u":"2022-08-01","st":"2019-07","ag":"18–80"},{"n":"NCT04278287","t":"Chemoradiotherapy in Unresectable Esophageal Cancer","s":"rec","p":"phase1phase2","d":[1],"c":[48,2,8,28],"lc":[2],"a":"adult older","h":[23,78,127,150,13],"l":[[23,"escc"]],"po":"2020-02-20","u":"2024-12-13","st":"2019-10","ag":"18–75"},{"n":"NCT04286841","t":"The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China","s":"rec","p":"na","d":[4],"c":[0],"a":"adult older","h":[43],"po":"2020-02-27","u":"2020-02-27","st":"2019-05","ag":"18 and over"},{"n":"NCT04365751","t":"To Compare the Efficacy of Microwave Ablation and Laparoscopic Hepatectomy for Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"hcc"]],"po":"2020-04-28","u":"2020-04-28","st":"2019-12","ag":"18 and over"},{"n":"NCT04451473","t":"Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery","s":"rec","p":"na","d":[4],"c":[27],"lc":[27],"a":"adult older","h":[356],"l":[[356,"lung"]],"po":"2020-06-30","u":"2022-11-16","st":"2019-10","ag":"18–85"},{"n":"NCT04454892","t":"Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS)","s":"rec","p":"na","d":[39],"c":[2],"lc":[2],"a":"child adult older","h":[115],"l":[[115,"als"]],"po":"2020-07-02","u":"2020-07-02","st":"2019-11","ag":"Not stated"},{"n":"NCT04937283","t":"Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm","s":"rec","p":"na","d":[4],"c":[23,17,40,61,5,31],"lc":[5],"a":"adult older","h":[56,110,54,68,182,64,202,139,222],"l":[[56,"lung"]],"po":"2021-06-24","u":"2026-04-13","st":"2019-10","ag":"20–79"},{"n":"NCT05060796","t":"Study of CXCR5 Modified EGFR Targeted CAR-T Cells for Advanced NSCLC","s":"rec","p":"earlyphase1","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"lung"]],"po":"2021-09-29","u":"2024-06-25","st":"2019-09","ag":"18–75"},{"n":"NCT05326295","t":"Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients","s":"rec","p":"na","d":[6],"c":[8],"lc":[8],"a":"adult older","x":"female","h":[13],"l":[[13,"breast"]],"po":"2022-04-13","u":"2022-04-13","st":"2019-03","ag":"18–75"},{"n":"NCT05701787","t":"Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2023-01-27","u":"2025-05-22","st":"2019-01","ag":"18 and over"},{"n":"NCT05838053","t":"Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2023-05-01","u":"2023-07-27","st":"2019-08","ag":"20–79"},{"n":"NCT06255197","t":"Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers","s":"rec","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2024-02-13","u":"2024-02-16","st":"2019-11","ag":"18 and over"},{"n":"NCT06692725","t":"De-escalation of Neoadjuvant Chemotherapy Regimens With Immunotherapy Among TNBC","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"child adult older","h":[48],"l":[[48,"breast"]],"po":"2024-11-18","u":"2024-11-20","st":"2019-01","ag":"Not stated"},{"n":"NCT06693024","t":"Adjuvant Therapy With Neratinib in HER2 Positive Early Breast Cancer","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"child adult older","h":[48],"l":[[48,"breast"]],"po":"2024-11-18","u":"2024-11-20","st":"2019-01","ag":"Not stated"},{"n":"NCT06693037","t":"Adjuvant Therapy Choice for Non-pCR HER2 Positive Early Breast Cancer After Neoadjuvant Therapy","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"child adult older","h":[48],"l":[[48,"breast"]],"po":"2024-11-18","u":"2024-11-20","st":"2019-01","ag":"Not stated"},{"n":"NCT06700382","t":"Different Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for TNBC","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"child adult older","h":[48],"l":[[48,"breast"]],"po":"2024-11-22","u":"2024-11-25","st":"2019-01","ag":"Not stated"},{"n":"NCT06711068","t":"Adjuvant Therapy for Intermediate Risk HER2 Positive, Lymph Node Negative Early Breast Cancer With Chemotherapy Combined Target Therapy","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"child adult older","h":[48],"l":[[48,"breast"]],"po":"2024-12-02","u":"2024-12-02","st":"2019-01","ag":"Not stated"},{"n":"NCT06722599","t":"Four Cycles Taxane With Trastuzumab and Pertuzumab Neoadjuvant Therapy Among Low Risk HER2 Positive Patients","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"child adult older","h":[48],"l":[[48,"breast"]],"po":"2024-12-09","u":"2024-12-09","st":"2019-01","ag":"Not stated"},{"n":"NCT06722612","t":"Chemotherapy Combined With Targeted Therapy for High-risk HER2 Positive and Lymph Node Negative Early Breast Cancer","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"child adult older","h":[48],"l":[[48,"breast"]],"po":"2024-12-09","u":"2024-12-09","st":"2019-01","ag":"Not stated"},{"n":"NCT06778512","t":"LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer","s":"rec","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[132],"l":[[132,"lung"]],"po":"2025-01-16","u":"2025-01-16","st":"2019-06","ag":"18–75"},{"n":"NCT06885307","t":"Construction of a Multi-center Clinical Research Collaboration Network for Children with Congenital Heart Disease in China","s":"rec","p":"na","d":[32],"c":[27,47,5,37,13],"lc":[5],"a":"child adult","h":[90,91,113,251,188,348],"l":[[90,"chd"]],"po":"2025-03-20","u":"2025-03-20","st":"2019-06","ag":"Up to 18"},{"n":"NCT06950697","t":"Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors","s":"rec","p":"na","d":[4],"c":[2,20],"lc":[2],"a":"adult older","h":[89,25,62],"l":[[89,"lung"]],"po":"2025-04-30","u":"2026-04-30","st":"2019-01","ag":"18 and over"},{"n":"NCT07779005","t":"The Shengjing Lung Cancer Cohort (SJ-LCC) Study on Risk Factors for Disease Development and Progression","s":"rec","p":"na","d":[4],"c":[11],"lc":[11],"a":"adult older","h":[143],"l":[[143,"lung"]],"po":"2026-08-21","u":"2026-08-21","st":"2019-02","ag":"18–75"},{"n":"NCT07782632","t":"Liver Volume Metrics for Predicting Immunotherapy Prognosis in Unresectable Hepatocellular Carcinoma","s":"rec","p":"na","d":[2],"c":[17],"lc":[17],"a":"adult older","h":[68],"l":[[68,"hcc"]],"po":"2026-08-24","u":"2026-08-24","st":"2019-01","ag":"18–75"},{"n":"NCT03217006","t":"Randomization of Single vs Multiple Arterial Grafts","s":"rec","p":"na","d":[31],"c":[2,15,5],"a":"adult older","h":[213,123,330],"po":"2017-07-13","u":"2026-08-20","st":"2018-01","ag":"18–70"},{"n":"NCT03378934","t":"Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention","s":"rec","p":"phase4","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"cad"]],"po":"2017-12-20","u":"2025-11-19","st":"2018-09","ag":"18–70"},{"n":"NCT03460977","t":"A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma","s":"rec","p":"phase1","d":[4,19],"c":[8,22,0,28,37],"a":"adult older","h":[40,132,13,81,60,120],"po":"2018-03-09","u":"2026-11-13","st":"2018-04","ag":"18 and over"},{"n":"NCT03494296","t":"A Prospective Study of Low-dose Decitabine Combined With COP Regimen in the Treatment of Relapsed and Refractory DLBCL","s":"rec","p":"na","d":[19],"c":[24],"lc":[24],"a":"adult older","h":[196],"l":[[196,"lymph"]],"po":"2018-04-11","u":"2018-04-11","st":"2018-03","ag":"18 and over"},{"n":"NCT03498326","t":"Gemcitabine and Celecoxib Combination Therapy in Treating Patients With R0 Resection Pancreatic Cancer","s":"rec","p":"phase2","d":[5],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"panc"]],"po":"2018-04-13","u":"2018-05-30","st":"2018-04","ag":"18–90"},{"n":"NCT03594422","t":"A Study of HQP1351 in Patients With GIST or Other Solid Tumors","s":"rec","p":"phase1","d":[12],"c":[2,0,5,13,20],"a":"child adult older","h":[12,26,43,37,9],"po":"2018-07-20","u":"2026-04-09","st":"2018-07","ag":"12 and over"},{"n":"NCT03612726","t":"The Overall Survival of Patients With Unresectable HCC in Real-life","s":"rec","p":"na","d":[2],"c":[2],"a":"adult older","h":[26],"po":"2018-08-02","u":"2025-03-24","st":"2018-07","ag":"18 and over"},{"n":"NCT03626480","t":"Peri-operative Nutrition in Infants With Congenital Heart Disease","s":"rec","p":"na","d":[32],"c":[23],"a":"child","h":[179],"po":"2018-08-13","u":"2020-02-11","st":"2018-07","ag":"1 day–12 months"},{"n":"NCT03647098","t":"Survival Outcomes of Lung Cancer","s":"rec","p":"na","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2018-08-27","u":"2025-02-14","st":"2018-08","ag":"18 and over"},{"n":"NCT03716089","t":"Comparison of Tumor Efficacy Safety in Laparoscopic Resection of Gastrointestinal Stromal Tumors Between Favorable and Unfavorable Site","s":"rec","p":"na","d":[3,12],"c":[16],"lc":[16],"a":"adult older","h":[140],"l":[[140,"gc"]],"po":"2018-10-23","u":"2025-04-08","st":"2018-10","ag":"18–75"},{"n":"NCT03747588","t":"The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer","s":"rec","p":"na","d":[5],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"panc"]],"po":"2018-11-20","u":"2022-10-03","st":"2018-12","ag":"18–75"},{"n":"NCT03755739","t":"Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors","s":"rec","p":"phase2phase3","d":[2,4,5,6],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"hcc"]],"po":"2018-11-28","u":"2024-06-25","st":"2018-11","ag":"18 and over"},{"n":"NCT03769129","t":"Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC","s":"rec","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"lung"]],"po":"2018-12-07","u":"2024-06-25","st":"2018-11","ag":"18 and over"},{"n":"NCT03778814","t":"TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors","s":"rec","p":"phase1","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"lung"]],"po":"2018-12-19","u":"2024-06-25","st":"2018-12","ag":"18–75"},{"n":"NCT03919552","t":"Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma","s":"rec","p":"phase3","d":[0],"c":[0],"lc":[0],"a":"adult","h":[70],"l":[[70,"npc"]],"po":"2019-04-18","u":"2023-06-18","st":"2018-01","ag":"18–64"},{"n":"NCT04025164","t":"Hypofractionated Vs Conventional Fractionated Radiotherapy After Breast Conserving Surgery","s":"rec","p":"na","d":[6],"c":[52,41,5],"lc":[5],"a":"adult older","x":"female","h":[9,155,117],"l":[[9,"breast"]],"po":"2019-07-18","u":"2019-07-18","st":"2018-07","ag":"18–70"},{"n":"NCT04263298","t":"Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[8,0,10,43,21,45],"a":"adult older","x":"female","h":[53,99,43,50,13,168,49,129,106,160,108],"po":"2020-02-10","u":"2022-09-30","st":"2018-05","ag":"18–75"},{"n":"NCT04316039","t":"Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery","s":"rec","p":"phase2phase3","d":[7],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"glioma"]],"po":"2020-03-20","u":"2020-03-20","st":"2018-04","ag":"18–70"},{"n":"NCT04483804","t":"Application of Radiomics in Breast Cancer","s":"rec","p":"na","d":[6],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"breast"]],"po":"2020-07-23","u":"2023-03-10","st":"2018-01","ag":"18–80"},{"n":"NCT05636605","t":"Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to Immunotherapy","s":"rec","p":"na","d":[4],"c":[23],"lc":[23],"a":"adult older","h":[343],"l":[[343,"lung"]],"po":"2022-12-05","u":"2022-12-20","st":"2018-01","ag":"18–80"},{"n":"NCT06876753","t":"Regional Lymph Node Metastasis and Survival Outcomes in Advanced HCC","s":"rec","p":"na","d":[2],"c":[28],"lc":[28],"a":"adult older","h":[120],"l":[[120,"hcc"]],"po":"2025-03-14","u":"2025-03-14","st":"2018-06","ag":"18–80"},{"n":"NCT03177902","t":"Evaluation of Thyroid Abnormity Incidence and Thyroid Toxicity During Chemotherapy Among Newly Diagnosed Breast Cancer","s":"rec","p":"na","d":[6],"c":[55],"lc":[55],"a":"adult older","x":"female","h":[164],"l":[[164,"breast"]],"po":"2017-06-06","u":"2026-09-04","st":"2017-06","ag":"18–85"},{"n":"NCT03192501","t":"iCAGES-guided Precision Therapy for Cancers in Contrast to Standard Care or IHC-guided Theray","s":"rec","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"lung"]],"po":"2017-06-20","u":"2024-06-25","st":"2017-07","ag":"18–70"},{"n":"NCT03193567","t":"Study of High Efficient Killing Cell Therapy for Advanced NSCLC","s":"rec","p":"phase1","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lung"]],"po":"2017-06-21","u":"2024-11-19","st":"2017-09","ag":"18–70"},{"n":"NCT03198052","t":"GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers","s":"rec","p":"phase1","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[278,49],"l":[[278,"lung"]],"po":"2017-06-23","u":"2024-06-25","st":"2017-07","ag":"18–75"},{"n":"NCT03198546","t":"GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression","s":"rec","p":"phase1","d":[2,4],"c":[0],"lc":[0],"a":"adult older","h":[278,49],"l":[[278,"hcc"]],"po":"2017-06-26","u":"2024-06-25","st":"2017-07","ag":"18–75"},{"n":"NCT03201861","t":"Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women","s":"rec","p":"phase3","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[41],"l":[[41,"breast"]],"po":"2017-06-28","u":"2025-05-16","st":"2017-07","ag":"18–70"},{"n":"NCT03219593","t":"Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer","s":"rec","p":"phase2","d":[3],"c":[55],"lc":[55],"a":"older","h":[164],"l":[[164,"gc"]],"po":"2017-07-17","u":"2026-09-08","st":"2017-09","ag":"65 and over"},{"n":"NCT03313271","t":"China Lymphoma Patient Registry Study","s":"rec","p":"na","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"lymph"]],"po":"2017-10-18","u":"2017-10-18","st":"2017-05","ag":"18 and over"},{"n":"NCT03351842","t":"Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%","s":"rec","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2017-11-24","u":"2017-12-19","st":"2017-09","ag":"19–70"},{"n":"NCT03353467","t":"Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma Patients","s":"rec","p":"na","d":[0],"c":[63,0,10,46],"a":"adult older","h":[53,96,49,198,134],"po":"2017-11-27","u":"2021-06-03","st":"2017-10","ag":"18–70"},{"n":"NCT03392233","t":"Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors","s":"rec","p":"phase2","d":[4,6],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"lung"]],"po":"2018-01-05","u":"2018-01-05","st":"2017-08","ag":"18–85"},{"n":"NCT04215211","t":"MR Based Survival Prediction of Glioma Patients Using Artificial Intelligence","s":"rec","p":"na","d":[7],"c":[20],"lc":[20],"a":"child adult older","h":[25],"l":[[25,"glioma"]],"po":"2020-01-02","u":"2021-02-08","st":"2017-01","ag":"1–90"},{"n":"NCT04215224","t":"Histopathology Images Based Survival Prediction of Glioma Patients Using Artificial Intelligence","s":"rec","p":"na","d":[7],"c":[20],"lc":[20],"a":"child adult older","h":[25],"l":[[25,"glioma"]],"po":"2020-01-02","u":"2021-02-08","st":"2017-01","ag":"1–90"},{"n":"NCT04217018","t":"MR Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence","s":"rec","p":"na","d":[7],"c":[20],"lc":[20],"a":"child adult older","h":[25],"l":[[25,"glioma"]],"po":"2020-01-03","u":"2021-02-08","st":"2017-01","ag":"1–95"},{"n":"NCT04217044","t":"Histopathology Images Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence","s":"rec","p":"na","d":[7],"c":[20],"lc":[20],"a":"child adult older","h":[25],"l":[[25,"glioma"]],"po":"2020-01-03","u":"2021-02-08","st":"2017-01","ag":"1–95"},{"n":"NCT05990244","t":"Magnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and Adhesion","s":"rec","p":"na","d":[7],"c":[11],"lc":[11],"a":"adult older","h":[143],"l":[[143,"glioma"]],"po":"2023-08-14","u":"2025-12-02","st":"2017-01","ag":"18–80"},{"n":"NCT06365424","t":"Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)","s":"rec","p":"phase2phase3","d":[50],"c":[39],"lc":[39],"a":"adult older","h":[131],"l":[[131,"pbc"]],"po":"2024-04-15","u":"2026-10-30","st":"2017-04","ag":"18–75"},{"n":"NCT02848274","t":"ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome","s":"rec","p":"na","d":[19],"c":[2],"a":"child adult older","h":[29],"po":"2016-07-28","u":"2025-10-22","st":"2016-10","ag":"Not stated"},{"n":"NCT02917369","t":"Integrative Analysis of Large-cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[5],"a":"adult older","h":[56,296],"po":"2016-09-28","u":"2016-09-28","st":"2016-01","ag":"18–75"},{"n":"NCT02954419","t":"IgA Nephropathy Biomarkers Evaluation Study (INTEREST)","s":"rec","p":"na","d":[46],"c":[0],"lc":[0],"a":"child adult older","h":[49],"l":[[49,"iga"]],"po":"2016-11-03","u":"2026-04-13","st":"2016-11","ag":"14 and over"},{"n":"NCT02972372","t":"Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer","s":"rec","p":"na","d":[1],"c":[48,36],"lc":[36],"a":"adult older","h":[87,150],"l":[[87,"escc"]],"po":"2016-11-23","u":"2025-02-10","st":"2016-11","ag":"18–75"},{"n":"NCT03005132","t":"Integrative Analysis of Human Glioblastoma Multiforme","s":"rec","p":"na","d":[7],"c":[5],"a":"adult older","h":[296],"po":"2016-12-29","u":"2016-12-29","st":"2016-01","ag":"18–75"},{"n":"NCT03023371","t":"National Registry of IgG4-RD in China","s":"rec","p":"na","d":[26],"c":[2],"lc":[2],"a":"child adult older","h":[38],"l":[[38,"igg4"]],"po":"2017-01-18","u":"2017-01-24","st":"2016-12","ag":"Not stated"},{"n":"NCT03196414","t":"Study of T Cells Targeting CD138/BCMA/CD19/More Antigens (CART-138/BCMA/19/More) for Chemotherapy Refractory and Relapsed Multiple Myeloma","s":"rec","p":"phase1phase2","d":[15],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"mm"]],"po":"2017-06-22","u":"2019-05-02","st":"2016-09","ag":"18–75"},{"n":"NCT03372980","t":"A Registry Study on Biomarkers of Takayasu's Arteritis (ARSBTA)","s":"rec","p":"na","d":[35],"c":[2],"a":"adult older","h":[109],"po":"2017-12-14","u":"2022-04-12","st":"2016-01","ag":"18–70"},{"n":"NCT04691037","t":"CCTA Improves Clinical Management of Stable Chest Pain","s":"rec","p":"na","d":[31],"c":[2,30],"lc":[30],"a":"adult older","h":[169,89,233],"l":[[169,"cad"]],"po":"2020-12-31","u":"2024-03-28","st":"2016-01","ag":"18 and over"},{"n":"NCT04977791","t":"Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2021-07-27","u":"2025-05-22","st":"2016-07","ag":"18 and over"},{"n":"NCT05397392","t":"Research on Optimal Diagnosis and Treatment of Cardiorenal Syndrome","s":"rec","p":"na","d":[31],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"cad"]],"po":"2022-05-31","u":"2022-06-02","st":"2016-01","ag":"18 and over"},{"n":"NCT05945745","t":"Molecular Analysis and Treatment Options of SCLC","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2023-07-14","u":"2024-11-29","st":"2016-01","ag":"18 and over"},{"n":"NCT06218901","t":"Association of Psychological Distress in Patients With Lung Cancer","s":"rec","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2024-01-23","u":"2025-05-22","st":"2016-01","ag":"18 and over"},{"n":"NCT07184814","t":"Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement","s":"rec","p":"na","d":[35],"c":[2],"lc":[2],"a":"adult older","h":[62],"l":[[62,"takayasu"]],"po":"2025-09-22","u":"2025-09-22","st":"2016-01","ag":"18 and over"},{"n":"NCT02535221","t":"Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer","s":"rec","p":"phase3","d":[6],"c":[2],"lc":[2],"a":"adult","x":"female","h":[74],"l":[[74,"breast"]],"po":"2015-08-28","u":"2021-11-29","st":"2015-07","ag":"35–55"},{"n":"NCT03131427","t":"China Registry for Genetic / Metabolic Liver Diseases","s":"rec","p":"na","d":[29],"c":[2],"lc":[2],"a":"child adult older","h":[39,181],"l":[[39,"wilson"]],"po":"2017-04-27","u":"2017-04-27","st":"2015-06","ag":"Not stated"},{"n":"NCT04938804","t":"Non-risk Based Lang Cancer Screening With a One-off LDCT","s":"rec","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[132],"l":[[132,"lung"]],"po":"2021-06-24","u":"2024-01-09","st":"2015-12","ag":"40–74"},{"n":"NCT05380622","t":"CHART Study of Coronary CT Angiography in Coronary Artery Disease","s":"rec","p":"na","d":[31],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"cad"]],"po":"2022-05-19","u":"2022-05-25","st":"2015-01","ag":"18 and over"},{"n":"NCT06700369","t":"De-escalation of Neoadjuvant Chemotherapy Regimens With Targeted Therapy Among HER2 Positive Patients","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"child adult older","h":[48],"l":[[48,"breast"]],"po":"2024-11-22","u":"2024-11-25","st":"2015-01","ag":"Not stated"},{"n":"NCT06711055","t":"Taxane Combined Targeted Therapy for Low-risk HER2 Positive and Lymph Node Negative Breast Cancer","s":"rec","p":"na","d":[6],"c":[2],"lc":[2],"a":"child adult older","x":"female","h":[48],"l":[[48,"breast"]],"po":"2024-12-02","u":"2024-12-02","st":"2015-01","ag":"Not stated"},{"n":"NCT02259556","t":"CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas","s":"rec","p":"phase1phase2","d":[19],"c":[2],"lc":[2],"a":"child adult older","h":[26],"l":[[26,"lymph"]],"po":"2014-10-08","u":"2016-01-28","st":"2014-10","ag":"16–80"},{"n":"NCT05388682","t":"Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement","s":"rec","p":"na","d":[35],"c":[2],"a":"child adult older","h":[213],"po":"2022-05-24","u":"2026-09-22","st":"2014-01","ag":"Not stated"},{"n":"NCT01653223","t":"Myocardial Protection Effect of Simvastatin Undergoing Cardiac Surgery","s":"rec","p":"na","d":[32],"c":[0],"lc":[0],"a":"adult older","h":[49],"l":[[49,"chd"]],"po":"2012-07-30","u":"2023-04-21","st":"2013-01","ag":"18 and over"},{"n":"NCT02897700","t":"A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast","s":"rec","p":"phase1","d":[6],"c":[15,5],"a":"adult older","x":"female","h":[147,296],"po":"2016-09-13","u":"2024-04-17","st":"2013-01","ag":"18 and over"},{"n":"NCT06451393","t":"Predicting Gastric Cancer Response to Chemo With Multimodal AI Model","s":"rec","p":"na","d":[3],"c":[0],"lc":[0],"a":"adult older","h":[75],"l":[[75,"gc"]],"po":"2024-06-11","u":"2024-06-11","st":"2013-02","ag":"20–90"},{"n":"NCT06795113","t":"Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma","s":"rec","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2025-01-27","u":"2025-01-27","st":"2013-06","ag":"18–100"},{"n":"NCT07379463","t":"Amino Acid Transporter System PET/CT Imaging in AATS-Related Diseases","s":"rec","p":"na","d":[7],"c":[17,26,30],"lc":[30],"a":"adult older","h":[59,68,55],"l":[[59,"glioma"]],"po":"2026-01-30","u":"2026-09-08","st":"2013-08","ag":"18–90"},{"n":"NCT07480512","t":"Causation And Prognosis Analyses of Coronary Artery Diseases: A Longitudinal Cohort Study","s":"rec","p":"na","d":[31],"c":[0],"lc":[0],"a":"adult older","h":[49],"l":[[49,"cad"]],"po":"2026-03-18","u":"2026-03-18","st":"2013-01","ag":"18 and over"},{"n":"NCT01670695","t":"A Prospective Cohort Study of IgG4RD in China","s":"rec","p":"na","d":[26],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"igg4"]],"po":"2012-08-22","u":"2017-04-11","st":"2012-01","ag":"18–75"},{"n":"NCT01994057","t":"A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment","s":"rec","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2013-11-25","u":"2023-04-12","st":"2012-09","ag":"18–85"},{"n":"NCT03001947","t":"IgA Nephropathy Registration Initiative of High Quality (INSIGHT)","s":"rec","p":"na","d":[46],"c":[0],"lc":[0],"a":"child adult older","h":[49],"l":[[49,"iga"]],"po":"2016-12-23","u":"2026-09-15","st":"2012-11","ag":"14 and over"},{"n":"NCT04522687","t":"Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer","s":"rec","p":"na","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"escc"]],"po":"2020-08-21","u":"2020-08-21","st":"2012-01","ag":"18 and over"},{"n":"NCT05961748","t":"Registry of Multicenter Brain-Heart Comorbidity in China","s":"rec","p":"na","d":[28,31],"c":[2,16,24,5,20],"lc":[2],"a":"adult older","h":[102,103,25,71,196,109,89,29,136],"l":[[102,"moyamoya"]],"po":"2023-07-27","u":"2023-09-21","st":"2012-01","ag":"18 and over"},{"n":"NCT06421805","t":"Establishing Prospective Mediastinal Tumor Database of PUMCH","s":"rec","p":"na","d":[19],"c":[2],"lc":[2],"a":"child adult older","h":[38],"l":[[38,"lymph"]],"po":"2024-05-20","u":"2024-05-20","st":"2012-01","ag":"Not stated"},{"n":"NCT02657785","t":"Treatment of PCNSL With R-IDARAM and Intrathecal Immunochemotherapy","s":"rec","p":"phase2phase3","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2016-01-18","u":"2020-09-09","st":"2010-09","ag":"18–75"},{"n":"NCT02836158","t":"Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With PCNSL","s":"rec","p":"phase2phase3","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2016-07-18","u":"2020-09-09","st":"2010-09","ag":"60–75"},{"n":"NCT06137521","t":"Risk Factors and Outcomes in Coronary Chronic Total Occlusion","s":"rec","p":"na","d":[31],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"cad"]],"po":"2023-11-18","u":"2026-08-18","st":"2010-01","ag":"18 and over"},{"n":"NCT07336394","t":"Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques","s":"rec","p":"na","d":[41],"c":[2],"lc":[2],"a":"child adult older","h":[213],"l":[[213,"fabry"]],"po":"2026-01-13","u":"2026-01-21","st":"2010-01","ag":"Not stated"},{"n":"NCT02851784","t":"Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma","s":"rec","p":"phase2phase3","d":[2],"c":[2],"lc":[2],"a":"child adult older","h":[26],"l":[[26,"hcc"]],"po":"2016-08-02","u":"2026-09-17","st":"2009-12","ag":"Not stated"},{"n":"NCT07351825","t":"CMR Prognostic Markers in Ischemic Heart Disease","s":"rec","p":"na","d":[31],"c":[2],"lc":[2],"a":"child adult older","h":[213],"l":[[213,"cad"]],"po":"2026-01-20","u":"2026-01-20","st":"2009-01","ag":"Not stated"},{"n":"NCT02889666","t":"A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer","s":"rec","p":"phase1","d":[4],"c":[15,5],"a":"adult older","h":[56,147],"po":"2016-09-05","u":"2024-04-17","st":"2008-01","ag":"18–75"},{"n":"NCT01341327","t":"Observational Study for Left Main Disease Treatment","s":"rec","p":"na","d":[31],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"cad"]],"po":"2011-04-25","u":"2026-10-15","st":"2007-07","ag":"18 and over"},{"n":"NCT04965545","t":"Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson Disease","s":"rec","p":"na","d":[29],"c":[23],"lc":[23],"a":"child adult older","h":[54],"l":[[54,"wilson"]],"po":"2021-07-16","u":"2021-07-16","st":"2004-01","ag":"6–65"},{"n":"NCT04965558","t":"Clinical Features and Outcome in Patients With Osseomuscular Type of Wilson's Disease","s":"rec","p":"na","d":[29],"c":[23],"lc":[23],"a":"child adult older","h":[54],"l":[[54,"wilson"]],"po":"2021-07-16","u":"2021-07-16","st":"2004-01","ag":"6–65"},{"n":"NCT05745740","t":"A Study of RC48-ADC Combined With Pyrotinib For Treatment of Local Advanced or Metastasis NSCLC With HER2 Mutation","s":"nyr","p":"phase1phase2","d":[4],"c":[5],"a":"adult older","h":[56],"po":"2023-02-27","u":"2026-09-22","st":"2027-12","ag":"18–80"},{"n":"NCT07138846","t":"A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Cancer","s":"nyr","p":"phase3","d":[5],"c":[5],"a":"adult older","h":[9],"po":"2025-08-24","u":"2026-05-15","st":"2027-01","ag":"18 and over"},{"n":"NCT07419880","t":"Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2026-02-19","u":"2026-09-25","st":"2027-01","ag":"18–70"},{"n":"NCT07466511","t":"Effect of Bifidobacterium Breve Supplementation on the Onset and Progression of Idiopathic Scoliosis","s":"nyr","p":"na","d":[33],"c":[37],"lc":[37],"a":"child","h":[188],"l":[[188,"scol"]],"po":"2026-03-12","u":"2026-03-12","st":"2027-01","ag":"6–15"},{"n":"NCT07657416","t":"NK521 in the Treatment of Advanced Solid Tumors","s":"nyr","p":"earlyphase1","d":[2],"c":[17],"a":"adult older","h":[112],"po":"2026-06-18","u":"2026-09-30","st":"2027-01","ag":"18–65"},{"n":"NCT07691645","t":"Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome","s":"nyr","p":"phase2","d":[2],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"hcc"]],"po":"2026-07-09","u":"2026-08-27","st":"2027-09","ag":"18–75"},{"n":"NCT07695740","t":"Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma","s":"nyr","p":"phase2","d":[15],"c":[2],"a":"adult older","h":[89],"po":"2026-07-10","u":"2026-11-06","st":"2027-12","ag":"18–75"},{"n":"NCT07700524","t":"Intraoperative Ultrasound Assessment of Coronary Artery and Bypass Graft Blood Flow During CABG","s":"nyr","p":"na","d":[31],"c":[28],"lc":[28],"a":"adult older","h":[60],"l":[[60,"cad"]],"po":"2026-07-14","u":"2026-08-11","st":"2027-01","ag":"18 and over"},{"n":"NCT07844018","t":"ADC Based Therapy Accroding to HER2 Heterogeneous","s":"nyr","p":"phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[48],"l":[[48,"breast"]],"po":"2026-09-28","u":"2026-10-02","st":"2027-01","ag":"18 and over"},{"n":"NCT07885982","t":"Conditioning Regimen Containing Low-Dose ATG for the Treatment of AA Receiving sUCBT","s":"nyr","p":"phase2","d":[17],"c":[17],"lc":[17],"a":"child adult","h":[68],"l":[[68,"aa"]],"po":"2026-10-21","u":"2026-10-21","st":"2027-08","ag":"1–50"},{"n":"NCT07912853","t":"Integration of Imaging, Molecular, Pathological, and Clinical Outcome Data in Hepatocellular Carcinoma.","s":"nyr","p":"na","d":[2],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"hcc"]],"po":"2026-11-03","u":"2026-11-03","st":"2027-01","ag":"18 and over"},{"n":"NCT07928882","t":"Clinical Study on Fuzheng Jiedu Huayu Therapy in Combination With Chemotherapy and Immunotherapy for Improving Survival Rates in Extensive-Stage Small Cell Lung Cancer","s":"nyr","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2026-11-10","u":"2026-11-10","st":"2027-01","ag":"18 and over"},{"n":"NCT07944313","t":"Comparing Single-session Versus Fractionated Stereotactic Radiotherapy for Elderly and Frail Patients With Early-stage Non-small Cell Lung Cancer.","s":"nyr","p":"phase2","d":[4],"c":[56],"lc":[56],"a":"adult older","h":[163],"l":[[163,"lung"]],"po":"2026-11-18","u":"2026-11-18","st":"2027-01","ag":"60–90"},{"n":"NCT04104854","t":"Safety and Efficacy of DCB Therapy for de Novo Lesions Under the Guidance of QFR in CHD Patients (UNIQUE-DCB-I Study )","s":"nyr","p":"na","d":[31],"c":[28],"lc":[28],"a":"adult older","h":[78,119],"l":[[78,"cad"]],"po":"2019-09-26","u":"2025-05-31","st":"2026-01","ag":"18–90"},{"n":"NCT04119986","t":"Safety and Efficacy of DCB Therapy for ISR Under the Guidance of QFR (UNIQUE-DCB-II Study )","s":"nyr","p":"na","d":[31],"c":[28],"lc":[28],"a":"adult older","h":[78,119],"l":[[78,"cad"]],"po":"2019-10-09","u":"2025-05-31","st":"2026-01","ag":"18–100"},{"n":"NCT06365008","t":"Sintilimab Plus FOLFIRI as Second-line Therapy for Patients With HER2-negative Advanced Gastric Cancer","s":"nyr","p":"phase2","d":[3],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"gc"]],"po":"2024-04-15","u":"2026-06-18","st":"2026-06","ag":"18 and over"},{"n":"NCT06706219","t":"Efficacy and Safety of Sacituzumab Tirumotecan (SKB264) in Combination With Toripalimab in Patients With Initially Unresectable Stage III NSCLC","s":"nyr","p":"phase2","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13,381],"l":[[13,"lung"]],"po":"2024-11-26","u":"2026-04-03","st":"2026-05","ag":"18–70"},{"n":"NCT06772363","t":"SERS-Based Serum Molecular Spectral Screening for Hematogenous Metastasis","s":"nyr","p":"na","d":[4],"c":[16],"lc":[16],"a":"adult older","h":[341],"l":[[341,"lung"]],"po":"2025-01-13","u":"2025-03-31","st":"2026-04","ag":"18 and over"},{"n":"NCT06775015","t":"SERS-Based Serum Molecular Spectral Detection of Invasive Lung Cancer","s":"nyr","p":"na","d":[4],"c":[16],"lc":[16],"a":"adult older","h":[341],"l":[[341,"lung"]],"po":"2025-01-14","u":"2025-03-31","st":"2026-04","ag":"18 and over"},{"n":"NCT06775587","t":"SERS-Based Serum Molecular Spectral Screening for Benign and Malignant Pulmonary Proliferative Nodules","s":"nyr","p":"na","d":[4],"c":[16],"lc":[16],"a":"adult older","h":[341],"l":[[341,"lung"]],"po":"2025-01-15","u":"2025-03-31","st":"2026-04","ag":"18 and over"},{"n":"NCT06952621","t":"Neoadjuvant Treatment of Toripalimab Combined With Nab-paclitaxel and Platinum Versus Neoadjuvant Docetaxel Combined With Cisplatin and 5-fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma","s":"nyr","p":"phase3","d":[1],"c":[39],"lc":[39],"a":"adult older","h":[122],"l":[[122,"escc"]],"po":"2025-05-01","u":"2026-01-30","st":"2026-02","ag":"18–75"},{"n":"NCT06970496","t":"A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.","s":"nyr","p":"phase1","d":[19],"c":[0,9,5,37,39],"a":"adult older","h":[53,123,121,0,81,116,131],"po":"2025-05-14","u":"2026-08-14","st":"2026-08","ag":"18–70"},{"n":"NCT06981390","t":"Ticagrelor-Based Dual Antiplatelet Therapy Duration in CABG","s":"nyr","p":"na","d":[31],"c":[15],"lc":[15],"a":"adult older","h":[156],"l":[[156,"cad"]],"po":"2025-05-20","u":"2026-11-19","st":"2026-05","ag":"18–80"},{"n":"NCT06986434","t":"CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation","s":"nyr","p":"earlyphase1","d":[19],"c":[2],"a":"adult older","h":[26],"po":"2025-05-23","u":"2026-04-08","st":"2026-04","ag":"18–75"},{"n":"NCT07001995","t":"Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression","s":"nyr","p":"phase2","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2025-06-03","u":"2026-03-16","st":"2026-05","ag":"18–80"},{"n":"NCT07014878","t":"A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors","s":"nyr","p":"phase1","d":[4,5],"c":[28,5],"a":"adult older","h":[9,78],"po":"2025-06-11","u":"2026-05-18","st":"2026-05","ag":"18–70"},{"n":"NCT07054541","t":"A Novel Echocardiography-Guided Strategy for Percutateous Closure of Atrial Septal Defect Assisted by PannaWire","s":"nyr","p":"phase4","d":[32],"c":[2],"lc":[2],"a":"child adult older","h":[213],"l":[[213,"chd"]],"po":"2025-07-08","u":"2026-03-17","st":"2026-03","ag":"2 and over"},{"n":"NCT07057713","t":"Total Arterial vs. Mixed Grafting in Left Coronary CABG","s":"nyr","p":"na","d":[31],"c":[15],"lc":[15],"a":"adult older","h":[156],"l":[[156,"cad"]],"po":"2025-07-10","u":"2026-11-19","st":"2026-08","ag":"18–80"},{"n":"NCT07064902","t":"Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma","s":"nyr","p":"phase2","d":[0],"c":[0,57,7],"lc":[0],"a":"adult older","h":[53,170,8],"l":[[53,"npc"]],"po":"2025-07-15","u":"2026-07-16","st":"2026-08","ag":"18–65"},{"n":"NCT07140419","t":"Coronary Computed Tomographic Angiography Combined With CT-FFR in Intermediate-Risk Chest Pain Patients.","s":"nyr","p":"na","d":[31],"c":[27],"lc":[27],"a":"adult older","h":[124],"l":[[124,"cad"]],"po":"2025-08-24","u":"2026-03-20","st":"2026-04","ag":"18 and over"},{"n":"NCT07175389","t":"JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure","s":"nyr","p":"phase1phase2","d":[5],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"panc"]],"po":"2025-09-16","u":"2026-08-19","st":"2026-09","ag":"18–75"},{"n":"NCT07222553","t":"Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatric Participants With IgG4-RD","s":"nyr","p":"phase2","d":[26],"c":[2,8],"a":"child adult","h":[38,10],"po":"2025-10-30","u":"2026-11-16","st":"2026-10","ag":"2–18"},{"n":"NCT07231250","t":"Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2025-11-17","u":"2025-11-19","st":"2026-01","ag":"18 and over"},{"n":"NCT07235618","t":"A Study of Entinostat in Combination With Fulvestrant for the Treatment of Locally Advanced or Metastatic Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[53],"l":[[53,"breast"]],"po":"2025-11-19","u":"2025-11-19","st":"2026-01","ag":"18–75"},{"n":"NCT07242911","t":"Study on Efficacy and Safety of VMAT Technique With Local Dose Escalation for Unresectable Pancreatic Cancer","s":"nyr","p":"na","d":[5],"c":[98],"lc":[98],"a":"adult older","h":[382],"l":[[382,"panc"]],"po":"2025-11-21","u":"2025-11-21","st":"2026-01","ag":"18–76"},{"n":"NCT07255612","t":"Bone Marrow Protection, Safety, Efficacy of Trilaciclib and Eribulin in Locally Advanced or Metastatic TNBC(Triple-negative Breast Cancer)","s":"nyr","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"breast"]],"po":"2025-12-01","u":"2025-12-01","st":"2026-11","ag":"18 and over"},{"n":"NCT07258147","t":"Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases","s":"nyr","p":"phase2","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"lung"]],"po":"2025-12-02","u":"2026-05-05","st":"2026-10","ag":"18–75"},{"n":"NCT07267884","t":"IABP for MI-VSD Patients in SCAI SHOCK Stage B","s":"nyr","p":"na","d":[32],"c":[27],"lc":[27],"a":"adult older","h":[124],"l":[[124,"chd"]],"po":"2025-12-05","u":"2026-03-19","st":"2026-02","ag":"18–75"},{"n":"NCT07268690","t":"Risk-Adapted Omission of Level Va Irradiation in Nasopharyngeal Carcinoma","s":"nyr","p":"phase3","d":[0],"c":[16],"lc":[16],"a":"adult older","h":[30],"l":[[30,"npc"]],"po":"2025-12-08","u":"2025-12-08","st":"2026-01","ag":"18–70"},{"n":"NCT07279987","t":"Comparison of RA-IVL and RA-SHP in Calcified Coronary Lesions","s":"nyr","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[89],"l":[[89,"cad"]],"po":"2025-12-12","u":"2025-12-29","st":"2026-01","ag":"18 and over"},{"n":"NCT07294339","t":"A Randomized Controlled Trial of Acupuncture for the Management of Hot Flashes in Patients With Hormone Receptor-Positive Breast Cancer","s":"nyr","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[48],"l":[[48,"breast"]],"po":"2025-12-19","u":"2026-03-19","st":"2026-04","ag":"18–75"},{"n":"NCT07298928","t":"A Study on the Efficacy and Safety of Telitacicept in the Treatment of Children Ocular Myasthenia Gravis","s":"nyr","p":"na","d":[27],"c":[23],"lc":[23],"a":"child adult","h":[179],"l":[[179,"mg"]],"po":"2025-12-23","u":"2026-03-06","st":"2026-03","ag":"Up to 18"},{"n":"NCT07303283","t":"Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma","s":"nyr","p":"phase2","d":[0],"c":[10],"lc":[10],"a":"adult older","h":[15],"l":[[15,"npc"]],"po":"2025-12-24","u":"2026-06-09","st":"2026-09","ag":"18–65"},{"n":"NCT07303881","t":"Golidocitinib for Refractory Immune-related Hematologic Toxicities of Advanced Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[132],"l":[[132,"lung"]],"po":"2025-12-26","u":"2025-12-26","st":"2026-02","ag":"18 and over"},{"n":"NCT07307443","t":"A Phase II Study of Anlotinib and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Lung Cancer.","s":"nyr","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2025-12-29","u":"2025-12-29","st":"2026-02","ag":"18 and over"},{"n":"NCT07311317","t":"Cellular-Level Fluorescence Imaging for Intraoperative Margin Assessment in Breast Cancer","s":"nyr","p":"na","d":[6],"c":[22],"lc":[22],"a":"adult older","x":"female","h":[40,287],"l":[[40,"breast"]],"po":"2025-12-30","u":"2025-12-30","st":"2026-01","ag":"18–70"},{"n":"NCT07312370","t":"Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing","s":"nyr","p":"phase4","d":[3],"c":[33],"a":"adult older","h":[142],"po":"2025-12-31","u":"2026-03-23","st":"2026-04","ag":"18–80"},{"n":"NCT07314203","t":"Clinical Efficacy of Adebrelimab With or Without Apatinib Mesilate and SOX Neoadjuvant Therapy in Locally Advanced Gastric Cancer","s":"nyr","p":"phase3","d":[3],"c":[16],"lc":[16],"a":"adult older","h":[140],"l":[[140,"gc"]],"po":"2026-01-02","u":"2026-01-02","st":"2026-12","ag":"18–75"},{"n":"NCT07314372","t":"FAD Subtype-Guided Combination Therapy for Unresectable Hepatocellular Carcinoma","s":"nyr","p":"phase2","d":[2],"c":[28],"lc":[28],"a":"adult older","h":[60],"l":[[60,"hcc"]],"po":"2026-01-02","u":"2026-01-20","st":"2026-02","ag":"18 and over"},{"n":"NCT07314554","t":"Recurrence After Gastric and Intestinal Polyp Resection","s":"nyr","p":"na","d":[3],"c":[33],"a":"adult older","h":[142],"po":"2026-01-02","u":"2026-06-09","st":"2026-07","ag":"18 and over"},{"n":"NCT07315035","t":"QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer","s":"nyr","p":"phase2","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"gc"]],"po":"2026-01-02","u":"2026-01-02","st":"2026-01","ag":"18–75"},{"n":"NCT07317778","t":"Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2026-01-05","u":"2026-01-05","st":"2026-02","ag":"18–75"},{"n":"NCT07318636","t":"NK-cell Therapy Combined With PD-1 Antibody and Platinum-Based Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC","s":"nyr","p":"phase1","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[132],"l":[[132,"lung"]],"po":"2026-01-06","u":"2026-01-06","st":"2026-01","ag":"18 and over"},{"n":"NCT07318883","t":"A Phase II/III Clinical Study to Evaluate HLX07 in Combination With Serplulimab and Chemotherapy Versus Placebo in Combination With Serplulimab or Pembrolizumab and Chemotherapy as First-Line Treatment in Advanced Squamous Non-Small Cell Lung Cancer","s":"nyr","p":"phase2phase3","d":[4],"c":[0],"a":"adult older","h":[43],"po":"2026-01-06","u":"2026-01-06","st":"2026-03","ag":"18 and over"},{"n":"NCT07324473","t":"Ivarmacitinib Combined With Camrelizumab and Apatinib for Unresectable Advanced Hepatocellular Carcinoma With Acquired Resistance to Immune Checkpoint Therapy: A Single-Arm Exploratory Clinical Study","s":"nyr","p":"phase2","d":[2],"c":[1],"lc":[1],"a":"adult older","h":[79],"l":[[79,"hcc"]],"po":"2026-01-07","u":"2026-01-07","st":"2026-01","ag":"18–75"},{"n":"NCT07325045","t":"Biomechanical Study of Lever Positioning Manipulation on Scoliosis","s":"nyr","p":"na","d":[33],"c":[23],"a":"child adult","h":[262,263],"l":[[262,"scol"]],"po":"2026-01-08","u":"2026-01-08","st":"2026-01","ag":"10–45"},{"n":"NCT07328802","t":"Exploration of Sintilimab + Bevacizumab + AG Chemotherapy as First-Line Treatment for Unresectable Advanced/Metastatic Cholangiocarcinoma","s":"nyr","p":"phase2","d":[2],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"hcc"]],"po":"2026-01-09","u":"2026-01-09","st":"2026-01","ag":"18–75"},{"n":"NCT07331454","t":"Robotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer","s":"nyr","p":"phase3","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"gc"]],"po":"2026-01-12","u":"2026-01-12","st":"2026-02","ag":"18–75"},{"n":"NCT07332494","t":"Digital Remote Management for Care and Continuous Optimization Versus Usual Care in Patients With Coronary Heart Disease (DigiCare-CHD)","s":"nyr","p":"na","d":[31],"c":[2,15,52],"lc":[2],"a":"adult older","h":[109,27,210,161],"l":[[109,"cad"]],"po":"2026-01-12","u":"2026-01-12","st":"2026-01","ag":"18–75"},{"n":"NCT07333196","t":"Tongji NADs Cohort","s":"nyr","p":"na","d":[25,27],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"nmosd"]],"po":"2026-01-12","u":"2026-01-21","st":"2026-03","ag":"18–80"},{"n":"NCT07333573","t":"A Hypoxia-Inducible CAR-T Cell Targeting AXL and CD73 for Advanced Gastric Cancer","s":"nyr","p":"phase1phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"gc"]],"po":"2026-01-12","u":"2026-01-12","st":"2026-01","ag":"18–75"},{"n":"NCT07334535","t":"Isa-VRD in TIE HRMM","s":"nyr","p":"phase4","d":[15],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"mm"]],"po":"2026-01-12","u":"2026-01-13","st":"2026-01","ag":"18–80"},{"n":"NCT07334574","t":"Clinical Study of XP-006 mRNA Vaccine for R/R B-NHL","s":"nyr","p":"phase1","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2026-01-12","u":"2026-01-13","st":"2026-01","ag":"18 and over"},{"n":"NCT07336771","t":"JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer","s":"nyr","p":"phase1phase2","d":[6],"c":[5],"a":"adult older","h":[9],"po":"2026-01-13","u":"2026-01-13","st":"2026-01","ag":"18 and over"},{"n":"NCT07337031","t":"A Trial of Behavioral Intervention on Prognostic Survival of Patients With Unresectable Liver Cancer","s":"nyr","p":"na","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[277],"l":[[277,"hcc"]],"po":"2026-01-13","u":"2026-01-13","st":"2026-01","ag":"18–75"},{"n":"NCT07338396","t":"A Prospective Multicenter Study of the Association Between TCM Syndromes and EGFR-TKI Efficacy in Lung Cancer Patients","s":"nyr","p":"na","d":[4],"c":[2,22,0],"a":"adult older","h":[47,107,280],"po":"2026-01-13","u":"2026-01-13","st":"2026-01","ag":"18 and over"},{"n":"NCT07343479","t":"Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metastases","s":"nyr","p":"phase2","d":[4],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"lung"]],"po":"2026-01-15","u":"2026-01-15","st":"2026-05","ag":"18–75"},{"n":"NCT07347288","t":"SHR2554 as Maintenance Therapy in Patients With Peripheral T-cell Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"lymph"]],"po":"2026-01-16","u":"2026-01-16","st":"2026-02","ag":"18 and over"},{"n":"NCT07347977","t":"Lidocaine Decreases Postoperative Lung Cancer Reoccurance and Metatasis Risk","s":"nyr","p":"na","d":[4],"c":[61],"lc":[61],"a":"adult older","h":[182],"l":[[182,"lung"]],"po":"2026-01-16","u":"2026-01-16","st":"2026-01","ag":"18–80"},{"n":"NCT07349979","t":"PCI With GDMT Versus GDMT Alone for Patients With Ischemic Cardiomyopathy and Reduced LVEF","s":"nyr","p":"na","d":[31],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"cad"]],"po":"2026-01-20","u":"2026-05-28","st":"2026-12","ag":"18 and over"},{"n":"NCT07352176","t":"Study on the Effectiveness and Safety of CLE Combined With Cryobiopsy for Diagnosis of Pulmonary Lesions","s":"nyr","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[132],"l":[[132,"lung"]],"po":"2026-01-20","u":"2026-01-20","st":"2026-02","ag":"18 and over"},{"n":"NCT07352345","t":"Head to Head, Prospective, Open Label Multicenter Study on the Diagnostic Efficacy of GPC3 Targeted PET Imaging and Enhanced Magnetic Resonance Imaging for Hepatocellular Carcinoma","s":"nyr","p":"earlyphase1","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"hcc"]],"po":"2026-01-20","u":"2026-01-20","st":"2026-01","ag":"18 and over"},{"n":"NCT07353554","t":"Application Study of 68Ga-NOTA-BCMA Nanoantibody Imaging in Multiple Myeloma","s":"nyr","p":"na","d":[15],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"mm"]],"po":"2026-01-20","u":"2026-01-20","st":"2026-02","ag":"18–85"},{"n":"NCT07353762","t":"Coronary Imaging and Metabolic Indicators-Based Risk Prediction Model for Coronary Artery Disease(CMI-RiskCAD)","s":"nyr","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[109],"l":[[109,"cad"]],"po":"2026-01-20","u":"2026-01-20","st":"2026-01","ag":"18 and over"},{"n":"NCT07355283","t":"IMM0306 in Combination With Lenalidomide vs Placebo in Combination With Lenalidomide in Patients With Relapsed/Refractory Follicular Lymphoma","s":"nyr","p":"phase3","d":[19],"c":[2],"a":"adult older","h":[74],"po":"2026-01-21","u":"2026-01-27","st":"2026-02","ag":"18 and over"},{"n":"NCT07355361","t":"Huaier Granule and Proteinuria","s":"nyr","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2026-01-21","u":"2026-01-21","st":"2026-01","ag":"18–75"},{"n":"NCT07356037","t":"Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma","s":"nyr","p":"phase3","d":[2],"c":[22],"a":"adult older","h":[40],"po":"2026-01-21","u":"2026-01-21","st":"2026-01","ag":"18–85"},{"n":"NCT07357532","t":"Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD","s":"nyr","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"lung"]],"po":"2026-01-22","u":"2026-01-22","st":"2026-01","ag":"18–80"},{"n":"NCT07358520","t":"Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients","s":"nyr","p":"phase4","d":[4],"c":[5,31],"a":"adult older","h":[101,90],"po":"2026-01-22","u":"2026-01-22","st":"2026-01","ag":"18 and over"},{"n":"NCT07358689","t":"Toripalimab Combined With Platinum-based Chemotherapy With or Without H1 Receptor Antagonist in the Perioperative Treatment of Resectable Non-small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2026-01-22","u":"2026-06-12","st":"2026-06","ag":"18–75"},{"n":"NCT07360132","t":"Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First-Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer","s":"nyr","p":"phase3","d":[4],"c":[5],"a":"adult older","h":[65],"po":"2026-01-22","u":"2026-01-22","st":"2026-01","ag":"18–75"},{"n":"NCT07361991","t":"IBI363 Plus Bevacizumab With or Without Nab-Paclitaxel for Second-Line Treatment of Advanced Gastric Cancer","s":"nyr","p":"phase1phase2","d":[3],"c":[20],"lc":[20],"a":"adult older","h":[25],"l":[[25,"gc"]],"po":"2026-01-23","u":"2026-01-23","st":"2026-03","ag":"18–75"},{"n":"NCT07363356","t":"Drug Sensitivity Testing-Based Tumor Organoids to Guide Adjuvant Therapy After Hepatectomy for Primary Liver Cancer","s":"nyr","p":"phase2","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[277],"l":[[277,"hcc"]],"po":"2026-01-23","u":"2026-01-23","st":"2026-01","ag":"18–70"},{"n":"NCT07365410","t":"Furmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety Study","s":"nyr","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2026-01-26","u":"2026-01-26","st":"2026-01","ag":"18–75"},{"n":"NCT07367542","t":"Effect of Esketamine on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery","s":"nyr","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[26],"l":[[26,"breast"]],"po":"2026-01-26","u":"2026-01-27","st":"2026-01","ag":"18 and over"},{"n":"NCT07367685","t":"Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma","s":"nyr","p":"phase1","d":[19],"c":[56],"lc":[56],"a":"adult older","h":[228],"l":[[228,"lymph"]],"po":"2026-01-26","u":"2026-01-26","st":"2026-05","ag":"18 and over"},{"n":"NCT07368023","t":"A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Unresectable Hepatocellular Carcinoma","s":"nyr","p":"na","d":[2],"c":[61],"lc":[61],"a":"child adult older","h":[215],"l":[[215,"hcc"]],"po":"2026-01-26","u":"2026-01-26","st":"2026-01","ag":"16 and over"},{"n":"NCT07370805","t":"18F-FAPI PET in Lung Cancer","s":"nyr","p":"na","d":[4],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"lung"]],"po":"2026-01-27","u":"2026-01-27","st":"2026-02","ag":"20–85"},{"n":"NCT07374250","t":"Perioperative Ivonescimab Plus S-1 and Oxaliplatin (SOX) for Locally Advanced Gastric or GEJ Adenocarcinoma","s":"nyr","p":"phase2","d":[3],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"gc"]],"po":"2026-01-28","u":"2026-01-28","st":"2026-02","ag":"18–75"},{"n":"NCT07374718","t":"Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk","s":"nyr","p":"na","d":[31],"c":[11],"lc":[11],"a":"adult older","h":[128],"l":[[128,"cad"]],"po":"2026-01-29","u":"2026-01-29","st":"2026-03","ag":"18 and over"},{"n":"NCT07375979","t":"A Multi-modal Integrating Imaging and Cell-free DNA Methylation in Lung Cancer Early Detection (CMe-Lung): a Multi-center, Observational Study","s":"nyr","p":"na","d":[4],"c":[15,47,5,11,20],"lc":[5],"a":"adult older","h":[56,42,25,27,135,18],"l":[[56,"lung"]],"po":"2026-01-29","u":"2026-01-29","st":"2026-02","ag":"40–74"},{"n":"NCT07376720","t":"A Clinical Study Evaluating the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Three or More Lines of Treatment","s":"nyr","p":"na","d":[15],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"mm"]],"po":"2026-01-29","u":"2026-01-29","st":"2026-02","ag":"18–78"},{"n":"NCT07376876","t":"Indocyanine Green-guided Omental Shield Anastomosis for Cervical Esophagogastric Anastomosis in Minimally Invasive McKeown Esophagectomy","s":"nyr","p":"phase2","d":[1],"c":[1],"lc":[1],"a":"adult older","h":[17],"l":[[17,"escc"]],"po":"2026-01-29","u":"2026-01-29","st":"2026-01","ag":"18–80"},{"n":"NCT07379398","t":"Iparomlimab and Tuvonralimab Injection Combined With SBRT in Patients With Early-Stage Non-Small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2026-01-30","u":"2026-04-29","st":"2026-04","ag":"18 and over"},{"n":"NCT07380230","t":"Efficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer Patients","s":"nyr","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2026-02-02","u":"2026-02-02","st":"2026-01","ag":"18 and over"},{"n":"NCT07381543","t":"Adebrelimab Maintenance Therapy for LS-SCLC Post Induction Chemo-Adebrelimab Plus CRT or CRT Alone","s":"nyr","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"lung"]],"po":"2026-02-02","u":"2026-02-04","st":"2026-03","ag":"18–75"},{"n":"NCT07382687","t":"Famitinib Combined With SHR-A1811, Versus SHR-A1811 for CDK4/6 Inhibitors-resistent Advanced HR+/HER2- Breast Cancer With SNF4 Subtype","s":"nyr","p":"phase3","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2026-02-03","u":"2026-02-03","st":"2026-02","ag":"18–70"},{"n":"NCT07383116","t":"Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer","s":"nyr","p":"phase3","d":[4],"c":[5],"a":"adult older","h":[65],"po":"2026-02-03","u":"2026-02-03","st":"2026-01","ag":"18–75"},{"n":"NCT07383922","t":"A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic Cancer","s":"nyr","p":"phase3","d":[5],"c":[5],"a":"adult older","h":[9],"po":"2026-02-03","u":"2026-02-04","st":"2026-02","ag":"18–80"},{"n":"NCT07385209","t":"Design and Application of a Home Care WeChat Mini-Program for Children After Congenital Heart Disease Surgery","s":"nyr","p":"na","d":[32],"c":[47],"lc":[47],"a":"child","h":[201],"l":[[201,"chd"]],"po":"2026-02-04","u":"2026-02-04","st":"2026-03","ag":"0–12"},{"n":"NCT07388758","t":"Scipibaimab Combined With Tislelizumab in Patients With First-Line Treatment-Failed Recurrent/Metastatic Nasopharyngeal Carcinoma","s":"nyr","p":"phase2","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2026-02-05","u":"2026-02-05","st":"2026-02","ag":"18–75"},{"n":"NCT07391826","t":"Megestrol Acetate Oral Suspension for Cachexia in Patients With cStage III Gastric/Gastroesophageal Junction Adenocarcinoma Receiving Neoadjuvant Therapy With Serplulimab Combined With SOX","s":"nyr","p":"phase2","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"gc"]],"po":"2026-02-06","u":"2026-02-06","st":"2026-02","ag":"18–80"},{"n":"NCT07392528","t":"Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases","s":"nyr","p":"earlyphase1","d":[25,27],"c":[30],"lc":[30],"a":"adult older","h":[281],"l":[[281,"nmosd"]],"po":"2026-02-06","u":"2026-02-11","st":"2026-03","ag":"18 and over"},{"n":"NCT07392866","t":"A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma","s":"nyr","p":"phase2phase3","d":[2],"c":[28,5],"a":"adult older","h":[6,105],"po":"2026-02-06","u":"2026-02-09","st":"2026-03","ag":"18–75"},{"n":"NCT07394205","t":"Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer","s":"nyr","p":"earlyphase1","d":[3,5],"c":[37],"lc":[37],"a":"adult older","h":[81],"l":[[81,"gc"]],"po":"2026-02-06","u":"2026-02-06","st":"2026-09","ag":"18–70"},{"n":"NCT07395375","t":"Non-intubated Versus Intubated Anesthesia for Thoracoscopic Sublobar Resection","s":"nyr","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[132],"l":[[132,"lung"]],"po":"2026-02-09","u":"2026-02-09","st":"2026-03","ag":"18–80"},{"n":"NCT07398560","t":"Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study","s":"nyr","p":"phase2","d":[4],"c":[24],"lc":[24],"a":"adult older","h":[383],"l":[[383,"lung"]],"po":"2026-02-10","u":"2026-02-10","st":"2026-02","ag":"18–99"},{"n":"NCT07398638","t":"Lisatoclax Plus R-CHOP or Pola-R-CHP in Untreated DLBCL: A Phase Ib/II Study","s":"nyr","p":"phase1phase2","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2026-02-10","u":"2026-02-10","st":"2026-02","ag":"18–70"},{"n":"NCT07399444","t":"A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Multiple Myeloma（LB2505-0001）","s":"nyr","p":"earlyphase1","d":[15],"c":[9,30,13,31,20],"lc":[30],"a":"adult older","h":[69,64,36,37,14],"l":[[69,"mm"]],"po":"2026-02-10","u":"2026-02-10","st":"2026-01","ag":"18 and over"},{"n":"NCT07402070","t":"IBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[2],"a":"adult older","h":[23],"po":"2026-02-11","u":"2026-02-11","st":"2026-02","ag":"18–75"},{"n":"NCT07403435","t":"Short-course Radiotherapy Combined With Serplulimab and Chemotherapy as Neoadjuvant Treatment for Resectable ESCC","s":"nyr","p":"phase2","d":[1],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"escc"]],"po":"2026-02-11","u":"2026-02-11","st":"2026-02","ag":"18–75"},{"n":"NCT07405255","t":"Zillion: Zanubrutinib Combined With Chemotherapy for Newly Diagnosed CNS Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2026-02-12","u":"2026-02-12","st":"2026-01","ag":"18–80"},{"n":"NCT07409129","t":"Tubeless Strategy for Enhanced Recovery After Sublobar Resection","s":"nyr","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[132],"l":[[132,"lung"]],"po":"2026-02-13","u":"2026-02-13","st":"2026-02","ag":"18–75"},{"n":"NCT07410559","t":"Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2026-02-13","u":"2026-02-18","st":"2026-07","ag":"18–75"},{"n":"NCT07410611","t":"ctDNA Monitoring Guides the Treatment of NSCLC With Befotertinib Combined With Radiotherapy","s":"nyr","p":"phase2","d":[4],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"lung"]],"po":"2026-02-13","u":"2026-02-13","st":"2026-02","ag":"18–75"},{"n":"NCT07413952","t":"Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases","s":"nyr","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[132],"l":[[132,"lung"]],"po":"2026-02-17","u":"2026-02-17","st":"2026-04","ag":"18–75"},{"n":"NCT07414927","t":"A Clinical Study for the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung Cancer Transformed From Non-Small Cell Lung Cancer Following EGFR TKI Therapy","s":"nyr","p":"phase1phase2","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2026-02-17","u":"2026-02-17","st":"2026-03","ag":"18 and over"},{"n":"NCT07415200","t":"Pedicled Lateral Chest Wall Lymph-Adipofascial Flap to Prevent Arm Lymphedema After Breast Cancer Surgery","s":"nyr","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2026-02-17","u":"2026-02-17","st":"2026-02","ag":"18–75"},{"n":"NCT07415525","t":"IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer","s":"nyr","p":"phase2","d":[5],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"panc"]],"po":"2026-02-17","u":"2026-02-17","st":"2026-02","ag":"18–75"},{"n":"NCT07419867","t":"A Platform Study Based on Specific Tracer for Evaluating the Therapeutic Efficacy of Systemic Treatment for Breast Cancer Using PET/MRI","s":"nyr","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2026-02-19","u":"2026-02-19","st":"2026-03","ag":"18–70"},{"n":"NCT07423611","t":"ctDNA-Guided Chemotherapy Omission With Ribociclib Plus Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2026-02-20","u":"2026-02-20","st":"2026-10","ag":"18–70"},{"n":"NCT07444346","t":"Intravascular Imaging-Guided Intravascular Lithotripsy for Severe Coronary Calcified Lesions.","s":"nyr","p":"na","d":[31],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"cad"]],"po":"2026-03-02","u":"2026-03-02","st":"2026-02","ag":"18 and over"},{"n":"NCT07446335","t":"A Phase III Study of First-line Anlotinib Combined With Benmelstobart in Patients With Advanced Esophageal Squamous Cell Carcinoma","s":"nyr","p":"phase3","d":[1],"c":[20],"lc":[20],"a":"adult older","h":[25],"l":[[25,"escc"]],"po":"2026-03-03","u":"2026-03-03","st":"2026-04","ag":"18 and over"},{"n":"NCT07448376","t":"EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases","s":"nyr","p":"na","d":[5],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"panc"]],"po":"2026-03-04","u":"2026-03-04","st":"2026-03","ag":"18–70"},{"n":"NCT07453875","t":"LDRT Sequential NIPS Immunochemotherapy for Peritoneal Metastasis of Gastric and Colorectal Cancer","s":"nyr","p":"phase1","d":[3],"c":[1],"lc":[1],"a":"adult older","h":[17],"l":[[17,"gc"]],"po":"2026-03-06","u":"2026-04-27","st":"2026-05","ag":"18–75"},{"n":"NCT07455045","t":"A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)","s":"nyr","p":"phase1","d":[7],"c":[0],"a":"adult older","h":[53],"po":"2026-03-06","u":"2026-03-06","st":"2026-03","ag":"18–70"},{"n":"NCT07458646","t":"Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Perioperative Negative Emotions in Breast Cancer Surgery Patients","s":"nyr","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"breast"]],"po":"2026-03-09","u":"2026-03-09","st":"2026-02","ag":"18 and over"},{"n":"NCT07459608","t":"Efficacy and Safety of Lisaftoclax (APG-2575) Monotherapy in Patients With Mature B-cell Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"lymph"]],"po":"2026-03-10","u":"2026-07-29","st":"2026-07","ag":"18 and over"},{"n":"NCT07466303","t":"Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for Triple-Negative Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[39],"lc":[39],"a":"adult older","x":"female","h":[131],"l":[[131,"breast"]],"po":"2026-03-12","u":"2026-03-12","st":"2026-03","ag":"18–70"},{"n":"NCT07466927","t":"Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With HER2-negative Breast Cancer With Liver Metastases","s":"nyr","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2026-03-12","u":"2026-03-12","st":"2026-03","ag":"18 and over"},{"n":"NCT07467005","t":"Video Double-Lumen Tube for Secondary Pulmonary Resection","s":"nyr","p":"na","d":[4],"c":[23],"a":"adult older","h":[44,46,343],"po":"2026-03-12","u":"2026-03-12","st":"2026-03","ag":"18 and over"},{"n":"NCT07469488","t":"A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients With EGFR-Mutated Advanced NSCLC Receiving Amivantamab-Based Regimens","s":"nyr","p":"phase4","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2026-03-13","u":"2026-03-13","st":"2026-04","ag":"18 and over"},{"n":"NCT07469735","t":"Vorasidenib Guided by AGX PET in Recurrent/Low-grade Glioma","s":"nyr","p":"na","d":[7],"c":[5],"lc":[5],"a":"adult older","h":[103],"l":[[103,"glioma"]],"po":"2026-03-13","u":"2026-03-13","st":"2026-04","ag":"18 and over"},{"n":"NCT07469956","t":"Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer","s":"nyr","p":"phase2","d":[5],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"panc"]],"po":"2026-03-13","u":"2026-03-13","st":"2026-03","ag":"18–75"},{"n":"NCT07472621","t":"Real-World Effectiveness and Safety of Glofitamab in Primary Refractory and Early Relapsed Diffuse Large B-Cell Lymphoma","s":"nyr","p":"na","d":[19],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"lymph"]],"po":"2026-03-16","u":"2026-03-16","st":"2026-03","ag":"18 and over"},{"n":"NCT07472790","t":"A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Glioma","s":"nyr","p":"phase1","d":[7],"c":[2],"a":"adult older","h":[241],"po":"2026-03-16","u":"2026-07-14","st":"2026-07","ag":"18 and over"},{"n":"NCT07478328","t":"Chaigui Longmu Ejiao Paste for Ischemic Heart Disease","s":"nyr","p":"phase2","d":[31],"c":[5],"lc":[5],"a":"adult older","h":[377],"l":[[377,"cad"]],"po":"2026-03-17","u":"2026-03-17","st":"2026-03","ag":"18–75"},{"n":"NCT07480382","t":"Safety and Efficacy of LVD + C-TACE + Tis/Len for Unresectable Right-Liver HCC","s":"nyr","p":"na","d":[2],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"hcc"]],"po":"2026-03-18","u":"2026-03-18","st":"2026-04","ag":"18–80"},{"n":"NCT07481721","t":"IL13Rα2 CAR-T Cells Secreting Anti-PD-L1 Antibody for Recurrent Malignant Glioma","s":"nyr","p":"phase1","d":[7],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"glioma"]],"po":"2026-03-19","u":"2026-03-19","st":"2026-05","ag":"18 and over"},{"n":"NCT07481903","t":"Effect of Acupuncture on Psychoneurological Symptom Cluster in Breast Cancer Survivors","s":"nyr","p":"na","d":[6],"c":[2,28,30],"lc":[30],"a":"adult older","x":"female","h":[191,78,58,26],"l":[[191,"breast"]],"po":"2026-03-19","u":"2026-03-19","st":"2026-04","ag":"18–75"},{"n":"NCT07483749","t":"HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors","s":"nyr","p":"na","d":[19],"c":[23],"lc":[23],"a":"child adult","h":[179],"l":[[179,"lymph"]],"po":"2026-03-19","u":"2026-03-19","st":"2026-03","ag":"1–21"},{"n":"NCT07485920","t":"A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedanib for Limited-stage Small Cell Lung Cancer","s":"nyr","p":"phase4","d":[4],"c":[26,19],"lc":[26],"a":"adult older","h":[55,28],"l":[[55,"lung"]],"po":"2026-03-20","u":"2026-03-20","st":"2026-05","ag":"18 and over"},{"n":"NCT07486310","t":"Evaluation of Pressurized Intraperitoneal Aerosol Chemotherapy With VRT106 Versus PIPAC in Patients With Advanced Gastric Cancer and PeritonealMetastasis: A Prospective, Multicenter, Open-Label, Randomized Controlled Trial","s":"nyr","p":"phase2","d":[3],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"gc"]],"po":"2026-03-20","u":"2026-03-20","st":"2026-03","ag":"18–75"},{"n":"NCT07486648","t":"Osimertinib Plus Capivasertib in NSCLC With PIK3CA/AKT1/PTEN Alterations Following Prior 1L Osimertinib","s":"nyr","p":"phase1phase2","d":[4],"c":[2,12],"lc":[12],"a":"adult older","h":[84,23],"l":[[84,"lung"]],"po":"2026-03-20","u":"2026-11-19","st":"2026-05","ag":"18 and over"},{"n":"NCT07487402","t":"Safety and Efficacy of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients With Unresectable Recurrent/Metastatic Hepatocellular Carcinoma","s":"nyr","p":"earlyphase1","d":[2],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"hcc"]],"po":"2026-03-23","u":"2026-04-21","st":"2026-03","ag":"19–75"},{"n":"NCT07487519","t":"Phase II Study of HLX43 Monotherapy or Combined With Immune Checkpoint Inhibitors in Patients With Locally Advanced, Recurrent, or Metastatic Triple-negative Breast Cancer.","s":"nyr","p":"phase2","d":[6],"c":[24],"a":"adult older","h":[45],"po":"2026-03-23","u":"2026-03-23","st":"2026-04","ag":"18 and over"},{"n":"NCT07491263","t":"Clinical Study of Universal CD19 CAR-γδ T Cell Infusion in the Treatment of Relapsed/Refractory Acute B Lymphoblastic Leukemia","s":"nyr","p":"phase1","d":[16],"c":[16],"lc":[16],"a":"child adult older","h":[136],"l":[[136,"ball"]],"po":"2026-03-24","u":"2026-03-24","st":"2026-05","ag":"14 and over"},{"n":"NCT07493980","t":"Study on the Efficacy and Safety of JSKN016 as Neoadjuvant Therapy in Resectable Stage II-III Non-small Cell Lung Cancer Patients","s":"nyr","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2026-03-27","u":"2026-03-27","st":"2026-03","ag":"18–80"},{"n":"NCT07493993","t":"Clinical Study on the Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Nab-Paclitaxel in Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma","s":"nyr","p":"phase2","d":[1],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"escc"]],"po":"2026-03-27","u":"2026-03-27","st":"2026-06","ag":"18 and over"},{"n":"NCT07497256","t":"Decision Aid for Women Newly Diagnosed With Breast Cancer","s":"nyr","p":"na","d":[6],"c":[7],"a":"adult older","x":"female","h":[8,384],"po":"2026-03-27","u":"2026-04-30","st":"2026-04","ag":"18 and over"},{"n":"NCT07499154","t":"Perioperative Lidocaine for Lung Protection in Infants Undergoing Cardiac Surgery","s":"nyr","p":"phase4","d":[32],"c":[23],"lc":[23],"a":"child","h":[179],"l":[[179,"chd"]],"po":"2026-03-30","u":"2026-03-30","st":"2026-04","ag":"Up to 12 months"},{"n":"NCT07501169","t":"Sacituzumab Tirumotecan in Combination With Anlotinib in Previously Treated Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC)","s":"nyr","p":"phase2","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"lung"]],"po":"2026-03-30","u":"2026-04-13","st":"2026-04","ag":"18–75"},{"n":"NCT07507071","t":"Comparison of the Sensitivity of pCLE and Pathological Biopsy for Gastric Mucosal Lesions","s":"nyr","p":"na","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[177],"l":[[177,"gc"]],"po":"2026-04-02","u":"2026-04-02","st":"2026-03","ag":"18–75"},{"n":"NCT07507526","t":"A Study of Disitamab Vedotin, Tunlametinib, and PD-1 Antibody for Advanced Gastric Cancer","s":"nyr","p":"phase2","d":[3],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"gc"]],"po":"2026-04-02","u":"2026-04-02","st":"2026-04","ag":"18 and over"},{"n":"NCT07508956","t":"Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment","s":"nyr","p":"phase3","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"gc"]],"po":"2026-04-02","u":"2026-06-08","st":"2026-06","ag":"18 and over"},{"n":"NCT07510867","t":"18F-FAPI PET/CT and MRI in Gastric Cancer","s":"nyr","p":"na","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"gc"]],"po":"2026-04-06","u":"2026-04-06","st":"2026-05","ag":"20–80"},{"n":"NCT07511114","t":"A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping","s":"nyr","p":"phase3","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2026-04-06","u":"2026-04-06","st":"2026-03","ag":"18–75"},{"n":"NCT07511231","t":"Angiography-Derived Physiological Indices for Outcome Prediction in Patients Undergoing OCT-Guided PCI","s":"nyr","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[109],"l":[[109,"cad"]],"po":"2026-04-06","u":"2026-04-06","st":"2026-04","ag":"18–84"},{"n":"NCT07511426","t":"U96-CAR-T-Cells For R/R B-ALL","s":"nyr","p":"phase1","d":[16,19],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"ball"]],"po":"2026-04-06","u":"2026-05-28","st":"2026-07","ag":"18 and over"},{"n":"NCT07511894","t":"Beta-Blockers on the Efficacy of Neoadjuvant Immunotherapy for Gastric Cancer","s":"nyr","p":"phase2","d":[3],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"gc"]],"po":"2026-04-06","u":"2026-05-12","st":"2026-05","ag":"18–75"},{"n":"NCT07517640","t":"Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II Trial","s":"nyr","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2026-04-08","u":"2026-04-08","st":"2026-04","ag":"18 and over"},{"n":"NCT07521488","t":"LLM-Based Intelligent Health Management Assistant in Life-Cycle Health Management of Cardiac Surgery Patients","s":"nyr","p":"na","d":[32],"c":[2],"lc":[2],"a":"adult older","h":[109],"l":[[109,"chd"]],"po":"2026-04-13","u":"2026-04-13","st":"2026-05","ag":"18 and over"},{"n":"NCT07522593","t":"Baduanjin Exercise on Upper Limb Dysfunction Among Breast Cancer Survivors","s":"nyr","p":"na","d":[6],"c":[64],"a":"adult older","x":"female","h":[273],"po":"2026-04-13","u":"2026-04-13","st":"2026-04","ag":"18 and over"},{"n":"NCT07523789","t":"Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC","s":"nyr","p":"na","d":[6],"c":[28],"lc":[28],"a":"adult older","x":"female","h":[78],"l":[[78,"breast"]],"po":"2026-04-13","u":"2026-04-13","st":"2026-05","ag":"18 and over"},{"n":"NCT07524374","t":"SHR-1701 in Combination With Irinotecan Liposome (II) for Second-line Treatment of ESCC After Immunotherapy","s":"nyr","p":"phase2","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"escc"]],"po":"2026-04-13","u":"2026-04-13","st":"2026-03","ag":"18 and over"},{"n":"NCT07525817","t":"A Real-World Study of Pirtobrutinib in cBTKi-Resistant/Intolerant Mature B-Cell Lymphoma","s":"nyr","p":"na","d":[19],"c":[15],"a":"adult older","h":[27],"po":"2026-04-13","u":"2026-04-13","st":"2026-04","ag":"18 and over"},{"n":"NCT07526662","t":"Maternal-Fetal Heart Sound/Electrocardiogram Monitoring and Cardiac Risk Early Warning","s":"nyr","p":"na","d":[32],"c":[2],"lc":[2],"a":"adult","x":"female","h":[385],"l":[[385,"chd"]],"po":"2026-04-13","u":"2026-04-13","st":"2026-05","ag":"18–45"},{"n":"NCT07528898","t":"Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study.","s":"nyr","p":"phase2","d":[6],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"breast"]],"po":"2026-04-14","u":"2026-04-14","st":"2026-05","ag":"18–70"},{"n":"NCT07531979","t":"Prospective, Open-label, Multi-cohort Study of Becotatug Vedotin With Tislelizumab and Chemotherapy in Esophageal Squamous Cell Carcinoma - Phase 2","s":"nyr","p":"phase2","d":[1],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"escc"]],"po":"2026-04-15","u":"2026-04-15","st":"2026-04","ag":"18 and over"},{"n":"NCT07533526","t":"Effects of Instrument-Assisted Constant-Speed Injection Versus Manual Injection on Pain From Large-Volume Subcutaneous Injection of Pertuzumab and Trastuzumab in Breast Cancer: A Randomized, Self-Controlled Study","s":"nyr","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2026-04-16","u":"2026-04-16","st":"2026-04","ag":"18–70"},{"n":"NCT07535710","t":"Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma","s":"nyr","p":"phase1phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2026-04-17","u":"2026-04-17","st":"2026-03","ag":"60 and over"},{"n":"NCT07535762","t":"Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"older","h":[123],"l":[[123,"lymph"]],"po":"2026-04-17","u":"2026-04-17","st":"2026-03","ag":"65 and over"},{"n":"NCT07536607","t":"Predictive Role of Photon Counting Computed Tomography in Acute Coronary Syndrom Patients","s":"nyr","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"cad"]],"po":"2026-04-17","u":"2026-04-17","st":"2026-04","ag":"18 and over"},{"n":"NCT07537712","t":"Proton vs Photon IMRT Toxicity in Breast Cancer","s":"nyr","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[123],"l":[[123,"breast"]],"po":"2026-04-17","u":"2026-04-17","st":"2026-04","ag":"18 and over"},{"n":"NCT07537777","t":"Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line Targeted Therapy","s":"nyr","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"hcc"]],"po":"2026-04-17","u":"2026-04-17","st":"2026-04","ag":"18 and over"},{"n":"NCT07537946","t":"Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer","s":"nyr","p":"phase3","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2026-04-17","u":"2026-04-17","st":"2026-05","ag":"18–75"},{"n":"NCT07537959","t":"Surgery Plus Systemic Therapy for Liver Cancer With Extrahepatic Metastases","s":"nyr","p":"na","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2026-04-17","u":"2026-04-17","st":"2026-04","ag":"18–75"},{"n":"NCT07537972","t":"Denosumab Strategy for Liver Cancer With Bone Metastases","s":"nyr","p":"phase2","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2026-04-17","u":"2026-04-17","st":"2026-05","ag":"18–75"},{"n":"NCT07538193","t":"Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung Cancer","s":"nyr","p":"na","d":[4],"c":[39],"lc":[39],"a":"adult older","h":[122],"l":[[122,"lung"]],"po":"2026-04-20","u":"2026-04-20","st":"2026-05","ag":"18 and over"},{"n":"NCT07538973","t":"A Clinical Study to Evaluate the Pharmacokinetics and Safety of Anecatibin Fumarate Capsules in Subjects With Impaired Liver Function Versus Normal Liver Function","s":"nyr","p":"phase1","d":[4],"c":[26,5],"a":"adult older","h":[55,202],"po":"2026-04-20","u":"2026-04-20","st":"2026-04","ag":"18–65"},{"n":"NCT07539233","t":"A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019B in Patients With Relapsed/Refractory Multiple Myeloma.","s":"nyr","p":"earlyphase1","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2026-04-20","u":"2026-04-20","st":"2026-04","ag":"18 and over"},{"n":"NCT07539545","t":"The Comparison Between M-E-BCS and C-O-BCS.","s":"nyr","p":"na","d":[6],"c":[22],"lc":[22],"a":"adult older","x":"female","h":[40],"l":[[40,"breast"]],"po":"2026-04-20","u":"2026-04-20","st":"2026-04","ag":"18–70"},{"n":"NCT07539610","t":"Evaluation of the Safety and Efficacy of Sup19 CAR-T Cells in Patients With Previously Failed CD19-Targeted Therapy or CD19-Weakly Expressed Hematologic Tumors","s":"nyr","p":"phase1","d":[16,19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"ball"]],"po":"2026-04-20","u":"2026-04-20","st":"2026-04","ag":"18–69"},{"n":"NCT07539753","t":"Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases","s":"nyr","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[70],"l":[[70,"breast"]],"po":"2026-04-20","u":"2026-04-30","st":"2026-06","ag":"18–75"},{"n":"NCT07540390","t":"GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC.","s":"nyr","p":"phase3","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2026-04-20","u":"2026-04-22","st":"2026-05","ag":"18–65"},{"n":"NCT07542912","t":"Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma","s":"nyr","p":"na","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2026-04-21","u":"2026-04-21","st":"2026-06","ag":"18 and over"},{"n":"NCT07544134","t":"Areola Preservation in NSM With Nipple Involvement","s":"nyr","p":"na","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2026-04-22","u":"2026-04-22","st":"2026-05","ag":"18 and over"},{"n":"NCT07545213","t":"Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis","s":"nyr","p":"phase2","d":[4],"c":[23],"lc":[23],"a":"adult older","h":[343],"l":[[343,"lung"]],"po":"2026-04-22","u":"2026-04-22","st":"2026-04","ag":"18 and over"},{"n":"NCT07548255","t":"The Efficacy and Safety of Sonrotoclax, Zanubrutinib Combined With Obinutuzumab in MCL","s":"nyr","p":"phase1","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2026-04-23","u":"2026-04-23","st":"2026-04","ag":"18 and over"},{"n":"NCT07549282","t":"Intranasal Dexmedetomidine and Perioperative Myocardial Injury","s":"nyr","p":"phase4","d":[31],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"cad"]],"po":"2026-04-24","u":"2026-07-30","st":"2026-08","ag":"18–85"},{"n":"NCT07550842","t":"A Clinical Study for the Safety and Efficacy of BL0020 Injection in Combination With Toripalimab Injection in Patients With Recurrent Extensive-Stage Small Cell Lung Cancer","s":"nyr","p":"phase1","d":[4],"c":[49,24,5,11,29,13,20],"a":"adult older","h":[42,56,12,45,118,37,145,66],"po":"2026-04-24","u":"2026-04-24","st":"2026-06","ag":"18 and over"},{"n":"NCT07551414","t":"Zorifertinib Plus Intra-Ommaya CSF Chemotherapy for Leptomeningeal Progression in NSCLC After Third-Generation EGFR-TKI","s":"nyr","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2026-04-24","u":"2026-04-24","st":"2026-05","ag":"18–75"},{"n":"NCT07552506","t":"Clinical Study on the Preservation of Ovarian Function in Patients With Aplastic Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation Using Goserelin","s":"nyr","p":"na","d":[17],"c":[23,13,20],"lc":[13],"a":"child adult","x":"female","h":[12,25,36,46],"l":[[12,"aa"]],"po":"2026-04-27","u":"2026-04-27","st":"2026-05","ag":"14–50"},{"n":"NCT07553767","t":"Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection","s":"nyr","p":"earlyphase1","d":[2],"c":[61],"a":"adult older","h":[215],"po":"2026-04-28","u":"2026-04-28","st":"2026-03","ag":"18–65"},{"n":"NCT07553793","t":"Chimeric Antigen Receptor Macrophages Targeting c-MET for Advanced Stage of Pancreatic Cancer Patients","s":"nyr","p":"phase1","d":[5],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"panc"]],"po":"2026-04-28","u":"2026-04-28","st":"2026-05","ag":"18–75"},{"n":"NCT07554482","t":"Selinexor Combined With Reduced-Dose Radiotherapy For Early-Stage Extranodal NK/T-Cell Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[161],"l":[[161,"lymph"]],"po":"2026-04-28","u":"2026-04-28","st":"2026-05","ag":"18–75"},{"n":"NCT07554742","t":"Non-Invasive Detection of claudin18.2 in Pancreatic and Gastric/Gastroesophageal Junction Cancer by [68Ga]Ga-NODAGA-SNA014 PET Imaging","s":"nyr","p":"na","d":[3,5],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"gc"]],"po":"2026-04-28","u":"2026-04-28","st":"2026-04","ag":"18–75"},{"n":"NCT07554859","t":"GFH375 Monotherapy and Combination Therapy as First-Line Treatment for Advanced KRAS G12D-Mutant Non-Small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[0],"a":"adult older","h":[43],"po":"2026-04-28","u":"2026-04-28","st":"2026-05","ag":"18–75"},{"n":"NCT07556120","t":"Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia Gravis (MG)","s":"nyr","p":"phase1","d":[27],"c":[17],"a":"adult older","h":[68],"po":"2026-04-29","u":"2026-08-12","st":"2026-12","ag":"18–80"},{"n":"NCT07556848","t":"A Study of 9MW2821 Versus Chemotherapy in Participants With Previously Treated Locally Advanced or Metastatic Triple-Negative Breast Cancer","s":"nyr","p":"phase3","d":[6],"c":[5],"a":"adult older","h":[9],"po":"2026-04-29","u":"2026-04-30","st":"2026-05","ag":"18–75"},{"n":"NCT07557238","t":"CHIP-CC Registry: A Prospective Multicenter Registry of Complex High-Risk PCI in China","s":"nyr","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[213],"l":[[213,"cad"]],"po":"2026-04-29","u":"2026-05-12","st":"2026-06","ag":"18–90"},{"n":"NCT07557914","t":"Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for Patients With Unresectable HCC and Diabetes","s":"nyr","p":"phase2","d":[2],"c":[11],"lc":[11],"a":"adult older","h":[118],"l":[[118,"hcc"]],"po":"2026-04-30","u":"2026-11-10","st":"2026-10","ag":"18–80"},{"n":"NCT07558200","t":"Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors","s":"nyr","p":"phase1","d":[2,4],"c":[5],"a":"adult older","h":[65],"po":"2026-04-30","u":"2026-04-30","st":"2026-05","ag":"18 and over"},{"n":"NCT07560124","t":"A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer","s":"nyr","p":"phase1phase2","d":[6],"c":[2,22,24],"a":"adult older","h":[23,40,45],"po":"2026-04-30","u":"2026-04-30","st":"2026-06","ag":"18–75"},{"n":"NCT07560358","t":"Adebrelimab Combined With Chemoradiotherapy in Patients With Large Bulky Stage III Unresectable Non-Small Cell Lung Cancer","s":"nyr","p":"phase3","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2026-05-01","u":"2026-05-01","st":"2026-05","ag":"18–75"},{"n":"NCT07560475","t":"Exploratory Study of SHR-A1811 Via Different Administration Routes in Patients","s":"nyr","p":"phase2","d":[6],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"breast"]],"po":"2026-05-01","u":"2026-06-11","st":"2026-06","ag":"18 and over"},{"n":"NCT07561073","t":"Stomach-Partitioning Versus Conventional Gastrojejunostomy for Malignant Gastric Outlet Obstruction: A Multicenter Randomized Controlled Trial","s":"nyr","p":"na","d":[3],"c":[10],"a":"adult older","h":[50],"po":"2026-05-01","u":"2026-10-15","st":"2026-10","ag":"18–75"},{"n":"NCT07561983","t":"Tislelizumab Plus Chemotherapy and BACE for Unresectable NSCLC","s":"nyr","p":"phase2","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[47],"l":[[47,"lung"]],"po":"2026-05-01","u":"2026-05-01","st":"2026-05","ag":"18–80"},{"n":"NCT07565415","t":"Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy","s":"nyr","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"hcc"]],"po":"2026-05-04","u":"2026-05-04","st":"2026-06","ag":"18 and over"},{"n":"NCT07569328","t":"Low-dose Colchicine for CABG Graft Failure Prevention","s":"nyr","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[109],"l":[[109,"cad"]],"po":"2026-05-06","u":"2026-05-06","st":"2026-09","ag":"18 and over"},{"n":"NCT07569757","t":"Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma","s":"nyr","p":"phase3","d":[15],"c":[2,55,8,50,22,1,0,41,23,24,17,27,47,33,73,9,28,10,26,5,11,18,12,39,31,45,20,99],"a":"adult older","h":[46,89,64,78,6,20,37,97,53,25,98,195,15,238,80,112,137,111,143,113,206,349,164,92,57,79,120,149,129,186,0,151,99,202,201,193,84,386],"po":"2026-05-06","u":"2026-05-08","st":"2026-06","ag":"18–75"},{"n":"NCT07574463","t":"Adaptive Digital Exercise Rehabilitation for Children After CHD Surgery","s":"nyr","p":"na","d":[32],"c":[23],"lc":[23],"a":"child","h":[179],"l":[[179,"chd"]],"po":"2026-05-08","u":"2026-05-08","st":"2026-12","ag":"6–12"},{"n":"NCT07574528","t":"A Phase II Study of Sintilimab, Pegaspargase and Selinexor Followed by Radiotherapy in Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2026-05-08","u":"2026-05-08","st":"2026-05","ag":"18 and over"},{"n":"NCT07580261","t":"YMN-A02 for Advanced Primary Hepatocellular Carcinoma.","s":"nyr","p":"phase1","d":[2],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"hcc"]],"po":"2026-05-12","u":"2026-05-12","st":"2026-07","ag":"18–70"},{"n":"NCT07582419","t":"Hybrid Deep Learning Integrating Multimodal CEUS and Enhanced MRI to Optimize Early-Stage HCC Treatment Decisions","s":"nyr","p":"na","d":[2],"c":[15],"lc":[15],"a":"adult older","h":[27],"l":[[27,"hcc"]],"po":"2026-05-12","u":"2026-05-12","st":"2026-04","ag":"18–85"},{"n":"NCT07583316","t":"A Phase 1 First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors","s":"nyr","p":"phase1","d":[2,4],"c":[2],"a":"adult older","h":[74],"po":"2026-05-13","u":"2026-05-13","st":"2026-05","ag":"18 and over"},{"n":"NCT07583771","t":"A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma","s":"nyr","p":"phase1","d":[4,5,19],"c":[5],"a":"adult older","h":[9],"po":"2026-05-13","u":"2026-05-13","st":"2026-06","ag":"18 and over"},{"n":"NCT07585747","t":"A Exploratory Study on Untreated Follicular Lymphoma With Orelabrutinib, Tafasitamab, and Lenalidomide","s":"nyr","p":"phase2","d":[19],"c":[27,9,21,30,20],"lc":[30],"a":"adult older","h":[69,124,37,14,104],"l":[[69,"lymph"]],"po":"2026-05-14","u":"2026-05-14","st":"2026-04","ag":"18 and over"},{"n":"NCT07589101","t":"5T4 Targeting Nanobody Probe for PET Imaging in Solid Tumors","s":"nyr","p":"na","d":[4,6],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"lung"]],"po":"2026-05-15","u":"2026-05-15","st":"2026-06","ag":"18–70"},{"n":"NCT07590596","t":"Preoperative Decision-Making in Patients With Pulmonary Nodules Suspected of Lung Cancer","s":"nyr","p":"na","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[47],"l":[[47,"lung"]],"po":"2026-05-15","u":"2026-05-18","st":"2026-05","ag":"18 and over"},{"n":"NCT07592754","t":"The Safety and Efficacy of KSVCBD Injection in Neuromyelitis Optica Spectrum Disorder.","s":"nyr","p":"earlyphase1","d":[25],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"nmosd"]],"po":"2026-05-18","u":"2026-05-18","st":"2026-05","ag":"18–65"},{"n":"NCT07593118","t":"Exergame-Based Physical Activity Promotion for Children and Adolescents With Congenital Heart Disease","s":"nyr","p":"na","d":[32],"c":[23],"lc":[23],"a":"child adult","h":[179],"l":[[179,"chd"]],"po":"2026-05-18","u":"2026-05-18","st":"2026-07","ag":"8–18"},{"n":"NCT07593365","t":"Clinical Application of Vagus Nerve Stimulation Combined With Immunoregulatory T Cells in Alleviating Aromatase Inhibitor-Induced Pain","s":"nyr","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[48],"l":[[48,"breast"]],"po":"2026-05-18","u":"2026-05-18","st":"2026-05","ag":"18 and over"},{"n":"NCT07593846","t":"The Comparison Between DEDTI BR and T/E BR","s":"nyr","p":"phase3","d":[6],"c":[22],"lc":[22],"a":"adult older","x":"female","h":[40],"l":[[40,"breast"]],"po":"2026-05-18","u":"2026-05-18","st":"2026-05","ag":"18–70"},{"n":"NCT07593911","t":"A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases","s":"nyr","p":"na","d":[26,27],"c":[2],"lc":[2],"a":"adult older","h":[3],"l":[[3,"igg4"]],"po":"2026-05-18","u":"2026-05-18","st":"2026-06","ag":"18–75"},{"n":"NCT07594899","t":"AI-Driven Treatment Strategy vs Pola-R-CHP in Untreated LBCL","s":"nyr","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2026-05-19","u":"2026-05-19","st":"2026-05","ag":"18–75"},{"n":"NCT07595120","t":"Application of Electromagnetic Navigation System in Pulmonary Nodule Localization","s":"nyr","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2026-05-19","u":"2026-05-19","st":"2026-05","ag":"18–80"},{"n":"NCT07596134","t":"Multimodal Thermal Therapy With Targeted and Immunotherapy for Untreated Unresectable HCC","s":"nyr","p":"na","d":[2],"c":[23,9,29],"a":"adult older","h":[46,80,54,66],"po":"2026-05-19","u":"2026-09-22","st":"2026-10","ag":"18–80"},{"n":"NCT07596472","t":"Ultrasound Monitoring of Clipped Lymph Nodes to Predict Axillary Response After Chemotherapy in Breast Cancer","s":"nyr","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2026-05-19","u":"2026-05-19","st":"2026-05","ag":"18 and over"},{"n":"NCT07596524","t":"Analysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor Therapy","s":"nyr","p":"na","d":[4],"c":[12],"a":"child adult older","h":[84],"po":"2026-05-19","u":"2026-05-19","st":"2026-07","ag":"1 and over"},{"n":"NCT07599423","t":"A Study of Glofitamab Plus GemOx Compared With Standard of Care in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"lymph"]],"po":"2026-05-20","u":"2026-07-13","st":"2026-07","ag":"18 and over"},{"n":"NCT07601048","t":"A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment","s":"nyr","p":"phase3","d":[4],"c":[30],"a":"adult older","h":[58],"po":"2026-05-22","u":"2026-05-22","st":"2026-06","ag":"18–75"},{"n":"NCT07601607","t":"Lisaftoclax Plus Chidamide and Rituximab in Relapsed or Refractory Diffuse Large B-cell Lymphoma","s":"nyr","p":"phase1phase2","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2026-05-22","u":"2026-05-22","st":"2026-05","ag":"18 and over"},{"n":"NCT07602322","t":"LME-Guided Precision Combination Therapy in B-cell Lymphoma Patients After CD19 CAR-T Failure","s":"nyr","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2026-05-22","u":"2026-05-22","st":"2026-05","ag":"18 and over"},{"n":"NCT07603349","t":"Adaptive Adjuvant Therapy After Neoadjuvant Therapy and Gastrectomy for Gastric or Gastroesophageal Junction Adenocarcinoma","s":"nyr","p":"phase2phase3","d":[3],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"gc"]],"po":"2026-05-22","u":"2026-05-22","st":"2026-06","ag":"18–75"},{"n":"NCT07609251","t":"A Clinical Study of SCTB41 Combined With Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer（Phase II Study Ongoing）","s":"nyr","p":"phase2","d":[4],"c":[13],"a":"adult older","h":[36],"po":"2026-05-27","u":"2026-05-27","st":"2026-05","ag":"18 and over"},{"n":"NCT07609355","t":"AI-Assisted Optimization of Online Adaptive Radiotherapy for Gastric Lymphoma","s":"nyr","p":"na","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2026-05-27","u":"2026-05-27","st":"2026-05","ag":"18–75"},{"n":"NCT07609446","t":"Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma","s":"nyr","p":"na","d":[19],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"lymph"]],"po":"2026-05-27","u":"2026-05-27","st":"2026-05","ag":"18 and over"},{"n":"NCT07610629","t":"Retlirafusp Alfa Combined With Apatinib and Nab-Paclitaxel as Second-line Treatment for Gastric or Gastroesophageal Junction Cancer","s":"nyr","p":"phase2","d":[3],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"gc"]],"po":"2026-05-28","u":"2026-05-28","st":"2026-05","ag":"18 and over"},{"n":"NCT07613788","t":"Rimegepant Plus Glofitamab and CD19 CAR-T Therapy in R/R LBCL","s":"nyr","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2026-05-29","u":"2026-05-29","st":"2026-05","ag":"18 and over"},{"n":"NCT07615283","t":"Adebrelimab Combined With SHR2554 in Relapsed/Refractory PTCL and NK/T-Cell Lymphoma","s":"nyr","p":"phase1phase2","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2026-05-29","u":"2026-05-29","st":"2026-05","ag":"18 and over"},{"n":"NCT07615907","t":"A Study on the Efficacy of Sodium Propionate Combined With Anti-PD-1 Immunotherapy in Gastric Cancer","s":"nyr","p":"na","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[93],"l":[[93,"gc"]],"po":"2026-05-29","u":"2026-05-29","st":"2026-05","ag":"18–80"},{"n":"NCT07617389","t":"Selective Mediastinal Lymph Node Sampling Versus Systematic medIastinal Lymph Node Dissection After Neoadjuvant Chemoimmunotherapy for Non-small Cell Lung Cancer (SCIENCE Study)","s":"nyr","p":"phase3","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"lung"]],"po":"2026-06-01","u":"2026-06-01","st":"2026-05","ag":"18–75"},{"n":"NCT07618793","t":"Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell Carcinoma","s":"nyr","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[71],"l":[[71,"lung"]],"po":"2026-06-01","u":"2026-06-01","st":"2026-06","ag":"18–75"},{"n":"NCT07618910","t":"Retlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCC","s":"nyr","p":"phase2","d":[1],"c":[39],"lc":[39],"a":"adult older","h":[122],"l":[[122,"escc"]],"po":"2026-06-01","u":"2026-06-01","st":"2026-05","ag":"18–75"},{"n":"NCT07621562","t":"Tafolecimab Combined With Sintilimab and SOX in the Treatment of pMMR/MSS Gastric Cancer","s":"nyr","p":"phase2","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"gc"]],"po":"2026-06-02","u":"2026-06-02","st":"2026-06","ag":"18–75"},{"n":"NCT07622784","t":"Pirtobrutinib Maintenance After CAR-T Therapy in Relapsed or Refractory B-Cell Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2026-06-03","u":"2026-06-03","st":"2026-06","ag":"18 and over"},{"n":"NCT07623226","t":"Super-Resolution Ultrasound Imaging for Assessing Response to Neoadjuvant Chemotherapy in Breast Cancer","s":"nyr","p":"na","d":[6],"c":[17],"a":"adult older","x":"female","h":[231,88],"l":[[231,"breast"]],"po":"2026-06-03","u":"2026-06-03","st":"2026-06","ag":"18–75"},{"n":"NCT07623642","t":"A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.","s":"nyr","p":"phase2","d":[1,4,5,6],"c":[2,24],"a":"adult older","h":[74,45],"po":"2026-06-03","u":"2026-06-08","st":"2026-06","ag":"18–80"},{"n":"NCT07624214","t":"Study of LT-010391 in Participants With KRAS G12D-Mutant Solid Tumors","s":"nyr","p":"phase1","d":[4,5],"c":[23],"a":"adult older","h":[44],"po":"2026-06-03","u":"2026-06-03","st":"2026-07","ag":"18 and over"},{"n":"NCT07627321","t":"Becotatug Vedotin Combined With Pucotenlimab ± Radiotherapy as First-Line Treatment for Driver-Gene-Negative, EGFR-Expression-Positive Advanced Non-Small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[17],"a":"adult older","h":[231,88],"l":[[231,"lung"]],"po":"2026-06-04","u":"2026-06-04","st":"2026-07","ag":"18–75"},{"n":"NCT07628504","t":"Sac-TMT Sequential Capecitabine Versus Capecitabine in Early-Stage High-Risk Triple-Negative Breast Cancer Without BRCA Mutations","s":"nyr","p":"phase3","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2026-06-05","u":"2026-06-05","st":"2026-05","ag":"18 and over"},{"n":"NCT07628595","t":"Safety and Efficacy of RN9101 in the Treatment of Relapsed/Refractory Multiple Myeloma","s":"nyr","p":"earlyphase1","d":[15],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"mm"]],"po":"2026-06-05","u":"2026-06-10","st":"2026-07","ag":"18 and over"},{"n":"NCT07630103","t":"Efficacy and Safety of Trastuzumab Rezetecan or Trastuzumab Deruxtecan in Advanced Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2026-06-05","u":"2026-06-05","st":"2026-06","ag":"18–75"},{"n":"NCT07637786","t":"Peptide Nanovaccine (ONVAX-01) Plus Anti-PD-1 Antibody and Chemotherapy in Advanced Pancreatic Cancer","s":"nyr","p":"phase1","d":[5],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"panc"]],"po":"2026-06-10","u":"2026-06-10","st":"2026-06","ag":"18–75"},{"n":"NCT07638787","t":"Pola-R-CHP Plus Sonrotoclax in Untreated BCL2-High/Double-Hit LBCL","s":"nyr","p":"phase1phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2026-06-10","u":"2026-06-30","st":"2026-06","ag":"18–75"},{"n":"NCT07639879","t":"TR115 VS Investigator's Choice in Relapsed/Refractory Peripheral T/NK Cell Lymphoma","s":"nyr","p":"phase3","d":[19],"c":[2],"a":"adult older","h":[74],"po":"2026-06-10","u":"2026-06-10","st":"2026-07","ag":"18 and over"},{"n":"NCT07641140","t":"Phase I/II Clinical Study to Evaluate the Safety, Tolerability and Efficacy of LY-M003 Injection in Adult Patients With Wilson's Disease","s":"nyr","p":"phase1phase2","d":[29],"c":[23],"a":"adult","h":[46],"po":"2026-06-11","u":"2026-07-02","st":"2026-06","ag":"18–60"},{"n":"NCT07647692","t":"Deep Learning Time-Series Prediction of Long-Term Growth Patterns of Pulmonary Ground-Glass Nodules Using Serial CT","s":"nyr","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"lung"]],"po":"2026-06-15","u":"2026-06-15","st":"2026-06","ag":"18 and over"},{"n":"NCT07650487","t":"Perioperative Myocardial Injury in Patients Undergoing Coronary Artery Bypass Grafting: A Prospective Clinical Study","s":"nyr","p":"na","d":[31],"c":[15],"lc":[15],"a":"adult older","h":[156],"l":[[156,"cad"]],"po":"2026-06-16","u":"2026-06-16","st":"2026-07","ag":"21–80"},{"n":"NCT07654465","t":"Rituximab Maintenance Versus Observation After R2 Induction in Previously Untreated Marginal Zone Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2026-06-17","u":"2026-06-17","st":"2026-07","ag":"18 and over"},{"n":"NCT07655661","t":"Mannatide Combined With CAPOX and Tislelizumab for Advanced Gastric Cancer.","s":"nyr","p":"phase2","d":[3],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"gc"]],"po":"2026-06-18","u":"2026-06-18","st":"2026-07","ag":"18–75"},{"n":"NCT07656740","t":"Non-Operative Management and Following Immunotherapy for Colorectal Cancer and Other GI Cancers","s":"nyr","p":"na","d":[3],"c":[2],"lc":[2],"a":"child adult older","h":[74],"l":[[74,"gc"]],"po":"2026-06-18","u":"2026-06-18","st":"2026-06","ag":"Not stated"},{"n":"NCT07657169","t":"Molecular Subtype-Guided Postoperative Radiotherapy for Phyllodes Tumor of the Breast","s":"nyr","p":"na","d":[6],"c":[0,27,26,21],"lc":[0],"a":"adult older","x":"female","h":[99,55,356,126],"l":[[99,"breast"]],"po":"2026-06-18","u":"2026-11-05","st":"2026-10","ag":"18–75"},{"n":"NCT07657273","t":"Yttrium-90 Carbon Microsphere Radioembolization in Previously Treated Hepatocellular Carcinoma","s":"nyr","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[278],"l":[[278,"hcc"]],"po":"2026-06-18","u":"2026-06-18","st":"2026-06","ag":"18 and over"},{"n":"NCT07657442","t":"Risk-Stratified Hypofractionated Radiotherapy After Breast-Conserving Surgery for Early Breast Cancer","s":"nyr","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2026-06-18","u":"2026-06-18","st":"2026-06","ag":"18–75"},{"n":"NCT07658352","t":"A First-in-Human Study of HP-002 for Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma","s":"nyr","p":"phase1phase2","d":[19],"c":[0],"a":"adult older","h":[53],"po":"2026-06-22","u":"2026-06-22","st":"2026-06","ag":"18 and over"},{"n":"NCT07661173","t":"A Prospective Study of Firmonertinib as First-line Adaptive Therapy Guided by Dynamic ctDNA (MRD) Changes in Locally Advanced or Metastatic EGFR-mutated Non-small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[17],"a":"adult older","h":[231,88],"l":[[231,"lung"]],"po":"2026-06-22","u":"2026-06-22","st":"2026-06","ag":"18 and over"},{"n":"NCT07663630","t":"A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight Loss","s":"nyr","p":"phase1","d":[4],"c":[21],"lc":[21],"a":"adult older","h":[32],"l":[[32,"lung"]],"po":"2026-06-23","u":"2026-09-25","st":"2026-10","ag":"18 and over"},{"n":"NCT07664813","t":"One-Click Autofocus Versus Segmented Focus in Gastric Endoscopy","s":"nyr","p":"na","d":[3],"c":[27],"lc":[27],"a":"adult older","h":[124],"l":[[124,"gc"]],"po":"2026-06-24","u":"2026-06-24","st":"2026-06","ag":"18 and over"},{"n":"NCT07669194","t":"Glofitamab Combined With Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma","s":"nyr","p":"na","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lymph"]],"po":"2026-06-25","u":"2026-06-25","st":"2026-06","ag":"18 and over"},{"n":"NCT07669740","t":"A Study on the Efficacy and Safety of Sintilimab Combined With Ramucirumab and Paclitaxel in the Treatment of Gastric Cancer Patients With Short-term Recurrence After Adjuvant Therapy","s":"nyr","p":"phase2","d":[3],"c":[28],"lc":[28],"a":"child adult older","h":[78],"l":[[78,"gc"]],"po":"2026-06-25","u":"2026-06-25","st":"2026-07","ag":"15–75"},{"n":"NCT07670260","t":"GoFast CAR T-Cell Therapy for Recurrent Refractory B-Cell Lymphoma","s":"nyr","p":"earlyphase1","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2026-06-26","u":"2026-06-26","st":"2026-06","ag":"18 and over"},{"n":"NCT07670715","t":"Phase II Trial of SFRT Plus Chemo-immunotherapy for LA-NSCLC With Suboptimal Neoadjuvant Response","s":"nyr","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2026-06-26","u":"2026-06-26","st":"2026-07","ag":"18 and over"},{"n":"NCT07672743","t":"A Phase II Study of Radiation Therapy to Treat Refractory Breast Cancer","s":"nyr","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2026-06-29","u":"2026-06-29","st":"2026-06","ag":"18–75"},{"n":"NCT07673419","t":"A Clinical Study GK01 Cell Injection in Subjects With Advanced Lung Cancer","s":"nyr","p":"earlyphase1","d":[4],"c":[2],"a":"adult older","h":[74],"po":"2026-06-29","u":"2026-06-29","st":"2026-07","ag":"18–75"},{"n":"NCT07674368","t":"Rucaparib Monoclonal Antibody for Lorlatinib-Induced Hypercholesterolemia / Mixed","s":"nyr","p":"phase4","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2026-06-29","u":"2026-07-01","st":"2026-07","ag":"18 and over"},{"n":"NCT07674524","t":"Management Strategy of 1L Lorlatinib With Hyperlipidemia in Stage IIIB-IV ALK Positive NSCLC","s":"nyr","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2026-06-29","u":"2026-06-29","st":"2026-08","ag":"18 and over"},{"n":"NCT07676175","t":"A Study of BEBT-908 in Combination With Chemotherapy in Patients With Previously Untreated Peripheral T-Cell Lymphoma (PTCL)","s":"nyr","p":"phase2","d":[19],"c":[0,30,39],"a":"adult older","h":[53,69,111],"po":"2026-06-30","u":"2026-06-30","st":"2026-07","ag":"18–75"},{"n":"NCT07676266","t":"A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy","s":"nyr","p":"phase1","d":[25,27],"c":[26],"lc":[26],"a":"adult older","h":[55],"l":[[55,"nmosd"]],"po":"2026-06-30","u":"2026-06-30","st":"2026-07","ag":"18–70"},{"n":"NCT07677813","t":"Orelabrutinib Combined With Induction Therapy Followed by Sequential Monotherapy Maintenance in MCD Subtype Diffuse Large B-cell Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[15],"a":"adult older","h":[27],"po":"2026-07-01","u":"2026-07-01","st":"2026-06","ag":"18 and over"},{"n":"NCT07678021","t":"Micro-axial Flow Pump-Supported PCI in Complex Coronary Artery Disease With Ischemic LV Dysfunction","s":"nyr","p":"na","d":[31],"c":[2],"a":"adult older","h":[213],"po":"2026-07-01","u":"2026-07-01","st":"2026-08","ag":"18–80"},{"n":"NCT07678580","t":"Neoadjuvant Short-Course Radiotherapy Plus Tislelizumab and Chemotherapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma","s":"nyr","p":"phase2","d":[1],"c":[39],"lc":[39],"a":"adult older","h":[122],"l":[[122,"escc"]],"po":"2026-07-01","u":"2026-07-01","st":"2026-07","ag":"18–75"},{"n":"NCT07682272","t":"A Trial of SHR-8068 Combined With Adebrelimab and Apatinib in Perioperative Treatment of Resectable Hepatocellular Carcinoma","s":"nyr","p":"phase2","d":[2],"c":[5],"a":"adult older","h":[6],"po":"2026-07-02","u":"2026-07-02","st":"2026-07","ag":"18–70"},{"n":"NCT07684040","t":"A Study of Combination Therapy in Patients With Resectable Liver Cancer","s":"nyr","p":"phase2","d":[2],"c":[45],"lc":[45],"a":"adult older","h":[129],"l":[[129,"hcc"]],"po":"2026-07-06","u":"2026-07-06","st":"2026-08","ag":"18 and over"},{"n":"NCT07684456","t":"Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast Cancer","s":"nyr","p":"phase3","d":[6],"c":[2],"a":"adult older","h":[23],"po":"2026-07-06","u":"2026-07-06","st":"2026-08","ag":"18–75"},{"n":"NCT07684950","t":"Lisaftoclax Plus Pirtobrutinib in Relapsed or Refractory Mantle Cell Lymphoma After BTK-Targeted Therapy","s":"nyr","p":"phase2","d":[19],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"lymph"]],"po":"2026-07-06","u":"2026-07-06","st":"2026-06","ag":"18 and over"},{"n":"NCT07685704","t":"Zanidatamab Combined With Chemotherapy as Neoadjuvant/Conversion Therapy for HER2-Positive (IHC 3+ or IHC 2+) Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a Phase II Open-Label Study","s":"nyr","p":"phase2","d":[3],"c":[39],"lc":[39],"a":"adult older","h":[131],"l":[[131,"gc"]],"po":"2026-07-06","u":"2026-07-06","st":"2026-07","ag":"18–75"},{"n":"NCT07686185","t":"A Non-interventional, Real-world Study on the Adjuvant Treatment of Chinese EGFR-positive Stage IA NSCLC Patients With High-risk Factors Using Third-generation EGFR-TKIs.","s":"nyr","p":"na","d":[4],"c":[10],"lc":[10],"a":"adult older","h":[15],"l":[[15,"lung"]],"po":"2026-07-07","u":"2026-07-07","st":"2026-09","ag":"18 and over"},{"n":"NCT07687004","t":"Sonrotoclax and BCMA Bispecific Antibody in Newly Diagnosed Systemic AL Amyloidosis Based on t(11;14) Genetic Stratification","s":"nyr","p":"phase1phase2","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2026-07-07","u":"2026-07-07","st":"2026-08","ag":"18–70"},{"n":"NCT07688291","t":"A Phase II Study of PD-1/IL-2α-bias Bispecific Antibody Fusion Protein Monotherapy in Advanced Esophageal Squamous Cell Carcinoma After Failure of Prior ICI Plus Platinum-Based Chemotherapy","s":"nyr","p":"phase2","d":[1],"c":[2],"lc":[2],"a":"adult older","h":[3],"l":[[3,"escc"]],"po":"2026-07-07","u":"2026-07-07","st":"2026-06","ag":"18–75"},{"n":"NCT07689929","t":"Research on AI Models for Predicting Breast Cancer Treatment Effectiveness to Guide Her-2 Targeted ADC Therapy","s":"nyr","p":"na","d":[6],"c":[23],"lc":[23],"a":"child adult older","x":"female","h":[44],"l":[[44,"breast"]],"po":"2026-07-08","u":"2026-07-08","st":"2026-08","ag":"Not stated"},{"n":"NCT07691333","t":"Kumorixilib Plus Capecitabine and Letrozole for Neoadjuvant Treatment of HR-Positive HER2-Negative Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[16,56],"lc":[16],"a":"adult older","x":"female","h":[30,228,148],"l":[[30,"breast"]],"po":"2026-07-08","u":"2026-07-08","st":"2026-06","ag":"18–75"},{"n":"NCT07691762","t":"A Study of TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE in Participants With Incurable Hepatocellular Carcinoma","s":"nyr","p":"phase3","d":[2],"c":[28,5],"a":"adult older","h":[6,120],"po":"2026-07-09","u":"2026-10-29","st":"2026-11","ag":"18–75"},{"n":"NCT07695896","t":"Real-World Study of Bispecific Antibody in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma","s":"nyr","p":"na","d":[19],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"lymph"]],"po":"2026-07-10","u":"2026-07-10","st":"2026-07","ag":"18 and over"},{"n":"NCT07696481","t":"Clinical Study on the Safety and Efficacy of PID23 Injection in Patients With Relapsed/Refractory Acute Leukemia","s":"nyr","p":"earlyphase1","d":[16],"c":[0],"lc":[0],"a":"child adult older","h":[0],"l":[[0,"ball"]],"po":"2026-07-10","u":"2026-07-10","st":"2026-08","ag":"3–75"},{"n":"NCT07697040","t":"Becotatug Vedotin Plus Cisplatin and Radiotherapy in LA-ESCC","s":"nyr","p":"phase1","d":[1],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"escc"]],"po":"2026-07-10","u":"2026-07-10","st":"2026-07","ag":"18–75"},{"n":"NCT07698990","t":"Segmentectomy Versus Lobectomy for Deep Solid-Dominant Early-Stage NSCLC","s":"nyr","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2026-07-13","u":"2026-08-26","st":"2026-08","ag":"18–80"},{"n":"NCT07699172","t":"EEG-Guided Cognitive Function Preservation in Patients With Brain Tumors","s":"nyr","p":"na","d":[7],"c":[30],"lc":[30],"a":"adult older","h":[281],"l":[[281,"glioma"]],"po":"2026-07-13","u":"2026-07-13","st":"2026-08","ag":"18–75"},{"n":"NCT07699757","t":"HSK41959 With Standard Therapy in Solid Tumors With MTAP Deletion","s":"nyr","p":"phase1","d":[4,5],"c":[5],"a":"adult older","h":[65],"po":"2026-07-13","u":"2026-07-14","st":"2026-07","ag":"18 and over"},{"n":"NCT07699770","t":"Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial","s":"nyr","p":"phase4","d":[25],"c":[2,15,1,47,11,39],"lc":[39],"a":"adult older","h":[122,102,27,79,118,201],"l":[[122,"nmosd"]],"po":"2026-07-13","u":"2026-07-13","st":"2026-06","ag":"18–75"},{"n":"NCT07701681","t":"Sacituzumab Tirumotecan (Sac-TMT/SKB264) Plus Tagitanlimab (KL-A167) in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma","s":"nyr","p":"phase2","d":[1,3],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"escc"]],"po":"2026-07-14","u":"2026-07-14","st":"2026-08","ag":"18 and over"},{"n":"NCT07704645","t":"The Clinical Study of Adalimumab Combined With Other Anti-tumor Therapy as a Treatment for Resectable Non-small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[5],"a":"adult older","h":[56],"po":"2026-07-15","u":"2026-07-15","st":"2026-08","ag":"18–70"},{"n":"NCT07705308","t":"A Prospective Study of Response-adapted Low-dose Radiotherapy Combined With Orelabrutinib for Localized Mucosa-associated Lymphoid Tissue Extranodal Marginal Zone Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123,90,139],"l":[[123,"lymph"]],"po":"2026-07-15","u":"2026-07-15","st":"2026-08","ag":"18 and over"},{"n":"NCT07706959","t":"New Genotype-guided Treatment in Newly Diagnosed PTCL","s":"nyr","p":"phase1phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2026-07-16","u":"2026-07-16","st":"2026-07","ag":"18–75"},{"n":"NCT07709884","t":"A Single-center, Prospective, Single-arm Clinical Study Exploring the Treatment of Newly Diagnosed Multiple Myeloma Patients With t(11;14) Suitable for Transplantation Using the SonKRd Regimen","s":"nyr","p":"phase4","d":[15],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"mm"]],"po":"2026-07-17","u":"2026-07-17","st":"2026-07","ag":"18 and over"},{"n":"NCT07710612","t":"A Phase 2 Study of ABSK043 Combined With Osimertinib","s":"nyr","p":"phase2","d":[4],"c":[0,23,24,5,11,12,13],"a":"adult older","h":[42,12,45,118,46,49,84],"po":"2026-07-17","u":"2026-07-17","st":"2026-08","ag":"18 and over"},{"n":"NCT07712588","t":"Birelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (TAI-SHAN19)","s":"nyr","p":"phase2phase3","d":[19],"c":[8,1,24,5],"a":"adult older","h":[123,45,2,13],"po":"2026-07-17","u":"2026-08-05","st":"2026-09","ag":"18–70"},{"n":"NCT07714304","t":"JS212 in Combination With JS111 as First-Line Treatment in EGFR-Mutant Advanced NSCLC","s":"nyr","p":"na","d":[4],"c":[17,5],"a":"adult older","h":[42,112],"po":"2026-07-20","u":"2026-07-20","st":"2026-07","ag":"18–75"},{"n":"NCT07714798","t":"Universal STAR-T Cell Injection in Generalized Myasthenia Gravis","s":"nyr","p":"phase1","d":[27],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"mg"]],"po":"2026-07-20","u":"2026-07-20","st":"2026-07","ag":"18–65"},{"n":"NCT07717177","t":"AI-Driven Treatment Strategy vs ZR2 in Older Treatment-naive Patients With LBCL","s":"nyr","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"older","h":[123],"l":[[123,"lymph"]],"po":"2026-07-21","u":"2026-07-21","st":"2026-06","ag":"70 and over"},{"n":"NCT07717580","t":"Efficacy and Safety of Brentuximab Vedotin Combined With Lisaftoclax in CD30+ Cutaneous T-cell Lymphoma (CTCL)","s":"nyr","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[29],"l":[[29,"lymph"]],"po":"2026-07-21","u":"2026-07-23","st":"2026-07","ag":"18 and over"},{"n":"NCT07719543","t":"Efficacy and Safety of Lenalidomide in Patients With IgG4-Related Disease","s":"nyr","p":"phase3","d":[26],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"igg4"]],"po":"2026-07-22","u":"2026-07-22","st":"2026-08","ag":"18–75"},{"n":"NCT07719855","t":"A Multicenter, Prospective, Open-Label, Randomized Controlled Clinical Study of Orelabrutinib Combined With Obinutuzumab and Lenalidomide Versus Obinutuzumab Plus Chemotherapy for Treatment-Naive Follicular Lymphoma","s":"nyr","p":"phase3","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2026-07-22","u":"2026-07-22","st":"2026-07","ag":"18 and over"},{"n":"NCT07721103","t":"Early Response-guided Sequential Radiotherapy After Chemoimmunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma","s":"nyr","p":"phase2","d":[1],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"escc"]],"po":"2026-07-22","u":"2026-07-22","st":"2026-07","ag":"18 and over"},{"n":"NCT07723053","t":"Machine Learning-Guided LIV Selection for Adolescent Idiopathic Scoliosis","s":"nyr","p":"na","d":[33],"c":[28],"lc":[28],"a":"child adult","h":[60],"l":[[60,"scol"]],"po":"2026-07-23","u":"2026-07-23","st":"2026-07","ag":"10–18"},{"n":"NCT07724951","t":"The Efficacy and Safety of Donafenib Plus PD-1/L1 Monoclonal Antibodies Plus TACE or HAIC as First-line Treatment for Unresectable Hepatocellular Carcinoma A Multi-center, Retrospective Clinical Study","s":"nyr","p":"na","d":[2],"c":[0,24,10,26,5],"lc":[5],"a":"adult older","h":[6,53,15,55,99,45,0],"l":[[6,"hcc"]],"po":"2026-07-24","u":"2026-07-27","st":"2026-07","ag":"18 and over"},{"n":"NCT07725484","t":"Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients","s":"nyr","p":"phase3","d":[31],"c":[52,16,0,23,17,27,28,26,5,12,39,20,46],"lc":[5],"a":"adult older","h":[6,43,124,25,111,120,49,46,65,55,68,210,184,148,387,388],"l":[[6,"cad"]],"po":"2026-07-24","u":"2026-10-28","st":"2026-11","ag":"18–75"},{"n":"NCT07726160","t":"A Study of KIV-318 Injection in Patients With BCMA-Positive Relapsed/Refractory Multiple Myeloma","s":"nyr","p":"phase1","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2026-07-24","u":"2026-07-24","st":"2026-07","ag":"18–70"},{"n":"NCT07729618","t":"AI-Guided First-Line Immunotherapy Selection in Unresectable Hepatocellular Carcinoma","s":"nyr","p":"na","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2026-07-27","u":"2026-07-27","st":"2026-10","ag":"18 and over"},{"n":"NCT07732504","t":"AI-Guided Surveillance and Curative Salvage of Recurrence After Hepatocellular Carcinoma Resection or Ablation","s":"nyr","p":"na","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2026-07-29","u":"2026-07-29","st":"2026-10","ag":"18 and over"},{"n":"NCT07733492","t":"Rehabilitation With Wearable Monitors for Post-Lung Cancer Surgery","s":"nyr","p":"na","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"lung"]],"po":"2026-07-29","u":"2026-09-02","st":"2026-08","ag":"18–85"},{"n":"NCT07740044","t":"Medical Large Language Model-Assisted Diagnosis and Treatment in Primary Care Chronic Disease Management","s":"nyr","p":"na","d":[31],"c":[96],"lc":[96],"a":"adult older","h":[373],"l":[[373,"cad"]],"po":"2026-07-31","u":"2026-07-31","st":"2026-08","ag":"18–65"},{"n":"NCT07742800","t":"Multi-Omics Prediction of Radiation Lung Injury in Immunotherapy-Treated Lung Cancer Patients","s":"nyr","p":"na","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lung"]],"po":"2026-08-03","u":"2026-08-03","st":"2026-08","ag":"18 and over"},{"n":"NCT07744724","t":"Pirtobrutinib+Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL","s":"nyr","p":"phase2","d":[19],"c":[49,28],"lc":[49],"a":"adult older","h":[230,78],"l":[[230,"lymph"]],"po":"2026-08-04","u":"2026-08-06","st":"2026-07","ag":"18–65"},{"n":"NCT07744737","t":"Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL","s":"nyr","p":"phase2","d":[19],"c":[49,28],"lc":[49],"a":"adult older","h":[230,78],"l":[[230,"lymph"]],"po":"2026-08-04","u":"2026-08-06","st":"2026-07","ag":"18–80"},{"n":"NCT07744750","t":"Pirtobrutinib+Sonrotoclax（PS) Regimen in the Treatment of B-Cell Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[49,28],"lc":[49],"a":"adult older","h":[230,78],"l":[[230,"lymph"]],"po":"2026-08-04","u":"2026-08-06","st":"2026-08","ag":"18 and over"},{"n":"NCT07745257","t":"Culmerciclib Plus Anlotinib and Endocrine Therapy for HR-Positive/HER2-Negative Metastatic Breast Cancer With Brain Metastases","s":"nyr","p":"phase2","d":[6],"c":[48,22,52,0,23,9,28,18,20],"lc":[0],"a":"adult older","x":"female","h":[53,24,44,37,60,155,98,239,150],"l":[[53,"breast"]],"po":"2026-08-04","u":"2026-08-04","st":"2026-08","ag":"18–80"},{"n":"NCT07745790","t":"Safety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With Metastatic Pancreatic Cancer","s":"nyr","p":"phase2","d":[4,5],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lung"]],"po":"2026-08-04","u":"2026-08-04","st":"2026-07","ag":"18 and over"},{"n":"NCT07746245","t":"The Efficacy of CAPCT in Patients With PTCL","s":"nyr","p":"phase2","d":[19],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"lymph"]],"po":"2026-08-05","u":"2026-08-05","st":"2026-08","ag":"18 and over"},{"n":"NCT07746830","t":"Prospective Assessment of Alignment Between Multimodal Artificial Intelligence and Multidisciplinary Team Decisions in Gastrointestinal Oncology","s":"nyr","p":"na","d":[3],"c":[5],"a":"adult older","h":[123],"po":"2026-08-05","u":"2026-08-05","st":"2026-08","ag":"18 and over"},{"n":"NCT07749859","t":"SHR-1701 Plus Apatinib for Second-Line Treatment in Targeted-Immune Pretreated Advanced Hepatocellular Carcinoma","s":"nyr","p":"phase2","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"hcc"]],"po":"2026-08-06","u":"2026-08-06","st":"2026-08","ag":"18–75"},{"n":"NCT07752550","t":"Retlirafusp Alfa Combined With Chemotherapy or Fuzuloparib for Triple-Negative Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[24],"lc":[24],"a":"adult older","x":"female","h":[45],"l":[[45,"breast"]],"po":"2026-08-07","u":"2026-08-07","st":"2026-07","ag":"18–100"},{"n":"NCT07752589","t":"Microbiota in Neoadjuvant Chemoimmunotherapy for NSCLC","s":"nyr","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"lung"]],"po":"2026-08-07","u":"2026-08-07","st":"2026-07","ag":"18–80"},{"n":"NCT07753642","t":"Golidocitinib Plus Anthracycline-based Therapy for Untreated Nodal T-follicular Helper (TFH) Cell Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2026-08-07","u":"2026-08-07","st":"2026-08","ag":"18–75"},{"n":"NCT07756190","t":"Radscopal Radiotherapy Plus Immunotherapy for Chemotherapy-Ineligible Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer: A Single-Center, Open-Label, Phase II Study","s":"nyr","p":"phase2","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2026-08-10","u":"2026-08-10","st":"2026-09","ag":"18–80"},{"n":"NCT07757074","t":"A Comparative Study of Delayed Endoscopic DTI and Latissimus Dorsi ±Impalnt Reconstruction Post-Mastectomy","s":"nyr","p":"na","d":[6],"c":[22],"lc":[22],"a":"adult older","x":"female","h":[40],"l":[[40,"breast"]],"po":"2026-08-11","u":"2026-08-11","st":"2026-09","ag":"18–70"},{"n":"NCT07758062","t":"Levetiracetam Extended-Release Plus Stupp Protocol for Hypoxic IDH-Wildtype Glioblastoma","s":"nyr","p":"phase2","d":[7],"c":[30],"lc":[30],"a":"adult older","h":[59],"l":[[59,"glioma"]],"po":"2026-08-11","u":"2026-08-11","st":"2026-09","ag":"18–69"},{"n":"NCT07758491","t":"A Phase I/II Study of FG-M131 in TRBC1+ Relapsed/Refractory Peripheral T-Cell Lymphoma","s":"nyr","p":"phase1phase2","d":[19],"c":[2],"a":"adult older","h":[74],"po":"2026-08-11","u":"2026-09-02","st":"2026-08","ag":"18–75"},{"n":"NCT07761286","t":"Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection for Hepatocellular Carcinoma","s":"nyr","p":"phase1phase2","d":[2],"c":[24],"a":"adult older","h":[45],"po":"2026-08-12","u":"2026-08-12","st":"2026-09","ag":"18 and over"},{"n":"NCT07762547","t":"Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moyamoya Disease.","s":"nyr","p":"na","d":[28],"c":[2],"lc":[2],"a":"adult older","h":[102],"l":[[102,"moyamoya"]],"po":"2026-08-13","u":"2026-08-13","st":"2026-07","ag":"18–70"},{"n":"NCT07762755","t":"Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT","s":"nyr","p":"phase4","d":[31],"c":[2],"a":"adult older","h":[213],"po":"2026-08-13","u":"2026-08-13","st":"2026-08","ag":"18–75"},{"n":"NCT07764523","t":"Home-based Whole Course Multimodal Prehabilitation Based on 5G + Artificial Intelligence Mobile Health","s":"nyr","p":"na","d":[3],"c":[26],"lc":[26],"a":"adult older","h":[55],"l":[[55,"gc"]],"po":"2026-08-14","u":"2026-08-14","st":"2026-08","ag":"18 and over"},{"n":"NCT07764601","t":"R-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lymphoma","s":"nyr","p":"na","d":[19],"c":[49,28],"a":"adult older","h":[78,145],"po":"2026-08-14","u":"2026-08-14","st":"2026-08","ag":"18–80"},{"n":"NCT07764861","t":"A Open-Label Phase in Participants With Multiple Myeloma","s":"nyr","p":"phase2","d":[15],"c":[2],"a":"adult older","h":[48],"po":"2026-08-14","u":"2026-08-14","st":"2026-08","ag":"18 and over"},{"n":"NCT07764887","t":"Impacted Tooth Management and Osteoradionecrosis Risk in NPC","s":"nyr","p":"na","d":[0],"c":[57,88,10,87,46],"lc":[10],"a":"adult older","h":[15,170,96,342,317,329,376],"l":[[15,"npc"]],"po":"2026-08-14","u":"2026-08-14","st":"2026-08","ag":"18–75"},{"n":"NCT07766551","t":"Construction and Validation of a Coronary Artery Disease-Specific Large Language Model and Its Evaluation Framework (CorAI)","s":"nyr","p":"na","d":[31],"c":[2,17],"a":"adult older","h":[213,68],"po":"2026-08-14","u":"2026-08-14","st":"2026-08","ag":"18 and over"},{"n":"NCT07766772","t":"Trastuzumab Rezetecan Followed by Pyrotinib, and Trastuzumab Combined With Capecitabine as First-line Treatment for Advanced HER2-positive Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[16],"lc":[16],"a":"adult older","x":"female","h":[30],"l":[[30,"breast"]],"po":"2026-08-14","u":"2026-08-14","st":"2026-09","ag":"18–75"},{"n":"NCT07767565","t":"Research on the Development and Validation of Personalized Exercise Prescription System for Breast Cancer Patients Based on Large Language Models","s":"nyr","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"breast"]],"po":"2026-08-17","u":"2026-08-17","st":"2026-09","ag":"18–75"},{"n":"NCT07768085","t":"Pragmatic RCT of AI-Assisted Reading for Malignant Hepatic Lesions on CE-CT","s":"nyr","p":"na","d":[2],"c":[11],"lc":[11],"a":"adult older","h":[143],"l":[[143,"hcc"]],"po":"2026-08-17","u":"2026-08-17","st":"2026-08","ag":"18 and over"},{"n":"NCT07768943","t":"GELAD-Based Response-Adapted Treatment for Early-Stage Extranodal NK/T-Cell Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lymph"]],"po":"2026-08-17","u":"2026-08-17","st":"2026-09","ag":"18–75"},{"n":"NCT07769658","t":"Standardized MRI and Structured Reporting for Esophageal Squamous Cell Carcinoma","s":"nyr","p":"na","d":[1],"c":[22,0,47,5,30,20],"lc":[20],"a":"adult older","h":[25,53,40,58,9,135],"l":[[25,"escc"]],"po":"2026-08-18","u":"2026-08-18","st":"2026-09","ag":"18–80"},{"n":"NCT07769866","t":"Retlirafusp Alfa Combined With Chemoradiotherapy in Unresectable ESCC","s":"nyr","p":"na","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"escc"]],"po":"2026-08-18","u":"2026-08-18","st":"2026-09","ag":"18–75"},{"n":"NCT07770672","t":"An Exploratory Clinical Study of Accurate Efficacy Assessment of Neoadjuvant Immunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Based on 68Ga-FAPI ([68Ga] Fibroblast Activation Protein Inhibitor)/¹⁸F-FDG (2-Deoxy-2-[¹⁸F]Fluoro-D-glucose) Dual Imaging","s":"nyr","p":"phase2","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"escc"]],"po":"2026-08-18","u":"2026-08-18","st":"2026-08","ag":"18–75"},{"n":"NCT07771764","t":"A Multicenter Exploratory Clinical Study of Iruplaltinib Combined With Pemetrexed as Neoadjuvant Therapy for Resectable ALK-Positive Non-Squamous Non-Small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[16],"lc":[16],"a":"adult older","h":[136],"l":[[136,"lung"]],"po":"2026-08-18","u":"2026-08-18","st":"2026-08","ag":"18–75"},{"n":"NCT07771881","t":"Romiplostim N01 for Injection for Secondary Prophylaxis of CIT in Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2026-08-18","u":"2026-08-18","st":"2026-08","ag":"18–75"},{"n":"NCT07774234","t":"Sonrotoclax, Glofitamab, Gemcitabine, and Oxaliplatin for Relapsed or Refractory Large B-Cell Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"lymph"]],"po":"2026-08-19","u":"2026-08-19","st":"2026-08","ag":"18 and over"},{"n":"NCT07775040","t":"Spatially Fractionated Radiotherapy With Tislelizumab and Chemotherapy for Bulky Stage III NSCLC: A Phase II Trial","s":"nyr","p":"phase2","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[47],"l":[[47,"lung"]],"po":"2026-08-20","u":"2026-11-19","st":"2026-08","ag":"18–75"},{"n":"NCT07778940","t":"Thiotepa Administration Via Ommaya Reservoir for Leptomeningeal Metastases in Non-Small Cell Lung Cancer Resistant to EGFR-TKI.","s":"nyr","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2026-08-21","u":"2026-08-21","st":"2026-09","ag":"18–75"},{"n":"NCT07780357","t":"HCC Risk Prediction Model Based on Multimodal Data in Chronic Hepatitis B","s":"nyr","p":"na","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[39],"l":[[39,"hcc"]],"po":"2026-08-21","u":"2026-08-28","st":"2026-08","ag":"18 and over"},{"n":"NCT07780578","t":"The Study Of Andamertinib Plus Anlotinib In Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2026-08-21","u":"2026-08-25","st":"2026-09","ag":"18 and over"},{"n":"NCT07780721","t":"Study of Adebrelimab Combined With Thymalfasin and Chemotherapy for Neoadjuvant Treatment of Esophageal Cancer","s":"nyr","p":"phase2","d":[1],"c":[92],"lc":[92],"a":"adult older","h":[357],"l":[[357,"escc"]],"po":"2026-08-21","u":"2026-08-21","st":"2026-08","ag":"18–80"},{"n":"NCT07781436","t":"A Randomized Controlled Trial: Fuzheng Yangxin Formula for ERAS After CABG","s":"nyr","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[115],"l":[[115,"cad"]],"po":"2026-08-24","u":"2026-08-24","st":"2026-08","ag":"20–80"},{"n":"NCT07782086","t":"A Study of T-DXd in AI-Assessed HER2-Ultralow Metastatic Breast Cancer","s":"nyr","p":"na","d":[6],"c":[2,22,17,73,28,5,39,31],"a":"adult older","h":[40,78,238,47,131,31,115,64,177],"po":"2026-08-24","u":"2026-08-24","st":"2026-09","ag":"18 and over"},{"n":"NCT07782294","t":"AI-Assisted Novel rbcDNA Detection for Early Gastric Cancer Diagnosis","s":"nyr","p":"na","d":[3],"c":[48,23,5],"lc":[23],"a":"adult older","h":[54,41,150],"l":[[54,"gc"]],"po":"2026-08-24","u":"2026-08-24","st":"2026-09","ag":"18–75"},{"n":"NCT07783321","t":"A Study of Anti-PD-1 Antibody With or Without BL-B01D1 as Maintenance Therapy Following Anti-PD-1 Antibody Plus Chemotherapy for the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma (PANKU-NPC02)","s":"nyr","p":"phase3","d":[0],"c":[0],"a":"adult older","h":[53],"po":"2026-08-24","u":"2026-09-15","st":"2026-09","ag":"18 and over"},{"n":"NCT07784049","t":"The Correlation Between Sodium Urate (MSU) Deposition and Coronary Atherosclerosis in Patients With Foot Gout","s":"nyr","p":"na","d":[31],"c":[26],"lc":[26],"a":"adult older","h":[55],"l":[[55,"cad"]],"po":"2026-08-25","u":"2026-08-25","st":"2026-08","ag":"18–90"},{"n":"NCT07784101","t":"A Phase 3 Study to Compare the Efficacy of ICP-248 in Combination With Orelabrutinib Versus Pirtobrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma (r/r MCL).","s":"nyr","p":"phase3","d":[19],"c":[2,8,22,1,16,0,23,17,27,47,28,5,11,18,30,13,39,20],"a":"adult older","h":[40,53,46,36,12,69,9,115,37,118,24,2,60,47,167,44,92,30,112,57,13,97,131,135],"po":"2026-08-25","u":"2026-08-25","st":"2026-10","ag":"18 and over"},{"n":"NCT07784413","t":"A Sequential Trial of Low-Dose Radiotherapy Followed by Concurrent Immunotherapy, Systemic Chemotherapy, and Intraperitoneal Perfusion in Gastric Cancer With Peritoneal Carcinomatosis","s":"nyr","p":"phase2","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"gc"]],"po":"2026-08-25","u":"2026-08-25","st":"2026-09","ag":"18 and over"},{"n":"NCT07787338","t":"SHR-A1811 Monotherapy or Sequential THPy as Neoadjuvant Therapy for Stage II-III HER2-Positive Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[46],"l":[[46,"breast"]],"po":"2026-08-26","u":"2026-08-26","st":"2026-09","ag":"18–75"},{"n":"NCT07788001","t":"A Non-inferiority Study of Indocyanine Green-guided Sentinel Lymph Node Mapping Versus Conventional Lymph Node Dissection in Esophageal Cancer","s":"nyr","p":"phase3","d":[1],"c":[16],"lc":[16],"a":"adult older","h":[140],"l":[[140,"escc"]],"po":"2026-08-26","u":"2026-08-26","st":"2026-10","ag":"18–75"},{"n":"NCT07790419","t":"A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Targeted Therapy and a PD-1 Inhibitor in Patients With Postoperative Hepatocellular Carcinoma and Microvascular Invasion","s":"nyr","p":"phase4","d":[2],"c":[20],"lc":[20],"a":"adult older","h":[25],"l":[[25,"hcc"]],"po":"2026-08-27","u":"2026-08-27","st":"2026-08","ag":"18–80"},{"n":"NCT07791550","t":"Baduanjin for Quality of Life in Pancreatic Cancer Chemotherapy","s":"nyr","p":"na","d":[5],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"panc"]],"po":"2026-08-28","u":"2026-08-28","st":"2026-08","ag":"18 and over"},{"n":"NCT07791771","t":"SLNB Combined With WLNB for Axillary De-escalation in Breast Cancer Patients With Abnormal Axillary Nodes","s":"nyr","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[74],"l":[[74,"breast"]],"po":"2026-08-28","u":"2026-08-28","st":"2026-07","ag":"18 and over"},{"n":"NCT07791979","t":"High-Flow Nasal Cannula Oxygenation During Sedated Gastrointestinal Endoscopy in Patients With Chronic Obstructive Pulmonary Disease","s":"nyr","p":"na","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"gc"]],"po":"2026-08-28","u":"2026-08-28","st":"2026-08","ag":"18 and over"},{"n":"NCT07793318","t":"TR115 in ARID1A-Mutated Advanced Solid Tumors","s":"nyr","p":"phase2","d":[3],"c":[5],"a":"adult older","h":[9],"po":"2026-08-28","u":"2026-08-28","st":"2026-09","ag":"18–70"},{"n":"NCT07794488","t":"Platinum-Free Regimen in Nasopharyngeal Carcinoma","s":"nyr","p":"phase2","d":[0],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"npc"]],"po":"2026-08-31","u":"2026-08-31","st":"2026-09","ag":"18–70"},{"n":"NCT07795424","t":"Culmerciclib Combined With Letrozole and Dual HER2 Blockade as Neoadjuvant Therapy for HR+/HER2+ Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[11],"lc":[11],"a":"adult older","x":"female","h":[143,18],"l":[[143,"breast"]],"po":"2026-08-31","u":"2026-08-31","st":"2026-09","ag":"18–70"},{"n":"NCT07796906","t":"Five-Element Music Therapy for Psychological Distress in Pancreatic Cancer Chemotherapy","s":"nyr","p":"na","d":[5],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"panc"]],"po":"2026-09-01","u":"2026-09-16","st":"2026-08","ag":"18 and over"},{"n":"NCT07797075","t":"Digital Rehabilitation With Wearable Monitors for Sequential Lung Cancer Resection","s":"nyr","p":"na","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"lung"]],"po":"2026-09-01","u":"2026-09-01","st":"2026-08","ag":"18–85"},{"n":"NCT07797881","t":"A Study of BL-B01D1 With or Without PD-1 Monoclonal Antibody in Patients With High-Risk Locally Advanced Nasopharyngeal Carcinoma","s":"nyr","p":"phase2","d":[0],"c":[0],"a":"adult older","h":[53],"po":"2026-09-01","u":"2026-09-16","st":"2026-09","ag":"18–75"},{"n":"NCT07799077","t":"Paclitaxel Polymeric Micelles and Cisplatin Plus Sintilimab as Neoadjuvant Therapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma","s":"nyr","p":"phase2","d":[1],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"escc"]],"po":"2026-09-02","u":"2026-09-02","st":"2026-09","ag":"18–75"},{"n":"NCT07799649","t":"ctDNA-MRD Monitoring After Neoadjuvant Therapy in Gastric Cancer With pCR or MPR","s":"nyr","p":"na","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"gc"]],"po":"2026-09-02","u":"2026-09-02","st":"2026-09","ag":"18–75"},{"n":"NCT07801898","t":"Neoadjuvant Endocrine Therapy Combined With Chemotherapy in ER-positive, HER2-negative Stage I-III Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[17],"lc":[17],"a":"adult","h":[31],"l":[[31,"breast"]],"po":"2026-09-03","u":"2026-09-03","st":"2026-09","ag":"18–18"},{"n":"NCT07803471","t":"Yiqi Fumai Lyophilized Injection for Chronic Heart Failure Caused by Coronary Heart Disease","s":"nyr","p":"na","d":[31],"c":[0,20],"a":"adult older","h":[107,34],"po":"2026-09-03","u":"2026-09-09","st":"2026-09","ag":"40–80"},{"n":"NCT07806045","t":"Nebulized UC-EVs for Recurrent or Refractory IMIDs With Lung Involvement","s":"nyr","p":"earlyphase1","d":[26],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"igg4"]],"po":"2026-09-08","u":"2026-09-08","st":"2026-10","ag":"18–80"},{"n":"NCT07807722","t":"Neoadjuvant Therapy With Firmonertinib Combined With Anlotinib and Platinum-Based Doublet Chemotherapy for Resectable EGFR-Mutated NSCLC","s":"nyr","p":"phase2","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[19],"l":[[19,"lung"]],"po":"2026-09-08","u":"2026-09-08","st":"2026-09","ag":"18–70"},{"n":"NCT07809724","t":"Efficacy and Safety of Low-Dose IL-2 in Neuromyelitis Optica Spectrum Disorder","s":"nyr","p":"phase2","d":[25],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"nmosd"]],"po":"2026-09-09","u":"2026-09-09","st":"2026-08","ag":"18–74"},{"n":"NCT07811986","t":"HP-001 Plus Dexamethasone for Relapsed/Refractory Multiple Myeloma With Extramedullary Disease","s":"nyr","p":"phase2","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2026-09-10","u":"2026-09-10","st":"2026-09","ag":"18 and over"},{"n":"NCT07812493","t":"Pirtobrutinib Plus Methotrexate-Based Chemoimmunotherapy for Systemic DLBCL With CNS Involvement","s":"nyr","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"child adult older","h":[123],"l":[[123,"lymph"]],"po":"2026-09-10","u":"2026-09-11","st":"2026-09","ag":"14–80"},{"n":"NCT07813572","t":"ZG005 Plus Bevacizumab vs Sintilimab Plus Bevacizumab as First-Line Therapy for Advanced Hepatocellular","s":"nyr","p":"phase3","d":[2],"c":[28],"a":"adult older","h":[105],"po":"2026-09-10","u":"2026-11-16","st":"2026-09","ag":"18 and over"},{"n":"NCT07814859","t":"Retlirafusp Alfa Combined With Famitinib, Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Unresectable Pancreatic Cancer","s":"nyr","p":"phase2","d":[5],"c":[20],"lc":[20],"a":"adult older","h":[25],"l":[[25,"panc"]],"po":"2026-09-11","u":"2026-09-11","st":"2026-08","ag":"18–80"},{"n":"NCT07815951","t":"Safety and Diagnostic Performance of 111In-TJD-31 SPECT Imaging in Patients With Solid Tumors","s":"nyr","p":"phase1","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[133],"l":[[133,"lung"]],"po":"2026-09-11","u":"2026-09-11","st":"2026-09","ag":"18–75"},{"n":"NCT07818291","t":"An Open-label, Dose-escalation Phase Ib Study of EA5 Injection in Adults With Anti-AChR Antibody-Positive Generalized Myasthenia Gravis","s":"nyr","p":"phase1","d":[27],"c":[2,5],"a":"adult older","h":[103,94],"po":"2026-09-14","u":"2026-09-14","st":"2026-09","ag":"18 and over"},{"n":"NCT07818486","t":"A Study of BL-M08D1 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma and Other Solid Tumors","s":"nyr","p":"phase1phase2","d":[0],"c":[1,0],"a":"adult older","h":[53,2],"po":"2026-09-14","u":"2026-09-14","st":"2026-09","ag":"18–75"},{"n":"NCT07818499","t":"A Study of BL-M08D1 in Combination With Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma","s":"nyr","p":"phase1phase2","d":[19],"c":[0,4],"a":"adult older","h":[53,5],"po":"2026-09-14","u":"2026-09-14","st":"2026-09","ag":"18–75"},{"n":"NCT07819188","t":"SCTB35 and SCTB41 With or Without Chemotherapy in Non-Hodgkin Lymphoma","s":"nyr","p":"phase1phase2","d":[19],"c":[30],"a":"adult older","h":[69],"po":"2026-09-14","u":"2026-09-14","st":"2026-09","ag":"18–80"},{"n":"NCT07819591","t":"Paclitaxel Polymeric Micelles Plus Ivonescimab in Recurrent or Refractory SCLC","s":"nyr","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2026-09-15","u":"2026-09-15","st":"2026-10","ag":"18 and over"},{"n":"NCT07819669","t":"Video-Assisted Thoracoscopic Surgery Combined With Radiofrequency Ablation Versus VATS Alone for Multiple Primary Lung Cancer","s":"nyr","p":"na","d":[4],"c":[2,21],"a":"adult older","h":[23,106],"po":"2026-09-15","u":"2026-09-15","st":"2026-09","ag":"18–80"},{"n":"NCT07822906","t":"Risk of Esophageal Cancer Returning After Immunotherapy, Chemotherapy, and Surgery","s":"nyr","p":"na","d":[1],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"escc"]],"po":"2026-09-16","u":"2026-09-16","st":"2026-10","ag":"18 and over"},{"n":"NCT07823270","t":"Neoadjuvant Sacituzumab Tirumotecan Plus Toripalimab in Locally Advanced Esophageal Squamous Cell Carcinoma","s":"nyr","p":"phase2","d":[1],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"escc"]],"po":"2026-09-16","u":"2026-09-16","st":"2026-10","ag":"18 and over"},{"n":"NCT07823348","t":"JS207 Plus JS007 Versus Toripalimab Plus Bevacizumab as First-Line Treatment for Advanced Liver Cancer","s":"nyr","p":"phase3","d":[2],"c":[24,5],"a":"adult older","h":[6,45],"po":"2026-09-16","u":"2026-09-16","st":"2026-10","ag":"18–75"},{"n":"NCT07824765","t":"Heterogeneity of Treatment Effects of Adding Locoregional Therapies to Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma (ISMIO-026)","s":"nyr","p":"na","d":[2],"c":[28],"lc":[28],"a":"adult older","h":[120],"l":[[120,"hcc"]],"po":"2026-09-17","u":"2026-09-17","st":"2026-09","ag":"18 and over"},{"n":"NCT07824856","t":"Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal Carcinoma","s":"nyr","p":"phase2","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2026-09-17","u":"2026-09-17","st":"2026-10","ag":"18–75"},{"n":"NCT07825753","t":"Protein-Matched ADC or PDC Umbrella Trial in Advanced Pancreatic and Breast Cancer","s":"nyr","p":"phase2","d":[5,6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"panc"]],"po":"2026-09-17","u":"2026-09-17","st":"2026-09","ag":"18–75"},{"n":"NCT07827261","t":"A Study of BL-B01D1 Combined With Glecirasib in Patients With KRAS G12C-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[0],"a":"adult older","h":[53],"po":"2026-09-18","u":"2026-09-18","st":"2026-09","ag":"18–75"},{"n":"NCT07828756","t":"Albumin-bound Paclitaxel (Ⅱ)-Combined Regimens for Pancreatic Cancer","s":"nyr","p":"phase2","d":[5],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"panc"]],"po":"2026-09-18","u":"2026-09-18","st":"2026-09","ag":"18–75"},{"n":"NCT07828899","t":"Safety and Efficacy Evaluation of Single-Port Versus Multi-Port Robotic-Assisted Radical Distal Gastrectomy for Gastric Cancer","s":"nyr","p":"na","d":[3],"c":[27,18,37],"lc":[37],"a":"adult older","h":[81,24,113],"l":[[81,"gc"]],"po":"2026-09-18","u":"2026-09-18","st":"2026-10","ag":"18–85"},{"n":"NCT07829640","t":"AI-Assisted Chest CT Interpretation Across the Lung Cancer Care Continuum","s":"nyr","p":"na","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lung"]],"po":"2026-09-21","u":"2026-09-21","st":"2026-09","ag":"18 and over"},{"n":"NCT07830095","t":"5G-Enabled Remote Robotic-Assisted Bronchoscopy-Guided Cryoablation for Pulmonary Malignancies","s":"nyr","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2026-09-21","u":"2026-11-18","st":"2026-11","ag":"18 and over"},{"n":"NCT07830238","t":"SNC116 Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia","s":"nyr","p":"earlyphase1","d":[16],"c":[15],"a":"adult older","h":[27],"po":"2026-09-21","u":"2026-09-21","st":"2026-09","ag":"18–75"},{"n":"NCT07830251","t":"AI-Assisted Versus Independent Heart Sound Screening for Congenital Heart Disease in Children","s":"nyr","p":"na","d":[32],"a":"child adult","h":[389],"l":[[389,"chd"]],"po":"2026-09-21","u":"2026-09-21","st":"2026-09","ag":"0–18"},{"n":"NCT07830485","t":"CM336 Plus Daratumumab and Lenalidomide in Transplant-Ineligible Newly Diagnosed Multiple Myeloma","s":"nyr","p":"phase2","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2026-09-21","u":"2026-10-26","st":"2026-10","ag":"18–75"},{"n":"NCT07831187","t":"Entacapone Plus Bevacizumab for Glioblastoma at First Recurrence","s":"nyr","p":"phase1phase2","d":[7],"c":[37],"lc":[37],"a":"adult older","h":[81],"l":[[81,"glioma"]],"po":"2026-09-21","u":"2026-09-21","st":"2026-10","ag":"18 and over"},{"n":"NCT07831863","t":"A Study of 7MW3711 Compared With Docetaxel in Advanced Squamous NSCLC After Prior Chemoimmunotherapy","s":"nyr","p":"phase3","d":[4],"c":[5],"a":"adult older","h":[42],"po":"2026-09-21","u":"2026-09-21","st":"2026-10","ag":"18–85"},{"n":"NCT07833202","t":"A Phase 3 Study of Sosimerasib in Combination With IN10018 Versus Standard Therapy for First Line Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation","s":"nyr","p":"phase3","d":[4],"c":[9],"a":"adult older","h":[80],"po":"2026-09-22","u":"2026-09-24","st":"2026-10","ag":"18–75"},{"n":"NCT07833241","t":"Surufatinib in Combination With Iparomlimab and Tuvonralimab Injection and AG Chemotherapy for Neoadjuvant Therapy of HRPC or BRPC","s":"nyr","p":"phase2","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"panc"]],"po":"2026-09-22","u":"2026-09-22","st":"2026-09","ag":"18–75"},{"n":"NCT07836257","t":"A Phase II Study of Trastuzumab Deruxtecan (T-DXd) Plus Pyrotinib in HER2-Positive Advanced Breast Cancer After Progression on T-DXd","s":"nyr","p":"phase2","d":[6],"c":[16],"lc":[16],"a":"adult older","h":[30],"l":[[30,"breast"]],"po":"2026-09-23","u":"2026-09-23","st":"2026-10","ag":"18 and over"},{"n":"NCT07836309","t":"TACE in Combination With Tislelizumab and Lenvatinib for Advanced HCC (CHANCE2602)","s":"nyr","p":"na","d":[2],"c":[28],"lc":[28],"a":"child adult older","h":[120],"l":[[120,"hcc"]],"po":"2026-09-23","u":"2026-09-23","st":"2026-09","ag":"16 and over"},{"n":"NCT07840976","t":"Immunotargeted Therapy Plus Low-Dose Chemotherapy in Newly Diagnosed Adult Ph+ B-ALL","s":"nyr","p":"phase2","d":[16],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"ball"]],"po":"2026-09-25","u":"2026-09-25","st":"2026-10","ag":"18 and over"},{"n":"NCT07842471","t":"Local Consolidative Therapy Versus Maintenance Immunotherapy After First-Line Chemoimmunotherapy in Metastatic NSCLC","s":"nyr","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"lung"]],"po":"2026-09-25","u":"2026-09-25","st":"2026-10","ag":"18 and over"},{"n":"NCT07842887","t":"Phase 1 Study of ATRA Plus a PD-1 Inhibitor in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI Resistance","s":"nyr","p":"phase1","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2026-09-25","u":"2026-09-25","st":"2026-10","ag":"18 and over"},{"n":"NCT07845916","t":"Quad Shot Radiotherapy Combined With Tislelizumab and Platinum-Based Chemotherapy Before Surgery for Stage II-III Non-Small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lung"]],"po":"2026-09-29","u":"2026-09-29","st":"2026-10","ag":"18–75"},{"n":"NCT07847580","t":"Intranasal Dexmedetomidine and Perioperative Myocardial Injury in Patients Having Percutaneous Coronary Interventions","s":"nyr","p":"na","d":[31],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"cad"]],"po":"2026-09-29","u":"2026-09-29","st":"2026-09","ag":"45–85"},{"n":"NCT07847671","t":"Fecal Microbiota Transplantation Combined With QL1706 Plus Bevacizumab for Advanced HCC","s":"nyr","p":"phase2","d":[2],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"hcc"]],"po":"2026-09-29","u":"2026-10-08","st":"2026-10","ag":"18–75"},{"n":"NCT07848984","t":"Chinese Herbal Acupoint Application Combined With Triple Antiemetic Therapy for Prevention of Chemotherapy-Induced Nausea and Vomiting in Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"breast"]],"po":"2026-09-30","u":"2026-09-30","st":"2026-10","ag":"18 and over"},{"n":"NCT07849400","t":"Video-guided Versus Conventional Right-sided Double-lumen Tube Placement for Thoracoscopic Surgery","s":"nyr","p":"na","d":[4],"c":[23,90],"a":"adult older","h":[46,390],"po":"2026-09-30","u":"2026-09-30","st":"2026-10","ag":"18 and over"},{"n":"NCT07849712","t":"An Exploratory Clinical Study Of Bempemab Combined With Anlotinib As First-Line Treatment For Elderly Patients With Locally Advanced Or Metastatic Non-Small-Cell Lung Cancer","s":"nyr","p":"na","d":[4],"c":[23],"lc":[23],"a":"child adult older","h":[44],"l":[[44,"lung"]],"po":"2026-09-30","u":"2026-09-30","st":"2026-10","ag":"75 days and over"},{"n":"NCT07850154","t":"Impact of Robotic Versus Endoscopic Surgery on Nipple Nerve Function Following Nipple-Sparing Mastectomy for Breast Cancer","s":"nyr","p":"na","d":[6],"c":[0],"lc":[0],"a":"child adult older","h":[1],"l":[[1,"breast"]],"po":"2026-09-30","u":"2026-09-30","st":"2026-10","ag":"Not stated"},{"n":"NCT07854145","t":"Starry-Sky Projection and Maternal Voice for Sleep After Pediatric Cardiac Surgery","s":"nyr","p":"na","d":[32],"c":[5],"lc":[5],"a":"child","h":[91],"l":[[91,"chd"]],"po":"2026-10-02","u":"2026-10-30","st":"2026-11","ag":"6 months–6"},{"n":"NCT07854639","t":"A Prospective Clinical Study of Zeprumetosta in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[29],"l":[[29,"lymph"]],"po":"2026-10-02","u":"2026-10-02","st":"2026-10","ag":"18 and over"},{"n":"NCT07855016","t":"A Phase II Study of TT-01488 Tablets in Combination With Anti-CD20 Monoclonal Antibody Therapy in Patients With Mantle Cell Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[0,5],"a":"adult older","h":[53,9],"po":"2026-10-02","u":"2026-10-02","st":"2026-10","ag":"18 and over"},{"n":"NCT07855614","t":"OPTIMized Diagnosis and Treatment System Based on AI and Multimodal Imaging Fusion for PCI (OPTIMAI-PCI)","s":"nyr","p":"na","d":[31],"c":[23],"lc":[23],"a":"adult older","h":[391,54,82,46,185,274,392],"l":[[391,"cad"]],"po":"2026-10-02","u":"2026-10-02","st":"2026-09","ag":"18–80"},{"n":"NCT07856303","t":"SHR-A1811 Versus Trastuzumab Plus Pertuzumab in ctDNA-Positive HER2-Positive Early Breast Cancer After Pathologic Complete Response","s":"nyr","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2026-10-02","u":"2026-10-02","st":"2026-10","ag":"18 and over"},{"n":"NCT07861425","t":"Phase 1 Trial of ACE723, A Dual-Payload Antibody Drug Conjugate, in Patients With Advanced HCC Who Have Failed or Progressed on Standard Systemic Therapy Containing ICIs","s":"nyr","p":"phase1","d":[2],"c":[28,5],"a":"adult older","h":[6,105],"po":"2026-10-06","u":"2026-11-17","st":"2026-11","ag":"18–75"},{"n":"NCT07865910","t":"A Study to Learn the Safety and Efficacy of HLX37 in Combination With Chemotherapy for First-line Treatment in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer","s":"nyr","p":"phase2phase3","d":[4],"c":[48,2,1,0,27,10,26,18,13,31,20,64],"a":"child","h":[43,74,24,55,37,2,64,19,50,273,150,199],"po":"2026-10-08","u":"2026-10-08","st":"2026-11","ag":"18 days–75 days"},{"n":"NCT07866612","t":"Surgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular Carcinoma","s":"nyr","p":"na","d":[2],"c":[2,22,1,16,0,28,5],"lc":[22],"a":"adult older","h":[40,6,53,78,166,99,38,79,148],"l":[[40,"hcc"]],"po":"2026-10-08","u":"2026-10-08","st":"2026-12","ag":"18–80"},{"n":"NCT07869524","t":"IMPT Versus IMRT for Diffuse Intrinsic Pontine Glioma","s":"nyr","p":"phase3","d":[7],"c":[27],"lc":[27],"a":"child adult","h":[57],"l":[[57,"glioma"]],"po":"2026-10-09","u":"2026-10-09","st":"2026-12","ag":"3–18"},{"n":"NCT07870772","t":"Lenvatinib Plus Bevacizumab and PD-1 Inhibition Versus Bevacizumab Plus PD-1 Inhibition After Progression on Bevacizumab Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Prospective, Randomized, Two-Cohort, Phase II Study","s":"nyr","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"hcc"]],"po":"2026-10-13","u":"2026-10-13","st":"2026-10","ag":"18–80"},{"n":"NCT07872696","t":"Exploring the Efficacy of Ferrous Sulfate/Ferrous Succinate Combined With Serplulimab and SOX Regimen in Neoadjuvant Therapy for Gastric Cancer: A Prospective Cohort Study","s":"nyr","p":"phase2","d":[3],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"gc"]],"po":"2026-10-14","u":"2026-10-14","st":"2026-09","ag":"18–75"},{"n":"NCT07873086","t":"MRD-Guided Aumolertinib-Based Adjuvant Therapy for Resected EGFR-Mutant NSCLC","s":"nyr","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"lung"]],"po":"2026-10-14","u":"2026-10-14","st":"2026-11","ag":"18 and over"},{"n":"NCT07873996","t":"Tris-CAR-T Cell Therapy Targeting CD44 and CD133 in Newly Diagnosed Glioblastoma","s":"nyr","p":"phase2phase3","d":[7],"c":[2],"lc":[2],"a":"adult older","h":[102],"l":[[102,"glioma"]],"po":"2026-10-14","u":"2026-10-14","st":"2026-10","ag":"18–65"},{"n":"NCT07874282","t":"Phase II Study to Evaluate Telisotuzumab Adizutecan in Combination With RC148(ABBV-1480) as First-Line Treatment for Patients With Non-Squamous Non-Small-Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[5],"a":"adult older","h":[65],"po":"2026-10-14","u":"2026-11-06","st":"2026-11","ag":"18–80"},{"n":"NCT07874464","t":"Prospective Phase II Study of Concurrent Radiotherapy Combined With Full-Course Immunotherapy or Consolidation Immunotherapy for Locally Advanced NSCLC","s":"nyr","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2026-10-14","u":"2026-10-14","st":"2026-10","ag":"18–75"},{"n":"NCT07875465","t":"Intestinal Low-Dose Radiotherapy Combined With Immune Checkpoint Inhibitors in Solid Tumors With Liver Metastases","s":"nyr","p":"phase2","d":[4,5],"c":[23],"lc":[23],"a":"adult older","h":[351],"l":[[351,"lung"]],"po":"2026-10-15","u":"2026-10-15","st":"2026-10","ag":"18 and over"},{"n":"NCT07875920","t":"Phase 1 Study of NW-301V TCR-T Cells in Advanced Solid Tumors With KRAS G12V Mutation","s":"nyr","p":"phase1","d":[4,5],"c":[23],"a":"adult older","h":[46],"po":"2026-10-15","u":"2026-10-15","st":"2026-10","ag":"18–75"},{"n":"NCT07876596","t":"A Drug-Drug Interaction Study of Rifampicin and Oral HRS-8080","s":"nyr","p":"phase1","d":[6],"c":[0],"a":"adult","h":[99],"po":"2026-10-15","u":"2026-10-15","st":"2026-11","ag":"18–55"},{"n":"NCT07878221","t":"A Phase II Study of Ipilimumab N01 Plus Sintilimab for MSI-H or dMMR Gastric and Gastroesophageal Junction Cancer","s":"nyr","p":"phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"gc"]],"po":"2026-10-16","u":"2026-10-16","st":"2026-10","ag":"18 and over"},{"n":"NCT07878585","t":"Tripterygium Wilfordii Plus Prednisone for Active IgG4-Related Disease","s":"nyr","p":"phase2","d":[26],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"igg4"]],"po":"2026-10-16","u":"2026-10-16","st":"2026-09","ag":"45–79"},{"n":"NCT07878871","t":"Firmonertinib Plus Chemotherapy for Unresectable EGFR PACC-Mutant Stage III Lung Cancer: A Phase II Study","s":"nyr","p":"phase2","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2026-10-16","u":"2026-10-16","st":"2026-11","ag":"18 and over"},{"n":"NCT07880106","t":"Multimodal Liquid-Biopsy Omics Biomarkers of Treatment Response in Breast Cancer","s":"nyr","p":"na","d":[2,3,4,6],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"hcc"]],"po":"2026-10-19","u":"2026-11-12","st":"2026-10","ag":"18–80"},{"n":"NCT07882056","t":"SBRT Combined With Iparomlimab and Tuvonralimab (QL1706) and Bevacizumab for Hepatocellular Carcinoma","s":"nyr","p":"phase2","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"hcc"]],"po":"2026-10-20","u":"2026-10-20","st":"2026-10","ag":"18 and over"},{"n":"NCT07882628","t":"Diagnostic Performance of an AI-Based Multi-Omics Model for Early Lung Cancer","s":"nyr","p":"na","d":[4],"c":[2,8],"lc":[2],"a":"adult older","h":[89,74,115,39,20],"l":[[89,"lung"]],"po":"2026-10-20","u":"2026-10-20","st":"2026-10","ag":"18–75"},{"n":"NCT07882758","t":"Union-LC-MPE Cohort:A Multicenter Cohort Study on Diagnosis and Prognosis of Malignant Pleural Effusion in Lung Cance","s":"nyr","p":"na","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lung"]],"po":"2026-10-20","u":"2026-10-27","st":"2026-10","ag":"18 and over"},{"n":"NCT07885709","t":"MRD and Imaging Guided Adaptive Neoadjuvant Therapy for Resectable NSCLC","s":"nyr","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"lung"]],"po":"2026-10-21","u":"2026-10-21","st":"2026-11","ag":"18 and over"},{"n":"NCT07886996","t":"AI-Based CT Analysis of Coronary Plaque Evolution","s":"nyr","p":"na","d":[31],"c":[23],"lc":[23],"a":"adult older","h":[391,82,46,392],"l":[[391,"cad"]],"po":"2026-10-21","u":"2026-10-21","st":"2026-10","ag":"18 and over"},{"n":"NCT07888556","t":"Exploring Curative Model for Advanced Breast Cancer: a Single-center, Prospective Phase II Clinical Study","s":"nyr","p":"na","d":[6],"c":[20],"lc":[20],"a":"child adult older","x":"female","h":[37],"l":[[37,"breast"]],"po":"2026-10-22","u":"2026-10-22","st":"2026-10","ag":"Not stated"},{"n":"NCT07888621","t":"Glofitamab Plus Gemcitabine and Oxaliplatin (GemOx) in Relapsed or Refractory Primary and Secondary Central Nervous System Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"lymph"]],"po":"2026-10-22","u":"2026-10-22","st":"2026-11","ag":"18 and over"},{"n":"NCT07889297","t":"Pulsed Field Ablation for the Treatment of Malignant Lung Tumors","s":"nyr","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2026-10-22","u":"2026-10-22","st":"2026-10","ag":"18 and over"},{"n":"NCT07890636","t":"Adebrelimab Plus Famitinib as Adjuvant Therapy in Non-pCR NSCLC","s":"nyr","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lung"]],"po":"2026-10-22","u":"2026-10-22","st":"2026-10","ag":"18–75"},{"n":"NCT07892274","t":"Trastuzumab Rezetecan Followed by Pyrotinib, Fulvestrant, and Dalpiciclib in HR-Positive, HER2-Positive Advanced Breast Cancer","s":"nyr","p":"phase3","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2026-10-23","u":"2026-10-23","st":"2026-11","ag":"18–80"},{"n":"NCT07892508","t":"Adding Preoperative Radiotherapy Based on Early Treatment Response in Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"breast"]],"po":"2026-10-23","u":"2026-10-23","st":"2026-11","ag":"18–75"},{"n":"NCT07894328","t":"A Phase III Clinical Study of HRS-6209 Plus Letrozole as First-line Therapy in Patients With Advanced or Metastatic Breast Cancer","s":"nyr","p":"phase3","d":[6],"c":[30],"a":"adult older","x":"female","h":[58],"po":"2026-10-26","u":"2026-10-26","st":"2026-11","ag":"18–75"},{"n":"NCT07895992","t":"SHR-A2009 Combined With Bevacizumab in the Treatment of Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer : a Randomized Controlled, Open, Multicenter Phase III Study","s":"nyr","p":"phase3","d":[4],"c":[0],"a":"adult older","h":[43],"po":"2026-10-26","u":"2026-11-12","st":"2026-11","ag":"18–75"},{"n":"NCT07896005","t":"A Study of SHR-A1811 Combined With Adebrelimab for the First-line HER2-overexpressing Non-squamous Non-small Cell Lung Cancer","s":"nyr","p":"phase3","d":[4],"c":[23,5],"a":"adult older","h":[42,44],"po":"2026-10-26","u":"2026-10-26","st":"2026-12","ag":"18–75"},{"n":"NCT07896590","t":"Orelabrutinib Plus ICP 248 vs Orelabrutinib for Relapsed/Refractory Marginal Zone Lymphoma","s":"nyr","p":"phase3","d":[19],"c":[2,8,22,1,16,0,6,23,24,17,27,47,33,36,9,28,5,11,18,12,30,13,39,7,20],"a":"adult older","h":[40,53,25,74,46,36,58,12,9,115,8,124,37,118,45,24,233,60,47,136,167,10,44,111,92,30,112,57,14,13,142,97,131,212,193,7,135,84,87,88],"po":"2026-10-27","u":"2026-10-27","st":"2026-10","ag":"18 and over"},{"n":"NCT07897188","t":"ASKC202 Plus Limertinib as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC","s":"nyr","p":"phase3","d":[4],"c":[5],"a":"adult older","h":[65],"po":"2026-10-27","u":"2026-10-27","st":"2026-10","ag":"18 and over"},{"n":"NCT07899047","t":"Albumin-Bound Paclitaxel (Ⅱ) in Patients With Advanced Breast Cancer","s":"nyr","p":"na","d":[6],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"breast"]],"po":"2026-10-27","u":"2026-10-27","st":"2026-10","ag":"18 and over"},{"n":"NCT07900789","t":"HRS-4642 Combined With Antitumor Agents for the Treatment of Perioperative Pancreatic Cancer","s":"nyr","p":"phase3","d":[5],"c":[2,5],"a":"adult older","h":[38,123],"po":"2026-10-28","u":"2026-10-28","st":"2026-10","ag":"18–75"},{"n":"NCT07902596","t":"Lymph Node Dissection After Neoadjuvant Therapy for Gastric and EGJ Adenocarcinoma","s":"nyr","p":"na","d":[3],"c":[28,26,5,18,4],"lc":[28],"a":"adult older","h":[78,60,55,24,5,9,127],"l":[[78,"gc"]],"po":"2026-10-29","u":"2026-10-29","st":"2026-10","ag":"18 and over"},{"n":"NCT07902713","t":"Becotatug Vedotin Plus Gemcitabine and a PD-1 Inhibitor in Recurrent or Metastatic Nasopharyngeal Carcinoma","s":"nyr","p":"phase2","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2026-10-29","u":"2026-10-29","st":"2026-11","ag":"18–70"},{"n":"NCT07903636","t":"QLS4131 for Relapsed/Refractory Multiple Myeloma With Extramedullary Disease","s":"nyr","p":"phase2","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"mm"]],"po":"2026-10-29","u":"2026-10-29","st":"2026-12","ag":"18 and over"},{"n":"NCT07903857","t":"SND002 Cell Injection in Participants With Advanced Malignant Solid Tumors","s":"nyr","p":"phase1","d":[3],"c":[23],"a":"adult older","h":[46],"po":"2026-10-29","u":"2026-11-04","st":"2026-12","ag":"18–80"},{"n":"NCT07904260","t":"Effect of High-flow Nasal Cannula Oxygenation on the Incidence of Hypoxemia During Painless Gastrointestinal Endoscopy in Patients at High Risk for Obstructive Sleep Apnea Syndrome in High-altitude Regions","s":"nyr","p":"na","d":[3],"c":[23],"a":"adult older","h":[46],"po":"2026-10-29","u":"2026-10-29","st":"2026-11","ag":"18 and over"},{"n":"NCT07906691","t":"A Study to Assess the Effect of Itraconazole on the Pharmacokinetics of HRS-4642 Following Intravenous Infusion in Healthy Participants","s":"nyr","p":"phase1","d":[5],"c":[8],"a":"adult","h":[20],"po":"2026-10-30","u":"2026-10-30","st":"2026-11","ag":"18–45"},{"n":"NCT07909863","t":"Low-Dose Radiotherapy Plus Adebrelimab and Chemotherapy for Extensive-Stage Small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2026-11-02","u":"2026-11-04","st":"2026-11","ag":"18–75"},{"n":"NCT07910903","t":"Study of CM336+CM313 Combination Therapy in Patients With Relapsed or Refractory Multiple Myeloma","s":"nyr","p":"phase3","d":[15],"c":[30],"a":"adult older","h":[69],"po":"2026-11-02","u":"2026-11-02","st":"2026-12","ag":"18 and over"},{"n":"NCT07912268","t":"Study of SIM0518 in Participants With ALK-Positive or ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer","s":"nyr","p":"phase1","d":[4],"c":[8,16,24,9,5],"a":"adult older","h":[56,45,13,14,30,65],"po":"2026-11-03","u":"2026-11-03","st":"2026-11","ag":"18 and over"},{"n":"NCT07912606","t":"D2 Gastrectomy With or Without Para-Aortic Lymph Node Dissection After Chemoimmunotherapy for Gastric Cancer","s":"nyr","p":"phase2","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"gc"]],"po":"2026-11-03","u":"2026-11-03","st":"2026-11","ag":"18–75"},{"n":"NCT07912801","t":"Roxadustat and Myocardial Injury After Off-Pump Coronary Artery Bypass Surgery","s":"nyr","p":"phase4","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[29],"l":[[29,"cad"]],"po":"2026-11-03","u":"2026-11-06","st":"2026-11","ag":"45 and over"},{"n":"NCT07912957","t":"Neoadjuvant SHR-A1811 ± Adebrelimab in GC/GEJ","s":"nyr","p":"phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"gc"]],"po":"2026-11-03","u":"2026-11-03","st":"2026-11","ag":"18 and over"},{"n":"NCT07915843","t":"Multi-center Prospective Validation of Real-Time AI-EGGIM System","s":"nyr","p":"na","d":[3],"c":[27],"lc":[27],"a":"child adult older","h":[124],"l":[[124,"gc"]],"po":"2026-11-04","u":"2026-11-04","st":"2026-11","ag":"Not stated"},{"n":"NCT07917624","t":"Prophylactic Strategies for Mitigating Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lymph"]],"po":"2026-11-04","u":"2026-11-04","st":"2026-11","ag":"18–80"},{"n":"NCT07917923","t":"A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Refractory Generalized Myasthenia Gravis","s":"nyr","p":"earlyphase1","d":[27],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"mg"]],"po":"2026-11-05","u":"2026-11-05","st":"2026-12","ag":"18–65"},{"n":"NCT07918755","t":"Development and Validation of a Biopsy Decision Model for Nasopharyngeal Carcinoma Based on Serological Markers and Endoscopic Features","s":"nyr","p":"na","d":[0],"c":[10,46],"lc":[46],"a":"adult older","h":[134,96],"l":[[134,"npc"]],"po":"2026-11-05","u":"2026-11-05","st":"2026-11","ag":"18 and over"},{"n":"NCT07918781","t":"Partial Cardiac Denervation for Preventing Atrial Fibrillation After CABG","s":"nyr","p":"na","d":[31],"c":[2,8,0,28],"a":"adult older","h":[213,78,43,10],"po":"2026-11-05","u":"2026-11-18","st":"2026-12","ag":"18 and over"},{"n":"NCT07919470","t":"Busulfan-Based Versus TBI-Based Conditioning for Adult ALL-CR2 Allo-HSCT","s":"nyr","p":"na","d":[16],"c":[2,97],"lc":[2],"a":"child adult older","h":[48,374],"l":[[48,"ball"]],"po":"2026-11-05","u":"2026-11-05","st":"2026-11","ag":"14–65"},{"n":"NCT07919717","t":"NIVO+IPI Neoadjuvant Therapy for Recurrent Resectable HCC","s":"nyr","p":"phase2","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"hcc"]],"po":"2026-11-05","u":"2026-11-05","st":"2026-11","ag":"18–75"},{"n":"NCT07920055","t":"Sirolimus-Coated Versus Paclitaxel-Coated Balloon for Recurrent Coronary In-Stent Restenosis After Prior Paclitaxel-Coated Balloon Treatment (SPRIT)","s":"nyr","p":"na","d":[31],"c":[23],"lc":[23],"a":"adult older","h":[82],"l":[[82,"cad"]],"po":"2026-11-05","u":"2026-11-05","st":"2026-11","ag":"18 and over"},{"n":"NCT07920133","t":"Hs-CRP-Guided Colchicine Treatment Targets in Very-High-Risk Patients With Coronary Artery Disease After PCI (TARGET-CHD)","s":"nyr","p":"na","d":[31],"c":[23],"lc":[23],"a":"adult older","h":[82],"l":[[82,"cad"]],"po":"2026-11-05","u":"2026-11-05","st":"2026-12","ag":"18 and over"},{"n":"NCT07923396","t":"GK01 Cell Therapy in Gastric Cancer With Peritoneal Metastasis","s":"nyr","p":"phase1","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"gc"]],"po":"2026-11-06","u":"2026-11-06","st":"2026-11","ag":"18 and over"},{"n":"NCT07928362","t":"A Multicenter, Prospective Single-arm Study of Multimodal Thermal Therapy Combined With Toripalimab and AG Chemotherapy in the Treatment of Advanced Pancreatic Cancer","s":"nyr","p":"na","d":[5],"c":[22,26,5,39],"lc":[5],"a":"adult older","h":[123,40,111,55,121],"l":[[123,"panc"]],"po":"2026-11-10","u":"2026-11-10","st":"2026-10","ag":"18–75"},{"n":"NCT07933757","t":"AIM2-NLRP3 Inflammasome Dual Inhibitor on hsCRP","s":"nyr","p":"na","d":[31],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"cad"]],"po":"2026-11-12","u":"2026-11-12","st":"2026-11","ag":"18 and over"},{"n":"NCT07936578","t":"Clinical Study of Ivonescimab Combined With Concurrent Chemoradiotherapy in the Treatment of Advanced Non-small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[41],"lc":[41],"a":"adult older","h":[245],"l":[[245,"lung"]],"po":"2026-11-13","u":"2026-11-13","st":"2026-10","ag":"18–75"},{"n":"NCT07938619","t":"Tafasitamab, Lenalidomide, Rituximab, and Orelabrutinib for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[0],"a":"adult older","h":[53],"po":"2026-11-16","u":"2026-11-16","st":"2026-12","ag":"18 and over"},{"n":"NCT07942103","t":"Study on the Construction and Implementation Effect of a Traditional Chinese Medicine-Based Mental-Physical Comorbidity Linked Health-Management System of \"Hospital-Community-Family\" for Breast Cancer Patients","s":"nyr","p":"na","d":[6],"c":[30],"lc":[30],"a":"adult older","x":"female","h":[191],"l":[[191,"breast"]],"po":"2026-11-17","u":"2026-11-17","st":"2026-10","ag":"18–70"},{"n":"NCT07943494","t":"Multimodal LLM for Breast Cancer Radiotherapy Target Auto-Contouring and Planning","s":"nyr","p":"na","d":[6],"c":[0],"lc":[0],"a":"child adult older","h":[99],"l":[[99,"breast"]],"po":"2026-11-17","u":"2026-11-17","st":"2026-11","ag":"Not stated"},{"n":"NCT07944651","t":"Pirtobrutinib With Sonrotoclax and Rituximab for High-Risk Relapsed/Refractory Mantle-Cell Lymphoma Following Covalent BTK-Inhibitor Failure","s":"nyr","p":"phase2","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lymph"]],"po":"2026-11-18","u":"2026-11-18","st":"2026-12","ag":"18 and over"},{"n":"NCT07944716","t":"Function-Friendly Semi-Fowler Positioning for Coronary Angiography and PCI","s":"nyr","p":"na","d":[31],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"cad"]],"po":"2026-11-18","u":"2026-11-18","st":"2026-11","ag":"18–75"},{"n":"NCT07945353","t":"Orelabrutinib Plus 4 Gy Radiotherapy Versus 24 Gy Radiotherapy for Stage I/II MALT Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lymph"]],"po":"2026-11-18","u":"2026-11-18","st":"2026-11","ag":"18 and over"},{"n":"NCT05562297","t":"Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer","s":"nyr","p":"phase2","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"panc"]],"po":"2022-09-30","u":"2025-01-22","st":"2025-03","ag":"18–75"},{"n":"NCT05871437","t":"Randomized Controlled Clinical Study on the Reduction of Tumor Marker Levels in Breast Cancer Patients by Huaier Granules","s":"nyr","p":"phase4","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2023-05-23","u":"2025-09-08","st":"2025-09","ag":"18–75"},{"n":"NCT05912582","t":"Prospective Study for Molecular Biomarkers and Spatial Transcriptomics of Nasopharyngeal Carcinoma","s":"nyr","p":"na","d":[0],"c":[28],"lc":[28],"a":"adult older","h":[127],"l":[[127,"npc"]],"po":"2023-06-22","u":"2025-12-26","st":"2025-12","ag":"18–80"},{"n":"NCT06177522","t":"Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer","s":"nyr","p":"phase2","d":[5],"c":[28],"lc":[28],"a":"adult older","h":[93],"l":[[93,"panc"]],"po":"2023-12-20","u":"2025-11-18","st":"2025-11","ag":"18–80"},{"n":"NCT06409637","t":"FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver Transplantation","s":"nyr","p":"phase1phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"hcc"]],"po":"2024-05-10","u":"2024-05-10","st":"2025-01","ag":"18–75"},{"n":"NCT06464601","t":"A Real-World Study of Neoadjuvant/Conversion Therapy for Locally Advanced or Metastatic Gastric Cancer","s":"nyr","p":"na","d":[3],"c":[13],"lc":[13],"a":"adult older","h":[133],"l":[[133,"gc"]],"po":"2024-06-18","u":"2024-06-18","st":"2025-04","ag":"18–75"},{"n":"NCT06485232","t":"Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.","s":"nyr","p":"earlyphase1","d":[25,27],"c":[2],"lc":[2],"a":"adult older","h":[71],"l":[[71,"nmosd"]],"po":"2024-07-03","u":"2025-01-01","st":"2025-02","ag":"18–75"},{"n":"NCT06556862","t":"Exploration of Dalpiciclib Plus HDACi in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor","s":"nyr","p":"phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"breast"]],"po":"2024-08-16","u":"2025-08-13","st":"2025-10","ag":"18 and over"},{"n":"NCT06580223","t":"Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma","s":"nyr","p":"phase3","d":[15],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"mm"]],"po":"2024-08-30","u":"2025-07-18","st":"2025-09","ag":"18–90"},{"n":"NCT06605131","t":"GP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal Carcinoma","s":"nyr","p":"phase2","d":[0],"c":[0],"lc":[0],"a":"child adult","h":[53],"l":[[53,"npc"]],"po":"2024-09-20","u":"2025-03-20","st":"2025-04","ag":"6–18"},{"n":"NCT06623734","t":"Liver Cancer Prognosis Investigation Study","s":"nyr","p":"na","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"hcc"]],"po":"2024-10-02","u":"2025-03-06","st":"2025-04","ag":"18–80"},{"n":"NCT06646211","t":"High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)","s":"nyr","p":"phase2","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2024-10-17","u":"2024-10-17","st":"2025-01","ag":"18–70"},{"n":"NCT06688656","t":"Neoadjuvant Chemotherapy Sequentially Combined with Sintilimab in Resectable EGFR-Mutant NSCLC","s":"nyr","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2024-11-14","u":"2024-11-14","st":"2025-03","ag":"18 and over"},{"n":"NCT06708650","t":"Combination of SFRT, PD-L1 Inhibitor, and Anti-VEGF in Advanced Hepatocellular Carcinoma","s":"nyr","p":"na","d":[2],"c":[100],"lc":[100],"a":"adult older","h":[393],"l":[[393,"hcc"]],"po":"2024-11-27","u":"2024-11-27","st":"2025-01","ag":"18–75"},{"n":"NCT06728046","t":"Erector Spinae Plane Block v.s Patient Controlled Analgesia in Correction Surgery for Idiopathic Scoliosis","s":"nyr","p":"na","d":[33],"c":[22],"lc":[22],"a":"child adult older","h":[40],"l":[[40,"scol"]],"po":"2024-12-11","u":"2024-12-11","st":"2025-01","ag":"14 and over"},{"n":"NCT06728605","t":"Protective Effect of EECP Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery","s":"nyr","p":"na","d":[31],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"cad"]],"po":"2024-12-11","u":"2024-12-11","st":"2025-12","ag":"18–80"},{"n":"NCT06730802","t":"Protective Effect of PCSK9 Inhibitor Against Negative Inflammatory Response and Organ Dysfunction After Coronary Artery Bypass Grafting (PANDA VIII)","s":"nyr","p":"na","d":[31],"c":[2,28],"lc":[28],"a":"adult older","h":[78,109],"l":[[78,"cad"]],"po":"2024-12-12","u":"2024-12-12","st":"2025-01","ag":"18 and over"},{"n":"NCT06735508","t":"MRNA Neoantigen Vaccine in Non-Small Cell Lung Cancer","s":"nyr","p":"earlyphase1","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"lung"]],"po":"2024-12-16","u":"2024-12-16","st":"2025-01","ag":"18–75"},{"n":"NCT06737146","t":"Study of MT027 in Patients with Recurrent or Progressive High-grade Glioma","s":"nyr","p":"phase1","d":[7],"c":[13],"a":"adult older","h":[36],"po":"2024-12-17","u":"2024-12-17","st":"2025-01","ag":"18–70"},{"n":"NCT06739317","t":"SBRT Combined with Camrelizumab and Apatinib for Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma.","s":"nyr","p":"phase2phase3","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[49],"l":[[49,"hcc"]],"po":"2024-12-18","u":"2024-12-18","st":"2025-01","ag":"18 and over"},{"n":"NCT06739421","t":"The Diagnostic Value of Bronchoscopic Needle-based Confocal Laser Endomicroscopy (nCLE) As a Real-time Detection Tool for Diagnosing Peripheral Lung Cancer: a Multi-centre Randomised Controlled Trial","s":"nyr","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[62],"l":[[62,"lung"]],"po":"2024-12-18","u":"2024-12-18","st":"2025-01","ag":"18–90"},{"n":"NCT06741501","t":"Preliminary Efficacy Analysis of \"C\" Single Flap Plasty Reconstruction After Laparoscopic Proximal Gastrectomy","s":"nyr","p":"na","d":[3],"c":[32],"lc":[32],"a":"adult older","h":[63],"l":[[63,"gc"]],"po":"2024-12-19","u":"2024-12-19","st":"2025-01","ag":"18–80"},{"n":"NCT06747299","t":"The Value of Artificial Intelligence-based 18F-FDG PET/CT in Diferential Diagnosis, Efficacy Prediction and Prognosis Prediction of T-NK Cell Lymphoma: a Clinical Study","s":"nyr","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2024-12-24","u":"2024-12-24","st":"2025-01","ag":"18–75"},{"n":"NCT06749678","t":"Effect of Prehabilitation During the Conversion Therapy on Postoperative Outcomes in Unresectable Hepatocellular Carcinoma","s":"nyr","p":"na","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"hcc"]],"po":"2024-12-27","u":"2024-12-27","st":"2025-01","ag":"18–75"},{"n":"NCT06750861","t":"QL1706 Plus Chemotherapy With AG Regime as First-line Treatment of Advanced PDAC","s":"nyr","p":"phase2","d":[5],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"panc"]],"po":"2024-12-27","u":"2025-02-10","st":"2025-02","ag":"18 and over"},{"n":"NCT06753318","t":"Validation of Joint-AI in Diagnosing Pancreatic Solid Lesions","s":"nyr","p":"na","d":[5],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"panc"]],"po":"2024-12-31","u":"2024-12-31","st":"2025-01","ag":"18 and over"},{"n":"NCT06757894","t":"Efficacy and Safety of Zuberitamab Combined with Bendamustine, Followed by Monotherapy Maintenance, in Treatment-naïve Follicular Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2025-01-03","u":"2025-01-03","st":"2025-02","ag":"18 and over"},{"n":"NCT06759090","t":"Metronomic Capecitabine with Camrelizumab and Apatinib Mesylate for Treatment of Advanced Pancreatic Cancer","s":"nyr","p":"phase2","d":[5],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"panc"]],"po":"2025-01-06","u":"2025-01-06","st":"2025-01","ag":"18 and over"},{"n":"NCT06759233","t":"Endoscopic Cryoablation Combined With PD-1 in Advanced Gastric Cancer","s":"nyr","p":"phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[103],"l":[[103,"gc"]],"po":"2025-01-06","u":"2025-04-29","st":"2025-05","ag":"18–80"},{"n":"NCT06759948","t":"An Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis","s":"nyr","p":"phase1","d":[27],"c":[5],"lc":[5],"a":"adult older","h":[103],"l":[[103,"mg"]],"po":"2025-01-06","u":"2025-01-06","st":"2025-02","ag":"18–75"},{"n":"NCT06768853","t":"The Accuracy of Targeted Lymph Node Dissection of Non-small Cell Lung Cancer Patients According to Predictive Models","s":"nyr","p":"na","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[133],"l":[[133,"lung"]],"po":"2025-01-10","u":"2025-01-10","st":"2025-01","ag":"18–70"},{"n":"NCT06772558","t":"Desflurane Potentially Induces Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Perioperative Procedures by Modulating Cdc42 and Clock Proteins","s":"nyr","p":"na","d":[31],"a":"older","h":[394],"l":[[394,"cad"]],"po":"2025-01-13","u":"2025-01-14","st":"2025-02","ag":"70 and over"},{"n":"NCT06778902","t":"AZA Combined with R-GemOx for Elderly DLBCL Patients","s":"nyr","p":"phase2","d":[19],"c":[1],"lc":[1],"a":"adult older","h":[17],"l":[[17,"lymph"]],"po":"2025-01-16","u":"2025-01-16","st":"2025-02","ag":"60–90"},{"n":"NCT06779318","t":"Maintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected Pancreatic Cancer With High Risk of Recurrence/Metastasis","s":"nyr","p":"phase4","d":[5],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"panc"]],"po":"2025-01-16","u":"2025-04-03","st":"2025-07","ag":"18–75"},{"n":"NCT06779461","t":"A Clinical Trial Assessing the Safety and Efficacy of Biodegradable Magnesium Embolic Microspheres for Primary Hepatocellular Carcinoma","s":"nyr","p":"phase3","d":[2],"c":[55,0,33,28,5,30,20],"a":"adult older","h":[209,58,120,9,142,164,37],"po":"2025-01-16","u":"2025-01-16","st":"2025-01","ag":"18–80"},{"n":"NCT06780839","t":"Adjuvant Treatment of ALK-positive Non-small Cell Lung Cancer with Ensartinib Guided by MRD","s":"nyr","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"lung"]],"po":"2025-01-17","u":"2025-01-17","st":"2025-01","ag":"18 and over"},{"n":"NCT06784206","t":"Adebrelimab Maintenance Therapy After Concurrent Chemoradiotherapy with Hyperfractionated Radiotherapy in Limited-Stage Small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"lung"]],"po":"2025-01-20","u":"2025-01-20","st":"2025-02","ag":"18–75"},{"n":"NCT06785584","t":"Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operable) ALK-Positive Lung Adenocarcinoma ：A Multicenter, Real-World Clinical Study","s":"nyr","p":"phase4","d":[4],"c":[16],"lc":[16],"a":"adult older","h":[140],"l":[[140,"lung"]],"po":"2025-01-21","u":"2025-01-21","st":"2025-02","ag":"18 and over"},{"n":"NCT06786208","t":"Real-world Study of Sunvozertinib Treatment in Advanced EGFR-Mutant NSCLC After EGFR-TKI Treatment Failure","s":"nyr","p":"na","d":[4],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"lung"]],"po":"2025-01-22","u":"2025-01-22","st":"2025-02","ag":"18 and over"},{"n":"NCT06786312","t":"A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[16,7],"lc":[16],"a":"adult older","h":[30,136,148,8],"l":[[30,"lung"]],"po":"2025-01-22","u":"2025-01-22","st":"2025-01","ag":"18–75"},{"n":"NCT06788600","t":"Mechanistic Study of EBV mRNA Vaccine (WGc-043) in EBV-Positive Relapsed/Refractory Lymphoma","s":"nyr","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2025-01-23","u":"2025-04-02","st":"2025-04","ag":"18–75"},{"n":"NCT06789276","t":"The Impact of Thoracic Paravertebral Nerve Block At Different Positions on Pain Relief in Patients Undergoing Single-Port Thoracoscopic Partial Lung Resection","s":"nyr","p":"na","d":[4],"c":[4],"lc":[4],"a":"adult older","h":[187],"l":[[187,"lung"]],"po":"2025-01-23","u":"2025-01-23","st":"2025-01","ag":"18–70"},{"n":"NCT06791824","t":"Study of CM313(SC) Injection in Subjects With Relapsed/Refractory Aplastic Anemia","s":"nyr","p":"phase1phase2","d":[17],"c":[30],"a":"adult older","h":[69],"po":"2025-01-24","u":"2025-02-18","st":"2025-03","ag":"18 and over"},{"n":"NCT06793228","t":"Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia","s":"nyr","p":"phase2","d":[4],"c":[36,20],"lc":[20],"a":"adult older","h":[37,87],"l":[[37,"lung"]],"po":"2025-01-27","u":"2025-01-27","st":"2025-01","ag":"18 and over"},{"n":"NCT06796127","t":"A Multicenter Study of Artificial Intelligence Model for Fetal Congenital Heart Disease","s":"nyr","p":"na","d":[32],"c":[2],"lc":[2],"a":"child adult older","x":"female","h":[109],"l":[[109,"chd"]],"po":"2025-01-28","u":"2025-01-28","st":"2025-02","ag":"Not stated"},{"n":"NCT06797622","t":"Heterogeneity of 68Ga-FAPI Uptake As Imaging Biomarker in T-DXd Treatment for Brain Metastasis of HER2 Positive Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2025-01-28","u":"2025-01-28","st":"2025-02","ag":"18 and over"},{"n":"NCT06798194","t":"Fusing Ultrasound and Magnetic Resonance Imaging to Intelligently Plan Highly Conformal Ablation Thermal Field for Hepatocellular Carcinoma","s":"nyr","p":"na","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"hcc"]],"po":"2025-01-29","u":"2026-11-18","st":"2025-01","ag":"18 and over"},{"n":"NCT06798506","t":"Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Triple-negative Breast Cancer","s":"nyr","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2025-01-29","u":"2025-01-29","st":"2025-02","ag":"18 and over"},{"n":"NCT06799676","t":"A Phase Ib/II Clinical Study on the Application of Linperlisib Combined with the VRD Regimen in Newly Diagnosed Patients with Multiple Myeloma","s":"nyr","p":"phase1phase2","d":[15],"c":[13,20],"a":"adult older","h":[25,133],"po":"2025-01-29","u":"2025-01-29","st":"2025-02","ag":"18–65"},{"n":"NCT06802653","t":"Investigation on the Prevalence and Etiology of Adolescent Idiopathic Scoliosis in Nanchang Region","s":"nyr","p":"na","d":[33],"c":[9],"lc":[9],"a":"child","h":[395],"l":[[395,"scol"]],"po":"2025-01-31","u":"2025-05-30","st":"2025-07","ag":"9–14"},{"n":"NCT06811857","t":"This Study Aims to Explore the Efficacy of Hyperbaric Oxygen in the Treatment of Flap Ischaemic Necrosis After Breast Cancer Surgery","s":"nyr","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult","x":"female","h":[43],"l":[[43,"breast"]],"po":"2025-02-06","u":"2025-02-06","st":"2025-01","ag":"18–60"},{"n":"NCT06814158","t":"Neoadjuvant Ivonescimab and Chemotherapy in Resectable Esophageal Cancer","s":"nyr","p":"phase2","d":[1],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"escc"]],"po":"2025-02-07","u":"2025-02-07","st":"2025-03","ag":"18–75"},{"n":"NCT06819501","t":"Hyperbaric Oxygen Therapy for Peripheral Neuropathy Due to Paclitaxel Analogs","s":"nyr","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult","x":"female","h":[43],"l":[[43,"breast"]],"po":"2025-02-11","u":"2025-02-11","st":"2025-02","ag":"18–60"},{"n":"NCT06820762","t":"Irinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell Lung Cancer : A Prospective, Single-arm, Multicenter Clinical Study","s":"nyr","p":"phase2","d":[4],"c":[52,11],"lc":[52],"a":"adult older","h":[155,143],"l":[[155,"lung"]],"po":"2025-02-11","u":"2025-02-11","st":"2025-02","ag":"18–75"},{"n":"NCT06822985","t":"QL1706 As Second-line Treatment in Patients with Advanced Hepatocellular Carcinoma","s":"nyr","p":"phase1","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2025-02-12","u":"2025-02-12","st":"2025-02","ag":"18–75"},{"n":"NCT06823050","t":"A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced HCC with DEB-TACE Combined with SALOX-HAIC","s":"nyr","p":"na","d":[2],"c":[20],"a":"adult older","h":[25],"po":"2025-02-12","u":"2025-02-12","st":"2025-03","ag":"18–80"},{"n":"NCT06825949","t":"A Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Hormone Receptor Positive Breast Cancer Patients","s":"nyr","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult","x":"female","h":[43],"l":[[43,"breast"]],"po":"2025-02-13","u":"2025-02-13","st":"2025-02","ag":"18–60"},{"n":"NCT06825975","t":"A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Triple-Negative and HER2+ Breast Cancer Patients","s":"nyr","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult","x":"female","h":[43],"l":[[43,"breast"]],"po":"2025-02-13","u":"2025-02-13","st":"2025-02","ag":"18–60"},{"n":"NCT06828757","t":"Clinical Study of Nanocrystalline Megestrol in Malnourished Patients With First-Line Non-Small Cell Lung Cancer","s":"nyr","p":"phase3","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2025-02-14","u":"2025-02-19","st":"2025-05","ag":"18 and over"},{"n":"NCT06833216","t":"Familial Breast Cancer in China","s":"nyr","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2025-02-18","u":"2025-02-18","st":"2025-02","ag":"18–75"},{"n":"NCT06837948","t":"Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCLC","s":"nyr","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2025-02-20","u":"2025-02-20","st":"2025-02","ag":"18 and over"},{"n":"NCT06844773","t":"Chemoradiotherapy in Elderly Patients with Locally Advanced Pancreatic Cancer (70+).","s":"nyr","p":"na","d":[5],"c":[5],"lc":[5],"a":"older","h":[6],"l":[[6,"panc"]],"po":"2025-02-25","u":"2025-02-25","st":"2025-02","ag":"70–85"},{"n":"NCT06845241","t":"Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma","s":"nyr","p":"phase1phase2","d":[19],"c":[16,0,9,30,20],"a":"adult older","h":[53,58,37,30,14],"po":"2025-02-25","u":"2025-02-25","st":"2025-02","ag":"18 and over"},{"n":"NCT06848426","t":"Xingbai Ji Formula Combined with Chemotherapy and Sintilimab in Metastatic Multi-Target Mutation-Negative Non-Small Cell Lung Cancer: a Clinical Trial","s":"nyr","p":"na","d":[4],"c":[9],"lc":[9],"a":"adult older","h":[216],"l":[[216,"lung"]],"po":"2025-02-27","u":"2025-02-27","st":"2025-03","ag":"18–75"},{"n":"NCT06851819","t":"Tislelizumab in Combination with Chemotherapy ± Radiotherapy for Extensive-Stage Oligometastatic Small Cell Lung Cancer.","s":"nyr","p":"phase2","d":[4],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"lung"]],"po":"2025-02-28","u":"2025-02-28","st":"2025-03","ag":"18 and over"},{"n":"NCT06853509","t":"Predicting Gastric Neoplasia in Patients with High-risk Endoscopic Features","s":"nyr","p":"na","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[139],"l":[[139,"gc"]],"po":"2025-03-03","u":"2025-03-03","st":"2025-03","ag":"45 and over"},{"n":"NCT06861348","t":"Effectiveness and Safety of InO±DLI for Relapsed B-ALL/LBL After Allo-HSCT","s":"nyr","p":"phase2","d":[16],"c":[23],"lc":[23],"a":"child adult older","h":[46],"l":[[46,"ball"]],"po":"2025-03-06","u":"2025-03-06","st":"2025-03","ag":"14–65"},{"n":"NCT06861777","t":"Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC","s":"nyr","p":"phase2phase3","d":[1],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"escc"]],"po":"2025-03-06","u":"2025-03-11","st":"2025-03","ag":"18 and over"},{"n":"NCT06861894","t":"Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC","s":"nyr","p":"phase2","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"escc"]],"po":"2025-03-06","u":"2025-05-15","st":"2025-07","ag":"18–75"},{"n":"NCT06863441","t":"The Value of PET Imaging Targeting Granzyme B in Predicting Efficacy and Prognosis in T-NK Cell Lymphoma","s":"nyr","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2025-03-07","u":"2025-03-07","st":"2025-03","ag":"18 and over"},{"n":"NCT06866977","t":"A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer","s":"nyr","p":"phase1phase2","d":[5],"c":[8],"lc":[8],"a":"adult older","h":[11],"l":[[11,"panc"]],"po":"2025-03-10","u":"2025-03-10","st":"2025-03","ag":"18 and over"},{"n":"NCT06871527","t":"Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer","s":"nyr","p":"phase1phase2","d":[3],"c":[0],"lc":[0],"a":"adult older","h":[75],"l":[[75,"gc"]],"po":"2025-03-12","u":"2025-03-12","st":"2025-03","ag":"18–75"},{"n":"NCT06879470","t":"JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Lymphoma","s":"nyr","p":"na","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"lymph"]],"po":"2025-03-17","u":"2025-03-17","st":"2025-03","ag":"18–75"},{"n":"NCT06885840","t":"Study of MCLA-129 in the Treatment of Advanced Non-small Cell Lung Cancer with AGA and MET Amplification.","s":"nyr","p":"phase2","d":[4],"c":[2,15,8,63,0,23,24,17,27,33,11,30,13,39,20],"a":"adult older","h":[57,58,43,12,111,45,118,46,13,54,27,37,112,61,138,142,198],"po":"2025-03-20","u":"2025-03-20","st":"2025-03","ag":"18 and over"},{"n":"NCT06886139","t":"A Phase 2 Study of TRS005 in Patients With CD20-positive R/R DLBCL.","s":"nyr","p":"phase2","d":[19],"c":[2],"a":"adult older","h":[23],"po":"2025-03-20","u":"2025-08-22","st":"2025-09","ag":"18 and over"},{"n":"NCT06888037","t":"Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer","s":"nyr","p":"phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"gc"]],"po":"2025-03-21","u":"2025-03-21","st":"2025-03","ag":"18 and over"},{"n":"NCT06888648","t":"Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer.","s":"nyr","p":"phase1phase2","d":[5],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"panc"]],"po":"2025-03-21","u":"2025-03-21","st":"2025-04","ag":"18–75"},{"n":"NCT06888674","t":"Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer.","s":"nyr","p":"phase1phase2","d":[5],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"panc"]],"po":"2025-03-21","u":"2025-03-21","st":"2025-04","ag":"18–75"},{"n":"NCT06889402","t":"Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy","s":"nyr","p":"na","d":[1],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"escc"]],"po":"2025-03-21","u":"2025-03-21","st":"2025-04","ag":"18–85"},{"n":"NCT06890585","t":"Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double-Expressor DLBCL","s":"nyr","p":"phase2","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2025-03-24","u":"2025-03-24","st":"2025-06","ag":"18–65"},{"n":"NCT06895512","t":"A Study to Evaluate the Efficacy and Safety of HLX15-IV Versus DARZALEX® in Combination with Lenalidomide-Dexamethasone (Rd) in Transplant-ineligible Patients with Newly Diagnosed Multiple Myeloma","s":"nyr","p":"phase3","d":[15],"c":[5],"a":"adult older","h":[6],"po":"2025-03-26","u":"2025-03-26","st":"2025-04","ag":"18 and over"},{"n":"NCT06896396","t":"Icaritin Soft Capsules+TACE+Immunotherapy+Targeted Therapy Versus TACE+Immunotherapy+Targeted Therapy for Unresectable Hepatocellular Carcinoma","s":"nyr","p":"phase1phase2","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2025-03-26","u":"2025-03-26","st":"2025-04","ag":"18–75"},{"n":"NCT06900218","t":"PD-1 Antibody Sintilimab Combined With Capecitabine as Adjuvant Therapy for High-Risk Nasopharyngeal Carcinoma","s":"nyr","p":"phase3","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2025-03-28","u":"2025-04-02","st":"2025-05","ag":"18–65"},{"n":"NCT06900478","t":"Icariin Soft Capsules Combined With TACE as Adjuvant Therapy for HCC","s":"nyr","p":"phase2","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[209],"l":[[209,"hcc"]],"po":"2025-03-28","u":"2025-03-28","st":"2025-03","ag":"18–80"},{"n":"NCT06902025","t":"JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Leukemia","s":"nyr","p":"na","d":[16],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"ball"]],"po":"2025-03-30","u":"2025-03-30","st":"2025-03","ag":"18–75"},{"n":"NCT06902935","t":"Establishment and Clinical Application of Breast Cancer Risk Prediction Model Based on Traditional Chinese Medicine Four Diagnostic Instruments and Ultrasound","s":"nyr","p":"na","d":[6],"c":[29],"lc":[29],"a":"adult older","x":"female","h":[366],"l":[[366,"breast"]],"po":"2025-03-30","u":"2025-03-30","st":"2025-04","ag":"30–75"},{"n":"NCT06903871","t":"Toripalimab Adjuvant Therapy in Subjects With Resected Esophageal Squamous Cell Carcinoma Who Achieved Pathological Complete Response (pCR)","s":"nyr","p":"phase2","d":[1],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"escc"]],"po":"2025-04-01","u":"2025-04-01","st":"2025-04","ag":"18 and over"},{"n":"NCT06913218","t":"A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC","s":"nyr","p":"phase1","d":[5],"c":[5],"a":"adult older","h":[9],"po":"2025-04-06","u":"2025-04-06","st":"2025-07","ag":"18–75"},{"n":"NCT06916975","t":"Adebrelimab Combined With AG Regimen in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer","s":"nyr","p":"phase2","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"panc"]],"po":"2025-04-08","u":"2025-04-08","st":"2025-04","ag":"18–75"},{"n":"NCT06918015","t":"Zanubrutinib Plus GCVP (Obinutuzumab, Cyclophosphamide, Vindesine, Prednisolone) in Previously Untreated Follicular Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"lymph"]],"po":"2025-04-09","u":"2025-04-15","st":"2025-05","ag":"18–80"},{"n":"NCT06924736","t":"SONICURE（SONICracker for the Treatment of UndeRExpansion）","s":"nyr","p":"na","d":[31],"c":[2],"a":"adult older","h":[197],"po":"2025-04-11","u":"2025-04-11","st":"2025-05","ag":"18–80"},{"n":"NCT06925555","t":"Brentuximab Vedotin Combined With R-CHP in Newly Diagnosed EBV+ DLBCL-NOS","s":"nyr","p":"phase2","d":[19],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"lymph"]],"po":"2025-04-13","u":"2025-09-30","st":"2025-09","ag":"18–70"},{"n":"NCT06931145","t":"Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer","s":"nyr","p":"phase4","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"lung"]],"po":"2025-04-17","u":"2025-04-23","st":"2025-04","ag":"18–75"},{"n":"NCT06933563","t":"UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia Gravis","s":"nyr","p":"earlyphase1","d":[27],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"mg"]],"po":"2025-04-18","u":"2025-04-18","st":"2025-04","ag":"18 and over"},{"n":"NCT06934733","t":"The Efficacy of Oral Cryotherapy in Preventing TROP2-ADC-Induced Oral Mucositis in Patients With Advanced Breast Cancer","s":"nyr","p":"na","d":[6],"c":[20],"lc":[20],"a":"adult older","x":"female","h":[37],"l":[[37,"breast"]],"po":"2025-04-18","u":"2025-04-18","st":"2025-05","ag":"18 and over"},{"n":"NCT06935136","t":"Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Injection as First-Line Therapy of High-Risk Large B-Cell Lymphoma","s":"nyr","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2025-04-20","u":"2025-04-22","st":"2025-04","ag":"18 and over"},{"n":"NCT06935175","t":"A Study of SHR-1826 Monotherapy or in Combination With Immunotherapy in the Treatment of Advanced Hepatocellular Cancer","s":"nyr","p":"phase2","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"hcc"]],"po":"2025-04-20","u":"2025-04-20","st":"2025-05","ag":"18–75"},{"n":"NCT06938451","t":"Relationship Between FGF19 Overexpression and Disease Prognosis","s":"nyr","p":"na","d":[2],"c":[2],"a":"adult older","h":[100],"po":"2025-04-22","u":"2025-04-22","st":"2025-05","ag":"18 and over"},{"n":"NCT06939400","t":"Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence","s":"nyr","p":"na","d":[7],"c":[23],"lc":[23],"a":"adult older","h":[183],"l":[[183,"glioma"]],"po":"2025-04-22","u":"2025-04-22","st":"2025-06","ag":"18 and over"},{"n":"NCT06941987","t":"Evaluate the Clinical Feasibility of a Novel Neoantigen-Reactive CD8+ T Cell (NART) Detection Technology for Postoperative MRD Surveillance of Pancreatic Cancer","s":"nyr","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"panc"]],"po":"2025-04-24","u":"2025-04-24","st":"2025-04","ag":"18 and over"},{"n":"NCT06944496","t":"A Study of Disitamab Vedotin Combined With Tislelizumab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in HER2-Low Advanced Gastric or Gastroesophageal Junction Adenocarcinoma","s":"nyr","p":"phase3","d":[3],"c":[2],"a":"adult older","h":[74],"po":"2025-04-25","u":"2025-04-25","st":"2025-05","ag":"18–75"},{"n":"NCT06951841","t":"Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction","s":"nyr","p":"phase4","d":[4],"c":[11],"lc":[11],"a":"adult older","h":[118],"l":[[118,"lung"]],"po":"2025-04-30","u":"2025-04-30","st":"2025-04","ag":"18 and over"},{"n":"NCT06951971","t":"Dose-modified Emapalumab and Ruxolitinib (E-Ru) Regimens for Hemophagocytic Lymphohistiocytosis","s":"nyr","p":"phase2phase3","d":[18],"c":[4],"lc":[4],"a":"child adult older","h":[5],"l":[[5,"hlh"]],"po":"2025-04-30","u":"2025-04-30","st":"2025-06","ag":"1–70"},{"n":"NCT06956092","t":"Glofitamab for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma","s":"nyr","p":"phase4","d":[19],"c":[20],"lc":[20],"a":"adult older","h":[25],"l":[[25,"lymph"]],"po":"2025-05-02","u":"2025-05-02","st":"2025-05","ag":"18–75"},{"n":"NCT06957977","t":"A Randomized Controlled Study of Endoscopic Cryoablation Combined With PD-1 Inhibitor for Maintenance Therapy in Advanced Gastric Cancer","s":"nyr","p":"phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[103],"l":[[103,"gc"]],"po":"2025-05-06","u":"2025-05-06","st":"2025-05","ag":"18 and over"},{"n":"NCT06960122","t":"Clinical Study on Fecal Microbiota Transplantation for Diarrhea After Total Pancreatectomy","s":"nyr","p":"na","d":[5],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"panc"]],"po":"2025-05-07","u":"2025-05-07","st":"2025-05","ag":"18 and over"},{"n":"NCT06961188","t":"Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology Analysis","s":"nyr","p":"phase3","d":[4],"c":[13],"a":"adult older","h":[12],"po":"2025-05-07","u":"2025-05-07","st":"2025-06","ag":"18–85"},{"n":"NCT06961201","t":"Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in the Cachexia Phase","s":"nyr","p":"phase3","d":[4],"c":[22],"a":"adult older","h":[40],"po":"2025-05-07","u":"2025-05-07","st":"2025-05","ag":"18–85"},{"n":"NCT06961500","t":"Obinutuzumab With CHOP Versus Obinutuzumab With Bendamustine in the Treatment of Newly Diagnosed Follicular Lymphoma Grade 3A","s":"nyr","p":"phase2","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2025-05-08","u":"2025-05-08","st":"2025-05","ag":"18 and over"},{"n":"NCT06963502","t":"A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors","s":"nyr","p":"phase1","d":[4],"c":[0,23],"a":"adult older","h":[53,54],"po":"2025-05-09","u":"2025-05-09","st":"2025-05","ag":"18 and over"},{"n":"NCT06963866","t":"Comparing ASCT Followed by Anti-BCMA CAR-T vs. ASCT Alone in NDMM Patients Eligible for ASCT","s":"nyr","p":"phase2","d":[15],"c":[31],"lc":[31],"a":"adult older","h":[64],"l":[[64,"mm"]],"po":"2025-05-09","u":"2025-05-09","st":"2025-05","ag":"18–70"},{"n":"NCT06964971","t":"Treatment of Transfusion-dependent Nonsevere Aplastic Anemia With Luspatercept: a Multicenter Prospective Clinical Study","s":"nyr","p":"na","d":[17],"c":[23],"lc":[23],"a":"adult older","h":[275],"l":[[275,"aa"]],"po":"2025-05-11","u":"2025-05-11","st":"2025-05","ag":"18–80"},{"n":"NCT06965556","t":"Patient Education Strategy for Breast Cancer Patients During Perioperative Hospitalization Stage","s":"nyr","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2025-05-11","u":"2025-05-13","st":"2025-06","ag":"18 and over"},{"n":"NCT06966583","t":"NAD+ Supplement（NMN）With Radioimmunotherapy in Advanced NSCLC","s":"nyr","p":"phase1","d":[4],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"lung"]],"po":"2025-05-12","u":"2025-05-12","st":"2025-05","ag":"18–75"},{"n":"NCT06977386","t":"The Application Value of Spectral CT in the Accurate Staging of Gastric Cancer","s":"nyr","p":"na","d":[3],"c":[47],"lc":[47],"a":"adult older","h":[135],"l":[[135,"gc"]],"po":"2025-05-18","u":"2025-05-18","st":"2025-06","ag":"18–80"},{"n":"NCT06977828","t":"A Prospective, Single-arm, Phase II Clinical Study of Tislelizumab Combined With Anlotinib and Platinum-based Doublet Perioperative Therapy for Resectable Stage II-IIIB Driver Gene-negative NSCLC","s":"nyr","p":"phase2","d":[4],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"lung"]],"po":"2025-05-18","u":"2025-06-29","st":"2025-07","ag":"18–75"},{"n":"NCT06978738","t":"UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases","s":"nyr","p":"phase1","d":[26,27],"c":[49],"lc":[49],"a":"adult older","h":[230],"l":[[230,"igg4"]],"po":"2025-05-18","u":"2025-05-18","st":"2025-05","ag":"18 and over"},{"n":"NCT06980389","t":"Node-Sparing Short-Course Radiotherapy Plus First-Line Therapy and PD-1 Inhibitor in Unresectable/Metastastic pMMR/MSS Gastric Cancer (MODIFI-GC)","s":"nyr","p":"phase2","d":[3],"c":[0],"lc":[0],"a":"adult older","h":[75],"l":[[75,"gc"]],"po":"2025-05-20","u":"2025-05-20","st":"2025-05","ag":"18–75"},{"n":"NCT06994078","t":"Clinical Application of PET Imaging Targeting Nectin-4 in Malignant Tumors","s":"nyr","p":"na","d":[4,6],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lung"]],"po":"2025-05-29","u":"2025-05-29","st":"2025-07","ag":"18–65"},{"n":"NCT06994351","t":"Acupuncture for Anxiety and Depression","s":"nyr","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[280],"l":[[280,"breast"]],"po":"2025-05-29","u":"2025-05-29","st":"2025-05","ag":"18–70"},{"n":"NCT06996093","t":"Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 Inhibitor","s":"nyr","p":"phase3","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2025-05-30","u":"2025-05-30","st":"2025-06","ag":"18–70"},{"n":"NCT06998719","t":"Neoadjuvant Durvalumab and Chemotherapy Followed by Surgery/CRT and Durvalumab in Borderline Resectable Stage III NSCLC","s":"nyr","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2025-05-31","u":"2025-05-31","st":"2025-07","ag":"18 and over"},{"n":"NCT07004075","t":"FCN-159 Monotherapy Versus Chemotherapy by Investigator's Choice in Pediatric Low-grade Glioma Patients With BRAF Alteration","s":"nyr","p":"phase3","d":[7],"c":[2],"a":"child adult","h":[102],"po":"2025-06-04","u":"2025-06-04","st":"2025-06","ag":"2–18"},{"n":"NCT07004712","t":"Efficacy and Biomarkers of the Second-line Treatment of Adebelizumab Combined With Irinotecan Liposome in Advanced Small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"lung"]],"po":"2025-06-04","u":"2025-06-08","st":"2025-06","ag":"18–75"},{"n":"NCT07005583","t":"Clinical Study of QL1706 in Combination With Olaparib for the Treatment of Patients With Previously Treated Homologous Recombination Repair-Deficient Recurrent or Metastatic Triple-Negative Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[30],"lc":[30],"a":"adult older","x":"female","h":[58],"l":[[58,"breast"]],"po":"2025-06-05","u":"2025-06-05","st":"2025-06","ag":"18–75"},{"n":"NCT07005791","t":"AI-Based Ultrasound Prediction Model for Intracranial Pressure and Prognosis in Lung Cancer Patients With Leptomeningeal Metastasis: A Dual-Center Study","s":"nyr","p":"na","d":[4],"c":[28],"lc":[28],"a":"adult older","h":[60],"l":[[60,"lung"]],"po":"2025-06-05","u":"2025-06-05","st":"2025-07","ag":"18–75"},{"n":"NCT07008053","t":"BR Combined With OR in Treatment-naïve Marginal Zone Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[8,16,27,26,18,30],"lc":[30],"a":"adult older","h":[58,55,24,30,57,13],"l":[[58,"lymph"]],"po":"2025-06-06","u":"2025-06-06","st":"2025-07","ag":"18 and over"},{"n":"NCT07009938","t":"DCB for CAD With Type 2 Diabetes","s":"nyr","p":"na","d":[31],"c":[5,20],"a":"adult older","h":[25,296],"po":"2025-06-08","u":"2025-06-08","st":"2025-07","ag":"18 and over"},{"n":"NCT07010588","t":"Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High Risk","s":"nyr","p":"na","d":[2],"c":[2,15,1,24,27,26,13,39],"lc":[2],"a":"adult older","h":[48,12,124,55,193,45,97,147,156],"l":[[48,"hcc"]],"po":"2025-06-08","u":"2025-06-08","st":"2025-06","ag":"18–75"},{"n":"NCT07012694","t":"22G-Adapt vs 22G-Franseen Needle Biopsy in EUS-Guided Tissue Acquisition of Solid Lesions","s":"nyr","p":"na","d":[5],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"panc"]],"po":"2025-06-10","u":"2025-07-01","st":"2025-07","ag":"18–85"},{"n":"NCT07014254","t":"Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies","s":"nyr","p":"na","d":[3,5],"c":[39],"lc":[39],"a":"adult older","h":[131],"l":[[131,"gc"]],"po":"2025-06-10","u":"2025-06-10","st":"2025-06","ag":"18–80"},{"n":"NCT07018063","t":"Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric Cancer","s":"nyr","p":"phase2","d":[3],"c":[2],"lc":[2],"a":"child adult","h":[48],"l":[[48,"gc"]],"po":"2025-06-12","u":"2025-06-12","st":"2025-10","ag":"16–45"},{"n":"NCT07018505","t":"EpCAM-Targeted Surface-Enhanced Raman Spectroscopy Nanotags for Rapid Evaluation of Surgical Margins and Sentinel Lymph Node Metastasis Status in Breast Cancers","s":"nyr","p":"na","d":[6],"c":[47],"lc":[47],"a":"adult older","x":"female","h":[135],"l":[[135,"breast"]],"po":"2025-06-12","u":"2025-06-12","st":"2025-06","ag":"18–75"},{"n":"NCT07020052","t":"Phase II Exploratory Study of Sequential Triple Therapy (Temozolomide/Anlotinib/Bemarituzumab) in Combination With Concurrent Radiotherapy With Temozolomide and Anlotinib for the Maintenance Treatment of Diffuse Midline Gliomas in Children","s":"nyr","p":"na","d":[7],"c":[13],"lc":[13],"a":"child adult","h":[12],"l":[[12,"glioma"]],"po":"2025-06-13","u":"2025-07-08","st":"2025-07","ag":"3–18"},{"n":"NCT07024147","t":"JWCAR239 in Patients With B Cell Non-Hodgkin Lymphoma","s":"nyr","p":"phase1","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"lymph"]],"po":"2025-06-17","u":"2025-06-17","st":"2025-07","ag":"18 and over"},{"n":"NCT07026123","t":"A Real-world Study of Liposomal Irinotecan (Onivyde)-Based Therapy in Patients With Locally Advanced/Metastatic Pancreatic Cancer in China","s":"nyr","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"panc"]],"po":"2025-06-18","u":"2025-06-18","st":"2025-07","ag":"18 and over"},{"n":"NCT07031011","t":"PD-1-M1-NK Cells in the Treatment of Advanced Gastric or Colorectal Cancer","s":"nyr","p":"phase1","d":[3],"c":[15],"lc":[15],"a":"adult older","h":[27],"l":[[27,"gc"]],"po":"2025-06-22","u":"2025-06-22","st":"2025-06","ag":"18–75"},{"n":"NCT07031154","t":"A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[7],"lc":[7],"a":"adult older","h":[8],"l":[[8,"lung"]],"po":"2025-06-22","u":"2025-06-22","st":"2025-06","ag":"18–70"},{"n":"NCT07032324","t":"A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG1101 )","s":"nyr","p":"phase1","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lymph"]],"po":"2025-06-23","u":"2025-06-23","st":"2025-07","ag":"18–75"},{"n":"NCT07032532","t":"Assessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23)","s":"nyr","p":"phase2","d":[19],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lymph"]],"po":"2025-06-24","u":"2025-06-26","st":"2025-07","ag":"18 and over"},{"n":"NCT07034118","t":"Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase I Clinical Study","s":"nyr","p":"phase1","d":[1],"c":[17],"lc":[17],"a":"adult older","h":[68],"l":[[68,"escc"]],"po":"2025-06-24","u":"2025-06-24","st":"2025-08","ag":"18–75"},{"n":"NCT07034508","t":"A Phase II Trial of 4 vs 6 Cycles of CHP Combined With Polatuzumab Vedotin-Rituximab in Untreated DLBCL Patients With IPI 0-1","s":"nyr","p":"phase2","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"lymph"]],"po":"2025-06-24","u":"2025-06-24","st":"2025-06","ag":"18–80"},{"n":"NCT07034755","t":"Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma","s":"nyr","p":"na","d":[15],"c":[31],"lc":[31],"a":"adult older","h":[64],"l":[[64,"mm"]],"po":"2025-06-24","u":"2025-07-02","st":"2025-07","ag":"18–70"},{"n":"NCT07035379","t":"A Phase I/II Study of TRS005 in Combination With Cyclophosphamide, Doxorubicin, and Prednisone（T-CHP） in Previously Untreated Patients With CD20-positive DLBCL","s":"nyr","p":"phase1phase2","d":[19],"c":[2],"a":"adult older","h":[23],"po":"2025-06-25","u":"2025-08-22","st":"2025-09","ag":"18 and over"},{"n":"NCT07035444","t":"Enteral Nutrition With L-Carnitine for Cachexia in Non-Small Cell Lung Cancer","s":"nyr","p":"na","d":[4],"c":[1],"lc":[1],"a":"adult older","h":[17],"l":[[17,"lung"]],"po":"2025-06-25","u":"2025-06-25","st":"2025-06","ag":"18 and over"},{"n":"NCT07035860","t":"Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer","s":"nyr","p":"na","d":[4],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"lung"]],"po":"2025-06-25","u":"2025-06-25","st":"2025-06","ag":"18–75"},{"n":"NCT07036185","t":"A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors","s":"nyr","p":"phase1","d":[3,4,6],"c":[5],"a":"adult older","h":[9],"po":"2025-06-25","u":"2025-06-25","st":"2025-06","ag":"18 and over"},{"n":"NCT07038460","t":"A Multicenter Phase II Randomized Trial of Limertinib Followed by Sintilimab and Chemotherapy vs. Limertinib Followed by Limertinib and Chemotherapy as Neoadjuvant Therapy in Resectable Stage II-IIIB EGFR-Mutant NSCLC","s":"nyr","p":"phase2","d":[4],"c":[8,0,23],"a":"adult older","h":[11,13,54,95],"po":"2025-06-26","u":"2025-06-26","st":"2025-07","ag":"18–75"},{"n":"NCT07040579","t":"Bioabsorbable Occluder for Outlet VSD: Safety and Aortic Valve Effects","s":"nyr","p":"na","d":[32],"c":[10],"lc":[10],"a":"child adult older","h":[15],"l":[[15,"chd"]],"po":"2025-06-27","u":"2025-06-27","st":"2025-06","ag":"1 and over"},{"n":"NCT07040644","t":"A Study of Sacituzumab Govitecan Plus Toripalimab Versus Toripalimab Plus Nab-Paclitaxel in PD-L1 Positive Advanced TNBC","s":"nyr","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2025-06-27","u":"2025-09-08","st":"2025-09","ag":"18 and over"},{"n":"NCT07043218","t":"A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia","s":"nyr","p":"phase1","d":[16],"c":[5],"lc":[5],"a":"adult older","h":[162],"l":[[162,"ball"]],"po":"2025-06-29","u":"2025-06-29","st":"2025-07","ag":"18–75"},{"n":"NCT07045168","t":"Risk-adapted Therapeutic Strategy in +1q NDMM","s":"nyr","p":"na","d":[15],"c":[15],"lc":[15],"a":"child adult older","h":[27],"l":[[27,"mm"]],"po":"2025-07-01","u":"2025-09-15","st":"2025-09","ag":"Not stated"},{"n":"NCT07045558","t":"HAIC + Atezolizumab Plus Bevacizumab in Unresectable HCC","s":"nyr","p":"na","d":[2],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"hcc"]],"po":"2025-07-01","u":"2025-07-01","st":"2025-08","ag":"18–75"},{"n":"NCT07047443","t":"SHR-1811 Combined With Carboplatin in the Treatment of Advanced Breast Cancer With HER2 Expression","s":"nyr","p":"phase2","d":[6],"c":[17],"a":"adult older","x":"female","h":[231,88],"l":[[231,"breast"]],"po":"2025-07-02","u":"2025-07-02","st":"2025-08","ag":"18–75"},{"n":"NCT07050524","t":"Omega-3 Supplementation and Immunotherapy in Gastric Cancer: A Phase II Trial","s":"nyr","p":"phase2","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"gc"]],"po":"2025-07-03","u":"2025-07-03","st":"2025-09","ag":"18–80"},{"n":"NCT07054242","t":"A Prospective, Single-center, Phase II Study of Sacituzumab Tirumotecan in Combination With Pembrolizumab for Neoadjuvant Treatment of Triple-Negative Breast Cancer (TNBC)","s":"nyr","p":"phase2","d":[6],"c":[19],"lc":[19],"a":"adult older","h":[28],"l":[[28,"breast"]],"po":"2025-07-08","u":"2025-10-01","st":"2025-10","ag":"18–75"},{"n":"NCT07060599","t":"Human-AI Collaborative INSIGHT Diagnostic Workflow for in Breast Cancer With Extensive Intraductal Component","s":"nyr","p":"na","d":[6],"c":[0],"lc":[0],"a":"child adult older","x":"female","h":[53],"l":[[53,"breast"]],"po":"2025-07-11","u":"2025-07-11","st":"2025-08","ag":"Not stated"},{"n":"NCT07061717","t":"Comparing Endocrine Therapy Combined With High-Dose Palbociclib and Hydroxychloroquine to Endocrine Therapy Combined With Standard-Dose Palbociclib for Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer","s":"nyr","p":"phase3","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2025-07-11","u":"2025-07-11","st":"2025-07","ag":"18–70"},{"n":"NCT07062484","t":"A Real-world Study of the Efficacy and Safety of PD-1 Inhibitors Combined With Chemoradiotherapy in Lung Metastatic Nasopharyngeal Carcinoma","s":"nyr","p":"na","d":[0],"c":[22],"lc":[22],"a":"adult older","h":[47],"l":[[47,"npc"]],"po":"2025-07-14","u":"2025-07-14","st":"2025-07","ag":"18 and over"},{"n":"NCT07063667","t":"Artificial Intelligence Model-Assisted Accurate Diagnosis of Early-Stage Breast Cancer","s":"nyr","p":"na","d":[6],"c":[1],"lc":[1],"a":"adult older","h":[17],"l":[[17,"breast"]],"po":"2025-07-14","u":"2025-07-14","st":"2025-08","ag":"19–85"},{"n":"NCT07064668","t":"Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective Study","s":"nyr","p":"phase2","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2025-07-15","u":"2025-07-15","st":"2025-07","ag":"18–80"},{"n":"NCT07064876","t":"Serplulimab Combined With Cryoablation for Early-Stage Non-Small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"lung"]],"po":"2025-07-15","u":"2025-09-15","st":"2025-10","ag":"18 and over"},{"n":"NCT07068516","t":"Perioperative Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone in MHC-II-Positive Gastric/GEJ Cancer","s":"nyr","p":"phase3","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"gc"]],"po":"2025-07-16","u":"2025-07-16","st":"2025-07","ag":"18–80"},{"n":"NCT07068906","t":"A Clinical Study Exploring CT1194C in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma","s":"nyr","p":"phase1","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"lymph"]],"po":"2025-07-16","u":"2025-07-16","st":"2025-07","ag":"18–75"},{"n":"NCT07072000","t":"Shrinking the Anterior Border of CTV2 for Nasopharyngeal Carcinoma to Reduce the Radiation of Nasal Cavity","s":"nyr","p":"phase3","d":[0],"c":[63,0,88,87,45],"a":"adult older","h":[53,129,198,342,317],"po":"2025-07-18","u":"2025-07-18","st":"2025-08","ag":"18–70"},{"n":"NCT07077018","t":"Fasting-Mimicking Diet as an Adjunct to Neoadjuvant Chemotherapy for Hormone-Receptor-Positive Breast Cancer","s":"nyr","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult older","h":[43],"l":[[43,"breast"]],"po":"2025-07-22","u":"2025-07-22","st":"2025-07","ag":"18–75"},{"n":"NCT07078721","t":"Efficacy and Safety of UCBT With TMI -Based Conditioning Regimen for Adults With Refractory/Relapsed Aplastic Anemia","s":"nyr","p":"phase2","d":[17],"c":[30],"lc":[30],"a":"adult","h":[69],"l":[[69,"aa"]],"po":"2025-07-22","u":"2025-07-22","st":"2025-07","ag":"18–50"},{"n":"NCT07083375","t":"A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer.","s":"nyr","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2025-07-24","u":"2025-07-24","st":"2025-08","ag":"18 and over"},{"n":"NCT07086326","t":"A Phase II Randomized Trial of Neoadjuvant Ivonescimab or Penpulimab Plus Chemotherapy in Resectable NSCLC","s":"nyr","p":"phase2","d":[4],"c":[2,8,23,5,39],"a":"adult older","h":[42,111,13,54,48],"po":"2025-07-25","u":"2025-07-25","st":"2025-07","ag":"18 and over"},{"n":"NCT07087847","t":"Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute Leukemia","s":"nyr","p":"na","d":[16],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"ball"]],"po":"2025-07-28","u":"2025-07-28","st":"2025-09","ag":"18 and over"},{"n":"NCT07088588","t":"Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors","s":"nyr","p":"phase1","d":[6],"c":[5],"a":"adult older","h":[9],"po":"2025-07-28","u":"2025-07-28","st":"2025-07","ag":"18 and over"},{"n":"NCT07088744","t":"Comparison of the Sensitivity of pCLE and Pathological Biopsy Before ESD","s":"nyr","p":"na","d":[3],"c":[22,5],"lc":[5],"a":"adult older","h":[177,40],"l":[[177,"gc"]],"po":"2025-07-28","u":"2025-07-28","st":"2025-07","ag":"18–80"},{"n":"NCT07090954","t":"A Study of GR1803 Injection in Combination With Anti-CD38 Monoclonal Antibody for the Treatment of Participants With Multiple Myeloma","s":"nyr","p":"phase1phase2","d":[15],"c":[5,39],"a":"adult older","h":[111,286],"po":"2025-07-29","u":"2025-07-29","st":"2025-08","ag":"18 and over"},{"n":"NCT07093762","t":"Efficacy and Safety Analysis of First-Line ABCP Therapy in Advanced SMARCA4-Mutated NSCLC","s":"nyr","p":"na","d":[4],"c":[16],"lc":[16],"a":"adult older","h":[341],"l":[[341,"lung"]],"po":"2025-07-30","u":"2025-07-30","st":"2025-08","ag":"18 and over"},{"n":"NCT07093931","t":"Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer","s":"nyr","p":"phase4","d":[6],"c":[27],"lc":[27],"a":"adult older","x":"female","h":[57],"l":[[57,"breast"]],"po":"2025-07-30","u":"2025-07-30","st":"2025-08","ag":"18–70"},{"n":"NCT07097948","t":"Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Incidental Small Cell Lung Cancer After Radical Resection of Lung Cancer: A Single-Center, Randomized Controlled Clinical Study Protocol Number: LungMate-033","s":"nyr","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2025-08-01","u":"2025-08-01","st":"2025-08","ag":"18 and over"},{"n":"NCT07098949","t":"Acupuncture Combined With Chemotherapy for Gastric Cancer After Surgery","s":"nyr","p":"na","d":[3],"c":[0],"a":"adult older","h":[49,75,107],"po":"2025-08-01","u":"2025-08-01","st":"2025-08","ag":"18–75"},{"n":"NCT07100236","t":"29-Gene Liver Cancer Subtype and Immunotherapy Effectiveness","s":"nyr","p":"na","d":[2],"c":[2,16,0,23,17,5,37,20],"a":"adult older","h":[6,49,277,25,23,81,68,82,54,44,148,123],"po":"2025-08-03","u":"2025-08-03","st":"2025-08","ag":"18 and over"},{"n":"NCT07101627","t":"A Prospective, Multicenter Clinical Study of Hetrombopag in the Prevention of Thrombocytopenia Caused by Lung Cancer Therapy","s":"nyr","p":"phase2","d":[4],"c":[28,5],"lc":[5],"a":"adult older","h":[56,127],"l":[[56,"lung"]],"po":"2025-08-03","u":"2025-08-03","st":"2025-08","ag":"18 and over"},{"n":"NCT07103408","t":"A Study Evaluating Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade for Limited-stage Small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2025-08-05","u":"2025-08-05","st":"2025-10","ag":"18–75"},{"n":"NCT07112833","t":"A Phase II Clinical Study of Induction Adebrelimab Combined With Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC)","s":"nyr","p":"phase2","d":[1],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"escc"]],"po":"2025-08-08","u":"2025-08-08","st":"2025-08","ag":"18–75"},{"n":"NCT07113496","t":"RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies","s":"nyr","p":"phase1","d":[15,16,19],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"mm"]],"po":"2025-08-08","u":"2025-08-13","st":"2025-08","ag":"18 and over"},{"n":"NCT07113964","t":"QL1706 With Olaparib for Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency (HRD)","s":"nyr","p":"phase2","d":[6],"c":[28],"lc":[28],"a":"adult older","x":"female","h":[78],"l":[[78,"breast"]],"po":"2025-08-11","u":"2025-08-11","st":"2025-08","ag":"18–75"},{"n":"NCT07114432","t":"RN1201 Injection in Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma","s":"nyr","p":"phase1","d":[15],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"mm"]],"po":"2025-08-11","u":"2025-08-11","st":"2025-08","ag":"18 and over"},{"n":"NCT07114666","t":"XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic Cancer","s":"nyr","p":"na","d":[5],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"panc"]],"po":"2025-08-11","u":"2025-08-11","st":"2025-08","ag":"18–75"},{"n":"NCT07117305","t":"CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation","s":"nyr","p":"phase1phase2","d":[19],"c":[20],"lc":[20],"a":"child adult older","h":[25],"l":[[25,"lymph"]],"po":"2025-08-12","u":"2025-08-12","st":"2025-09","ag":"14–65"},{"n":"NCT07122609","t":"Pirtobrutinib in Combination With Rituximab, Gemcitabine, Oxaliplatin With or Without Polatuzumab Vedotin in Covalent BTK Inhibitor-Pretreated Relapsed/Refractory Diffuse Large B-Cell Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2025-08-14","u":"2025-08-14","st":"2025-08","ag":"18 and over"},{"n":"NCT07129161","t":"Iparomlimab and Tuvonralimab Combined With 2 or 4 Cycles of Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC","s":"nyr","p":"phase2","d":[4],"c":[0,39],"lc":[0],"a":"adult older","h":[53,122],"l":[[53,"lung"]],"po":"2025-08-19","u":"2025-08-19","st":"2025-08","ag":"18 and over"},{"n":"NCT07131501","t":"A Single-Arm, Multicenter, Exploratory Clinical Study of TACE Combined With Iparomlimab and Tuvonralimab Injection (QL1706) and Lenvatinib for Perioperative Treatment of Resectable Hepatocellular Carcinoma","s":"nyr","p":"phase2","d":[2],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"hcc"]],"po":"2025-08-20","u":"2025-08-20","st":"2025-08","ag":"18–75"},{"n":"NCT07135297","t":"Novel Thin Bronchoscope Versus Ultrathin Bronchoscope for the Diagnosis of Peripheral Pulmonary Nodules","s":"nyr","p":"na","d":[4],"c":[2,28,61,5,20],"lc":[5],"a":"adult older","h":[42,92,182,29,120],"l":[[42,"lung"]],"po":"2025-08-22","u":"2025-08-22","st":"2025-09","ag":"18 and over"},{"n":"NCT07136974","t":"Efficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer.","s":"nyr","p":"phase2","d":[6],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"breast"]],"po":"2025-08-22","u":"2025-08-22","st":"2025-09","ag":"18–70"},{"n":"NCT07139470","t":"Sacituzumab Tirumotecan Plus Anlotinib for Metastatic Triple Negative Breast Cancer","s":"nyr","p":"phase1phase2","d":[6],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"breast"]],"po":"2025-08-24","u":"2025-08-24","st":"2025-08","ag":"18 and over"},{"n":"NCT07139587","t":"The Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With Albumin-bound Paclitaxel in Second-line Treatment of Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma","s":"nyr","p":"na","d":[3],"c":[18],"lc":[18],"a":"adult older","h":[297],"l":[[297,"gc"]],"po":"2025-08-24","u":"2025-09-10","st":"2025-09","ag":"18–75"},{"n":"NCT07150416","t":"Nebulized Inhalation of Recombinant Human p53 Adenovirus Injection for Treatment of Multiple Ground-Glass Lung Nodules: A Single-Arm Clinical Study","s":"nyr","p":"phase2","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[132],"l":[[132,"lung"]],"po":"2025-09-02","u":"2025-09-02","st":"2025-10","ag":"18 and over"},{"n":"NCT07153757","t":"De-escalation Therapy in Stage I ER-Positive Breast Cancer: A Non-Inferiority Trial","s":"nyr","p":"phase3","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2025-09-04","u":"2025-09-04","st":"2025-09","ag":"18 and over"},{"n":"NCT07153965","t":"Sacituzumab Tirumotecan Plus Tagitanlimab in Previously Treated Locally Advanced or Metastatic Triple Negative Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"breast"]],"po":"2025-09-04","u":"2025-09-04","st":"2025-09","ag":"18 and over"},{"n":"NCT07154108","t":"Endostatin Adenovirus With Checkpoint Inhibitor in Advanced Head and Neck or Esophageal Cancer","s":"nyr","p":"phase1","d":[1],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"escc"]],"po":"2025-09-04","u":"2025-09-04","st":"2025-09","ag":"18–75"},{"n":"NCT07156604","t":"Vebreltinib for Neoadjuvant in METex 14 Skipping Mutant Stage IIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)","s":"nyr","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2025-09-05","u":"2025-09-05","st":"2025-09","ag":"18 and over"},{"n":"NCT07156617","t":"A Study on the Heterogeneity of Efficacy of Interventional Therapy Combined With Systemic Therapy for Liver Cancer Based on Multi-center Real-world Data","s":"nyr","p":"na","d":[2],"c":[6,9,20],"a":"adult older","h":[25,14,7],"po":"2025-09-05","u":"2025-09-05","st":"2025-10","ag":"18 and over"},{"n":"NCT07157306","t":"Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma","s":"nyr","p":"phase2","d":[2],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"hcc"]],"po":"2025-09-05","u":"2025-09-05","st":"2025-09","ag":"18–80"},{"n":"NCT07158840","t":"AK112 in Non-squamous Non-small Cell Lung Cancer (NSCLC)Patients With Actionable Genomic Alterations (AGA) Who Have Failed to Previous Tyrosine Kinase Inhibitor (TKI) Treatment","s":"nyr","p":"phase2","d":[4],"c":[0],"a":"adult older","h":[43],"po":"2025-09-08","u":"2025-09-08","st":"2025-09","ag":"18–75"},{"n":"NCT07159906","t":"Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma","s":"nyr","p":"phase1phase2","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"lymph"]],"po":"2025-09-08","u":"2025-09-08","st":"2025-09","ag":"18–99"},{"n":"NCT07162259","t":"Cohort Study on Sequential ADC Therapy in HR-positive/HER2-negative Advanced Breast Cancer","s":"nyr","p":"phase4","d":[6],"c":[39],"lc":[39],"a":"adult older","x":"female","h":[247],"l":[[247,"breast"]],"po":"2025-09-09","u":"2025-09-09","st":"2025-10","ag":"18–85"},{"n":"NCT07163481","t":"A Trial to Evaluate Sacituzumab Govitecan in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Metastatic Breast Cancer Progressed on CDK4/6 Inhibitors","s":"nyr","p":"phase1","d":[6],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"breast"]],"po":"2025-09-09","u":"2025-09-16","st":"2025-10","ag":"18 and over"},{"n":"NCT07168291","t":"Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma","s":"nyr","p":"earlyphase1","d":[19],"c":[39],"lc":[39],"a":"adult older","h":[111],"l":[[111,"lymph"]],"po":"2025-09-11","u":"2025-09-17","st":"2025-12","ag":"18 and over"},{"n":"NCT07169864","t":"Simple Surgical Glove Compression to Prevent Chemotherapy-Induced Peripheral Neuropathy","s":"nyr","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"breast"]],"po":"2025-09-12","u":"2025-09-12","st":"2025-09","ag":"18 and over"},{"n":"NCT07169903","t":"Segmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCT","s":"nyr","p":"phase3","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2025-09-12","u":"2025-09-12","st":"2025-10","ag":"20–79"},{"n":"NCT07172412","t":"Open-Label, Biomarker-Integrated Umbrella Trial for First-Line Treatment of Extensive-stage Small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2025-09-15","u":"2025-09-30","st":"2025-11","ag":"18–75"},{"n":"NCT07172503","t":"Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors","s":"nyr","p":"na","d":[3,5],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"gc"]],"po":"2025-09-15","u":"2025-09-15","st":"2025-10","ag":"18–70"},{"n":"NCT07175870","t":"Preoperative vs Postoperative Revascularization in Coronary Heart Disease Patients Undergoing Time-Sensitive Non-Cardiac Surgery (CHRONOS-PCI)","s":"nyr","p":"na","d":[31],"c":[37],"lc":[37],"a":"adult older","h":[81],"l":[[81,"cad"]],"po":"2025-09-16","u":"2025-09-16","st":"2025-10","ag":"18–80"},{"n":"NCT07179445","t":"Analysis of Deoxyribonucleic Acid and Ribonucleic Acid Next-Generation Sequencing in Non-Small Cell Lung Cancer Patients Without Pathological Complete Response Following Neoadjuvant Immunotherapy","s":"nyr","p":"na","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2025-09-17","u":"2025-09-17","st":"2025-09","ag":"18–100"},{"n":"NCT07180459","t":"The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib：A Prospective, Single-arm, Multicenter, Observational Study","s":"nyr","p":"na","d":[2],"c":[6],"a":"adult older","h":[7],"po":"2025-09-18","u":"2025-09-18","st":"2025-10","ag":"18–80"},{"n":"NCT07181239","t":"Study of CM336 in Relapsed or Refractory Multiple Myeloma Patients","s":"nyr","p":"phase3","d":[15],"c":[30],"a":"adult older","h":[69],"po":"2025-09-18","u":"2025-09-18","st":"2025-09","ag":"18 and over"},{"n":"NCT07182708","t":"High-Dose Firmonertinib Plus Bevacizumab as Neoadjuvant Therapy for Resectable EGFRm Stage II-IIIB NSCLC","s":"nyr","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"lung"]],"po":"2025-09-19","u":"2025-09-19","st":"2025-10","ag":"18 and over"},{"n":"NCT07183358","t":"Family-Supervised Prehabilitation to Reduce Postoperative Complications After Neoadjuvant Chemotherapy in Gastric Cancer","s":"nyr","p":"na","d":[3],"c":[26],"lc":[26],"a":"adult older","h":[55],"l":[[55,"gc"]],"po":"2025-09-19","u":"2025-09-19","st":"2025-09","ag":"18–80"},{"n":"NCT07183813","t":"Acupuncture for Anxiety/Depression in Patients With Breast Cancer","s":"nyr","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[280],"l":[[280,"breast"]],"po":"2025-09-19","u":"2025-09-24","st":"2025-09","ag":"18–70"},{"n":"NCT07185308","t":"Postbiotics Ameliorate Cachexia in Patients With Non-small-cell Lung Cancer","s":"nyr","p":"na","d":[4],"c":[1],"lc":[1],"a":"adult older","h":[17],"l":[[17,"lung"]],"po":"2025-09-22","u":"2025-09-25","st":"2025-11","ag":"18 and over"},{"n":"NCT07187284","t":"EDN Combined With TACE/HAIC and Second-Line Immune-Targeted Treatment Versus TACE/HAIC Alone in Locally Advanced HCC With Portal Vein Tumor Thrombosis After First-Line Therapy Failure: A Prospective, Multicenter, Randomized Controlled Trial","s":"nyr","p":"phase1phase2","d":[2],"c":[28],"lc":[28],"a":"adult older","h":[120],"l":[[120,"hcc"]],"po":"2025-09-22","u":"2025-09-22","st":"2025-09","ag":"18–75"},{"n":"NCT07187960","t":"Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma","s":"nyr","p":"phase3","d":[19],"c":[2,1,41,6,33,25,9,28,5,11,12,30,13,39,19,20],"a":"adult older","h":[123,25,74,78,58,69,37,79,162,111,28,143,116,137,141,152,7,19,84],"po":"2025-09-23","u":"2025-09-23","st":"2025-11","ag":"18–80"},{"n":"NCT07188116","t":"Correlation Between COVID-19 and Radiation Pneumonitis in Breast Cancer","s":"nyr","p":"na","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[391,274],"l":[[391,"breast"]],"po":"2025-09-23","u":"2025-09-23","st":"2025-09","ag":"18–80"},{"n":"NCT07192848","t":"Adebrelimab + Apatinib in Advanced HCC Post-Systemic Therapy","s":"nyr","p":"phase2","d":[2],"c":[21],"lc":[21],"a":"adult older","h":[106],"l":[[106,"hcc"]],"po":"2025-09-25","u":"2025-09-25","st":"2025-09","ag":"18 and over"},{"n":"NCT07198620","t":"A Real-World Study of IBI351 for KRAS G12C+ NSCLC in China","s":"nyr","p":"na","d":[4],"c":[0],"a":"child adult older","h":[43],"po":"2025-09-30","u":"2025-09-30","st":"2025-10","ag":"Not stated"},{"n":"NCT07199010","t":"Real-world Study of Taletrectinib in Advanced ROS1+ NSCLC Following Entrectinib Progression","s":"nyr","p":"na","d":[4],"c":[5],"a":"adult older","h":[65],"po":"2025-09-30","u":"2025-09-30","st":"2025-10","ag":"18 and over"},{"n":"NCT07200154","t":"Adebrelimab Plus Chemoradiotherapy Followed by Adebrelimab Maintenance in Limited-Stage SCLC","s":"nyr","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"lung"]],"po":"2025-09-30","u":"2025-09-30","st":"2025-09","ag":"18–75"},{"n":"NCT07200947","t":"A Phase II Study of QL1706 and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Non-Small Cell Lung Cancer.","s":"nyr","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2025-10-01","u":"2025-10-01","st":"2025-12","ag":"18 and over"},{"n":"NCT07206264","t":"Chemotherapy Combined With Targeted Therapy as First-line Treatment for Mantle Cell Lymphoma Based on MRD and PET-CT Assessment","s":"nyr","p":"phase2","d":[19],"c":[16,24,27,30],"lc":[30],"a":"adult older","h":[58,45,30,57],"l":[[58,"lymph"]],"po":"2025-10-03","u":"2025-10-03","st":"2025-10","ag":"60 and over"},{"n":"NCT07206563","t":"Penfluridol for Relapsed/Refractory Small Cell Cancers","s":"nyr","p":"phase1phase2","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lung"]],"po":"2025-10-03","u":"2025-10-03","st":"2025-10","ag":"18–75"},{"n":"NCT07231094","t":"A Clinical Study Evaluating the Safety, Tolerability, Preliminary Efficacy and Immunogenicity of a Tumor Vaccine Injection Targeting Stressinducible Proteins MICA/B in Combination With the AG Regimen in Patients With Metastatic Pancreatic Cancer","s":"nyr","p":"earlyphase1","d":[5],"c":[8],"lc":[8],"a":"adult older","h":[20],"l":[[20,"panc"]],"po":"2025-11-17","u":"2025-11-17","st":"2025-11","ag":"18 and over"},{"n":"NCT07231523","t":"EFG vs IVIG in TAMG","s":"nyr","p":"phase3","d":[27],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"mg"]],"po":"2025-11-17","u":"2025-11-17","st":"2025-12","ag":"18–75"},{"n":"NCT07233317","t":"Evaluating the Safety and Effectiveness of a Vascular Interventional Robotic System in Assisting With Percutaneous Coronary Intervention Procedures: A Prospective, Multicenter, Randomized Controlled Clinical Trial","s":"nyr","p":"na","d":[31],"c":[2],"a":"adult older","h":[213],"po":"2025-11-18","u":"2025-11-18","st":"2025-12","ag":"18–80"},{"n":"NCT07233850","t":"A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers","s":"nyr","p":"phase2","d":[3,5],"c":[13],"a":"adult older","h":[36],"po":"2025-11-18","u":"2025-11-18","st":"2025-11","ag":"18–75"},{"n":"NCT07234045","t":"A Clinical Study to Explore CT1195E in Patients With Relapsed/Refractory B-Cell Neoplasms","s":"nyr","p":"phase1","d":[16,19],"c":[30],"lc":[30],"a":"adult older","h":[69],"l":[[69,"ball"]],"po":"2025-11-18","u":"2025-11-18","st":"2025-11","ag":"18–75"},{"n":"NCT07237828","t":"Drain Removal on Postoperative Safety and Patient Satisfaction in R-E-NSM With Prepectoral DIBR","s":"nyr","p":"na","d":[6],"c":[22],"lc":[22],"a":"adult older","x":"female","h":[40],"l":[[40,"breast"]],"po":"2025-11-20","u":"2025-11-20","st":"2025-12","ag":"18–70"},{"n":"NCT07239986","t":"A Phase 2 Study of BB102 in Patients With Hepatocellular Carcinoma","s":"nyr","p":"phase2","d":[2],"c":[17,5],"a":"adult older","h":[6,68],"po":"2025-11-20","u":"2025-11-20","st":"2025-12","ag":"18 and over"},{"n":"NCT07242274","t":"Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSCLC","s":"nyr","p":"phase3","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2025-11-21","u":"2025-11-21","st":"2025-12","ag":"18 and over"},{"n":"NCT07244666","t":"Safety and Preliminary Efficacy of a Metabolically Armed Chimeric Antigen Receptor T Cell Therapy Targeting EGFRvIII for Recurrent Glioblastoma","s":"nyr","p":"earlyphase1","d":[7],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"glioma"]],"po":"2025-11-24","u":"2025-11-24","st":"2025-11","ag":"19–70"},{"n":"NCT07244926","t":"Sac-TMT Plus Bevacizumab as Second-Line Treatment for Advanced Non-Squamous Non-Small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2025-11-24","u":"2025-11-24","st":"2025-12","ag":"18 and over"},{"n":"NCT07246317","t":"Evaluation of Neoadjuvant Therapy With Trastuzumab, Pertuzumab, Docetaxel, and QL1706 in Early or Locally Advanced HER2+ Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[0,36,18,30],"lc":[30],"a":"adult older","x":"female","h":[58,24,43,49,87],"l":[[58,"breast"]],"po":"2025-11-24","u":"2025-11-28","st":"2025-12","ag":"18–70"},{"n":"NCT07254858","t":"Combined Chemo-immunotherapy Plus SBRT in Neoadjuvant Treatment for Luminal Subtype Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[37],"lc":[37],"a":"adult older","x":"female","h":[81],"l":[[81,"breast"]],"po":"2025-11-28","u":"2025-11-28","st":"2025-12","ag":"18–75"},{"n":"NCT07257003","t":"A Nationwide Multicenter, Single-arm, Retrospective Study of Delayed Endoscopic DTI-BR After Simple Mastectomy","s":"nyr","p":"na","d":[6],"c":[22],"lc":[22],"a":"adult older","x":"female","h":[40],"l":[[40,"breast"]],"po":"2025-12-02","u":"2025-12-02","st":"2025-12","ag":"18–70"},{"n":"NCT07257380","t":"Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)","s":"nyr","p":"phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"gc"]],"po":"2025-12-02","u":"2025-12-02","st":"2025-12","ag":"18–79"},{"n":"NCT07264881","t":"For Patients With Myocardial Infarction and Multiple Vessel: Testing if Ultrasound (UFR) Can Guide All Needed Treatment in One Procedure, Avoiding a Return Hospital Visit for a Second Operation.","s":"nyr","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[109],"l":[[109,"cad"]],"po":"2025-12-04","u":"2025-12-04","st":"2025-12","ag":"18 and over"},{"n":"NCT07264894","t":"ZSDT for the Treatment of R/R Mantle Cell Lymphoma After BTK Inhibitor Failure: a Multi-center Prospective Clinical Trial","s":"nyr","p":"phase4","d":[19],"c":[20],"lc":[20],"a":"adult older","h":[25],"l":[[25,"lymph"]],"po":"2025-12-04","u":"2025-12-04","st":"2025-12","ag":"18–70"},{"n":"NCT07266051","t":"Prospective Cohort Study of Neuromyelitis Optica Spectrum Disorders (NMOSD)","s":"nyr","p":"na","d":[25],"c":[5,7],"lc":[7],"a":"adult older","h":[314,8,6,243],"l":[[314,"nmosd"]],"po":"2025-12-05","u":"2025-12-18","st":"2025-12","ag":"18 and over"},{"n":"NCT07269691","t":"RaSOLVE: 125I Radioactive Seed Marking Effects on Pathological Complete Response Rate and Prognosis Post-Neoadjuvant Therapy in Early/Advanced Breast Cancer","s":"nyr","p":"phase3","d":[6],"c":[27],"lc":[27],"a":"adult older","x":"female","h":[57],"l":[[57,"breast"]],"po":"2025-12-08","u":"2025-12-08","st":"2025-12","ag":"18–70"},{"n":"NCT07273227","t":"A Multicenter Randomized Controlled Trial of Echocardiography-Guided Atrial Septal Defect Closure Performed in a Mobile Surgical Unit","s":"nyr","p":"phase4","d":[32],"c":[2],"a":"child adult older","h":[213],"po":"2025-12-09","u":"2025-12-09","st":"2025-12","ag":"8 and over"},{"n":"NCT07276854","t":"Novel Humanized Ferritin-based NIR Fluorescent Molecular Probe for Identifying Tumor Margins in Gastric Tissue","s":"nyr","p":"na","d":[3],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"gc"]],"po":"2025-12-11","u":"2025-12-11","st":"2025-12","ag":"18 and over"},{"n":"NCT07277088","t":"The Percutaneous Interventional Surgery Control System for Pulmonary Nodule Biopsy","s":"nyr","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2025-12-11","u":"2025-12-11","st":"2025-12","ag":"18–80"},{"n":"NCT07277452","t":"Nimotuzumab Combined With Nab-paclitaxel/Gemcitabine in the Perioperative Treatment of High-risk Resectable/Borderline Resectable Pancreatic Cancer","s":"nyr","p":"phase2","d":[5],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"panc"]],"po":"2025-12-11","u":"2025-12-11","st":"2025-12","ag":"18–75"},{"n":"NCT07286942","t":"Stereotactic Body Radiotherapy With Sequential Iparomlimab and Tuvonralimab (QL1706) + Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Non-small-cell Lung Cancer in China (LUNG-Nanjing01): a Single-arm, Single-centre, Phase 2 Trial","s":"nyr","p":"phase2","d":[4],"c":[28],"lc":[28],"a":"adult older","h":[127],"l":[[127,"lung"]],"po":"2025-12-16","u":"2025-12-16","st":"2025-12","ag":"18–75"},{"n":"NCT07287904","t":"Prediction of Targeted Therapy Efficacy in EGFR-mutant Lung Cancer Patients Using AI-based Multimodal Data","s":"nyr","p":"na","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lung"]],"po":"2025-12-17","u":"2025-12-17","st":"2025-12","ag":"18–80"},{"n":"NCT07292896","t":"A Multicenter Study on the Normal Reference Range and Clinical Significance of the Right Atrioventricular Coupling Index Assessed by Artificial Intelligence-Based Three-Dimensional Echocardiography","s":"nyr","p":"na","d":[32],"c":[2,15,22,26,5,11,21,12,13,39,20],"lc":[11],"a":"adult older","h":[118,40,12,6,92,111,55,168,42,89,396,156],"l":[[118,"chd"]],"po":"2025-12-18","u":"2025-12-18","st":"2025-12","ag":"18–79"},{"n":"NCT07298590","t":"An Exploratory Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-NK in the Treatment of Relapsed and Refractory IgG4-related Disease","s":"nyr","p":"earlyphase1","d":[26],"c":[5],"lc":[5],"a":"adult older","h":[177],"l":[[177,"igg4"]],"po":"2025-12-23","u":"2025-12-23","st":"2025-12","ag":"18–70"},{"n":"NCT07301138","t":"BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients","s":"nyr","p":"phase2","d":[16],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"ball"]],"po":"2025-12-24","u":"2026-11-17","st":"2025-12","ag":"18–75"},{"n":"NCT07304258","t":"A Prospective, Phase II Clinical Study of HIPEC Combined With NIPS and Tislelizumab Conversion Therapy for Gastric Cancer With Peritoneal Metastasis With Positive Cytology Alone or PCI Score ≤10","s":"nyr","p":"phase2","d":[3],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"gc"]],"po":"2025-12-26","u":"2025-12-26","st":"2025-12","ag":"18–75"},{"n":"NCT07309926","t":"Gait and Paraspinal sEMG in Degenerative Spinal Diseases","s":"nyr","p":"na","d":[33],"c":[2],"lc":[2],"a":"adult older","h":[71],"l":[[71,"scol"]],"po":"2025-12-30","u":"2025-12-30","st":"2025-12","ag":"60 and over"},{"n":"NCT07315399","t":"The Correlation Between Obstructive Sleep Apnea-Related Nocturnal Hypoxemia Parameters and Coronary Microvascular Dysfunction: A Prospective Cohort Study (SLEEP-CMD)","s":"nyr","p":"na","d":[31],"c":[2],"lc":[2],"a":"adult older","h":[109],"l":[[109,"cad"]],"po":"2026-01-02","u":"2026-01-02","st":"2025-12","ag":"18–80"},{"n":"NCT07316907","t":"A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies","s":"nyr","p":"phase1","d":[19],"c":[49],"lc":[49],"a":"adult older","h":[285],"l":[[285,"lymph"]],"po":"2026-01-05","u":"2026-01-05","st":"2025-12","ag":"18–70"},{"n":"NCT07316920","t":"A Clinical Study of of RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas","s":"nyr","p":"phase1","d":[19],"c":[49],"lc":[49],"a":"adult older","h":[285],"l":[[285,"lymph"]],"po":"2026-01-05","u":"2026-01-06","st":"2025-12","ag":"18–75"},{"n":"NCT07320326","t":"ASPIRE: A Registry Study Of Chinese Patients With TCE-RRMM Treated By Elranatamab","s":"nyr","p":"na","d":[15],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"mm"]],"po":"2026-01-06","u":"2026-01-06","st":"2025-12","ag":"18 and over"},{"n":"NCT07345741","t":"Clinical Study on the Safety and Efficacy of CD20/CD19 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin Lymphoma","s":"nyr","p":"na","d":[19],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"lymph"]],"po":"2026-01-16","u":"2026-01-16","st":"2025-12","ag":"18–78"},{"n":"NCT07350070","t":"TACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for Unresectable HCC With Cirrhotic Portal Hypertension","s":"nyr","p":"phase2","d":[2],"c":[16,27,10,26,13],"lc":[13],"a":"adult older","h":[36,15,124,55,30],"l":[[36,"hcc"]],"po":"2026-01-20","u":"2026-01-20","st":"2025-12","ag":"18–75"},{"n":"NCT07350824","t":"Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC","s":"nyr","p":"na","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2026-01-20","u":"2026-01-20","st":"2025-12","ag":"18–75"},{"n":"NCT07352007","t":"Sintilimab Combined With Stereotactic Body Radiotherapy as Neoadjuvant Therapy for Resectable Hepatocellular","s":"nyr","p":"phase2","d":[2],"c":[27],"lc":[27],"a":"adult older","h":[57],"l":[[57,"hcc"]],"po":"2026-01-20","u":"2026-01-20","st":"2025-12","ag":"18–75"},{"n":"NCT07354828","t":"Optimization and Validation of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet Therapy","s":"nyr","p":"na","d":[31],"c":[11],"lc":[11],"a":"adult older","h":[128],"l":[[128,"cad"]],"po":"2026-01-21","u":"2026-01-21","st":"2025-12","ag":"18 and over"},{"n":"NCT05498766","t":"Effect and Safety of Huaier Granule Versus SOX Regimen in Gastric Cancer Patients","s":"nyr","p":"phase4","d":[3],"c":[26,13],"lc":[13],"a":"adult older","h":[12,55],"l":[[12,"gc"]],"po":"2022-08-12","u":"2024-06-24","st":"2024-07","ag":"18–75"},{"n":"NCT06012214","t":"RAE Versus MIE in Patients With Esophageal Cancer After Neoadjuvant Therapy","s":"nyr","p":"na","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"escc"]],"po":"2023-08-25","u":"2023-08-25","st":"2024-01","ag":"18–75"},{"n":"NCT06089369","t":"Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion","s":"nyr","p":"phase3","d":[2],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"hcc"]],"po":"2023-10-18","u":"2024-04-30","st":"2024-06","ag":"18–75"},{"n":"NCT06095167","t":"Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC","s":"nyr","p":"phase3","d":[0],"c":[16],"lc":[16],"a":"adult older","h":[30],"l":[[30,"npc"]],"po":"2023-10-23","u":"2023-10-23","st":"2024-01","ag":"18–70"},{"n":"NCT06156267","t":"Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino","s":"nyr","p":"earlyphase1","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"panc"]],"po":"2023-12-05","u":"2023-12-05","st":"2024-01","ag":"18–75"},{"n":"NCT06166589","t":"Second-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic Cancer","s":"nyr","p":"phase2","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"panc"]],"po":"2023-12-12","u":"2023-12-12","st":"2024-01","ag":"18 and over"},{"n":"NCT06196775","t":"A Study of Cadonilimab Combined With AK112 as Second-line Therapy in Patients With Advanced Hepatocellular Carcinoma","s":"nyr","p":"phase2","d":[2],"c":[24],"lc":[24],"a":"adult older","h":[333],"l":[[333,"hcc"]],"po":"2024-01-09","u":"2024-01-09","st":"2024-01","ag":"18–75"},{"n":"NCT06202313","t":"Study of Cadonilimab (AK104) Plus Eribulin vs. Eribulin Monotherapy for Recurrent or Metastatic Triple-negative Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[11],"lc":[11],"a":"adult older","x":"female","h":[143],"l":[[143,"breast"]],"po":"2024-01-11","u":"2024-01-11","st":"2024-02","ag":"18–75"},{"n":"NCT06217042","t":"HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer","s":"nyr","p":"phase3","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"panc"]],"po":"2024-01-22","u":"2024-01-22","st":"2024-02","ag":"18–75"},{"n":"NCT06234072","t":"Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients","s":"nyr","p":"phase2","d":[5],"c":[21],"lc":[21],"a":"adult older","h":[326],"l":[[326,"panc"]],"po":"2024-01-31","u":"2024-02-02","st":"2024-02","ag":"18 and over"},{"n":"NCT06234150","t":"Aerobic Dance During Chemotherapy in Breast Cancer Patients With Cognitive Impairment","s":"nyr","p":"na","d":[6],"c":[28],"lc":[28],"a":"adult older","x":"female","h":[78],"l":[[78,"breast"]],"po":"2024-01-31","u":"2024-02-20","st":"2024-04","ag":"18–65"},{"n":"NCT06236997","t":"Adebrelimab and Concurrent Radiochemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[13,20],"lc":[20],"a":"adult older","h":[37,36],"l":[[37,"lung"]],"po":"2024-02-01","u":"2024-02-01","st":"2024-02","ag":"18–75"},{"n":"NCT06241469","t":"Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction，a Phase II Clinical Study","s":"nyr","p":"phase2","d":[3],"c":[49],"lc":[49],"a":"adult older","h":[145],"l":[[145,"gc"]],"po":"2024-02-05","u":"2024-02-05","st":"2024-02","ag":"18–80"},{"n":"NCT06245824","t":"Trastuzumab Deruxtecan (T-DXd) With Pyrotinib in First-line HER2-positive Unresectable or Metastatic Breast Cancer Trial","s":"nyr","p":"phase4","d":[6],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"breast"]],"po":"2024-02-07","u":"2024-02-07","st":"2024-01","ag":"18 and over"},{"n":"NCT06254599","t":"A Study Of SY-3505 Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC","s":"nyr","p":"phase3","d":[4],"c":[2],"a":"adult older","h":[23],"po":"2024-02-12","u":"2024-02-12","st":"2024-05","ag":"18 and over"},{"n":"NCT06255704","t":"A Single-arm, Single-center, Open-label Phase II Study of Zanubrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle CellLymphoma Patients","s":"nyr","p":"phase2","d":[19],"c":[12],"lc":[12],"a":"adult older","h":[84],"l":[[84,"lymph"]],"po":"2024-02-13","u":"2024-02-13","st":"2024-03","ag":"18–70"},{"n":"NCT06255795","t":"The Efficacy and Safety of Chidamide, Anti-PD-1 Antibody in Combination With Pegaspargase Versus DDGP in the Treatment of Newly Diagnosed, Stage III to IV Extranodal Natural Killer/T-Cell Lymphoma","s":"nyr","p":"phase3","d":[19],"c":[5],"lc":[5],"a":"child adult older","h":[123],"l":[[123,"lymph"]],"po":"2024-02-13","u":"2024-02-13","st":"2024-02","ag":"14–70"},{"n":"NCT06289959","t":"Plasma cfDNA Testing Guiding the Treatment Decisions of DLBCL","s":"nyr","p":"na","d":[19],"c":[4],"lc":[4],"a":"adult older","h":[187],"l":[[187,"lymph"]],"po":"2024-03-04","u":"2024-03-04","st":"2024-02","ag":"18 and over"},{"n":"NCT06297811","t":"Myeloprotection With Trilaciclib in Pan-cancer Population","s":"nyr","p":"phase2","d":[4,6],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"lung"]],"po":"2024-03-07","u":"2024-03-07","st":"2024-03","ag":"18 and over"},{"n":"NCT06298266","t":"To Assess Safety, Tolerability, and Efficacy of Anti-GPRC5D-CD19-CAR-T in Relapsed/Refractory Multiple Myeloma","s":"nyr","p":"earlyphase1","d":[15],"c":[0],"lc":[0],"a":"adult older","h":[368],"l":[[368,"mm"]],"po":"2024-03-07","u":"2024-03-07","st":"2024-03","ag":"18–75"},{"n":"NCT06310473","t":"Neoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial","s":"nyr","p":"phase2","d":[3],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"gc"]],"po":"2024-03-15","u":"2024-03-15","st":"2024-03","ag":"18–75"},{"n":"NCT06317896","t":"Value of Dynamic Monitoring of Early Recurrence of Hepatocellular Carcinoma After Radical Resection Based on CTCS","s":"nyr","p":"na","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[0,95],"l":[[0,"hcc"]],"po":"2024-03-19","u":"2024-03-19","st":"2024-04","ag":"18–75"},{"n":"NCT06318884","t":"A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma","s":"nyr","p":"phase1","d":[19],"c":[2,30,20],"a":"adult older","h":[74,58,37],"po":"2024-03-19","u":"2024-03-22","st":"2024-04","ag":"18 and over"},{"n":"NCT06324994","t":"Linperlisib Plus Obinutuzumab and Venetoclax for Relapsed and Refractory Blastoid Variant of Mantle Cell Lymphoma.","s":"nyr","p":"phase2","d":[19],"c":[52],"a":"adult older","h":[155],"po":"2024-03-22","u":"2024-03-22","st":"2024-05","ag":"18 and over"},{"n":"NCT06332950","t":"Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy","s":"nyr","p":"phase1phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2024-03-27","u":"2024-03-27","st":"2024-04","ag":"18–75"},{"n":"NCT06346808","t":"Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC","s":"nyr","p":"phase1","d":[5],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"panc"]],"po":"2024-04-04","u":"2024-04-04","st":"2024-05","ag":"18–75"},{"n":"NCT06354114","t":"A Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011","s":"nyr","p":"phase2","d":[6],"c":[24],"a":"adult older","h":[45],"po":"2024-04-09","u":"2024-04-09","st":"2024-04","ag":"18 and over"},{"n":"NCT06361030","t":"Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer","s":"nyr","p":"phase2","d":[5],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"panc"]],"po":"2024-04-11","u":"2024-04-11","st":"2024-06","ag":"18–75"},{"n":"NCT06368167","t":"A Phase II Study of SHR2554 in Patients With Relapsed or Refractory Follicular Lymphoma","s":"nyr","p":"phase2","d":[19],"c":[2],"a":"adult older","h":[74],"po":"2024-04-16","u":"2024-04-16","st":"2024-04","ag":"18 and over"},{"n":"NCT06368934","t":"Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma","s":"nyr","p":"na","d":[7],"c":[5],"lc":[5],"a":"adult older","h":[103,397],"l":[[103,"glioma"]],"po":"2024-04-16","u":"2024-04-16","st":"2024-04","ag":"18–80"},{"n":"NCT06369935","t":"A Real World Study of Equecabtagene Autoleucel in Subjects With Relapsed and Refractory Multiple Myeloma.","s":"nyr","p":"na","d":[15],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"mm"]],"po":"2024-04-17","u":"2024-04-17","st":"2024-06","ag":"18 and over"},{"n":"NCT06370026","t":"KSD-101 Therapy for Standard Treatment Failed EBV-associated NPC: an Exploratory Clinical Trial","s":"nyr","p":"earlyphase1","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2024-04-17","u":"2024-05-02","st":"2024-05","ag":"18–70"},{"n":"NCT06370754","t":"Newly Emerging Immunotherapy for Pancreatic Cancer Treatment","s":"nyr","p":"phase1phase2","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"panc"]],"po":"2024-04-17","u":"2024-04-17","st":"2024-04","ag":"18–75"},{"n":"NCT06374901","t":"Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment.","s":"nyr","p":"phase2","d":[3],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"gc"]],"po":"2024-04-19","u":"2024-04-19","st":"2024-04","ag":"18–75"},{"n":"NCT06396481","t":"Clinical Study of Allogeneic Vγ9Vδ2 T Cells in the Treatment of Brain Malignant Glioma","s":"nyr","p":"earlyphase1","d":[7],"c":[2],"lc":[2],"a":"child adult older","h":[102],"l":[[102,"glioma"]],"po":"2024-05-02","u":"2024-05-02","st":"2024-04","ag":"4 and over"},{"n":"NCT06409429","t":"Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer","s":"nyr","p":"phase2phase3","d":[5],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"panc"]],"po":"2024-05-10","u":"2024-05-10","st":"2024-05","ag":"18–75"},{"n":"NCT06416852","t":"Clinical Study of 18F-Alfatide Injection PET/CT","s":"nyr","p":"phase3","d":[4],"c":[13],"a":"adult older","h":[12],"po":"2024-05-16","u":"2024-05-16","st":"2024-08","ag":"18 and over"},{"n":"NCT06421220","t":"Evaluation of the Efficacy and Safety of Indocyanine Green Tracing in 3D Fluorescent Laparoscopic Lymph Node Dissection for Gastric Cancer","s":"nyr","p":"na","d":[3],"c":[27],"lc":[27],"a":"adult older","h":[124],"l":[[124,"gc"]],"po":"2024-05-20","u":"2024-05-20","st":"2024-05","ag":"18–75"},{"n":"NCT06422637","t":"A Prospective Interventional Study on Early Screening for Lung Cancer Using Liquid Biopsy","s":"nyr","p":"na","d":[4],"c":[0],"lc":[0],"a":"adult older","h":[132],"l":[[132,"lung"]],"po":"2024-05-21","u":"2024-05-21","st":"2024-06","ag":"40–75"},{"n":"NCT06435104","t":"Aromatherapy in the Treatment of Early Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2024-05-30","u":"2024-07-09","st":"2024-07","ag":"18–80"},{"n":"NCT06449846","t":"Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular Carcinoma","s":"nyr","p":"na","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[0,53],"l":[[0,"hcc"]],"po":"2024-06-10","u":"2024-06-10","st":"2024-06","ag":"18–75"},{"n":"NCT06453889","t":"Efficacy and Safety of Multimode Thermal Therapy in the Treatment of Early Peripheral Lung Cancer","s":"nyr","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2024-06-12","u":"2024-06-12","st":"2024-06","ag":"18 and over"},{"n":"NCT06454435","t":"Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric Cancer","s":"nyr","p":"phase2","d":[3],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"gc"]],"po":"2024-06-12","u":"2024-06-12","st":"2024-06","ag":"18–70"},{"n":"NCT06456138","t":"Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC","s":"nyr","p":"phase1phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2024-06-13","u":"2024-06-13","st":"2024-07","ag":"18–75"},{"n":"NCT06470165","t":"Priority-Matching Correction Technique in Degenerative Lumbar Scoliosis","s":"nyr","p":"na","d":[33],"c":[2],"lc":[2],"a":"adult older","h":[71],"l":[[71,"scol"]],"po":"2024-06-24","u":"2024-06-24","st":"2024-08","ag":"50 and over"},{"n":"NCT06472479","t":"LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma","s":"nyr","p":"na","d":[15],"c":[17,28,20],"lc":[28],"a":"adult older","h":[78,37,88],"l":[[78,"mm"]],"po":"2024-06-25","u":"2024-06-28","st":"2024-07","ag":"18 and over"},{"n":"NCT06475066","t":"Clinical Effectiveness of CEM in Diagnosis of Additional Findings at Preoperative Breast Magnetic Resonance Imaging","s":"nyr","p":"na","d":[6],"c":[13],"lc":[13],"a":"adult older","x":"female","h":[12],"l":[[12,"breast"]],"po":"2024-06-26","u":"2024-06-26","st":"2024-07","ag":"18–75"},{"n":"NCT06475755","t":"Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC","s":"nyr","p":"phase2","d":[4],"c":[39],"lc":[39],"a":"adult older","h":[122],"l":[[122,"lung"]],"po":"2024-06-26","u":"2024-06-26","st":"2024-06","ag":"18–75"},{"n":"NCT06487702","t":"A Phase lb/lI Clinical Study in Advanced or Metastatic Esophageal Squamous Cell Carcinoma","s":"nyr","p":"phase2","d":[1],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"escc"]],"po":"2024-07-05","u":"2024-07-05","st":"2024-07","ag":"18–75"},{"n":"NCT06492317","t":"RC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric Cancer","s":"nyr","p":"phase2","d":[3],"c":[20],"lc":[20],"a":"adult older","h":[25],"l":[[25,"gc"]],"po":"2024-07-09","u":"2024-07-09","st":"2024-07","ag":"18 and over"},{"n":"NCT06493448","t":"Prospective Observational Cohort Study","s":"nyr","p":"na","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"gc"]],"po":"2024-07-10","u":"2024-07-10","st":"2024-07","ag":"18 and over"},{"n":"NCT06495749","t":"Early Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures","s":"nyr","p":"na","d":[5],"c":[23],"lc":[23],"a":"child adult older","h":[46],"l":[[46,"panc"]],"po":"2024-07-11","u":"2024-07-16","st":"2024-08","ag":"Not stated"},{"n":"NCT06496165","t":"Remimazolam Besylate and Propofol Sedation on Hemodynamic for Coronary Artery Bypass Graft Patients","s":"nyr","p":"na","d":[31],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"cad"]],"po":"2024-07-11","u":"2024-07-11","st":"2024-07","ag":"60 and over"},{"n":"NCT06496919","t":"A Real-world Research on the Prevention and Treatment of Peritoneal Metastasis and Malignant Ascites by Intraperitoneal Infusion of rmhTNF in Gastric and Colorectal Malignant Tumors","s":"nyr","p":"na","d":[3],"c":[13],"lc":[13],"a":"adult older","h":[133],"l":[[133,"gc"]],"po":"2024-07-11","u":"2024-07-11","st":"2024-08","ag":"18–80"},{"n":"NCT06499610","t":"Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric Cancer","s":"nyr","p":"phase4","d":[3],"c":[39],"lc":[39],"a":"adult older","h":[111],"l":[[111,"gc"]],"po":"2024-07-12","u":"2024-07-12","st":"2024-07","ag":"18 and over"},{"n":"NCT06500507","t":"A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma","s":"nyr","p":"phase1","d":[15],"c":[30],"a":"adult older","h":[69],"po":"2024-07-15","u":"2024-07-15","st":"2024-08","ag":"18 and over"},{"n":"NCT06506227","t":"Research on Key Technologies for Risk Prediction and Precise Diagnosis and Treatment of AIS Based on Epigene-phenotype","s":"nyr","p":"na","d":[33],"c":[23],"lc":[23],"a":"child adult","h":[275],"l":[[275,"scol"]],"po":"2024-07-17","u":"2024-07-17","st":"2024-09","ag":"10–18"},{"n":"NCT06510465","t":"Neoadjuvant Therapy With Weekly Utidelone Combined With Cisplatin for Patients With Breast Cancer (NeoURANIA)","s":"nyr","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"breast"]],"po":"2024-07-19","u":"2024-07-19","st":"2024-08","ag":"18 and over"},{"n":"NCT06524518","t":"A Multicenter Randomized Controlled Study of Interventional Treatment for Operable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer With Potential Recurrence as Minimal Residual Disease(MRD) Positive","s":"nyr","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[71],"l":[[71,"lung"]],"po":"2024-07-29","u":"2024-08-06","st":"2024-08","ag":"18–80"},{"n":"NCT06528223","t":"Research of the Application of Artificial Intelligence Model \"PANDA\"","s":"nyr","p":"na","d":[5],"c":[23],"lc":[23],"a":"child adult older","h":[46],"l":[[46,"panc"]],"po":"2024-07-30","u":"2024-07-30","st":"2024-08","ag":"Not stated"},{"n":"NCT06531291","t":"Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine Differentiation","s":"nyr","p":"phase2","d":[3,5],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"gc"]],"po":"2024-07-31","u":"2024-07-31","st":"2024-08","ag":"18–75"},{"n":"NCT06548178","t":"T-DXd Versus THP for Medium-risk HER2-positive Early Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2024-08-12","u":"2024-08-12","st":"2024-09","ag":"18 and over"},{"n":"NCT06549335","t":"Zanubrutinib, Obinutuzumab and Lenalidomide (ZGR) in High-risk Treatment-naive Patients with Follicular Lymphoma (FL)","s":"nyr","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2024-08-12","u":"2024-10-15","st":"2024-12","ag":"18 and over"},{"n":"NCT06559644","t":"Hema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute Leukemia","s":"nyr","p":"earlyphase1","d":[16],"c":[4],"lc":[4],"a":"adult older","h":[5],"l":[[5,"ball"]],"po":"2024-08-19","u":"2024-08-19","st":"2024-09","ag":"18–70"},{"n":"NCT06561646","t":"To Evaluate the Effectiveness and Safety of the Single-port Robotic-assisted Breast Surgery in Breast Cancer","s":"nyr","p":"na","d":[6],"c":[28],"lc":[28],"a":"adult older","x":"female","h":[78],"l":[[78,"breast"]],"po":"2024-08-20","u":"2024-08-20","st":"2024-08","ag":"18–75"},{"n":"NCT06563778","t":"Chidamide+Decitabine Plus Anti-PD-1 Antibody for Patients With R/R cHL Who Are Transplant-ineligible or Refused Transplant.","s":"nyr","p":"phase2","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"lymph"]],"po":"2024-08-21","u":"2024-08-21","st":"2024-09","ag":"18–75"},{"n":"NCT06567080","t":"JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases","s":"nyr","p":"phase1","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"lymph"]],"po":"2024-08-22","u":"2024-08-22","st":"2024-09","ag":"18–70"},{"n":"NCT06567366","t":"CAR T-cell Therapy in Combination With Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma With High-Risk Prognostic Factors","s":"nyr","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2024-08-22","u":"2024-08-22","st":"2024-09","ag":"18 and over"},{"n":"NCT06580665","t":"Cryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung Cancer","s":"nyr","p":"na","d":[4],"c":[9,5,37,13],"lc":[5],"a":"adult older","h":[42,36,14,81],"l":[[42,"lung"]],"po":"2024-08-30","u":"2024-08-30","st":"2024-09","ag":"18 and over"},{"n":"NCT06585059","t":"Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung Cancers","s":"nyr","p":"phase1","d":[4],"c":[0],"a":"adult older","h":[53],"po":"2024-09-05","u":"2024-09-05","st":"2024-09","ag":"18–75"},{"n":"NCT06585644","t":"A Clinical Trial of Furmonertinib Combination Therapy As Neoadjuvant Treatment in Resectable EGFR-Mutated NSCLC","s":"nyr","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2024-09-05","u":"2024-09-05","st":"2024-10","ag":"18 and over"},{"n":"NCT06594211","t":"Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cells (ACT-001) in Patients With Relapsed or Refractorymultiple Myeloma","s":"nyr","p":"na","d":[15],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"mm"]],"po":"2024-09-19","u":"2024-09-19","st":"2024-10","ag":"18–75"},{"n":"NCT06594432","t":"Molecular Subtype-Guided R-CHOP-MTX±Zanubrutinib Treatment in Newly Diagnosed DLBCL Patients with Central Nervous System Involvement","s":"nyr","p":"phase2","d":[19],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"lymph"]],"po":"2024-09-19","u":"2024-09-19","st":"2024-10","ag":"18–80"},{"n":"NCT06594874","t":"A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Participants with KRAS G12C Mutation Advanced Solid Tumors","s":"nyr","p":"phase1","d":[4],"c":[13],"a":"adult older","h":[12],"po":"2024-09-19","u":"2024-09-19","st":"2024-10","ag":"18 and over"},{"n":"NCT06604351","t":"Bronchoscopic Cryoablation Combined With Chemo-Immunotherapy in NSCLC With Central Airway Obstruction","s":"nyr","p":"phase2","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2024-09-19","u":"2024-09-19","st":"2024-09","ag":"18–80"},{"n":"NCT06614751","t":"A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway","s":"nyr","p":"phase1","d":[3,5,6],"c":[2],"a":"adult older","h":[74,23],"po":"2024-09-26","u":"2024-09-27","st":"2024-11","ag":"18 and over"},{"n":"NCT06619886","t":"TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor","s":"nyr","p":"earlyphase1","d":[4,5],"c":[5],"lc":[5],"a":"adult older","h":[121],"l":[[121,"lung"]],"po":"2024-10-01","u":"2024-10-01","st":"2024-09","ag":"18–75"},{"n":"NCT06620822","t":"Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical Trial","s":"nyr","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2024-10-01","u":"2024-10-01","st":"2024-09","ag":"18 and over"},{"n":"NCT06621095","t":"Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)","s":"nyr","p":"phase2","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[41],"l":[[41,"panc"]],"po":"2024-10-01","u":"2024-10-01","st":"2024-10","ag":"18–75"},{"n":"NCT06634667","t":"Third-generation EGFR-TKI Plus Anlotinib as Maintenance for NSCLC With Small Cell Transformation After EGFR-TKI Resistance","s":"nyr","p":"phase2","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[13],"l":[[13,"lung"]],"po":"2024-10-10","u":"2024-10-10","st":"2024-11","ag":"18 and over"},{"n":"NCT06641024","t":"Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL","s":"nyr","p":"phase1","d":[16],"c":[5],"a":"adult older","h":[123],"po":"2024-10-15","u":"2024-10-15","st":"2024-11","ag":"18 and over"},{"n":"NCT06641453","t":"CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma","s":"nyr","p":"phase1phase2","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"hcc"]],"po":"2024-10-15","u":"2024-10-16","st":"2024-11","ag":"18–70"},{"n":"NCT06646666","t":"ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT","s":"nyr","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2024-10-17","u":"2024-11-01","st":"2024-12","ag":"18 and over"},{"n":"NCT06647329","t":"CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors","s":"nyr","p":"phase1","d":[19],"c":[20],"lc":[20],"a":"child adult older","h":[25],"l":[[25,"lymph"]],"po":"2024-10-17","u":"2024-10-17","st":"2024-12","ag":"14–75"},{"n":"NCT06656234","t":"The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter Study","s":"nyr","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2024-10-24","u":"2024-10-24","st":"2024-10","ag":"18 and over"},{"n":"NCT06666166","t":"SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer","s":"nyr","p":"phase2","d":[3],"c":[11],"lc":[11],"a":"adult older","h":[118],"l":[[118,"gc"]],"po":"2024-10-30","u":"2024-10-30","st":"2024-12","ag":"18–75"},{"n":"NCT06671249","t":"Comparing the Safety and Cosmetic Outcomes Between Laparoscopic Versus Traditional Open Breast-conserving Surgery","s":"nyr","p":"na","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2024-11-04","u":"2024-11-04","st":"2024-10","ag":"18 and over"},{"n":"NCT06671717","t":"Pralatrexate Combined With Chidamide Bridging Allogeneic HSCT for Refractory/Relapsed Peripheral T-cell Lymphoma","s":"nyr","p":"na","d":[19],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"lymph"]],"po":"2024-11-04","u":"2024-11-06","st":"2024-12","ag":"18–65"},{"n":"NCT06680115","t":"Neoadjuvant and Adjuvant Sintilimab Combined with Chemoradiotherapy Versus Chemoradiotherapy Alone in Stage TanyN3M0 Nasopharyngeal Carcinoma","s":"nyr","p":"phase2","d":[0],"c":[10],"lc":[10],"a":"adult older","h":[15],"l":[[15,"npc"]],"po":"2024-11-08","u":"2024-11-08","st":"2024-11","ag":"18 and over"},{"n":"NCT06681285","t":"Cadonilimab Combined With Anlotinib Followed by Radiotherapy in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma (CAR-RMEC)","s":"nyr","p":"phase2","d":[1],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"escc"]],"po":"2024-11-08","u":"2024-11-08","st":"2024-11","ag":"18 and over"},{"n":"NCT06690671","t":"A Single-Arm, Phase Ⅰb Study of Golidocitinib Combined With Anti-PD-1 for the Treatment of Previously Treated NSCLC","s":"nyr","p":"phase1phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"lung"]],"po":"2024-11-15","u":"2024-11-15","st":"2024-12","ag":"18 and over"},{"n":"NCT06704620","t":"Study of Tislelizumab and Platinum-based Chemotherapy Combination With H1 Receptor Antagonist（Diphenhydramine）in Advanced and Metastatic Non-Small Cell Lung Cancer","s":"nyr","p":"phase3","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2024-11-26","u":"2024-12-16","st":"2024-12","ag":"18–75"},{"n":"NCT06709274","t":"Minimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLC","s":"nyr","p":"na","d":[4],"c":[8,22,63,0,28,40,21,13],"a":"adult older","h":[11,110,36,127,13,0,98,168,126,198],"po":"2024-11-29","u":"2024-11-29","st":"2024-11","ag":"18–75"},{"n":"NCT06724263","t":"A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors","s":"nyr","p":"phase2","d":[2,4,6],"c":[5],"a":"adult older","h":[65],"po":"2024-12-09","u":"2024-12-09","st":"2024-12","ag":"18 and over"},{"n":"NCT06731153","t":"JAK1 Inhibitor Ivarmacitinib Reversing Immunotherapy Resistance in TNBC","s":"nyr","p":"phase2","d":[6],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"breast"]],"po":"2024-12-12","u":"2024-12-12","st":"2024-12","ag":"18–70"},{"n":"NCT06748508","t":"Comparing the Efficacy of Sintilimab Plus Nab-POF Regimen, Sintilimab Plus XELOX Chemotherapy, and Lenvatinib, Sintilimab Plus XELOX Chemotherapy in the Treatment of HER2-negative, Metastatic Gastric Cancer","s":"nyr","p":"phase2","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"gc"]],"po":"2024-12-27","u":"2024-12-27","st":"2024-12","ag":"18 and over"},{"n":"NCT06750848","t":"Chidamide Combined With Angiogenesis Inhibitors and Fulvestrant for Advanced HR-positive, HER2-negative Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[43],"lc":[43],"a":"adult older","h":[125],"l":[[125,"breast"]],"po":"2024-12-27","u":"2024-12-27","st":"2024-12","ag":"18–75"},{"n":"NCT06752382","t":"Sintilimab Combined With Bevacizumab and TP Chemotherapy in the Treatment of High Risk Locally-advanced NPC","s":"nyr","p":"phase2","d":[0],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"npc"]],"po":"2024-12-30","u":"2024-12-30","st":"2024-12","ag":"18–75"},{"n":"NCT06752408","t":"Aumolertinib Versus Osimertinib As First-line Therapy for Patients with EGFR Mutated Locally Advanced or Metastatic Non-small-cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"lung"]],"po":"2024-12-30","u":"2024-12-30","st":"2024-12","ag":"18–75"},{"n":"NCT06756841","t":"Safety and Efficacy Study of Pulsed Electric Field (PEF) Therapy in Patients With Advanced or Unresectable Esophageal Squamous Cell Carcinoma","s":"nyr","p":"na","d":[1],"c":[5],"a":"adult older","h":[42],"po":"2025-01-03","u":"2025-01-03","st":"2024-12","ag":"20 and over"},{"n":"NCT06769919","t":"A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for Early-stage Breast Cancer","s":"nyr","p":"phase2phase3","d":[6],"c":[39],"lc":[39],"a":"adult older","x":"female","h":[131],"l":[[131,"breast"]],"po":"2025-01-10","u":"2025-01-10","st":"2024-12","ag":"18–65"},{"n":"NCT05496166","t":"The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer","s":"nyr","p":"phase3","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2022-08-11","u":"2023-05-17","st":"2023-08","ag":"18–70"},{"n":"NCT05540275","t":"Tislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent Glioblastoma","s":"nyr","p":"phase2","d":[7],"c":[20],"lc":[20],"a":"adult older","h":[92],"l":[[92,"glioma"]],"po":"2022-09-14","u":"2023-10-06","st":"2023-10","ag":"18 and over"},{"n":"NCT05602974","t":"Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study","s":"nyr","p":"na","d":[2],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"hcc"]],"po":"2022-11-02","u":"2023-02-17","st":"2023-03","ag":"18–75"},{"n":"NCT05681403","t":"Clinical Study of Improved BEAM Conditioning Regimen for ASCT in Lymphoma","s":"nyr","p":"na","d":[19],"c":[39],"lc":[39],"a":"adult","h":[111],"l":[[111,"lymph"]],"po":"2023-01-12","u":"2023-01-12","st":"2023-01","ag":"18–60"},{"n":"NCT05718232","t":"SBRT Plus Lenvatinib and TACE for Advanced Primary HCC: A Phase 3 Trial (SEARCH)","s":"nyr","p":"phase3","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[49],"l":[[49,"hcc"]],"po":"2023-02-08","u":"2023-02-08","st":"2023-03","ag":"18–75"},{"n":"NCT05767892","t":"YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations","s":"nyr","p":"phase3","d":[4],"c":[2,55,8,22,1,16,0,23,24,17,65,27,47,36,9,28,26,5,11,18,4,12,29,30,13,39,7,20],"a":"adult older","h":[40,23,56,58,78,38,25,12,111,74,45,118,36,24,46,124,55,13,79,80,14,164,37,82,61,30,135,68,166,187,98,99,20,66,95,8,205,116,84,87,199],"po":"2023-03-14","u":"2023-04-05","st":"2023-05","ag":"18 and over"},{"n":"NCT05780294","t":"A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC","s":"nyr","p":"phase3","d":[0],"c":[0],"lc":[0],"a":"adult","h":[53],"l":[[53,"npc"]],"po":"2023-03-22","u":"2023-03-22","st":"2023-04","ag":"18–60"},{"n":"NCT05802654","t":"Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung Cancer","s":"nyr","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[115],"l":[[115,"lung"]],"po":"2023-04-06","u":"2023-06-22","st":"2023-06","ag":"18–80"},{"n":"NCT05822284","t":"ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction Chemoimmunotherapy","s":"nyr","p":"na","d":[4],"c":[8],"lc":[8],"a":"adult older","h":[10],"l":[[10,"lung"]],"po":"2023-04-20","u":"2023-04-20","st":"2023-04","ag":"18–75"},{"n":"NCT05841849","t":"Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer","s":"nyr","p":"phase4","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[54],"l":[[54,"breast"]],"po":"2023-05-03","u":"2023-05-03","st":"2023-07","ag":"18–70"},{"n":"NCT05842746","t":"Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma","s":"nyr","p":"phase2","d":[7],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"glioma"]],"po":"2023-05-06","u":"2023-05-06","st":"2023-05","ag":"18–70"},{"n":"NCT05857904","t":"Clinical Outcomes of CT-FFR Versus QFR-guided Strategy for Decision-Making in Patients With Stable Chest Pain","s":"nyr","p":"na","d":[31],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"cad"]],"po":"2023-05-15","u":"2023-05-15","st":"2023-05","ag":"18 and over"},{"n":"NCT05860907","t":"Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral Metastasis","s":"nyr","p":"phase4","d":[6],"c":[8,23,5,18,32,20],"lc":[5],"a":"adult older","h":[9,24,44,25,20,90,63],"l":[[9,"breast"]],"po":"2023-05-16","u":"2023-09-26","st":"2023-10","ag":"18–75"},{"n":"NCT05863871","t":"Real World Study of Linperlisib for Lymphoma Treatment","s":"nyr","p":"na","d":[19],"c":[5,30],"lc":[5],"a":"adult older","h":[123,58],"l":[[123,"lymph"]],"po":"2023-05-18","u":"2023-05-18","st":"2023-05","ag":"18 and over"},{"n":"NCT05890339","t":"Laparoscopic Proximal Gastrectomy With Double-flap Technique Versus Laparoscopic Total Gastrectomy With Roux-en-Y Reconstruction for Proximal Early Gastric Cancer","s":"nyr","p":"na","d":[3],"c":[0],"lc":[0],"a":"adult older","h":[99],"l":[[99,"gc"]],"po":"2023-06-06","u":"2023-06-06","st":"2023-06","ag":"20–80"},{"n":"NCT05903703","t":"Canagliflozin With Gemcitabine in Pancreatic Carcinoma","s":"nyr","p":"na","d":[5],"c":[23],"lc":[23],"a":"adult older","h":[185],"l":[[185,"panc"]],"po":"2023-06-15","u":"2023-06-15","st":"2023-10","ag":"18 and over"},{"n":"NCT05909098","t":"Safety and Efficacy of Autologous NK Cell Adjuvant Therapy for Relapsed/Refractory Non-Hodgkin's B-cell Lymphoma","s":"nyr","p":"phase1phase2","d":[19],"c":[71],"a":"adult older","h":[227],"po":"2023-06-18","u":"2023-06-22","st":"2023-07","ag":"18–80"},{"n":"NCT05940116","t":"A Phase I Clinical Study of HS-20117 in Participants With Advanced Solid Tumors","s":"nyr","p":"phase1","d":[4],"c":[30],"a":"adult older","h":[58],"po":"2023-07-11","u":"2023-07-12","st":"2023-07","ag":"18–75"},{"n":"NCT05970627","t":"Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma","s":"nyr","p":"phase2","d":[3],"c":[23,61],"a":"adult older","h":[46,54,182,215],"po":"2023-08-01","u":"2023-08-01","st":"2023-07","ag":"18–80"},{"n":"NCT05976568","t":"A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma","s":"nyr","p":"phase2phase3","d":[2],"c":[28,5],"a":"adult older","h":[6,105],"po":"2023-08-04","u":"2023-08-04","st":"2023-09","ag":"18–75"},{"n":"NCT05979220","t":"Study of Dalpiciclib Combined With Letrozole in the Maintenance Treatment of HR Positive and HER2 Negative Metastatic Breast Cancer After First-line Chemotherapy","s":"nyr","p":"phase2","d":[6],"c":[22],"lc":[22],"a":"adult older","x":"female","h":[40],"l":[[40,"breast"]],"po":"2023-08-07","u":"2023-08-07","st":"2023-12","ag":"18–75"},{"n":"NCT05983094","t":"Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast Cancer","s":"nyr","p":"phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2023-08-09","u":"2023-08-09","st":"2023-09","ag":"18–70"},{"n":"NCT05988177","t":"Efficacy and Safety of Carrimycin Tablets in HLH Patients With Carbapenem-resistant Infections","s":"nyr","p":"na","d":[18],"c":[2],"lc":[2],"a":"adult older","h":[39],"l":[[39,"hlh"]],"po":"2023-08-14","u":"2023-08-14","st":"2023-08","ag":"18 and over"},{"n":"NCT05990127","t":"A Study of AK104/Tislelizumab With Chemotherapy as First-line Treatment in PD-L1 TPS < 1% Non-small Cell Lung Cancer","s":"nyr","p":"phase3","d":[4],"c":[2,55,15,8,22,1,16,0,23,24,17,27,47,36,9,26,5,11,18,4,12,30,34,13,39,14,31,58,20],"a":"adult older","h":[23,57,58,44,25,5,6,11,26,111,74,45,118,10,24,46,55,13,47,27,14,164,37,70,30,2,135,16,49,68,18,64,19,186,169,172,72,95,84,21,87],"po":"2023-08-14","u":"2023-08-14","st":"2023-11","ag":"18 and over"},{"n":"NCT06014047","t":"Radial Artery Versus No-touch Saphenous Vein","s":"nyr","p":"na","d":[31],"c":[2],"a":"adult older","h":[213],"po":"2023-08-28","u":"2023-10-17","st":"2023-11","ag":"18 and over"},{"n":"NCT06015113","t":"Efficacy and Safety of Disitamab Vedotin Plus Pyrotinib or Naratinib in HER2-positive Breast Cancer Patients With Brain Metastasis","s":"nyr","p":"na","d":[6],"c":[39],"lc":[39],"a":"adult older","x":"female","h":[247],"l":[[247,"breast"]],"po":"2023-08-29","u":"2023-08-29","st":"2023-09","ag":"18 and over"},{"n":"NCT06015568","t":"Study of MCLA-129 Combined With Befotertinib in the Treatment of Advanced Non-small Cell Lung Cancer With EGFR Sensitive Mutation","s":"nyr","p":"phase1","d":[4],"c":[55,8,5],"a":"adult older","h":[42,13,164],"po":"2023-08-29","u":"2023-08-29","st":"2023-09","ag":"18–75"},{"n":"NCT06041490","t":"Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation","s":"nyr","p":"phase2","d":[2],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"hcc"]],"po":"2023-09-18","u":"2023-09-18","st":"2023-09","ag":"18–75"},{"n":"NCT06062641","t":"Selinexor Combined With R-GDP Regimen for TP53-altered R/R DLBCL","s":"nyr","p":"phase2","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2023-10-02","u":"2023-11-07","st":"2023-10","ag":"18 and over"},{"n":"NCT06102161","t":"Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020)","s":"nyr","p":"phase3","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"lung"]],"po":"2023-10-26","u":"2023-10-26","st":"2023-11","ag":"18–80"},{"n":"NCT06109402","t":"Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer","s":"nyr","p":"phase2","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2023-10-31","u":"2023-12-19","st":"2023-12","ag":"18 and over"},{"n":"NCT06131489","t":"Segmental Resection Combined With DEP Regimen for EBV-HLH Patients With Intestinal Involvement","s":"nyr","p":"na","d":[18],"c":[2],"lc":[2],"a":"adult older","h":[39],"l":[[39,"hlh"]],"po":"2023-11-14","u":"2023-11-14","st":"2023-12","ag":"18 and over"},{"n":"NCT06136988","t":"A Study of Docetaxel for Injection (Albumin-bound) and SG001 in Combination With Cisplatin and Simultaneous Radiotherapy for Locally Advanced Unresectable Esophageal Squamous Carcinoma.","s":"nyr","p":"phase1phase2","d":[1],"c":[30],"a":"adult older","h":[58],"po":"2023-11-18","u":"2023-11-18","st":"2023-12","ag":"18 and over"},{"n":"NCT06140576","t":"The Efficacy and Safety of Lenvatinib Combined With Sindilimab and Nab-paclitaxel in the First-line Treatment for Recurrent and Metastatic Triple Negative Breast Cancer: a Phase Ib/IIa Clinical Trial.","s":"nyr","p":"phase1phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","x":"female","h":[44],"l":[[44,"breast"]],"po":"2023-11-20","u":"2023-11-20","st":"2023-11","ag":"18–70"},{"n":"NCT06142188","t":"Relmacabtagene Autoleucel in Hematologic Malignancies","s":"nyr","p":"na","d":[19],"c":[2],"a":"adult older","h":[74],"po":"2023-11-21","u":"2023-11-21","st":"2023-12","ag":"18 and over"},{"n":"NCT06142617","t":"A Prospective Study of Pembrolizumab Combining Chemotherapy in Advanced NSCLC Patients With EGFR Exon 21 Point Mutation.","s":"nyr","p":"phase2","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"lung"]],"po":"2023-11-21","u":"2023-11-21","st":"2023-12","ag":"18 and over"},{"n":"NCT06152978","t":"A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma","s":"nyr","p":"phase2","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"escc"]],"po":"2023-12-01","u":"2023-12-01","st":"2023-12","ag":"18–75"},{"n":"NCT06178211","t":"Neoadjuvant Adebrelimab Plus Chemotherapy for Resectable ESCC: a Single Arm, Prospective Phase 2 Clinical Trial","s":"nyr","p":"phase2","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[42],"l":[[42,"escc"]],"po":"2023-12-20","u":"2023-12-20","st":"2023-12","ag":"18–75"},{"n":"NCT04605562","t":"Umbrella Biomarker-Guided Therapy in NPC","s":"nyr","p":"phase2","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2020-10-28","u":"2021-09-05","st":"2022-06","ag":"18–65"},{"n":"NCT05132985","t":"Neoadjuvant Icotinib With Chemotherapy for Epidermal Growth Factor Receptor(EGFR)-Mutated Resectable Lung Adenocarcinoma","s":"nyr","p":"phase2","d":[4],"c":[11],"lc":[11],"a":"adult older","h":[18],"l":[[18,"lung"]],"po":"2021-11-24","u":"2021-12-10","st":"2022-01","ag":"18–75"},{"n":"NCT05175274","t":"Colchicine Use for Primary Prevention of Coronary Artery Disease","s":"nyr","p":"phase3","d":[31],"c":[26],"lc":[26],"a":"adult older","h":[319],"l":[[319,"cad"]],"po":"2022-01-03","u":"2022-03-21","st":"2022-12","ag":"40–70"},{"n":"NCT05181501","t":"A Study of Fully Human BCMA CAR-T (CT103A) in Patients With Newly Diagnosed High-risk Multiple Myeloma (FUMANBA-2)","s":"nyr","p":"phase1","d":[15],"c":[49,17,28],"a":"adult older","h":[78,60,145,88],"po":"2022-01-06","u":"2022-01-06","st":"2022-04","ag":"18–70"},{"n":"NCT05235932","t":"the Clinical Efficacy of Robotic and Laparoscopic Radical Total Gastrectomy in Locally Advanced Middle and Upper Gastric Cancer","s":"nyr","p":"na","d":[3],"c":[16],"lc":[16],"a":"adult older","h":[140],"l":[[140,"gc"]],"po":"2022-02-11","u":"2022-02-11","st":"2022-02","ag":"18–75"},{"n":"NCT05244798","t":"Sintilimab Plus NCT or NCRT Versus NCRT for ESCC","s":"nyr","p":"phase3","d":[1],"c":[22],"lc":[22],"a":"adult older","h":[47],"l":[[47,"escc"]],"po":"2022-02-17","u":"2022-10-25","st":"2022-11","ag":"18–75"},{"n":"NCT05343377","t":"A Clinical Study of the Value of Circulating Free Methylated EBV DNA in Extranodal NK/T Cell Lymphoma","s":"nyr","p":"na","d":[19],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"lymph"]],"po":"2022-04-25","u":"2022-04-25","st":"2022-06","ag":"18–80"},{"n":"NCT05356156","t":"The Safe Study of Routine Closure of Mesenteric Defects Versus Non-closure After Radical Gastrectomy","s":"nyr","p":"na","d":[3],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"gc"]],"po":"2022-05-02","u":"2022-05-02","st":"2022-04","ag":"18–75"},{"n":"NCT05386056","t":"Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell Carcinoma","s":"nyr","p":"phase2","d":[1],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"escc"]],"po":"2022-05-23","u":"2022-11-28","st":"2022-12","ag":"18 and over"},{"n":"NCT05411809","t":"The ctDNA for Evaluating Whether to Use Adjuvant Therapy After SBRT in Patients With Early Lung Cancer","s":"nyr","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[115],"l":[[115,"lung"]],"po":"2022-06-09","u":"2022-06-09","st":"2022-06","ag":"18–80"},{"n":"NCT05420480","t":"Two-field Versus Three-field Lymph Node Dissection in ESCC After Neoadjuvant Therapy","s":"nyr","p":"na","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[6],"l":[[6,"escc"]],"po":"2022-06-15","u":"2022-06-21","st":"2022-07","ag":"18–75"},{"n":"NCT05431504","t":"The Efficacy and Safety of Dalpiciclib Plus Endocrine Therapy in HR-positive / HER2-negative Advanced Breast Cancer Patients With Visceral Crisis","s":"nyr","p":"phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2022-06-24","u":"2022-06-24","st":"2022-06","ag":"18 and over"},{"n":"NCT05460819","t":"Acupuncture for Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.","s":"nyr","p":"na","d":[6],"c":[28],"a":"adult older","x":"female","h":[78],"po":"2022-07-15","u":"2022-07-20","st":"2022-08","ag":"18–75"},{"n":"NCT05502991","t":"Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse Glioblastoma","s":"nyr","p":"phase2","d":[7],"c":[20],"lc":[20],"a":"adult older","h":[92],"l":[[92,"glioma"]],"po":"2022-08-16","u":"2022-09-27","st":"2022-12","ag":"18 and over"},{"n":"NCT05505812","t":"Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Breast Cancer","s":"nyr","p":"earlyphase1","d":[6],"c":[26],"lc":[26],"a":"adult older","x":"female","h":[55],"l":[[55,"breast"]],"po":"2022-08-18","u":"2022-08-18","st":"2022-10","ag":"18–75"},{"n":"NCT05512325","t":"Study on Gene Evolution in Glioma Under Stress Therapy","s":"nyr","p":"na","d":[7],"c":[20],"lc":[20],"a":"adult older","h":[92],"l":[[92,"glioma"]],"po":"2022-08-23","u":"2022-09-27","st":"2022-12","ag":"18–75"},{"n":"NCT05524974","t":"Clinical Study of Camrelizumab, Apatinib Mesylate and Nab-paclitaxel Combined With Oxplatin and S-1 in the Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Genotypes","s":"nyr","p":"phase2","d":[3],"c":[16],"lc":[16],"a":"adult older","h":[140],"l":[[140,"gc"]],"po":"2022-09-01","u":"2022-09-01","st":"2022-09","ag":"18–75"},{"n":"NCT05532969","t":"Correlation Between Psychological Stress and Progression of Diffuse Astrocytoma Towards Secondary Glioma","s":"nyr","p":"na","d":[7],"c":[20],"lc":[20],"a":"adult older","h":[92],"l":[[92,"glioma"]],"po":"2022-09-08","u":"2022-09-27","st":"2022-12","ag":"18–75"},{"n":"NCT05541042","t":"Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers","s":"nyr","p":"na","d":[7],"c":[20],"lc":[20],"a":"adult older","h":[92],"l":[[92,"glioma"]],"po":"2022-09-15","u":"2022-09-27","st":"2022-12","ag":"18 and over"},{"n":"NCT05610332","t":"Clinical Efficacy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Immunotypes","s":"nyr","p":"phase3","d":[3],"c":[16],"lc":[16],"a":"adult older","h":[140],"l":[[140,"gc"]],"po":"2022-11-09","u":"2022-11-09","st":"2022-11","ag":"18–75"},{"n":"NCT05613504","t":"Study of Acupuncture in the Treatment of Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.","s":"nyr","p":"na","d":[6],"c":[28],"a":"adult older","x":"female","h":[78],"po":"2022-11-14","u":"2022-11-16","st":"2022-12","ag":"30–75"},{"n":"NCT05622474","t":"A Multicenter Randomized Controlled Clinical Study on the Treatment of T3N1M0 High Risk Nasopharyngeal Carcinoma With or Without Induction Chemotherapy Before Concurrent Radiotherapy and Chemotherapy","s":"nyr","p":"na","d":[0],"c":[0],"lc":[0],"a":"adult older","h":[53],"l":[[53,"npc"]],"po":"2022-11-18","u":"2022-11-18","st":"2022-11","ag":"18–70"},{"n":"NCT04215510","t":"Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRT","s":"nyr","p":"phase3","d":[0],"c":[16,9,5],"lc":[5],"a":"adult older","h":[236,9,14,140],"l":[[236,"npc"]],"po":"2020-01-02","u":"2021-02-23","st":"2021-03","ag":"18–70"},{"n":"NCT04384601","t":"Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer","s":"nyr","p":"phase3","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"gc"]],"po":"2020-05-12","u":"2021-07-19","st":"2021-09","ag":"18–80"},{"n":"NCT04670055","t":"A Study of Humanized BCMA-targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma","s":"nyr","p":"earlyphase1","d":[15],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"mm"]],"po":"2020-12-17","u":"2020-12-17","st":"2021-01","ag":"30–75"},{"n":"NCT04736589","t":"Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM Pathway","s":"nyr","p":"phase3","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2021-02-03","u":"2021-02-03","st":"2021-02","ag":"18–85"},{"n":"NCT04795063","t":"Total Robotic Versus Robotic Assisted Distal Gastrectomy for Gastric Cancer","s":"nyr","p":"na","d":[3],"c":[16],"lc":[16],"a":"adult older","h":[140],"l":[[140,"gc"]],"po":"2021-03-12","u":"2021-03-12","st":"2021-03","ag":"18–75"},{"n":"NCT04846634","t":"Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043)","s":"nyr","p":"phase2","d":[4],"c":[9,30],"lc":[30],"a":"adult older","h":[58,14],"l":[[58,"lung"]],"po":"2021-04-15","u":"2021-04-15","st":"2021-08","ag":"18–70"},{"n":"NCT04890522","t":"An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC","s":"nyr","p":"phase2phase3","d":[0],"c":[0],"lc":[0],"a":"adult","h":[53],"l":[[53,"npc"]],"po":"2021-05-18","u":"2021-05-18","st":"2021-07","ag":"18–60"},{"n":"NCT04973319","t":"Trastuzumab Combined With Pertuzumab for Adjuvant Treatment of Breast Cancer After Neoadjuvant Therapy","s":"nyr","p":"phase3","d":[6],"c":[11],"lc":[11],"a":"adult older","x":"female","h":[143],"l":[[143,"breast"]],"po":"2021-07-22","u":"2021-07-22","st":"2021-08","ag":"18–75"},{"n":"NCT04995159","t":"Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System","s":"nyr","p":"na","d":[31],"c":[2,55,15,8,1,0,41,6,23,24,17,89,27,47,33,36,9,28,10,26,5,43,18,12,30,13,39,31,19,58,45,20,46,59,91],"a":"adult older","h":[109,78,123,206,124,12,25,54,169,111,120,89,38,92,11,121,39,79,15,82,112,80,125,27,65,16,55,115,107,71,147,195,7,133,64,156,184,202,42,216,117,28,166,297,164,172,129,142,122,90,173,97,14,340,212,177,171,87,197,387,352,388,398,264,34,399,290],"po":"2021-08-06","u":"2021-08-06","st":"2021-09","ag":"18 and over"},{"n":"NCT04426136","t":"A Prospective Cohort Study Comparing Disparity in Surgical Procedure (Wide Local Excision Only vs Any Other Surgery Procedures) Among the Elderly Breast Cancer Patients","s":"nyr","p":"na","d":[6],"c":[2],"lc":[2],"a":"older","x":"female","h":[38],"l":[[38,"breast"]],"po":"2020-06-11","u":"2020-06-11","st":"2020-06","ag":"70 and over"},{"n":"NCT04541368","t":"A Study of CS1-targeted CAR-T Cells Therapy for Relapsed Multiple Myeloma After BCMA CAR-T Cells Therapy","s":"nyr","p":"earlyphase1","d":[15],"c":[23],"lc":[23],"a":"adult older","h":[46],"l":[[46,"mm"]],"po":"2020-09-09","u":"2020-12-10","st":"2020-12","ag":"30–75"},{"n":"NCT04609241","t":"CD79b CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's Lymphoma","s":"nyr","p":"earlyphase1","d":[16],"c":[23],"lc":[23],"a":"child adult older","h":[46],"l":[[46,"ball"]],"po":"2020-10-30","u":"2020-10-30","st":"2020-11","ag":"Not stated"},{"n":"NCT03857737","t":"Endoscopic Submucosal Dissection Versus Surgery in the Treatment of Early Gastric Cancer","s":"nyr","p":"na","d":[3],"c":[2],"lc":[2],"a":"child adult older","h":[115],"l":[[115,"gc"]],"po":"2019-02-28","u":"2019-02-28","st":"2019-03","ag":"Not stated"},{"n":"NCT07352137","t":"Endoscopic Nipple-Sparing Mastectomy (E-NSM) With Immediate Multistage Autologous Fat Grafting(IMAFG) for Total Breast Reconstruction Via the Axillary Incision","s":"inv","p":"na","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[107],"l":[[107,"breast"]],"po":"2026-01-20","u":"2026-01-20","st":"2026-01","ag":"18–70"},{"n":"NCT07373899","t":"Comparison of the Effect of Surgical Resection Based on Lesion Extent Before and After Neoadjuvant Therapy in Patients With Stage II-IIIB Non-Small Cell Lung Cancer: A Single-Center, Real-World, Open-Label Study","s":"inv","p":"na","d":[4],"c":[2],"lc":[2],"a":"child adult older","h":[23],"l":[[23,"lung"]],"po":"2026-01-28","u":"2026-07-24","st":"2026-01","ag":"Not stated"},{"n":"NCT07376681","t":"Fertility Outcomes In Young Breast Cancer Patients And Their Prognosis And Offspring Health","s":"inv","p":"na","d":[6],"c":[29],"lc":[29],"a":"adult","x":"female","h":[366],"l":[[366,"breast"]],"po":"2026-01-29","u":"2026-01-29","st":"2026-01","ag":"18–40"},{"n":"NCT07416344","t":"A Coronary Computed Tomography Angiography-guided Intervention for High Risk Cardiovascular Disease Population in Rural China","s":"inv","p":"na","d":[31],"c":[24],"lc":[24],"a":"adult older","h":[206],"l":[[206,"cad"]],"po":"2026-02-18","u":"2026-06-15","st":"2026-04","ag":"40–75"},{"n":"NCT07419971","t":"Influencing Factors and Mechanisms of Capsular Contracture After Prosthesis Reconstruction in Patients With Breast Cancer","s":"inv","p":"na","d":[6],"c":[22],"lc":[22],"a":"adult older","x":"female","h":[40],"l":[[40,"breast"]],"po":"2026-02-19","u":"2026-03-17","st":"2026-03","ag":"18–80"},{"n":"NCT07444099","t":"Early Postoperative Intervention in Gastric Cancer Patients","s":"inv","p":"na","d":[3],"c":[27],"lc":[27],"a":"adult older","h":[124],"l":[[124,"gc"]],"po":"2026-03-02","u":"2026-03-02","st":"2026-02","ag":"18–80"},{"n":"NCT07583927","t":"Anemia on Sublingual Microcirculation in GDFT","s":"inv","p":"na","d":[3],"c":[5],"lc":[5],"a":"adult older","h":[9],"l":[[9,"gc"]],"po":"2026-05-13","u":"2026-05-13","st":"2026-05","ag":"18 and over"},{"n":"NCT07646574","t":"Non-surgical Management After NIT for dMMR/MSI-H GC","s":"inv","p":"na","d":[3],"c":[22],"lc":[22],"a":"adult older","h":[40],"l":[[40,"gc"]],"po":"2026-06-12","u":"2026-08-19","st":"2026-07","ag":"18 and over"},{"n":"NCT07732101","t":"Exercise Intervention for Breast Cancer Patients With Sarcopenia","s":"inv","p":"na","d":[6],"c":[2],"a":"adult older","h":[26],"po":"2026-07-28","u":"2026-11-17","st":"2026-09","ag":"18 and over"},{"n":"NCT07738367","t":"Bronchial Artery Chemoembolization (BACE) Combination Therapy for Advanced NSCLC","s":"inv","p":"phase2","d":[4],"c":[16],"lc":[16],"a":"adult older","h":[30],"l":[[30,"lung"]],"po":"2026-07-31","u":"2026-07-31","st":"2026-04","ag":"18–75"},{"n":"NCT07784309","t":"A Clinical Study of HY035 Cell Injection in the Treatment of CD7-positive Relapsed or Refractory Hematologic Malignancies","s":"inv","p":"phase1","d":[19],"c":[30],"lc":[30],"a":"child adult older","h":[69],"l":[[69,"lymph"]],"po":"2026-08-25","u":"2026-08-25","st":"2026-08","ag":"3–70"},{"n":"NCT07833046","t":"Long-term Follow-up Study in Subjects With Multiple Myeloma Previously Treated With GC012F Injection","s":"inv","p":"na","d":[15],"c":[5],"lc":[5],"a":"child adult older","h":[41],"l":[[41,"mm"]],"po":"2026-09-22","u":"2026-11-09","st":"2026-11","ag":"Not stated"},{"n":"NCT07920822","t":"Evaluation of the I-phase Clinical Trial of 177Lu-HX02 Injection in Patients With Advanced Malignant Solid Tumors","s":"inv","p":"phase1","d":[4],"c":[13],"a":"adult older","h":[12],"po":"2026-11-06","u":"2026-11-06","st":"2026-01","ag":"18–75"},{"n":"NCT06650748","t":"Multigene Risk Score Combined With Ki-67 Dynamic Assessment in Stratified Neoadjuvant Endocrine Therapy Treatment With or Without CDK4/6 Inhibitors in HR+/HER2- Breast Cancer","s":"inv","p":"phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[74],"l":[[74,"breast"]],"po":"2024-10-21","u":"2026-03-17","st":"2025-05","ag":"18–70"},{"n":"NCT06747546","t":"Research on Circulation Management Strategy Based on Oxygen Metabolism Balance After CHD Surgery","s":"inv","p":"na","d":[32],"c":[5],"lc":[5],"a":"child adult","h":[76],"l":[[76,"chd"]],"po":"2024-12-24","u":"2026-03-16","st":"2025-01","ag":"1 week–18"},{"n":"NCT06763640","t":"Prognostic Value of TIL in Nasopharyngeal Carcinoma","s":"inv","p":"na","d":[0],"c":[9],"lc":[9],"a":"adult older","h":[116],"l":[[116,"npc"]],"po":"2025-01-08","u":"2025-01-09","st":"2025-01","ag":"18–70"},{"n":"NCT06791161","t":"A Multicenter Prospective Cohort Study of Adjuvant Therapy for BRCA1/2 Mutated Hormone Receptor-positive HER2-negative Early High-risk Breast Cancer","s":"inv","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2025-01-24","u":"2025-02-14","st":"2025-01","ag":"18–75"},{"n":"NCT06793306","t":"A Study Comparing the Differences Between Young and Non-young Breast Cancer","s":"inv","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2025-01-27","u":"2025-02-14","st":"2025-01","ag":"18–75"},{"n":"NCT06827782","t":"Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma","s":"inv","p":"phase1","d":[19],"c":[23],"lc":[23],"a":"adult older","h":[54],"l":[[54,"lymph"]],"po":"2025-02-14","u":"2025-08-15","st":"2025-03","ag":"18–75"},{"n":"NCT06843681","t":"Trastuzumab Plus Taxane Neoadjuvant Therapy for HER2-Positive Breast Ductal Carcinoma In Situ (DCIS) : A Phase II Study","s":"inv","p":"phase2","d":[6],"c":[0],"lc":[0],"a":"adult older","x":"female","h":[99],"l":[[99,"breast"]],"po":"2025-02-25","u":"2025-11-28","st":"2025-03","ag":"18–70"},{"n":"NCT06882876","t":"JS014 Combined With Toripalimab and TACE in Unresectable HCC: a Phase Ib Study","s":"inv","p":"phase1","d":[2],"c":[8],"lc":[8],"a":"adult older","h":[11],"l":[[11,"hcc"]],"po":"2025-03-19","u":"2025-09-19","st":"2025-07","ag":"18–75"},{"n":"NCT06883136","t":"Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients","s":"inv","p":"na","d":[4],"c":[27],"lc":[27],"a":"adult older","h":[220],"l":[[220,"lung"]],"po":"2025-03-19","u":"2025-03-19","st":"2025-03","ag":"60–80"},{"n":"NCT06910072","t":"Paclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Therapy for Triple-negative Breast Cancer（UPGRADE-TNBC）","s":"inv","p":"phase2phase3","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2025-04-04","u":"2026-08-18","st":"2025-07","ag":"18–75"},{"n":"NCT06914661","t":"Efficacy and Safety of DS8201 in Metastatic Breast Cancer's Treatment","s":"inv","p":"na","d":[6],"c":[15],"lc":[15],"a":"adult older","h":[27],"l":[[27,"breast"]],"po":"2025-04-06","u":"2025-07-08","st":"2025-05","ag":"18–100"},{"n":"NCT06943313","t":"Breast Cancer PET/CT Imaging With 68Ga-pAKTi","s":"inv","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2025-04-24","u":"2025-04-24","st":"2025-04","ag":"18 and over"},{"n":"NCT06947096","t":"Radiomics-Based AI Model for Predicting Para-Aortic Lymph Node Metastasis in Gastric Cancer Patients","s":"inv","p":"na","d":[3],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"gc"]],"po":"2025-04-27","u":"2025-04-27","st":"2025-01","ag":"18–80"},{"n":"NCT06957678","t":"AI-Based Prediction of Lymph Node Metastasis in Gastric Cancer Using Preoperative Multimodal Data","s":"inv","p":"na","d":[3],"c":[18],"lc":[18],"a":"adult older","h":[24],"l":[[24,"gc"]],"po":"2025-05-04","u":"2025-05-04","st":"2025-01","ag":"18–80"},{"n":"NCT06984055","t":"Diagnostic Accuracy of Endocytoscopy for Superficial Esophageal Neoplasia","s":"inv","p":"na","d":[1],"c":[5],"lc":[5],"a":"adult older","h":[177],"l":[[177,"escc"]],"po":"2025-05-22","u":"2025-05-22","st":"2025-03","ag":"18–85"},{"n":"NCT07023848","t":"PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors","s":"inv","p":"earlyphase1","d":[3,6],"c":[60],"lc":[60],"a":"adult older","h":[180],"l":[[180,"gc"]],"po":"2025-06-17","u":"2025-06-17","st":"2025-07","ag":"18–75"},{"n":"NCT07023861","t":"The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies","s":"inv","p":"earlyphase1","d":[3,6],"c":[60],"lc":[60],"a":"child adult older","h":[180],"l":[[180,"gc"]],"po":"2025-06-17","u":"2025-06-17","st":"2025-07","ag":"15–75"},{"n":"NCT07047937","t":"Explainable Machine Learning for Predicting Early Gastric Cancer","s":"inv","p":"na","d":[3],"c":[37],"lc":[37],"a":"child adult older","h":[400],"l":[[400,"gc"]],"po":"2025-07-02","u":"2025-07-02","st":"2025-06","ag":"Not stated"},{"n":"NCT07074847","t":"Coronary Arterial Microcirculation and Metabolism","s":"inv","p":"na","d":[31],"c":[39],"lc":[39],"a":"adult older","h":[144],"l":[[144,"cad"]],"po":"2025-07-20","u":"2025-07-20","st":"2025-02","ag":"18–80"},{"n":"NCT07125573","t":"The Effect of Esketamine Combined With Dexmedetomidine on Postoperative Recovery Quality in Patients Undergoing Thoracoscopic Surgery","s":"inv","p":"na","d":[4],"c":[47],"lc":[47],"a":"adult older","h":[201],"l":[[201,"lung"]],"po":"2025-08-15","u":"2025-08-15","st":"2025-05","ag":"18–65"},{"n":"NCT07126990","t":"Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma","s":"inv","p":"phase1phase2","d":[7],"c":[2],"lc":[2],"a":"adult older","h":[241],"l":[[241,"glioma"]],"po":"2025-08-17","u":"2026-03-23","st":"2025-02","ag":"18–80"},{"n":"NCT07274579","t":"An Artificial Intelligence Model for Aiding Claudin18.2 Expression Diagnosis in Gastric Adenocarcinoma","s":"inv","p":"na","d":[3],"c":[0,27],"lc":[0],"a":"adult older","h":[70,220],"l":[[70,"gc"]],"po":"2025-12-10","u":"2026-02-10","st":"2025-10","ag":"18 and over"},{"n":"NCT07290764","t":"Survival Analysis of Surgical Resection Versus Observation in Patients With Initially uHCC Achieving CR After Systemic Therapy","s":"inv","p":"na","d":[2],"c":[16],"lc":[16],"a":"adult older","h":[148],"l":[[148,"hcc"]],"po":"2025-12-18","u":"2025-12-18","st":"2025-12","ag":"18–75"},{"n":"NCT07312578","t":"Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma","s":"inv","p":"phase2","d":[1],"c":[2],"lc":[2],"a":"adult older","h":[74],"l":[[74,"escc"]],"po":"2025-12-31","u":"2025-12-31","st":"2025-11","ag":"18–70"},{"n":"NCT07356466","t":"Clinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma","s":"inv","p":"earlyphase1","d":[3],"c":[16],"lc":[16],"a":"adult older","h":[140],"l":[[140,"gc"]],"po":"2026-01-21","u":"2026-01-21","st":"2025-05","ag":"18–75"},{"n":"NCT07371247","t":"Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy","s":"inv","p":"earlyphase1","d":[1],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"escc"]],"po":"2026-01-27","u":"2026-01-27","st":"2025-12","ag":"18–80"},{"n":"NCT07373951","t":"Retrospective Multicenter Study of Patient-level T1CE/FLAIR MRI Deep Learning to Predict EGFR/ALK Driver Status in NSCLC Brain Metastases With External Validation and Survival Analysis","s":"inv","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"lung"]],"po":"2026-01-28","u":"2026-01-29","st":"2025-11","ag":"18 and over"},{"n":"NCT07376629","t":"A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC","s":"inv","p":"phase2","d":[6],"c":[48,15,8,22,16,0,23,24,17,27,25,28,5,11,4,12,30,13,39,7,31],"a":"adult older","h":[9,78,58,53,45,43,12,11,57,27,18,97,47,8,68,82,30,187,84,150,67,101],"po":"2026-01-29","u":"2026-01-29","st":"2025-08","ag":"18–75"},{"n":"NCT07386704","t":"Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer","s":"inv","p":"phase2","d":[5],"c":[2],"lc":[2],"a":"adult older","h":[29],"l":[[29,"panc"]],"po":"2026-02-04","u":"2026-02-04","st":"2025-12","ag":"18–80"},{"n":"NCT07409298","t":"Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor Therapy","s":"inv","p":"na","d":[6],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"breast"]],"po":"2026-02-13","u":"2026-02-13","st":"2025-07","ag":"18–80"},{"n":"NCT07488312","t":"Safety and Efficacy of Leucine-Restricted Diet in Gastric Cancer","s":"inv","p":"phase1","d":[3],"c":[27],"lc":[27],"a":"adult older","h":[124],"l":[[124,"gc"]],"po":"2026-03-23","u":"2026-04-20","st":"2025-10","ag":"18–70"},{"n":"NCT07494006","t":"Spontaneous Breathing Mode: A Risk for Hypoxemia During OLV?","s":"inv","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[48],"l":[[48,"lung"]],"po":"2026-03-27","u":"2026-03-27","st":"2025-07","ag":"18 and over"},{"n":"NCT07514728","t":"Concept-verification Clinical Trial on the Inhibition of Breast Cancer Lung Metastasis Progression by Hyperbaric Oxygen","s":"inv","p":"na","d":[6],"c":[27],"lc":[27],"a":"adult older","x":"female","h":[83],"l":[[83,"breast"]],"po":"2026-04-07","u":"2026-04-07","st":"2025-11","ag":"18–75"},{"n":"NCT07533825","t":"Laparoscopic Staging for Stage III Gastric Cancer","s":"inv","p":"na","d":[3],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"gc"]],"po":"2026-04-16","u":"2026-04-16","st":"2025-02","ag":"18–75"},{"n":"NCT07567716","t":"Infiltration Pattern of Locally Advanced ESCC","s":"inv","p":"na","d":[1],"c":[5],"lc":[5],"a":"child adult older","h":[42],"l":[[42,"escc"]],"po":"2026-05-05","u":"2026-05-05","st":"2025-10","ag":"Not stated"},{"n":"NCT07798466","t":"Immediate Autologous Tissue Breast Reconstruction and Radiotherapy Strategy After Breast Cancer Surgery","s":"inv","p":"na","d":[6],"c":[5],"lc":[5],"a":"adult older","x":"female","h":[9],"l":[[9,"breast"]],"po":"2026-09-01","u":"2026-09-01","st":"2025-09","ag":"18 and over"},{"n":"NCT07916129","t":"Single-center Transformational Study on Feasibility and Efficacy of Respiratory Motion Management Using Novel Position Fixation Device for Lung Cancer Patients Undergoing Stereotactic Body Radiation Therapy(2023 No.358 Project)","s":"inv","p":"na","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2026-11-04","u":"2026-11-04","st":"2025-09","ag":"18–85"},{"n":"NCT06370416","t":"the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib","s":"inv","p":"phase2","d":[4],"c":[20],"lc":[20],"a":"adult older","h":[37],"l":[[37,"lung"]],"po":"2024-04-17","u":"2026-01-28","st":"2024-04","ag":"18 and over"},{"n":"NCT06405269","t":"Effect of (neo)Adjuvant Therapy on Lipids in Young Breast Cancer Patients","s":"inv","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult","x":"female","h":[23],"l":[[23,"breast"]],"po":"2024-05-08","u":"2025-02-14","st":"2024-05","ag":"18–40"},{"n":"NCT06405295","t":"Intensive Adjuvant Therapy for TNBC with BRCA Gene Mutation","s":"inv","p":"na","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2024-05-08","u":"2025-02-14","st":"2024-05","ag":"18–75"},{"n":"NCT06610240","t":"Perioperative Treatment Outcomes of Early NSCLC","s":"inv","p":"na","d":[4],"c":[5],"lc":[5],"a":"child adult older","h":[42],"l":[[42,"lung"]],"po":"2024-09-24","u":"2024-11-13","st":"2024-11","ag":"Not stated"},{"n":"NCT06620458","t":"Influencing Factors and Outcomes of DCB Angioplasty","s":"inv","p":"na","d":[31],"c":[20],"a":"adult older","h":[264],"po":"2024-10-01","u":"2026-10-09","st":"2024-10","ag":"18 and over"},{"n":"NCT06647264","t":"A Multicenter Prospective Observational Study of Computer-aided Risk Perception and Prognosis Prediction in the Whole Process of Laparoscopic Hepatobiliary and Pancreatic Surgery","s":"inv","p":"na","d":[2],"c":[0],"lc":[0],"a":"adult older","h":[70],"l":[[70,"hcc"]],"po":"2024-10-17","u":"2024-10-17","st":"2024-09","ag":"18–80"},{"n":"NCT06688175","t":"IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma","s":"inv","p":"phase2","d":[0],"c":[7],"lc":[7],"a":"older","h":[8],"l":[[8,"npc"]],"po":"2024-11-14","u":"2025-08-07","st":"2024-11","ag":"65–80"},{"n":"NCT06690216","t":"Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors","s":"inv","p":"phase1phase2","d":[1,4,7],"c":[27],"lc":[27],"a":"adult older","h":[57],"l":[[57,"escc"]],"po":"2024-11-15","u":"2025-03-30","st":"2024-03","ag":"18 and over"},{"n":"NCT06712017","t":"Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China","s":"inv","p":"na","d":[2],"c":[2,0,5],"a":"adult older","h":[277,52,278,100],"po":"2024-12-02","u":"2024-12-05","st":"2024-08","ag":"18 and over"},{"n":"NCT06715501","t":"Efficacy and Safety of Cadonilimab and Chemoradiotherapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma","s":"inv","p":"na","d":[1],"c":[61],"lc":[61],"a":"adult older","h":[182],"l":[[182,"escc"]],"po":"2024-12-04","u":"2025-03-25","st":"2024-12","ag":"18–75"},{"n":"NCT06747832","t":"INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer","s":"inv","p":"earlyphase1","d":[4],"c":[42],"a":"adult older","h":[114],"po":"2024-12-24","u":"2024-12-24","st":"2024-12","ag":"18–75"},{"n":"NCT06763965","t":"Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.","s":"inv","p":"phase1phase2","d":[7],"c":[2],"a":"adult older","h":[241],"po":"2025-01-08","u":"2026-03-23","st":"2024-11","ag":"18 and over"},{"n":"NCT06767891","t":"Real-world Study of Acalabrutinib","s":"inv","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[123],"l":[[123,"lymph"]],"po":"2025-01-10","u":"2026-09-08","st":"2024-07","ag":"18 and over"},{"n":"NCT06773156","t":"Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer","s":"inv","p":"phase2","d":[4],"c":[9],"lc":[9],"a":"adult older","h":[80],"l":[[80,"lung"]],"po":"2025-01-14","u":"2025-01-14","st":"2024-11","ag":"18–75"},{"n":"NCT06863831","t":"A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC","s":"inv","p":"na","d":[1],"c":[2],"lc":[2],"a":"adult older","h":[23],"l":[[23,"escc"]],"po":"2025-03-07","u":"2025-03-07","st":"2024-08","ag":"18–80"},{"n":"NCT06876675","t":"LORLATINIB-related HYPERLIPIDEMIA in ALK+ Non-Small Cell Lung Cancer","s":"inv","p":"na","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[115],"l":[[115,"lung"]],"po":"2025-03-14","u":"2025-03-14","st":"2024-10","ag":"18–80"},{"n":"NCT06881550","t":"Real-world Study on Shenbailing Granules for Improving Qi and Blood Deficiency in Patients After Breast Cancer Surgery","s":"inv","p":"na","d":[6],"c":[11],"lc":[11],"a":"adult older","x":"female","h":[143],"l":[[143,"breast"]],"po":"2025-03-18","u":"2025-03-18","st":"2024-12","ag":"18–75"},{"n":"NCT06890871","t":"Radiotherapy with Immunotherapy and Anti-Angiogenic Therapy for Advanced HER2-Negative Breast Cancer: a Single-Arm Study","s":"inv","p":"phase1phase2","d":[6],"c":[13],"lc":[13],"a":"adult older","x":"female","h":[133],"l":[[133,"breast"]],"po":"2025-03-24","u":"2025-03-24","st":"2024-08","ag":"18–75"},{"n":"NCT06962449","t":"Real-World Assessment of Therapeutic Strategies and Survival Outcomes Following First-Line Tislelizumab Therapy in Advanced Non-Small Cell Lung Cancer","s":"inv","p":"na","d":[4],"c":[5],"lc":[5],"a":"child adult older","h":[42],"l":[[42,"lung"]],"po":"2025-05-08","u":"2025-05-08","st":"2024-08","ag":"Not stated"},{"n":"NCT07016737","t":"Immunochemotherapy ± Salvage Chemoradiation for Local Recurrence of Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy","s":"inv","p":"phase3","d":[1],"c":[28],"lc":[28],"a":"adult older","h":[127],"l":[[127,"escc"]],"po":"2025-06-12","u":"2025-06-12","st":"2024-08","ag":"18 and over"},{"n":"NCT07023068","t":"⁶⁸Ga-DPA in the Lung Cancer Diagnosis","s":"inv","p":"earlyphase1","d":[4],"c":[2],"lc":[2],"a":"adult older","h":[38],"l":[[38,"lung"]],"po":"2025-06-15","u":"2025-06-15","st":"2024-09","ag":"18–85"},{"n":"NCT07060625","t":"The Effect of Semi-recumbent Position on Hypoxemia After Lung Segment/Lobe Surgery","s":"inv","p":"na","d":[4],"c":[5],"lc":[5],"a":"adult older","h":[56],"l":[[56,"lung"]],"po":"2025-07-11","u":"2025-07-11","st":"2024-12","ag":"18–85"},{"n":"NCT07186959","t":"EGPSS for Weight Management in an in Vivo Human Model","s":"inv","p":"na","d":[3],"c":[2],"lc":[2],"a":"adult older","h":[26],"l":[[26,"gc"]],"po":"2025-09-22","u":"2025-09-22","st":"2024-07","ag":"18–70"},{"n":"NCT07330882","t":"Health Behavior Management Program for Patients With Coronary Heart Disease","s":"inv","p":"na","d":[31],"c":[55],"lc":[55],"a":"adult older","h":[164],"l":[[164,"cad"]],"po":"2026-01-09","u":"2026-01-09","st":"2024-10","ag":"18–80"},{"n":"NCT07348575","t":"A Multicenter, Prospective, Randomized, Controlled Study of Decitabine in Combination With R-CHOP for Initial Treatment of EBV+ Diffuse Large B-cell Lymphoma","s":"inv","p":"phase3","d":[19],"c":[9],"lc":[9],"a":"adult older","h":[80],"l":[[80,"lymph"]],"po":"2026-01-16","u":"2026-01-16","st":"2024-07","ag":"18–75"},{"n":"NCT07359404","t":"Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC","s":"inv","p":"phase2","d":[6],"c":[2],"lc":[2],"a":"adult older","x":"female","h":[23],"l":[[23,"breast"]],"po":"2026-01-22","u":"2026-01-22","st":"2024-04","ag":"18 and over"},{"n":"NCT07450040","t":"Efficacy and Safety of Tislelizumab Combined With Gemcitabine and Peraspartase in the Treatment of Patients With Primary Stage I-II NK/T Cell Lymphoma","s":"inv","p":"na","d":[19],"c":[5],"lc":[5],"a":"adult older","h":[236],"l":[[236,"lymph"]],"po":"2026-03-04","u":"2026-03-04","st":"2024-09","ag":"18–70"},{"n":"NCT07859046","t":"18F-FES PET/CT in the Treatment Planning, and Response Assessment of ER-Positive Breast Cancer","s":"inv","p":"na","d":[6],"c":[8],"lc":[8],"a":"adult older","x":"female","h":[13],"l":[[13,"breast"]],"po":"2026-10-05","u":"2026-10-05","st":"2024-05","ag":"18–80"},{"n":"NCT07875335","t":"Fufang Tongluo Decoction as an Adjunct to Aspirin and Atorvastatin for Ischemic Moyamoya Disease","s":"inv","p":"na","d":[28],"c":[28],"lc":[28],"a":"adult","h":[78],"l":[[78,"moyamoya"]],"po":"2026-10-15","u":"2026-10-16","st":"2024-12","ag":"18–60"},{"n":"NCT07894640","t":"Clinical Safety and Efficacy Evaluation of the Blood-cooling and Stasis-removing Formula as an Adjunct to Atorvastatin in the Treatment of Hemorrhagic Moyamoya Disease.","s":"inv","p":"earlyphase1","d":[28],"c":[28],"lc":[28],"a":"adult","h":[78],"l":[[78,"moyamoya"]],"po":"2026-10-26","u":"2026-10-26","st":"2024-12","ag":"18–60"},{"n":"NCT07906652","t":"Clinical Evaluation of the Safety and Efficacy of \"Buyan Huan Wu Tang\" Combined With Atorvastatin in the Treatment of Atypical Pneumonia","s":"inv","p":"earlyphase1","d":[28],"c":[28],"lc":[28],"a":"adult","h":[78],"l":[[78,"moyamoya"]],"po":"2026-10-30","u":"2026-10-30","st":"2024-12","ag":"18–60"},{"n":"NCT07915193","t":"Application of Generative Artificial Intelligence in Perioperative Personalized Rehabilitation for Older Adults With Lung Cancer","s":"inv","p":"na","d":[4],"c":[2],"lc":[2],"a":"older","h":[74],"l":[[74,"lung"]],"po":"2026-11-04","u":"2026-11-04","st":"2024-10","ag":"65 and over"},{"n":"NCT05678933","t":"AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH","s":"inv","p":"phase3","d":[19],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lymph"]],"po":"2023-01-10","u":"2023-01-10","st":"2023-01","ag":"18–70"},{"n":"NCT06025305","t":"Identifying Vulnerable CoronAry PLaqUes With Artificial IntElligence-assisted CT Angiography","s":"inv","p":"na","d":[31],"c":[28],"lc":[28],"a":"adult older","h":[93],"l":[[93,"cad"]],"po":"2023-09-06","u":"2026-05-11","st":"2023-07","ag":"18 and over"},{"n":"NCT06028412","t":"Comparison of Sublobar and Lobectomy in Small (2 Cm or Less 0.5<CTR<1) Non-small Cell Lung Cancer: a Prospective, Multicenter Randomized Controlled Study","s":"inv","p":"na","d":[4],"c":[39],"lc":[39],"a":"adult older","h":[122],"l":[[122,"lung"]],"po":"2023-09-08","u":"2024-10-15","st":"2023-01","ag":"18–75"},{"n":"NCT06076252","t":"Modified vs Conventional Blumgart Anastomosis of LPD for the Effects of Pancreatic Fistula of Periampullary Carcinoma","s":"inv","p":"na","d":[5],"c":[45],"lc":[45],"a":"adult older","h":[129],"l":[[129,"panc"]],"po":"2023-10-10","u":"2023-10-10","st":"2023-07","ag":"18–75"},{"n":"NCT06160557","t":"A Clinical Study of Non-curative Resection Plus Radiotherapy After Endoscopic ESD for Superficial Esophageal Squamous Cell Carcinoma","s":"inv","p":"na","d":[1],"c":[16],"lc":[16],"a":"adult older","h":[148],"l":[[148,"escc"]],"po":"2023-12-07","u":"2024-01-03","st":"2023-11","ag":"18–75"},{"n":"NCT06258863","t":"Investigating the Effects of Different Incision Types on Aesthetic Outcomes and Incision-related Complications After Breast Reconstruction Surgery","s":"inv","p":"na","d":[6],"c":[13],"lc":[13],"a":"adult older","x":"female","h":[19],"l":[[19,"breast"]],"po":"2024-02-14","u":"2025-03-17","st":"2023-07","ag":"18 and over"},{"n":"NCT06281964","t":"Efficacy and Safety Evaluation of PLB1004 in Patients With Non-squamous NSCLC Harboring EGFR Exon 20 Insertion.","s":"inv","p":"phase3","d":[4],"c":[0],"a":"adult older","h":[43],"po":"2024-02-28","u":"2026-04-23","st":"2023-12","ag":"18 and over"},{"n":"NCT06481956","t":"T-DM1 Combined With CDK4/6 Inhibitor Ribociclib","s":"inv","p":"phase2","d":[6],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"breast"]],"po":"2024-07-01","u":"2024-07-01","st":"2023-10","ag":"18–75"},{"n":"NCT06616727","t":"The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM","s":"inv","p":"phase1","d":[7],"c":[2],"a":"adult older","h":[26],"po":"2024-09-27","u":"2024-09-27","st":"2023-12","ag":"18 and over"},{"n":"NCT06643858","t":"Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)","s":"inv","p":"na","d":[25],"c":[2],"lc":[2],"a":"child adult older","h":[102],"l":[[102,"nmosd"]],"po":"2024-10-16","u":"2025-12-30","st":"2023-12","ag":"6–90"},{"n":"NCT06776835","t":"Screening of Small Non-coding RNAs as an Auxiliary Diagnostic Biomarker for Gastric Cancer","s":"inv","p":"na","d":[3],"c":[40],"lc":[40],"a":"adult older","h":[110],"l":[[110,"gc"]],"po":"2025-01-15","u":"2025-01-15","st":"2023-12","ag":"18–85"},{"n":"NCT06816966","t":"Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC","s":"inv","p":"phase2","d":[4],"c":[16],"lc":[16],"a":"adult older","h":[140],"l":[[140,"lung"]],"po":"2025-02-10","u":"2025-02-10","st":"2023-12","ag":"18 and over"},{"n":"NCT07167459","t":"Personalized SBRT in Early-Stage Peripheral NSCLC","s":"inv","p":"phase2","d":[4],"c":[30],"lc":[30],"a":"adult older","h":[58],"l":[[58,"lung"]],"po":"2025-09-11","u":"2025-09-11","st":"2023-08","ag":"18 and over"},{"n":"NCT07362706","t":"Prolonged Extubation in Gastric Cancer With OSA","s":"inv","p":"na","d":[3],"c":[27],"lc":[27],"a":"adult older","h":[124],"l":[[124,"gc"]],"po":"2026-01-23","u":"2026-01-23","st":"2023-01","ag":"18–85"},{"n":"NCT06048926","t":"Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma","s":"inv","p":"na","d":[1],"c":[28],"lc":[28],"a":"adult older","h":[78],"l":[[78,"escc"]],"po":"2023-09-21","u":"2023-09-21","st":"2022-07","ag":"18–75"},{"n":"NCT06303583","t":"Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma","s":"inv","p":"phase1phase2","d":[1],"c":[23],"lc":[23],"a":"adult older","h":[44],"l":[[44,"escc"]],"po":"2024-03-12","u":"2024-03-12","st":"2022-06","ag":"18–75"},{"n":"NCT07299123","t":"Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA","s":"inv","p":"phase1phase2","d":[17],"c":[2],"lc":[2],"a":"child adult","h":[26],"l":[[26,"aa"]],"po":"2025-12-23","u":"2026-06-23","st":"2022-08","ag":"6–60"},{"n":"NCT04762459","t":"Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection","s":"inv","p":"phase3","d":[4],"c":[2,8,22,1,0,23,47,9,28,61,5,11,21,18,4,12,30,34,42,37,13,39,20],"a":"adult older","h":[40,23,42,9,43,38,25,5,12,111,24,127,13,54,47,79,14,81,135,18,215,98,106,169,72,114,116,84],"po":"2021-02-21","u":"2022-02-24","st":"2021-08","ag":"18–130"},{"n":"NCT05441475","t":"A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC Patients","s":"inv","p":"phase2","d":[2],"c":[13],"a":"adult older","h":[36],"po":"2022-07-01","u":"2026-02-25","st":"2021-12","ag":"18 and over"},{"n":"NCT06647836","t":"The Therapeutic Effect of Immunotherapy in Patients With Advanced Lung Squamous Carcinoma","s":"inv","p":"na","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lung"]],"po":"2024-10-18","u":"2024-12-12","st":"2021-01","ag":"18–80"},{"n":"NCT06730477","t":"Plasma Exosomes Reveal the Efficacy of Targeted Therapy in Patients With EGFR Mutation in Lung Adenocarcinoma","s":"inv","p":"na","d":[4],"c":[13],"lc":[13],"a":"adult older","h":[12],"l":[[12,"lung"]],"po":"2024-12-12","u":"2024-12-12","st":"2021-01","ag":"18–80"},{"n":"NCT06759857","t":"FHND9041 Versus Afatinib for Non-small Cell Lung Cancer","s":"inv","p":"phase3","d":[4],"c":[2],"a":"child adult older","h":[23],"po":"2025-01-06","u":"2025-01-06","st":"2021-08","ag":"18 months and over"},{"n":"NCT06685939","t":"The Differences of Complications Between LPD(Laparoscopic Pancreaticoduodenectomy) and OPD(Open Pancreaticoduodenectomy)","s":"inv","p":"na","d":[5],"c":[5],"lc":[5],"a":"adult older","h":[139],"l":[[139,"panc"]],"po":"2024-11-13","u":"2024-11-13","st":"2020-01","ag":"19 and over"},{"n":"NCT07052448","t":"The Efficacy of Sequential RT After Triple Therapy for uHCC","s":"inv","p":"na","d":[2],"c":[16],"lc":[16],"a":"adult older","h":[148],"l":[[148,"hcc"]],"po":"2025-07-04","u":"2025-07-04","st":"2020-11","ag":"18–75"},{"n":"NCT07410403","t":"AI-Based Fine Morphological Subtyping of Myeloma Single Cells for Predicting FISH Abnormalities","s":"inv","p":"na","d":[15],"c":[13],"lc":[13],"a":"child adult older","h":[133],"l":[[133,"mm"]],"po":"2026-02-13","u":"2026-02-13","st":"2018-08","ag":"Not stated"},{"n":"NCT02751060","t":"Evaluation of Plasma Non-coding RNAs as Biomarkers in Coronary Heart Disease","s":"inv","p":"na","d":[31],"c":[13],"lc":[13],"a":"adult older","h":[36],"l":[[36,"cad"]],"po":"2016-04-26","u":"2024-04-10","st":"2016-04","ag":"18 and over"},{"n":"NCT04210791","t":"Autologous Stem Cell Transplantation for Patients With AL Amyloidosis","s":"inv","p":"na","d":[15],"c":[28],"lc":[28],"a":"adult older","h":[93],"l":[[93,"mm"]],"po":"2019-12-26","u":"2024-02-26","st":"2010-07","ag":"18–75"}]}